date,open,high,low,close,volume,title,description,title_sentiment,desc_sentiment,daily_change_pct,market_sentiment,next_day_change_pct,next_day_sentiment
2017-12-14 18:01:08.843,858.5,868.95,855.45,861.0,3111309.0,Lupin gets USFDA nod for generic contraceptive tablets,"The company has received final approval from the US Food and Drug Administration (USFDA) to market Tydemy, which is a generic version of Bayer HealthCare Pharmaceuticals' Safyral Tablets, Lupin said in a statement.",neutral,positive,0.29120559114735,neutral,0.4566473988439358,neutral
2017-12-14 18:02:24.110,858.5,868.95,855.45,861.0,3111309.0,Lupin gets USFDA nod for generic contraceptive tablets,"The company has received final approval from the US Food and Drug Administration (USFDA) to market Tydemy, which is a generic version of Bayer HealthCare Pharmaceuticals' Safyral Tablets, Lupin said.",neutral,positive,0.29120559114735,neutral,0.4566473988439358,neutral
2017-12-20 13:00:42.247,878.45,885.5,876.05,880.0,1037846.0,"Top intraday trading ideas for afternoon trade for Wednesday, 20 December 2017",Lupin is a 'Buy' call with a target price of Rs 910 and a stop loss of Rs 870.,neutral,neutral,0.1764471512322789,neutral,-1.0227272727272727,negative
2017-12-20 13:01:55.496,878.45,885.5,876.05,880.0,1037846.0,"Buy Cummins India, Lupin, PVR, Camlin Fine: Prakash Gaba","Prakash Gaba of prakashgaba.com recommends buying Cummins India, Lupin, PVR and Camlin Fine Sciences.",neutral,neutral,0.1764471512322789,neutral,-1.0227272727272727,negative
2017-12-25 13:01:00.743,872.0,876.2,864.35,871.2,1381322.0,10 largecaps ruined your money even as BSE m-cap scaled Mt. 150 lakh cr mark,Data showed shares of Lupin have tumbled over 41 per cent this year.,neutral,negative,-0.0917431192660498,neutral,0.3493899994272242,neutral
2017-12-28 13:01:06.086,895.0,899.75,881.55,887.05,2587075.0,"Buy Lupin, NIIT Technologies, UPL: Sudarshan Sukhani","Sudarshan Sukhani of s2analytics.com is of the view that one may buy Lupin, NIIT Technologies and UPL.",neutral,neutral,-0.888268156424586,neutral,-0.4496908375491849,neutral
2017-12-29 13:01:46.777,895.0,899.75,881.55,887.05,2587075.0,Lupin rises 2% on USFDA approval for Calcipotriene Topical Solution,"Calcipotriene Topical Solution, 0.005% (Scalp Solution) had annual sales of approximately USD 5.9 million in the US, as per IMS MAT October 2017 data.",neutral,neutral,-0.888268156424586,neutral,-0.4496908375491849,neutral
2018-01-04 18:00:45.171,880.0,904.3,876.0,900.8,2687231.0,"For Lupin, uncertainties of FY18 would continue in FY19: Ramesh Swaminathan","“Biosimilars, complex generics and speciality would be key elements of Lupin strategy going forward”",neutral,neutral,2.3636363636363584,positive,1.776257722859667,positive
2018-01-05 18:00:15.693,880.0,904.3,876.0,900.8,2687231.0,Lupin launches generic anti-infection capsules in US,Lupin has launched its generic version of Ancobon tablets in the strengths of 250 mg and 500 mg after having received USFDA approval,neutral,neutral,2.3636363636363584,positive,1.776257722859667,positive
2018-01-10 18:00:51.646,929.65,934.95,925.65,928.7,908694.0,Lupin gets USFDA nod for generic version of Tamiflu capsules,"Lupin says it received approval from US Food and Drug Administration to market a generic version of Tamiflu capsules, used in treating influenza",neutral,positive,-0.1021889958586491,neutral,-1.5682062298603676,negative
2018-01-11 13:01:37.690,931.0,937.0,908.25,916.4,1289521.0,Lupin receives USFDA nod to market Tamiflu capsules to treat influenza,Oseltamivir phosphate capsules are indicated for the treatment of influenza,positive,neutral,-1.5682062298603676,negative,-0.5381019676051672,neutral
2018-01-15 18:00:23.506,920.0,924.0,905.0,908.0,959028.0,Jhunjhunwala stake in Lupin at record high! What he sold in Q3,Brokerage Prabhudas Lilladher expects a 6% sequential decline in Lupins sales in Dec qtr.,neutral,negative,-1.3043478260869563,negative,1.106828193832594,positive
2018-01-16 13:03:34.412,908.0,920.5,894.5,918.05,1477337.0,Lupin forays into OTC segment; eyes Rs300 crore turnover in 5 years,Lupin plans to come up with regular product launches every 3-4 months and aims to be present across all the major OTC product categories,neutral,neutral,1.106828193832594,positive,-0.3084916382529656,neutral
2018-01-17 13:00:42.907,923.85,926.7,918.0,921.0,2316523.0,Lupin forays into the domestic OTC drug market,"Pegged at over Rs 18,862 crore by a Nicholas Hall 2017 report, the Indian OTC market is expected to grow at a compounded annual growth rate (CAGR) of 9 percent to cross Rs 44,115 crore.",neutral,positive,-0.3084916382529656,neutral,-0.2162162162162162,neutral
2018-01-23 18:00:39.149,937.0,962.0,934.05,961.0,1969985.0,"Use variable pay as bigger talent differentiator, advise experts","In fact, the RPG Group, Lupin, Deloitte and many other companies are already changing the way variable payouts are positioned as an incentive.",positive,neutral,2.56136606189968,positive,-1.645962732919252,negative
2018-02-02 13:01:31.946,860.8,878.5,845.0,846.0,2522649.0,Company News: Lupin,Lupin on Thursday said it has received final nod from the US health regulator to market its Clobetasol Propionate cream used for the treatment of various skin conditions. The company has received fina,neutral,positive,-1.7193308550185822,negative,0.9489916963226572,positive
2018-02-06 18:01:47.580,796.0,813.0,782.9,804.4,5018524.0,Lupin Q3 net drops 64% YoY to Rs 309 crore,"Total revenue from operations stood at Rs 2,531.25 against Rs 3,295.52 crore last year.",negative,negative,1.055276381909545,positive,0.5062353376960147,neutral
2018-02-07 13:00:18.955,809.9,816.0,800.0,814.0,2053509.0,Lupin’s jt venture YL Biologics announces successful clincial trial outcome on biosimilar Etanercept,Drugmaker Lupin and Yoshindo’s joint venture YL Biologics has said that its late phase clinical studies on a biosimilar version of Etanercept (YLB113) has met with a successful outcome.The global Phas,positive,positive,0.5062353376960147,neutral,2.1766169154228856,positive
2018-02-07 18:01:06.746,809.9,816.0,800.0,814.0,2053509.0,Lupin's JV completes global trials for RA biosimilar,"The randomised trial of 52 weeks was conducted in 11 countries and included over 500 patients, Lupin said.",neutral,neutral,0.5062353376960147,neutral,2.1766169154228856,positive
2018-02-08 18:03:09.015,804.0,829.2,799.5,821.5,2762108.0,"Lupin to file application for biosimilar etanercept in EU, Japan in next quarter","YL Biologics, a JV of Lupin and Japanese firm Yoshindo, says phase-III trial of Etanercept met the primary endpoint and the product’s safety and immunogenicity was found to be similar to the reference drug Enbrel",neutral,neutral,2.1766169154228856,positive,1.4720077220077277,positive
2018-02-11 13:02:10.431,828.8,847.0,825.5,841.0,1778423.0,"Pharma weekly wrap: Lupin, Glenmark post nos; Singh brothers resign from Fortis board",The highlights of the week include resignation Malvinder and Shivinder Singh promoters of Fortis from the Board and Q3 results of some major pharmaceutical companies.,neutral,neutral,1.4720077220077277,positive,-2.554120214711258,negative
2018-02-12 13:00:56.104,828.8,847.0,825.5,841.0,1778423.0,"Lupin, Dr Reddy's, Glenmark and Taro see up to 40% decline in the US sales","Except a few, large pharmaceutical players see up to 40% decline in the US sales",negative,negative,1.4720077220077277,positive,-2.554120214711258,negative
2018-02-12 18:01:17.119,828.8,847.0,825.5,841.0,1778423.0,Lupin launches generic influenza treatment capsules in US,Drug firm Lupin launches its generic Oseltamivir Phosphate capsules used for treatment of influenza in the US market,neutral,positive,1.4720077220077277,positive,-2.554120214711258,negative
2018-02-21 18:01:20.121,813.0,815.45,796.9,801.1,1658327.0,Lupin gets USFDA nod to market generic Tamiflu,"Lupin has received a final approval to market its generic Oseltamivir Phosphate for oral suspension, used in influenza treatment, from USFDA, the company said",neutral,positive,-1.4637146371463687,negative,0.7782343419250404,neutral
2018-02-26 13:01:20.410,824.7,831.45,819.15,826.0,974265.0,"From insurance claim to Lupin diabetes drug, here are the key court orders",A weekly selection of key court orders,neutral,neutral,0.1576330786952776,neutral,-0.23061051098434,neutral
2018-02-27 13:00:17.228,823.9,828.9,815.1,822.0,880600.0,Lupin launches generic Axiron topical solution in US,"Lupin has launched Testosterone Topical Solution, 30 mg per actuation, in the US after receiving approval from the (USFDA), the company said in a filing to BSE",positive,positive,-0.23061051098434,neutral,-1.951219512195122,negative
2018-02-27 18:00:25.704,823.9,828.9,815.1,822.0,880600.0,"Pricing woes force Cipla, Glenmark, Lupin to go slow on US drug pipeline",Indian pharmaceutical companies focusing on selective product launches in US market. Companies focus on complex products as tough competition in generic impact markets.,neutral,neutral,-0.23061051098434,neutral,-1.951219512195122,negative
2018-03-05 13:01:09.082,792.0,795.0,768.6,771.0,2520369.0,"Lupin stock in 2017 global worst-performer list, says Evaluate report",US Food and Drug Administration's warning letters to two Lupin plants in Goa and Indore in November was the main reason for the decline in the stock price,negative,negative,-2.6515151515151514,negative,-1.2046632124352272,negative
2018-03-08 13:02:58.622,775.0,781.0,762.6,764.05,811381.0,Lupin rises 1%; signs agreement with CSIR-National Chemical,The company signed agreement with CSIR-National Chemical Laboratory and Department of Science and Technology for conducting research on a continuous purification process development of a biosimilar monoclonal antibody therapeutic.,positive,positive,-1.4129032258064576,negative,0.4557291666666667,neutral
2018-03-09 13:02:09.690,775.0,781.0,762.6,764.05,811381.0,"Lupin signs research pact with CSIR-NCL, Dept of Science & Tech","Pharma major Lupin has signed an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for conducting research on a continuous purifi",positive,positive,-1.4129032258064576,negative,0.4557291666666667,neutral
2018-03-13 18:01:39.972,779.9,786.8,778.5,781.5,694237.0,Lupin gets USFDA nod for contraceptive tablet 'Tydemy' for women,"The approved Tydemy tablets are generic equivalents of Bayer HealthCare Pharmaceuticals Inc's Safyral tablets, Lupin said",neutral,neutral,0.2051545069880783,neutral,-0.7682458386683738,neutral
2018-03-19 13:00:47.174,761.4,774.0,757.25,772.25,972026.0,Lupin rises 1% on USFDA approval for Desoximetasone topical spray,"Desoximetasone Topical Spray is the generic equivalent of Taro Pharmaceuticals USA Inc.'s Topicort Topical Spray, 0.25%.",neutral,neutral,1.4250065668505416,positive,-0.3822233739310614,neutral
2018-03-19 18:01:34.923,761.4,774.0,757.25,772.25,972026.0,Lupin gets USFDA nod for psoriasis treatment spray,"Drug major Lupin today said it has received approval from the US health regulator to market Desoximetasone Topical spray, used for treatment of plaque psoriasis, in the American market. It is a generi",neutral,positive,1.4250065668505416,positive,-0.3822233739310614,neutral
2018-03-26 18:01:52.940,742.8,752.8,742.8,750.0,941822.0,Lupin launches generic Lodosyn tablets in US,Lupin’s Lodosyn tablets is the generic version of Aton Pharma Inc.’s Lodosyn tablets in the same strength,positive,neutral,0.9693053311793276,positive,-1.8800000000000032,negative
2018-03-27 13:01:58.627,750.0,755.7,732.85,735.9,2215807.0,Lupin launches generic Lodosyn tablets in US for Parkinson's disease,The product is the generic version of Aton Pharma Inc's Lodosyn tablets in the same strength,positive,neutral,-1.8800000000000032,negative,4.795856595143603,positive
2018-04-02 13:00:17.925,772.15,799.0,766.35,787.8,2353290.0,Lupin’s Pithampur unit gets Health Canada clearance,"Lupin Ltd’s Pithampur unit 2 manufacturing facility located in Indore has been cleared by Health Canada after a review.“Following the review, Health Canada has maintained the compliant rating for unit",neutral,neutral,2.0268082626432657,positive,-1.893939393939394,negative
2018-04-03 13:01:20.879,792.0,796.3,771.1,777.0,1473489.0,UK health regulator completes inspection of Lupin’s Goa plant,"Lupin has said the UK health regulator has completed the inspection of its Goa facility without making any critical observations.In a BSE filing today, Lupin “announced the successful completion of th",neutral,positive,-1.893939393939394,negative,0.5619412515964212,neutral
2018-04-05 13:02:19.408,788.0,842.8,785.3,808.95,5613646.0,Lupin to go for restructuring of its domestic business in FY19,"During 2018-19, Lupin will add four new divisions to maintain a product and therapy-specific approach, with a special emphasis on chronic therapy which brings 57% of its revenue",neutral,positive,2.658629441624371,positive,-1.889355396394166,negative
2018-04-06 13:02:42.641,788.0,842.8,785.3,808.95,5613646.0,"Lupin receives EIR from USFDA for Pithampur facility, shares jump 7%","Lupin shares jump 7% after the company receives an EIR from the USFDA for its Pithampur, Unit 1 manufacturing facility in Madhya Pradesh",positive,positive,2.658629441624371,positive,-1.889355396394166,negative
2018-04-09 13:01:51.492,799.0,805.0,785.65,790.6,1130963.0,"Lupin stock gains on EIR from USFDA, but not out of the woods yet","While approvals will help it launch its drugs in the US market, clearance for its various units removes a potential overhang",positive,positive,-1.051314142678345,negative,-0.5113636363636307,neutral
2018-04-09 18:01:27.506,799.0,805.0,785.65,790.6,1130963.0,"We expect domestic business to grow at 15%: S Ramesh, Lupin",I expect the price erosion to continue in America in the first two quarters at least for the current year before it stabilises around 8-10%.,positive,negative,-1.051314142678345,negative,-0.5113636363636307,neutral
2018-04-16 13:01:16.126,795.1,809.0,795.1,804.8,2202344.0,"New products, over-the-counter business to fuel Glenmark's India growth","With growth of 8.6 per cent in the year ended March, Glenmark was the third-fastest among top 20 pharmaceutical companies, behind Lupin and Sanofi",positive,positive,1.2199723305244536,positive,-2.3518518518518463,negative
2018-04-17 13:01:47.856,810.0,813.05,787.5,790.95,1267138.0,Lupin Q4 PAT may dip 18.5% YoY to Rs. 309.8 cr: Edelweiss,"Net Sales are expected to decrease by 8.4 percent Y-o-Y (down 2 percent Q-o-Q) to Rs. 3,895.1 crore, according to Edelweiss.",neutral,negative,-2.3518518518518463,negative,-0.0252477434829176,neutral
2018-04-18 13:00:54.321,792.15,795.0,783.0,791.95,891114.0,USFDA nod for drug may buoy Lupin,"Lupin has received tentative approval for its Testosterone Gel, 1.62 per cent (20.25 mg/1.25 gm actuation) from the United States Food and Drug Administration to market a generic version of AbbVie Inc",neutral,positive,-0.0252477434829176,neutral,1.2594936708860816,positive
2018-04-19 13:01:43.321,790.0,801.6,785.1,799.95,1412158.0,Lupin showing signs of revival under its second-generation leadership team,But the going is still tricky,positive,neutral,1.2594936708860816,positive,1.739674593241549,positive
2018-04-23 18:01:51.636,815.85,832.95,814.0,819.4,2162337.0,Lupin gets USFDA nod to market Tetrabenazine tablets,Drug firm Lupin today said it has received approval from the US health regulator to market in America its Tetrabenazine tablets used for the treatment of involuntary movements associated with Huntingt,neutral,positive,0.4351290065575724,neutral,-0.1412429378531185,neutral
2018-05-07 10:03:05.457,785.0,787.0,763.0,774.6,1937240.0,Lupin slips 2%; Credit Suisse neutral on stock with over 9% fall,"Credit Suisse has maintained its neutral stance on the stock with a target cut to Rs 770 from Rs 850, implying a downside of over 9 percent.",positive,negative,-1.3248407643312072,negative,-1.124169647419514,negative
2018-05-07 13:01:42.222,782.8,786.8,772.5,774.0,1356353.0,Lupin slips 2% as Credit Suisse sees massive volume loss in diabetes franchise; sees 9% downside,"Credit Suisse has maintained its neutral stance on the stock with a target cut to Rs 770 from Rs 850, implying a downside of over 9 percent.",negative,negative,-1.124169647419514,negative,-1.432258064516132,negative
2018-05-08 10:02:31.592,782.8,786.8,772.5,774.0,1356353.0,"Stocks in the news: ICICI Bank, Pfizer, Lupin, Bharti Infratel, Unichem Labs, Jubilant Foodworks",ICICI Bank| Pfizer| Firstsource| Axis Bank| Balrampur Chini| Lupin| Unichem Labs| Bharti Infratel| One Life Capital| Hero MotoCorp| INOX Leisure are the stocks which are in news today.,neutral,neutral,-1.124169647419514,negative,-1.432258064516132,negative
2018-05-08 23:02:13.422,775.0,779.5,759.1,763.9,1054704.0,Biosimilar push may boost Lupin,Drug firm Lupin on Tuesday said its Japanese arm and YL Biologics have submitted a new drug application with the Japanese health regulator PMDA for marketing authorisation of a biosimilar of Etanercep,positive,positive,-1.432258064516132,negative,-1.3910658307210002,negative
2018-05-10 23:00:56.204,761.5,761.5,743.55,752.4,1184157.0,Lupin launches calcium supplement for women,"New Delhi, May 10 (PTI) Drug major Lupin today launched a calcium product for women, tapping into the country’s fast growing OTC market which is led by supplements.Corcal Bone and Beauty has been intr",neutral,positive,-1.1950098489822747,negative,0.0664451827242525,neutral
2018-05-14 13:00:21.714,755.0,773.0,723.65,763.9,5814076.0,USFDA completes inspection of Lupin's Nagpur plant,No observations were made following the inspection of the facility that manufactures oral solid products in the coastal state of Maharashtra.,neutral,neutral,1.1788079470198645,positive,2.162341982701264,positive
2018-05-14 23:01:36.468,755.0,773.0,723.65,763.9,5814076.0,"Focus on PNB, RCom, Syndicate Bank results","Britannia, Clariant Chemicals, CG Consumer, Dhanlaxmi Bank, Electrosteel Castings, Endurance Tech, INEOS Styrolution, JBM Auto, JHS Svendgaard, Jindal Poly, Lupin, Mangalam Cement, Monsanto, MRPL, PI",neutral,neutral,1.1788079470198645,positive,2.162341982701264,positive
2018-05-15 18:03:04.538,751.5,772.0,750.1,767.75,3122009.0,Lupin posts surprise Q4 loss at Rs784 crore on one-time charge,Lupin’s net loss for the fourth quarter came in at Rs784 crore compared with a profit of Rs380 crore a year earlier,negative,negative,2.162341982701264,positive,-0.6186909801367633,neutral
2018-05-16 10:00:11.978,751.5,772.0,750.1,767.75,3122009.0,Lupin shows signs of stabilization but growth triggers are still missing,"While there was a knee-jerk reaction that dragged the Lupin stock to a 52-week low, it quickly recovered when investors realized the core operating performance was fine",neutral,positive,2.162341982701264,positive,-0.6186909801367633,neutral
2018-05-16 18:01:40.677,767.75,771.8,754.5,763.0,1401447.0,"Asian Paints, Britannia Industries among stocks that hit 52-week highs on NSE","Hindustan Unilever, Lupin, ITC remained the top gainers in the Nifty index on Wednesday.",neutral,positive,-0.6186909801367633,neutral,-2.6963350785340348,negative
2018-05-17 10:00:49.755,767.75,771.8,754.5,763.0,1401447.0,Add  Lupin Ltd.  target Rs  815:   ICICI Direct,Add  Lupin Ltd.  at a price target of Rs  815.,neutral,positive,-0.6186909801367633,neutral,-2.6963350785340348,negative
2018-05-18 10:00:29.084,764.0,768.05,741.8,743.4,1183351.0,Good home show to help Lupin limit fallout of US woes,Indian pharmaceutical companies are facing regulatory issues and steep competition in US market.,neutral,negative,-2.6963350785340348,negative,-1.141859215475551,negative
2018-05-21 18:01:11.663,735.0,745.45,725.2,742.1,1076826.0,Hold Lupin; target of Rs 785: KR Choksey,"KR Choksey recommended hold rating on Lupin with a target price of Rs 785 in its research report dated May 17, 2018.",neutral,positive,0.9659863945578264,positive,-1.4761137949543746,negative
2018-05-25 13:00:27.583,743.05,747.35,733.1,745.0,1428214.0,"Top intraday trading ideas for afternoon trade for Friday, 25 May 2018",Lupin  is a 'Buy' call with a target price of Rs 775 and a stop loss of Rs 725.,neutral,neutral,0.2624318686494913,neutral,4.622073578595312,positive
2018-05-27 18:02:18.658,747.5,785.95,747.5,782.05,2529081.0,"Nonsense to think a business is dead, they do come back: Shankar Sharma","In India, there are many examples of companies turning around such as Jindals and Lupin.",neutral,neutral,4.622073578595312,positive,-0.3194888178913738,neutral
2018-05-29 10:03:18.652,782.5,798.9,768.95,780.0,2600071.0,"From Sun Pharma to Lupin, pharma stocks rally on quarterly show",Companies put up stellar performance in Indian as well as US markets,positive,positive,-0.3194888178913738,neutral,1.1948051948052008,positive
2018-05-30 10:01:17.495,770.0,790.4,770.0,779.2,1231441.0,Pharmaceutical companies offering freebies may come under GST lens,"The tax heads of firms such as Novartis India, Sun Pharma, Cipla, Lupin have been summoned for meetings with tax officials, they said.",neutral,neutral,1.1948051948052008,positive,-1.2675966622077897,negative
2018-05-31 18:02:41.321,770.75,781.9,761.6,764.45,1296446.0,Lupin hire Nicholas Hart to head US business,"His past experiences include Business Unit Head for Reproductive Health at Ferring Pharmaceuticals, Inc and Senior Vice President of Sales and Marketing at URL Pharma.",neutral,neutral,-0.817385663314947,neutral,1.0760401721664274,positive
2018-06-01 10:01:22.629,770.75,781.9,761.6,764.45,1296446.0,Lupin appoints Nicholas Hart as head of specialty biz in US,"Hart will be based in Baltimore, Maryland in the US, and will report to Gupta",neutral,neutral,-0.817385663314947,neutral,1.0760401721664274,positive
2018-06-04 18:01:56.729,775.45,778.4,745.1,763.0,1360980.0,Lupin launches generic drug in US,Lupin’s product is the generic equivalent of Novartis Pharmaceuticals Corp.’s Methergine which is indicated for prevention and control of postpartum hemorrhage,positive,neutral,-1.6055193758462885,negative,1.3092105263157956,positive
2018-06-08 13:00:37.657,764.8,824.0,763.05,808.4,4901392.0,Pharma shares in focus as Nifty Pharma index rises 2%,"Sun Pharma, Cadila Healthcare, Dr Reddy's Laboratories, Cipla, Glenmark Pharma and Lupin from the Nifty Pharma index were up in the range of 2% to 3% on the NSE.",positive,positive,5.700836820083685,positive,-0.2466091245376079,neutral
2018-06-10 13:02:09.557,811.0,829.9,804.3,809.0,3442718.0,"Complex generics, biosimilars & specialty to be growth drivers: Lupin","While sustaining and growing its presence in the generics segment, Lupin is planning to invest heavily in developing high barrier products in complex generics, the presentation said.",neutral,positive,-0.2466091245376079,neutral,5.638036809815956,positive
2018-06-13 18:00:17.484,877.95,904.5,863.2,903.0,6598585.0,Lupin launches generic antibiotic inhalation solution in US,"Lupin ’s Tobramycin Inhalation Solution USP, 300 mg/5 ml, is the generic version of Novartis Pharmaceuticals Corporation’s Tobi 300 mg/5 ml",neutral,neutral,2.85323765590295,positive,-0.1373626373626373,neutral
2018-06-14 18:32:36.894,910.0,924.5,901.25,908.75,8147868.0,Lupin gets USFDA approval for generic contraceptive drug,The company has received final approval from the USFDA to market its product which is a generic version of Bayer HealthCare Pharmaceutical Inc's Beyaz tablets.,positive,positive,-0.1373626373626373,neutral,-0.5654369784804543,neutral
2018-06-15 10:00:29.676,910.0,924.5,901.25,908.75,8147868.0,"Stocks in the news: ICICI Bank, Maruti, Lupin, Wipro, TNPL, Blue Star, Punj Lloyd, Thomas Cook",ICICI Bank| Maruti| Lupin| Wipro| TNPL| Blue Star| Punj Lloyd| Thomas Cook are the stocks which are in news today.,neutral,neutral,-0.1373626373626373,neutral,-0.5654369784804543,neutral
2018-06-17 13:00:37.638,910.8,917.0,887.2,905.65,3501085.0,Lupin expects single digit sales growth this fiscal,"The drug maker reported negative growth in 2017-18 for the first time in a decade, with net sales dropping to Rs 15,560 crore, a decline of 9 per cent from 2016-17.",positive,negative,-0.5654369784804543,neutral,-0.0997782705099753,neutral
2018-06-17 23:01:54.698,910.8,917.0,887.2,905.65,3501085.0,Lupin expects single digit sales growth in 2018-19,"Lupin, however, is anticipating double-digit sales growth in Latin America, South Africa and India",positive,positive,-0.5654369784804543,neutral,-0.0997782705099753,neutral
2018-06-18 10:00:33.818,910.8,917.0,887.2,905.65,3501085.0,Stock market prediction for June 18-22: Satish Gupta,"Lupin, Ajanta Pharma, Alembic Pharma, Glenmark Pharma, Aurobindo Pharma and Sun Pharmaceutical Industries will get astrological support, says Satish Gupta of astrostocktips.",neutral,positive,-0.5654369784804543,neutral,-0.0997782705099753,neutral
2018-06-18 13:01:13.409,902.0,921.0,894.05,901.1,4718875.0,"Lupin, Nichi-Iko tie up for commercialization of biosimilar Etanercept in Japan","Mumbai based Lupin pharma and Japan's Nichi-Iko have tied up for the distribution, promotion and sale of Lupins recently-filed biosimilar Etanercept in Japan.",positive,positive,-0.0997782705099753,neutral,-0.9216844196699622,negative
2018-06-19 10:00:56.753,902.0,921.0,894.05,901.1,4718875.0,"Lupin, Japan’s Nichi-Iko tie up to distribute biosimilar drug",Lupin’s recently filed biosimilar Etanercept will be launched by Nichi-Iko in Japan after receiving approval from the Japanese pharma regulator,positive,neutral,-0.0997782705099753,neutral,-0.9216844196699622,negative
2018-06-22 13:00:51.481,898.0,909.3,881.65,904.0,3658643.0,Lupin aims to be numero uno in biosimilar etanercept in Japan,It takes 12-13 months for the Japanese drug authorities to give product approvals.,neutral,neutral,0.6681514476614699,neutral,1.1496794163166015,positive
2018-06-24 23:01:16.304,904.6,920.0,904.15,915.0,3539254.0,Lupin to launch nearly 30 products in US market in FY18,The drug firm is banking on the introduction of complex generics and biosimilars in the US to maintain its top five position in the market.,positive,positive,1.1496794163166015,positive,-1.8431671938052108,negative
2018-06-25 10:01:35.287,904.6,920.0,904.15,915.0,3539254.0,Lupin to launch nearly 30 products in US market this fiscal,The Mumbai-based company currently has 162 abbreviated new drug applications (ANDAs) pending approval with the US Food and Drug Administration (USFDA).,positive,positive,1.1496794163166015,positive,-1.8431671938052108,negative
2018-06-26 10:00:50.180,916.9,921.6,899.55,900.0,2305980.0,Lupin Pharmaceuticals eyes the next wave of growth in Japanese market,Lupin's Japan story assumes significance as it held on to the highly regulated market when most of its Indian peers quit,positive,neutral,-1.8431671938052108,negative,-1.2851761577664549,negative
2018-06-27 10:02:23.122,902.6,907.4,877.6,891.0,2799760.0,"Despite positives, pharma major Lupin not a re-rating candidate","Analysts continue to be cautious, given the USFDA's warning letter to its plants at Goa and Indore, resolution of which is necessary to improve growth visibility",neutral,negative,-1.2851761577664549,negative,0.4700089525514695,neutral
2018-06-28 13:02:58.150,903.8,913.8,893.6,906.0,2412292.0,Lupin-Mylan team up for biosimilar Etanercept,"Under the terms of the agreement, Lupin will receive an up-front payment of $15 million and potential commercial milestones together with an equal share in net profits of the product.",neutral,neutral,0.2434166851073296,neutral,-1.9347705914870093,negative
2018-06-28 18:02:32.856,903.8,913.8,893.6,906.0,2412292.0,Mylan to commercialise Lupin’s etanercept biosimilar,"Under the terms of the agreement, Lupin will receive an upfront payment of $15 million and potential commercial milestones together with an equal share in net profits of the product",neutral,neutral,0.2434166851073296,neutral,-1.9347705914870093,negative
2018-07-04 13:00:32.151,940.0,946.2,920.0,921.3,3040069.0,Lupin hits over four month high; stock rises 5% in two days,"In past one month, Lupin has outperformed the market by surging 23% as compared to 1.4% rise in the S&P BSE Sensex.",positive,positive,-1.989361702127664,negative,-0.7865046647862877,neutral
2018-07-09 18:01:16.864,919.9,921.0,900.0,902.9,1836977.0,Lupin gets USFDA nod for generic malaria drug,"Drug firm Lupin today said it has received approval from the US health regulator for Hydroxychloroquine Sulfate tablets, which is used to treat malaria. The company has received final approval from th",neutral,positive,-1.8480269594521144,negative,-0.6589147286821756,neutral
2018-07-10 18:02:24.854,903.0,914.4,895.5,897.05,2590205.0,Lupin appoints Yashwant Mahadik as Global HR President,"Drug firm Lupin today said it has appointed Yashwant Mahadik as President, Global Human Resources. Mahadik will be based in Mumbai and will report to Lupin CEO Vinita Gupta and its Managing Director N",neutral,neutral,-0.6589147286821756,neutral,-2.0909392631928285,negative
2018-07-11 13:00:25.271,903.9,906.4,881.7,885.0,1814330.0,"Lupin, Boehringer Ingelheim to co-market two oral anti-diabetic drugs in India",Drug major Lupin today said it has expanded its collaboration with Germany’s Boehringer Ingelheim for co-marketing two oral anti-diabetic drugs in India.The two new oral anti-diabetics drugs -- Gibtul,neutral,positive,-2.0909392631928285,negative,-2.480270574971815,negative
2018-07-12 18:00:51.658,887.0,892.65,862.8,865.0,1880289.0,Lupin gets USFDA nod to market antibacterial capsules,"Lupin has received final approval from the US health regulator to market its antibacterial Nitrofurantoin capsules used for treating urinary tract infections. According to a company statement, Lupin w",neutral,positive,-2.480270574971815,negative,-5.88235294117647,negative
2018-07-16 13:00:22.631,821.0,831.5,810.35,828.0,2381431.0,Lupin gets UK health regulator’s approval for Goa facility,"Pharma major Lupin today said it has received approval from the UK health regulator for its Goa facility. Lupin in a regulatory filing said, “it has received approval from UK MHRA (United Kingdom’s Me",positive,positive,0.8526187576126675,neutral,-1.1280487804878048,negative
2018-07-18 18:02:20.581,813.75,814.7,787.15,799.0,2613397.0,Lupin Q1 PAT may dip 2.9% YoY to Rs. 347.5 cr: Kotak,"Net Sales are expected to increase by 6.1 percent Y-o-Y (up 1.7 percent Q-o-Q) to Rs. 4,104.2 crore, according to Kotak.",neutral,positive,-1.812596006144393,negative,0.2002628449840301,neutral
2018-07-19 10:00:17.110,813.75,814.7,787.15,799.0,2613397.0,"Rakesh Jhunjhunwala ups stake in Lupin & JP Associates, cuts Titan holding in June quarter","Only 15 of nearly 30 companies in Jhunjhunwala’s portfolio released their shareholding data for the quarter-ended June till now. Of the 14 companies, only two have delivered positive returns.",negative,neutral,-1.812596006144393,negative,0.2002628449840301,neutral
2018-07-19 18:01:56.820,798.95,802.4,792.5,800.55,3229661.0,Lupin gets USFDA nod for generic erectile dysfunction drug,The product is a generic version of Eli Lilly and the company's Cialis tablets in the same strengths.,neutral,neutral,0.2002628449840301,neutral,-0.49813200498132,neutral
2018-07-24 18:01:42.627,822.9,823.05,790.0,797.0,1810181.0,Lupin CSR arm to adopt 3 backward districts,"Taking the aspirational districts programme a notch further, government think tank Niti Aayog on Tuesday signed a statement of intent with Lupin’s corporate social responsibility (CSR) arm.Lupin Human",neutral,positive,-3.1474055170737607,negative,2.1642306003387493,positive
2018-07-27 18:01:18.137,818.0,825.7,810.5,817.2,1671116.0,Lupin launches plaque psoriasis treatment spray in US market,"Quoting IQVIA MAT May 2018 data, Lupin said Desoximetasone Topical Spray, 0.25 per cent, had annual sales of approximately USD 18.7 million in the US.
",positive,neutral,-0.0977995110024394,neutral,0.6438557763061075,neutral
2018-07-30 18:00:45.632,825.0,830.0,815.0,822.8,2215865.0,Lupin gets EDQM nod for its Mandideep facility,The inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with facility inspection for Quality Management Systems ,neutral,neutral,-0.2666666666666721,neutral,2.296830495121513,positive
2018-07-31 10:01:07.449,825.0,830.0,815.0,822.8,2215865.0,"Top trading ideas by Anand Rathi Research: Buy Sun Pharma, Lupin, M&M","Nifty outlook and top trading ideas by Jay Anand Thakkar, CMT -Assistant Vice President - Equity Research, Anand Rathi Research.",neutral,neutral,-0.2666666666666721,neutral,2.296830495121513,positive
2018-08-02 13:00:57.746,870.0,895.8,863.4,885.55,4130753.0,"D-Street Buzz: Auto, PSU banks underperform dragged by Hero Moto, PNB; Lupin top gainer, Venkys zooms 15%","The breadth of the market favoured declines, with 510 stocks advancing, 1079 declining and 471 remaining unchanged. On BSE, 691 stocks advanced, 1103 declined and 75 remained unchanged.",neutral,positive,1.7873563218390751,positive,-2.2975685924604083,negative
2018-08-02 13:01:17.538,870.0,895.8,863.4,885.55,4130753.0,"Sun Pharma, Divis Lab, Ajanta Pharma, Lupin, Wockhrdt to get astrological support: Satish Gupta","Sun Pharma, Divis Lab, Ajanta Pharma, Lupin and Wockhrdt will get astrological support, says Satish Gupta of astrostocktips.",neutral,positive,1.7873563218390751,positive,-2.2975685924604083,negative
2018-08-02 18:00:27.522,870.0,895.8,863.4,885.55,4130753.0,Pharma shares in focus; Nifty Pharma index hits 6-month high,"Divi's Lab, Aurobindo Pharma, Lupin, Dr Reddy's Lab, Sun Pharma, Glenmark Pharma and Cipla from the Nifty pharma index were up in the range of 1% to 3% on the NSE.",neutral,positive,1.7873563218390751,positive,-2.2975685924604083,negative
2018-08-03 10:01:23.842,870.0,895.8,863.4,885.55,4130753.0,"Top trading ideas by Anand Rathi Research: Buy Max India, Lupin","Nifty outlook and top trading ideas by Jay Anand Thakkar, CMT -Assistant Vice President - Equity Research, Anand Rathi Research.",neutral,neutral,1.7873563218390751,positive,-2.2975685924604083,negative
2018-08-06 13:00:37.576,877.4,890.0,856.6,867.9,2699237.0,"Talking stock: Hold Ruchi Soya, Glenmark, Lupin","You may hold Ruchi Soya for now, but sell if the stock comes close to your cost price as the company is making huge losses.",neutral,neutral,-1.082744472304536,negative,-5.29316898974773,negative
2018-08-07 23:00:14.751,868.1,884.8,818.55,822.15,13269404.0,"Cipla, Indian Bank, HCC, Lupin, 8K Miles results","Over 175 companies including 8K Miles, 20 Microns, AB Capital, Asahi Songwon, Balrampur Chini, BEML, BPCL, Blue Star, Cipla, City Union Bank, EID Parry, Emami Infra, Forbes, Future Consumer, Goodyear,",neutral,neutral,-5.29316898974773,negative,1.5884743258219405,positive
2018-08-08 13:00:13.322,812.1,844.0,804.45,825.0,9868685.0,Lupin Q1 preview: Net profit to narrow marginally despite low base in India biz,A Reuters poll of analyst forecasts drop in net profit to Rs 347.6 crore,positive,negative,1.5884743258219405,positive,-2.035623409669206,negative
2018-08-08 18:00:21.741,812.1,844.0,804.45,825.0,9868685.0,"Lupin Q1 profit down 43%, misses estimates","Lupin’s net profit was Rs 203 crore in the quarter ended 30 June, compared with a profit of Rs 358 crore a year earlier",negative,positive,1.5884743258219405,positive,-2.035623409669206,negative
2018-08-09 10:00:36.297,812.1,844.0,804.45,825.0,9868685.0,"Weak US sales take toll on Lupin Q1 performance, stock slides 4.5%","North America sales fall by a quarter, indicating intense pricing pressures",neutral,negative,1.5884743258219405,positive,-2.035623409669206,negative
2018-08-09 13:01:17.418,825.3,827.9,806.0,808.5,4010508.0,"Lupin Q1 Results: Brokerages Give A Thumbs Down To Lupin On Poor Q1, Credit Suisse Downgrades","Brokerages were disappointed with Lupin Ltd.’s weak financials in the April-June period, especially in the U.S. markets which dropped below the $200 million per quarter revenue mark and margins hit a multi-year low of 14 percent.",neutral,negative,-2.035623409669206,negative,1.0565568676196395,positive
2018-08-10 10:00:44.237,825.3,827.9,806.0,808.5,4010508.0,Lupin Q1 result points to a tough year ahead,"The decline in Lupin’s Q1 result can be attributed to lower share of sales of some of its key generic products, including TamiFlu as the flu season is now over",negative,negative,-2.035623409669206,negative,1.0565568676196395,positive
2018-08-20 13:02:21.258,872.0,891.9,865.0,889.15,3425388.0,Talking stock: Lupin a better bet than Sun Pharma,Lupin can move up faster than Sun Pharma from the current levels.,positive,positive,1.9667431192660525,positive,0.1108647450110864,neutral
2018-08-21 13:01:23.184,872.0,891.9,865.0,889.15,3425388.0,Lupin gets USFDA nod for atopic dermatitis treatment lotion,"Drug major Lupin today said it has received final approval from the United States Food and Drug Administration (USFDA) to market Hydrocortisone Butyrate lotion, used for the treatment of mild atopic d",neutral,positive,1.9667431192660525,positive,0.1108647450110864,neutral
2018-08-22 23:01:33.581,902.0,917.8,890.0,903.0,4995824.0,"Lupin recalls over 11,000 bottles of hypertension drug in US","The product being recalled by Lupin Pharmaceuticals Inc is in the strength of 10mg, the US health regulator said in an Enforcement Report.",neutral,neutral,0.1108647450110864,neutral,0.287356321839083,neutral
2018-08-23 10:01:37.201,902.0,917.8,890.0,903.0,4995824.0,Lupin gets USFDA approval for generic oral contraceptive tablets,"The company's product, which is an estrogen/progestin combined oral contraceptive indicated for use by women to prevent pregnancy",positive,neutral,0.1108647450110864,neutral,0.287356321839083,neutral
2018-08-23 18:02:02.729,904.8,914.7,885.5,907.4,3446415.0,Lupin enters prescription dermatology segment in Brazil,"Valued at USD 28 billion, Brazil is the world's sixth largest pharmaceutical market, driven by growing public health expenditure and increasing household income. 
",neutral,neutral,0.287356321839083,neutral,-0.1967643200699557,neutral
2018-08-24 18:01:37.498,904.8,914.7,885.5,907.4,3446415.0,Lupin gets ‘positive’ inspection report from USFDA for Nagpur facility,"The plant in Nagpur was inspected by the United States Food and Drug Administration (USFDA) in May 2018, Lupin said in a filing to BSE",positive,neutral,0.287356321839083,neutral,-0.1967643200699557,neutral
2018-08-27 18:01:12.423,913.0,918.7,898.0,903.05,1771666.0,Lupin launches contraceptive drug in US market,"Lupin has launched Drospirenone, Ethinyl Estradiol and Levomefolate Calcium tablets and and Levomefolate Calcium tablets used to prevent pregnancy, in the US market. According to a BSE filing, the com",positive,neutral,-1.0898138006571791,negative,-1.5384615384615334,negative
2018-08-28 18:02:23.939,897.0,905.45,883.0,883.2,2676415.0,JSW Steel To Replace Lupin In Nifty 50 From Sept. 28,"JSW Steel Ltd. will replace Lupin Ltd. in the benchmark NSE Nifty 50 Index. JSW Steel will join Tata Steel Ltd., the only other steelmaker on the index, according to a press release by the National Stock Exchange. ",neutral,neutral,-1.5384615384615334,negative,1.2146892655367232,positive
2018-08-28 18:02:41.831,897.0,905.45,883.0,883.2,2676415.0,Lupin gets USFDA nod to market its postherpetic neuralgia drug,"The company's tablets are generic version of Pfizer Inc's Neurontin tablets in the same strengths, Lupin said.",neutral,neutral,-1.5384615384615334,negative,1.2146892655367232,positive
2018-08-29 10:00:54.733,897.0,905.45,883.0,883.2,2676415.0,JSW Steel to replace pharma firm Lupin in Nifty 50 from September 28,"The inclusion of JSW Steel is expected to boost the steelmaker's stock, given that several exchange-traded funds (ETFs) track the Nifty index",neutral,positive,-1.5384615384615334,negative,1.2146892655367232,positive
2018-08-29 13:00:35.949,885.0,900.0,880.0,895.75,2412788.0,"JSW Steel hits 52-week high, Lupin falls 2% after NSE announces rejig of Nifty","The Nifty Midcap 50 index also underwent some changes as Adani Power, Biocon, Engineers India, IDFC and PC Jeweller will be replaced with Cummins India, Jubilant Foodworks, Power Finance Corporation, Punjab National Bank and Rural Electrification Corporation.",neutral,neutral,1.2146892655367232,positive,3.869313113291709,positive
2018-08-29 13:01:15.505,885.0,900.0,880.0,895.75,2412788.0,JSW Steel hits record high; to replace Lupin in Nifty50,"Shares of JSW Steel Ltd jumped as much as 3.66 per cent to a record high of Rs 379.60.According to NSE Indices, the company will replace drugmaker Lupin Ltd in the Nifty 50 index from September 28. Mo",positive,positive,1.2146892655367232,positive,3.869313113291709,positive
2018-08-30 10:02:15.434,885.0,900.0,880.0,895.75,2412788.0,"'BUY' or 'SELL' ideas from experts for Thursday, 30 August 2018",Lupin is a 'Sell' call with a target price of Rs 875 and a stop loss of Rs 895.,neutral,neutral,1.2146892655367232,positive,3.869313113291709,positive
2018-08-30 10:02:40.562,885.0,900.0,880.0,895.75,2412788.0,Fall in Lupin post Nifty exit may be a chance to accumulate stock,"Lupin has gained over 50 per cent in absolute terms since its inclusion in the Nifty in September 2012.
",positive,positive,1.2146892655367232,positive,3.869313113291709,positive
2018-08-31 13:00:23.067,896.8,939.8,895.75,931.5,6883690.0,"D-Street Buzz: IT & pharma stocks outperform with Tech Mahindra, Lupin up 3%; RIL falls 2%","Abbott, Divis Labs, Glenmark Pharma, Godrej Consumer, Infosys, ITC, Sun Pharma and Whirlpool are some of the few stocks which have hit new 52-week high in the afternoon trade.",positive,neutral,3.869313113291709,positive,-0.0533902829684997,neutral
2018-08-31 18:00:31.115,896.8,939.8,895.75,931.5,6883690.0,Lupin gets USFDA nod for generic potassium chloride oral solution,Drug firm Lupin today said it has received approval from the US health regulator to sell its potassium chloride oral solution used for the treatment of low potassium levels in the American market.The,neutral,positive,3.869313113291709,positive,-0.0533902829684997,neutral
2018-09-03 13:00:13.370,941.0,944.6,908.0,917.6,3291967.0,Lupin hits more than 7-mth high; technicals suggest further upside,"
Trend Intensity (TI) indicator is up at 21, suggesting prices are trending upwards. MACD is also positive and above its signal line.",positive,positive,-2.4867162592986163,negative,-1.1688879178501128,negative
2018-09-04 10:00:38.389,941.0,944.6,908.0,917.6,3291967.0,What should be your strategy for Lupin and JSW Steel after Nifty50 rejig?,"JSW Steel's profit in Q1FY19 rose nearly four-fold to Rs 2,366 crore from Rs 626 crore in year-ago period, backed by higher realisations and strong volume growth.",neutral,positive,-2.4867162592986163,negative,-1.1688879178501128,negative
2018-09-04 13:02:12.618,915.4,926.5,895.2,904.7,3294701.0,Lupin gets USFDA observation for Tarapur facility,"The US health regulator has issued one observation after the completion of inspection at Lupin’s Tarapur facility in Maharashtra.“The inspection closed with one observation, a procedural deficiency. T",neutral,neutral,-1.1688879178501128,negative,1.033421284080912,positive
2018-09-06 18:02:22.011,920.0,962.7,906.8,960.9,8388376.0,"Lupin to train over 1,000 graduates for pharma industry",Mumbai-headquartered Lupin has estimated that by the year 2020 they would be spending almost Rs 20 crore on this programme.,neutral,neutral,4.445652173913041,positive,-1.9689119170984457,negative
2018-09-12 18:02:41.885,939.0,963.15,922.0,961.45,4139040.0,Lupin's pneumonia drug Atovaquone oral suspension receives USFDA approval,"As per IQVIA MAT June 2018 data, Atovaquone oral suspension, 750 mg/5 mL had annual sales of around $117.4 million in the US",neutral,neutral,2.3908413205537853,positive,-1.0165314714036324,negative
2018-09-12 23:01:19.096,939.0,963.15,922.0,961.45,4139040.0,Lupin gets booster nod from USFDA,Lupin on Wednesday said it has received nod from the US Food and Drug Administration to market its Atovaquone oral suspension in the strength of 750 mg/5 mL. The product is a generic version of GlaxoS,neutral,neutral,2.3908413205537853,positive,-1.0165314714036324,negative
2018-09-14 13:02:52.170,973.9,981.5,962.05,964.0,4036166.0,"Nifty Pharma index rises 2% as Sun Pharma, Lupin receive USFDA approval",Sun Pharma rose over 3 per cent to an intra-day high of Rs 670.90 on the NSE after the drug maker announced USFDA approval of XELPROS to treat open-angle Glaucoma or Ocular Hypertension.,positive,positive,-1.0165314714036324,negative,-0.8294642391361099,neutral
2018-09-17 10:02:47.209,958.45,978.0,945.55,950.5,2574295.0,"Lupin, Dr Reddy's Labs, Wipro, Tech Mahindra will get astrological support for the week: Satish Gupta","Pharma stocks like Glenmark Pharma,   Strides Pharma, Lupin, Ajanta Pharma, Dr Reddy’s Labs will get astrological support, says Satish Gupta of astrostocktips.",neutral,positive,-0.8294642391361099,neutral,-2.3020450970110167,negative
2018-09-17 18:00:59.336,953.5,963.15,926.4,931.55,2381671.0,Lupin Confident Of Meeting U.S. Sales Forecast For This Year,Lupin Ltd. is confident of meeting its $800-850 million U.S. sales forecast for the ongoing financial year on the back of new launches.,neutral,positive,-2.3020450970110167,negative,-2.798656644810491,negative
2018-09-18 23:01:27.962,937.95,939.6,901.6,911.7,3615984.0,Can Alok Sonig bring the mojo back to Lupin's US generics business?,The company said Sonig will lead and have overall responsibility for the US generics business including Research & Development in India and the US and the Commercial side of the business in the US.,neutral,neutral,-2.798656644810491,negative,-2.658186562296144,negative
2018-09-21 18:01:26.880,919.8,931.5,853.6,895.35,4483640.0,Exclusive | How Lupin plans to counter dwindling sales growth in Japan,"Even as the company faces another price cut in Japan, Lupin looks to rationalise costs, shift manufacturing units and looks at non-Japanese markets to continue growth

",positive,positive,-2.658186562296144,negative,-3.984375000000005,negative
2018-09-28 10:02:45.528,898.35,918.0,882.0,904.0,4432063.0,JSW Steel gains nearly 2% as co replaces Lupin in Nifty 50 index,"The NSE announced the exclusion of Lupin from the Nifty index, while it will be replaced with JSW Steel on the benchmark 50-share index.",positive,neutral,0.6289308176100603,neutral,-0.9441775716415388,negative
2018-10-01 18:00:47.255,905.55,905.55,879.5,897.0,2128950.0,Lupin inks pact to distribute Eli Lilly’s diabetes injection in India,Drug major Lupin on Monday announced a partnership with Eli Lilly and Company (India) to distribute Eli Lilly’s diabetes injection Aplevant in the country. Lupin said the expansion of the business par,positive,positive,-0.9441775716415388,negative,-0.1114827201783723,neutral
2018-10-04 23:01:44.965,851.0,866.55,830.0,834.0,2351103.0,Lupin launches potassium chloride oral solution in US,"The firm had earlier received approval for the product from the United States Food and Drug Administration (USFDA), it said in a statement.

",neutral,positive,-1.99764982373678,negative,1.574850299401195,positive
2018-10-05 13:02:10.755,851.0,866.55,830.0,834.0,2351103.0,"Stocks To Watch: Cadila Healthcare, Jet Airways, Lupin, United Spirits ","The S&P BSE Sensex and the NSE Nifty 50 Index fell more than 2 percent to 35,169.16 and 10,599.25, respectively. The Indian rupee slumped to a fresh low of 73.58 against the U.S. dollar, raising fears of a widening current account deficit.",neutral,negative,-1.99764982373678,negative,1.574850299401195,positive
2018-10-09 18:00:45.897,874.95,885.0,855.0,861.0,2150745.0,Lupin launches skin ointment in US,It has annual sales of around USD 93.4 million in the US market,neutral,neutral,-1.594376821532664,negative,-0.8333333333333334,neutral
2018-10-12 18:01:49.742,841.0,853.0,836.05,846.0,1554255.0,Lupin Q2 PAT may dip 51.2% YoY to Rs. 222.2 cr: ICICI Direct,"Net Sales are expected to increase by 2 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs. 4,032.1 crore, according to ICICI Direct.",neutral,positive,0.5945303210463734,neutral,4.681978798586572,positive
2018-10-14 18:01:25.557,849.0,892.45,849.0,888.75,2995125.0,Exploring ways to establish presence in China as part of APAC region push: Lupin,"The Mumbai-based firm expects to generate revenues of over USD 100 million from the region, excluding the Japanese market, over the next few years.",neutral,positive,4.681978798586572,positive,0.5061867266591676,neutral
2018-10-15 13:00:39.000,889.0,911.05,889.0,893.5,2573432.0,"Pharma shares in focus; Dr Reddy's, Biocon, Lupin, Natco Pharma up over 3%","Nifty Pharma index, the largest gainer among sectoral indices, was up 1.7% as compared to 0.17% decline in Nifty 50 index at 09:36 am.",positive,positive,0.5061867266591676,neutral,-0.5555555555555556,neutral
2018-10-15 13:01:56.106,889.0,911.05,889.0,893.5,2573432.0,"Top intraday trading ideas for afternoon trade for Monday, 15 October 2018","Lupin is a 'Buy' call with a target price of Rs 910 and a stop loss of Rs 850.
",neutral,neutral,0.5061867266591676,neutral,-0.5555555555555556,neutral
2018-10-16 10:00:57.100,889.0,911.05,889.0,893.5,2573432.0,"Rakesh Jhunjhunwala Tweaks Positions In DHFL, SpiceJet And Lupin","Jhunjhunwala buys more DHFL, SpiceJet, sells Lupin.",neutral,neutral,0.5061867266591676,neutral,-0.5555555555555556,neutral
2018-10-17 23:02:46.312,900.0,909.35,885.0,895.0,1608312.0,Lupin Q2 PAT may dip 59.1% YoY to Rs. 190 cr: HDFC Securities,"Net Sales are expected to decrease by 2.9 percent Y-o-Y (down 0.4 percent Q-o-Q) to Rs. 3,840 crore, according to HDFC Securities.",neutral,negative,-0.5555555555555556,neutral,-1.0135135135135136,negative
2018-10-19 10:00:16.223,888.0,905.8,859.2,879.0,2572885.0,Icertis doubles down on APAC business driven by India; to scale revenues to 20% in 3-5 years,"The firm which counts IT giants like Infosys, Wipro, Genpact, Cognizant as also Lupin and Mindtree amongst its clients in India is looking to widen its clientele in the country.",neutral,positive,-1.0135135135135136,negative,-0.1864406779660991,neutral
2018-10-21 23:00:05.903,885.0,893.45,876.2,883.35,1526244.0,"Lupin to develop Brazil as Latin American manufacturing, export hub",Most neighbouring countries recognise the Brazilian drug regulator's approvals,neutral,neutral,-0.1864406779660991,neutral,-3.1727112775980526,negative
2018-10-22 18:01:46.886,880.95,880.95,848.05,853.0,1653797.0,Lupin gets USFDA nod for generic skin treatment ointment,"The company has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Mylan Pharmaceuticals Inc's Triamcinolone Acetonide Ointment, Lupin said in a statement.",neutral,positive,-3.1727112775980526,negative,1.0408139398900689,positive
2018-10-22 23:00:26.001,880.95,880.95,848.05,853.0,1653797.0,Company news: Lupin,"Lupin on Monday said it has received an approval from the US Food and Drug Administration to market its Triamcinolone Acetonide ointment, used to treat skin conditions, in the US. The drug is a generi",neutral,positive,-3.1727112775980526,negative,1.0408139398900689,positive
2018-10-30 13:02:07.891,879.6,914.9,867.55,880.0,4916858.0,"Tata Motors, Divi’s, Lupin among 127 stocks ready to rally, shows MACD","The only silver lining is that Nifty50 is defending the 10,000 mark strongly. 
",neutral,positive,0.0454752160072734,neutral,-2.7599999999999976,negative
2018-10-31 10:01:06.047,879.6,914.9,867.55,880.0,4916858.0,"Stocks in the news: Coal India, Tata Motors, Vedanta, Lupin and Tech Mahindra",Here's a look at the top stocks that may hog the limelight in today's session.,neutral,neutral,0.0454752160072734,neutral,-2.7599999999999976,negative
2018-10-31 18:01:13.615,875.0,880.25,848.1,850.85,2608805.0,"Lupin Q2 net profit falls, misses estimates","Lupin’s net profit was Rs 266 crore in the quarter ended Sept. 30, compared with a profit of Rs 455 crore a year earlier",negative,positive,-2.7599999999999976,negative,-1.2237762237762235,negative
2018-11-01 10:00:16.474,875.0,880.25,848.1,850.85,2608805.0,Lupin's Q2 net profit falls 41% to Rs 2.66 bn as sales slip in US,Net profit  stood at Rs 2.68 billion compared to Rs 4.53 billion in the year-ago period,negative,positive,-2.7599999999999976,negative,-1.2237762237762235,negative
2018-11-01 18:00:39.428,858.0,864.0,845.1,847.5,1360527.0,Lupin falls 2.6% on weak results,"Shares of Lupin Ltd, India's second-largest drugmaker by revenue, fell as much as 2.6 per cent to Rs 862.2, in their biggest daily percentage drop in over a week.The company&rsquo;s Q2 net profit plun",negative,negative,-1.2237762237762235,negative,0.4766388136989472,neutral
2018-11-01 18:01:57.880,858.0,864.0,845.1,847.5,1360527.0,Lupin still on track to meet $800-million FY19 sales target:  Ramesh Swaminathan,"
Things not as bad as they were in the past and should be looking better, says Lupin CFO.",positive,neutral,-1.2237762237762235,negative,0.4766388136989472,neutral
2018-11-04 13:00:09.426,849.7,860.65,843.0,853.75,1224736.0,"Lupin recalls 6,752 bottles of Testosterone topical solution from US",The product is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.,neutral,neutral,0.4766388136989472,neutral,1.1548306446812229,positive
2018-11-05 18:00:37.897,839.95,856.4,839.0,849.65,1369310.0,Lupin gets USFDA nod to market generic injection for kidney disease,The product is a generic version of Sanofi Genzyme's Hectorol injection,neutral,neutral,1.1548306446812229,positive,-0.3040935672514647,neutral
2018-11-12 10:01:58.383,858.0,876.8,853.1,859.25,1950651.0,"Lupin to Cipla, pharma firms on course to shed 'underperformer' tag in FY19","Easing of pricing pressures, launch of limited competition drugs in the US, weak rupee are key triggers",neutral,negative,0.1456876456876457,neutral,-0.7269555103227682,neutral
2018-11-12 13:00:57.995,859.75,865.6,847.0,853.5,1001215.0,Lupin gets EIR from USFDA for its Nagpur facility,USFDA gives EIR on closure of inspection of an establishment that is the subject of an FDA or FDA-contracted inspection. ,neutral,neutral,-0.7269555103227682,neutral,-2.0745920745920694,negative
2018-11-13 18:02:33.039,858.0,860.3,831.1,840.2,1465183.0,Lupin gets USFDA nod for Asthma drug,"Quoting IQVIA MAT September data, Lupin said, the said Asthma drug had annual sales of around USD 474.5 million in the US. 
",neutral,neutral,-2.0745920745920694,negative,1.3674197384066586,positive
2018-11-15 13:02:35.588,857.9,869.9,855.45,862.0,1154477.0,Lupin gains 1% on USFDA approval to Decitabine for Injection,"Decitabine is a generic version of Otsuka's Dacogen for Injection, 50 mg/vial, Single-Dose Vial.",positive,neutral,0.4779111784590305,neutral,-1.370967741935481,negative
2018-11-15 18:01:09.631,857.9,869.9,855.45,862.0,1154477.0,Lupin gets USFDA nod for myelodysplastic syndrome drug,"Lupin has received approval from the US health regulator to market Decitabine for Injection, used for the treatment of myelodysplastic syndrome. The company has received approval from the United State",neutral,positive,0.4779111784590305,neutral,-1.370967741935481,negative
2018-11-21 13:00:43.654,852.0,855.9,844.5,850.25,961448.0,Lupin launches generic of Xenazine in US,"The company had received approval from the United States Food and Drug Administration (USFDA) earlier this year to market the drug in the strengths of 12.5 mg and 25 mg tablets, Lupin said in a BSE filing.",positive,positive,-0.2053990610328638,neutral,-0.7050528789659225,neutral
2018-11-21 18:01:24.302,852.0,855.9,844.5,850.25,961448.0,Lupin gains 1% on generic Tetrabenazine tablets launch in US,Tetrabenazine is indicated for the treatment of chorea associated with Huntington's disease.,positive,neutral,-0.2053990610328638,neutral,-0.7050528789659225,neutral
2018-11-22 23:00:05.771,852.0,855.9,844.5,850.25,961448.0,"Sensex rejig: Wipro, Adani Ports to move out; HCL Tech, Bajaj Fin to enter","Bharti Infratel, Lupin and Hindustan Petroleum Corporation will be excluded from the Sensex 50 index and these firms will be replaced by Bajaj Finserv, Britannia Industries and JSW Steel",neutral,neutral,-0.2053990610328638,neutral,-0.7050528789659225,neutral
2018-11-26 18:01:31.405,849.0,857.7,842.0,849.75,1956135.0,Lupin gets USFDA nod for antidepressant drug,"The capsules are indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD), Lupin said.",neutral,neutral,0.0883392226148409,neutral,4.182692307692302,positive
2018-11-27 10:01:51.507,849.0,857.7,842.0,849.75,1956135.0,"Stocks in the news: Lupin, Future Retail, Sun Pharma, IFCI, Jet Airways and PSU banks",Here's a list of stocks which may hog limelight ni today's session:,neutral,neutral,0.0883392226148409,neutral,4.182692307692302,positive
2018-11-27 23:00:23.189,832.0,870.0,830.0,866.8,4458475.0,"Lupin CFO quits, to pursue opportunities outside pharma","Swaminathan as the CFO of Lupin, was part of some of company's biggest mergers and acquisition in US and Japan",neutral,neutral,4.182692307692302,positive,-0.3114186851211125,neutral
2018-11-28 10:00:43.345,832.0,870.0,830.0,866.8,4458475.0,"Stocks To Watch: Lupin, IDBI Bank, Inox Wind, Reliance Capital",Indian equity benchmarks rebounded from day’s low. ,neutral,positive,4.182692307692302,positive,-0.3114186851211125,neutral
2018-11-30 18:01:07.427,870.0,891.6,866.0,881.3,2418712.0,Lupin launches skin-treatment cream in US,"The company has launched the product after having received approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in a regulatory filing.",neutral,neutral,1.2988505747126384,positive,2.0021431391348488,positive
2018-11-30 18:02:57.944,870.0,891.6,866.0,881.3,2418712.0,Lupin rises 2% after launch of skin infection treatment cream in US,Lupin's drug is the generic equivalent of Taro Pharmaceuticals' Nystatin and Triamcinolone Acetonide Cream.,positive,neutral,1.2988505747126384,positive,2.0021431391348488,positive
2018-12-04 23:00:12.142,888.0,889.8,848.0,858.7,3255391.0,Lupin launches generic prostate gland drug in US,"Drug firm Lupin on Tuesday said it has launched generic Silodosin capsules, used for treatment of signs and symptoms of benign enlargement of the prostate gland, in the US market. The company has laun",positive,positive,-3.2995495495495444,negative,-0.5809859154929631,neutral
2018-12-05 10:00:44.273,888.0,889.8,848.0,858.7,3255391.0,"Kesoram Industries, Tata Motors and Lupin among top stocks to track",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,-3.2995495495495444,negative,-0.5809859154929631,neutral
2018-12-05 18:01:09.582,852.0,869.0,845.4,847.05,1719916.0,USFDA makes 22 observations post inspection of Lupin's Mandideep facilities,"Lupin said the observations are ""largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalosporin API block” and the company is confident of addressing them satisfactorily.",neutral,neutral,-0.5809859154929631,neutral,-1.6705744431418523,negative
2018-12-10 18:01:18.216,803.0,842.0,802.3,836.0,2003706.0,Lupin gets EIR from USFDA for Pithampur facility unit,"Lupin's Pithampur facility manufactures dermatological products, dry product inhalers, and metered dose inhalers.",neutral,neutral,4.10958904109589,positive,-1.547192353643972,negative
2018-12-11 10:02:14.038,803.0,842.0,802.3,836.0,2003706.0,Lupin receives approval from USFDA for generic Apixaban tablets,The product is a generic version of Bristol-Myers Squibb Company's Eliquis tablets in the same strengths,positive,neutral,4.10958904109589,positive,-1.547192353643972,negative
2018-12-11 10:02:16.905,803.0,842.0,802.3,836.0,2003706.0,"Titagarh Wagons, Lupin and GMR Infra among top stocks to watch",Here's a look at the top stocks that may remain in focus in today's trading session -,neutral,neutral,4.10958904109589,positive,-1.547192353643972,negative
2018-12-13 10:00:35.496,815.0,855.0,806.2,852.5,4846999.0,"Lupin, PSU bank stocks and Punjab & Sind Bank among top stocks to track",Here's a look at the top stocks that may hog the limelight in today's session -,neutral,neutral,4.601226993865031,positive,-0.828534492889876,neutral
2018-12-13 10:02:10.352,815.0,855.0,806.2,852.5,4846999.0,European court upholds fine against drugmakers Lupin and Unichem,A total fine of 315 million Euros have been upheld on six companies.,positive,positive,4.601226993865031,positive,-0.828534492889876,neutral
2018-12-13 13:02:09.537,850.9,857.0,830.5,843.85,2701335.0,EU Court upholds 40-mn euro fine on Lupin over Perindopril litigation,Drug maker Lupin on Wednesday said a court in Europe has upheld a decision to impose a fine of 40 million euros (over Rs 325 crore) on the company by the European Commission (EC) in a litigation over,positive,positive,-0.828534492889876,neutral,-0.2063679245283018,neutral
2018-12-17 18:01:34.762,846.35,848.5,836.8,845.7,891852.0,Lupin gets USFDA nod for generic Tadalafil tablets,"Lupin on Monday said it has received tentative approval from the US health regulator for Tadalafil tablets, used to treat erectile dysfunction and enlarged prostate, in the American market. The compan",neutral,positive,-0.0768003780941664,neutral,-0.3537735849056604,neutral
2018-12-24 13:01:06.496,874.0,876.85,832.2,835.55,3541326.0,"Lupin partners with AbbVie to develop, commercialise novel oncology drug","Additionally, Lupin will be entitled to receive a double-digit royalty on the sales of the product and will retain commercial rights to the programme in India, the company added.",neutral,positive,-4.39931350114417,negative,0.5555555555555582,neutral
2018-12-24 23:00:56.819,874.0,876.85,832.2,835.55,3541326.0,"After Market: Realty, tyre stocks skid; Lupin, ACC below 200-DMAs","ICICI Bank, Apollo Tyres,  Maruti, Ceat, PVR and Bajaj Auto showed bearish crossovers on BSE. ",neutral,negative,-4.39931350114417,negative,0.5555555555555582,neutral
2018-12-26 10:02:03.356,828.0,840.4,817.05,832.6,1439853.0,Lupin falls 2% as PhillipCapital sees 20% downside on likely weak Q3 earnings,PhillipCapital expects company's Q3FY19 earnings to remain weak and estimates 22 percent YoY decline in earnings.,negative,negative,0.5555555555555582,neutral,0.2449223416965298,neutral
2018-12-28 23:00:33.522,841.0,852.0,836.8,837.65,1132998.0,"After Market: 78 stocks giving bullish signals; Lupin, ACC above 200-DMAs","The BSE Midcap and Smallcap indices settled 0.93 per cent and 0.86 per cent up, respectively.",positive,positive,-0.3983353151010728,neutral,-0.1536643026004674,neutral
2018-12-31 23:00:58.393,848.7,852.7,839.0,842.0,1122538.0,Lupin gets USFDA nod for oral suspension drug to treat seizures,"Drug maker Lupin Monday said it has received approval from the US health regulator for Clobazam Oral Suspension, used to treat seizures associated with Lennox-Gastaut Syndrome. The company has receive",neutral,positive,-0.7894426770354713,neutral,-1.187648456057007,negative
2019-01-01 10:00:38.352,848.7,852.7,839.0,842.0,1122538.0,"Stocks in the news: HDFC, Lupin, JMC Projects, Axis Bank and Indiabulls Real Estate",Here are a few stocks which may buzz the most in todays session.,neutral,neutral,-0.7894426770354713,neutral,-1.187648456057007,negative
2019-01-01 10:01:26.985,848.7,852.7,839.0,842.0,1122538.0,"Lupin, JMC Projects and Fortis Healthcare among top stocks to track",Here's a look at the top stocks that are likely to remain in focus today -,neutral,neutral,-0.7894426770354713,neutral,-1.187648456057007,negative
2019-01-01 18:01:57.604,842.0,847.0,826.05,832.0,1115133.0,"ICICI Bank, HCL Tech, Lupin among 63 stocks ready to rally, shows MACD","The technical indicator has signalled an upward crossover, meaning a bullish signal.",positive,positive,-1.187648456057007,negative,-1.7822966507177007,negative
2019-01-04 13:00:10.733,824.0,832.0,820.3,828.5,1279060.0,"Credit Suisse expects strong Q3 quarter for Aurobindo, Torrent Pharma, Cadila","For Lupin, Credit Suisse sees margin improving but weak Tamiflu season could be an overhang.",positive,negative,0.5461165048543689,neutral,-1.636592530423833,negative
2019-01-07 18:00:27.742,823.8,843.75,821.15,840.3,1404068.0,Lupin gets USFDA nod for generic schizophrenia drug,"Drug maker Lupin on Monday said it has received approval from the US health regulator to market Lurasidone Hydrochloride tablets, used in the treatment of schizophrenia, in the American market.The com",neutral,positive,2.002913328477786,positive,-0.8767772511848314,neutral
2019-01-08 13:00:08.327,844.0,844.9,830.05,836.6,927559.0,Lupin gets European Commission nod for myotonia drug,"Lupin on Tuesday said the European Commission (EC) has approved its product NaMuscla, used for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NOM) disorders. Non-dystrop",neutral,positive,-0.8767772511848314,neutral,-0.155390867798239,neutral
2019-01-08 18:02:53.426,844.0,844.9,830.05,836.6,927559.0,Lupin gets European Commission nod for myotonia treatment drug,"Lupin said it is preparing for the launch of NaMuscla, which will occur in the initial markets of Germany and the UK in the first quarter of 2019. 
",neutral,neutral,-0.8767772511848314,neutral,-0.155390867798239,neutral
2019-01-09 18:00:17.060,836.6,842.9,833.5,835.3,736811.0,"Lupin recalls over 23,000 bottles of antibiotic drug in US","Drug major Lupin is recalling over 23,000 bottles of an antibiotic drug in the US for being sub-potent, US Food and Drug Administration (USFDA) said.",neutral,negative,-0.155390867798239,neutral,-0.1788908765652951,neutral
2019-01-11 23:02:13.571,838.5,842.0,828.1,837.0,824225.0,Lupin Q3 PAT seen up 20.7% YoY to Rs. 267.1 cr: ICICI Direct,"Net Sales are expected to increase by 0.4 percent Y-o-Y (up 1 percent Q-o-Q) to Rs. 3,991 crore, according to ICICI Direct.",positive,positive,-0.1788908765652951,neutral,-0.50131296252088,neutral
2019-01-13 13:02:06.442,837.8,840.95,828.5,833.6,921943.0,"Lupin developing new products to treat cancer, other diseases","Sharing details, Kamboj said the the Mumbai-based company is currently working on developing various products, including two major ones to treat chronic kidney diseases and lung cancer. ",positive,neutral,-0.50131296252088,neutral,1.6736401673640169,positive
2019-01-15 23:01:38.039,850.4,865.5,845.1,860.6,1681018.0,"After Market: Lupin, ACC above 200-DMAs; 91 stocks look bullish",Tuesday's gains boosted the cumulative m-cap of BSE-listed firms by Rs 1.52 lakh crore.,positive,positive,1.1994355597365998,positive,0.1621027036415188,neutral
2019-01-20 13:00:07.987,857.0,879.7,857.0,870.9,1709908.0,"Lupin, Sun Pharma, Glenmark Recall Products In The U.S.","Indian drugmakers Lupin, Sun Pharma, and Glenmark  are recalling various drugs from the U.S. market for a variety of reasons.",neutral,negative,1.6219369894982472,positive,-0.115473441108545,neutral
2019-01-20 18:00:28.310,857.0,879.7,857.0,870.9,1709908.0,"Lupin, Sun Pharma, Glenmark recall products in US","Indian drug majors Lupin, Sun Pharma and Glenmark Pharmaceuticals are recalling various drugs from the US market for a variety of reasons.As per the latest Enforcement Report published by the US Food",neutral,negative,1.6219369894982472,positive,-0.115473441108545,neutral
2019-01-20 23:01:30.734,857.0,879.7,857.0,870.9,1709908.0,"Stocks To Watch: HDFC Bank, Kotak Mahindra Bank, L&T, Lupin, Wipro",Here are the stocks to watch in trade today.,neutral,neutral,1.6219369894982472,positive,-0.115473441108545,neutral
2019-01-21 18:00:46.326,866.0,872.4,851.0,865.0,1257970.0,Lupin gets USFDA nod to market hypothyroidism treatment drug,The tablets are also indicated as an adjunct to surgery and radioiodine therapy,neutral,neutral,-0.115473441108545,neutral,-0.115473441108545,neutral
2019-01-22 10:00:34.766,866.0,872.4,851.0,865.0,1257970.0,"Prabhat Dairy, Asian Paints, Lupin and Justdial among top stocks to track",Here's a look at the top stocks that may remain in focus in today's session -,neutral,neutral,-0.115473441108545,neutral,-0.115473441108545,neutral
2019-01-24 18:00:16.823,870.0,879.4,855.1,865.0,1344907.0,Lupin's specialty drug Solosec gains traction in US on rising prescriptions,"Lupin expects the drug to hit peak sales of $100-$150mn over next 3-4 years, making it a big contributor.",positive,positive,-0.5747126436781609,neutral,1.866572454807752,positive
2019-01-27 10:01:06.117,849.15,870.65,844.3,865.0,2415674.0,Lupin gets 6 observations from USFDA for its Pithampur Unit-2,"The inspection of Pithampur Unit -2 was carried out by the United States Food and Drug administration (USFDA) between January 14 and January 25, 2019.
",neutral,neutral,1.866572454807752,positive,-0.1505152251939409,neutral
2019-01-28 13:02:25.421,863.7,875.0,855.0,862.4,1468790.0,Lupin falls 2% as USFDA after inspection issues 6 observations to Pithampur unit,"The inspection was carried out between January 14 and January 25, 2019.",neutral,neutral,-0.1505152251939409,neutral,0.7781649245063932,neutral
2019-02-01 23:00:25.389,879.7,888.0,870.3,881.0,1032159.0,"Lupin’s new launch in Germany, UK eyed","Lupin on Friday launched NaMuscla, an orphan drug used for the treatment of myotonia in adults, in Germany and the United Kingdom. An orphan drug is a synthetic pharmaceutical, which remains commercia",neutral,positive,0.1477776514720875,neutral,-3.7884364913075537,negative
2019-02-03 18:01:31.335,882.95,888.65,848.85,849.5,1351213.0,"Lupin recalls over 24,000 bottles of skin treatment drug from US","The reason for the recall is failed impurities or degradation specifications, it added.",negative,negative,-3.7884364913075537,negative,-2.308591466978376,negative
2019-02-05 18:01:54.918,838.0,851.5,805.0,847.5,6428360.0,Lupin launches generic antidepressant drug in US,The product is a generic version of SP ECGX LLC's Anafranil capsules in the same strengths.,neutral,neutral,1.133651551312649,positive,-1.0997596153846128,negative
2019-02-06 10:00:08.874,838.0,851.5,805.0,847.5,6428360.0,"Tech Mahindra, Cipla, Lupin and Jubilant FoodWorks may hog the limelight",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,1.133651551312649,positive,-1.0997596153846128,negative
2019-02-06 13:01:41.150,832.0,844.55,810.4,822.85,3613377.0,Lupin Q3 results today: Here's what experts say,"According to an ET Now poll, the drug maker is likely to report a 7 per cent YoY jump in net sales.",neutral,positive,-1.0997596153846128,negative,1.551094890510949,positive
2019-02-06 18:00:30.428,832.0,844.55,810.4,822.85,3613377.0,"Lupin reports Rs 152 crore Q3 loss on one-time hit from European suit; sales rise 12% to Rs 4,378 crore",​Analysts in an ET Now poll had projected a profit of Rs 268 crore.,positive,neutral,-1.0997596153846128,negative,1.551094890510949,positive
2019-02-07 10:01:17.500,832.0,844.55,810.4,822.85,3613377.0,"Lupin registers tepid growth in India revenues, US sales remain subdued","While the actual Dec quarter revenue was much more than estimates, the same was due to higher licensing income",positive,positive,-1.0997596153846128,negative,1.551094890510949,positive
2019-02-07 13:00:12.346,822.0,836.3,805.1,834.75,2050681.0,Lupin falls nearly 4% after poor Q3 show,Brokerage Credit Suisse has maintained 'Underperform' view on the stock with a target price at Rs 800 per share.,neutral,positive,1.551094890510949,positive,-0.1825928180158247,neutral
2019-02-12 23:00:51.667,816.0,820.0,782.55,790.85,2905140.0,Company news: Lupin,Lupin on Tuesday said it has launched generic Tadalafil tablets in the US market used for the treatment of pulmonary arterial hypertension. The company has launched the tablets in the strength of 20 m,neutral,positive,-3.082107843137252,negative,1.967089086438437,positive
2019-02-13 23:01:51.591,793.05,812.0,790.5,808.65,1848531.0,"Delhi HC sets aside govt ban on Lupin FDC, refers matter back to Drug Board","Govt had in September 2018 banned 344 FDC drugs, including Lupin's combo for diabetics, citing lack of therapeutic justification",neutral,neutral,1.967089086438437,positive,-4.326328800988875,negative
2019-02-15 18:00:25.449,809.0,809.95,767.1,774.0,2938240.0,Lupin launches seizures drug in US,"The company has launched its Clobazam oral suspension 2.5mg/mL after having received approval from the United States Food and Drug Administration (USFDA) earlier, Lupin said in a statement.

",neutral,neutral,-4.326328800988875,negative,-0.6554427451484414,neutral
2019-02-18 10:01:21.497,778.1,785.0,760.5,773.0,2332182.0,"Late Flu Surge In U.S. To Help Lupin, Cadila Healthcare And Natco Pharma","Flu season usually ends mid-February, but this time influenza is widespread in 30 U.S. states causing a shortage of medications.",neutral,neutral,-0.6554427451484414,neutral,-1.7783505154639117,negative
2019-02-18 13:00:44.355,776.0,776.0,761.1,762.2,1381730.0,"Prefer niche pharma cos to those in generic space: Devang Mehta, Centrum Wealth","
We have stayed underweight on Sun Pharma, Lupin and Dr Reddys, says Mehta",neutral,positive,-1.7783505154639117,negative,-0.4046997389033973,neutral
2019-02-21 18:00:17.466,771.95,782.65,767.05,774.5,1503176.0,"Lupin recalls 43,860 bottles of ophthalmic solution in US","Drug maker Lupin is recalling 43,860 bottles of Moxifloxacin Ophthalmic solution, used to treat bacterial conjunctivitis, in the US market.The Mumbai-based drug firm is recalling 43,860 bottles (3ml)",neutral,negative,0.3303322754064323,neutral,-0.2570694087403599,neutral
2019-02-22 23:01:27.030,771.95,782.65,767.05,774.5,1503176.0,Delhi HC sets aside govt ban on Lupin's anti-diabetic drug Gluconorm-30,"Government had in 2018 banned Lupin's anti-diabetic drug Gluconorm-30, used to control diabetes",neutral,neutral,0.3303322754064323,neutral,-0.2570694087403599,neutral
2019-02-25 18:00:14.310,777.0,781.0,764.1,774.2,1302425.0,Lupin gets USFDA nod for anti-inflammatory drug,Drug firm Lupin on Monday said it has received approval from the US health regulator to market Methylprednisolone tablets used for treatment of inflammation in many conditions.The company has received,neutral,positive,-0.3603603603603545,neutral,-1.6709511568123392,negative
2019-02-26 10:01:01.899,777.0,781.0,764.1,774.2,1302425.0,"Stocks in the news: Britannia, HPCL, DHFL, Lupin, Thermax, Jet Airways and Bharti Airtel","Meanwhile, Thermax announced acquiring of the remaining stake in JV Thermax SPX Energy. ",neutral,neutral,-0.3603603603603545,neutral,-1.6709511568123392,negative
2019-02-28 13:01:00.864,771.2,790.55,768.45,790.55,2349159.0,Lupin launches chronic angina treatment drug in the US,"The newly launched product, in strengths of 500 mg and 1,000 mg, is a generic version of Gilead Sciences' Ranexa ER tablets, Lupin said.",positive,neutral,2.509076763485465,positive,-0.8022234855662825,neutral
2019-03-05 13:00:18.834,786.0,794.6,781.05,786.9,1395250.0,"EIL, Dabur, Lupin, DRL, CESC among 74 stocks signalling bullishness in MACD",The MACD is known for signalling trend reversal in traded securities or indices.,positive,negative,0.1145038167938902,neutral,0.5076142131979695,neutral
2019-03-06 10:01:09.907,786.0,794.6,781.05,786.9,1395250.0,"Stocks in the news: Lupin, ITC, Wipro, Reliance Capital, YES Bank and Inox Leisure","Meanwhile, Blue Star has announced appointment of Shailesh Haribhakti as its chairman. ",neutral,neutral,0.1145038167938902,neutral,0.5076142131979695,neutral
2019-03-06 23:01:01.354,788.0,803.5,785.3,792.0,1852357.0,"Natco, Lupin get USFDA nod",Natco Pharma Ltd announced the final approval of Abbreviated New Drug Application (ANDA) for Imatinib Mesylate tablets from the US Food and Drug Administration (USFDA). The tablets will be marketed in,neutral,positive,0.5076142131979695,neutral,-2.744704850231856,negative
2019-03-07 23:01:29.057,797.9,799.8,775.35,776.0,1970976.0,Lupin gets USFDA nod to market its cholesterol lowering drug  Atorvastatin ,The tablets are indicated to lower cholesterol in blood for adults and children over 10 years of age.The product is a generic version of Pfizer Inc's Lipitor tablets in the same strengths,neutral,neutral,-2.744704850231856,negative,1.7994364754098449,positive
2019-03-08 10:00:09.445,797.9,799.8,775.35,776.0,1970976.0,"Stocks in the news: Sun Pharma, Tata Motors, Lupin, L&T Finance and Wipro"," Meanwhile, RIL has leased 4,000 acres of land from NMSEZ to develop a global economic hub.",neutral,neutral,-2.744704850231856,negative,1.7994364754098449,positive
2019-03-14 10:00:26.597,757.6,782.0,755.5,765.95,3896228.0,"Stocks in the news: Lupin, DHFL, Mindtree, Wipro, Zee and Jet Airways",Kedaara Capital and Warburg Pincus have emerged as the highest bidders for Avanse Financial Services.,neutral,positive,1.1021647307286198,positive,2.4771838331160363,positive
2019-03-14 10:00:38.382,757.6,782.0,755.5,765.95,3896228.0,"Lupin, Sun Pharma, Wipro, RIL and SpiceJet among top stocks to track today",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,1.1021647307286198,positive,2.4771838331160363,positive
2019-03-15 10:01:11.609,767.0,789.6,767.0,786.0,3649618.0,Latest FDA action is a 'sentimentally negative outcome' for Lupin,The company has slipped to being the seventh-largest pharma company in terms of market cap,negative,negative,2.4771838331160363,positive,-1.0889530307006123,negative
2019-03-18 13:01:30.630,753.9,765.8,751.5,755.7,1908000.0,Lupin slips 6% after USFDA classifies Somerset facility as OAI,The facility may be subject to regulatory or administrative action and the US FDA may withhold approval of any pending applications or supplements in which this facility is listed,neutral,neutral,0.23875845602866,neutral,-0.395778364116095,neutral
2019-03-18 18:00:31.864,753.9,765.8,751.5,755.7,1908000.0,Lupin shares fall 4% on USFDA action,Shares of Lupin Monday fell by 4 per cent after the company said it has been cautioned by the US health regulator that its Somerset (New Jersey) facility may be subject to regulatory or administrative,negative,negative,0.23875845602866,neutral,-0.395778364116095,neutral
2019-03-22 18:00:40.827,755.0,758.0,740.25,743.8,1413543.0,Lupin launches Levothyroxine Sodium tablets in US,The tablets are indicated as replacement or supplemental therapy for hypothyroidism.,neutral,neutral,-1.4834437086092775,negative,-1.720892713094912,negative
2019-03-26 13:01:51.476,735.5,740.85,722.3,723.5,1879531.0,Lupin gains on PMDA approval for Etanercept biosimilar in Japan,The approval to treat moderate to severe Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis was received on March 26,positive,positive,-1.6315431679129844,negative,-0.1097694840834185,neutral
2019-03-26 18:00:44.252,735.5,740.85,722.3,723.5,1879531.0,"Lupin, YL Biologics get nod to market rheumatoid arthritis drug in Japan","In February 2018, YL Biologics had announced completion of the global phase III study of their biosimilar Etanercept",neutral,positive,-1.6315431679129844,negative,-0.1097694840834185,neutral
2019-03-28 18:00:09.448,731.0,745.45,730.0,738.95,2556264.0,Lupin launches generic skin treatment cream in US market,"Drug maker Lupin on Thursday said it has launched Fluocinonide ointment, used to treat inflammatory and pruritic manifestations, in the US market.The product is a generic version of County Line Pharma",positive,neutral,1.0875512995896095,positive,3.554054054054048,positive
2019-03-29 18:00:42.140,731.0,745.45,730.0,738.95,2556264.0,Lupin gains 2% on launch of fluocinonide ointment in US,The company said that the drug will be used for providing relief to the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.,positive,neutral,1.0875512995896095,positive,3.554054054054048,positive
2019-04-01 18:01:01.391,767.0,783.65,759.05,776.5,2665350.0,Lupin jumps 4% after launch of erectile dysfunction drug,Tadalafil is the generic equivalent of Eli Lilly and company's Cialis tablets,positive,neutral,1.238591916558018,positive,-0.5795235028976174,neutral
2019-04-02 13:00:15.441,776.5,789.8,769.85,772.0,2584800.0,Lupin's Pithampur unit gets inspection closure report from USFDA,Pithampur Unit-3 facility is involved in the manufacture of metered dose inhalers. ,neutral,neutral,-0.5795235028976174,neutral,1.817244490269368,positive
2019-04-02 13:01:09.869,776.5,789.8,769.85,772.0,2584800.0,"Jindal Steel, JK Tyre, IOB, Lupin among 125 stocks that look set to rally, shows MACD",The MACD is known for signalling trend reversals in traded securities or indices.,positive,neutral,-0.5795235028976174,neutral,1.817244490269368,positive
2019-04-02 18:01:55.583,776.5,789.8,769.85,772.0,2584800.0,Lupin gets nod from USFDA for Pithampur unit,Drug major Lupin Ltd on Tuesday announced receipt of the Establishment Inspection Report (EIR) from the US health regulator for its Pithampur facility in Madhya Pradesh.The US Food and Drug Administra,neutral,positive,-0.5795235028976174,neutral,1.817244490269368,positive
2019-04-03 13:01:47.046,775.9,792.5,771.0,790.0,1266608.0,Lupin gains as USFDA completed inspection without any observations,"This inspection also included review of studies done at the center’s new site at Lupin Research Park, Pune",neutral,neutral,1.817244490269368,positive,-0.7244094488188977,neutral
2019-04-03 18:01:01.550,775.9,792.5,771.0,790.0,1266608.0,Lupin Bioresearch Centre in Pune completes fifth successful USFDA inspection,Drug firm Lupin on Wednesday said inspection by the US health regulator of its bioresearch centre in Pune has been completed without any observations. “This is the fifth successive inspection without,positive,neutral,1.817244490269368,positive,-0.7244094488188977,neutral
2019-04-07 13:01:10.479,788.0,802.0,785.35,792.15,1883434.0,"Lupin recalls over 12,000 cartons of birth control pills from US",The product was manufactured by Lupin Ltd at its Pithampur facility in Madhya Pradesh,neutral,neutral,0.5266497461928905,neutral,1.905660377358488,positive
2019-04-10 18:00:27.971,805.0,812.7,802.5,811.1,877213.0,Lupin launches generic antidepressant tablets in US,The company has launched its Fluoxetine tablets USP in the strength of 60mg after having received an approval from the United States Food and Drug Administration.,neutral,positive,0.7577639751552823,neutral,2.715684463329017,positive
2019-04-11 18:02:45.119,811.95,836.0,811.0,834.0,4349534.0,Lupin gets USFDA nod to market testosterone gel,"The company has received approval from the United States Food and Drug Administration (USFDA) to market its generic testosterone gel, 1.62 per cent (20.25 mg/1.25 g pump actuation), Lupin said in a statement.",neutral,positive,2.715684463329017,positive,0.2469879518072234,neutral
2019-04-12 13:01:10.076,811.95,836.0,811.0,834.0,4349534.0,Top intraday trading ideas for afternoon trade for Friday 12 April 2019,Lupin is a 'Buy' call with a target price of Rs 860 and a stop loss of Rs 850.,neutral,neutral,2.715684463329017,positive,0.2469879518072234,neutral
2019-04-15 23:01:07.035,834.1,844.5,826.4,831.35,1338279.0,"From Lupin to Dr. Reddy's, year may end on a good note for pharma firms","During the previous quarter too, the Indian drug firms had reported a better than expected performance in the US",positive,positive,-0.3296966790552691,neutral,0.3361344537815071,neutral
2019-04-16 23:00:35.687,834.1,844.5,826.4,831.35,1338279.0,US FDA nod for drug to keep Lupin in focus," Lupin has said it received approval for its Fluoxetine tablets USP, 10 and 20 mg, from the US FDA to market a generic version of Eli Lilly’s Prozac tablets, 10 and 20 mg. It is indicated in the treat",neutral,positive,-0.3296966790552691,neutral,0.3361344537815071,neutral
2019-04-18 18:00:58.037,833.0,837.6,820.95,835.8,1120443.0,Lupin seeks more time from commerce ministry to complete Indore SEZ project,Company is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations - metered dose inhalers and dry powder inhalers.,neutral,neutral,0.3361344537815071,neutral,-0.4329004329004355,neutral
2019-04-23 13:02:15.618,838.5,867.6,835.0,863.5,2960377.0,Lupin rises on Morgan Stanley upgrade,"Shares of Lupin Ltd has risen as much as 4.5 per cent to ₹868.95 in early trade, their biggest intra-day per cent gain since Oct. 29, 2018.Morgan Stanley has upgraded Lupin to &#39;overweight&#39; fro",neutral,positive,2.9815146094215863,positive,1.523255813953491,positive
2019-04-23 18:00:19.876,838.5,867.6,835.0,863.5,2960377.0,"Morgan Stanley upgrades Lupin to overweight, raises target price by 40%","After a sharp fall in earnings and stock price over the past four years, Lupin now appears well positioned for recovery.",positive,positive,2.9815146094215863,positive,1.523255813953491,positive
2019-04-23 18:00:22.748,838.5,867.6,835.0,863.5,2960377.0,"Pharma shares in focus; Lupin, Sun Pharma gain up to 5%","Lupin gained 5 per cent to Rs 869 in intra-day deal today, after Morgan Stanley upgraded the stock to 'overweight' from 'equal-weight' rating.",positive,positive,2.9815146094215863,positive,1.523255813953491,positive
2019-04-23 18:00:37.789,838.5,867.6,835.0,863.5,2960377.0,"After Market: Lupin, RIL, Capacite log gains; HDFC Bank extends fall",Crude oil is creating havoc in the market. The rally has mainly affected a few Asian countries.,positive,negative,2.9815146094215863,positive,1.523255813953491,positive
2019-04-23 23:01:45.230,838.5,867.6,835.0,863.5,2960377.0,"Lupin's Pithampur facility may face regulatory action, says USFDA","The Mumbai-based drug maker, however, said it does not believe that the classification would have an impact.The USFDA had classified the inspection conducted at its Somerset (New Jersey) facility in December 2018, as OAI",negative,neutral,2.9815146094215863,positive,1.523255813953491,positive
2019-04-24 10:00:26.758,838.5,867.6,835.0,863.5,2960377.0,Lupin Falls After U.S. FDA Classifies Pithampur Unit For Official Action,The company said one of its units in Pithampur was classified as “official action indicated” after an inspection by the U.S. FDA.,neutral,neutral,2.9815146094215863,positive,1.523255813953491,positive
2019-04-24 10:01:12.970,838.5,867.6,835.0,863.5,2960377.0,"Stocks in the news: Lupin, Indiabulls Housing, Hotel Leelaventure, UltraTech  Cement and Tata Power",TataPower has signed an agreement to sell its 32-mw operating wind assets. ,neutral,positive,2.9815146094215863,positive,1.523255813953491,positive
2019-04-24 18:01:03.077,860.0,874.9,853.1,873.1,2086868.0,"Jhunjhunwala increases stake in DHFL, is cautious on auto holding",Raises stake in luggage maker VIP Industries and pharma major Lupin,neutral,neutral,1.523255813953491,positive,-0.3336401288541292,neutral
2019-05-02 13:01:21.617,880.0,880.8,864.8,866.35,847470.0,Lupin gains as co receives USFDA approval for Bosentan tablets,"Bosentan tablets is the generic version of Actelion Pharmaceuticals Tracleer Tablets, 62.5 mg and 125 mg.",positive,neutral,-1.551136363636361,negative,1.5668094595387625,positive
2019-05-05 13:00:21.489,852.05,870.45,852.05,865.4,848912.0,"Lupin, Zydus Pharmaceuticals recall products in the US","Zydus Pharmaceuticals USA Inc, a subsidiary of Zydus Cadila, is also recalling 7,668 bottles of Carvedilol Tablets, used to treat high blood pressure, in the American market. ",negative,negative,1.5668094595387625,positive,-1.4902186421173815,negative
2019-05-05 18:00:55.141,852.05,870.45,852.05,865.4,848912.0,"Lupin, Zydus Pharmaceuticals recall products in the US","Zydus Pharmaceuticals USA Inc is also recalling 7,668 bottles of Carvedilol Tablets, used to treat high blood pressure. ",negative,negative,1.5668094595387625,positive,-1.4902186421173815,negative
2019-05-07 23:00:58.403,850.0,858.8,844.0,848.55,926035.0,Company news: Lupin receives tentative approval for Fosaprepitant for Injection,"Pharma major Lupin has received tentative approval for its Fosaprepitant for Injection, 150-mg Single-Dose Vial, from the United States Food and Drug Administration. Lupin&#39;s Fosaprepitant for Inje",positive,positive,-0.170588235294123,neutral,2.2491145218417894,positive
2019-05-08 18:00:55.787,847.0,868.0,835.0,866.05,1349105.0,Lupin gets more time from govt to complete project in Indore SEZ,The company is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations metered dose inhalers and dry powder inhalers. ,neutral,neutral,2.2491145218417894,positive,-3.92156862745098,negative
2019-05-09 13:01:47.855,867.0,867.0,831.45,833.0,1589555.0,"Lupin, Aptissen sign pact to sell Osteoarthritis injection in Canada","New Delhi, May 9 Drug firm Lupin on Thursday said it has entered into a definitive agreement with Swiss company Aptissen to market, distribute and sell the current Aptissen products in Canada.This in",positive,positive,-3.92156862745098,negative,-3.5594237695078004,negative
2019-05-10 18:01:02.763,867.0,867.0,831.45,833.0,1589555.0,Lupin launches generic seizure drug in US,"The company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United States Food and Drug Administration",neutral,neutral,-3.92156862745098,negative,-3.5594237695078004,negative
2019-05-13 18:01:17.472,796.5,817.75,794.5,807.5,1568952.0,Pharma stocks bleed as US states file lawsuit against generic drug firms,"Lupin, Aurobindo Pharma, Dr Reddys, Glenmark, Wockhardt USA and Zydus have been named in the lawsuit.",negative,neutral,1.381042059008161,positive,-3.728395061728401,negative
2019-05-14 13:02:50.523,810.0,819.45,768.2,779.8,4168923.0,Lupin gets four observations from USFDA,"Lupin has received the EIR from the USFDA for the post-marketing adverse drug experience inspection.The inspection was conducted at its global pharmacovigilance group DSRM based out of Mumbai between 14-18 January, 2019",neutral,neutral,-3.728395061728401,negative,1.0377912668885902,positive
2019-05-15 10:00:28.725,810.0,819.45,768.2,779.8,4168923.0,"Hindalco, Tata Global, Lupin, Jubilant Food, Pidilite top stocks to watch",Here's a look at the top stocks that are likely to remain in focus today -,neutral,neutral,-3.728395061728401,negative,1.0377912668885902,positive
2019-05-15 10:00:57.699,810.0,819.45,768.2,779.8,4168923.0,"Stocks in the news: Lupin, Jet Airways, Nestle India, DHFL and JSW Steel",Jefferies has maintained underperform rating on Vodafone Idea.,neutral,positive,-3.728395061728401,negative,1.0377912668885902,positive
2019-05-15 18:00:41.819,766.05,788.75,736.4,774.0,10069132.0,"Lupin to review US lawsuit accusing it of price fixing, customer allocation","The company faces charges along with other companies such as Sun Pharma, Dr Reddy's Laboratories and Wockhardt",neutral,neutral,1.0377912668885902,positive,-2.2697795071335927,negative
2019-05-15 18:01:31.282,766.05,788.75,736.4,774.0,10069132.0,"Lupin Q4 net profit at  ₹289 crore, misses estimates","Revenues for Q4 increased to  ₹4,406.3 crore in March quarter.Lupin shares were down over 2% in late trade",negative,positive,1.0377912668885902,positive,-2.2697795071335927,negative
2019-05-16 10:03:00.761,766.05,788.75,736.4,774.0,10069132.0,"Lupin, Lancor Holdings among top losers on BSE ","In the Nifty pack, 31 stocks were trading in the green, while 19 stocks were in the red. ",negative,neutral,1.0377912668885902,positive,-2.2697795071335927,negative
2019-05-16 13:01:25.744,771.0,773.0,746.3,753.5,2930189.0,Lupin shares fall 6% on USFDA observations,The USFDA carried out an inspection of the plant from May 6 to May 15.,negative,neutral,-2.2697795071335927,negative,-1.6883116883116882,negative
2019-05-17 10:01:37.627,771.0,773.0,746.3,753.5,2930189.0,"Despite the pressure of business in the US, pharma major Lupin Limited recorded a 5.2 per cent rise in revenues to Rs 16,369.4 crore in FY19","Despite the pressure of business in the US, pharma major Lupin Limited recorded a 5.2 per cent rise in revenues to Rs 16,369.4 crore in FY19",positive,positive,-2.2697795071335927,negative,-1.6883116883116882,negative
2019-05-17 18:00:41.030,771.0,773.0,746.3,753.5,2930189.0,"Hold  Lupin, target Rs  861:   Karvy Stock Broking","Lupin is a largecap company, operating in pharmaceuticals and health care sector.  ",neutral,neutral,-2.2697795071335927,negative,-1.6883116883116882,negative
2019-05-19 18:00:41.057,770.0,770.8,746.05,757.0,1924703.0,Lupin: Margins pick up,"Pharma major Lupin has reported a consolidated net profit of ₹289.6 crore in the fourth quarter of 2018-19, against the net loss of ₹783.5 crore in the same quarter in FY-18.However, the consolidated",neutral,negative,-1.6883116883116882,negative,-1.2632275132275073,negative
2019-05-22 10:02:49.376,748.0,760.95,741.65,760.0,1556805.0,Why investors should be more worried about Lupin than DRL,Main focus area remains complex generics where other cos have an advantage,negative,neutral,1.6042780748663104,positive,-2.036539846768379,negative
2019-05-26 23:02:00.993,742.55,755.9,720.0,745.1,3298889.0,Go long on Lupin," The long-term outlook for Lupin ₹765) remains negative. However, in the short term, the pharma stock is expected to remain resilient. The stock finds immediate support at ₹725, and a close below this",neutral,positive,0.3434112180998004,neutral,-0.6675567423230975,neutral
2019-05-27 10:00:44.800,742.55,755.9,720.0,745.1,3298889.0,Lupin declines 5% as USFDA classifies inspection as OAI,The inspection at the Goa facility had closed with two observations.,negative,neutral,0.3434112180998004,neutral,-0.6675567423230975,neutral
2019-05-27 13:00:16.142,749.0,754.65,742.05,744.0,1656602.0,Lupin shares fall after USFDA Goa plant observations,The company’s stock was lowest in the morning since 28 March.The share of Lupin fell nearly 10% this year as of the last close,negative,negative,-0.6675567423230975,neutral,-1.214574898785425,negative
2019-05-30 23:02:09.164,746.5,749.0,737.55,744.8,1196824.0,"Lupin's Goa facility may face regulatory action, says USFDA",Lupin has received a letter from the USFDA classifying the inspection conducted at its Goa facility between 28 Jan to 8 Feb as Official Action Indicated.Shares of Lupin today ended 1.38% higher at  ₹743.70 apiece on the BSE,negative,positive,-0.2277294038848018,neutral,-0.4543025120256517,neutral
2019-05-31 10:00:50.605,746.5,749.0,737.55,744.8,1196824.0,"Stocks in the news: Lupin, ONGC, IDBI Bank, Coal India and Bharti Airtel",UBS has maintained buy rating on Motherson Sumi and lowered target price to ₹160.,neutral,negative,-0.2277294038848018,neutral,-0.4543025120256517,neutral
2019-06-03 18:00:15.076,746.7,755.0,738.3,740.75,811398.0,"HCL Tech, Lupin, Havells among 11 stocks that analysts say can give solid returns in 2-3 weeks",Analysts said one must execute trades with caution in this market.,positive,neutral,-0.796839426811309,neutral,-2.119408972387514,negative
2019-06-04 23:01:13.471,746.7,755.0,738.3,740.75,811398.0,PMDA completes inspection of Lupin's Mandideep facility unit with no major observations,"Drug firm Lupin on Tuesday said the Japanese regulatory agency, PMDA, has concluded the inspection of Unit 2 at the Mandideep facility in Madhya Pradesh with no major observations.The inspection was c",neutral,neutral,-0.796839426811309,neutral,-2.119408972387514,negative
2019-06-16 13:00:32.861,720.0,720.0,705.0,705.05,1427008.0,"India's Lupin Recalls 18,000 Antibiotic Drug Bottles in the U.S.","India's Lupin Recalls 18,000 Antibiotic Drug Bottles in the U.S.",neutral,neutral,-2.0763888888888955,negative,-0.3880344292366304,neutral
2019-06-17 10:01:01.206,720.0,720.0,705.0,705.05,1427008.0,"Lupin, Bharti Airtel, Voda Idea and Jet Airways among top stocks to watch",Here's a look at some of the companies whose shares are expected to trade actively in today's trade -,neutral,neutral,-2.0763888888888955,negative,-0.3880344292366304,neutral
2019-06-17 13:00:28.688,708.7,714.0,705.1,705.95,976473.0,Lupin stock down 1% on recalling antibiotic drug bottles in US,"Lupin Pharmaceuticals Inc, an American subsidiary of the Mumbai-based company, is recalling the lot due to ",negative,negative,-0.3880344292366304,neutral,-1.0550007033338022,negative
2019-06-18 13:00:16.694,710.9,712.0,697.2,703.4,1393314.0,Hold Lupin; target of Rs 810: ICICI Direct,"ICICI Direct recommended hold rating on Lupin with a target price of Rs 810 in its research report dated May 16, 2019.",neutral,positive,-1.0550007033338022,negative,1.3120567375886525,positive
2019-06-24 13:03:02.566,731.0,758.0,730.55,753.6,2389149.0,"Lupin gains 3% after Credit Suisse upgrades, raises target price","Japanese brokerage Nomura also maintained its buy call on Lupin with a price target at Rs 1,017 as it expects the consolidation trend in pharma to continue",positive,positive,3.091655266757869,positive,1.6843501326260009,positive
2019-06-25 10:02:24.644,731.0,758.0,730.55,753.6,2389149.0,"Lupin gains 3% on Credit Suisse upgrade, Nomura’s buy rating","Nomura has maintained a ‘buy rating on Lupin with a target price of Rs 1,017. ",positive,positive,3.091655266757869,positive,1.6843501326260009,positive
2019-06-26 13:00:09.836,767.25,774.75,754.15,765.0,2341918.0,"Nifty Pharma index gains 2% led by Aurobindo, Sun Pharma","Aurobindo jumped 4% and among top gainer in the pharma index, followed by shares of Sun Pharma, Cadila, Biocon and Lupin rose 3-2% respectively, were also among top contributors.",positive,positive,-0.2932551319648094,neutral,-2.207792207792208,negative
2019-06-28 10:00:22.274,770.0,790.0,751.05,753.0,3642555.0,"Stocks to watch: Cox & Kings, Tata Steel, Lupin, Mindtree, NMDC, Sun Pharma",Here's a list of some of the companies whose shares are expected to trade actively in today's session,neutral,neutral,-2.207792207792208,negative,1.8271767810026416,positive
2019-06-28 10:01:12.912,770.0,790.0,751.05,753.0,3642555.0,Lupin gets tentative USFDA nod for Mirabegron ER Tablets,"Lupin's Mirabegron ER Tablets, 25 mg and 50 mg, is a generic version of Myrbetriq Extended Release Tablets, 25 mg and 50 mg, of Astellas.",neutral,neutral,-2.207792207792208,negative,1.8271767810026416,positive
2019-07-03 18:00:43.764,754.7,759.75,748.15,754.35,1593873.0,Lupin gets USFDA nod for Phenylephrine and Ketorolac Intraocular Solution,"Lupin's Phenylephrine and Ketorolac Intraocular Solution, 1%/0.3%, is the generic version of Omidria Intraocular Solution, 1%/0.3%, of Omeros Corporation (Omeros), the company said.",neutral,neutral,-0.0463760434609808,neutral,-2.5579854208084765,negative
2019-07-04 10:01:22.192,754.7,759.75,748.15,754.35,1593873.0,Lupin gets booster from USFDA for cinacalcet,"Lupin said on Wednesday said it has received approval for its cinacalcet tablets, 30 mg, 60 mg, and 90 mg from the USFaDA. It is indicated in the treatment of secondary hyper-parathyroidism in adult p",positive,positive,-0.0463760434609808,neutral,-2.5579854208084765,negative
2019-07-08 10:01:57.254,725.0,740.65,725.0,733.75,963550.0,"Kotak adds Lupin to model portfolio, cuts weight on ICICI, NTPC","The brokerages has also recommended mid-cap stocks in automobile, auto components, banks, diversified financials, capital goods and gas utilities. ",neutral,neutral,1.206896551724138,positive,2.476463364715511,positive
2019-07-09 18:00:36.102,755.25,762.0,748.0,761.9,1593830.0,Lupin launches generic cancer drug in US,Drug firm Lupin on Tuesday said it has launched in the US generic Imatinib Mesylate tablets used for treatment of certain types of cancer. The company’s alliance partner Natco had received an approval,neutral,positive,0.8805031446540851,neutral,-1.5294117647058882,negative
2019-07-12 18:02:00.843,757.0,764.7,752.0,761.55,1165657.0,Lupin Q1 PAT seen up 17.6% YoY to Rs. 296.5 cr: Prabhudas Lilladher,"Net Sales are expected to increase by 14.6 percent Y-o-Y to Rs. 4,324.2 crore, according to Prabhudas Lilladher.",positive,positive,0.6010568031704036,neutral,-0.1372549019607783,neutral
2019-07-14 13:00:56.809,765.0,767.95,750.5,763.95,861331.0,Lupin aims to launch new products across geographies this fiscal,"""Looking ahead, FY2020 is an exciting year for Lupin as we plan to bring our first biosimilar to market,"" company said.",positive,positive,-0.1372549019607783,neutral,1.9700242162445127,positive
2019-07-19 23:01:33.333,758.0,763.0,742.15,747.0,796310.0,Lupin resets ‘audacious’ goalpost,Pharma major charts growth strategy that will be driven by specialised products,neutral,neutral,-1.4511873350923483,negative,1.8088897854885408,positive
2019-07-22 13:01:47.556,760.0,765.9,751.2,756.0,1285472.0,Lupin's Nagpur facility wins ENR Global Best Project Award; stock gains 2%,The ENR Global Best Projects Awards are annual awards given by ENR globally as part of an annual competition that identifies and honours the best project teams behind outstanding design and construction efforts.,positive,positive,-0.5263157894736842,neutral,-2.4191949236565624,negative
2019-07-25 13:01:07.077,770.0,780.0,761.0,775.9,1096911.0,"Nifty Pharma index gains over 1.5% led by Cadila, Lupin, Cipla","Divi’s Lab, Aurobindo Pharma, Dr Reddy’s, and Sun Pharma also gained in today’s session in the range of 1-2% respectively.",positive,positive,0.7662337662337633,neutral,-1.049222797927464,negative
2019-07-29 13:00:19.063,763.1,795.0,748.05,758.9,3261855.0,"HeroMoto, HDFC Bank, Lupin, PowerGrid among 11 stocks that analysts say may deliver gains in 2-3 weeks","FPIs have been on a selling spree on Dalal Street since the Union Budget.
",positive,neutral,-0.5503865810509823,neutral,1.6116195781933913,positive
2019-08-05 13:00:57.692,756.0,771.0,742.5,750.0,1257981.0,Lupin down 1% after Aurangabad facility receives EIR from USFDA,"The facility was inspected by the USFDA between May 6, 2019 and May 15, 2019.",negative,neutral,-0.7936507936507936,neutral,3.5038635758060157,positive
2019-08-06 10:01:03.872,756.0,771.0,742.5,750.0,1257981.0,Lupin gets Establishment Inspection Report from FDA for Aurangabad facility,The facility was inspected by the US Food and Drug Administration,neutral,neutral,-0.7936507936507936,neutral,3.5038635758060157,positive
2019-08-06 13:02:20.654,750.6,786.4,748.05,776.9,3018694.0,France ANSM completes inspection at Lupin Mandideep plant; stock up 1%,"The ANSM inspection closed with no critical or major observations, the company stated.",positive,neutral,3.5038635758060157,positive,-3.1560193433443566,negative
2019-08-07 10:03:15.112,750.6,786.4,748.05,776.9,3018694.0,"Board Meetings Today: Adani Ports, Cipla, HCL Technologies, M&M, Tata Steel","HPCL, Lupin, Adani Power, Aurobindo Pharma and India Cements will announce Q1 earnings today. ",neutral,neutral,3.5038635758060157,positive,-3.1560193433443566,negative
2019-08-07 18:00:18.927,785.8,791.4,750.4,761.0,3238506.0,Lupin up 2.5% as net profit jumps ~50% yoy in Q1FY20,Lupin received approvals for 5 ANDAs from the USFDA during the quarter.,positive,positive,-3.1560193433443566,negative,-1.4423076923076952,negative
2019-08-08 10:01:27.015,785.8,791.4,750.4,761.0,3238506.0,"Lupin, Cipla numbers raise hopes of a recovery","We are pleased with the robust all-round performance in our key markets, said Lupin MD.",positive,positive,-3.1560193433443566,negative,-1.4423076923076952,negative
2019-09-04 20:16:21.445,745.85,769.9,741.0,766.1,2636916.0,"Lupin signs second partnership for its oncology pipeline, this time with German drug maker BI",BI and Lupin will together develop and commercialise a new drug called MEK inhibitor that will target specific cancer cells and potentially treat patients of skin and stomach cancer.,positive,positive,2.715023127974794,positive,0.3770150806032211,neutral
2019-09-04 23:00:28.582,745.85,769.9,741.0,766.1,2636916.0,Lupin signs $700 million deal with Boehringer Ingelheim to develop cancer drug,"While Lupin will receive an upfront payment of $20 mn, additional payments of over $700 mn would be based on successful achievement of agreed clinical, regulatory and commercial milestones.Lupin would also be entitled to receive double-digit royalties on the sales of the product",positive,positive,2.715023127974794,positive,0.3770150806032211,neutral
2019-09-05 13:01:44.491,769.2,774.65,757.0,772.1,1348958.0,"Lupin jumps 2% after Morgan Stanley maintains overweight, sees 32% upside",Lupin entered into a licensing agreement with Germany’s Boehringer Ingelheim to develop and commercialise a novel anti-cancer compound in a deal valued at $700 million.,positive,positive,0.3770150806032211,neutral,-0.8419689119170984,neutral
2019-09-05 18:01:23.535,769.2,774.65,757.0,772.1,1348958.0,"After Market: Auto stocks, Lupin rally; 152 stocks hit 52-week lows","Sensex closed 0.22% lower at 36,644.42 points while Nifty index closed 0.03%, up at 10,847.90 points.",positive,negative,0.3770150806032211,neutral,-0.8419689119170984,neutral
2019-09-06 10:02:58.620,769.2,774.65,757.0,772.1,1348958.0,Uncertainty over US biz growth keeps Street cautious on Lupin stock,"A strong product pipeline and growth in India and emerging markets are positives, but regulatory hurdles, delayed drug approvals in the US could hurt prospects",positive,positive,0.3770150806032211,neutral,-0.8419689119170984,neutral
2019-09-06 18:00:13.748,769.2,774.65,757.0,772.1,1348958.0,Lupin gets USFDA approval for Fosaprepitant for Injection; stock up ~1%,"Lupin’s Fosaprepitant for Injection, 150 mg Single-Dose Vial, is the generic version of Emend for Injection, 150 mg Single-Dose Vial, of Merck Sharp & Dohme Corp.",positive,neutral,0.3770150806032211,neutral,-0.8419689119170984,neutral
2019-09-09 10:01:52.142,772.0,778.65,764.5,765.5,929488.0,Lupin Ltd ADR 2020 Q1 - Results - Earnings Call Slides,The following slide deck was published by Lupin Ltd ADR in conjunction with their 2020 Q1 earnings call.,neutral,neutral,-0.8419689119170984,neutral,-1.166883963494139,negative
2019-09-13 10:00:40.107,762.4,766.0,753.6,764.5,518539.0,"Dr Reddy's to Lupin, Indian pharma players get a leg up from domestic sales","Dr Reddy's, Lupin, Sun Pharma and Cadila Healthcare outperformed the local industry growth in recent months, a trend expected to continue",positive,positive,0.2754459601259211,neutral,0.4449679361340108,neutral
2019-09-13 23:01:05.163,762.4,766.0,753.6,764.5,518539.0,Company news: Lupin,"Lupin has received approval for its propranolol hydrochloride extended-release (ER) capsules, 60 mg, 80 mg, 120 mg and 160 mg from Health Canada. Lupin is the first generic company to receive an appro",neutral,positive,0.2754459601259211,neutral,0.4449679361340108,neutral
2019-09-19 13:01:36.527,747.7,758.85,734.15,757.0,2688340.0,Lupin gets warning letter from USFDA for Mandideep facility,Shares of Lupin were trading 1.36 per cent lower at Rs 749.15 apiece on BSE. ,negative,negative,1.2438143640497463,positive,-4.0682414698162725,negative
2019-09-19 13:03:15.016,747.7,758.85,734.15,757.0,2688340.0,US FDA issues warning letter for Lupin's Mandideep facility,"Mumbai (Maharashtra) [India], Sep 19 (ANI): The US Food and Drug Administration (US FDA) has issued a warning letter to pharma major Lupin Ltd for its facility at Mandideep in Madhya Pradesh.",neutral,negative,1.2438143640497463,positive,-4.0682414698162725,negative
2019-09-20 18:02:42.875,747.7,758.85,734.15,757.0,2688340.0,Lupin rises 2% on USFDA approval for Levothyroxine Sodium Tablets,"Levothyroxine Sodium Tablets USP was originally approved on January 18, 2019 as generic equivalent of SYNTHROID manufactured by ABBVIE Inc.",neutral,positive,1.2438143640497463,positive,-4.0682414698162725,negative
2019-09-23 10:00:48.832,762.0,765.3,723.4,731.0,2456575.0,Lupin shares decline on USFDA observations for Tarapur facility,The inspection at the Tarapur facility closed with three observations.,negative,neutral,-4.0682414698162725,negative,0.4149659863945517,neutral
2019-09-23 13:01:17.915,735.0,746.4,731.05,738.05,1202986.0,Lupin gets 3 observations from USFDA for its Tarapur facility,"The inspection of Tarapur facility was carried out by the United States Food and Drug administration (USFDA) between September 16-20, 2019.",neutral,neutral,0.4149659863945517,neutral,-1.3262958451752542,negative
2019-09-25 18:01:30.861,733.0,735.9,725.45,728.95,958313.0,Lupin ropes in Jon Stelzmiller to head US speciality business,"Pharma major Lupin on Wednesday announced the appointment of Jon Stelzmiller as the President of its US speciality business. Stelzmiller, who was most recently Senior Vice-President and General Manage",neutral,neutral,-0.5525238744883977,neutral,-1.1293210301611412,negative
2019-09-30 18:01:20.298,716.0,726.25,700.5,702.5,1160594.0,Lupin closes offloading of Japanese subsidiary Kyowa Criticare to Neopharma Group,"Mumbai (Maharashtra) [India], Sep 30 (ANI): Pharma major Lupin Ltd said on Monday it has closed a definitive agreement for the sale of its Japanese injectables business and related assets to Neo Ala Co Ltd, a wholly-owned subsidiary of Neopharma Group which is the UAE's largest pharmaceutical manufacturer headquartered in Abu Dhabi.",neutral,neutral,-1.885474860335196,negative,1.125541125541119,positive
2019-10-01 10:02:19.692,716.0,726.25,700.5,702.5,1160594.0,Japan's drug regulator PMDA completes inspection of Lupin's Goa facility,"The inspection was conducted between September 24 and 27, it added.",positive,neutral,-1.885474860335196,negative,1.125541125541119,positive
2019-10-01 23:03:50.908,716.0,726.25,700.5,702.5,1160594.0,Lupin gets US FDA approval for extended phenytoin sodium capsules,Extended phenytoin sodium capsules 100 mg had annual sales of approximately $105 million in the US in the year ending June.The capsules are indicated for prevention and treatment of seizures occurring during or following neurosurgery and for treatment of tonic-clonic and psychomotor seizures,positive,neutral,-1.885474860335196,negative,1.125541125541119,positive
2019-10-03 13:01:22.294,702.0,708.5,684.1,685.2,1105522.0,Lupin appoints Sreeji Gopinathan as chief information officer,"Sreeji Gopinathan joins Lupin from Reckitt Benckiser.rior to that, he was associated with Philips, Procter & Gamble, ISRO and Asea Brown Boveri",neutral,neutral,-2.393162393162387,negative,-3.686234670923733,negative
2019-10-04 18:01:10.046,702.0,708.5,684.1,685.2,1105522.0,USFDA red flags Lupin for significant violations at MP unit,"The USFDA said it had inspected the Unit 1 at the Mandideep facility of the company from November 26 to December 4, 2018.",negative,neutral,-2.393162393162387,negative,-3.686234670923733,negative
2019-10-07 10:00:43.083,689.05,690.85,646.3,663.65,2751193.0,Lupin launches Mycophenolate Mofetil Capsules USP,"Mycophenolate Mofetil Capsules USP, 250 mg, had annual sales of approximately USD 53 million in the US (IQVIA MAT August 2019).",neutral,neutral,-3.686234670923733,negative,2.8726124229207435,positive
2019-10-07 10:02:22.867,689.05,690.85,646.3,663.65,2751193.0,"Top stocks in focus: Lupin, Ashok Leyland, BEML, JSW Steel",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.686234670923733,negative,2.8726124229207435,positive
2019-10-07 18:00:19.017,689.05,690.85,646.3,663.65,2751193.0,"Lakshmi Vilas Bank, IndusInd Bank & 32 other BSE500 stocks hit 52-wk low","Aurobindo Pharmaceuticals, BHEL, Ambuja Cements, Grasim Industries, Zee Entertainment, Glenmark Pharmaceuticals, Lupin and LIC Housing Finance were among the 34 stocks that hit their 52-week lows",negative,neutral,-3.686234670923733,negative,2.8726124229207435,positive
2019-10-08 10:01:47.649,664.9,685.0,660.0,684.0,1499988.0,"Facing regulator’s heat, Lupin shows urgency with quality control hire","Whether Johnny Mikell will be given enough authority to steer the ship will be an important factor, say analysts.Resolving the issues soon will be crucial for the company, considering that further delays would make it more prominent on US FDA’s heat map",positive,neutral,2.8726124229207435,positive,1.5514705882352875,positive
2019-10-09 13:01:13.901,680.0,698.8,676.85,690.55,1506949.0,Japan's PMDA issues GMP certificate to Lupin's unit at Mandideep facility,"Mumbai (Maharashtra) [India], Oct 9 (ANI): Pharma major Lupin Ltd on Wednesday announced the receipt of good manufacturing practice (GMP) certificate from the Pharmaceutical and Medical Devices Agency (PMDA) of Japan for its active pharmaceutical ingredient facility at Mandideep in Madhya Pradesh.",neutral,positive,1.5514705882352875,positive,1.4220746408720166,positive
2019-10-10 18:04:33.212,692.65,704.0,683.0,702.5,1130399.0,US FDA red flags lack of proper batch records at Lupin’s Tarapur plant,"The observations were part of a Form 483 issued after an inspection of the facility during 16-20 September.The US FDA had made three observations for the facility in the Form 483 then, which Lupin had announced on 23 September",negative,neutral,1.4220746408720166,positive,1.6051136363636298,positive
2019-10-11 23:01:37.110,692.65,704.0,683.0,702.5,1130399.0,"Lupin plans to file Etanercept, Pegfilgrastim biosimilars in US by Q4FY20","In Europe, the second largest market for the Etanercept, Lupin is expecting approval in March 2020, and plans to commercialise it by Q1FY21.",neutral,positive,1.4220746408720166,positive,1.6051136363636298,positive
2019-10-14 13:02:24.126,718.0,726.9,711.5,720.55,1438452.0,"Maruti, Dabur, Lupin, TechM among 12 money-making ideas for short term",The broader market is throwing up plenty of stock-specific opportunities.,neutral,neutral,0.355153203342612,neutral,1.590594744121715,positive
2019-10-18 18:00:29.650,726.5,746.15,722.85,739.8,1813542.0,Lupin gets EIR from USFDA for Nagpur facility,"USFDA conducted the inspection between August 5-8, 2019, Lupin said in a filing to the BSE.",neutral,neutral,1.8306951135581493,positive,0.7984842333197967,neutral
2019-10-22 18:01:49.616,749.5,749.5,730.7,735.45,1361851.0,Lupin's Nagpur facility receives EIR from USFDA,The inspection for the oral solid facility at Nagpur closed without any Form 483 observation.,neutral,neutral,-1.8745830553702407,negative,-0.8418194161575079,neutral
2019-11-01 10:01:11.790,754.0,775.0,751.75,765.0,2368740.0,Lupin looks to sell Japanese arm Kyowa for $600 million,"Kyowa grew a modest 5% over the year-ago level. Its net profit halved to Rs 68.6 crore constituting 11.3% of Lupins consolidated profit. ""Pricing pressure in Japan has hit the company very hard, especially last year. Since then, gross margins have dropped from 55% in FY18 to 31% in FY19,"" Lupin MD Nilesh Gupta said.",neutral,negative,1.4588859416445623,positive,-1.1845873470450432,negative
2019-11-06 10:00:19.846,757.75,787.6,740.2,758.55,4843704.0,Lupin Q2 preview: Profit may grow in double-digits on better operating income,Motilal Oswal expects EBITDA margin to grow 470 bps to 18.6 percent YoY on account of superior product mix and better operating leverage,positive,positive,0.1055757175849494,neutral,-0.9261744966442924,negative
2019-11-06 10:00:52.445,757.75,787.6,740.2,758.55,4843704.0,"Stocks to watch: Realty stocks, Lupin, Tata Steel, Tech Mahindra, Titan Co",Here's a list of stocks that may trade actively in today's trading session.,neutral,neutral,0.1055757175849494,neutral,-0.9261744966442924,negative
2019-11-06 10:01:05.048,757.75,787.6,740.2,758.55,4843704.0,"What to watch: Tata Steel, Canara Bank, Cipla, Lupin results","Over 60 firms including Bannari Amman Sugars, Bajaj Electricals, Bosch, BSE, Canara Bank, Cipla, Clariant Chem, Corporation Bank, Exide, EID Parry, Emami, Fortis Health, Firstsource, Godrej Consumer,",neutral,neutral,0.1055757175849494,neutral,-0.9261744966442924,negative
2019-11-06 10:04:13.792,757.75,787.6,740.2,758.55,4843704.0,"Board Meetings Today: Tata Steel, Cipla, Canara Bank, Lupin and IB Housing",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges. ,neutral,neutral,0.1055757175849494,neutral,-0.9261744966442924,negative
2019-11-06 13:04:37.980,745.0,754.15,735.25,738.1,6217985.0,Indian drugmakers continue to be in trouble with new FDA warning letters,"The latest regulatory crackdown shows US regulator’s stance is hardening toward lapses in quality control.Cadila, Glenmark and Lupin are the latest local medicine makers to be reprimanded by the USFDA",negative,positive,-0.9261744966442924,negative,-3.0364372469635628,negative
2019-11-06 23:00:44.010,745.0,754.15,735.25,738.1,6217985.0,Lupin posts Rs1.3 billion loss in second quarter,"Lupin’s operational performance, however, was strong, with its consolidated revenue rising 10.3% to Rs43.6 billion.Lupin plans to ask the USFDA to reinspect the Goa and Somerset plants by March, and the other two plants in the following quarter",negative,positive,-0.9261744966442924,negative,-3.0364372469635628,negative
2019-11-07 13:00:39.687,741.0,743.0,715.25,718.5,1522617.0,"Lupin Consolidated September 2019 Net Sales at Rs 4,359.65 crore, up 10.34% Y-o-Y","Lupin Consolidated September 2019 Net Sales at Rs 4,359.65 crore, up 10.34% Y-o-Y",positive,positive,-3.0364372469635628,negative,1.929460580912869,positive
2019-11-07 13:03:52.035,741.0,743.0,715.25,718.5,1522617.0,Lupin share price falls 3% post Q2 loss; CLSA retains sell,Lupin reported a consolidated net loss of Rs 127.1 crore in the quarter-ended September as against a profit of Rs 266 crore in the same period last fiscal and Rs 303 crore in Q1 FY20.,negative,negative,-3.0364372469635628,negative,1.929460580912869,positive
2019-11-08 13:00:54.241,741.0,743.0,715.25,718.5,1522617.0,Hold Lupin; target of Rs 720: ICICI Direct,"ICICI Direct recommended hold rating on Lupin with a target price of Rs 720 in its research report dated November 07, 2019.",neutral,positive,-3.0364372469635628,negative,1.929460580912869,positive
2019-11-08 23:02:57.595,741.0,743.0,715.25,718.5,1522617.0,Lupin's prophylaxis and chronic asthma treatment drug gets USFDA nod,"The medicine is indicated for prophylaxis and treatment of chronic asthma in adults and children 12 years of age and older, it added.",neutral,neutral,-3.0364372469635628,negative,1.929460580912869,positive
2019-11-11 10:01:21.098,723.0,739.85,721.05,736.95,1500951.0,Lupin share price gains on USFDA approval,"The company has received approval for its Zileuton Extended-Release Tablets, 600 mg, from the USFDA.",positive,positive,1.929460580912869,positive,-3.309018567639263,negative
2019-11-11 10:02:19.813,723.0,739.85,721.05,736.95,1500951.0,"Top stocks in focus: Lupin, IDBI Bank, Laurus Labs, Goa Carbon",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.929460580912869,positive,-3.309018567639263,negative
2019-11-11 23:01:20.083,723.0,739.85,721.05,736.95,1500951.0,"Under the terms of agreement, Lupin's subsidiary Nanomi BV will divest its entire stake in Kyowa to Unison's entity Plutus Ltd for an enterprise value of JPY 57,361","Under the terms of agreement, Lupin's subsidiary Nanomi BV will divest its entire stake in Kyowa to Unison's entity Plutus Ltd for an enterprise value of JPY 57,361",neutral,neutral,1.929460580912869,positive,-3.309018567639263,negative
2019-11-12 10:03:32.433,754.0,758.8,727.0,729.05,3036229.0,"Lupin to sell Japanese biz for enterprise value of  ₹3,702 cr","Pharma firm will get  ₹2,104 crore in cash from sale of a 99.82% stake in Kyowa to Plutus.Lupin expects the transaction to complete by March end, subject to requisite approvals",neutral,neutral,-3.309018567639263,negative,0.6958657388456847,neutral
2019-11-12 13:04:42.211,754.0,758.8,727.0,729.05,3036229.0,Deals Buzz: Masdar’s $150 mn investment values Hero Future at $750 mn,"In other news, Lupin has entered into a definitive agreement to sell its entire stake in Japanese subsidiary Kyowa Pharmaceutical Industry Co. to Plutus Ltd for an enterprise value of 57.36 billion yen, or  ₹3,702 crore",neutral,positive,-3.309018567639263,negative,0.6958657388456847,neutral
2019-11-13 10:00:22.080,754.0,758.8,727.0,729.05,3036229.0,"Top stocks in focus: Lupin, Indian Hotels, Godrej Industries, Tata Power",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.309018567639263,negative,0.6958657388456847,neutral
2019-11-13 10:01:04.728,754.0,758.8,727.0,729.05,3036229.0,"Stocks to watch: Vodafone Idea, CIL, BHEL, Infosys, Lupin, Tata Motors",Here's a look at the top stocks that may remain in focus today.,neutral,neutral,-3.309018567639263,negative,0.6958657388456847,neutral
2019-11-19 18:00:45.270,752.2,781.0,749.1,777.45,2880405.0,Lupin launches generic hypokalemia drug in US,Pharma firm Lupin on Tuesday said it has launched in the US generic potassium chloride for oral solution used for treatment and prevention of hypokalemia. The company had earlier received approval for,neutral,positive,3.3568199946822657,positive,-1.7666943044837071,negative
2019-11-20 18:01:25.965,783.95,787.95,768.7,770.1,1845701.0,Nifty Pharma index hits two-month high; Sun Pharma surges 7%,"Among other individual stocks, Lupin, Dr Reddy's Laboratories, Divi's Laboratories and Aurobindo Pharma from the Nifty Pharma index were up 3 per cent each on the NSE.",positive,positive,-1.7666943044837071,negative,-0.4256965944272533,neutral
2019-11-21 10:04:32.023,783.95,787.95,768.7,770.1,1845701.0,"'BUY' or 'SELL' ideas from experts for Thursday, 21 November, 2019",Lupin is a 'Buy' call with a target price of Rs 805 and a stop loss of Rs 764.,neutral,neutral,-1.7666943044837071,negative,-0.4256965944272533,neutral
2019-11-22 10:01:38.261,775.2,781.95,767.2,771.9,1322662.0,"Top stock recommendations by Anand Rathi: Buy Lupin, Zensar Tech","Trading calls by Jay Anand Thakkar, CMT -Assistant Vice President - Equity Research, Anand Rathi Shares and Stock Brokers",neutral,neutral,-0.4256965944272533,neutral,0.8002065049044974,neutral
2019-11-22 18:01:29.180,775.2,781.95,767.2,771.9,1322662.0,Lupin launches Hydrocortisone Valerate Cream,"Lupin's Hydrocortisone Valerate Cream USP, 0.2%, is the generic equivalent of Westcort Cream, 0.2%, of Sun Pharmaceutical Industries Inc.",neutral,neutral,-0.4256965944272533,neutral,0.8002065049044974,neutral
2019-11-27 18:04:16.874,788.0,806.0,788.0,804.0,1588785.0,Pharma Inc agrees to cap margins on non-price control drugs at 30%,"Big pharma companies with generic divisions — such as Sun Pharma, Cipla and Lupin — will have to reduce MRP.",neutral,negative,2.030456852791878,positive,-0.4355942750466708,neutral
2019-11-27 18:04:24.439,788.0,806.0,788.0,804.0,1588785.0,Pharma Inc agrees to cap margins on non-price control drugs at 30%,"Big pharma companies with generic divisions — such as Sun Pharma, Cipla and Lupin — will have to reduce MRP.",neutral,negative,2.030456852791878,positive,-0.4355942750466708,neutral
2019-12-02 18:00:54.512,796.05,798.65,783.6,785.5,627574.0,"Maruti, Lupin among 12 stock ideas that analysts say should deliver gains in few weeks",Here are 14 money-making ideas that should deliver gains over the next few weeks.,positive,positive,-1.3252936373343327,negative,1.1508951406649617,positive
2019-12-16 10:00:22.776,753.5,761.85,745.8,749.0,906850.0,Violation of drug price control order: Drug cos under NPPA lens for self-exemption from price cap,"Pricing watchdog has found that companies such as Lupin and Boehringer Ingelheim launched products bypassing the regulatory framework. The NPPA noted that these drug cos had launched anti-diabetes drugs under para 32 of the DPCO, without submitting the requisite application. This allows the NPPA to exempt certain classes of drugs from price control for a period of five years. ",neutral,neutral,-0.5972130059721301,neutral,0.7270544290288062,neutral
2019-12-17 13:01:22.261,755.5,767.9,753.8,767.0,1246323.0,Lupin announces completion of Kyowa divestiture to Unison; stock up 1%,"The divestiture, which valued Kyowa at an Enterprise Value of JPY 57,361 million, was announced on November 11, 2019, and approved by Lupin’s shareholders.",positive,positive,1.5221707478491064,positive,0.7822685788787485,neutral
2019-12-17 13:01:25.100,755.5,767.9,753.8,767.0,1246323.0,Lupin announces completion of Kyowa divestiture to Unison,"Mumbai (Maharashtra) [India], Dec 17 (ANI): Pharma major Lupin Ltd said on Tuesday that its subsidiary Nanomi BV has completed the divestiture of the entire 99.82 per cent stake in Kyowa Pharmaceutical Industry Co Ltd to Unison Capital Partners IV.",neutral,neutral,1.5221707478491064,positive,0.7822685788787485,neutral
2019-12-17 18:01:58.236,755.5,767.9,753.8,767.0,1246323.0,Lupin’s arm completes stake sale in Kyowa,Drug maker Lupin on Tuesday said its subsidiary Nanomi BV has completed divestment of its entire stake in Kyowa Pharmaceutical Industry to Japan-based equity fund Unison Capital Partners.Nanomi BV hel,neutral,positive,1.5221707478491064,positive,0.7822685788787485,neutral
2019-12-17 23:01:49.291,755.5,767.9,753.8,767.0,1246323.0,Debt reduction may strengthen Lupin," Lupin Ltd on Tuesday said that its subsidiary Nanomi B.V. has completed the divestiture of the entire stake in Kyowa Pharmaceutical Industry Co Ltd to Unison Capital Partners IV, LPS and Unison Capit",positive,neutral,1.5221707478491064,positive,0.7822685788787485,neutral
2019-12-17 23:02:22.171,755.5,767.9,753.8,767.0,1246323.0,Lupin's arm Nanomi BV completes stake divestment in Kyowa Pharma,"Last month, Lupin's board had approved the stake sale in Kyowa",positive,positive,1.5221707478491064,positive,0.7822685788787485,neutral
2019-12-19 18:00:35.280,775.0,778.0,767.1,768.95,1140911.0,Lupin share price gains on USFDA nod for Mycophenolic drug,"With this approval, the company said it would market a generic equivalent of Myfortic delayed release tablets of Novartis Pharmaceuticals Corporation,",positive,positive,-0.7806451612903167,neutral,0.1365498406918466,neutral
2019-12-19 18:02:29.853,775.0,778.0,767.1,768.95,1140911.0,Lupin launches Doxercalciferol Injection; stock trades flat,It is indicated for the treatment of secondary hyperparathyroidism in adult patients with CKD on dialysis.,neutral,neutral,-0.7806451612903167,neutral,0.1365498406918466,neutral
2019-12-19 18:05:59.400,775.0,778.0,767.1,768.95,1140911.0,Lupin receives USFDA approval for Mycophenolic Acid Delayed-Release tablets,"Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg, are indicated for use in combination with cyclosporine and corticosteroids.",positive,neutral,-0.7806451612903167,neutral,0.1365498406918466,neutral
2019-12-19 23:01:35.938,775.0,778.0,767.1,768.95,1140911.0,Lupin's partner Concord gets USFDA nod to market generic Myfortic tablet,"The product is a generic version of Novartis Pharmaceuticals Corporation's Myfortic delayed-release tablets in the same strengths, it added",neutral,neutral,-0.7806451612903167,neutral,0.1365498406918466,neutral
2019-12-19 23:03:17.193,775.0,778.0,767.1,768.95,1140911.0,Lupin stock may shine on USFDA approval," Lupin Ltd in alliance with Concord Biotech has received approval from the United States Food and Drug Administration for Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg. The drug is",positive,positive,-0.7806451612903167,neutral,0.1365498406918466,neutral
2019-12-20 10:03:36.377,775.0,778.0,767.1,768.95,1140911.0,Lupin in alliance with Concord gets nod for Mycophenolic Acid Delayed-Release Tablets USP,"Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg RLD: Myfortic had an annual sale of approximately USD 174 million in the US, as per IQVIA MAT September 2019.",neutral,neutral,-0.7806451612903167,neutral,0.1365498406918466,neutral
2019-12-20 13:05:21.200,775.0,778.0,767.1,768.95,1140911.0,Hold Lupin; target of Rs 760: Prabhudas Lilladher,"Prabhudas Lilladher recommended hold rating on Lupin with a target price of Rs 760 in its research report dated December 19, 2019.
",neutral,positive,-0.7806451612903167,neutral,0.1365498406918466,neutral
2019-12-20 18:00:18.676,775.0,778.0,767.1,768.95,1140911.0,Lupin share price gains on USFDA nod for rheumatic disorder drug,"The product will be manufactured at Lupin's Pithampur facility, the company said in its BSE filing.",positive,neutral,-0.7806451612903167,neutral,0.1365498406918466,neutral
2019-12-20 18:01:32.828,775.0,778.0,767.1,768.95,1140911.0,Lupin gets USFDA nod to market skin ointment,"The approval by the United States Food and Drug Administration (USFDA) is to market its generic Betamethasone Dipropionate ointment USP (augmented), 0.05 per cent, it added.",neutral,positive,-0.7806451612903167,neutral,0.1365498406918466,neutral
2019-12-20 18:02:49.046,775.0,778.0,767.1,768.95,1140911.0,Lupin gets USFDA nod to market skin ointment,"The product will be manufactured at the company's Pithampur, Unit 3 facility, Lupin said in a filing to the BSE. The approval by the United States Food and Drug Administration (USFDA) is to market its generic Betamethasone Dipropionate ointment USP (augmented), 0.05 per cent, it added.",neutral,neutral,-0.7806451612903167,neutral,0.1365498406918466,neutral
2019-12-24 18:02:02.106,770.0,770.9,762.65,765.1,425349.0,Lupin's Ankleshwar cacility wins Frost & Sullivan's India manufacturing excellence awards 2019,"Mumbai (Maharashtra) [India], Dec 24 (ANI): Pharma major Lupin Ltd said on Tuesday that its Ankleshwar facility has been awarded 'Future Ready Factory of the Year' by Frost & Sullivan's India Manufacturing Excellence Awards (IMEA) 2019.",positive,positive,-0.6363636363636335,neutral,-1.434159061277705,negative
2019-12-26 10:01:46.998,767.0,771.0,755.05,756.0,548392.0,Lupin's Ankleshwar facility wins Frost & Sullivan's India Manufacturing Excellence Awards 2019,Lupin's Ankleshwar facility wins Frost & Sullivan's India Manufacturing Excellence Awards 2019,positive,positive,-1.434159061277705,negative,1.4216137949190408,positive
2019-12-26 10:06:52.572,767.0,771.0,755.05,756.0,548392.0,"Stocks in the news: Yes Bank, HCL Tech, Lupin, Bharti Infratel, Federal Bank, IDBI Bank",Yes Bank | HCL Tech | Lupin | Bharti Infratel | Federal Bank | IDBI Bank and Stampede Capital are among the stocks that are in news today.,neutral,neutral,-1.434159061277705,negative,1.4216137949190408,positive
2020-01-10 13:00:31.369,763.15,778.5,757.5,760.0,1819030.0,"Pharma shares in focus; Dr Reddy's, Divi's, Granules hit 52-week highs","Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.",positive,positive,-0.4127628906505899,neutral,-0.991407799074686,negative
2020-01-10 23:02:45.415,763.15,778.5,757.5,760.0,1819030.0,Lupin appoints J Alan Butcher as Chief Corporate Development Officer,Lupin on Friday announced the appointment of J Alan Butcher as its Chief Corporate Development Officer. Alan will lead the company’s global corporate development efforts and will be responsible for it,neutral,neutral,-0.4127628906505899,neutral,-0.991407799074686,negative
2020-01-12 10:00:28.174,756.5,763.0,740.5,749.0,2326310.0,"A Prior Approval Inspection was carried out by the United States Food and Drug Administration at Lupin's Nagpur oral solid dosage manufacturing facility between January 6-10, 2020","A Prior Approval Inspection was carried out by the United States Food and Drug Administration at Lupin's Nagpur oral solid dosage manufacturing facility between January 6-10, 2020",neutral,neutral,-0.991407799074686,negative,-0.1660688189185598,neutral
2020-01-12 10:02:12.396,756.5,763.0,740.5,749.0,2326310.0,Lupin gets two observations from USFDA for Nagpur facility,"Lupin will address the observations raised by the agency satisfactorily, said Lupin MD.The Nagpur facility is Lupin's latest oral solid dosage facility, and this was the seventh USFDA inspection at the facility",neutral,neutral,-0.991407799074686,negative,-0.1660688189185598,neutral
2020-01-13 10:03:54.647,756.5,763.0,740.5,749.0,2326310.0,Lupin issued two 483 observations by USFDA at Nagpur oral solid dosage manufacturing facility,"The inspection was carried out between January 6, 2020 and January 10, 2020.",negative,neutral,-0.991407799074686,negative,-0.1660688189185598,neutral
2020-01-13 13:02:14.128,752.7,758.9,750.45,751.45,1212518.0,USFDA classifies inspection of Lupin's Tarapur facility as 'Official Action Indicated',"According to FDA's definitions, Official Action Indicated means ""objectionable conditions were found and regulatory administrative sanctions by FDA are indicated"" during inspections.  The company, however, said that it does not believe this inspection classification will have an impact on disruption of supplies or the existing revenues from operations of this facility. ",neutral,neutral,-0.1660688189185598,neutral,0.2659574468085106,neutral
2020-01-13 13:02:32.303,752.7,758.9,750.45,751.45,1212518.0,Lupin slips 2% after USFDA classifies Tarapur facility inspection as OAI,The Company does not believe that this inspection classification will have an impact on disruption of supplies or the existing revenues from operations of this facility.,neutral,neutral,-0.1660688189185598,neutral,0.2659574468085106,neutral
2020-01-13 13:02:35.923,752.7,758.9,750.45,751.45,1212518.0,Lupin dips 2% as USFDA classifies Tarapur unit as Official Action Indicated,"The company, however, said it does not believe that this inspection classification will have an impact on disruption of supplies or the existing revenues from operations of this facility.",neutral,neutral,-0.1660688189185598,neutral,0.2659574468085106,neutral
2020-01-13 13:03:32.048,752.7,758.9,750.45,751.45,1212518.0,USFDA classifies inspection of Lupin's Tarapur facility as 'Official Action Indicated',"""The company has received a communication from the US FDA classifying the inspection conducted at its Tarapur manufacturing (API) facility between September 16 to September 20, 2019 as Official Action Indicated (OAI),"" Lupin Ltd said in a filing to BSE.",neutral,neutral,-0.1660688189185598,neutral,0.2659574468085106,neutral
2020-01-13 13:04:45.164,752.7,758.9,750.45,751.45,1212518.0,Lupin share price falls 2% after USFDA classifies Tarapur unit as OAI,USFDA inspected company's manufacturing (API) facility between September 16 to September 20.,negative,neutral,-0.1660688189185598,neutral,0.2659574468085106,neutral
2020-01-13 18:03:26.129,752.7,758.9,750.45,751.45,1212518.0,US FDA to take regulatory action against Lupin’s Tarapur unit,"US FDA has classified the inspection conducted at pharmaceutical company Lupin Ltd’s Tarapur manufacturing facility as official action indicated.The US regulator, which conducted the inspection from 16-20 September 2019, has concluded with three observations",neutral,neutral,-0.1660688189185598,neutral,0.2659574468085106,neutral
2020-01-14 10:06:27.747,752.7,758.9,750.45,751.45,1212518.0,USFDA classifies inspection of Lupin unit as 'Official Action Indicated',Official Action Indicated means 'objectionable conditions were found and regulatory administrative sanctions by FDA are indicated' during inspections,neutral,neutral,-0.1660688189185598,neutral,0.2659574468085106,neutral
2020-01-14 13:04:35.385,752.0,756.8,746.7,754.0,1220417.0,Lupin share price up 1% after Nomura maintains buy,Kotak Institutional Equities has maintained add rating with a target at Rs 840 per share.,positive,positive,0.2659574468085106,neutral,0.4258150365934857,neutral
2020-01-14 18:03:37.141,752.0,756.8,746.7,754.0,1220417.0,Lupin's US FDA compliance woes suggest the problem runs deeper,Tarapur is Lupin’s fifth facility in the past 12 months to be hit by regulatory compliance issues. ,negative,negative,0.2659574468085106,neutral,0.4258150365934857,neutral
2020-01-14 23:00:41.886,752.0,756.8,746.7,754.0,1220417.0,"A couple of days ago, Lupin said that it had received two observations from the US health regulator following the inspection at its Nagpur manufacturing facility, one of its most modern plants","A couple of days ago, Lupin said that it had received two observations from the US health regulator following the inspection at its Nagpur manufacturing facility, one of its most modern plants",neutral,neutral,0.2659574468085106,neutral,0.4258150365934857,neutral
2020-01-20 11:53:36.124,760.0,760.25,730.1,733.35,3213029.0,Lupin falls 3% as USFDA issues 5 observations for Vizag facility,"The United States Food and Drug Administration (USFDA) carried out the inspection of the company's Vizag API manufacturing facility between January 13, 2020 and January 17, 2020.",neutral,neutral,-3.506578947368418,negative,0.9276944065484248,positive
2020-01-20 11:55:28.935,760.0,760.25,730.1,733.35,3213029.0,USFDA completes inspection of Lupin's Vizag API facility,The inspection at the API facility at Vizag closed with five 483 observations.,neutral,positive,-3.506578947368418,negative,0.9276944065484248,positive
2020-01-20 18:02:28.346,733.0,744.25,727.25,739.8,1619851.0,Lupin share price dips 4% after USFDA issues observations for Vizag facility,"The inspection was carried out between January 13, 2020 and January 17, 2020.",negative,neutral,0.9276944065484248,positive,-0.5718129835183317,neutral
2020-01-27 13:02:17.202,755.0,756.7,745.1,745.45,1321625.0,Lupin's Pithampur facilities complete successful MHRA inspection,"Mumbai (Maharashtra) [India], Jan 27 (ANI): Pharma major Lupin Ltd on Monday announced the successful completion of inspection carried out by the UK Medicines and Healthcare products Regulatory Agency (MHRA) at its three manufacturing units in Pithampur town of Madhya Pradesh.",positive,positive,-1.2649006622516497,negative,-0.7600000000000061,neutral
2020-01-30 10:05:03.349,745.9,745.9,725.55,728.2,1152786.0,Coronavirus pandemic threatens to cut pharmaceutical industry’s lifeline,"Raw materials from China are used in making antibiotics, paracetamol, and diabetes and cardiovascular drugs, among others. Companies including Lupin, Sun Pharmaceuticals, Glenmark, Mankind, Dr Reddys, Torrent, Aurobindo Pharma and Abbott are hugely dependent on Chinese imports. ",negative,neutral,-2.3729722482906466,negative,-2.138964577656682,negative
2020-02-06 10:01:50.131,731.5,738.75,706.0,728.0,5684763.0,"Board Meetings Today: Sun Pharma, Hero MotoCorp, Eicher Motors, Lupin and IDFC"," Bata India, Aurobindo Pharma, NMDC and UCO Bank are some of the companies which will report Q3 results today.",neutral,neutral,-0.4784688995215311,neutral,-0.3107344632768426,neutral
2020-02-06 10:03:28.480,731.5,738.75,706.0,728.0,5684763.0,"Top stocks in focus: Lupin, Avenue Supermarts, Sun Pharma, Eicher, Hero MotoCorp",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.4784688995215311,neutral,-0.3107344632768426,neutral
2020-02-06 10:05:18.905,731.5,738.75,706.0,728.0,5684763.0,"Important results today: Eicher Motors, Hero MotoCorp, Sun Pharma, Indraprastha Gas","Eicher Motors, Hero MotoCorp, Sun Pharmaceutical, Lupin, Aurobindo Pharma, Metropolis Healthcare and RITES will release their December quarter numbers today.",neutral,neutral,-0.4784688995215311,neutral,-0.3107344632768426,neutral
2020-02-06 23:00:33.390,708.0,714.25,695.0,705.8,7355196.0,"Lupin Q3 net loss widens to Rs 835 crore, sales drop to Rs 3,716 crore","Consolidated sales of the company stood at Rs 3,716 crore for the quarter under consideration",negative,neutral,-0.3107344632768426,neutral,-0.7011828033146887,neutral
2020-02-06 23:00:35.117,708.0,714.25,695.0,705.8,7355196.0,Lupin's net loss widens at Rs835cr in Q3; exceptional loss of Rs289cr,"The pharma company’s revenue fell by 5% yoy at Rs3,769cr in Q3FY20 as against Rs3,947cr in the same quarter last year.",positive,negative,-0.3107344632768426,neutral,-0.7011828033146887,neutral
2020-02-06 23:00:56.559,708.0,714.25,695.0,705.8,7355196.0,Lupin expects to end FY20 with 18% margins,Lupin reported loss of Rs 835 crore for the quarter ended December due to impairment of certain intangible assets worth Rs 405.4 crore. ,positive,negative,-0.3107344632768426,neutral,-0.7011828033146887,neutral
2020-02-06 23:03:10.684,708.0,714.25,695.0,705.8,7355196.0,Lupin posts Rs835 crore loss in Oct-Dec on second Gavis impairment,"The impairment provision for Gavis Pharmaceuticals was Rs1,580 crore.Another factor leading to the company’s consolidated net loss was the sharp rise in tax outgo to Rs767 crore from Rs245 crore",neutral,negative,-0.3107344632768426,neutral,-0.7011828033146887,neutral
2020-02-06 23:04:10.263,708.0,714.25,695.0,705.8,7355196.0,Lupin Q3 out: The pharma firm reported a widening of its consolidated net loss to Rs 835 crore for Q3FY19. Shares of Lupin ended at Rs 720.05 on the BSE. Here's for more,Lupin Q3 out: The pharma firm reported a widening of its consolidated net loss to Rs 835 crore for Q3FY19. Shares of Lupin ended at Rs 720.05 on the BSE. Here's for more,neutral,neutral,-0.3107344632768426,neutral,-0.7011828033146887,neutral
2020-02-07 10:07:17.824,708.0,714.25,695.0,705.8,7355196.0,Lupin faces regulatory challenges; high costs hit profit margins in Q3,"High costs have hit Q3 margins, while multiple one-offs have impacted firm's bottom line",negative,negative,-0.3107344632768426,neutral,-0.7011828033146887,neutral
2020-02-07 18:04:23.831,708.0,714.25,695.0,705.8,7355196.0,D-Street Buzz: Nifty Pharma outperforms led by Aurobindo Pharma; Eicher Motors drags,"The most active stocks included Indiabulls Housing Finance, State Bank of India, Aurobindo Pharma, Hero MotoCorp and Lupin.",neutral,neutral,-0.3107344632768426,neutral,-0.7011828033146887,neutral
2020-02-11 18:00:47.205,708.0,712.0,698.5,703.5,2265392.0,Hold Lupin; target of Rs 675: ICICI Direct,"ICICI Direct recommended hold rating on Lupin with a target price of Rs 675 in its research report dated February 11, 2019.",neutral,positive,-0.6355932203389831,neutral,-0.481313703284255,neutral
2020-02-12 18:01:21.976,706.4,708.6,699.55,703.0,2356366.0,USFDA completes inspection of Lupin's Pithampur (Unit-I) facility,"The inspection for the Pithampur (Unit-I) facility closed with two 483 observations, the pharma company said.",neutral,negative,-0.481313703284255,neutral,2.1291696238467,positive
2020-02-12 18:03:12.204,706.4,708.6,699.55,703.0,2356366.0,USFDA issues 2 observations after inspection of Lupin's Pithampur unit,The inspection of the company's Pithampur Unit-I facility by the USFDA has been completed.,neutral,positive,-0.481313703284255,neutral,2.1291696238467,positive
2020-02-14 23:04:00.039,704.5,721.45,704.5,719.5,1845382.0,Lupin launches moxifloxacin ophthalmic solution,"Lupin has launched moxifloxacin ophthalmic solution USP, 0.5%, having received approval from the United States Food and Drug Administration earlier. The product would be manufactured at Lupin&#39;s Pi",neutral,neutral,2.1291696238467,positive,-1.0160055671537862,negative
2020-02-17 00:55:04.000,718.5,731.25,710.6,711.2,1401379.0,Lupin: Soft Earnings Result Highlights The Challenged Outlook,Lupin reported a soft 3Q FY20 performance with widened losses driven by exceptional events as well as operational weakness amid regulatory challenges.The ramp-up of Levothyroxine sales and the expected 1H FY21 launch of Albuterol in the US are the keys to margin expansion in FY21.Management has impl…,neutral,negative,-1.0160055671537862,negative,-1.0551491277433878,negative
2020-02-17 10:00:37.497,718.5,731.25,710.6,711.2,1401379.0,Two stocks that Vaishali Parekh of Prabhudas Lilladher is bullish on,Lupin has witnessed some erosion in recent times and has currently showed signs of bottoming out near Rs 695 levels,positive,negative,-1.0160055671537862,negative,-1.0551491277433878,negative
2020-02-17 10:04:54.114,718.5,731.25,710.6,711.2,1401379.0,"Tata Global, Lupin, Biocon among top 12 money-making ideas for next few weeks",Market direction remains uncertain but analysts see stock-picking opportunities everywhere.,neutral,neutral,-1.0160055671537862,negative,-1.0551491277433878,negative
2020-02-17 18:04:08.150,710.8,710.95,694.0,703.3,1224454.0,USFDA inspection of Lupin's Aurangabad facility completed with no observation,"The inspection was carried out by the United States Food and Drug Administration (USFDA) between February 10 to 14, 2020, Lupin said in a filing to the BSE.

",neutral,neutral,-1.0551491277433878,negative,0.5531914893616989,neutral
2020-02-24 18:00:33.601,680.0,680.0,667.4,671.0,2838101.0,Lupin share price down 2% after 2 USFDA observations on Pithampur unit,One of observations was that Lupin has failed to thoroughly investigate an unexplained discrepancy.,negative,negative,-1.3235294117647058,negative,0.2469690166142759,neutral
2020-02-25 18:01:00.606,668.1,676.0,664.55,669.75,2121767.0,Lupin launches Ethacrynic Acid Tablets USP,"The product would be manufactured at Lupin's Nagpur OSD facility, India.",neutral,neutral,0.2469690166142759,neutral,-0.762217904648038,neutral
2020-03-03 10:04:10.970,637.0,660.55,635.3,650.35,2135560.0,Lupin share price gains nearly 3% as brokerages expect up to 50% upside,Morgan Stanley has maintained overweight call with a target at Rs 948 per share.,positive,positive,2.0957613814756706,positive,1.6533986527862758,positive
2020-03-06 10:04:03.802,665.0,673.8,657.2,663.3,3466575.0,Lupin launches authorized generic version of Vimovo,"Naproxen and Esomeprazole Magnesium Delayed-Release Tablets (RLD: Vimovo) had an annual sale of ~USD 400 million in the US (IQVIA MAT January 2020), the pharma company added.",neutral,neutral,-0.2556390977443677,neutral,0.9302325581395348,positive
2020-03-06 10:04:55.948,665.0,673.8,657.2,663.3,3466575.0,"Stocks to watch today on March 6: YES Bank, Tata Power, Cadila, Lupin, PNB, Union Bank among others are the top stocks to watch out for in Friday's trading session","Stocks to watch today on March 6: YES Bank, Tata Power, Cadila, Lupin, PNB, Union Bank among others are the top stocks to watch out for in Friday's trading session",neutral,neutral,-0.2556390977443677,neutral,0.9302325581395348,positive
2020-03-11 13:05:15.654,629.0,629.0,583.65,597.0,4991014.0,"Stocks to watch today on March 11: Asian Paints, Cadila, Lupin, City Union Bank among others are the top stocks to watch out for in Wednesday's trading session","Stocks to watch today on March 11: Asian Paints, Cadila, Lupin, City Union Bank among others are the top stocks to watch out for in Wednesday's trading session",neutral,neutral,-5.087440381558029,negative,11.445454545454552,positive
2020-03-20 10:01:34.574,640.7,665.1,631.25,644.7,2707862.0,"Top stocks in focus: Indiabulls Housing, Yes Bank, Sobha, SBI, Lupin",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.6243171531137818,neutral,-1.3114754098360657,negative
2020-03-23 10:01:50.556,610.0,631.95,586.1,602.0,1676395.0,Lupin launches Betamethasone Dipropionate Ointment USP,"The product would be manufactured at Lupin's Pithampur (Unit Ill) facility, India.",neutral,neutral,-1.3114754098360657,negative,0.5543710021321961,neutral
2020-03-23 10:02:53.821,610.0,631.95,586.1,602.0,1676395.0,"Top stocks in focus: Escorts, SBI, Shree Cement, Titan, Eicher Motors, Lupin",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.3114754098360657,negative,0.5543710021321961,neutral
2020-03-27 10:02:08.544,565.05,591.6,542.35,553.0,4898915.0,Lupin appoints Ramesh Swaminathan as CFO and Head Corporate Affairs,"Ramesh will lead Lupin’s Finance, Investor Relations, Strategic Planning, Information Technology, Corporate Communications and Administration functions.",neutral,positive,-2.132554641182188,negative,2.030825022665466,positive
2020-03-27 10:02:29.218,565.05,591.6,542.35,553.0,4898915.0,"Stocks to watch: NTPC, YES Bank, Future Group stks, Lupin, Aurobindo Pharma",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,-2.132554641182188,negative,2.030825022665466,positive
2020-03-27 10:02:45.814,565.05,591.6,542.35,553.0,4898915.0,"Stocks to watch today on March 27: Laurus Labs, Wabco India, Sonata Software, Sanghvi Movers, Lupin, Mindtree, Motilal Oswal among others are the top stocks to watch out for in Friday's trading session","Stocks to watch today on March 27: Laurus Labs, Wabco India, Sonata Software, Sanghvi Movers, Lupin, Mindtree, Motilal Oswal among others are the top stocks to watch out for in Friday's trading session",neutral,neutral,-2.132554641182188,negative,2.030825022665466,positive
2020-03-27 23:00:34.330,565.05,591.6,542.35,553.0,4898915.0,Lupin Appoints Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs,Lupin Appoints Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs,neutral,neutral,-2.132554641182188,negative,2.030825022665466,positive
2020-03-30 10:03:51.380,551.5,573.5,535.25,562.7,2777198.0,"Top stocks in focus: Sun Pharma, Maruti Suzuki, Coffee Day, IndusInd Bank, Lupin",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,2.030825022665466,positive,2.940663176265274,positive
2020-03-30 10:05:26.607,551.5,573.5,535.25,562.7,2777198.0,"Stocks in the news: SBI, IDBI Bank, Tata Power, Graphite, Lupin, Godawari Power, Sun Pharma",Graphit India | Sun Pharma | Future Supply Chain | SBI | Abott India | HeidelbergCement India | Sobha | Future Enterprises and aviation stocks are in the news today.,neutral,neutral,2.030825022665466,positive,2.940663176265274,positive
2020-03-30 13:03:40.719,573.0,594.4,568.25,589.85,3151198.0,Lupin gets EIR from USFDA for Florida-based inhalation research centre,"The facility was inspected by the US Food and Drug Administration (USFDA), between February 19, 2020, and February 26, 2020, on behalf of the UK Medicines and Healthcare Products Regulatory Agency (UKMHRA) for company's application for generic Fostair.",neutral,neutral,2.940663176265274,positive,-1.5681953038908198,negative
2020-03-30 13:04:38.306,573.0,594.4,568.25,589.85,3151198.0,Lupin gets EIR from USFDA for Florida-based inhalation research centre,"The Center at Coral Springs, Florida, focuses on research and development of respiratory products for the treatment of asthma, chronic obstructive pulmonary diseases and other respiratory ailments.",neutral,neutral,2.940663176265274,positive,-1.5681953038908198,negative
2020-03-30 13:04:39.374,573.0,594.4,568.25,589.85,3151198.0,Lupin share price jumps 5% on EIR from USFDA,"The company received the establishment inspection report for its Inhalation Research Center located at Coral Springs, Florida.",positive,neutral,2.940663176265274,positive,-1.5681953038908198,negative
2020-03-31 13:01:34.349,589.85,590.8,575.45,580.6,1298751.0,"L&T, Reliance, Lupin stocks rise after brokerage views",Larsen & Toubro (L&T) stock gained 1% after a media report said that Credit Suisse upgraded the stock to “outperform” from “neutral”.,positive,positive,-1.5681953038908198,negative,13.082668040175111,positive
2020-04-03 13:04:07.624,582.45,665.9,578.0,658.65,6492140.0,Lupin's Aurangabad facility receives EIR from USFDA; stock up 3.6%,"The inspection for the facility was carried out by the USFDA between February 10, 2020 and February 14, 2020 and concluded with no observations.",positive,neutral,13.082668040175111,positive,1.3043478260869563,positive
2020-04-03 13:05:46.233,582.45,665.9,578.0,658.65,6492140.0,Lupin share price rises 3% as USFDA clears its Aurangabad facility,"The inspection for the facility was carried out by the USFDA between February 10, 2020 and February 14, 2020 and concluded with no observations.",positive,neutral,13.082668040175111,positive,1.3043478260869563,positive
2020-04-03 18:03:52.090,582.45,665.9,578.0,658.65,6492140.0,Lupin’s Aurangabad facility gets establishment inspection report from USFDA,Pharma major Lupin Ltd has received Establishment Inspection Report (EIR) from the US Food and Drug Administration for its Aurangabad facility. The inspection for the facility was carried out by the U,neutral,neutral,13.082668040175111,positive,1.3043478260869563,positive
2020-04-06 10:03:55.901,690.0,738.65,670.25,699.0,8164444.0,"Gainers & Losers: 10 stocks that moved most last week; ITC, RBL Bank, Lupin top charts","Experts suggest that 7,800 would be a crucial level to watch out for. If it breaks, then it could touch 2020's lows.",neutral,neutral,1.3043478260869563,positive,1.369472182596294,positive
2020-04-06 18:02:14.888,690.0,738.65,670.25,699.0,8164444.0,Lupin launches generic drug used for prevention of organ rejection in kidney transplant in US,"Drug firm Lupin on Monday said it has launched generic Mycophenolic acid delayed-release tablets, which is used to prevent organ rejection in patients receiving kidney transplants in the US market.",neutral,positive,1.3043478260869563,positive,1.369472182596294,positive
2020-04-07 10:00:52.031,690.0,738.65,670.25,699.0,8164444.0,Lupin launches Mycophenolic Acid Delayed-Release Tablets; stock up 6%,Lupin’s alliance partner Concord Biotech Limited (Concord) had received approval from the USFDA earlier.,positive,positive,1.3043478260869563,positive,1.369472182596294,positive
2020-04-07 10:01:26.325,690.0,738.65,670.25,699.0,8164444.0,"ITC, Britannia, Torrent, Abbott, Sanofi, Lupin better choices now","For traders, there will be plenty of opportunities with low risk-reward ratio due to higher stop-loss.",positive,positive,1.3043478260869563,positive,1.369472182596294,positive
2020-04-07 10:01:39.146,690.0,738.65,670.25,699.0,8164444.0,"Top stocks in focus: CESC, Lupin, Sobha, IndusInd Bank, PNB Housing Finance",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.3043478260869563,positive,1.369472182596294,positive
2020-04-07 10:03:33.361,690.0,738.65,670.25,699.0,8164444.0,"Stocks to watch today on April 7: HDFC Bank, Lupin, Kotak Mahindra Bank, IndusInd Bank, Sobha, DCB Bank, MOIL, NMDC, Force Motors, Dhampur Sugar Mills, Bharat Gears, Axis Bank, ICICI Bank among others are the top stocks to watch out for in Tuesday's trading session","Stocks to watch today on April 7: HDFC Bank, Lupin, Kotak Mahindra Bank, IndusInd Bank, Sobha, DCB Bank, MOIL, NMDC, Force Motors, Dhampur Sugar Mills, Bharat Gears, Axis Bank, ICICI Bank among others are the top stocks to watch out for in Tuesday's trading session",neutral,neutral,1.3043478260869563,positive,1.369472182596294,positive
2020-04-07 13:00:42.801,701.0,734.45,698.55,710.6,6926219.0,Lupin share price jumps 3% on launch of generic drug; Morgan Stanley sees target of Rs 948,"The tablets are generic version of Novartis Pharmaceuticals Corporation's Myfortic delayed-release tablets, 180 mg and 360 mg, Lupin said.",positive,neutral,1.369472182596294,positive,7.581128988273797,positive
2020-04-07 18:03:34.375,701.0,734.45,698.55,710.6,6926219.0,Stock prices of Lupin Ltd witnessed a jump of over 3 percent during early morning trade on Tuesday. The share price rise came a day after Lupin launched generic mycophenolic acid delayed-release tablets in the US market.,Stock prices of Lupin Ltd witnessed a jump of over 3 percent during early morning trade on Tuesday. The share price rise came a day after Lupin launched generic mycophenolic acid delayed-release tablets in the US market.,positive,positive,1.369472182596294,positive,7.581128988273797,positive
2020-04-07 18:04:06.915,701.0,734.45,698.55,710.6,6926219.0,Winners & Losers: 10 stocks that moved the most on April 7,IndusInd Bank and HDFC Bank from the banking space were the top gainers while Dr Reddy's Labs and Lupin rallied from the pharma space.,neutral,positive,1.369472182596294,positive,7.581128988273797,positive
2020-04-08 18:02:53.077,733.4,798.0,733.4,789.0,13727927.0,"Nifty Pharma index gains led by Cadila, Sun Pharma","Cipla rose 4%, Dr Reddy’s, Piramal, Glenmark and Lupin was up in the range of 2-1% respectively and Biocon was up 1.5%.",positive,positive,7.581128988273797,positive,2.6119402985074625,positive
2020-04-09 10:13:01.000,733.4,798.0,733.4,789.0,13727927.0,"Sensex, Nifty trade with healthy gains, pvt banks, IT stocks rally; key factors from today’s trade","Among all sectoral indices, Nifty Pharma was the top gainer, up 5.6 per cent led by gains in Cipla, Lupin and Sun Pharma. SImilarly, Nifty Bank index gained 620 points with IDFC First Bank, Kotak Mahindra Bank and Axis Bank as top index gainers.",positive,positive,7.581128988273797,positive,2.6119402985074625,positive
2020-04-09 21:21:00.000,733.4,798.0,733.4,789.0,13727927.0,Coronavirus outbreak: Quick USFDA approvals for asthma drug makers,Cipla gets nod for drug from USFDA earlier than expected; Lupin in fray,positive,neutral,7.581128988273797,positive,2.6119402985074625,positive
2020-04-13 05:30:00.000,804.0,848.8,799.0,825.0,10063712.0,BRIEF-Lupin Says Nagpur Facility Gets EIR From U.S. FDA - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,2.6119402985074625,positive,-3.5733238988147966,negative
2020-04-13 06:00:00.000,804.0,848.8,799.0,825.0,10063712.0,Lupin’s Nagpur Facility Receives EIR from USFDA; stock surges 4%,"The inspection for the facility was carried out by the USFDA between January 6, 2020 and January 10, 2020.",positive,neutral,2.6119402985074625,positive,-3.5733238988147966,negative
2020-04-13 09:00:00.000,804.0,848.8,799.0,825.0,10063712.0,"Lupin, Cipla, Cadila, Maruti, M&M, CONCOR good buys",. Traders are advised to keep following stock-centric approach and should keep booking timely profits on a regular basis.,positive,neutral,2.6119402985074625,positive,-3.5733238988147966,negative
2020-04-13 11:41:43.000,804.0,848.8,799.0,825.0,10063712.0,"Lupin gets EIR from USFDA for Nagpur plant; MD says committed to enhance compliance, quality standards at all sites - Firstpost",Drug maker Lupin on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant in Nagpur,positive,positive,2.6119402985074625,positive,-3.5733238988147966,negative
2020-04-13 12:45:43.000,804.0,848.8,799.0,825.0,10063712.0,Lupin gets USFDA nod for Nagpur facility,Pharma major Lupin Ltd has received an Establishment Inspection Report (EIR) after closure of the US FDA inspection of its Nagpur facility. The inspection for the facility was carried out between Janu,neutral,neutral,2.6119402985074625,positive,-3.5733238988147966,negative
2020-04-13 12:50:00.000,804.0,848.8,799.0,825.0,10063712.0,Lupin share price gains 8% after Nagpur unit receives EIR from USFDA,"The US Food and Drug Administration inspected the facility between January 6 and 10, 2020.",positive,neutral,2.6119402985074625,positive,-3.5733238988147966,negative
2020-04-13 12:55:31.000,804.0,848.8,799.0,825.0,10063712.0,Lupin gets EIR from USFDA for its manufacturing plant in Nagpur,The companys shares surged 4.14% to Rs 820.40 after they received the inspection report (EIR) from the US drug regulator,neutral,positive,2.6119402985074625,positive,-3.5733238988147966,negative
2020-04-13 15:42:37.000,804.0,848.8,799.0,825.0,10063712.0,"Pharmaceutical stocks rally yet again: Cipla shares hit all-time high; Cadila Healthcare, Lupin jump","Even after a three-day break from trading, the story for pharma shares such as Cipla, Cadila Healthcare and Lupin remains the same -- hitting fresh highs and moving up, defying the benchmark indices which have been unable to exit the red on Monday.",positive,neutral,2.6119402985074625,positive,-3.5733238988147966,negative
2020-04-13 17:51:00.000,804.0,848.8,799.0,825.0,10063712.0,"Market Movers: L&T, Lupin, DRL gain; HDFC twins key drag; 50 stocks enter ‘buy’ zone","HDFC twins and Reliance Industries were among the biggest drags, but a jump in L&T after three ’large order wins cushion the fall to some extent.",positive,positive,2.6119402985074625,positive,-3.5733238988147966,negative
2020-04-13 19:02:00.000,804.0,848.8,799.0,825.0,10063712.0,Lupin share price rises 8% intra day after Nagpur unit gets EIR from USFDA,Lupin share price closed higher in trade today after the pharma firm’s Nagpur facility received Establishment Inspection Report (EIR) from the US health regulator. Issuance of an EIR after completion of inspection is considered good for a pharma or healt,positive,positive,2.6119402985074625,positive,-3.5733238988147966,negative
2020-04-14 16:18:00.000,847.95,854.0,791.35,817.65,7000183.0,"Four Indian drug makers’ manufacturing plants get USFDA clearance, says report","On April 13, Lupin received an Establishment Inspection Report from the FDA for its Nagpur plant.",neutral,positive,-3.5733238988147966,negative,2.981366459627329,positive
2020-04-15 00:47:00.000,847.95,854.0,791.35,817.65,7000183.0,Clearance from US drug regulator key for Lupin to sustain stock gains,The recent gains came on Monday after the company received the USFDA approval for its Nagpur facility,positive,positive,-3.5733238988147966,negative,2.981366459627329,positive
2020-04-15 05:30:00.000,847.95,854.0,791.35,817.65,7000183.0,BRIEF-Lupin’s Mandideep Unit II Facility Gets EIR From U.S. FDA. - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-3.5733238988147966,negative,2.981366459627329,positive
2020-04-15 06:00:00.000,847.95,854.0,791.35,817.65,7000183.0,Lupin’s Mandideep unit II facility gets EIR from USFDA; stock gains 2%,"The inspection at the facility was carried out by the USFDA between November 26, 2018, and December 4, 2018, Lupin said.",positive,neutral,-3.5733238988147966,negative,2.981366459627329,positive
2020-04-15 09:43:00.000,847.95,854.0,791.35,817.65,7000183.0,Lupin share price rises over 3% on receiving EIR from USFDA,"The inspection at the facility was carried out by the USFDA between November 26, 2018 and December 4, 2018.",positive,neutral,-3.5733238988147966,negative,2.981366459627329,positive
2020-04-15 10:41:00.000,847.95,854.0,791.35,817.65,7000183.0,Lupin extends gain into sixth session as Mandideep unit gets EIR from USFDA,"The stock of the drug maker has rallied 47 per cent in the past six trading days, and was quoting close to its 52-week high level of Rs 882",positive,positive,-3.5733238988147966,negative,2.981366459627329,positive
2020-04-15 10:56:31.000,847.95,854.0,791.35,817.65,7000183.0,Lupin’s Mandideep Unit II facility receives EIR from USFDA,"The inspection at the facility was carried out by the US Food and Drug Administration between November 26, 2018, and December 4, 2018.In a filing to BSE, the company said Lupin has received the EIR after closure of the USFDA inspection of its Mandideep Unit II facility, classifying the ins…",neutral,neutral,-3.5733238988147966,negative,2.981366459627329,positive
2020-04-15 11:20:10.000,847.95,854.0,791.35,817.65,7000183.0,Lupin’s Mandideep Unit II facility in Madhya Pradesh receives EIR from USFDA - Firstpost,Pharma major Lupin on Wednesday said it has received an establishment inspection report (EIR) from the US health regulator for its Mandideep Unit II facility in Madhya Pradesh,neutral,neutral,-3.5733238988147966,negative,2.981366459627329,positive
2020-04-15 12:21:00.000,805.0,832.5,787.05,829.0,3962494.0,Lupin pharma receives EIR from USFDA for Mandideep Unit II facility,"The inspection at the facility was carried out by the US Food and Drug Administration between November 26, 2018",neutral,neutral,2.981366459627329,positive,-2.6159334126040426,negative
2020-04-20 06:00:00.000,822.0,822.0,795.35,811.0,2294411.0,Nifty Pharma index declines; Nifty PSU Bank outperforms in trade today,"Dr Reddy’s and Cipla fell 2% each, followed by Lupin and Aurobindo Pharma, which are also down 1% on the Nifty Pharma index.",negative,negative,-1.338199513381995,negative,1.8227529855436837,positive
2020-04-22 05:30:00.000,805.0,829.6,802.9,807.0,3630431.0,BRIEF-Lupin Says SOLOSEC Achieves Preferred Status On Express Scripts National Preferred Formulary - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.2484472049689441,neutral,1.6029593094944512,positive
2020-04-23 06:25:07.000,811.0,837.3,811.0,824.0,3411214.0,"Stocks To Watch: Bharti Infratel, Britannia, Future Retail, Lupin, MCX, NBCC, Vodafone Idea, Yes Bank",Here are the stocks to watch in trade today.,neutral,neutral,1.6029593094944512,positive,6.881290166121014,positive
2020-04-23 11:00:00.000,811.0,837.3,811.0,824.0,3411214.0,Lupin shares climb 4% on reports of receiving preferred coverage for a medicine,"Shares of most pharma companies were trading with healthy gains. Stocks such as Pfizer, Glenmark, Jubilant Life and Hikal jumped up to 6 percent on BSE.",positive,positive,1.6029593094944512,positive,6.881290166121014,positive
2020-04-23 14:11:00.000,824.7,891.0,820.7,881.45,14718603.0,Share market update: Pharma shares rise; Lupin gains over 2%,The Nifty Pharma index was trading 0.83 per cent up at 9454.75 .,positive,positive,6.881290166121014,positive,-0.3833546308128279,neutral
2020-04-24 10:41:00.000,824.7,891.0,820.7,881.45,14718603.0,Trending stocks: Lupin shares climb over 4% in early trade,Shares of Lupin Ltd. traded 4.57 per cent up in trade at 10:38AM on Friday .,positive,positive,6.881290166121014,positive,-0.3833546308128279,neutral
2020-04-24 12:43:00.000,824.7,891.0,820.7,881.45,14718603.0,"Pharma shares rally; Alembic, Sun Pharma, Laurus Labs hit 52-wk highs","Strides Pharma Science, Alkem Laboratories, Ajanta Pharma, Lupin, Ipca Laboratories, Jubilant Life Sciences and FDC were up in the range of 5 per cent to 10 per cent on the BSE",positive,positive,6.881290166121014,positive,-0.3833546308128279,neutral
2020-04-24 14:32:00.000,824.7,891.0,820.7,881.45,14718603.0,Share market update: Pharma shares rise; Lupin jumps over 6%,The Nifty Pharma index was trading 1.32 per cent up at 9513.25 .,positive,positive,6.881290166121014,positive,-0.3833546308128279,neutral
2020-04-27 07:22:00.000,899.95,906.0,875.7,896.5,6447531.0,Hot Stocks | Here’s why Lupin and Hero MotoCorp are a buy for the short term,"If we observe the daily chart, Nifty is gyrating within the boundaries of a ‘rising wedge’ pattern and we are approaching the ‘apex’ point now.",positive,neutral,-0.3833546308128279,neutral,-4.733333333333336,negative
2020-04-27 08:38:00.000,899.95,906.0,875.7,896.5,6447531.0,"Buy Lupin, target price Rs 945: Chandan Taparia",The analyst suggested a stoploss at Rs 843 .,neutral,neutral,-0.3833546308128279,neutral,-4.733333333333336,negative
2020-04-28 14:18:00.000,860.0,872.7,848.75,853.5,3284259.0,Share market update: Pharma shares down; Lupin slips 4%,The Nifty Pharma index was trading 2.46 per cent down at 9365.6 .,negative,negative,-0.7558139534883721,neutral,-4.560521202423132,negative
2020-04-29 05:30:00.000,860.0,872.7,848.75,853.5,3284259.0,BRIEF-Lupin -Gets Tentative USFDA Approval For Arformoterol Tartrate Inhalation Solution 15 Mcg (Base)/2 Ml - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.7558139534883721,neutral,-4.560521202423132,negative
2020-04-29 08:28:00.000,860.0,872.7,848.75,853.5,3284259.0,Lupin gets tentative approval for Arformoterol Tartrate Inhalation Solution,"Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL, Unit-dose Vials (RLD: Brovana) had an annual sales of approximately USD 489 million in the US, as per IQVIA MAT Feb 2020.",positive,neutral,-0.7558139534883721,neutral,-4.560521202423132,negative
2020-04-29 15:56:05.000,874.9,878.2,811.55,835.0,7640251.0,Lupin gets USFDA nod for generic inhalation solution,"Drug maker Lupin on Wednesday said it has received approval from the US health regulator to sell Arformoterol Tartrate inhalation solution, used to treat chronic obstructive pulmonary disease. The com",neutral,positive,-4.560521202423132,negative,1.888619854721552,positive
2020-04-30 04:01:00.000,874.9,878.2,811.55,835.0,7640251.0,Lupin’s Pithampur facility receives EIR from USFDA; stock spikes 2%,"The inspection for the facility was conducted by the USFDA between February 3, 2020, and February 11, 2020, and concluded with two observations.",neutral,neutral,-4.560521202423132,negative,1.888619854721552,positive
2020-04-30 05:30:00.000,874.9,878.2,811.55,835.0,7640251.0,BRIEF-Lupin Ltd’s Pithampur Facility Gets EIR From U.S. FDA - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-4.560521202423132,negative,1.888619854721552,positive
2020-04-30 12:52:17.000,874.9,878.2,811.55,835.0,7640251.0,Lupin gets inspection closure report from USFDA for Pithampur manufacturing plant in Madhya Pradesh - Firstpost,"Drug maker Lupin on Thursday said the US health regulator has closed the inspection of its manufacturing facility in Pithampur, Madhya Pradesh",neutral,negative,-4.560521202423132,negative,1.888619854721552,positive
2020-04-30 13:12:29.000,874.9,878.2,811.55,835.0,7640251.0,Lupin gets inspection closure report from USFDA for Pithampur plant,"Lupin Managing Director Nilesh Gupta, said the company has received the EIR for the plant with Voluntary Action Indicated (VAI) status",neutral,neutral,-4.560521202423132,negative,1.888619854721552,positive
2020-05-04 05:30:00.000,826.0,865.8,815.0,841.6,5481822.0,BRIEF-Lupin Says Positive Topline Results From Phase 3 Study Of Single-Dose Solosec For Treatment Of Trichomoniasis - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,1.888619854721552,positive,-4.833227720490816,negative
2020-05-04 05:30:00.000,826.0,865.8,815.0,841.6,5481822.0,BRIEF-Lupin Announces Positive Topline Results From Study Of Single-Dose Solosec® For Treatment Of Trichomoniasis - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,1.888619854721552,positive,-4.833227720490816,negative
2020-05-04 07:15:00.000,826.0,865.8,815.0,841.6,5481822.0,"Analyst Calls: Laurus Labs, Lupin, Rallis India","Nomura has retained buy rating on Lupin and raised target price to Rs 1,049 from Rs 913.",neutral,positive,1.888619854721552,positive,-4.833227720490816,negative
2020-05-04 08:28:00.000,826.0,865.8,815.0,841.6,5481822.0,"Buy Lupin, target price Rs 1,049: Nomura",The brokerage said risk reward is favourable as Lupins domestic formulation business provides valuation support.,neutral,positive,1.888619854721552,positive,-4.833227720490816,negative
2020-05-04 11:30:00.000,826.0,865.8,815.0,841.6,5481822.0,"Pharma shares trade firm in the weak market; Cipla, Lupin gain over 2%",Pharma stocks got a new lease of life as coronavirus pandemic got a tighter grip on the country in April.,positive,neutral,1.888619854721552,positive,-4.833227720490816,negative
2020-05-05 02:27:00.000,867.95,867.95,821.0,826.0,3483410.0,"Top stocks in focus: Lupin, Adani Ports, ICICI Bank, Varun Beverages, Rallis India",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-4.833227720490816,negative,-0.7605245823103206,neutral
2020-05-05 02:50:00.000,867.95,867.95,821.0,826.0,3483410.0,Lupin announced positive topline result from Phase 3 study for trichomoniasis treatment,"Based on the data, Lupin plans to submit a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (USFDA) for Solosec for the treatment of trichomoniasis in the second half of 2020.",positive,neutral,-4.833227720490816,negative,-0.7605245823103206,neutral
2020-05-05 04:04:00.000,867.95,867.95,821.0,826.0,3483410.0,Lupin announced positive topline result from Phase 3 study for trichomoniasis treatment; stock up 1%,"Based on the data, Lupin plans to submit a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (USFDA) for Solosec for the treatment of trichomoniasis in the second half of 2020.",positive,neutral,-4.833227720490816,negative,-0.7605245823103206,neutral
2020-05-05 06:24:56.000,867.95,867.95,821.0,826.0,3483410.0,"Stocks To Watch: Adani Ports And SEZ, Colgate-Palmolive, ICICI Bank, Lupin, Marico, Rallis India, Tata Coffee",Here are the stocks to watch in trade today.,neutral,neutral,-4.833227720490816,negative,-0.7605245823103206,neutral
2020-05-05 07:26:00.000,867.95,867.95,821.0,826.0,3483410.0,"Stocks in focus: Marico, Adani Ports, ITC, Lupin, SBI Life, NIIT Tech and Varun Beverages",Here are a few stocks that may buzz the most in Tuesdays trade.,neutral,neutral,-4.833227720490816,negative,-0.7605245823103206,neutral
2020-05-05 08:10:00.000,867.95,867.95,821.0,826.0,3483410.0,"In pics | Stocks in the news: Ceat, Marico, Graphite India, ICICI Bank, Colgate","Automotive Axles, Orbit Exports, Lupin and ICICI Bank are some of the stocks which are in focus today.",neutral,neutral,-4.833227720490816,negative,-0.7605245823103206,neutral
2020-05-05 08:50:00.000,867.95,867.95,821.0,826.0,3483410.0,"Stocks to watch: Banks, NBFCs, Marico, liquor stocks, Lupin, RBL, ICICI Bk",Heres a look at the stocks that may trade actively in todays trading session -,neutral,neutral,-4.833227720490816,negative,-0.7605245823103206,neutral
2020-05-05 09:09:00.000,867.95,867.95,821.0,826.0,3483410.0,"Stocks in news: Marico, Lupin, Adani Ports, Varun Beverages, SBI Life, Astec Lifesciences and more","Stocks to watch today on May 5: Marico, Lupin, Adani Ports, Varun Beverages, SBI Life, Astec Lifesciences among others are the top stocks to watch out for in Tuesday’s trading session",neutral,neutral,-4.833227720490816,negative,-0.7605245823103206,neutral
2020-05-05 11:00:00.000,867.95,867.95,821.0,826.0,3483410.0,Trending stocks: Lupin share price rises nearly 1%,Shares of Lupin Ltd. traded 0.59 per cent up in trade at 10:57AM on Tuesday .,positive,positive,-4.833227720490816,negative,-0.7605245823103206,neutral
2020-05-05 18:02:00.000,834.95,840.65,817.05,828.6,2242717.0,"Market Movers: Banks bleed; 300 stocks hit lower circuits; ‘sell’ signals on Nalco, Hind Zinc, Lupin","For every one stock that closed with gains, two stocks declined.",neutral,neutral,-0.7605245823103206,neutral,-0.5121951219512251,neutral
2020-05-07 13:13:00.000,820.0,839.65,817.3,835.0,2633280.0,"Cipla, Sun Pharma, Lupin top picks in pharma space: MOFSL",’Investors should increase allocation as the pharma story is here to stay,positive,neutral,1.829268292682927,positive,1.048640322293964,positive
2020-05-08 05:30:00.000,820.0,839.65,817.3,835.0,2633280.0,BRIEF-Lupin Says Co’s Pithampur Facilities Complete UK MHRA Inspection - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,1.829268292682927,positive,1.048640322293964,positive
2020-05-11 03:27:00.000,843.95,857.7,832.05,852.8,3945555.0,Lupin’s Pithampur facilities complete successful UK MHRA inspection,"The inspection for the three units at Pithampur (Unit I, Unit II and Unit III) was conducted in January 2020, the pharma company said on Friday.",positive,neutral,1.048640322293964,positive,0.2235294117647032,neutral
2020-05-11 07:45:00.000,843.95,857.7,832.05,852.8,3945555.0,"In pics | Stock in the news: Apollo Pipes, Dr Lal PathLabs, Lupin, VIP Industries","Sobha, TCI Express, Magma Fincorp and NOCIL are some of the stocks in focus today.",neutral,neutral,1.048640322293964,positive,0.2235294117647032,neutral
2020-05-11 07:59:00.000,843.95,857.7,832.05,852.8,3945555.0,"Top stock picks by CapitalVia Global Research: Buy Sun Pharma, Lupin","Technical Calls by Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor",neutral,neutral,1.048640322293964,positive,0.2235294117647032,neutral
2020-05-11 08:42:00.000,843.95,857.7,832.05,852.8,3945555.0,"Stocks to watch: RIL, IRCTC, ICICI Bank, Lupin, HDFC AMC, Wockhardt, MOFSL",Heres a look at the top stocks that may remain in focus today,neutral,neutral,1.048640322293964,positive,0.2235294117647032,neutral
2020-05-11 08:45:00.000,843.95,857.7,832.05,852.8,3945555.0,"Buy Lupin, target price Rs 875: Chandan Taparia",The analyst suggested a stoploss at Rs 815 .,neutral,neutral,1.048640322293964,positive,0.2235294117647032,neutral
2020-05-11 09:33:00.000,843.95,857.7,832.05,852.8,3945555.0,"Stocks in news: RIL, HDFC AMC, ICICI Bank, Adani Transmission, Cipla, Lupin, Shree Cement, SBI Cards and more","Stocks to watch today on May 11: RIL, HDFC AMC, ICICI Bank, Adani Transmission, Cipla, Lupin, Shree Cement, SBI Cards among others are the top stocks to watch out for in Monday’s trading session",neutral,neutral,1.048640322293964,positive,0.2235294117647032,neutral
2020-05-11 10:51:00.000,843.95,857.7,832.05,852.8,3945555.0,"Rakesh Jhunjhunwala cuts stake in Titan, Lupin, Escorts in March quarter","Currently, Rakesh Jhunjhunwala and his familys net worth in listed companies stands at Rs 8,517 crore, compared to Rs 8,388 crore as on March 31, 2020.",negative,neutral,1.048640322293964,positive,0.2235294117647032,neutral
2020-05-11 14:33:00.000,850.0,860.6,845.0,851.9,2000553.0,Share market update: Pharma shares mixed; Lupin rises over 2%,The Nifty Pharma index was trading 0.06 per cent down at 9337.9 .,positive,negative,0.2235294117647032,neutral,-2.4390243902439024,negative
2020-05-12 07:30:00.000,850.0,860.6,845.0,851.9,2000553.0,"Hot Stocks | Sun Pharma, Lupin, Torrent Pharma are three short-term ideas","After bearish development on the short-term charts, Nifty has not seen follow up selling. The level of 9,100 has been acting as strong support for the index.",neutral,positive,0.2235294117647032,neutral,-2.4390243902439024,negative
2020-05-12 16:51:00.000,861.0,863.0,835.2,840.0,2252804.0,Buy Lupin; target of Rs 978: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 978 in its research report dated May 10, 2020.",neutral,positive,-2.4390243902439024,negative,2.7797619047619078,positive
2020-05-14 10:46:00.000,840.0,866.4,828.7,863.35,3473124.0,Lupin’s Vizag API facility receives EIR from USFDA; stock gains over 1.5%,"The inspection for the API facility was conducted by the USFDA between January 13-17, 2020.",positive,neutral,2.7797619047619078,positive,-2.6939343027634552,negative
2020-05-14 11:12:00.000,840.0,866.4,828.7,863.35,3473124.0,Share price of Lupin Ltd. rises as Nifty drops,Shares of Lupin Ltd. gained 1.28 per cent to Rs 850.5 in Thursday’s trade as of 11:12AM (IST). The stock of Lupin Ltd. hit a high price of Rs 855.0 and low of Rs 829.9 during the session. The return on equity (ROE) for the stock stood at 4.41 per cent. Traded volume on the counter stood at 5…,positive,positive,2.7797619047619078,positive,-2.6939343027634552,negative
2020-05-14 12:46:00.000,863.05,863.05,836.1,839.8,1983712.0,Lupin gains 3% as Vizag API facility receives EIR from USFDA,Brokerage firm Prabhudas Lilladher has upgraded Lupins stock to Buy from earlier Reduce with target price of Rs 978,positive,positive,-2.6939343027634552,negative,2.028639618138425,positive
2020-05-14 18:10:26.000,863.05,863.05,836.1,839.8,1983712.0,Mutual funds were busy buying during the market rally of April; top stock bought by fund houses,"Mutual funds during the month of April were seen picking large-cap stocks like Wipro, Eicher Motors, UPL, and Lupin.",neutral,neutral,-2.6939343027634552,negative,2.028639618138425,positive
2020-05-15 08:17:00.000,863.05,863.05,836.1,839.8,1983712.0,Bull Spread strategy on Lupin by Nandish Shah of HDFC Securities,Primary trend of the stock is positive where stock price is trading above its 100 and 200-day SMA,neutral,positive,-2.6939343027634552,negative,2.028639618138425,positive
2020-05-19 05:30:00.000,863.5,870.0,833.35,846.0,3413792.0,BRIEF-Lupin Launches Generic Version Of Apriso - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-2.026635784597568,negative,2.7705422685294785,positive
2020-05-19 07:22:00.000,863.5,870.0,833.35,846.0,3413792.0,"Hot Stocks | Lupin looks attractive on technical charts; Bata, Amara Raja show weakness","During the last couple of weeks, Nifty failed to surpass the resistance of 50-DMA. At present 20 and 50 DMA, both are placed almost at the same levels at 9,250. This level will act as a far resistance.",positive,neutral,-2.026635784597568,negative,2.7705422685294785,positive
2020-05-19 08:55:00.000,863.5,870.0,833.35,846.0,3413792.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term","Sudarshan Sukhani of s2analytics.com recommends buying Lupin with a stop loss of Rs 835, target at Rs 875 and TCS with a stop loss of Rs 1,900, target at Rs 2,000.",neutral,neutral,-2.026635784597568,negative,2.7705422685294785,positive
2020-05-19 11:58:00.000,863.5,870.0,833.35,846.0,3413792.0,Lupin launches authorized generic version of Apriso; stock dips 1%,"Mesalamine Extended-Release Capsules 0.375 g, RLD: Apriso had an annual sale of ~USD 290 million in the US, as per IQVIA MAT March 2020 data.",positive,neutral,-2.026635784597568,negative,2.7705422685294785,positive
2020-05-20 12:49:00.000,870.0,889.95,863.15,884.4,2664171.0,Nifty Pharma index gains ~2%; Dr Reddy’s Lab in focus,"Cipla and Lupin surged 3% in the Nifty Pharma index, followed by Piramal, Aurobindo and Divi’s Lab are up 2%.",positive,positive,1.6551724137931008,positive,1.3337116912599318,positive
2020-05-22 02:27:00.000,881.0,898.0,875.35,892.75,2371930.0,Lupin gets nod for Trientine Hydrochloride Capsules USP; stock up 1%,"The product would be manufactured at Lupin’s Nagpur (Unit 1) facility, India.",positive,neutral,1.3337116912599318,positive,1.136618141097422,positive
2020-05-22 08:44:00.000,881.0,898.0,875.35,892.75,2371930.0,"Top buy and sell ideas by Ashwani Gujral, Mitesh Thakkar, Prakash Gaba for short term","Mitessh Thakkar of mitesshthakkar.com recommends buying Amara Raja Batteries with a stop loss of Rs 583, target at Rs 620 and Lupin with a stop loss of Rs 869, target at Rs 920.",neutral,neutral,1.3337116912599318,positive,1.136618141097422,positive
2020-05-26 07:12:00.000,893.0,919.2,893.0,903.15,5435835.0,"Hot Stocks | Technical charts show Britannia, Tech Mahindra and Lupin can gain up to 10%","In this truncated week, we have F&amp;O expiry for the May series. The options data indicates that the maximum Put base is placed at 9,000 followed by 8,800 strikes.",positive,neutral,1.136618141097422,positive,-1.8101545253863112,negative
2020-05-28 06:23:11.000,887.5,890.8,868.25,886.6,3225267.0,"Stocks To Watch: Adani Power, Aditya Birla Fashion, Lupin, SBI, TVS Motor, United Spirits, Vedanta",Here are the stocks to watch in trade today.,neutral,neutral,-0.1014084507042227,neutral,-0.4597701149425287,neutral
2020-05-28 07:40:00.000,887.5,890.8,868.25,886.6,3225267.0,"Market Ahead, May 28: Top factors that could guide markets today","A total of 24 companies, including TVS Motor, Lupin, and Federal Bank, are scheduled to announce their March quarter results today",neutral,neutral,-0.1014084507042227,neutral,-0.4597701149425287,neutral
2020-05-28 07:44:00.000,887.5,890.8,868.25,886.6,3225267.0,"Stocks in the news: Kotak Bank, Lupin, TVS Motor, Federal Bank, United Spirits, Quess Corp and NTPC",The country’s first InvIT in the power sector reported an over two-fold jump in Q4 net profit.,neutral,positive,-0.1014084507042227,neutral,-0.4597701149425287,neutral
2020-05-28 07:46:00.000,887.5,890.8,868.25,886.6,3225267.0,"Lupin Q4 preview: Double-digit decline seen in profit, revenue","Motilal Oswal feels domestic formulation business is expected to drive revenue growth, but US sales may decline 10 percent YoY.",negative,negative,-0.1014084507042227,neutral,-0.4597701149425287,neutral
2020-05-28 07:57:00.000,887.5,890.8,868.25,886.6,3225267.0,"Top stocks in focus: Lupin, Adani Power, TVS Motor, Dabur, SBI",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.1014084507042227,neutral,-0.4597701149425287,neutral
2020-05-28 08:49:37.000,887.5,890.8,868.25,886.6,3225267.0,"Stocks in focus: Lupin, TVS Motor, United Spirits, Adani Power, among others to remain in action","Federal Bank, CEAT, Heidelbergcement India, Lupin, TVS Motor, IIFL Finance, Muthoot Capital Services, Radico Khaitan, Rain Industries, Tata Steel Long Products and Wendt (India) are among 24 companies are scheduled to announce their March quarter earnings",neutral,neutral,-0.1014084507042227,neutral,-0.4597701149425287,neutral
2020-05-28 08:54:00.000,887.5,890.8,868.25,886.6,3225267.0,"Stocks to watch: Sun Pharma, TVS Motor, SBI, Lupin, USL, Adani Power, Ceat",Heres a look at the top stocks that may remain in focus today,neutral,neutral,-0.1014084507042227,neutral,-0.4597701149425287,neutral
2020-05-28 09:04:00.000,887.5,890.8,868.25,886.6,3225267.0,"Stocks in news: Ujjivan Financial, United Spirits, Wendt, Ceat, Federal Bank, Lupin, TVS Motor and more","Stocks to watch today on May 28: Ujjivan Financial, United Spirits, Wendt, Ceat, Federal Bank, Lupin, TVS Motor among others are the top stocks to watch out for in Thursday’s trading session",neutral,neutral,-0.1014084507042227,neutral,-0.4597701149425287,neutral
2020-05-28 09:29:20.000,887.5,890.8,868.25,886.6,3225267.0,"Sensex gains 140 points, Nifty opens above 9,350","01 IST, the Sensex was up 350.00 points or 1.11% at 31955.22, while the Nifty gained 86.40 points or 0.93% at 9401.35. A total of 24 companies, including TVS Motor, Lupin, and Federal Bank, will announce their March quarter results on Thursday.",positive,positive,-0.1014084507042227,neutral,-0.4597701149425287,neutral
2020-05-28 10:30:00.000,887.5,890.8,868.25,886.6,3225267.0,Trending stocks: Lupin shares down over 1%,"A total of 37,727 shares changed hands on the counter till 10:28AM (IST).",negative,neutral,-0.1014084507042227,neutral,-0.4597701149425287,neutral
2020-05-28 12:17:00.000,870.0,881.8,840.5,866.0,9471622.0,Share market update: Pharma shares down; Lupin dips 2% - The Economic Times,The Nifty Pharma index was trading 0.35 per cent down at 9430.45.,negative,negative,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-28 16:15:00.000,870.0,881.8,840.5,866.0,9471622.0,"Share Market Update: Sensex ends 595 points higher, Nifty at 9,490; Eicher Motors, Hero MotoCorp top performers","Stock Market LIVE Updates: Ceat, Agro Tech Foods, Daawat, Federal Bank, Lupin, Muthoot Finance, Radico, TVS Motors, Wendt among others will announce will be reporting their quarterly results today.",positive,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-28 17:38:00.000,870.0,881.8,840.5,866.0,9471622.0,"Sensex reclaims 32K, Nifty closes at 9,490 as banking stocks extend gains","Meanwhile, companies set to announce their earnings are Ceat, Agro Tech Foods, Daawat, Lupin, Muthoot Finance, TVS Motors, Wendt among others",positive,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 01:54:00.000,870.0,881.8,840.5,866.0,9471622.0,"Nifty Pharma index up 2%; Glenmark, Biocon stocks climb","All the components are trading in the positive zone, except Lupin.",positive,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 07:21:08.000,870.0,881.8,840.5,866.0,9471622.0,"Stocks To Watch: Vodafone Idea, Lupin, Rain Industries, Bank Of India",Here are the stocks to watch in trade today.,neutral,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 07:51:00.000,870.0,881.8,840.5,866.0,9471622.0,"Top stocks in focus: Lupin, Cadila, Vodafone Idea, Grasim, Voltas",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 09:18:59.000,870.0,881.8,840.5,866.0,9471622.0,"Stocks On The Radar: Vodafone Idea, Lupin & Ceat","Stocks On The Radar: Vodafone Idea, Lupin & Ceat",neutral,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 10:28:24.000,870.0,881.8,840.5,866.0,9471622.0,Lupin posts 35% jump in Jan-Mar consolidated profit on one-time gain,Lupin had in November announced the sale of 99.82% stake in its Japanese subsidiary Kyowa Pharmaceutical Industry Co Ltd for an enterprise value of 57.4 billion yen,positive,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 10:36:00.000,870.0,881.8,840.5,866.0,9471622.0,"Lupin Consolidated March 2020 Net Sales at Rs 3,845.74 crore, down 12.72% Y-o-Y",,negative,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 10:36:00.000,870.0,881.8,840.5,866.0,9471622.0,"Lupin Standalone March 2020 Net Sales at Rs 2,483.88 crore, down 16.42% Y-o-Y",,negative,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 10:36:00.000,870.0,881.8,840.5,866.0,9471622.0,Lupin’s Q4 PAT rises 34.5% yoy; Indian market drives sales; stock down 2%,The latest profit accounted for 10.3% of the sales.,negative,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 11:33:00.000,870.0,881.8,840.5,866.0,9471622.0,Lupin Q4 results: Net profit rises 35% to Rs 390 crore,"Consolidated income from operations of the company stood at Rs 3,791 crore for the quarter under consideration as against Rs 3,807.02 crore for the same period year ago.",positive,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 12:38:45.000,870.0,881.8,840.5,866.0,9471622.0,"Lupin Q4 results: Consolidated net profit rises 35% to Rs 390 cr; income from operations marginally down - Business News , Firstpost",Drug firm Lupin has reported a 34.55 percent rise in its consolidated net profit to Rs 389.63 crore for the quarter ended March 2020 mainly on account of robust sales in the domestic market and lower tax expenses,positive,positive,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 14:24:00.000,870.0,881.8,840.5,866.0,9471622.0,"Lupin Q4 net profit up 35% to Rs 390 cr on robust sales, lower tax expenses","In the current times, Lupin has been able to ensure business continuity while safeguarding the health and safety of its employees",positive,positive,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 22:43:00.000,870.0,881.8,840.5,866.0,9471622.0,Lupin reports 25% fall in pre-tax profit at Rs 412 cr in Q4 on low sales,"On a sequential basis, however, the company fared better, both in terms of sales and profits. The stock ended days trade at Rs 869.8, down 1.3 per cent.",negative,positive,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-29 23:01:19.000,870.0,881.8,840.5,866.0,9471622.0,Lupin Ltd ADR 2020 Q4 - Results - Earnings Call Presentation (OTCMKTS:LUPNY),The following slide deck was published by Lupin Ltd ADR in conjunction with their 2020 Q4 earnings call.,neutral,neutral,-0.4597701149425287,neutral,-2.857142857142857,negative
2020-05-31 17:30:45.000,875.0,876.0,846.1,850.0,5211964.0,Lupin Q4 FY20 Results: Key Highlights Of Concall,The company expects specialty portfolio to breakeven in FY22.,neutral,positive,-2.857142857142857,negative,2.09626419955498,positive
2020-05-31 20:40:00.000,875.0,876.0,846.1,850.0,5211964.0,Lupin steps up production of key drugs in potential use for Covid-19,Expects US approval for Albuterol soon,neutral,positive,-2.857142857142857,negative,2.09626419955498,positive
2020-06-01 03:47:56.000,875.0,876.0,846.1,850.0,5211964.0,Lupin: A Watershed Year For The US Business?,Lupin: A watershed year for the US business?,neutral,neutral,-2.857142857142857,negative,2.09626419955498,positive
2020-06-01 12:09:00.000,853.9,873.95,851.55,871.8,4738650.0,"Stock Ideas: Motilal has a buy call on Lupin, target price Rs 1,000","The brokerage expects 40 per cent earnings CAGR over FY20-22E, led by niche launches.",positive,positive,2.09626419955498,positive,-1.4772727272727273,negative
2020-06-01 12:39:00.000,853.9,873.95,851.55,871.8,4738650.0,"Better compliance in US, improving finances augur well for Lupin stock","Earnings review, impact of Covid to reflect in April-June numbers.",positive,neutral,2.09626419955498,positive,-1.4772727272727273,negative
2020-06-01 15:19:50.000,853.9,873.95,851.55,871.8,4738650.0,Buy Lupin; Target Of Rs 1000: Motilal Oswal,"Motilal Oswal is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1000 in its research report dated May 30, 2020.",neutral,positive,2.09626419955498,positive,-1.4772727272727273,negative
2020-06-01 23:38:00.000,853.9,873.95,851.55,871.8,4738650.0,"New launches, cost-control efforts, margin improvement crucial for Lupin","Resolution of compliance issues at Goa, Indore plants are other triggers",positive,neutral,2.09626419955498,positive,-1.4772727272727273,negative
2020-06-02 05:30:00.000,853.9,873.95,851.55,871.8,4738650.0,BRIEF-Lupin Gets Approval For Meloxicam Capsules - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,2.09626419955498,positive,-1.4772727272727273,negative
2020-06-02 08:54:19.000,853.9,873.95,851.55,871.8,4738650.0,Hold Lupin; Target Of Rs 930: ICICI Direct,"ICICI Direct recommended hold rating on Lupin with a target price of Rs 930 in its research report dated May 31, 2020.",neutral,positive,2.09626419955498,positive,-1.4772727272727273,negative
2020-06-02 09:01:35.000,853.9,873.95,851.55,871.8,4738650.0,Lupin rating: ‘Buy’; Performance in the quarter was weak,"Despite 14.5/5% cut in FY21/22e EPS, outlook for earnings is good; ‘Buy’ retained with TP of Rs 1,000.",negative,negative,2.09626419955498,positive,-1.4772727272727273,negative
2020-06-02 11:43:45.000,853.9,873.95,851.55,871.8,4738650.0,Hold Lupin; Target Of Rs 905: Emkay Global Financial,"Emkay Global Financial recommended hold rating on Lupin with a target price of Rs 905 in its research report dated May 30, 2020.",neutral,positive,2.09626419955498,positive,-1.4772727272727273,negative
2020-06-02 17:23:06.000,880.0,885.85,861.15,867.0,3865123.0,Lupin Gets USFDA Nod For Generic Osteoarthritis Pain Drug,"The company has received approval from the US Food and Drug Administration (USFDA) for meloxicam capsules in strength of 5 mg and 10 mg, Lupin Ltd said in a statement.",neutral,positive,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 05:30:00.000,880.0,885.85,861.15,867.0,3865123.0,BRIEF-Lupin- Signs Distribution Agreement In Key EU Territories For Orphan Drug Namuscla - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 06:34:00.000,880.0,885.85,861.15,867.0,3865123.0,Lupin signs distribution agreement in key EU Territories for orphan drug NaMuscla,Lupin will continue commercialization of NaMuscla in Germany and the UK and will launch the product in Austria and France later this year.,positive,positive,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 07:50:42.000,880.0,885.85,861.15,867.0,3865123.0,"In Pics | Stocks In The News: Britannia, InterGlobe Aviation, Kotak Bank, Just Dial",Lupin | ADF Foods | Coromandel International | Quess Corp | Minda Industries | Syngene International | Tribhovandas Bhimji Zaveri | Granules India | Everest Organics | Transport Corporation of India | Axita Cotton are also in focus today.,neutral,neutral,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 08:27:00.000,880.0,885.85,861.15,867.0,3865123.0,"Add Lupin, target price Rs 890: Centrum",The brokerage expects the India business to report healthy double digit growth for the company and emerge as a key growth driver.,neutral,positive,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 08:37:00.000,880.0,885.85,861.15,867.0,3865123.0,"Stocks to watch: IndiGo, Britannia, RIL, Eris Life, Lupin, Syngene Int’l",Heres a list of the top stocks that may remain in focus today,neutral,neutral,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 09:01:00.000,880.0,885.85,861.15,867.0,3865123.0,"No Chinese supply threat for drug companies, but scaling Great Wall is tough","“The concerns over supply of Chinese raw material proved to be ill-founded,” Nilesh Gupta, managing director of Lupin, told ET.",negative,negative,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 09:02:34.000,880.0,885.85,861.15,867.0,3865123.0,"Top Buy And Sell Ideas By Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar For Short Term","Sudarshan Sukhani of s2analytics.com recommends buying Axis Bank with a stop loss of Rs 400, target at Rs 430 and Lupin with a stop loss of Rs 850, target at Rs 900.",neutral,neutral,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 09:07:45.000,880.0,885.85,861.15,867.0,3865123.0,"Stocks in focus: RIL, Aurobindo Pharma, Syngene International, Britannia, IndiGo, Lupin","Orient Hotels, DCM Shriram, BPCL, Aurobindo Pharma, MAS Financial Services, Cholamandalam Investment and Dishman Carbogen are among 15 companies which are scheduled to announce their March quarter earnings today",neutral,neutral,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 09:31:00.000,880.0,885.85,861.15,867.0,3865123.0,"Stocks in news: ICICI Bank, Aurobindo Pharma, BPCL, Lupin, Britannia, IndiGo, Motherson Sumi and more","Stocks to watch today on May June 3: ICICI Bank, Aurobindo Pharma, BPCL, Lupin, Britannia, IndiGo, Motherson Sumi among others are the top stocks to watch out for in Wednesday’s trading session",neutral,neutral,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 10:36:00.000,880.0,885.85,861.15,867.0,3865123.0,"Stocks in the news: RIL, BPCL, IndiGo, Lupin, Dixon Tech, HUL, YES Bank and Aurobindo Pharma","MAS Financial Services, Orient Hotels and DCM Shriram will announce Q4 results today.",neutral,neutral,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 10:41:00.000,880.0,885.85,861.15,867.0,3865123.0,Trending stocks: Lupin shares rise over 1%,"A total of 44,197 shares changed hands on the counter till 10:38AM (IST).",positive,neutral,-1.4772727272727273,negative,4.61494252873563,positive
2020-06-03 13:18:00.000,870.0,913.0,868.85,910.15,6241054.0,Lupin inks distribution pact with 3 firms to commercialise NaMuscla in Europe,"Exeltis Healthcare SL, Cresco Pharma BV and Macure Pharma ApS will commercialise NaMuscla for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders in certain European Union (EU) territories, Lupin said in a statement.",neutral,neutral,4.61494252873563,positive,-1.8371562126318053,negative
2020-06-04 05:30:00.000,870.0,913.0,868.85,910.15,6241054.0,"BRIEF-Lupin And Mylan Receive European Marketing Authorization For Nepexto, Biosimilar Etanercept - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,4.61494252873563,positive,-1.8371562126318053,negative
2020-06-04 05:30:00.000,870.0,913.0,868.85,910.15,6241054.0,"BRIEF-Mylan And Lupin Receive European Marketing Authorization For Nepexto, Biosimilar Etanercept - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,4.61494252873563,positive,-1.8371562126318053,negative
2020-06-04 09:49:00.000,870.0,913.0,868.85,910.15,6241054.0,"Lupin and Mylan receive European Marketing Authorization for Nepexto, Biosimilar Etanercept","Enbrel had sales of approximately $9.6 billion globally for the 12 months ending December 2019, according to IQVIA.",neutral,neutral,4.61494252873563,positive,-1.8371562126318053,negative
2020-06-04 11:48:12.000,870.0,913.0,868.85,910.15,6241054.0,"D-Street Buzz: Nifty Pharma Gains Led By Biocon; Lupin; Volumes Of Sun Pharma, Aurobindo Pharma Rise","Among the sectors, Nifty Pharma added over a percent led by Sun Pharma, Biocon, Lupin and Torrent Pharma which gained 2 percent each followed by Aurobindo Pharma, Cipla, Divis Labs and Dr Reddy’s Labs among others.",neutral,positive,4.61494252873563,positive,-1.8371562126318053,negative
2020-06-04 12:20:00.000,919.9,923.9,898.1,903.0,3692121.0,Share market update: Pharma shares up; Lupin rises over 2%,The Nifty Pharma index was trading 1.11 per cent up at 9973.95.,positive,positive,-1.8371562126318053,negative,-0.8950276243093948,neutral
2020-06-05 06:39:12.000,919.9,923.9,898.1,903.0,3692121.0,"Stocks To Watch: DLF, Exide Industries, L&T, Lupin, NIIT, Power Grid, SBI, UPL",Here are the stocks to watch in trade today.,neutral,neutral,-1.8371562126318053,negative,-0.8950276243093948,neutral
2020-06-05 09:01:57.000,919.9,923.9,898.1,903.0,3692121.0,"Top Buy And Sell Ideas By Ashwani Gujral, Mitesh Thakkar, Prakash Gaba For Short Term","Prakash Gaba of prakashgaba.com suggests buying Lupin with a stop loss of Rs 900, target at Rs 940 and Sun Pharma with a stop loss of Rs 487, target at Rs 515.",neutral,neutral,-1.8371562126318053,negative,-0.8950276243093948,neutral
2020-06-05 09:42:00.000,919.9,923.9,898.1,903.0,3692121.0,"Stocks in news: SBI, Exide, Bharti Airtel, Lupin, L&T, Ashok Leyland, Powergrid, Jyothi Labs, NIIT and more","Stocks to watch today on June 5: SBI, Exide, Bharti Airtel, Lupin, L&T, Ashok Leyland, Powergrid, Jyothi Labs, NIIT among others are the top stocks to watch out for in Friday’s trading session",neutral,neutral,-1.8371562126318053,negative,-0.8950276243093948,neutral
2020-06-05 13:17:00.000,919.9,923.9,898.1,903.0,3692121.0,"Top stocks in focus: RIL, SBI, Lupin, Power Grid, NIIT, Exide Industries",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.8371562126318053,negative,-0.8950276243093948,neutral
2020-06-08 05:30:00.000,905.0,911.9,880.75,896.9,2880411.0,BRIEF-Lupin Ltd Gets Orphan Drug Status For Mexiletine From U.S. FDA - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.8950276243093948,neutral,1.8002000222246968,positive
2020-06-08 05:30:00.000,905.0,911.9,880.75,896.9,2880411.0,BRIEF-Lupin Says U.S. FDA Grants Mexiletine Orphan Drug Designation - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.8950276243093948,neutral,1.8002000222246968,positive
2020-06-08 12:24:05.000,899.9,930.8,895.5,916.1,4736713.0,USFDA Grants Orphan Drug Status To Mexiletine Hydrochloride: Lupin,The Mumbai-based company’s drug NaMuscula (mexiletine hydrochloride) is the first and only licensed product to treat myotonia in adults with non-dystrophic myotonic (NDM) disorders.,neutral,neutral,1.8002000222246968,positive,0.5625270445694555,neutral
2020-06-08 12:57:00.000,899.9,930.8,895.5,916.1,4736713.0,US FDA grants orphan drug status to mexiletine hydrochloride: Lupin,The Mumbai-based companys drug NaMuscula (mexiletine hydrochloride) is the first and only licensed product to treat myotonia in adults with non-dystrophic myotonic (NDM) disorders,positive,neutral,1.8002000222246968,positive,0.5625270445694555,neutral
2020-06-08 17:43:00.000,899.9,930.8,895.5,916.1,4736713.0,Lupin trades flat; USFDA grants Mexiletine Orphan Drug Designation,"Myotonic disorders are a group of heterogeneous, inherited, neuromuscular disorders characterized by a shared symptom called myotonia, Lupin said.",neutral,neutral,1.8002000222246968,positive,0.5625270445694555,neutral
2020-06-08 17:49:18.000,899.9,930.8,895.5,916.1,4736713.0,USFDA grants orphan drug status to mexiletine hydrochloride: Lupin,Pharma major Lupin on Monday said the US health regulator has granted orphan drug designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders. The Mumbai-based company’s drug,positive,positive,1.8002000222246968,positive,0.5625270445694555,neutral
2020-06-09 05:30:00.000,899.9,930.8,895.5,916.1,4736713.0,"BRIEF-Ceek Women’s Health Says Co, Lupin Sign Marketing Agreement - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,1.8002000222246968,positive,0.5625270445694555,neutral
2020-06-10 10:23:05.000,924.4,936.95,918.0,929.6,3076090.0,"Sensex trades higher, Nifty holds 10,050; check what’s moving Dalal Street today","Nifty Pharma index was up 0.75 per cent led by gains in Cadila Healthcare, Lupin and Cipla. While Nifty Metal index was down half a per cent dragged by Tata Steel, Ratnamani Metals & Tubes and Welspun Corp.",positive,positive,0.5625270445694555,neutral,-0.5303030303030278,neutral
2020-06-11 05:30:00.000,924.0,931.8,912.05,919.1,1943862.0,BRIEF-Lupin Ltd Says Got Approval For Its Albendazole Tablets From U.S. FDA - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.5303030303030278,neutral,0.7409045670684558,neutral
2020-06-11 05:30:00.000,924.0,931.8,912.05,919.1,1943862.0,BRIEF-Lupin Pharmaceuticals Says Voluntarily Recalling Metformin Hydrochloride Extended-Release Tablets To Consumer Level - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.5303030303030278,neutral,0.7409045670684558,neutral
2020-06-11 12:26:00.000,904.3,920.5,901.05,911.0,2105327.0,"Indian pharma companies Aurobindo, Glenmark, Lupin, Sun, Wockhardt dragged to court in US","The multistate law suit filed by Maryland Attorney General Brian E. Frosh on June 10 alleges a broad conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States",neutral,negative,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-11 17:25:15.000,904.3,920.5,901.05,911.0,2105327.0,"Pricing problems: Aurobindo Pharma, Sun Pharma, Lupin named in lawsuit in US","The complaint is the third to be filed in an ongoing investigation that is possibly the largest domestic corporate cartel case in the history of the United States.The lawsuit seeks damages, civil penalties, and actions by the court to restore competition to the generic drug market",neutral,neutral,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-11 17:46:05.000,904.3,920.5,901.05,911.0,2105327.0,Lupin Gets USFDA Nod To Market Generic Anthelmintic Tablets,"The product is a generic version of Impax Laboratories Inc’s Albenza tablets in the same strength, it added.",neutral,neutral,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-11 18:17:00.000,904.3,920.5,901.05,911.0,2105327.0,Lupin recieves USFDA nod to market generic anthelmintic tablets,"According to IQVIA MAT April 2020 data, Albendazole tablets had an annual sales of around $34 million in the US, Lupin said",neutral,neutral,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-11 21:11:26.000,904.3,920.5,901.05,911.0,2105327.0,"Aurobindo, Glenmark, Lupin, Sun among 26 firms facing lawsuit in US","The multi-state lawsuit filed in the District Court of Connecticut alleges that the 26 firms had ‘a broad conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs’ across the US",neutral,negative,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-11 21:17:10.000,904.3,920.5,901.05,911.0,2105327.0,"Aurobindo Pharma, Sun Pharma, Lupin Named In Lawsuit In The U.S.",The three Indian drugmakers are among the twenty-six that have been accused of manipulating generic drug prices across the U.S.,neutral,neutral,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-11 21:21:53.000,904.3,920.5,901.05,911.0,2105327.0,"Price ‘manipulation’: Sun Pharma, Lupin, Aurobindo named in US lawsuit","Aurobindo Pharma, Sun Pharma and Lupin are among the 26 drug makers facing a multi-state lawsuit filed in the US by Maryland Attorney General for alleged “conspiracy to artificially inflate and manipu",neutral,neutral,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-12 06:59:32.000,904.3,920.5,901.05,911.0,2105327.0,"Stocks To Watch: Eicher Motors, Hindalco Industries, Lupin, M&M, Oil India, SBI",Here are the stocks to watch in trade today.,neutral,neutral,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-12 07:48:30.000,904.3,920.5,901.05,911.0,2105327.0,"In Pics | Stocks In The News: RIL, Aarey Drugs, SBI Life Insurance, Wipro, Capital Trust, Dixon Technologies","IndoStar Capital Finance, HDFC AMC, Lupin, , Aditya Birla Fashion and EID Parry are some of the stocks in focus today.",neutral,neutral,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-12 08:20:05.000,904.3,920.5,901.05,911.0,2105327.0,"Pricing Problems: Aurobindo Pharma, Sun Pharma, Lupin Named In Lawsuit In US","Attorney General Brian E Frosh in a statement issued on Wednesday said the new complaint, filed in the U.S. District Court for the District of Connecticut, focuses on 80 topical generic drugs that account for billions of dollars of sales in the United States and the complaint names 26 corporate defe…",neutral,neutral,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-12 08:49:00.000,904.3,920.5,901.05,911.0,2105327.0,Top domestic pharma companies in US probe for price-fixing,"Domestic majors — including Sun Pharma, Lupin and Aurobindo Pharma — along with US biggies Sandoz, Pfizer and Mylan have been charged with price-fixing and collusion on topical dermatology medication in a fresh lawsuit filed in the US.",neutral,neutral,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-12 09:44:00.000,904.3,920.5,901.05,911.0,2105327.0,"Stocks in news: SBI, Lupin, Oil India, HDFC Asset Management, TVS Srichakra, M&M, Eicher Motors, Hindalco","Stocks to watch today on June 12: SBI, Lupin, Oil India, HDFC Asset Management, TVS Srichakra, M&M, Eicher Motors, Hindalco among others are the top stocks to watch out for in Tuesday’s trading session.",neutral,neutral,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-12 13:23:00.000,904.3,920.5,901.05,911.0,2105327.0,"Top stocks in focus: Hindalco, Eicher Motors, Lupin, SBI, M&M",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.7409045670684558,neutral,2.900763358778628,positive
2020-06-14 12:49:00.000,917.0,956.0,914.0,943.6,6157989.0,Plan to approach USFDA for re-inspection of key plants in next few months: Lupin,"The US drug regulator, after inspecting the two sites, had expressed concerns over quality-control procedures that include handling of out-of-specification results and conducting hold-time studies.",neutral,negative,2.900763358778628,positive,-1.9711742263671077,negative
2020-06-14 14:36:00.000,917.0,956.0,914.0,943.6,6157989.0,Lupin to approach US health regulator for re-inspection of key plants,"The company’s Unit 2 manufacturing plant in Pithampur, along with its Goa site, is under the US Food and Drug Administration’s (USFDA) warning letter since November 2017 for violation of current goods manufacturing practices",neutral,neutral,2.900763358778628,positive,-1.9711742263671077,negative
2020-06-15 09:36:00.000,917.0,956.0,914.0,943.6,6157989.0,"Stocks in news: Hindalco Industries, Dr Reddys, Lupin, PNB Housing, BHEL, UTI AMC, Eicher Motors, RIL, MCX","Stocks to watch today on June 15: Hindalco Industries, Dr Reddys, Lupin, PNB Housing, BHEL, UTI AMC, Eicher Motors, RIL, MCX among others are the top stocks to watch out for in Monday’s trading session",neutral,neutral,2.900763358778628,positive,-1.9711742263671077,negative
2020-06-15 15:30:27.000,943.6,948.1,918.05,925.0,2458059.0,Gladiator Stocks - Lupin: ICICI Direct,"According to ICICI Direct, Buy Lupin in the range of Rs 905.00–927.00 for target price of Rs 1080.00 with a stop loss of Rs 835.00. Time Frame: Six months",neutral,neutral,-1.9711742263671077,negative,0.2851915626345219,neutral
2020-06-16 08:05:00.000,943.6,948.1,918.05,925.0,2458059.0,Top Trades for Tuesday’s Session: Buy Alembic Pharma and Lupin - Investing.com India,Read Top Trades for Tuesday’s Session: Buy Alembic Pharma and Lupin by CapitalVia Global Research on Investing.com India,neutral,neutral,-1.9711742263671077,negative,0.2851915626345219,neutral
2020-06-18 07:48:00.000,931.9,937.0,915.1,919.4,1745435.0,"India must manufacture more APIs locally, depend less on China: Experts","India, the worlds third-largest drug producer by volumes, imports 70% of its APIs from China. For some APIs, especially antibiotics, dependence on China is over 90%. Indias top drug makers, including Dr Reddys, Lupin, Glenmark, Mylan, Zydus and Pfizer are dependent on China for APIs.",neutral,neutral,-1.3413456379439854,negative,-0.5437442227176337,neutral
2020-06-21 12:32:00.000,922.45,950.0,916.25,937.0,2541486.0,"Unichem, Lupin recall hypertension drugs in US","As per the latest enforcement report issued by the US Food and Drug Administration (USFDA), Unichem is voluntarily recalling 1,90,992 bottles of Clonodine Hydrochloride tablets, which are used to treat high blood pressure.",neutral,negative,1.5773212640251455,positive,0.2405773857257417,neutral
2020-06-21 13:10:00.000,922.45,950.0,916.25,937.0,2541486.0,"Unichem, Lupin recall high blood pressure drugs from US over quality issues","The specified batch, which is being recalled, has been manufactured at Unichems Goa-based facility",negative,neutral,1.5773212640251455,positive,0.2405773857257417,neutral
2020-06-22 12:45:31.000,935.25,943.55,924.05,937.5,1869192.0,"D-Street Buzz: Pharma Stocks Rally; Glenmark Zooms 35%, Cipla, Sun Pharma, Biocon Gain","Cipla jumped over 4 percent after the country’s drug regulator on June 20 gave permission to Hetero and Cipla to manufacture and market antiviral drug remdesivir while Lupin, Sun Pharma, Torrent Pharma, Biocon and Divis Labs were the other gainers.",neutral,positive,0.2405773857257417,neutral,-1.5957446808510638,negative
2020-06-24 09:08:00.000,940.0,944.7,916.3,925.0,1642033.0,"Sensex, Nifty snap 4-day’s winning streak; ICICI Bank top loser","The Nifty Pharma index dropped 2% with all the constituents in the red. Glenmark, Cipla, Sun Pharma and Lupin fell in the range 2-5% each.",positive,negative,-1.5957446808510638,negative,1.0109747526625965,positive
2020-06-25 12:11:00.000,936.0,943.7,922.0,926.0,1224579.0,Share market update: Pharma shares up; Lupin rises 2%,The Nifty Pharma index was trading 0.09 per cent up at 10119.7.,positive,positive,-1.0683760683760684,negative,-0.0917183706501238,neutral
2020-06-26 17:19:00.000,936.0,943.7,922.0,926.0,1224579.0,Replacing China as API supplier for pharma will be a medium to long term story: Lupin,"’In the case of Lupin, the actual API import from China is on the lower side.",neutral,neutral,-1.0683760683760684,negative,-0.0917183706501238,neutral
2020-06-29 18:58:53.000,935.0,935.0,907.3,910.0,1889714.0,"Relisted in January, Stocks of Patanjali’s Ruchi Soya Soar 8,818% in Just 103 Sessions","In terms of market-cap, Ruchi Soya is now bigger than several biggies like Lupin, Torrent Pharma, Tata Steel, Ambuja Cements, HPCL, Grasim, PNB, Hindalco, Colgate-Palmolive and Havells India.",neutral,neutral,-2.6737967914438503,negative,-0.5549145651337789,neutral
2020-07-05 15:47:00.000,896.0,899.45,873.0,874.9,2748275.0,Indian drug firms recall products in US market,"While Lupin and Marksans Pharma are recalling diabetes drug, Aurobindo and Alembic are recalling psychiatric medication in the US market.",negative,negative,-2.3549107142857166,negative,-0.8623151162126611,neutral
2020-07-06 07:41:00.000,896.0,899.45,873.0,874.9,2748275.0,"Stocks in the news: Reliance Ind, ICICI Bank, Future Retail, Indiabulls Housing, YES Bank, Biocon and NBCC","Lupin, Marksans Pharma, Aurobindo Pharma and Alembic Pharmaceuticals are recalling products in the US market.",neutral,negative,-2.3549107142857166,negative,-0.8623151162126611,neutral
2020-07-06 08:54:19.000,896.0,899.45,873.0,874.9,2748275.0,"Stocks in focus: ICICI Bank, Yes Bank, Coal India, Federal Bank, Lupin, Aurobindo Pharma, NBCC","Sadbhav Infrastructure Project, NBCC (India), BCL Industries, BMW Industries, Bodal Chemicals, DCW, Dynamic Industries, IFB Agro Industries, IFB Industries, JMD Ventures, Nyssa Corporation, Welcure Drugs & Pharmaceuticals are among 35 companies that are scheduled to announce their March quarter earn…",neutral,neutral,-2.3549107142857166,negative,-0.8623151162126611,neutral
2020-07-08 05:30:00.000,874.0,889.65,862.0,862.8,3515556.0,BRIEF-Lupin Voluntarily Recalls Metformin Hydrochloride Extended-Release Tablets In U.S. - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.2814645308924535,negative,-0.6139545558870809,neutral
2020-07-08 11:25:40.000,874.0,889.65,862.0,862.8,3515556.0,Lupin recalls diabetes treatment drug in US,"Drug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tablets in the US market.In a regulatory filing, the company sai",neutral,negative,-1.2814645308924535,negative,-0.6139545558870809,neutral
2020-07-08 11:40:00.000,874.0,889.65,862.0,862.8,3515556.0,Lupin voluntary recalls Metformin Hydrocholride in US,"The step has been taken due to the detection of N-Nitrosodimethylamine (NDMA) impurity in Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg.",negative,neutral,-1.2814645308924535,negative,-0.6139545558870809,neutral
2020-07-08 11:50:00.000,874.0,889.65,862.0,862.8,3515556.0,Lupin recalls diabetes treatment drug Metformin Hydrochloride in US,Drug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tablets in the US market,neutral,negative,-1.2814645308924535,negative,-0.6139545558870809,neutral
2020-07-08 12:03:00.000,871.4,882.0,862.5,866.05,2104189.0,Lupin recalls diabetes treatment drug in the US,"In a regulatory filing, the company said that it is voluntarily recalling its Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg products in the US.",neutral,negative,-0.6139545558870809,neutral,-1.206896551724138,negative
2020-07-09 11:57:47.000,871.4,882.0,862.5,866.05,2104189.0,Recall of metformin formulations in the US by Lupin may hit profitability,"While Lupin said it expects to relaunch the products, there could still be an impact as it could lose market share",negative,negative,-0.6139545558870809,neutral,-1.206896551724138,negative
2020-07-09 14:27:00.000,870.0,874.9,858.0,859.5,1824565.0,"Buy Lupin, target price Rs 1,040: Nomura",In FY21F the company is also likely to incur one-time additional expenses of $10 million related to the recall of Metformin extended-release tablets from the US market.,neutral,negative,-1.206896551724138,negative,0.35679346262301,neutral
2020-07-14 05:30:00.000,871.0,883.3,868.55,871.9,2540726.0,Lupin says 18 staff test positive for COVID-19 at drug plant - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",positive,neutral,0.1033295063145783,neutral,-1.776939778311058,negative
2020-07-14 14:44:00.000,875.1,878.9,855.1,859.55,1623163.0,Tech charts signal Lupin and Havells ready to move out of consolidation - The Economic Times,The market is currently supportive of advances in the second line of leader stocks and both these stocks fall under that category.,neutral,positive,-1.776939778311058,negative,2.169877001624512,positive
2020-07-14 18:41:00.000,875.1,878.9,855.1,859.55,1623163.0,These 7 pharma stocks gave over 50% return since COVID-19 outbreak,"Sun Pharma, Dr Reddy’s Laboratories, Cipla, Torrent Pharmaceuticals, Lupin and Cadila Healthcare have given over 50 per cent return since January 30 when the first coronavirus case was reported",positive,neutral,-1.776939778311058,negative,2.169877001624512,positive
2020-07-14 19:18:49.000,875.1,878.9,855.1,859.55,1623163.0,Lupin’s Ankleshwar facility reports Covid cases,The company shuts one plant inside the facility after at least eight employees test positive.,neutral,neutral,-1.776939778311058,negative,2.169877001624512,positive
2020-07-14 20:32:37.000,875.1,878.9,855.1,859.55,1623163.0,Lupin Shuts Drug Manufacturing Plant in Gujarat after 17 Employees Test Positive for Covid-19,"Lupin has some 11 manufacturing plants at the Ankleshwar site in Gujarat state, which is spread out over 40 acres and has 984 employees, according to the company website.",neutral,neutral,-1.776939778311058,negative,2.169877001624512,positive
2020-07-14 20:44:00.000,875.1,878.9,855.1,859.55,1623163.0,Lupin shuts manufacturing drug plant after 17 employees test positive for Covid-19 - The Economic Times,"The company has some 11 manufacturing plants at the Ankleshwar site in Gujarat state, which is spread out over 40 acres and has 984 employees, according to the company website. Employees from one of those plants, which produces tuberculosis drugs, have tested positive in recent days, said MD Modia, …",neutral,neutral,-1.776939778311058,negative,2.169877001624512,positive
2020-07-14 22:18:00.000,875.1,878.9,855.1,859.55,1623163.0,Lupin shuts drug plant in Gujarat after 17 staff test positive for COVID-19,"Lupin makes everything from heart drugs to asthma and diabetes medicines that are sold in over 100 countries, with its largest market being North America.",neutral,neutral,-1.776939778311058,negative,2.169877001624512,positive
2020-07-14 23:25:00.000,875.1,878.9,855.1,859.55,1623163.0,Lupin shuts manufacturing plant after 17 staff test Covid-19 positive,"The firm has some 11 manufacturing plants at the Ankleshwar site in Gujarat state, which is spread out over 40 acres and has 984 employees, according to the company website.",neutral,neutral,-1.776939778311058,negative,2.169877001624512,positive
2020-07-15 07:33:00.000,875.1,878.9,855.1,859.55,1623163.0,Coronavirus: 18 employees test positive at Lupin’s west Gujarat plant,"A representative for Lupin, one of India’s top five drugmakers, confirmed at least 18 workers at the manufacturing site in Ankleshwar had tested positive for the disease caused by the novel coronavirus",positive,positive,-1.776939778311058,negative,2.169877001624512,positive
2020-07-17 14:29:00.000,884.85,903.75,870.0,896.55,3562554.0,Share market update: Pharma shares advance; Lupin gains 2% - The Economic Times,The Nifty Pharma index was trading 0.75 per cent up at 10460.1.,positive,positive,1.3222580098321672,positive,-3.3875640739915287,negative
2020-07-20 11:52:00.000,897.4,900.7,862.25,867.0,2389228.0,"D-Street Buzz: Pharma stocks trade mixed; Glenmark, Sun Pharma slip, Granules India edges higher","Glenmark Pharma was down over 3 percent followed by Sun Pharma, Lupin, Aurobindo Pharma, Cipla and Biocon.",positive,negative,-3.3875640739915287,negative,-2.293577981651376,negative
2020-07-20 15:04:57.000,872.0,872.45,846.0,852.0,2207948.0,Indian Energy Exchange Ltd leads losers in ‘A’ group,"Vakrangee Ltd, Sun Pharmaceuticals Industries Ltd, Hindustan Copper Ltd and Lupin Ltd are among the other losers in the BSEs A group today, 20 July 2020.",positive,negative,-2.293577981651376,negative,0.1114958042368459,neutral
2020-07-20 15:33:00.000,872.0,872.45,846.0,852.0,2207948.0,Over 158 applications for generic products pending with USFDA for approval: Lupin,"Sharing information with company’s shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company’s US business stabilised last fiscal and saw an increase of 5 per cent on the back of products like Levothyroxine and Oseltamivir.",neutral,positive,-2.293577981651376,negative,0.1114958042368459,neutral
2020-07-20 15:35:00.000,872.0,872.45,846.0,852.0,2207948.0,Over 158 ANDAs pending with USFDA for approval: Lupin,"Sharing information with company’s shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company’s US business stabilised last fiscal and saw an increase of 5 percent on the back of products like Levothyroxine and Oseltamivir.",neutral,positive,-2.293577981651376,negative,0.1114958042368459,neutral
2020-07-22 15:23:00.000,852.15,864.9,851.3,861.95,1589197.0,"Rakesh Jhunjhunwala picked these stocks in June quarter; total holding stood at Rs 11,549 crore","Jhunjhunwala raised his holding in Rallis India, Federal Bank, Edelweiss Financial Services, NCC, Jubilant Life Sciences, Delta Corp and Firstsource Solutions (FSL), while cut his stake in Lupin and Agro Tech Foods",neutral,positive,1.150032271313744,positive,-1.8166089965397925,negative
2020-07-23 04:56:00.000,852.15,864.9,851.3,861.95,1589197.0,Lupin receives tentative USFDA approval for Empagliflozin and Linagliptin tablets,These tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.,positive,neutral,1.150032271313744,positive,-1.8166089965397925,negative
2020-07-23 18:17:00.000,867.0,873.4,848.2,851.25,2149015.0,Lupin receives USFDA tentative approval for Empagliflozin and Linagliptin Tablets,Empagliflozin and Linagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.,positive,positive,-1.8166089965397925,negative,-0.9400705052878966,negative
2020-07-24 06:34:29.000,867.0,873.4,848.2,851.25,2149015.0,"Stocks To Watch: ABB, Adani Transmission, Asian Paints, Future Consumer, HPCL, ITC, JSW Steel, Lupin, Wipro, Yes Bank, Zee Entertainment",Here are the stocks to watch in trade today.,neutral,neutral,-1.8166089965397925,negative,-0.9400705052878966,negative
2020-07-24 07:24:00.000,867.0,873.4,848.2,851.25,2149015.0,"In pics | Stocks in the news: Wipro, ABB India, Ujaas Energy, Supreme Petrochem, Axis Bank, Lupin",Can Fin Homes | Bank Of Maharashtra | AU Small Finance Bank | IndiaMART InterMESH | Rossari Biotech | Simmonds Marshall are also among the stocks in focus today.,neutral,neutral,-1.8166089965397925,negative,-0.9400705052878966,negative
2020-07-24 08:02:52.000,867.0,873.4,848.2,851.25,2149015.0,"Stocks to Watch: Axis Bank, AU Small Finance, Lupin, Biocon, Sun Pharma","AU Small Finance Bank reported a 6% rise in its net profit at ₹201 crore in the April-June quarter of the current fiscal year.Biocon’s Q1FY21 consolidated revenue grew 14% to ₹1,690 crore from ₹1,483 crore in Q1FY20",neutral,positive,-1.8166089965397925,negative,-0.9400705052878966,negative
2020-07-24 08:25:00.000,867.0,873.4,848.2,851.25,2149015.0,"Wipro, Lupin, ABB India in spotlight","ITC, Asian Paints and Ambuja Cements will declare their April - June 2020 quarterly results today, 24 July 2020.",neutral,neutral,-1.8166089965397925,negative,-0.9400705052878966,negative
2020-07-24 08:27:00.000,867.0,873.4,848.2,851.25,2149015.0,Lupin gets tentative nod for Empagliflozin and Linagliptin tablets,"Lupin announced that it has received tentative approval for its Empagliflozin and Linagliptin Tablets, from the USFDA to market a generic version of Glyxambi Tablets of Boehringer Ingelheim Pharmaceuticals, Inc.",neutral,positive,-1.8166089965397925,negative,-0.9400705052878966,negative
2020-07-24 08:50:00.000,867.0,873.4,848.2,851.25,2149015.0,"Stocks to watch: RIL, Asian Paints, ITC, Biocon, Wipro, Mphasis, Lupin",Heres a list of stocks that may trade actively in todays trading session.,neutral,neutral,-1.8166089965397925,negative,-0.9400705052878966,negative
2020-07-24 09:03:04.000,867.0,873.4,848.2,851.25,2149015.0,"Market LIVE: Sensex, Nifty largely flat at pre-open","In today’s trade, shares of Axis Bank, AU Small Finance, Lupin, Biocon, Sun Pharma will be in focus.A total of 71 companies including ITC, Asian Paints, and Ambuja Cements will announce their June quarter earnings",neutral,neutral,-1.8166089965397925,negative,-0.9400705052878966,negative
2020-07-24 09:09:26.000,867.0,873.4,848.2,851.25,2149015.0,"Stocks in focus: ITC, Asian Paints, Axis Bank, Lupin, SpiceJet, realty stocks, to remain in news","Ambuja Cements, JSW Steel, Coromandel International, ITC, Asian Paints, Crompton Greaves Consumer Electricals, TCI Express, Texmo Pipes, Welspun India, etc., are scheduled to announce their quarterly earnings later in the day today.",neutral,neutral,-1.8166089965397925,negative,-0.9400705052878966,negative
2020-07-24 13:40:00.000,867.0,873.4,848.2,851.25,2149015.0,"Lupin allots 49,698 equity shares under ESOP","In view of the above, the issued and paid-up capital of the Company has been increased to s 90,62,81,440
consisting 45,31,40,720 equity shares of s 2/- each.",neutral,neutral,-1.8166089965397925,negative,-0.9400705052878966,negative
2020-07-24 23:03:00.000,867.0,873.4,848.2,851.25,2149015.0,Indian drug companies start off a price war on experimental Covid-19 drug,"Over the next few weeks, close to 10 drug companies including Abbott, Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr Reddys Laboratories are expected to launch their own brands of favipiravir, despite inconclusive evidence of its effectiveness.",negative,neutral,-1.8166089965397925,negative,-0.9400705052878966,negative
2020-07-26 15:16:00.000,851.0,853.45,828.4,843.0,1902870.0,"Lupin, Granules India recall 971,000 diabetes drug bottles from US market","As per the USFDA, the companies are recalling the product due to deviation from the current good manufacturing practices",neutral,negative,-0.9400705052878966,negative,-0.9433962264150944,negative
2020-07-26 15:26:05.000,851.0,853.45,828.4,843.0,1902870.0,"Lupin, Granules India recall 9.71 lakh bottles of diabetes drug in US market","As per the USFDA, Lupin and Granules India are recalling the generic diabetes drugs due to deviation from the current good manufacturing practices",negative,negative,-0.9400705052878966,negative,-0.9433962264150944,negative
2020-07-26 15:30:49.000,851.0,853.45,828.4,843.0,1902870.0,"Lupin, Granules India Recall Around 9.71 Lakh Bottles Of Diabetes Drug In U.S.",The affected lot is suspected of having cancer-causing nitrosodimethylamine above the acceptable intake limit.,neutral,neutral,-0.9400705052878966,negative,-0.9433962264150944,negative
2020-07-26 16:42:00.000,851.0,853.45,828.4,843.0,1902870.0,"Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market","As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Lupin is recalling 4,92,858 bottles of Metformin Hydrochloride extended-release tablets in 500 mg and 1,000 strengths.",negative,negative,-0.9400705052878966,negative,-0.9433962264150944,negative
2020-07-26 19:26:15.000,851.0,853.45,828.4,843.0,1902870.0,"Lupin, Granules India Recall 9.71 Lakh Bottles of Diabetes Drug in US Market","According to the USFDA, Lupin is recalling 4,92,858 bottles of Metformin Hydrochloride extended-release tablets in 500 mg and 1,000 mg strengths, while Hydera.",neutral,negative,-0.9400705052878966,negative,-0.9433962264150944,negative
2020-07-26 19:39:17.000,851.0,853.45,828.4,843.0,1902870.0,"Lupin, Granules India recall 9.71 lakh bottles of diabetes drug in the US market",Drug makers Lupin and Granules India are recalling close to 9.71 lakh bottles of generic diabetes drug in the US due to possibility of the affected lot containing cancer causing nitrosodimethylamine (,negative,negative,-0.9400705052878966,negative,-0.9433962264150944,negative
2020-07-26 21:27:34.000,851.0,853.45,828.4,843.0,1902870.0,"Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market","Lupin is recalling 1,23,912 bottles of the 500 mg Metformin Hydrochloride extended-release tablets and 3,68,946 bottles of the same drug of 1,000 mg strength.",negative,negative,-0.9400705052878966,negative,-0.9433962264150944,negative
2020-07-30 10:53:00.000,864.3,894.45,863.05,888.4,4112527.0,"Pharma stocks gain led by Dr Reddy’s Labs, stock hits 52-week high; Cadila Health, Lupin rise","Dr Reddy’s Labs was the top gainer hitting new 52-week high followed by Divis Labs, Torrent Pharma, Lupin, Cadila Healthcare, Cipla and Aurobindo Pharma.",positive,positive,2.788383663079952,positive,3.2243643475831267,positive
2020-07-30 12:22:00.000,894.75,931.0,878.7,923.6,5232179.0,Nifty Pharma index rally nearly 3% led by Dr Reddy’s,"Shares of Divi’s Lab climbed 4.5%, followed by Torrent Pharma, Lupin, Biocon, Aurobindo Pharma and Sun Pharma were up over in the range of 3-2%, respectively.",positive,positive,3.2243643475831267,positive,1.087431693989076,positive
2020-07-31 05:31:00.000,894.75,931.0,878.7,923.6,5232179.0,Lupin (₹889.9): Buy,"The stock of Lupin gained 3.5 per cent on Thursday, extending the upmove, it decisively breached the 21-day moving average. This rally provides investors with a short-term perspective an opportunity t",neutral,positive,3.2243643475831267,positive,1.087431693989076,positive
2020-07-31 13:31:45.000,894.75,931.0,878.7,923.6,5232179.0,Lupin Ltd gains for third straight session,"Lupin Ltd is quoting at Rs 914.95, up 2.76% on the day as on 12:54 IST on the NSE. The stock is up 20.54% in last one year as compared to a 0.82% jump in NIFTY and a 40.99% jump in the Nifty Pharma index.",positive,positive,3.2243643475831267,positive,1.087431693989076,positive
2020-07-31 16:36:00.000,894.75,931.0,878.7,923.6,5232179.0,Pharma largecaps should lead the rally going forward: Rahul Shah,"Sun Pharma, Lupin have underperformed vis-à-vis the other pharma stocks and there could be some more catch up in those stocks.",positive,positive,3.2243643475831267,positive,1.087431693989076,positive
2020-08-02 13:15:00.000,915.0,946.5,913.05,924.95,3943093.0,"Lupin recalls 35,928 bottles of generic antibiotic drug ‘Cefdinir’ in the US market","As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), the Mumbai-based company is recalling Cefdinir for oral suspension USP, 250 mg/5mL, packaged in 60 ml bottles.",neutral,neutral,1.087431693989076,positive,0.7556675062972243,neutral
2020-08-02 20:33:40.000,915.0,946.5,913.05,924.95,3943093.0,"Lupin recalls 35,928 bottles of generic antibiotic drug in the US","Drug major Lupin is recalling 35,928 bottles of a generic antibiotic drug in the US market following unfavourable result in retention samples, the US health regulator said in a report.Per the latest E",neutral,negative,1.087431693989076,positive,0.7556675062972243,neutral
2020-08-04 02:26:00.000,932.95,947.5,912.0,940.0,2870007.0,"Nifty Pharma index gains 1%; Alkem Lab, Wockhardt stocks shine","Torrent Pharma and Dr Reddy’s Lab climbed 2% on the pharma index, followed by Sun Pharma, Lupin, Cadila and Divis Lab were also up 1% on the pharma index.",positive,positive,0.7556675062972243,neutral,-1.381509032943677,negative
2020-08-04 03:35:00.000,932.95,947.5,912.0,940.0,2870007.0,Lupin gets tentative approval for Empagliflozin tablets by USFDA,Empagliflozin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.,positive,positive,0.7556675062972243,neutral,-1.381509032943677,negative
2020-08-04 05:30:00.000,932.95,947.5,912.0,940.0,2870007.0,BRIEF-Lupin Gets Tentative Approval For Empagliflozin Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.7556675062972243,neutral,-1.381509032943677,negative
2020-08-04 13:16:10.000,941.0,954.6,924.0,928.0,3670694.0,"Lupin Ltd soars 0.36%, up for fifth straight session","Lupin Ltd is quoting at Rs 930.95, up 0.36% on the day as on 12:49 IST on the NSE. The stock is up 23.03% in last one year as compared to a 1.73% spurt in NIFTY and a 43.18% spurt in the Nifty Pharma.",positive,positive,-1.381509032943677,negative,0.2894511149228179,neutral
2020-08-04 14:58:00.000,941.0,954.6,924.0,928.0,3670694.0,Lupin receives USFDA tentative approval for Empagliflozin Tablets,Empagliflozin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.,positive,positive,-1.381509032943677,negative,0.2894511149228179,neutral
2020-08-04 15:22:00.000,941.0,954.6,924.0,928.0,3670694.0,Lupin rises after tentative USFDA approval for diabetes drug,Lupin gained 1.49% to Rs 940.80 after the company said it received tentative approval from the US drug regulator for Empagliflozin tablets.,positive,positive,-1.381509032943677,negative,0.2894511149228179,neutral
2020-08-04 16:42:06.000,941.0,954.6,924.0,928.0,3670694.0,Lupin gets USFDA nod for generic diabetes drug,Drug maker Lupin on Tuesday said it has received approval from the US health regulator to market a generic diabetes drug in America. The Mumbai-based company has received a tentative approval from the,neutral,positive,-1.381509032943677,negative,0.2894511149228179,neutral
2020-08-04 19:30:00.000,941.0,954.6,924.0,928.0,3670694.0,Lupin gets US FDA approval to market generic diabetes drug in the US,The Mumbai-based company has received a tentative approval from the USFDA for its Empagliflozin tablets,positive,positive,-1.381509032943677,negative,0.2894511149228179,neutral
2020-08-05 01:15:00.000,941.0,954.6,924.0,928.0,3670694.0,Lupin launches Favipiravir Drug Covihalt for treatment of mild to moderate Covid-19,"It is available as 200 mg tablets in the form of a strip of 10 tablets, and priced at Rs49 per tablet.",neutral,neutral,-1.381509032943677,negative,0.2894511149228179,neutral
2020-08-05 11:31:18.000,941.0,954.6,924.0,928.0,3670694.0,"At ₹49 per tablet, Lupin launches Covihalt for covid treatment",Covihalt is available as 200 mg tablets in the form of a strip of 10 tablets for treatment of mild to moderate COVID-19: Lupin,neutral,neutral,-1.381509032943677,negative,0.2894511149228179,neutral
2020-08-05 12:13:00.000,932.8,945.8,925.5,935.5,3300286.0,Lupin launches coronavirus drug Favipiravir in India at Rs 49 per tablet,"Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filing. Its Covihalt dosage strength has been developed keeping in mind convenience of administration.",neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-05 12:18:00.000,932.8,945.8,925.5,935.5,3300286.0,Coronavirus treatment: Lupin launches Favipiravir for Rs 49 per tablet; names drug Covihalt,"Coronavirus treatment: Lupin’s announcement comes after Sun Pharma on Tuesday announced the launch of its Favipiravir drug, FluGuard for Rs 35 per tablet",neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-05 12:31:03.000,932.8,945.8,925.5,935.5,3300286.0,India’s Lupin to Sell Generic Covid-19 Drug Favipiravir,Lupin Ltd became the latest Indian drugmaker to launch a version of the antiviral drug favipiravir to treat COVID19 in the world’s third most affected country.,neutral,positive,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-05 12:31:29.000,932.8,945.8,925.5,935.5,3300286.0,Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet,"Its Covihalt dosage strength has been developed keeping in mind convenience of administration, it stated, adding that the drug is available as 200 mg tablets in the form of a strip of 10 tablets, and priced at Rs 49 per tablet.",neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-05 13:05:00.000,932.8,945.8,925.5,935.5,3300286.0,Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet,"Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filing.",neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-05 13:18:00.000,932.8,945.8,925.5,935.5,3300286.0,Lupin launches Covihalt for COVID treatment,The drug major on Wednesday announced the launch of its Favipiravir in India under the brand name Covihalt for the treatment of mild to moderate COVID-19.,neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-05 13:27:00.000,932.8,945.8,925.5,935.5,3300286.0,Lupin launches Covid-19 drug Favipiravir in India at Rs 49 per tablet,Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use of its product,positive,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-05 18:11:51.000,932.8,945.8,925.5,935.5,3300286.0,Lupin launches COVID-19 drug Favipiravir in India at ₹49 per tablet,"Favipiravir has received authorisation from DCGI for emergency use, Lupin said in a regulatory filing.",neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-05 18:16:37.000,932.8,945.8,925.5,935.5,3300286.0,Lupin launches its version of Covid-19 drug favipiravir,"Rolled out under the brand name Covihalt, a 200 mg tablet costs ₹49",neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-05 18:47:00.000,932.8,945.8,925.5,935.5,3300286.0,Lupin launches its version of Favipiravir,"Drug-maker Lupin Limited has launched its version of Favipiravir in India under the brand name Covihalt for the treatment of mild to moderate Covid-19.Priced at ₹49 per 200 mg tablet, the launch comes",neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-05 21:15:46.000,932.8,945.8,925.5,935.5,3300286.0,Lupin introduced anti-COVID-19 drug at ₹49 a tablet,Lupin Ltd. has announced the introduction of its Favipiravir version in India under the brand name Covihalt for treatment of mild to moderate COVID-19. Lupin’s Covihalt dosage strength has been develo,positive,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-06 02:58:00.000,932.8,945.8,925.5,935.5,3300286.0,Lupin’s alliance partner Concord receives USFDA nod for Mycophenolate Mofetil tablets,"Mycophenolate Mofetil Tablets are indicated for the prophylaxis of organ rejection in recipients of allogeneic kidney, heart or liver transplants.",neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-06 05:00:00.000,932.8,945.8,925.5,935.5,3300286.0,Lupin’s signs exclusive distribution pact with ForDoz Pharma,Lupin Pharmaceuticals enters into an agreement with ForDoz for granting Lupin rights to market 2 complex injectable assets in advanced stages of development in the US.,positive,positive,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-06 06:27:04.000,932.8,945.8,925.5,935.5,3300286.0,"Stocks To Watch: Adani Gas, Apollo Tyres, DLF, HDFC, INOX Leisure, JK Lakshmi Cement, Lupin, Vodafone Idea",Here are the stocks to watch in trade today.,neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-06 07:33:00.000,932.8,945.8,925.5,935.5,3300286.0,"Stocks in the news: HDFC, Vodafone Idea, HPCL, Lupin, Adani Enterprises and JK Tyre",Mortgage lender Housing Development Finance Corp (HDFC) said it has launched its qualified institutional placement (QIP).,neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-06 07:55:00.000,932.8,945.8,925.5,935.5,3300286.0,"Top stocks in focus: Lupin, HDFC, Apollo Tyres, Adani Gas, HPCL, Vodafone Idea",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-06 09:04:04.000,932.8,945.8,925.5,935.5,3300286.0,"Stocks in focus: HDFC, Vodafone Idea, HPCL, Adani Power, Lupin, banking and auto stocks",The rate-sensitive stocks such as banking and auto stocks will remain in focus ahead of RBI MPC meeting outcome. Comments on moratorium will be keenly watched by the market participants,neutral,neutral,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-06 10:34:27.000,932.8,945.8,925.5,935.5,3300286.0,Alkem Labs launches Alfluenza for coronavirus treatment,"Earlier this week, top drug makers including Lupin and Sun Pharma have launched a generic version of the antiviral drug favipiravir to treat COVID-19 in India.",neutral,positive,0.2894511149228179,neutral,-2.7518888214856814,negative
2020-08-06 17:48:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin alliance partner Concord gets USFDA nod for generic medicine,Concord has received approval from the US Food and Drug Administration (USFDA) to market the drug to prevent organ transplant rejection,neutral,positive,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-06 19:15:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin enters into agreement with ForDoz for two complex injectable assets under development,"The two assets are in the Oncology and Anti-infective therapeutic areas which when approved, will provide affordable alternatives to patients and healthcare professionals.",positive,positive,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-06 20:38:20.000,906.65,918.4,874.1,881.7,12138046.0,Lupin signs exclusive pact for distribution of 2 complex injectable drugs,"Lupin has so far launched women’s health drugs Methergine and Solosec, as well as cholesterol-lowering Antara.For ForDoz, Lupin’s marketing and distribution network in the US will be provide an advantage for sale of its products",positive,positive,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 02:29:00.000,906.65,918.4,874.1,881.7,12138046.0,"Sensex, Nifty trade volatile; Lupin, Biocon stocks dip","Biocon, Torrent Pharma, Sun Pharma, Aurobindo Pharma and Cipla also fell in the pharma index.",neutral,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 07:06:00.000,906.65,918.4,874.1,881.7,12138046.0,"In pics | Stocks in the news: Vodafone Idea, Lupin, Pidilite Industries, Adani Enterprises, Wipro, Asian Paints, GOCL Corporation",HPCL | Deepak Nitrite | Torrent Power | Indian Hotels | Novartis India | PNB Housing Finance | Mindspace Business Parks REIT | Gayatri Projects | Aarti Surfactants | Eveready Industries | Yes Bank | Gujarat State Petronet | Minda Industries | Mangalore Chemicals | KEI Industries | TD Power Systems |…,neutral,neutral,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 07:24:00.000,906.65,918.4,874.1,881.7,12138046.0,"Top stocks in focus: M&M, Cipla, Jubilant FoodWorks, Lupin, HPCL",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 08:02:51.000,906.65,918.4,874.1,881.7,12138046.0,"Stocks to Watch: Vodafone Idea, Yes Bank, HPCL, Jubilant FoodWorks, Lupin, IHCL","Vodafone Idea reported widening of net loss to ₹25,460 crore in the June quarter after it made additional provisioning to pay AGR related dues.HPCL reported a 157% jump in its June quarter net profit on the back of inventory gains and better than industry performance",neutral,positive,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 08:06:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin consolidated net profit declines 64.73% in the June 2020 quarter,Sales decline 9.09% to Rs 3468.63 crore,negative,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 08:43:00.000,906.65,918.4,874.1,881.7,12138046.0,"Stocks to watch: HPCL, Voda Idea, Mindspace REIT, Lupin, M&M, Cipla, Abbott",Heres a list of stocks that may trade acively in todays trading session.,neutral,neutral,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 08:55:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin Q1FY21; consolidated net profit falls by ~59% yoy,The company recorded a consolidated profit of ~Rs109cr in Q1FY21.,negative,positive,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 09:27:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin tumbles after weak Q1 performance,"Shares of the drug major slumped 4.98% to Rs 889.65 after its consolidated net profit tumbled 96.5% to Rs 106.9 crore on a 9.1% decline in sales to Rs 3,468.6 crore in Q1 FY21 over Q1 FY20.",negative,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 09:27:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin stock in focus: Q1 PAT drops 60% yoy to Rs107cr as Covid-19 impacts key biz in India and US,"Consolidated sales was at Rs3,468.6cr in Q1 decreasing by 9.1% from Rs3,815.5cr a year ago same period.",neutral,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 09:31:00.000,906.65,918.4,874.1,881.7,12138046.0,"Sensex slips over 100 points; Lupin, Vodafone Idea stocks drop",The market breadth is in favour of the gainers on the NSE with 935 stocks opened with gains and 455 declined.,neutral,positive,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 10:15:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin plunges 6% as June quarter profit tanks 60% YoY to Rs 107 crore,"EBITDA tood at Rs 531.4 cror for the quarter under review, down 34.7 per cent, from Rs 813.4 crore of Q1FY20, and by 27.6 per from Rs 733.9 crore logged in Q4FY20",negative,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 10:30:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin Q1 net profit drops 65% to Rs 107 crore,"Drug firm Lupin has reported a 64.72 per cent decline in its consolidated net profit to Rs 106.90 crore for the quarter to June 2020, hit by the COVID-19 pandemic.",negative,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 10:31:38.000,906.65,918.4,874.1,881.7,12138046.0,Lupin Q1 net profit drops 65 per cent to ₹107 crore,"Drug firm Lupin has reported a 64.72 per cent decline in its consolidated net profit to ₹ 106.90 crore for the quarter to June 2020, hit by the COVID-19 pandemic. The company had posted a net profit o",negative,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 10:33:45.000,906.65,918.4,874.1,881.7,12138046.0,"Lupin’s Q1 net profit falls 59% YoY as covid-19, lockdowns drag India, US sales","Lupin’s consolidated revenue from operations were down 9% at ₹3,529 crore.All regions that Lupin operates in witnessed a decline in sales, with its two largest markets, the US and India, seeing a 21% slump and 1.7% decline, respectively",neutral,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 11:06:54.000,906.65,918.4,874.1,881.7,12138046.0,"Lupin’s Q1 disappoints, its stock may nurse its wounds for some time",Lupin’s revenues tumbled 9% y-o-y even belying the lower analyst expectations.A revival in business will depend on new launches in the coming quarter and whether it can sustain some of the cost cuts,negative,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 11:17:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin shares fall 6% after Q1 net profit falls 60% YoY fall,"Lupin’s Q1FY21 net profit from continuing operations stood at Rs 106.9 crore against Rs 264.7 crore in Q1FY20, the company said on August 6.",negative,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 11:20:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin Q1 net profit drops 65% to Rs 107 crore slammed by Covid-19,"Consolidated total revenue from operations stood at Rs 3,527.9 crore for the quarter under consideration. It was Rs 3,877.7 crore for the same period a year ago",negative,neutral,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 11:38:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin shares tumble over 6% on earnings disappointment,"On the NSE, it tumbled 6.24 per cent to Rs 877.80.",negative,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 11:53:00.000,906.65,918.4,874.1,881.7,12138046.0,Share market update: Pharma stocks down; Lupin crumbles 6%,The Nifty Pharma index was trading -0.55 per cent down at 11340.5.,negative,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 14:44:48.000,906.65,918.4,874.1,881.7,12138046.0,Lupin tumbles 7% after weak Q1 performance,"Lupin’s net sales declined 9.1% to ₹3,468.6 crore in the quarter under review. Investment in R&D amounted to ₹357.50 crore, about 10.3% of sales for Q1 FY21 compared with ₹344.20 in the year-ago quarter",negative,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 14:55:00.000,906.65,918.4,874.1,881.7,12138046.0,Lupin share price slips over 6% after Q1 net profit falls 64.72%,Lupin stock declined 6.55% to Rs 874.9 against previous close of Rs 936.25 on BSE,negative,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 15:03:00.000,906.65,918.4,874.1,881.7,12138046.0,"Weak US sales drags Lupin’s Q1 show, revival hinges on key launches","The company reported a sharp 21 per cent decline in revenues in the US, much higher than its peers",positive,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-07 21:49:29.000,906.65,918.4,874.1,881.7,12138046.0,"Lupin Q1 net catches Covid, drops 60%",Pharma major Lupin Ltd has reported 60 per cent year-on-year decline in its net profit for the April to June quarter at Rs 107 crore.,neutral,negative,-2.7518888214856814,negative,7.49802683504341,positive
2020-08-09 13:59:05.000,886.9,999.4,886.05,953.4,14693072.0,"Lupin, Sun Pharma Recall Drugs In The U.S. Market","Lupin is recalling 11,688 bottles of Lisinopril tablets while Sun Pharma is recalling 3,516 bottlews of Clonazepam.",neutral,negative,7.49802683504341,positive,-0.5960402197574375,neutral
2020-08-09 14:25:00.000,886.9,999.4,886.05,953.4,14693072.0,"Lupin, Sun Pharma recalling products in the US market, says USFDA","Leading drug makers Lupin and Sun Pharma are recalling different products in the US, according to the US Food and Drug Administration (USFDA).",negative,negative,7.49802683504341,positive,-0.5960402197574375,neutral
2020-08-09 15:18:00.000,886.9,999.4,886.05,953.4,14693072.0,"Lupin, Sun Pharma recall Lisinopril and Clonazepam respectively in the US market","The Mumbai-based drug maker Lupin is recalling 11,688 bottles of Lisinopril tablets USP, 10 mg, which is used to treat high blood pressure, in the US market, as per the latest Enforcement Report by the US health regulator.",neutral,negative,7.49802683504341,positive,-0.5960402197574375,neutral
2020-08-10 01:33:00.000,886.9,999.4,886.05,953.4,14693072.0,"Nifty Pharma index outperforms; Cipla, Divi’s Lab extends gain","Shares of Lupin climbed over 7%, followed by Aurobindo Pharma, Cadila, Sun Pharma and Torrent Pharma which are up in the range of 5-3%, respectively.",positive,positive,7.49802683504341,positive,-0.5960402197574375,neutral
2020-08-10 03:27:00.000,886.9,999.4,886.05,953.4,14693072.0,Markets close higher; Pharma stocks outperform,"The Nifty Pharma index closed ~5% higher as the share price of its major heavyweights like Lupin, Divis labs & Cipla surged ~10% higher.",positive,positive,7.49802683504341,positive,-0.5960402197574375,neutral
2020-08-10 06:29:54.000,886.9,999.4,886.05,953.4,14693072.0,‘Pharma needs more govt sops’,"We are optimizing by doing as many virtual calls as possible with a smaller sales force. We are basically living to fight another day, says Nilesh Gupta, MD, Lupin Ltd",neutral,neutral,7.49802683504341,positive,-0.5960402197574375,neutral
2020-08-10 09:55:00.000,886.9,999.4,886.05,953.4,14693072.0,"Lupin Consolidated June 2020 Net Sales at Rs 3,527.86 crore, down 20.15% Y-o-Y",,negative,neutral,7.49802683504341,positive,-0.5960402197574375,neutral
2020-08-10 11:01:11.000,886.9,999.4,886.05,953.4,14693072.0,Lupin: Execution for US portfolio a key monitorable,Lupin’s guidance for the portfolio rollout in the US market is encouraging. New launches and an improving market share in Levothyroxine are expected to help tide over structural pricing erosion in the near to medium term,neutral,positive,7.49802683504341,positive,-0.5960402197574375,neutral
2020-08-10 11:37:00.000,886.9,999.4,886.05,953.4,14693072.0,"D-Street Buzz: Pharma stocks rally led by Divis Labs, Cipla; Lupin, Sun Pharma gain 3% each","Lupin gained over 5 percent followed by Sun Pharma and Dr Reddy’s Labs up 3 percent each while Biocon, Cadila Healthcare and Aurobindo Pharma were the other gainers.",positive,positive,7.49802683504341,positive,-0.5960402197574375,neutral
2020-08-10 13:02:00.000,964.7,969.55,945.0,958.95,6022716.0,Buy Lupin; target of Rs 1030: ICICI Direct,"ICICI Direct is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated August 09, 2020.",neutral,positive,-0.5960402197574375,neutral,-1.4323941444986716,negative
2020-08-10 15:48:00.000,964.7,969.55,945.0,958.95,6022716.0,Lupin- Recovery In Sight - Investing.com India,Read Lupin- Recovery In Sight by Bansi Desai on Investing.com India,neutral,neutral,-0.5960402197574375,neutral,-1.4323941444986716,negative
2020-08-10 17:09:00.000,964.7,969.55,945.0,958.95,6022716.0,"L&T, financials drive Sensex 142 points higher; Nifty above 11,250","Nifty Pharma rallied 5.46 per cent led by up to 12 per cent gains in Divis Labs, Lupin, Cipla, Aurobindo Pharma and Cadila Healthcare.",positive,positive,-0.5960402197574375,neutral,-1.4323941444986716,negative
2020-08-11 04:17:00.000,964.7,969.55,945.0,958.95,6022716.0,Lupin launches Zileuton Extended-Release tablets,The product would be manufactured at Lupin’s Nagpur facility.,neutral,neutral,-0.5960402197574375,neutral,-1.4323941444986716,negative
2020-08-11 05:30:00.000,964.7,969.55,945.0,958.95,6022716.0,BRIEF-Lupin Launches Zileuton Extended-Release Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.5960402197574375,neutral,-1.4323941444986716,negative
2020-08-11 07:15:00.000,964.7,969.55,945.0,958.95,6022716.0,Lupin first company to shift manufacturing of some drugs from India to US after Trump’s ‘Buy American’ order,CEO Vinita Gupta does not name the drugs. Analysts say move will not have much effect on Indian pharma sector. Gupta says US business was down 26 percent in Q1FY21 Q-o-Q. Efforts under way to bring Metformin back into the market within Q2FY21.,neutral,negative,-0.5960402197574375,neutral,-1.4323941444986716,negative
2020-08-11 15:19:00.000,952.95,952.95,925.0,939.3,2722663.0,Lupin launches Zileuton Extended-Release Tablets,"Zileuton Extended-Release Tablets, 600 mg, is the generic equivalent of Zyflo CR Extended-Release Tablets, 600 mg, of Chiesi USA, Inc. and is indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and",neutral,neutral,-1.4323941444986716,negative,-1.0955115932780333,negative
2020-08-11 16:16:00.000,952.95,952.95,925.0,939.3,2722663.0,Buy Lupin; target of Rs 980: HDFC Securities,"HDFC Securities is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 980 in its research report dated August 10, 2020.",neutral,positive,-1.4323941444986716,negative,-1.0955115932780333,negative
2020-08-11 16:17:00.000,952.95,952.95,925.0,939.3,2722663.0,Hold Lupin; target of Rs 905: Emkay Global Financial,"Emkay Global Financial recommended hold rating on Lupin with a target price of Rs 905 in its research report dated August 08, 2020.",neutral,positive,-1.4323941444986716,negative,-1.0955115932780333,negative
2020-08-11 18:42:00.000,952.95,952.95,925.0,939.3,2722663.0,Lupin pharma launches generic asthma treatment drug in US market,Drug firm Lupin on Tuesday said it has launched generic Zileuton extended-release tablets - used for the treatment of asthma - in the US market.,positive,positive,-1.4323941444986716,negative,-1.0955115932780333,negative
2020-08-11 18:59:00.000,952.95,952.95,925.0,939.3,2722663.0,Buy Lupin; target of Rs 1015: Motilal Oswal,"Motilal Oswal is bullish on Lupin recommended buy rating on the stock with a target price of Rs 1015 in its research report dated August 08, 2020.",neutral,positive,-1.4323941444986716,negative,-1.0955115932780333,negative
2020-08-12 12:15:00.000,940.2,946.0,926.9,929.9,2432328.0,"D-Street Buzz: Pharma stocks under pressure; Lupin, Biocon, Divis Labs, Cipla shed 2% each","Lupin, Cadila Healthcare, Divis Laboratories and Biocon shed over 2 percent each while Sun Pharma and Aurobindo Pharma were down a percent.",negative,neutral,-1.0955115932780333,negative,8.774940999785448,positive
2020-08-12 16:07:00.000,940.2,946.0,926.9,929.9,2432328.0,Buy Lupin; target of Rs 979; KRChoksey,"KRChoksey is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 979 in its research report dated August 11, 2020.",neutral,positive,-1.0955115932780333,negative,8.774940999785448,positive
2020-08-13 00:16:00.000,940.2,946.0,926.9,929.9,2432328.0,"Lupin appoints K B S Anand, Punita Kumar Sinha as independent directors",Drug firm Lupin on Wednesday announced the appointment of K B S Anand and Punita Kumar-Sinha as independent directors.,neutral,neutral,-1.0955115932780333,negative,8.774940999785448,positive
2020-08-13 02:37:00.000,940.2,946.0,926.9,929.9,2432328.0,"Lupin appoints K.B.S. Anand, Dr Punita Kumar-Sinha as Independent Directors; stock trades volatile","On Sensex, Lupin stock opened flat at Rs940 per piece and touched an intraday high and low of Rs945.75 per piece and Rs927.15 per piece respectively.",neutral,neutral,-1.0955115932780333,negative,8.774940999785448,positive
2020-08-14 02:10:00.000,932.2,1023.55,932.2,1014.0,26826399.0,"Market at day’s low; Lupin, Sun Pharma stocks gain","All the pharma constituents were trading higher except Dr Reddy’s, Biocon and Divis Lab in the afternoon session.",negative,positive,8.774940999785448,positive,-2.440684558537547,negative
2020-08-14 05:30:00.000,932.2,1023.55,932.2,1014.0,26826399.0,BRIEF-Lupin Announces Results From Phase 3 Clinical Trial Of Solosec In Female Patients - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,8.774940999785448,positive,-2.440684558537547,negative
2020-08-14 05:30:00.000,932.2,1023.55,932.2,1014.0,26826399.0,BRIEF-Lupin Pharmaceuticals Presents Phase 3 Data For Solosec - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,8.774940999785448,positive,-2.440684558537547,negative
2020-08-14 11:11:00.000,932.2,1023.55,932.2,1014.0,26826399.0,"Nifty Pharma index rallies nearly 3%; Lupin surges 10%, Cipla, Cadila up 3%",All the 10 constituents of the Nifty Pharma index were trading in the green.,positive,neutral,8.774940999785448,positive,-2.440684558537547,negative
2020-08-14 11:49:00.000,932.2,1023.55,932.2,1014.0,26826399.0,"Lupin trades above Rs 1,000 for the first time since Nov 2017","The pharma major last week reported a 64.72 per cent decline in its consolidated net profit to Rs 106.90 crore for the quarter to June 2020, hit by the Covid-19 pandemic.",neutral,negative,8.774940999785448,positive,-2.440684558537547,negative
2020-08-14 11:56:00.000,932.2,1023.55,932.2,1014.0,26826399.0,"D-Street Buzz: Pharma stocks gain led by Lupin; Glenmark, Cipla, Sun Pharma up 2%","S&P BSE Healthcare gained over a percent led by Bliss GVS which jumped over 4 percent followed by Glenmark Pharma, Hikal, Indoco Remedies, Marksans Pharma, Neuland Lab, Vivimed Labs and Eris Lifesciences.",positive,positive,8.774940999785448,positive,-2.440684558537547,negative
2020-08-14 12:02:00.000,932.2,1023.55,932.2,1014.0,26826399.0,Stock market update: Nifty Pharma index gains 2%; Lupin surges 9%,The index was trading 1.94 per cent up at 11701.1.,positive,positive,8.774940999785448,positive,-2.440684558537547,negative
2020-08-17 07:39:00.000,1028.4,1035.0,994.5,1003.3,7592723.0,"In pics | Stocks in the news: Fortis Healthcare, Berger Paints, Lupin, NLC India, Borosil, Jindal Steel & Power, Zee Learn, Ajanta Pharma, ICICI Bank","Sun TV Network, CG Power, PTC Industries, Man Industries (I), Satin Creditcare RE, IIFL Wealth Management, Gammon India, S Chand and Company and Dilip Buildcon are also in focus today",neutral,neutral,-2.440684558537547,negative,-1.7535070140280562,negative
2020-08-17 08:32:00.000,1028.4,1035.0,994.5,1003.3,7592723.0,"ICICI Bank, Lupin, telecom stocks in focus","ICICI Bank has completed the allotment of equity shares under its Qualified Institutions Placement (QIP) and raised approximately Rs 15,000 crore (approximately US$ 2 billion) through the issuance of 418,994,413 equity shares at an issue price of",neutral,positive,-2.440684558537547,negative,-1.7535070140280562,negative
2020-08-17 10:23:00.000,1028.4,1035.0,994.5,1003.3,7592723.0,Lupin presents Phase 3 clinical trial data for Solosec; stock dips 2%,"The trial results showed a clinically and statistically significant response rate, or microbiological cure, in patients treated with Solosec as compared to placebo (p",neutral,positive,-2.440684558537547,negative,-1.7535070140280562,negative
2020-08-17 12:27:00.000,998.0,1022.9,978.3,980.5,6241804.0,Lupin corrects on profit taking,Shares of the drug major fell 1.70% to Rs 1001 amid profit selling after a recent steep surge.,neutral,negative,-1.7535070140280562,negative,0.0,neutral
2020-08-21 17:39:00.000,998.7,1004.0,978.0,983.25,4142158.0,Lupin recalls around 5.61 lakh pouches of birth control pills in the US market,"The product is used to prevent pregnancy. It is manufactured in India and then supplied in the US market by Lupin Pharmaceuticals Inc, the report said. One pouch of Mibelas 24 Fe contains 28 chewable tablets. The reason for the recall is failed impurities specifications: Out of specification result…",negative,neutral,-1.547011114448788,negative,-1.74265450861196,negative
2020-08-21 18:04:00.000,998.7,1004.0,978.0,983.25,4142158.0,"Lupin recalls around 561,000 pouches of birth control pills in US market","Drug major Lupin is recalling 5,60,922 pouches of a birth control product in the US, as per the US Food and Drug Administration (USFDA)",neutral,negative,-1.547011114448788,negative,-1.74265450861196,negative
2020-08-24 01:09:00.000,987.0,992.5,960.5,969.8,4364263.0,Sensex at day’s high; Pharma stocks decline,"The Nifty Pharma index is trading lower by 83 points at 11,532.15 levels. Lupin, Cadila and Alkem fell 2% each",negative,negative,-1.74265450861196,negative,-2.6450000000000045,negative
2020-08-24 08:17:00.000,987.0,992.5,960.5,969.8,4364263.0,"Stocks in the news: SBI, ICICI Lombard, LIC Housing, Granules India, Lupin, BHEL and Union Bank","NOCIL, Scooters India and Globus Spirits are among of the companies which will announce their June quarter results today.",neutral,neutral,-1.74265450861196,negative,-2.6450000000000045,negative
2020-08-24 13:16:00.000,1000.0,1017.15,968.7,973.55,7213616.0,Lupin shars slips 2% after Investec retains ‘sell’ but raises target,Investec raised target on lupin to Rs 815 from Rs 665 per share.,positive,positive,-2.6450000000000045,negative,-0.2093759575120077,neutral
2020-08-24 14:20:00.000,1000.0,1017.15,968.7,973.55,7213616.0,Stock market update: Pharma stocks fall; Lupin loses nearly 2%,The Nifty Pharma index was trading 0.48 per cent down at 11559.1.,negative,negative,-2.6450000000000045,negative,-0.2093759575120077,neutral
2020-08-25 01:01:00.000,1000.0,1017.15,968.7,973.55,7213616.0,Lupin gains after receiving USFDA approval for generic Albuterol Sulphate MDI,"The total Albuterol Sulfate Inhalation Aerosol market had US sales of approximately US$2.9 billion, of which the ProAir HFA market accounted for US$1.3 billion, as per IQVIA MAT June 2020.",positive,neutral,-2.6450000000000045,negative,-0.2093759575120077,neutral
2020-08-25 09:24:00.000,1000.0,1017.15,968.7,973.55,7213616.0,Lupin receives USFDA approval for Albuterol Sulfate Inhalation Aerosol,"ProAir HFA (Albuterol Sulfate Inhalation Aerosol) is the registered trademark of Teva Branded Pharmaceutical Products R&D, Inc. (Teva) and is indicated for the treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms.",positive,neutral,-2.6450000000000045,negative,-0.2093759575120077,neutral
2020-08-25 09:33:00.000,1000.0,1017.15,968.7,973.55,7213616.0,Lupin rises after USFDA nod for generic Albuterol Sulphate MDI,The drug major rose 1.97% to Rs 987.45 after the company said it received approval from the US drug regulator for its Albuterol Sulfate inhalation aerosol.,neutral,positive,-2.6450000000000045,negative,-0.2093759575120077,neutral
2020-08-25 09:51:00.000,1000.0,1017.15,968.7,973.55,7213616.0,Trending stocks: Lupin shares rise over 1%,Shares of Lupin Ltd. traded 1.16 per cent up in trade at 09:48AM on Tuesday.,positive,positive,-2.6450000000000045,negative,-0.2093759575120077,neutral
2020-08-25 10:00:00.000,1000.0,1017.15,968.7,973.55,7213616.0,Lupin share price rises 5% on US FDA approval,The generic Albuterol Sulphate MDI will be manufactured at its Indore (Unit III) facility in India.,positive,neutral,-2.6450000000000045,negative,-0.2093759575120077,neutral
2020-08-25 10:35:00.000,1000.0,1017.15,968.7,973.55,7213616.0,Lupin gets USFDA approval for asthmatic symptoms prevention drug,Drug major Lupin on Tuesday said it has received approval from the US health regulator for its Albuterol Sulfate Inhalation Aerosol,positive,positive,-2.6450000000000045,negative,-0.2093759575120077,neutral
2020-08-25 10:45:00.000,1000.0,1017.15,968.7,973.55,7213616.0,Lupin gets US health regulator’s approval for asthmatic symptoms prevention drug,"The approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D, Inc. In a regulatory filing, Lupin said it has received approval from the United States Food and Drug Administration (USFDA) for its Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation.",positive,positive,-2.6450000000000045,negative,-0.2093759575120077,neutral
2020-08-25 11:15:18.000,1000.0,1017.15,968.7,973.55,7213616.0,Lupin gets USFDA nod for asthmatic symptoms prevention drug,The approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D,neutral,neutral,-2.6450000000000045,negative,-0.2093759575120077,neutral
2020-08-25 12:54:00.000,979.1,986.2,964.0,977.05,3847093.0,"Lupin allots 13,316 equity shares under ESOP","In view of the above, the issued and paid-up capital of the Company has been increased to s 90,63,08,072
consisting 45,31,54,036 equity shares of s 2/- each.",neutral,neutral,-0.2093759575120077,neutral,0.5466155810983421,neutral
2020-08-25 12:56:29.000,979.1,986.2,964.0,977.05,3847093.0,Lupin gets US FDA approval for generic of blockbuster respiratory drug ProAir,"The approval is timely as Albuterol MDI is a key rescue inhalation product for asthma patients who are at an increased risk of covid-related complications, the company said",positive,positive,-0.2093759575120077,neutral,0.5466155810983421,neutral
2020-08-25 16:19:00.000,979.1,986.2,964.0,977.05,3847093.0,Lupin share rises 5% on USFDA approval for asthma drug,Lupin share price rose over 5% on Tuesday after the firm announced it received approval from the United States Food and Drug Administration (USFDA) for inhalation product Albuterol Sulfate for asthma patients.,positive,positive,-0.2093759575120077,neutral,0.5466155810983421,neutral
2020-08-26 04:22:00.000,979.1,986.2,964.0,977.05,3847093.0,Lupin along with Mylan unveils Nepexto in the German market; stock ends higher,Nepexto has been approved for all therapeutic indications of the reference product Enbrel.,positive,positive,-0.2093759575120077,neutral,0.5466155810983421,neutral
2020-08-26 05:30:00.000,979.1,986.2,964.0,977.05,3847093.0,"BRIEF-India’s Lupin And Mylan Launch Nepexto, Biosimilar Etanercept In Germany - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.2093759575120077,neutral,0.5466155810983421,neutral
2020-08-26 10:38:03.000,979.1,986.2,964.0,977.05,3847093.0,Lupin: At the inflection point for complex generics,The traction in complex generic products and the restructuring initiatives can accelerate earnings growth for Lupin,neutral,positive,-0.2093759575120077,neutral,0.5466155810983421,neutral
2020-08-26 10:48:00.000,979.1,986.2,964.0,977.05,3847093.0,"Buy Lupin, target price Rs 1130: Motilal Oswal","Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 44047.24 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.2093759575120077,neutral,0.5466155810983421,neutral
2020-08-26 13:36:49.000,978.75,994.5,975.25,984.1,3894767.0,Motilal Oswal: Lupin’s gProAir U.S. FDA Approval - Milestone In Complex Generics Segment,Motilal Oswal: Lupin’s gProAir U.S. FDA Approval - Milestone In Complex Generics Segment,neutral,neutral,0.5466155810983421,neutral,-0.832910106653128,neutral
2020-08-26 14:26:00.000,978.75,994.5,975.25,984.1,3894767.0,"New asthma drug to lift earnings for Lupin, but will it be enough to make shareholders happy?","The stock has gained 64 per cent since March lows and 27 per cent YTD but is still 54 per cent down from the all-time high level of Rs 2,127 that it hit in October 2015.",positive,negative,0.5466155810983421,neutral,-0.832910106653128,neutral
2020-08-26 14:37:00.000,978.75,994.5,975.25,984.1,3894767.0,Expect good gross margins from ProAir generic due to price stickiness: Lupin CFO,It is a product which has a very high level of complexity and there is a fair degree of stickiness associated with it because we do not expect too much of competition,positive,neutral,0.5466155810983421,neutral,-0.832910106653128,neutral
2020-08-26 14:51:00.000,978.75,994.5,975.25,984.1,3894767.0,Lupin firms up on launching Nepexto biosimilar in Germany,"Lupin rose 1.26% to Rs 984.10 after the drug major announced the launch of Nepexto, biosimilar etanercept, in the German market.",neutral,positive,0.5466155810983421,neutral,-0.832910106653128,neutral
2020-08-26 18:12:00.000,978.75,994.5,975.25,984.1,3894767.0,Launch of inhalation product improves Lupin’s revenue visibility,More US launches and uptick in the Indian market are key near-term triggers,positive,positive,0.5466155810983421,neutral,-0.832910106653128,neutral
2020-08-26 18:21:12.000,978.75,994.5,975.25,984.1,3894767.0,Lupin Gets Long-Pending U.S. FDA Approval For Key Generic Asthma Drug,ProAir generic will be manufactured at Lupin’s Indore (unit III) facility in India.,neutral,neutral,0.5466155810983421,neutral,-0.832910106653128,neutral
2020-08-26 22:02:33.000,978.75,994.5,975.25,984.1,3894767.0,Lupin’s Albuterol launch will boost US revenues; stock is priced to perfection,"The launch of Albuterol is expected to add about $80-90 million in sales in FY22, say analysts",positive,positive,0.5466155810983421,neutral,-0.832910106653128,neutral
2020-08-26 23:37:40.000,978.75,994.5,975.25,984.1,3894767.0,"Lupin gets USFDA nod for gProAir HFA, launch likely in September",All three brands launched authorised generics in 2019. The USFDA also approved the first generic of ProAir in February (Perrigo’s ANDA) and Proventil in April (CIPLA’s ANDA).,neutral,positive,0.5466155810983421,neutral,-0.832910106653128,neutral
2020-08-27 14:06:00.000,984.5,991.75,972.0,976.3,2527339.0,Buy Lupin; target of Rs 1085: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1085 in its research report dated August 25, 2020.",neutral,positive,-0.832910106653128,neutral,-5.661914460285135,negative
2020-08-27 14:08:00.000,984.5,991.75,972.0,976.3,2527339.0,Buy Lupin; target of Rs 1130: Motilal Oswal,"Motilal Oswal is bullish on Lupin recommended buy rating on the stock with a target price of Rs 1130 in its research report dated August 25, 2020.",neutral,positive,-0.832910106653128,neutral,-5.661914460285135,negative
2020-09-02 05:30:00.000,950.35,970.0,940.35,966.0,3754684.0,BRIEF-Lupin Launches Leflunomide Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,1.6467617193665467,positive,-0.6031860596999559,neutral
2020-09-02 15:20:20.000,969.85,972.5,954.0,964.0,2216318.0,"Live: Sensex, Nifty Advance; Lupin Launches New Drug","Catch all live updates on share prices, index moves, corporate announcements and more from the Sensex and Nifty, today.",neutral,neutral,-0.6031860596999559,neutral,-1.1703239289446232,negative
2020-09-02 16:18:00.000,969.85,972.5,954.0,964.0,2216318.0,Lupin launches Leflunomide Tablets USP,"Leflunomide Tablets USP, 10 mg and 20 mg, is the generic equivalent of Arava Tablets, 10 mg and 20 mg, of
Sanofi-Aventis U.S. LLC., and is indicated for the treatment of adults with active rheumatoid arthritis (RA).",neutral,neutral,-0.6031860596999559,neutral,-1.1703239289446232,negative
2020-09-02 16:38:07.000,969.85,972.5,954.0,964.0,2216318.0,Lupin launches generic rheumatoid arthritis drug in US market,The Mumbai-based company’s product is the generic equivalent of Sanofi-Aventis US LLC’s Arava tablets.The company has launched the product in 10 mg and 20 mg strengths after receiving the approval from the USFDA,positive,neutral,-0.6031860596999559,neutral,-1.1703239289446232,negative
2020-09-02 17:44:00.000,969.85,972.5,954.0,964.0,2216318.0,Lupin launches generic rheumatoid arthritis drug ‘Leflunomide’ in US market,"Drug maker Lupin on Wednesday said it has launched
Leflunomide tablets, used to treat rheumatoid arthritis, in the US market.",positive,positive,-0.6031860596999559,neutral,-1.1703239289446232,negative
2020-09-03 08:45:00.000,969.85,972.5,954.0,964.0,2216318.0,"Bharti Airtel a clear buy after AGR verdict, Vodafone-Idea still an avoid: Hemang Jani","Pharma stocks like Laurus, Divis Lab and to some extent Lupin, are looking extremely attractive now because of the new product launch and specialty product portfolio.",positive,positive,-0.6031860596999559,neutral,-1.1703239289446232,negative
2020-09-03 12:29:00.000,957.0,966.6,935.55,945.8,2964469.0,Lupin launches Leflunomide tablets after USFDA approval; stock trades volatile,"In India, Lupin will manufacture the product from its Pithampur (Unit I) facility.",neutral,neutral,-1.1703239289446232,negative,-2.544783983140145,negative
2020-09-07 14:25:00.000,930.3,937.75,911.8,913.0,1919603.0,Stock market update: Pharma stocks slip; Lupin drops 2%,The Nifty Pharma index was trading 0.51 per cent down at 11223.75.,negative,negative,-1.8596151778995973,negative,2.508297513466452,positive
2020-09-15 10:59:00.000,972.85,1005.0,967.0,1004.0,6022134.0,"D-Street Buzz: Pharma stocks gain led by Aurobindo Pharma, Cipla, Dr Reddy’s Labs; JB Chemicals jumps 10%","The top gainers included Aurobindo Pharma which gained over 4 percent followed by Cipla, Dr Reddy’s Labs, Lupin and Sun Pharma which added 3 percent each.",positive,positive,3.201932466464509,positive,1.6005567153792648,positive
2020-09-15 13:04:23.000,1005.9,1033.0,995.85,1022.0,5332106.0,"Lupin Ltd soars 3.45%, rises for fifth straight session","Lupin Ltd is quoting at Rs 1001.35, up 3.45% on the day as on 12:49 IST on the NSE. The stock is up 30.19% in last one year as compared to a 4.57% spurt in NIFTY and a 42.69% spurt in the Nifty Pharma.",positive,positive,1.6005567153792648,positive,2.0758698532659348,positive
2020-09-15 13:31:08.000,1005.9,1033.0,995.85,1022.0,5332106.0,Lupin Ltd extends gains,"Lupin Ltd is quoting at Rs 1001.35, up 3.45% on the day as on 12:49 IST on the NSE. The stock is up 30.19% in last one year as compared to a 4.57% spurt in NIFTY and a 42.69% spurt in the Nifty Pharma.",positive,positive,1.6005567153792648,positive,2.0758698532659348,positive
2020-09-18 01:38:00.000,1075.0,1122.3,1070.4,1085.0,15240251.0,"Bulls of D-Street! Nifty Pharma spurts over 5%; Dr Reddy’s, Cipla, Lupin in the fast lane","The Nifty Pharma has surged over 5%, while the S&P BSE Healthcare also trades higher by 4%.",neutral,positive,0.9302325581395348,positive,-4.171846940185104,negative
2020-09-18 10:04:00.000,1075.0,1122.3,1070.4,1085.0,15240251.0,"BSE Healthcare index hits record high; Laurus Labs, Dr Reddy’s at new highs","Lupin, Stride Pharma, Neuland Labs, Lincoln Pharma, and Hikal hit their respective 52-week highs on the BSE",positive,positive,0.9302325581395348,positive,-4.171846940185104,negative
2020-09-18 11:22:00.000,1075.0,1122.3,1070.4,1085.0,15240251.0,"Lupin shares hit 52-week high, Cipla shares jump 6% after Perrigo recalls albuterol sulfate",Both stocks attracted traction after the Irish pharma company Perrigo voluntarily recalled albuterol sulfate inhalation aerosols over concerns that some may not dispense properly due to clogging.,positive,positive,0.9302325581395348,positive,-4.171846940185104,negative
2020-09-18 11:24:00.000,1075.0,1122.3,1070.4,1085.0,15240251.0,"Lupin, Cipla spurt after Perrigo recalls albuterol sulfate inhalation aerosols",Shares of Lupin and Cipla rose 5% to 6% after Perrigo Company plc announced a voluntary U.S. nationwide recall of albuterol sulfate inhalation aerosol over concerns that some may not dispense properly due to clogging.,positive,positive,0.9302325581395348,positive,-4.171846940185104,negative
2020-09-18 12:12:00.000,1075.0,1122.3,1070.4,1085.0,15240251.0,Stock market news: Lupin shares leaps 7%,"A total of 301,591 shares changed hands on the counter till 12:07PM (IST).",neutral,neutral,0.9302325581395348,positive,-4.171846940185104,negative
2020-09-18 12:16:10.000,1075.0,1122.3,1070.4,1085.0,15240251.0,Natco Pharma Ltd leads gainers in ‘A’ group,"Sudarshan Chemical Industries Ltd, Dr Reddys Laboratories Ltd, Cipla Ltd and Lupin Ltd are among the other gainers in the BSEs A group today, 18 September 2020.",positive,neutral,0.9302325581395348,positive,-4.171846940185104,negative
2020-09-18 13:28:50.000,1075.0,1122.3,1070.4,1085.0,15240251.0,"Stocks Across Pharma, Auto and Other Sectors to Keep An Eye On","In the pharmaceutical sector, top Indian firms Cipla and Lupin can expect notable gains owing to the fresh setback to Perrigo Company.",neutral,positive,0.9302325581395348,positive,-4.171846940185104,negative
2020-09-18 14:41:00.000,1075.0,1122.3,1070.4,1085.0,15240251.0,"Lupin, Cipla to benefit from Perrigo’s recall of asthma drug albuterol sulphate MDI in the US","Cipla has already launched the gProventil in April, while Lupin’s gProAir launch is expected this month. Dublin-based Perrigo recalled the device, saying some units may fail to dispense due to clogging",positive,negative,0.9302325581395348,positive,-4.171846940185104,negative
2020-09-18 15:22:00.000,1075.0,1122.3,1070.4,1085.0,15240251.0,"Cipla, Lupin may gain from Perrigo’s drug recall, says Macquarie",Perrigo announced the voluntary nationwide recall of albuterol sulfate following complaints that some units may not dispense due to clogging. A definitive timeline for reintroduction has not been determined.,positive,negative,0.9302325581395348,positive,-4.171846940185104,negative
2020-09-18 17:50:00.000,1075.0,1122.3,1070.4,1085.0,15240251.0,Pharma is in focus but there is no valuation comfort: Prabhudas Lilladher,"’We have a buy on Dr Reddys and Lupin. Dr Reddys definitely has a positive but the valuation remains very challenging after this recent run up of Rs 1,000 or more.",neutral,positive,0.9302325581395348,positive,-4.171846940185104,negative
2020-09-18 17:57:37.000,1075.0,1122.3,1070.4,1085.0,15240251.0,"Pharma stocks today have their best day in over a month. Cipla, Dr Reddy’s surge","The Nifty Pharma index closed up 5%, led by gains in Dr Reddy’s, Cipla and Lupin",positive,positive,0.9302325581395348,positive,-4.171846940185104,negative
2020-09-21 14:03:36.000,1040.55,1053.55,1017.8,1039.95,5216140.0,Motilal Oswal: Perrigo’s Loss Can Be Lupin’s Chance To Gain Market Share Versus Cipla,Motilal Oswal: Perrigo’s Loss Can Be Lupin’s Chance To Gain Market Share Versus Cipla,neutral,neutral,-0.0576618134640247,neutral,-3.8198728290784847,negative
2020-09-21 18:16:00.000,1040.55,1053.55,1017.8,1039.95,5216140.0,"Innovative diabetes drug portfolio, local partnerships help Boehringer Ingelheim take big strides in India","The German drugmaker, working on its own and through tie-ups with Lupin and Cipla, has cornered half the Sodium Glucose co-Transporter-2 market with its new class of oral anti-diabetic drugs. The rapidly growing SGLT segment currently accounts for 10 percent of the total oral anti-diabetic market, w…",positive,positive,-0.0576618134640247,neutral,-3.8198728290784847,negative
2020-09-22 03:01:00.000,1040.55,1053.55,1017.8,1039.95,5216140.0,Lupin launches Divalproex Sodium ER Tablets USP,The product will be manufactured at Lupin’s Nagpur facility in India.,neutral,neutral,-0.0576618134640247,neutral,-3.8198728290784847,negative
2020-09-22 05:30:00.000,1040.55,1053.55,1017.8,1039.95,5216140.0,BRIEF-Lupin Launches Divalproex Sodium ER Tablets USP - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.0576618134640247,neutral,-3.8198728290784847,negative
2020-09-22 15:34:00.000,1053.7,1053.7,1002.0,1013.45,3204682.0,Lupin launches Divalproex Sodium ER Tablets USP,"Divalproex Sodium ER Tablets USP, 250 mg and 500 mg, is the generic equivalent of Depakote ExtendedRelease (ER) Tablets, 250 mg and 500 mg, of AbbVie Inc., indicated for:",neutral,neutral,-3.8198728290784847,negative,-2.973240832507433,negative
2020-09-22 18:41:00.000,1053.7,1053.7,1002.0,1013.45,3204682.0,Lupin launches generic Divalproex Sodium tablets for bipolar disorder in US,"According to IQVIA MAT July 2020 data, Divalproex Sodium extended-release tablets USP had annual sales of approximately USD 130 million (about Rs 950 crore) in the US",neutral,neutral,-3.8198728290784847,negative,-2.973240832507433,negative
2020-09-23 02:05:00.000,1053.7,1053.7,1002.0,1013.45,3204682.0,"Nifty Pharma plummets 2%; Lupin, Alkem Lab, Cadila among major underperformers","The Nifty Pharma index has touched the day’s low of 11,627.50 with selling bias recorded in all listed stocks.",negative,negative,-3.8198728290784847,negative,-2.973240832507433,negative
2020-09-23 15:05:00.000,1009.0,1019.0,971.25,979.0,2896769.0,"Lupin allots 86,297 equity shares under ESOP","In view of the above, the issued and paid-up capital of the Company has been increased to s 90,64,80,666 consisting 45,32,40,333 equity shares of s 2/- each.",neutral,neutral,-2.973240832507433,negative,0.942249240121576,positive
2020-09-28 03:36:00.000,1008.6,1014.9,981.0,1004.75,4087381.0,Lupin launches Fosaprepitant for Injection,"Fosaprepitant for Injection, 150 mg Single-Dose Vial, (RLD: Emend) had annual sales of approximately USD 136 million in the US, as per IQVIA MAT July 2020.",positive,neutral,-0.3817172318064666,neutral,-1.96745562130178,negative
2020-09-28 05:30:00.000,1008.6,1014.9,981.0,1004.75,4087381.0,BRIEF-Lupin Ltd Says Launches Fosaprepitant For Injection - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.3817172318064666,neutral,-1.96745562130178,negative
2020-09-28 05:30:00.000,1008.6,1014.9,981.0,1004.75,4087381.0,BRIEF-Lupin Launches Atorvastatin Calcium Tablets USP - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.3817172318064666,neutral,-1.96745562130178,negative
2020-09-28 12:59:00.000,1014.0,1014.0,994.0,994.05,2639883.0,Lupin launches Atorvastatin Calcium tablets USP,The product will be manufactured at Lupin’s Nagpur facility in India.,neutral,neutral,-1.96745562130178,negative,0.6149999999999978,neutral
2020-09-28 13:40:00.000,1014.0,1014.0,994.0,994.05,2639883.0,Lupin launches cholesterol drug Atorvastatin Calcium Tablets,"Atorvastatin Calcium Tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, is the generic equivalent of Lipitor
Tablets, 10 mg, 20 mg, 40 mg and 80 mg, of Pfizer Inc., and indicated to lower cholesterol in blood for adults
and children over 10 years of age.",neutral,neutral,-1.96745562130178,negative,0.6149999999999978,neutral
2020-09-28 15:07:00.000,1014.0,1014.0,994.0,994.05,2639883.0,Lupin launches Fosaprepitant for Injection,"Fosaprepitant for Injection, 150 mg Single-Dose Vial, is the generic equivalent of Emend for Injection, 150 mg Single-Dose Vial, of Merck Sharp & Dohme Corp. (Merck), indicated for adults in combination with other antiemetic agents, for the",positive,neutral,-1.96745562130178,negative,0.6149999999999978,neutral
2020-09-28 15:23:00.000,1014.0,1014.0,994.0,994.05,2639883.0,Lupin launches generic cholesterol-lowering drug in the US,"The company has launched Atorvastatin Calcium tablets USP in the strengths of 10 mg, 20 mg, 40 mg, and 80 mg, having received an approval earlier from the United States Food and Drug Administration (USFDA), Lupin said in a statement.",positive,neutral,-1.96745562130178,negative,0.6149999999999978,neutral
2020-09-30 04:37:00.000,1000.0,1025.0,992.25,1006.15,5225675.0,Lupin launches Lapatinib tablet after alliance partner Natco Pharma bags USFDA approval,"As of June 2020, the tablets had annual sales of approximately $61M in the US.",neutral,neutral,0.6149999999999978,neutral,-0.2764306498545014,neutral
2020-09-30 19:41:00.000,1031.0,1032.0,1007.0,1028.15,4878941.0,Lupin launches Lapatinib Tablets 250 mg,"Lapatinib Tablets, 250 mg, are the generic equivalent of Tykerb Tablets, 250 mg, of Novartis Pharmaceutical Corporation, and are indicated in combination with:",neutral,neutral,-0.2764306498545014,neutral,1.4197500850877751,positive
2020-09-30 23:28:35.000,1031.0,1032.0,1007.0,1028.15,4878941.0,Lupin unveils Natco Pharma drug for breast cancer in U.S.,"Natco Pharma’s marketing partner Lupin has introduced Lapatinib Tablets, 250 mg, in the U.S. market. It followed Natco receiving the final approval for its abbreviated new drug application (ANDA) from",neutral,positive,-0.2764306498545014,neutral,1.4197500850877751,positive
2020-10-01 06:19:49.000,1031.0,1032.0,1007.0,1028.15,4878941.0,"Stocks To Watch: Auto Stocks, GAIL, Hotel Stocks, IGL, Inox Leisure, Lupin, ONGC, Oil India, PVR, RIL",Here are the stocks to watch in trade today.,neutral,neutral,-0.2764306498545014,neutral,1.4197500850877751,positive
2020-10-01 07:30:00.000,1031.0,1032.0,1007.0,1028.15,4878941.0,"Top stocks in focus: Lupin, RIL, ONGC, Oil India, Inox, PVR, GAIL",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.2764306498545014,neutral,1.4197500850877751,positive
2020-10-01 08:13:00.000,1031.0,1032.0,1007.0,1028.15,4878941.0,"Stocks in the news | RIL, Lupin, Sobha, CG Power & Industrial Solution, Usha Martin, DB Corp","Chemcon Speciality Chemicals, Computer Age Management Services, Bank of Baroda, Sunflag Iron & Steel, Mangalam Cement, Thomas Cook India are also among the stocks in focus today.",neutral,neutral,-0.2764306498545014,neutral,1.4197500850877751,positive
2020-10-01 08:30:00.000,1031.0,1032.0,1007.0,1028.15,4878941.0,"RIL, CAMS, Chemcon Speciality, Lupin in focus","Reliance Industries (RIL) and Reliance Retail Ventures (RRVL) announced that co-investors of Silver Lake will invest an additional Rs 1,875 crore into RRVL, a subsidiary of RIL. This brings the aggregate investment by Silver Lake and its",neutral,neutral,-0.2764306498545014,neutral,1.4197500850877751,positive
2020-10-01 08:37:00.000,1031.0,1032.0,1007.0,1028.15,4878941.0,Lupin launches Lapatinib tablets,"Lupin announced yesterday the launch of Lapatinib Tablets, 250 mg, after Lupins alliance partner Natco Pharma received final approval for its ANDA from the United States Food and Drug Administration (U.S. FDA).",neutral,positive,-0.2764306498545014,neutral,1.4197500850877751,positive
2020-10-01 09:31:00.000,1031.0,1032.0,1007.0,1028.15,4878941.0,"Stocks in news: RIL, Dr Reddy, Lupin, PNB, HDFC","Stocks to watch today on October 1: RIL, Dr Reddy, Lupin, PNB, HDFC among others are the top stocks to watch out for in Thursday’s trading session",neutral,neutral,-0.2764306498545014,neutral,1.4197500850877751,positive
2020-10-01 09:56:00.000,1031.0,1032.0,1007.0,1028.15,4878941.0,What to buy in October? ICICIDirect picks over 20 bargain bets across 8 sectors,"If investors are looking to invest in October, ICICIdirect handpicks over 20 stocks across 8 sectors that include names like Lupin, Natco Pharma, Abbott, HUL, CEAT, BEL, Bandhan Bank, and Rallis India etc. among others.",positive,neutral,-0.2764306498545014,neutral,1.4197500850877751,positive
2020-10-01 13:44:00.000,1031.0,1032.0,1007.0,1028.15,4878941.0,Buy Lupin; target of Rs 1085: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1085 in its research report dated September 30, 2020.",neutral,positive,-0.2764306498545014,neutral,1.4197500850877751,positive
2020-10-01 16:15:52.000,1031.0,1032.0,1007.0,1028.15,4878941.0,3 pharma stocks set to gain 25% as cardiac remains dominant therapy in Indian pharma market,"According to the brokerage firm, Lupin, Glenmark, JB Chemicals, and Cipla are likely to gain market share among listed players.",positive,positive,-0.2764306498545014,neutral,1.4197500850877751,positive
2020-10-06 05:30:00.000,1045.6,1053.85,1021.7,1026.9,2627162.0,BRIEF-Lupin Gets U.S. FDA Approval For Dimethyl Fumarate Delayed-Release Capsules - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.7884468247895775,negative,-0.2520356727413638,neutral
2020-10-06 12:50:00.000,1031.6,1038.95,1018.4,1029.0,1828958.0,Lupin gets nod for Dimethyl Fumarate Delayed-Release Capsules,After getting the required USFDA approval the product is expected to be launched shortly.,neutral,neutral,-0.2520356727413638,neutral,1.6587447861092162,positive
2020-10-06 13:34:00.000,1031.6,1038.95,1018.4,1029.0,1828958.0,Lupin gets USFDA nod for multiple sclerosis drug,"The drug major received approval for its dimethyl fumarate delayed-release capsules, 120 mg and 240 mg, from the US drug regulator.",neutral,positive,-0.2520356727413638,neutral,1.6587447861092162,positive
2020-10-06 13:58:00.000,1031.6,1038.95,1018.4,1029.0,1828958.0,Lupin receives USFDA approval for Dimethyl Fumarate Delayed-Release Capsules,"Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg, are indicated for the treatment of patients
with relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease,
and active secondary",positive,positive,-0.2520356727413638,neutral,1.6587447861092162,positive
2020-10-06 15:47:00.000,1031.6,1038.95,1018.4,1029.0,1828958.0,Lupin gets USFDA nod to market drug for treating relapsing sclerosis,Lupin said it has received approval from the US health regulator to market generic Dimethyl Fumarate delayed-release capsules used for treatment of relapsing forms of multiple sclerosis in adults,neutral,positive,-0.2520356727413638,neutral,1.6587447861092162,positive
2020-10-09 07:49:00.000,1048.65,1055.85,1025.0,1028.0,2436561.0,Here’s a Bull Spread Strategy on Lupin by Nandish Shah of HDFC Securities,Primary trend of the stock is positive where stock price is trading above its 200-day SMA,neutral,positive,-1.9691984933009192,negative,1.3009708737864163,positive
2020-10-12 16:21:00.000,1050.0,1087.8,1045.3,1050.9,9408695.0,USFDA inspections taking longer time than usual due to COVID-19 safety protocols,"Sun Pharma, Auro Life, Lupin in the queue. Though generally, most inspections are done in a fortnight, now it’s taking almost a month. USFDA is taking precautions to ensure the safety of the investigators and the employees of the facility who assist its staff, say sources.",neutral,neutral,0.0857142857142943,neutral,-2.323279924599443,negative
2020-10-13 07:28:00.000,1050.0,1087.8,1045.3,1050.9,9408695.0,"Hot Stocks | Can bet on PNC Infratech, Strides Pharma and Lupin for short term","The short-term trend has turned bullish as Nifty is trading above its 5 and 11-day simple moving averages that are currently placed at 11,800 and 11,620, respectively.",neutral,positive,0.0857142857142943,neutral,-2.323279924599443,negative
2020-10-13 12:25:00.000,1061.0,1061.45,1022.55,1036.35,3482172.0,"Pharma stocks gain; Cipla hits record high, Lupin nears 52-week high","In the past month, Cipla and Lupin outperformed the market by gaining 12 per cent each, against 8 per cent rise in Nifty Pharma index",positive,positive,-2.323279924599443,negative,-3.3005211349160435,negative
2020-10-14 02:27:00.000,1061.0,1061.45,1022.55,1036.35,3482172.0,"Nifty Pharma index underperforms; Lupin, Cipla stocks drag","Lupin and Torrent Pharma dipped 2% each, Cipla fell over 1.5%, Dr Reddy’s and Divis Lab was also down nearly 1% on the pharma index.",neutral,negative,-2.323279924599443,negative,-3.3005211349160435,negative
2020-10-14 02:27:00.000,1061.0,1061.45,1022.55,1036.35,3482172.0,"Nifty Pharma index underperform; Lupin, Cipla stocks drag","Lupin and Torrent Pharma dipped 2% each, Cipla fell over 1.5%, Dr Reddy’s and Divis Lab was also down nearly 1% on the pharma index.",negative,negative,-2.323279924599443,negative,-3.3005211349160435,negative
2020-10-14 08:12:00.000,1061.0,1061.45,1022.55,1036.35,3482172.0,"Stocks in the news | Wipro, TVS Motor, HFCL, Lupin, PNB Gilts, Karnataka Bank","SRF, Sulabh Engineers & Services, CSL Finance, PH Trading, AAA Technologies, Gayatri Projects, Gujarat State Petronet, Shish Industries, are also among the stocks in focus today.",neutral,neutral,-2.323279924599443,negative,-3.3005211349160435,negative
2020-10-14 08:57:00.000,1061.0,1061.45,1022.55,1036.35,3482172.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani for short term","Sudarshan Sukhani of s2analytics.com suggests buying Lupin with a stop loss of Rs 1,025, target at Rs 1,101 and Pidilite Industries with a stop loss of Rs 1,465, target at Rs 1,512.",neutral,neutral,-2.323279924599443,negative,-3.3005211349160435,negative
2020-10-14 17:50:00.000,1036.2,1042.0,996.15,1002.0,2851674.0,"Rakesh Jhunjhunwala-held Lupin share doubled in seven months, here’s how",Lupin share has doubled investor wealth in last seven months. The stock which is part of ace investor Rakesh Jhunjhunwala’s portfolio fell to its 52-week low of Rs 505 on March 13 this year. The pharma stock has gained 105% since then. The stock was tradi,positive,positive,-3.3005211349160435,negative,3.2783618155547893,positive
2020-10-15 12:35:00.000,1003.55,1045.9,998.0,1036.45,4430196.0,"Nifty Pharma trades lower; Sun Pharma, Lupin stocks down","On the flip side, Aurobindo Pharma and Biocon trading higher. on the pharma index",negative,positive,3.2783618155547893,positive,-2.9141544645420656,negative
2020-10-16 12:49:00.000,1003.55,1045.9,998.0,1036.45,4430196.0,"Nifty Pharma gains over 1%; Cadila, Lupin, Biocon in the fast lane","Cadila, Lupin and Biocon were among top gainers to drive the index. While Dr Reddy’s, Cipla and Aurobindo Pharma also lifted the performance.",positive,positive,3.2783618155547893,positive,-2.9141544645420656,negative
2020-10-21 11:12:00.000,1012.0,1014.9,988.0,1001.3,3130852.0,Contrarian LIC tweaked market strategy in Q2: Check out its latest buys,"Data showed LIC increased stakes in Lupin, Alkem Laboratories and Pfizer in Q2. These stocks advanced up to 24 per cent during the quarter.",positive,positive,-1.0573122529644314,negative,-1.6276300119094855,negative
2020-10-22 10:50:00.000,1007.6,1007.6,977.6,991.2,2889038.0,Nifty Pharma index slumps 2%; Aurobindo Pharma sinks 6%,"Shares of Dr Reddy is ~3% down, Cipla slipped over 2%, while Cadila, Lupin and Biocon are down over 1.5% each. On other hand, Divis Lab is slightly down on the pharma index.",negative,negative,-1.6276300119094855,negative,-0.528169014084507,neutral
2020-10-22 11:52:00.000,1007.6,1007.6,977.6,991.2,2889038.0,Lupin allots 36303 equity shares under ESOP,"In view of the above, the issued and paid-up capital of the Company has been increased to s 90,65,53,272 consisting 45,32,76,636 equity shares of s 2/- each.",neutral,neutral,-1.6276300119094855,negative,-0.528169014084507,neutral
2020-10-22 13:30:08.000,994.0,1010.0,986.4,988.75,2797161.0,Contract Advertising creates a series of films for Lupin’s Lupisafe Wipes,The films encourage people to use alcohol based wipes to stay safe during these times,neutral,positive,-0.528169014084507,neutral,-3.1220101717105595,negative
2020-10-22 14:40:00.000,994.0,1010.0,986.4,988.75,2797161.0,"Rakesh Jhunjhunwala rejigs portfolio in Q2; ups stake in Lupin, Tata Motors",The shareholding pattern disclosed by the Tata group automaker showed Rakesh Jhunjhunwala holding 40 million shares,positive,neutral,-0.528169014084507,neutral,-3.1220101717105595,negative
2020-10-22 17:34:00.000,994.0,1010.0,986.4,988.75,2797161.0,"Rakesh Jhunjhunwala increases stake in Lupin, Tata Motors in September quarter","Stock market veteran Rakesh Jhunjhunwala has increased stake in companies such as Lupin, Tata Motors, among others during the second quarter of fiscal year 2021",positive,positive,-0.528169014084507,neutral,-3.1220101717105595,negative
2020-10-23 17:05:00.000,994.0,1010.0,986.4,988.75,2797161.0,Lupin wins five INDIASTAR 2020 for excellence in packaging of its derma products,"The INDIASTAR Award is a national award for excellence in packaging. A jury of eminent personalities from
institutions, government bodies, and industry experts selected the winners from a total of 305 entries.
INDIASTAR Awards are duly recognized",positive,positive,-0.528169014084507,neutral,-3.1220101717105595,negative
2020-11-04 07:49:00.000,945.0,962.7,939.8,944.05,4821557.0,"Nifty Pharma outperforms by over 2%; Sun Pharma advances 5%, Divis Lab, Cipla among gainers",Pharma stocks were in focus following corporate result announcements by major companies like Sun Pharma. Lupin will present Q2 result today.,positive,neutral,-0.1005291005291053,neutral,-0.3248136315228918,neutral
2020-11-04 08:12:00.000,945.0,962.7,939.8,944.05,4821557.0,"Market Ahead, November 4: All you need to know before the opening bell","A total of 91 companies including State Bank of India, Lupin, and Adani Enterprises, are scheduled to announce their quarterly results today",neutral,neutral,-0.1005291005291053,neutral,-0.3248136315228918,neutral
2020-11-04 08:36:35.000,945.0,962.7,939.8,944.05,4821557.0,"Companies and stocks to track today: November 4, 2020","Key Results: SBI, Lupin, Happiest Minds, Jubilant Life, United Spirits, Sundram FastenersAdani Enerprises, Adani Green Energy, Asahi India Glass, BASF, Balrampur Chini, Bannari Amman Sugars, Butterfly",neutral,neutral,-0.1005291005291053,neutral,-0.3248136315228918,neutral
2020-11-04 08:48:00.000,945.0,962.7,939.8,944.05,4821557.0,"Stocks to watch: PVR, Adani Ports, SBI, Ajanta Pharma, IT stocks, Lupin",Heres a list of stocks that may trade actively in todays session.,neutral,neutral,-0.1005291005291053,neutral,-0.3248136315228918,neutral
2020-11-04 12:09:00.000,939.0,953.8,921.8,935.95,5843622.0,"Lupin Q2 Preview: Adjusted profit may decline sharply on subdued revenue, operating performance",Guidance for launches and traction in the US in the second half of FY21 and update on albuterol market share after its launch in the American market would be key things to watch out for.,negative,positive,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-04 13:06:00.000,939.0,953.8,921.8,935.95,5843622.0,"Top stocks in focus: SBI, Lupin, HPCL, Adani Enterprises, PVR, Cera Sanitaryware",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-04 13:31:36.000,939.0,953.8,921.8,935.95,5843622.0,Lupin Ltd jumps 1.78%,"Lupin Ltd is quoting at Rs 954, up 1.78% on the day as on 12:59 IST on the NSE. The stock is up 26.37% in last one year as compared to a 0.18% fall in NIFTY and a 47.67% fall in the Nifty Pharma index.",positive,positive,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-04 17:07:00.000,939.0,953.8,921.8,935.95,5843622.0,Lupin Ltd turns around to net profit in Q2 at Rs214cr,"Lupin Ltd reported 1.21% fall in the Sep-20 quarter top line sales revenues at Rs3,835cr.",neutral,negative,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-05 05:30:00.000,939.0,953.8,921.8,935.95,5843622.0,BRIEF-Lupin Says Recently Experienced Information Security Incident - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-05 07:37:00.000,939.0,953.8,921.8,935.95,5843622.0,"Lupin reports Rs 211 crore net profit in Q2FY21, led by recovery in US business","Revenues of Lupin dropped 1.2 percent year-on-year (YoY) to Rs 3,835 crore, compared to previous year’s Rs 3,882 crore. On QoQ basis the revenues rose 8.7 percent.",positive,positive,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-05 08:00:00.000,939.0,953.8,921.8,935.95,5843622.0,"Lupin records a stellar Q2FY21 sequentially led by a recovery in India, US biz","Consolidated sales stood at Rs3,781.8cr in the quarter under review, increasing by 9% from Rs3,468.6cr of the preceding quarter.",positive,positive,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-05 08:01:00.000,939.0,953.8,921.8,935.95,5843622.0,Lupin reports consolidated net profit of Rs 211.02 crore in the September 2020 quarter,Sales decline 1.01% to Rs 3781.79 crore,neutral,negative,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-05 08:07:00.000,939.0,953.8,921.8,935.95,5843622.0,"Stocks in the news | HPCL, Tata Motors, Adani Ports, KEC International, Gati, Apollo Tyres, Lupin","Pidilite Industries, EIH, Godrej Agrovet, JK Lakshmi, Indian Hotels, Kalpataru Power Transmission, PVR, Inox Leisure in focus, SRF, United Spirits, Jubilant Life, BASF India, are also among the stocks in focus today.",neutral,neutral,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-05 08:26:00.000,939.0,953.8,921.8,935.95,5843622.0,"HPCL, Lupin, Pidilite Industries to be watched","HPCL reported its Q2 September 2020 result on Wednesday. The company’s net profit surged 135.4% to Rs 2,247.75 crore on 14.16% decline in total income to Rs 52,590.08 crore in Q2 September 2020 over Q2 September 2019.",neutral,positive,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-05 09:27:00.000,939.0,953.8,921.8,935.95,5843622.0,Lupin records PAT of Rs 211 cr in Q2 FY21,The drug major reported a consolidated net profit of Rs 211 crore in Q2 FY21 compared with net loss of Rs 127.1 crore in Q2 FY20.,neutral,positive,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-05 09:46:00.000,939.0,953.8,921.8,935.95,5843622.0,"Stocks in news: Pidilite Industries, Lupin, HPCL, Adani Green, Adani Gas, SAIL","Stocks to watch today on November 5: Pidilite Industries, Lupin, HPCL, Adani Green, Adani Gas, SAIL among others are the top stocks to watch out for in Thursday’s trading session",neutral,neutral,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-05 10:13:00.000,939.0,953.8,921.8,935.95,5843622.0,"With US sales recovering, Lupin Q2 profit up 97% over Q1 to Rs 211 cr","The revenues, however, dropped by 1.2 percent on a year on year (YoY) basis to Rs 3,835 crore, but sequentially the revenues rose 8.7 percent",positive,negative,-0.3248136315228918,neutral,-2.6702127659574493,negative
2020-11-05 12:48:00.000,940.0,944.45,913.15,914.9,3833897.0,Lupin Q2 results: Net profit at Rs 211 crore,"We are very pleased with the strong recovery of our business during the quarter, demonstrated by sequential growth across all our geographies, in particular US and India, Lupin Ltd MD Nilesh Gupta said.",neutral,positive,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-05 13:41:00.000,940.0,944.45,913.15,914.9,3833897.0,Lupin shares fall 2% in strong market post September quarter results,"In Q2FY21, the companys revenues declined 12 per cent YoY to Rs 3,835 crore mainly due to Kyowa divestment",positive,negative,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-05 15:00:50.000,940.0,944.45,913.15,914.9,3833897.0,"Lupin confirms ‘security incident’, days after Dr Reddy’s cyber attack",Drugmaker Lupin has confirmed an “information security incident” that has affected its IT systems. The incident comes barely a fortnight after Dr Reddy’s Laboratories reported a cyber-attack and isola,neutral,neutral,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-05 16:18:00.000,940.0,944.45,913.15,914.9,3833897.0,Lupin share falls over 2% despite strong Q2 earnings,"Lupin share fell over 2% intra day today despite the firm reporting a 266% rise in Q2 net profit. The stock has fallen after 3 days of consecutive gain. The stock touched an intraday low of Rs 922, down 2.36% against previous close of Rs 944.25 on BSE.",negative,negative,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-05 16:36:00.000,940.0,944.45,913.15,914.9,3833897.0,"Lupin Consolidated September 2020 Net Sales at Rs 3,835.00 crore, down 12.03% Y-o-Y",,negative,neutral,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-05 20:49:00.000,940.0,944.45,913.15,914.9,3833897.0,"Lupin: Q2 unimpressive, more triggers required to drive stock","US growth has picked up as anticipated, but India and a few other markets still lag",neutral,positive,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-05 21:57:00.000,940.0,944.45,913.15,914.9,3833897.0,Experienced information security incident that affected select internal IT systems: Lupin,"Restoration of the impacted systems is a priority and is underway, it added. The incident comes after another pharma major DrReddy’s Laboratories had also experienced an information security incident in October this year. The incident involved a ransomware attack, the company had said.",neutral,neutral,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-05 22:09:00.000,940.0,944.45,913.15,914.9,3833897.0,"Lupin experiences information security incident, select IT systems affected","Restoration of the impacted systems is a priority and is underway, it added",neutral,neutral,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-05 22:48:00.000,940.0,944.45,913.15,914.9,3833897.0,"Lupin expects 18.5% EBITDA margins in the second half of FY21 led by rebound of US, India businesses","Lupin said in order to achieve 18.5 percent EBITDA, it would also keep its expenses tight by restricting employee costs at 18 percent of sales",positive,positive,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-06 01:12:33.000,940.0,944.45,913.15,914.9,3833897.0,Lupin Q2 net profit at Rs 211 cr,"Drug firm Lupin has reported a consolidated net profit of Rs 211.02 crore for the quarter ended September 30, 2020 mainly on account of robust sales in the US market.",neutral,positive,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-06 08:48:21.000,940.0,944.45,913.15,914.9,3833897.0,"Dolat Capital: Lupin Posts In-Line Q2, Albuterol Ramp Up Delayed To Q4","Dolat Capital: Lupin Posts In-Line Q2, Albuterol Ramp Up Delayed To Q4",neutral,neutral,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-06 09:41:47.000,940.0,944.45,913.15,914.9,3833897.0,Lupin: Covid opportunity strengthens US business,The possibility of positive developments on the product pipeline front and restructuring initiatives can accelerate earnings growth for Lupin,positive,positive,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-06 11:06:00.000,940.0,944.45,913.15,914.9,3833897.0,"Buy Lupin, target price Rs 1130: Motilal Oswal","Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 42332.65 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-06 14:17:00.000,940.0,944.45,913.15,914.9,3833897.0,Lupin-On A Path To Higher Profitability - Investing.com India,Read Lupin-On A Path To Higher Profitability by Bansi Desai on Investing.com India,neutral,neutral,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-06 19:51:08.000,940.0,944.45,913.15,914.9,3833897.0,Analyst Corner: Retain ‘hold’ on Lupin stock with revised TP of Rs964/share,Company’s gross margin remained flat YoY but improved 50bps QoQ to 64.0% with improvement in US business.,positive,positive,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-06 21:50:54.000,940.0,944.45,913.15,914.9,3833897.0,Lupin confirms ‘security incident’ days after cyber attack at Dr Reddy’s,It comes soon after the cyber attack on Dr Reddy’s,neutral,neutral,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-06 22:18:10.000,940.0,944.45,913.15,914.9,3833897.0,Lupin Ltd ADR 2021 Q2 - Results - Earnings Call Presentation (OTCMKTS:LUPNY),The following slide deck was published by Lupin Ltd ADR in conjunction with their 2021 Q2 earnings call.,neutral,neutral,-2.6702127659574493,negative,-0.6920415224913471,neutral
2020-11-09 05:30:00.000,924.8,926.95,905.7,918.4,4262263.0,BRIEF-Lupin’s Novel Labs Unit in New Jersey Gets 13 Observations in FDA Inspection - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.6920415224913471,neutral,-6.260869565217393,negative
2020-11-09 08:08:29.000,924.8,926.95,905.7,918.4,4262263.0,Motilal Oswal: Lupin’s Profitability On An Uptrend For Three Quarters Now,Motilal Oswal: Lupin’s Profitability On An Uptrend For Three Quarters Now,neutral,neutral,-0.6920415224913471,neutral,-6.260869565217393,negative
2020-11-09 11:16:00.000,924.8,926.95,905.7,918.4,4262263.0,USFDA issues 13 observations after inspection of Lupin arm’s Somerset facility,Lupin said it does not believe that this will have an impact on disruption of supplies or the existing revenues from operations of this facility.,neutral,neutral,-0.6920415224913471,neutral,-6.260869565217393,negative
2020-11-09 12:14:00.000,920.0,920.0,855.35,862.4,7105980.0,USFDA issues 13 observations after inspection of Lupin arm’s facility in US,Drug firm Lupin said the US health regulator has issued 13 observations after inspection of its subsidiarys Somerset facility in New Jersey,neutral,neutral,-6.260869565217393,negative,4.252873563218391,positive
2020-11-09 15:30:00.000,920.0,920.0,855.35,862.4,7105980.0,USFDA inspection of Lupin’s Somerset facility; stock dip marginally,"The inspection commenced on September 10, 2020, and concluded on November 5, 2020.",neutral,neutral,-6.260869565217393,negative,4.252873563218391,positive
2020-11-09 16:23:00.000,920.0,920.0,855.35,862.4,7105980.0,Buy Lupin; target of Rs 1120: HDFC Securities,"HDFC Securities is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1120 in its research report dated November 06, 2020.",neutral,positive,-6.260869565217393,negative,4.252873563218391,positive
2020-11-10 08:22:00.000,920.0,920.0,855.35,862.4,7105980.0,"Nifty Pharma index nosedives by 4% despite Covid-19 vaccine hopes rise; Cipla, Cadila, Lupin stocks tumble 6% each",Drugmaker Pfizer achieved success in the first interim analysis from the Phase 3 study.,negative,positive,-6.260869565217393,negative,4.252873563218391,positive
2020-11-10 16:58:00.000,870.0,913.4,865.0,907.0,7538205.0,Why Lupin’s Solosec is a cautionary tale for the much-hyped speciality drug business,"The company’s speciality business has contracted 50 percent, as Covid continues to take a toll and limits its ability to promote Solosec to prescribing doctors",positive,neutral,4.252873563218391,positive,-1.1674008810572714,negative
2020-11-11 06:56:00.000,870.0,913.4,865.0,907.0,7538205.0,"Bulls of Wednesday! Nifty Pharma outperforms 3%; Aurobindo Pharma, Lupin top gainers",The sector limited losses in benchmarks Sensex and Nifty which have pared early gains and were trading flat led by selling in heavyweight stocks.,positive,negative,4.252873563218391,positive,-1.1674008810572714,negative
2020-11-12 08:36:00.000,908.0,937.2,888.55,897.4,7633430.0,Lupin’s alliance partner Concord receives USFDA nod for Tacrolimus Capsules,Tacrolimus Capsules USP are indicated for the prophylaxis of organ rejection in adult and pediatric patients.,neutral,neutral,-1.1674008810572714,negative,0.2222222222222222,neutral
2020-11-12 15:25:00.000,900.0,907.15,890.65,902.0,3817276.0,Buy Lupin; target of Rs 1212: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1212 in its research report dated November 06, 2020.",neutral,positive,0.2222222222222222,neutral,0.0441988950276218,neutral
2020-11-12 17:16:29.000,900.0,907.15,890.65,902.0,3817276.0,"Lupin, Concord Biotech get USFDA nod for immunosuppressant capsules","Drug firm Lupin on Thursday said that in alliance with Concord Biotech, it has received approval from the US health regulator to market generic immunosuppressant Tacrolimus capsules used in the Americ",neutral,positive,0.2222222222222222,neutral,0.0441988950276218,neutral
2020-11-12 17:19:00.000,900.0,907.15,890.65,902.0,3817276.0,"Lupin, Concord Biotech get USFDA nod for generic immunosuppressant capsules","In alliance with Concord Biotech, the company has received approval from the United States Food and Drug Administration (USFDA) to market Tacrolimus capsules USP, in the strengths of 0.5 mg, 1 mg, and 5 mg, Lupin said in a filing to the BSE.",neutral,positive,0.2222222222222222,neutral,0.0441988950276218,neutral
2020-11-12 22:06:21.000,900.0,907.15,890.65,902.0,3817276.0,Lupin Gets U.S. FDA Nod For Generic Immunosuppressant Capsules,The capsules are indicated for the prophylaxis of organ rejection in adult and pediatric patients.,neutral,neutral,0.2222222222222222,neutral,0.0441988950276218,neutral
2020-11-17 08:39:00.000,915.25,915.3,885.5,886.8,2888803.0,"Nifty Pharma under pressure; Torrent Pharma, Lupin, Biocon drag the performance",Pfizer Inc and its group companies have filed a petition against Aurobindo Pharma Ltd and Dr Reddy’s Laboratories in a US court.,positive,neutral,-3.1084403168533234,negative,-0.2316384180790909,neutral
2020-11-24 08:40:00.000,887.75,899.0,879.0,898.1,3060696.0,"Nifty Pharma picks up pace as investors turn bullish; Aurobindo Pharma, Biocon rallies","Dr Reddy’s Laboratories , Sun Pharma and Lupin were also among the top gainers to trade over 1%.",positive,positive,1.165868769360746,positive,-0.9080841638981224,negative
2020-11-24 11:29:00.000,887.75,899.0,879.0,898.1,3060696.0,"TCS, Infy, Lupin, Zee among 24 stocks looking strong for a rally",MACD is known for signalling trend reversals in traded securities or indices. It is the difference between the 26-day and 12-day exponential moving averages.,positive,neutral,1.165868769360746,positive,-0.9080841638981224,negative
2020-11-25 05:30:00.000,903.0,907.3,888.3,894.8,4847249.0,BRIEF-Lupin Ltd - Lupin Launches Tacrolimus Capsules USP - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.9080841638981224,negative,0.2898550724637706,neutral
2020-11-25 10:18:00.000,903.0,907.3,888.3,894.8,4847249.0,Lupin launches Tacrolimus capsules after alliance partner Concord Biotech bags USFDA approval,The capsules had an annual sales of approximately $303M in the U.S. (IQVIA MAT September 2020).,neutral,neutral,-0.9080841638981224,negative,0.2898550724637706,neutral
2020-11-25 13:02:00.000,897.0,906.95,893.3,899.6,2325867.0,Lupin launches Tacrolimus Capsules,"Tacrolimus Capsules USP, 0.5 mg, 1 mg, and 5 mg, are the generic equivalent of Prograf Capsules, 0.5 mg, 1 mg, and 5 mg, of Astellas Pharma US, Inc., and are indicated for the prophylaxis of organ rejection, in adult patients receiving allogeneic",neutral,neutral,0.2898550724637706,neutral,-1.234772978959023,negative
2020-11-25 13:19:00.000,897.0,906.95,893.3,899.6,2325867.0,Lupin gains after launch of tacrolimus capsules,"Shares of the drug maker added 0.61% to Rs 900.65 after the company announced the launch of tacrolimus capsules USP, 0.5 mg, 1 mg, and 5 mg, in the US market.",positive,positive,0.2898550724637706,neutral,-1.234772978959023,negative
2020-11-25 13:44:00.000,897.0,906.95,893.3,899.6,2325867.0,Lupin launches generic immunosuppressant drug in US,"The company has launched Tacrolimus capsules USP in the strengths of 0.5 mg, 1 mg, and 5 mg, after Concord Biotech Ltd received an approval for its abbreviated new drug application (ANDA) from the United States Food and Drug Administration (USFDA), Lupin said in a regulatory filing.",positive,positive,0.2898550724637706,neutral,-1.234772978959023,negative
2020-11-26 07:38:00.000,897.0,906.95,893.3,899.6,2325867.0,"Hot Stocks | ‘Can bet on SBI, Lupin and Grindwell Norton for the short term’","Bank Nifty has formed a bearish ABCD harmonic pattern on the daily timeframe which is placed near 200 percent retracement from its previous intermediate low of 20,404 levels.",neutral,positive,0.2898550724637706,neutral,-1.234772978959023,negative
2020-11-26 13:23:00.000,903.0,914.3,889.5,891.85,5120586.0,Lupin allots 1.33 lakh equity shares under ESOP,"In view of the above, the issued and paid-up capital of the Company has been increased to Rs 90,68,1 9,370 consisting 45,34,09,685 equity shares of Rs 2/- each.",neutral,neutral,-1.234772978959023,negative,2.013422818791946,positive
2020-12-01 05:30:00.000,894.0,914.35,892.15,912.0,2914781.0,BRIEF-Lupin Gets U.S. FDA Approval For Its Penicillamine Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,2.013422818791946,positive,0.219298245614035,neutral
2020-12-01 07:36:00.000,894.0,914.35,892.15,912.0,2914781.0,Lupin receives approval for Penicillamine Tablets USP,Penicillamine Tablets USP had an annual sales of approximately USD 4 million in the U.S.,positive,neutral,2.013422818791946,positive,0.219298245614035,neutral
2020-12-01 14:30:00.000,912.0,920.9,902.6,914.0,3049507.0,Lupin rises 2% on receiving USFDA approval for generic drug,"The company told stock exchanges that it received approval for its Penicillamine Tablets USP, 250 mg, from the us drug regulator to market a generic equivalent of Depen Tablets, 250 mg, of Mylan Specialty.",neutral,positive,0.219298245614035,neutral,-0.770148606139497,neutral
2020-12-01 15:05:00.000,912.0,920.9,902.6,914.0,3049507.0,Lupin firms up after approval for Penicillamine tablets,"Lupin rose 1.98% to Rs 909.50 after the drug major announced that it has received US drug regulators approval for its Penicillamine tablets USP, 250 mg.",neutral,positive,0.219298245614035,neutral,-0.770148606139497,neutral
2020-12-01 17:10:20.000,912.0,920.9,902.6,914.0,3049507.0,Lupin gets USFDA nod to market generic Penicillamine tablets,Drug firm Lupin on Tuesday said it has received approval from the US health regulator to market its generic Penicillamine tablets used for treatment of Wilson’s disease and Cystinuria in the American,neutral,positive,0.219298245614035,neutral,-0.770148606139497,neutral
2020-12-07 13:04:47.000,971.0,975.45,940.0,947.1,4404948.0,"Lupin Ltd spurts 2.49%, up for five straight sessions","Lupin Ltd is quoting at Rs 956.5, up 2.49% on the day as on 12:44 IST on the NSE. The stock is up 26.53% in last one year as compared to a 11.67% gain in NIFTY and a 58.09% gain in the Nifty Pharma.",positive,positive,-2.46138002059732,negative,-0.3144654088050315,neutral
2020-12-07 18:25:00.000,971.0,975.45,940.0,947.1,4404948.0,"Nifty Pharma rallies by 2% as Covid-19 vaccine progress lifts mood; Sun Pharma, Dr Reddys top gainers","Lupin also advanced 2.49% higher. Biocon (up 1.77%, Auro Pharma (up 1.40%) and Cipla (up 1.02%) also stayed 1% higher.",positive,positive,-2.46138002059732,negative,-0.3144654088050315,neutral
2020-12-08 08:15:00.000,971.0,975.45,940.0,947.1,4404948.0,"Pharma stocks in sell-off as fresh Covid-19 restriction globally weighs sentiments; Lupin, Sun Pharma drags",Dr Reddys Laboratories was the only company in the pharma sector to trade in the green.,negative,neutral,-2.46138002059732,negative,-0.3144654088050315,neutral
2020-12-09 07:22:00.000,954.0,960.75,944.1,951.0,2443563.0,Nifty Pharma trades higher on positive Covid-19 vaccine news; Dr Reddys drives the performance,"Biocon, Cadila, Divis Lab, Sun Pharma and Lupin were also trading in the green.",positive,neutral,-0.3144654088050315,neutral,-1.0796645702306031,negative
2020-12-16 05:30:00.000,953.25,963.9,942.3,962.0,3014914.0,BRIEF-Lupin Resolves Dispute With Sellers In Gavis/Novel Transaction - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.917912404930501,positive,0.4968944099378835,neutral
2020-12-16 08:45:00.000,953.25,963.9,942.3,962.0,3014914.0,Pharma stocks overcome morning lows to trade ~1% higher; Divi’s Lab gains the most,"Lupin, (up 1.64%) Torrent Pharma (up 1.34%) and Biocon (up 1.15%) were also well over 1% to drive the Pharma sector.",positive,positive,0.917912404930501,positive,0.4968944099378835,neutral
2020-12-16 09:55:00.000,953.25,963.9,942.3,962.0,3014914.0,Lupin settles dispute with GAVIS Pharma and Novel Laboratories; stock ends higher,"Lupin Ltd, an Indian multinational pharmaceutical company based in Mumbai, is one of the largest generic pharmaceutical companies by revenue in the world.",positive,neutral,0.917912404930501,positive,0.4968944099378835,neutral
2020-12-16 13:31:17.000,966.0,984.5,960.5,970.8,5260271.0,Lupin Ltd in demand,"Lupin Ltd is quoting at Rs 955.8, up 1.21% on the day as on 12:49 IST on the NSE. The stock is up 26.71% in last one year as compared to a 12.03% spurt in NIFTY and a 56.61% spurt in the Nifty Pharma index.",positive,positive,0.4968944099378835,neutral,0.0513901022663035,neutral
2020-12-17 13:30:00.000,972.95,977.0,955.55,973.45,2188823.0,Lupin rises on settling dispute with Gavis and Novel; gains 5% in four days,"On Wednesday, Lupin announced in a BSE filing that its dispute with the sellers in the Gavis and Novel transaction has been resolved amicably to the satisfaction of all parties.",positive,positive,0.0513901022663035,neutral,-5.0864699898270604,negative
2020-12-18 07:07:00.000,972.95,977.0,955.55,973.45,2188823.0,"Stock recommendations by Anand Rathi: Buy HDFC Bank, Lupin, Sonata Software",The stock of HDFC Bank is showing signs of reversal which hints of further positive momentum in the counter,neutral,positive,0.0513901022663035,neutral,-5.0864699898270604,negative
2020-12-18 13:04:13.000,972.95,977.0,955.55,973.45,2188823.0,"Lupin Ltd spurts 0.28%, gains for five straight sessions","Lupin Ltd is quoting at Rs 973.25, up 0.28% on the day as on 12:44 IST on the NSE. The stock is up 26.3% in last one year as compared to a 11.72% gain in NIFTY and a 57.11% gain in the Nifty Pharma.",positive,positive,0.0513901022663035,neutral,-5.0864699898270604,negative
2020-12-18 13:31:04.000,972.95,977.0,955.55,973.45,2188823.0,Lupin Ltd extends winning streak,"Lupin Ltd is quoting at Rs 973.25, up 0.28% on the day as on 12:44 IST on the NSE. The stock is up 26.3% in last one year as compared to a 11.72% gain in NIFTY and a 57.11% gain in the Nifty Pharma.",positive,positive,0.0513901022663035,neutral,-5.0864699898270604,negative
2020-12-18 17:28:00.000,972.95,977.0,955.55,973.45,2188823.0,Nifty Pharma index maintains upside on vaccine trials; Dr Reddys leads the gains,"DR Reddys led the gains while Biocon, Lupin, and Cipla also continued the winning streak.",positive,positive,0.0513901022663035,neutral,-5.0864699898270604,negative
2020-12-18 19:33:46.000,972.95,977.0,955.55,973.45,2188823.0,Lupin gets USFDA nod for marketing cholesterol drug,Drug firm Lupin on Friday said it has received approval from the US health regulator to market generic Colesevelam Hydrochloride tablets used for reducing elevated low-density lipoprotein cholesterol.,neutral,positive,0.0513901022663035,neutral,-5.0864699898270604,negative
2020-12-23 12:32:00.000,969.0,981.5,961.85,978.0,2225553.0,Lupin allots 1.03 lakh equity shares under ESOP,Powered by Capital Market - Live News,neutral,neutral,0.9287925696594428,positive,-0.8181818181818205,neutral
2020-12-24 05:30:00.000,969.0,981.5,961.85,978.0,2225553.0,BRIEF-Lupin Ltd - Receives Tentative Approval For Efinaconazole Topical Solution - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.9287925696594428,positive,-0.8181818181818205,neutral
2020-12-24 19:04:00.000,969.0,981.5,961.85,978.0,2225553.0,Lupin gets tentative nod from USFDA for its toenail fungus treatment topical solution,"The company has received tentative approval to market its Efinaconazole topical solution, 10%, from the United States Food and Drug Administration (USFDA), Lupin said in a regulatory filing.",neutral,positive,0.9287925696594428,positive,-0.8181818181818205,neutral
2020-12-24 19:55:00.000,969.0,981.5,961.85,978.0,2225553.0,Lupin receives USFDA tentative approval for Efinaconazole Topical Solution,"Efinaconazole Topical Solution, 10%, is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.",positive,positive,0.9287925696594428,positive,-0.8181818181818205,neutral
2020-12-28 07:45:00.000,990.0,990.0,975.2,981.9,2494995.0,Lupin launches Maloxicam capsules for osteoarthritis after approval from USFDA,Meloxicam Capsules had an annual sales of approximately USD 11 million in the U.S.,neutral,neutral,-0.8181818181818205,neutral,-0.8689024390243857,neutral
2020-12-28 08:16:00.000,990.0,990.0,975.2,981.9,2494995.0,"Stocks in focus: Lupin, NIIT, Coal India & more",Here are the top stocks that are likely to be in focus in today’s trading.,neutral,neutral,-0.8181818181818205,neutral,-0.8689024390243857,neutral
2020-12-28 08:40:00.000,990.0,990.0,975.2,981.9,2494995.0,"RIL, Lupin, DLF in focus","Shares of Reliance Industries (RIL) will be in focus. RIL has entered into definitive agreements to acquire the shares held by IMG Singapore Pte. Ltd in IMG-R, for a cash consideration not exceeding Rs 52.08 crore. Post completion of acquisition,",neutral,positive,-0.8181818181818205,neutral,-0.8689024390243857,neutral
2020-12-28 08:50:00.000,990.0,990.0,975.2,981.9,2494995.0,Lupin gets tentative approval for Efinaconazole Topical Solution,"Lupin announced that it has received tentative approval for its Efinaconazole Topical Solution, 10%, from the United States Food and Drug Administration, to market a generic equivalent of Jublia Topical Solution, 10%, of Bausch Health Americas, Inc.",positive,positive,-0.8181818181818205,neutral,-0.8689024390243857,neutral
2020-12-28 09:24:00.000,990.0,990.0,975.2,981.9,2494995.0,"Stocks in the news: RIL, PNB, DLF, Lupin, Coal India, Vedanta","Stocks to watch today on December 28: RIL, PNB, DLF, Lupin, Coal India, Vedanta among others are the top stocks to watch out for in Monday’s trading session",neutral,neutral,-0.8181818181818205,neutral,-0.8689024390243857,neutral
2020-12-28 13:10:00.000,984.0,992.8,970.5,975.45,2118276.0,"Top stocks in focus: Reliance Industries, Advanced Enzyme Technology, Biocon, Lupin, Cadila, Central Bank of India",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.8689024390243857,neutral,-0.6109979633401221,neutral
2020-12-28 14:09:00.000,984.0,992.8,970.5,975.45,2118276.0,Lupin launches Meloxicam Capsules,"Meloxicam Capsules, 5 mg and 10 mg, is the generic equivalent of Vivlodex Capsules, 5 mg and 10 mg, of Zyla Life Sciences US, Inc., and indicated for management of osteoarthritis (OA) pain.",neutral,neutral,-0.8689024390243857,neutral,-0.6109979633401221,neutral
2020-12-28 15:24:00.000,984.0,992.8,970.5,975.45,2118276.0,Lupin gains on launcing Meloxicam capsules in US,"Lupin rose 0.91% to Rs 985 after the drug major announced the launch of Meloxicam capsules, 5 mg, and 10 mg, having received an approval from the United States Food and Drug Administration.",positive,positive,-0.8689024390243857,neutral,-0.6109979633401221,neutral
2020-12-28 16:02:00.000,984.0,992.8,970.5,975.45,2118276.0,Lupin receives approval from USFDA to market Efinaconazole Topical solution,"The approval is bagged to market a generic equivalent of Jublia Topical Solution, 10%, of Bausch Health Americas, Inc.",positive,neutral,-0.8689024390243857,neutral,-0.6109979633401221,neutral
2020-12-28 17:17:00.000,984.0,992.8,970.5,975.45,2118276.0,Lupin launches generic drug in the US market,The Mumbai-based drug firm’s product is the generic equivalent of Zyla Life Sciences’ Vivlodex Capsules (5 mg and 10 mg). The capsules are indicated for management of osteoarthritis (OA) pain.,positive,neutral,-0.8689024390243857,neutral,-0.6109979633401221,neutral
2020-12-29 05:30:00.000,984.0,992.8,970.5,975.45,2118276.0,BRIEF-Lupin Ltd - Launches Mycophenolate Mofetil Tablets USP - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.8689024390243857,neutral,-0.6109979633401221,neutral
2020-12-29 07:32:00.000,984.0,992.8,970.5,975.45,2118276.0,"Stocks in the news: Axis Bank, SpiceJet, Coal India, NTPC, Lupin & 3i Infotech",Axis Bank is pruning its overseas operation as part of a strategy of focusing Indian market.,neutral,neutral,-0.8689024390243857,neutral,-0.6109979633401221,neutral
2020-12-29 08:20:00.000,984.0,992.8,970.5,975.45,2118276.0,Lupin launches Mycophenolate Mofetil tablets USP after approval from USFDA,Mycophenolate Mofetil Tablets USP had an annual sales of approximately USD 87 million in the U.S.,neutral,neutral,-0.8689024390243857,neutral,-0.6109979633401221,neutral
2020-12-29 09:27:00.000,984.0,992.8,970.5,975.45,2118276.0,"Stocks in news: Coal India, NTPC, Lupin, Biocon, HDFC Bank, SBI Life","Stocks to watch today on December 29: Coal India, NTPC, Lupin, Biocon, HDFC Bank, SBI Life among others are the top stocks to watch out for in Tuesday’s trading session",neutral,neutral,-0.8689024390243857,neutral,-0.6109979633401221,neutral
2020-12-29 13:07:00.000,982.0,982.0,964.5,976.0,1908221.0,Lupin launches Mycophenolate Mofetil Tablets,"Mycophenolate Mofetil Tablets USP, 500 mg, are the generic equivalent of CellCept Tablets of Roche Palo
Alto LLC, indicated for the prophylaxis of organ rejection in recipients of allogeneic kidney, heart or liver
transplants, and should be used in",neutral,neutral,-0.6109979633401221,neutral,0.1741446424912857,neutral
2020-12-29 14:54:00.000,982.0,982.0,964.5,976.0,1908221.0,Lupin launches mycophenolate mofetil tablets,"The drug major announced the launch of mycophenolate mofetil tablets USP, 500 mg, after its alliance partner Concord Biotech received an approval for its ANDA from the United States Food and Drug Administration (USFDA).",neutral,positive,-0.6109979633401221,neutral,0.1741446424912857,neutral
2020-12-29 15:31:12.000,982.0,982.0,964.5,976.0,1908221.0,Lupin Launches Mycophenolate Mofetil Tablets In US,The newly launched product is the generic equivalent of CellCept tablets of Roche Palo Alto LLC.,neutral,neutral,-0.6109979633401221,neutral,0.1741446424912857,neutral
2021-01-04 18:20:00.000,1024.95,1047.5,1016.05,1041.3,3519091.0,"Pharma stocks recover early losses, surges 1%; Lupin leads the charge",Auro Pharma and Sun Pharma closely followed Lupin in gains while Cadila and Dr Reddys were also bullish.,positive,positive,1.5951997658422274,positive,-3.8415308428289854,negative
2021-01-05 13:31:48.000,1039.95,1039.95,991.0,1000.0,5547863.0,Lupin Ltd increases around 1.5%,"Lupin Ltd is quoting at Rs 1042.05, up 1.47% on the day as on 12:49 IST on the NSE. The stock is up 36.73% in last one year as compared to a 17.99% jump in NIFTY and a 65.27% jump in the Nifty Pharma index.",positive,positive,-3.8415308428289854,negative,0.7733990147783274,neutral
2021-01-05 18:10:00.000,1039.95,1039.95,991.0,1000.0,5547863.0,"Pharma stocks rally again to trade 0.50% higher; Auro Pharma, Lupin among leading gainers",Sun Pharma (up 0.26%) was also bullish. The stock has touched a 52-week high of Rs610 per piece in early deals on Tuesday at the Dalal Street.,positive,positive,-3.8415308428289854,negative,0.7733990147783274,neutral
2021-01-06 05:30:00.000,1039.95,1039.95,991.0,1000.0,5547863.0,BRIEF-Lupin Gets Nod For Sulfamethoxazole And Trimethoprim Oral Suspension - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-3.8415308428289854,negative,0.7733990147783274,neutral
2021-01-06 07:18:20.000,1039.95,1039.95,991.0,1000.0,5547863.0,"Hot Stocks | Can Bet On Muthoot Finance, Lupin And Aurobindo Pharma For Short Term","On the derivative front, Put writers have been continuously adding up hefty open interest at 14,000 and 14,100 strikes which indicates limited downside in Nifty as of now.",neutral,positive,-3.8415308428289854,negative,0.7733990147783274,neutral
2021-01-06 08:45:00.000,1039.95,1039.95,991.0,1000.0,5547863.0,Nifty Pharma trades lower tracking benchmarks downside; Lupin nosedives 4%,"The index tumbled to the day’s low of 12,965.65.",negative,negative,-3.8415308428289854,negative,0.7733990147783274,neutral
2021-01-06 18:49:00.000,1015.0,1029.7,993.15,1022.85,4824453.0,Lupin receives USFDA approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP,"Sulfamethoxazole and Trimethoprim Oral Suspension USP, 200 mg/40 mg per 5 mL, is indicated for the
treatment and prevention of a wide variety of bacterial infections (such as middle ear, urine, respiratory, and
intestinal infections), and certain",positive,neutral,0.7733990147783274,neutral,1.2750366389838743,positive
2021-01-07 07:35:16.000,1015.0,1029.7,993.15,1022.85,4824453.0,"Stocks In The News | PNC Infratech, Wipro, Ceat, Dixon Technologies, IIFL Finance, Lupin","Wendt, Dish TV India, Capital Trust, Maruti Suzuki, Kanpur Plastipack, Take Solutions, Archidply Industries, Ramco Systems, Sterling Tools, Saint-Gobain Sekurit India, are also among the stocks in focus today.",neutral,neutral,0.7733990147783274,neutral,1.2750366389838743,positive
2021-01-07 07:37:00.000,1015.0,1029.7,993.15,1022.85,4824453.0,"Stocks in the news: Bandhan Bank, Maruti Suzuki, PNC Infratech, TCS and Lupin",CN Infrabuild sold shares of PNC Infratech worth over Rs 276 crore through an open market transaction.,neutral,neutral,0.7733990147783274,neutral,1.2750366389838743,positive
2021-01-07 08:22:00.000,1015.0,1029.7,993.15,1022.85,4824453.0,"Stocks to watch: Bandhan Bank, Sobha, Lupin, Maruti Suzuki, CEAT, Wendt","Bandhan Bank said its loans and advances grew by 23 per cent YoY to Rs 80,255 crore during the third quarter of the current fiscal",neutral,positive,0.7733990147783274,neutral,1.2750366389838743,positive
2021-01-07 08:22:01.000,1015.0,1029.7,993.15,1022.85,4824453.0,"Stocks To Watch: Bandhan Bank, Future Consumer, Lupin, NMDC",Here are the stocks to watch in trade today.,neutral,neutral,0.7733990147783274,neutral,1.2750366389838743,positive
2021-01-07 08:35:00.000,1015.0,1029.7,993.15,1022.85,4824453.0,Pharma stocks under pressure; Lupin offsets losses by surging 2%,"Divis Lab leads the laggards to drag the Pharma sector. Biocon, Auro Pharma, Sun Pharma and Dr Reddy were also under extreme selling pressure.",positive,positive,0.7733990147783274,neutral,1.2750366389838743,positive
2021-01-07 08:46:00.000,1015.0,1029.7,993.15,1022.85,4824453.0,"Maruti Suzuki, Lupin, Dixon Technologies in spotlight","Maruti Suzuki India said total production increased to 1.55 lakh vehicles in December 2020, from 1.15 lakh vehicles in December 2019.",neutral,positive,0.7733990147783274,neutral,1.2750366389838743,positive
2021-01-07 08:51:00.000,1015.0,1029.7,993.15,1022.85,4824453.0,Lupin gets nod for Sulfamethoxazole and Trimethoprim Oral Suspension USP,"Lupin announced that it has received approval for its Sulfamethoxazole and Trimethoprim Oral Suspension USP from the USFDA to market a generic equivalent of Bactrim Oral Suspension of Sun Pharmaceutical Industries, Inc.",neutral,positive,0.7733990147783274,neutral,1.2750366389838743,positive
2021-01-07 09:41:00.000,1015.0,1029.7,993.15,1022.85,4824453.0,"Stocks in news: Bandhan Bank, Lupin, TCS, SBI, Wipro, Maruti","Stocks to watch today on January 7: Bandhan Bank, Lupin, TCS, SBI, Wipro, Maruti among others are the top stocks to watch out for in Thursday’s trading session",neutral,neutral,0.7733990147783274,neutral,1.2750366389838743,positive
2021-01-07 10:02:00.000,1015.0,1029.7,993.15,1022.85,4824453.0,Lupin receives USFDA approval on Empagliflozin and Metformin Hydrochloride ER tablets,Lupin will manufacture the product from its Nagpur facility in India.,positive,neutral,0.7733990147783274,neutral,1.2750366389838743,positive
2021-01-07 13:10:00.000,1023.5,1047.35,1022.6,1036.55,3920378.0,"Top stocks in focus: Maruti Suzuki, CEAT. NMDC, Sobha, Lupin, Ramco Systems",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.2750366389838743,positive,3.5576923076923075,positive
2021-01-07 15:16:00.000,1023.5,1047.35,1022.6,1036.55,3920378.0,Lupin rose on USFDA nod for diabetes drug,"Lupin rose 2.12% to Rs 1,021.80 after the company said that it received a tentative approval for its Empagliflozin and Metformin Hydrochloride ER tablets from the US drug regulator.",positive,positive,1.2750366389838743,positive,3.5576923076923075,positive
2021-01-07 15:49:00.000,1023.5,1047.35,1022.6,1036.55,3920378.0,Lupin receives tentative approval for Empagliflozin and Metformin Hydrochloride ER tablets,From USFDA,positive,neutral,1.2750366389838743,positive,3.5576923076923075,positive
2021-01-07 16:53:00.000,1023.5,1047.35,1022.6,1036.55,3920378.0,Lupin | USFDA : Lupin gets USFDA nod for generic diabetes drug,"The company has received tentative approval for the product in multiple strengths from the United States Food and Drug Administration (USFDA), Lupin said in a statement.",neutral,positive,1.2750366389838743,positive,3.5576923076923075,positive
2021-01-07 16:54:00.000,1023.5,1047.35,1022.6,1036.55,3920378.0,USFDA approves Lupin’s Sulfamethoxazole and Trimethoprim Oral Suspension USP; Stock gains,upin stated that Sulfamethoxazole and Trimethoprim Oral Suspension USP had estimated annual sales of approximately USD 19 million in the U.S.,positive,neutral,1.2750366389838743,positive,3.5576923076923075,positive
2021-01-07 17:26:28.000,1023.5,1047.35,1022.6,1036.55,3920378.0,Lupin Gets USFDA Nod For Generic Diabetes Drug,The product will be manufactured at Lupin’s Nagpur-based manufacturing facility.,neutral,neutral,1.2750366389838743,positive,3.5576923076923075,positive
2021-01-07 17:43:03.000,1023.5,1047.35,1022.6,1036.55,3920378.0,Lupin gets USFDA nod for generic diabetes drug,"Drug maker Lupin on Thursday said it has received approval from the US health regulator for its Empagliflozin and Metformin Hydrochloride extended-release (ER) tablets, used to treat diabetes, in the",neutral,positive,1.2750366389838743,positive,3.5576923076923075,positive
2021-01-08 11:33:48.000,1023.5,1047.35,1022.6,1036.55,3920378.0,"D-Street Buzz: Pharma Stocks Gain Led By Sun Pharma, Biocon; CLSA Picks DRL, Downgrades Aurobindo Pharma","CLSA has a buy on Sun Pharma, Cadila Healthcare and Dr Reddy’s Labs and has a sell on Biocon and Lupin. The research firm has downgraded Aurobindo Pharma to underperform from outperform.",neutral,positive,1.2750366389838743,positive,3.5576923076923075,positive
2021-01-11 13:31:21.000,1078.9,1084.0,1055.2,1059.0,2293406.0,Lupin Ltd jumps nearly 3%,"Lupin Ltd is quoting at Rs 1069.45, up 2.95% on the day as on 12:49 IST on the NSE. The stock is up 42.86% in last one year as compared to a 17.09% jump in NIFTY and a 65.52% jump in the Nifty Pharma index.",positive,positive,-1.8444712206877456,negative,0.5281524096953821,neutral
2021-01-12 08:22:00.000,1078.9,1084.0,1055.2,1059.0,2293406.0,"Pharma stocks under pressure; Sun Pharma, Divis lab drag","Heavyweights Sun Pharma, Divis Lab, Cipla, Lupin and DR Reddy’s led the losses.",negative,negative,-1.8444712206877456,negative,0.5281524096953821,neutral
2021-01-13 13:35:17.000,1069.0,1113.3,1062.65,1103.0,4715361.0,"BofA Securities Outlook For India’s Pharma Sector In 2021, Suggests Top Bets","BofA Securities has upgraded Lupin, but downgraded Sun Pharma and Divi’s Laboratories.",neutral,positive,3.180542563143125,positive,-1.9589342678707784,negative
2021-01-18 20:01:00.000,1070.0,1098.9,1070.0,1090.9,2377793.0,"New product launches to drive growth for Lupin, US business a key trigger",This should reverse the US underperformance in FY15-20 with margins too moving up sharply,positive,negative,1.953271028037392,positive,-0.8821244115361846,neutral
2021-01-20 07:37:00.000,1093.95,1102.05,1082.85,1084.3,2079624.0,"Lupin, Reliance Industries: Stock picks by Ajit Mishra of Religare Broking",We’re seeing consistent buying interest in the pharma pack and Lupin is also catching up with the other pharma majors,neutral,positive,-0.8821244115361846,neutral,-2.583227214844469,negative
2021-01-24 11:03:02.000,1092.0,1103.7,1049.25,1085.05,3533447.0,Markets may remain volatile in holiday-shortened week: Analysts,"Among major earnings to focus on this week are from UCO Bank, Axis Bank, Bank of Baroda, Canara Bank, Hindustan Unilever Limited, Lupin, Maruti Suzuki India and Tata Motors.",negative,neutral,-0.6364468864468906,neutral,-1.2901744719926496,negative
2021-01-24 18:13:42.000,1092.0,1103.7,1049.25,1085.05,3533447.0,Netflix’s ‘Lupin’ Marks Rise Of International TV Content,"The emergence of international platforms, mainly Netflix but also more recently Amazon and Disney+, has played a leading role in driving this appetite for content.",neutral,neutral,-0.6364468864468906,neutral,-1.2901744719926496,negative
2021-01-25 05:30:00.000,1092.0,1103.7,1049.25,1085.05,3533447.0,BRIEF-Lupin Receives Approval For Sevelamer Carbonate Tablets,BRIEF-Lupin Receives Approval For Sevelamer Carbonate Tablets,neutral,neutral,-0.6364468864468906,neutral,-1.2901744719926496,negative
2021-01-25 09:40:00.000,1092.0,1103.7,1049.25,1085.05,3533447.0,Lupin receives approval from USFDA to market Sevelamer Carbonate tablets,"Sevelamer Carbonate Tablets (RLD: RenvelA) had estimated annual sales of $348 million in the U.S. (IQVIA MAT September 2020), Lupin highlighted.",positive,neutral,-0.6364468864468906,neutral,-1.2901744719926496,negative
2021-01-25 12:20:00.000,1092.0,1103.7,1049.25,1085.05,3533447.0,Lupin receives USFDA approval for Sevelamer Carbonate Tablets,"Sevelamer Carbonate Tablets, 800 mg, are indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis.",positive,neutral,-0.6364468864468906,neutral,-1.2901744719926496,negative
2021-01-25 13:25:00.000,1092.0,1103.7,1049.25,1085.05,3533447.0,Lupin gains on USFDA nod for hyperphosphatemia medication,Lupin rose 1.54% to Rs 1096.20 after the drug major received US drug regulator’s approval for Sevelamer Carbonate tablets.,positive,positive,-0.6364468864468906,neutral,-1.2901744719926496,negative
2021-01-25 13:54:35.000,1092.0,1103.7,1049.25,1085.05,3533447.0,Lupin Gets USFDA Nod To Market Generic Sevelamer Carbonate Tablets,"The product is a generic version of Genzyme Corporation’s Renvela tablets in the same strength, Lupin added.",neutral,neutral,-0.6364468864468906,neutral,-1.2901744719926496,negative
2021-01-25 13:57:06.000,1092.0,1103.7,1049.25,1085.05,3533447.0,Lupin Share Price Gains 2% On USFDA Approval,"The share touched its 52-week high Rs 1,121.85 and 52-week low Rs 505.00 on 18 September, 2020 and 13 March, 2020, respectively.",neutral,negative,-0.6364468864468906,neutral,-1.2901744719926496,negative
2021-01-25 16:38:30.000,1092.0,1103.7,1049.25,1085.05,3533447.0,Lupin gets USFDA nod to market generic Sevelamer Carbonate tablets,The product is a generic version of Genzyme Corporation’s Renvela tablets used to treat chronic kidney disease,neutral,neutral,-0.6364468864468906,neutral,-1.2901744719926496,negative
2021-01-25 18:07:00.000,1092.0,1103.7,1049.25,1085.05,3533447.0,Market Movers: Grasim paints green on charts as RIL tumbles post earnings,"As many as 55 stocks listed on the NSE gave a “sell” signal based on MACD indicators. The list included Tata Motors, Vodafone Idea, DLF, and Lupin.",neutral,neutral,-0.6364468864468906,neutral,-1.2901744719926496,negative
2021-01-28 07:40:00.000,1061.95,1077.45,1037.5,1049.4,2262164.0,"Stocks in the news: Axis Bank, Maruti Suzuki, IRCTC, Lupin, HUL and IndiGo","Laurus Labs, Aarti Industries, AU SFB and Shriram Transport are among companies which will announce their December quarter results on Thursday.",neutral,neutral,-1.1817882197843548,negative,-4.848914069877245,negative
2021-01-28 13:00:00.000,1059.0,1059.0,995.1,1007.65,6104187.0,"Top stocks in focus: Infosys, Maruti Suzuki, Lupin, TVS Motor, Axis Bank, HUL",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 07:58:00.000,1059.0,1059.0,995.1,1007.65,6104187.0,Lupin reports consolidated net profit of Rs 438.25 crore in the December 2020 quarter,Sales rise 5.41% to Rs 3917.30 crore,neutral,positive,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 08:45:00.000,1059.0,1059.0,995.1,1007.65,6104187.0,"Lupin, Indigo, IRCTC, Pidilite Industries in focus",Lupin reported consolidated net profit of Rs 438.30 crore in Q3 December 2020 as compared to net loss of Rs 835 crore in Q3 December 2019. Total income rose 6.6% to Rs 4017.40 crore in Q3 December 2020 over Q3 December 2019.,neutral,positive,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 09:24:00.000,1059.0,1059.0,995.1,1007.65,6104187.0,"Stocks in focus: Lupin, Indigo, IRCTC, TVS Motors and more","Here are the top stocks that are likely to be in focus in today’s trading. Lupin, Indigo, IRCTC, TVS Motors and RBL Bank.",neutral,neutral,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 09:50:24.000,1059.0,1059.0,995.1,1007.65,6104187.0,Lupin Ltd Slides 4.1%,Lupin Ltd has added 3.05% over last one month compared to 2.79% fall in S&P BSE Healthcare index and 1.32% drop in the SENSEX,neutral,positive,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 10:15:56.000,1059.0,1059.0,995.1,1007.65,6104187.0,"Lupin Reports Rs 438.3 Crore Net Profit In Q3 FY21, Led By Improved Sales In US, India","Revenues of Lupin rose 5.4 percent year-on-year (YoY) to Rs 3,917.3 crore, compared to previous year’s Rs 3716 crore.",neutral,positive,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 10:40:00.000,1059.0,1059.0,995.1,1007.65,6104187.0,"Buy Lupin, target price Rs 1135: Motilal Oswal","Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 47589.44 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 10:56:47.000,1059.0,1059.0,995.1,1007.65,6104187.0,Lupin posts net profit of ₹438.25 cr in December quarter,"Pharma major Lupin has reported a consolidated net profit of ₹438.25 crore for the quarter ended December 31, 2020. The company had posted a net loss of ₹835 crore for the corresponding period of the",neutral,neutral,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 11:03:00.000,1059.0,1059.0,995.1,1007.65,6104187.0,Lupin Q3 results: Net profit at Rs 438.25 crore,"The company had posted a net loss of Rs 835 crore for the corresponding period of the previous fiscal, Lupin said in a late night filing to the BSE.",neutral,negative,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 11:43:00.000,1059.0,1059.0,995.1,1007.65,6104187.0,Lupin posts Q3 PAT of Rs 438 cr,"On a consolidated basis, the mdrug major reported net profit of Rs 438.25 crore in Q3 FY21 as against a net loss of Rs 835 crore reported in Q3 FY20.",neutral,positive,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 14:10:00.000,1059.0,1059.0,995.1,1007.65,6104187.0,Complex drugs to drive further growth: Lupin management,"Ramesh Swaminathan, CFO, Vinita Gupta, CEO, and Nilesh Gupta, MD, Lupin in conversation with ETNOW.",positive,neutral,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 14:14:07.000,1059.0,1059.0,995.1,1007.65,6104187.0,Lupin Ltd ADR (LUPNY) CEO Vinita Gupta on Q3 2021 Results - Earnings Call Transcript,"Lupin Ltd ADR (OTC:LUPNY) Q3 2021 Earnings Conference Call Jan 28, 2021, 09:30 PM ET Company Participants Kamal Sharma - Vice Chairman Vinita Gupta - CEO Ramesh Swaminathan - Executive...",neutral,neutral,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 16:30:00.000,1059.0,1059.0,995.1,1007.65,6104187.0,Lupin logs 108% qoq rise in Q3 PAT to Rs438.3cr as sales improve,Lupin had posted a net loss of Rs868.5cr a year ago same period.,positive,negative,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 16:31:17.000,1059.0,1059.0,995.1,1007.65,6104187.0,"Lupin Q3 Review - In-Line Sales Growth, Strong Margin Recovery: ICICI Direct","Lupin Q3 Review - In-Line Sales Growth, Strong Margin Recovery: ICICI Direct",neutral,neutral,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 17:16:00.000,1059.0,1059.0,995.1,1007.65,6104187.0,"Nifty Pharma under pressure amid corporate earnings; Lupin dives 3%; Cipla, Sun Pharma, Dr Reddy’s in focus","The index has touched an intraday high and low of 12,482.55 and 12,482.55 respectively.",negative,negative,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 17:44:00.000,1059.0,1059.0,995.1,1007.65,6104187.0,"Regulatory clearances, US growth near term triggers for Lupin",India business has seen steady uptick growth over the last few quarters,positive,positive,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-29 20:20:44.000,1059.0,1059.0,995.1,1007.65,6104187.0,Lupin - Cost Optimization Leads Earnings Upgrade In Q3: Prabhudas Lilladher,Lupin - Cost Optimization Leads Earnings Upgrade In Q3: Prabhudas Lilladher,neutral,neutral,-4.848914069877245,negative,-1.7361111111111112,negative
2021-01-31 17:34:27.000,1008.0,1010.0,978.0,990.5,3147780.0,"Lupin Delivers Operationally Strong Q3, Sustenance Remains Key: Dolat Capital","Lupin Delivers Operationally Strong Q3, Sustenance Remains Key: Dolat Capital",neutral,neutral,-1.7361111111111112,negative,3.1950000000000047,positive
2021-02-01 08:14:00.000,1008.0,1010.0,978.0,990.5,3147780.0,How did India’s Big Pharma fare in the December Quarter?,"Sun Pharma reported its highest-ever quarterly sales, and Cipla posted the highest-ever Ebitda margin in the company’s recent history. Lupin’s Ebitda margin improved for the fourth consecutive quarter.",neutral,positive,-1.7361111111111112,negative,3.1950000000000047,positive
2021-02-01 09:21:53.000,1008.0,1010.0,978.0,990.5,3147780.0,Lupin To Enter Chinese Market In Next One Year,"Lupin posted a net profit of Rs 438.3 crore in the quarter ended December 31, 2020, helped by growth of sales in the US, India and other markets.",neutral,positive,-1.7361111111111112,negative,3.1950000000000047,positive
2021-02-01 18:17:51.000,1000.0,1036.45,995.55,1031.95,3459889.0,Lupin Ltd ADR 2021 Q3 - Results - Earnings Call Presentation (OTCMKTS:LUPNY),The following slide deck was published by Lupin Ltd ADR in conjunction with their 2021 Q3 earnings call.,neutral,neutral,3.1950000000000047,positive,-0.1879155825383102,neutral
2021-02-01 18:38:48.000,1000.0,1036.45,995.55,1031.95,3459889.0,Buy Lupin; Target Of Rs 1350: Sharekhan,"Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated January 25, 2021.",neutral,positive,3.1950000000000047,positive,-0.1879155825383102,neutral
2021-02-02 13:25:00.000,1037.7,1068.3,1026.6,1035.75,3779076.0,Lupin appoints Mark D McDade as independent director,"McDade is the co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, including cell and gene therapy and digital health, Lupin said in a statement.",neutral,neutral,-0.1879155825383102,neutral,1.2013455069678038,positive
2021-02-03 09:57:57.000,1037.7,1068.3,1026.6,1035.75,3779076.0,Lupin: New Launches And Market Share Gains Are Likely To Override Pricing Erosion,"New launches in the US, particularly in the inhalation category, and an improving market share are expected to help ride over structural pricing erosion in the near term for Lupin",neutral,positive,-0.1879155825383102,neutral,1.2013455069678038,positive
2021-02-03 20:47:05.000,1040.5,1061.7,1032.0,1053.0,1931887.0,Buy Lupin; Target Of Rs 1180: Motilal Oswal,"Motilal Oswal is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1180 in its research report dated January 30, 2021.",neutral,positive,1.2013455069678038,positive,1.189352463658666,positive
2021-02-04 13:17:11.000,1059.4,1081.9,1042.85,1072.0,3225187.0,Lupin Ltd rises for third straight session,"Lupin Ltd is quoting at Rs 1054.35, up 1.49% on the day as on 12:49 IST on the NSE. The stock is up 45.93% in last one year as compared to a 22.8% jump in NIFTY and a 57.05% jump in the Nifty Pharma index.",positive,positive,1.189352463658666,positive,-1.0093527178442532,negative
2021-02-05 19:14:22.000,1059.4,1081.9,1042.85,1072.0,3225187.0,Buy Lupin; Target Of Rs 1165: ICICI Direct,"ICICI Direct is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1165 in its research report dated January 29, 2021.",neutral,positive,1.189352463658666,positive,-1.0093527178442532,negative
2021-02-05 20:57:17.000,1059.4,1081.9,1042.85,1072.0,3225187.0,Buy Lupin; Target Of Rs 1287: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1287 in its research report dated January 29, 2021.",neutral,positive,1.189352463658666,positive,-1.0093527178442532,negative
2021-02-08 05:30:00.000,1079.9,1087.0,1061.5,1069.0,2034788.0,Why Brokerages Are Recommending a Buy on Lupin?,Why Brokerages Are Recommending a Buy on Lupin?,neutral,neutral,-1.0093527178442532,negative,-1.3238858847659722,negative
2021-02-08 08:20:00.000,1079.9,1087.0,1061.5,1069.0,2034788.0,Nifty Pharma index trade higher as heavyweight Dr Reddy’s drive,"Auro Pharma, Cipla, Lupin and Biocon are also over 0.50% higher to support the sector. Alkem Lab, Divis Lab and Cadila drag the sector.",positive,neutral,-1.0093527178442532,negative,-1.3238858847659722,negative
2021-02-08 13:16:06.000,1072.6,1080.0,1053.0,1058.4,1390841.0,Lupin Ltd extends winning spree,"Lupin Ltd is quoting at Rs 1074.6, up 0.44% on the day as on 12:44 IST on the NSE. The stock is up 53.09% in last one year as compared to a 25.61% jump in NIFTY and a 57.44% jump in the Nifty Pharma.",positive,positive,-1.3238858847659722,negative,1.1149957478975674,positive
2021-02-08 16:07:30.000,1072.6,1080.0,1053.0,1058.4,1390841.0,Buy Lupin; Target Of Rs 1350: Sharekhan,"Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated January 29, 2021.",neutral,positive,-1.3238858847659722,negative,1.1149957478975674,positive
2021-02-09 05:30:00.000,1072.6,1080.0,1053.0,1058.4,1390841.0,BRIEF-Lupin Gets Approval For Tavaborole Topical Solution,BRIEF-Lupin Gets Approval For Tavaborole Topical Solution,neutral,neutral,-1.3238858847659722,negative,1.1149957478975674,positive
2021-02-09 09:13:00.000,1072.6,1080.0,1053.0,1058.4,1390841.0,"Lupin receives USFDA approval for Tavaborole Topical Solution, stock ends lower","The company has received approval for its Tavaborole Topical Solution, 5%, from the United States Food and Drug Administration.",neutral,positive,-1.3238858847659722,negative,1.1149957478975674,positive
2021-02-09 15:04:00.000,1058.3,1073.7,1048.7,1070.1,1280107.0,Lupin receives USFDA approval for Tavaborole Topical Solution,"Tavaborole Topical Solution, 5%, is an oxaborole antifungal indicated for the topical treatment of
onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.",positive,neutral,1.1149957478975674,positive,-0.714554343738239,neutral
2021-02-09 17:25:00.000,1058.3,1073.7,1048.7,1070.1,1280107.0,Lupin gets USFDA to market generic anti-fungal cream in US market,"The company has received approval from the US Food and Drug Administration (USFDA) to market its product, which is a generic version of Anacor Pharmaceuticals’ Kerydin Topical Solution, Lupin said in a statement.",neutral,positive,1.1149957478975674,positive,-0.714554343738239,neutral
2021-02-10 10:46:00.000,1058.3,1073.7,1048.7,1070.1,1280107.0,Lupin’s consumer healthcare biz launches ‘Be One’ a new ayurvedic energy supplement for men,Be One is a 100% Ayurvedic health and wellness supplement specially developed for men to help them stay energized and healthy.,neutral,neutral,1.1149957478975674,positive,-0.714554343738239,neutral
2021-02-11 13:37:00.000,1068.0,1068.0,1048.0,1051.5,954704.0,"Lupin launches Be One, an ayurvedic energy supplement for men","It is scientifically tested and contains 100 per cent ayurvedic natural ingredients including ashwagandha, shatavari and shilajit that boost energy levels and improve immunity, it added.",neutral,neutral,-1.544943820224719,negative,0.2843601895734597,neutral
2021-02-12 07:00:00.000,1068.0,1068.0,1048.0,1051.5,954704.0,"Bears take control on Nifty Pharma; Sun Pharma sinks 3%, Divis Lab struggles as well",Cipla was 0.56% down while Lupin trades 0.44% lower. DR Reddy and Auro Pharma were marginally lower.,neutral,negative,-1.544943820224719,negative,0.2843601895734597,neutral
2021-02-17 05:30:00.000,1100.0,1109.0,1060.0,1061.55,3927925.0,BRIEF-Lupin Launches Posaconazole Delayed-Release Tablets,BRIEF-Lupin Launches Posaconazole Delayed-Release Tablets,neutral,neutral,-3.4954545454545496,negative,-2.28544776119403,negative
2021-02-17 07:22:42.000,1100.0,1109.0,1060.0,1061.55,3927925.0,"Hot Stocks | Lupin, Ambuja Cements And Pidilite Can Give Up To 11% Return In Short Term","For the next few sessions, the market may remain volatile and trade in the range of 15,100-15,400 with some stock-specific action.",neutral,neutral,-3.4954545454545496,negative,-2.28544776119403,negative
2021-02-17 08:20:00.000,1100.0,1109.0,1060.0,1061.55,3927925.0,"Nifty Pharma dips 1.5% led by huge selloff in heavyweights Lupin, Dr Reddy’s Lab","The Nifty Pharma index has touched an intraday low of 12,571.05.",positive,negative,-3.4954545454545496,negative,-2.28544776119403,negative
2021-02-17 08:30:00.000,1100.0,1109.0,1060.0,1061.55,3927925.0,"Trading tips by Ajit Mishra of Religare Broking: Buy Lupin, LIC Housing Fin","LIC Housing Finance has witnessed a fresh breakout of late, after spending nearly a month in a consolidation range",neutral,neutral,-3.4954545454545496,negative,-2.28544776119403,negative
2021-02-17 09:29:00.000,1100.0,1109.0,1060.0,1061.55,3927925.0,"Buy Lupin, target price Rs 1200: Yes Securities","Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 49741.37 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-3.4954545454545496,negative,-2.28544776119403,negative
2021-02-17 11:44:38.000,1100.0,1109.0,1060.0,1061.55,3927925.0,Lupin Launches Posaconazole Delayed-release Tablets; Share Dips 2%,Posaconazole had estimated annual sales of USD 186 million in the US,neutral,neutral,-3.4954545454545496,negative,-2.28544776119403,negative
2021-02-17 11:47:00.000,1100.0,1109.0,1060.0,1061.55,3927925.0,Lupin launches Posaconazole Delayed-Release Tablets,"Posaconazole Delayed-Release Tablets, 100 mg, are the generic equivalent of Noxafil DelayedRelease Tablets, 100 mg, of Merck Sharp & Dohme Corp, and are indicated for prophylaxis of invasive
Aspergillus and Candida infections in patients who are at",neutral,neutral,-3.4954545454545496,negative,-2.28544776119403,negative
2021-02-17 12:51:00.000,1072.0,1072.5,1046.2,1047.5,2770516.0,Lupin launches Posaconazole delayed-release tablets,"In a regulatory filing, Lupin Ltd announced launch of Posaconazole delayed-release tablets, 100 mg, after its alliance partner AET Pharma US Inc. received an approval for its abbreviated new drug application from USFDA.",neutral,positive,-2.28544776119403,negative,-2.2966507177033493,negative
2021-02-17 14:24:00.000,1072.0,1072.5,1046.2,1047.5,2770516.0,Stock market update: Nifty Pharma index sheds over 1%; Lupin falls 3%,The index was trading 1.36 per cent down at 12629.5.,neutral,negative,-2.28544776119403,negative,-2.2966507177033493,negative
2021-02-17 17:50:00.000,1072.0,1072.5,1046.2,1047.5,2770516.0,Lupin launches Posaconazole Delayed-Release Tablets after alliance partner AET Pharma bags USFDA nod,The 100 mg tablets were launched today after pharma company’s alliance partner AET Pharma US Inc. received approval for its ANDA from USFDA.,neutral,positive,-2.28544776119403,negative,-2.2966507177033493,negative
2021-02-19 05:30:00.000,1045.0,1056.15,1016.0,1021.0,2804842.0,BRIEF-Lupin Ltd - Lupin Receives FDA Approval For Droxidopa Capsules,BRIEF-Lupin Ltd - Lupin Receives FDA Approval For Droxidopa Capsules,neutral,neutral,-2.2966507177033493,negative,-3.8072054527750754,negative
2021-02-19 10:37:00.000,1045.0,1056.15,1016.0,1021.0,2804842.0,USFDA allows Lupin to market Droxidopa Capsules,"The product will be manufactured at Lupin’s facility in Nagpur, India.",neutral,neutral,-2.2966507177033493,negative,-3.8072054527750754,negative
2021-02-19 15:44:00.000,1045.0,1056.15,1016.0,1021.0,2804842.0,Lupin receives USFDA approval for Droxidopa Capsules,"Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, are indicated for the treatment of orthostatic
dizziness, lightheadedness, or the feeling that you are about to black out in adult patients with
symptomatic neurogenic orthostatic hypotension (nOH)",positive,neutral,-2.2966507177033493,negative,-3.8072054527750754,negative
2021-02-19 17:08:00.000,1045.0,1056.15,1016.0,1021.0,2804842.0,Lupin gets USFDA nod for generic drug,"Drugmaker Lupin on Friday said it has received approval from the US health regulator to market Droxidopa capsules, used to treat dizziness. The company has received approval from the US Food and Drug Administration (USFDA) for Droxidopa capsules in strengths of 100 mg, 200 mg, and 300 mg.",neutral,positive,-2.2966507177033493,negative,-3.8072054527750754,negative
2021-02-22 09:08:00.000,1027.0,1029.5,985.05,987.9,3451111.0,Nifty closes lower; Pharma stocks underperformed,"Nifty Pharma index closed ~3% lower with the stocks like Aurobindo Pharma, Sun Pharma, Lupin & Dr Reddys adding fresh short positions",negative,negative,-3.8072054527750754,negative,1.1225256827862735,positive
2021-02-22 09:08:00.000,1027.0,1029.5,985.05,987.9,3451111.0,Nifty close lower; Pharma stocks underperformed,"Nifty Pharma index closed ~3% lower with the stocks like Aurobindo Pharma, Sun Pharma, Lupin & Dr Reddys adding fresh short positions",negative,negative,-3.8072054527750754,negative,1.1225256827862735,positive
2021-02-25 09:54:00.000,1021.95,1040.5,1015.0,1030.7,3303158.0,"Lupin allots 40,587 equity shares under ESOP; Stock ends 1% up",These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company.,neutral,neutral,0.8562062723225206,neutral,0.2868305227239099,neutral
2021-02-25 13:08:00.000,1011.05,1059.95,1003.25,1013.95,5618285.0,"Lupin allots 40,587 equity shares under ESOP","The issued and paid-up capital of the Company has been increased to Rs 90,72,82,820
consisting 45,36,41,410 equity shares of Rs 2/- each.",neutral,positive,0.2868305227239099,neutral,0.053739801651273,neutral
2021-02-26 12:23:00.000,1011.05,1059.95,1003.25,1013.95,5618285.0,Investors turn to pharma stocks amid market crash; Nifty Pharma gains 1.5%,"Among individual stocks, Lupin zoomed 3.4 per cent in the intra-day trade and hit a high of Rs 1,060, Sun Pharmaceuticals advanced 2 per cent, and Dr Reddy’s Labs gained 1.7 per cent.",positive,positive,0.2868305227239099,neutral,0.053739801651273,neutral
2021-03-02 05:30:00.000,1026.8,1057.6,1026.8,1053.2,2070364.0,"BRIEF-Lupin Says Launch Of Penicillamine Tablets Usp, 250 Mg","BRIEF-Lupin Says Launch Of Penicillamine Tablets Usp, 250 Mg",neutral,neutral,2.571094663030784,positive,-0.5461393596986774,neutral
2021-03-02 07:15:00.000,1026.8,1057.6,1026.8,1053.2,2070364.0,"Nifty Pharma rallies over 1%; Lupin and Cipla led the pack, Sun Pharma adds significant gains too","DR Reddys Lab was the lone laggard in the sector, shedding ~1% at Rs4,410.95 per piece.",positive,negative,2.571094663030784,positive,-0.5461393596986774,neutral
2021-03-02 08:33:00.000,1026.8,1057.6,1026.8,1053.2,2070364.0,Lupin launches Penicillamine Tablets USP after receiving USFDA approval,"Penicillamine Tablets USP, 250 mg (RLD: Depen®) had estimated annual sales of USD 5 million in the U.S.",neutral,neutral,2.571094663030784,positive,-0.5461393596986774,neutral
2021-03-02 15:13:00.000,1062.0,1064.7,1046.1,1056.2,1740668.0,Lupin launches Penicillamine Tablets,"Penicillamine Tablets USP, 250 mg, are the generic equivalent of Depen Tablets, 250 mg, of Mylan
Specialty, L.P., and indicated in the treatment of Wilson’s disease, Cystinuria, and in patients with
severe, active rheumatoid arthritis who have",neutral,neutral,-0.5461393596986774,neutral,0.0856327307326442,neutral
2021-03-02 16:38:00.000,1062.0,1064.7,1046.1,1056.2,1740668.0,Lupin launches generic drug to treat Wilson’s disease in US market,"The Mumbai-based drug firm’s product is the generic equivalent of Mylan Specialty’s Depen tablets, which are indicated for the treatment of Wilson’s disease, Cystinuria, and in patients with severe, active rheumatoid arthritis who have failed to respond to an adequate trial of conventional therapy.",positive,neutral,-0.5461393596986774,neutral,0.0856327307326442,neutral
2021-03-02 17:29:00.000,1062.0,1064.7,1046.1,1056.2,1740668.0,Lupin launches Penicillamine tablets for treating Wilson’s disease in US markets,The company has launched a generic product in the market after having received approval from the US and Drug Administration (U.S.FDA) earlier.,neutral,neutral,-0.5461393596986774,neutral,0.0856327307326442,neutral
2021-03-04 12:27:41.000,1048.0,1053.45,1029.95,1034.85,1714772.0,Long-term Picks: Axis Securities Recommends These 15 Names For Up To 36% Upside,"ICICI Bank, Manappuram Finance, Bharti Airtel, HCL Tech, Relaxo Footwears, Amber Enterprises, NOCIL, Steel Strip Wheels and Lupin are among the top picks by Axis Securities.",neutral,neutral,-1.2547709923664208,negative,1.370722525218403,positive
2021-03-05 14:57:00.000,1048.0,1053.45,1029.95,1034.85,1714772.0,Lupin allots 9203 equity shares under ESOP; Stock trades lower,Lupin allots 9203 equity shares under ESOP.,neutral,neutral,-1.2547709923664208,negative,1.370722525218403,positive
2021-03-05 18:18:00.000,1048.0,1053.45,1029.95,1034.85,1714772.0,"Nifty Pharma stocks in sell-off; Alkem Lab, Auro Pharma and Dr Reddys drag the sector",Lupin and Cipla lifted the spirit with marginal gains.,negative,positive,-1.2547709923664208,negative,1.370722525218403,positive
2021-03-08 06:55:00.000,1035.95,1064.25,1032.9,1050.15,1407839.0,"Nifty Pharma gain 1%; Lupin surges 2%; Cadila, Cipla, Divis Lab contribute to the gains",Alkem Lab and Biocon were marginally in the negative zone.,positive,negative,1.370722525218403,positive,-2.034235857556076,negative
2021-03-08 15:15:00.000,1054.45,1058.95,1013.5,1033.0,1654321.0,Stock market update: Pharma stocks advance; Lupin gains nearly 2%,The Nifty Pharma index was trading 0.35 per cent up at 12235.25.,positive,positive,-2.034235857556076,negative,1.633045148895293,positive
2021-03-09 05:30:00.000,1054.45,1058.95,1013.5,1033.0,1654321.0,BRIEF-Lupin Says Unit Announces Partnership With Endoceutics For Commercialization Of Intrarosa,BRIEF-Lupin Says Unit Announces Partnership With Endoceutics For Commercialization Of Intrarosa,neutral,neutral,-2.034235857556076,negative,1.633045148895293,positive
2021-03-09 10:38:00.000,1054.45,1058.95,1013.5,1033.0,1654321.0,Lupin subsidiary ties with Endoceutics to commercialize Intrarosa in Canada,"Intrarosa was developed in Quebec City, Canada by Endoceutics and will be manufactured in their facilities in Mont Saint Hilaire, Canada.",neutral,neutral,-2.034235857556076,negative,1.633045148895293,positive
2021-03-09 11:12:00.000,1054.45,1058.95,1013.5,1033.0,1654321.0,Lupin unit partners Endoceutics to commercialise Intrarosa in Canada,"Lupin Pharma, a subsidiary of the drug major, announced a partnership with Endoceutics, a women’s health focused innovative Canadian biotech company, to commercialize Intrarosa in Canada.",neutral,positive,-2.034235857556076,negative,1.633045148895293,positive
2021-03-09 11:57:00.000,1054.45,1058.95,1013.5,1033.0,1654321.0,Lupin Pharma partners with Endoceutics to commercialise Intrarosa in Canada,Intrarosa is Endoceutic’s flagship product indicated for the treatment of postmenopausal vulvovaginal atrophy.,neutral,neutral,-2.034235857556076,negative,1.633045148895293,positive
2021-03-09 15:00:00.000,1041.0,1061.5,1035.1,1058.0,1596408.0,Stock market update: Nifty Pharma index falls over 1%; Lupin dips over 2%,The index was trading 1.22 per cent down at 12090.8.,neutral,negative,1.633045148895293,positive,-1.5037593984962403,negative
2021-03-09 18:20:00.000,1041.0,1061.5,1035.1,1058.0,1596408.0,"Nifty Pharma under pressure, index dives 0.7%; Torrent Pharma, Dr Reddy’s, Biocon drags most","Cadila, Lupin and Sun Pharma also traded in the red to complete all negative trade from the Nifty Pharma sector.",neutral,negative,1.633045148895293,positive,-1.5037593984962403,negative
2021-03-10 05:30:00.000,1041.0,1061.5,1035.1,1058.0,1596408.0,BRIEF-Lupin Launches Authorized Generic Version Of Alinia,BRIEF-Lupin Launches Authorized Generic Version Of Alinia,neutral,neutral,1.633045148895293,positive,-1.5037593984962403,negative
2021-03-10 10:44:00.000,1041.0,1061.5,1035.1,1058.0,1596408.0,Lupin launches authorized generic version of Alinia Tablets,"Nitazoxanide Tablets, 500 mg, are indicated in the treatment of diarrhea.",neutral,neutral,1.633045148895293,positive,-1.5037593984962403,negative
2021-03-10 14:17:00.000,1041.0,1061.5,1035.1,1058.0,1596408.0,Lupin gains on launching generic anti-diarrheal drug in US,"Lupin gained 2.74% to Rs 1059.95 after the drug major announced the launch of the authorized generic version of Alinia (nitazoxanide) tablets, 500 mg of Romark Laboratories.",positive,positive,1.633045148895293,positive,-1.5037593984962403,negative
2021-03-10 16:08:00.000,1041.0,1061.5,1035.1,1058.0,1596408.0,Lupin launches generic diarrhea drug in US market,"Nitazoxanide tablets, 500 mg, are indicated in the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 years of age and older.",positive,neutral,1.633045148895293,positive,-1.5037593984962403,negative
2021-03-10 18:10:00.000,1041.0,1061.5,1035.1,1058.0,1596408.0,Nifty Pharma index rally 1%; Biocon and Lupin led the pack,Cipla and Sun Pharma were also bullish to push the sector further while Torrent Pharma and Alkem Lab lagged.,positive,positive,1.633045148895293,positive,-1.5037593984962403,negative
2021-03-11 12:48:51.000,1064.0,1064.0,1042.9,1048.0,1756387.0,"Lupin on firm ground with US product launches, but high base in Q4 a challenge",Lupin’s stock prices remain firm owing to product launches which remain positive and will strengthen its growth and base business in the US.The Street will be watching the drug maker for more large product approvals and launches to provide significant impetus to earnings moving forward,positive,positive,-1.5037593984962403,negative,1.849544801149972,positive
2021-03-12 11:41:00.000,1064.0,1064.0,1042.9,1048.0,1756387.0,"Titan, Lupin: How to trade dark horses in Rakesh Jhunjhunwala’s portfolio","Titan Company needs to decisively cross and sustain above Rs 1,500 levels, supported by volume, to attract the interest of market participants",neutral,positive,-1.5037593984962403,negative,1.849544801149972,positive
2021-03-15 08:02:00.000,1043.5,1067.65,1026.0,1062.8,1472852.0,"Nifty Pharma dips 2% as heavyweights Sun Pharma, Dr Reddy’s, Aurobindo skid on products recall; Lupin top gainer","The index has hovered between an intraday high of 12,215.15 and an intraday low of 11,848.30.",neutral,neutral,1.849544801149972,positive,-1.2628515093188155,negative
2021-03-17 07:26:00.000,1050.7,1052.95,1015.0,1017.9,1558665.0,"Nifty Pharma shed 164 pts amid resurgence in Covid-19 cases; Lupin, Cipla, Sun Pharma drags; Aurobindo only gainer","Except for Aurobindo Pharma, all stocks listed on Nifty Pharma were under sharp selloff with heavyweights Lupin, Cipla and Sun Pharma being top laggards.",negative,negative,-3.1217283715618223,negative,-2.3391812865497075,negative
2021-03-17 14:01:00.000,1026.0,1027.65,988.0,1002.0,1715265.0,Stock market update: Nifty Pharma index falls over 1%; Lupin slips over 2%,The index was trading 1.3 per cent down at 11856.4.,neutral,negative,-2.3391812865497075,negative,0.920662071741206,positive
2021-03-17 18:02:00.000,1026.0,1027.65,988.0,1002.0,1715265.0,Market Movers: Why ITC bucked weak trend; 94 stocks blink sell,"As many as 94 stocks listed on the NSE gave sell signal based on MACD indicators including BHEL, Vedanta, NMDC, Tata Communications, and Lupin.",negative,neutral,-2.3391812865497075,negative,0.920662071741206,positive
2021-03-18 07:25:00.000,1026.0,1027.65,988.0,1002.0,1715265.0,"Nifty Pharma index underperforms 1.5%; DR Reddys, Divis Lab, Cipla drags",Auro Pharma led the losses while Cadila and Lupin were also bearish. Biocon gained 1% amidst gloomy picture.,neutral,positive,-2.3391812865497075,negative,0.920662071741206,positive
2021-03-19 07:25:00.000,993.85,1017.25,978.3,1003.0,1722398.0,"Nifty Pharma index surges 1%; Biocon, Torrent Pharma, Divis Lab and DR Reddys in fast lane","Lupin, Cadila, Auro Pharma and Cipla also gained more than 1%. Sun Pharma also advanced 0.82% higher. Alkem Lab was lone laggard.",positive,positive,0.920662071741206,positive,1.1839617948462815,positive
2021-03-24 16:50:00.000,1011.4,1020.95,983.65,993.0,1449610.0,Lupin ties with Uttarakhand Police to promote ‘LupiSafe’ hand sanitizers at Kumbh Mela 2021,"During the Kumbh, LupinLife will provide five lakh LupiSafe hand sanitizers to policemen and frontline workers.",neutral,positive,-1.8192604310856215,negative,-2.3904382470119523,negative
2021-03-24 16:51:00.000,1011.4,1020.95,983.65,993.0,1449610.0,LupinLife partners with Uttarakhand Police to promote hand hygiene at Kumbh Mela,Drug firm Lupin on Wednesday said its consumer healthcare business LupinLife has partnered with the Uttarakhand Police to promote hand hygiene at the Kumbh Mela in Haridwar.,positive,positive,-1.8192604310856215,negative,-2.3904382470119523,negative
2021-03-25 05:30:00.000,1011.4,1020.95,983.65,993.0,1449610.0,BRIEF-Lupin To Subscribe To Partnership Interest In ABCD Tech (IndoHealth Services),BRIEF-Lupin To Subscribe To Partnership Interest In ABCD Tech (IndoHealth Services),neutral,neutral,-1.8192604310856215,negative,-2.3904382470119523,negative
2021-03-25 16:01:00.000,1004.0,1004.0,975.0,980.0,4298240.0,"Lupin allots 29,520 equity shares under ESOP","Lupin allots 29,520 equity shares under ESOP.",neutral,neutral,-2.3904382470119523,negative,1.3284170118193734,positive
2021-03-26 07:13:00.000,1004.0,1004.0,975.0,980.0,4298240.0,"Four pharma companies invest in ABCD Technologies; Sun Pharma, Torrent Pharma and Cadila surge 1-2% while Lupin dips",About Rs40cr each is invested by the companies.,positive,neutral,-2.3904382470119523,negative,1.3284170118193734,positive
2021-03-26 08:15:50.000,1004.0,1004.0,975.0,980.0,4298240.0,"Markets likely to be rangebound; Sun Pharma, Lupin, RIL in focus","India’s economy is on the path of gradual recovery, the International Monetary Fund has said ahead of its next month’s spring meeting with the World Bank",neutral,positive,-2.3904382470119523,negative,1.3284170118193734,positive
2021-03-26 09:04:14.000,1004.0,1004.0,975.0,980.0,4298240.0,Bounceback seen for benchmark indices,"Somany Home Innovation, Lupin, Sun Pharmaceuticals, Cadila Helathcare and Torrent Pharmaceuticals likely to see action today",neutral,neutral,-2.3904382470119523,negative,1.3284170118193734,positive
2021-03-31 07:20:00.000,1014.9,1024.2,1004.75,1020.0,1327708.0,"Nifty Pharma index gains near 1% led by sharp rally in Cadila, Lupin and Aurobindo",Auro Pharma gained 1.13% while Cipla and Sun Pharma also gained nearly 1% to lift the sectorial performance.,positive,positive,0.5025125628140726,neutral,-0.8712487899322363,neutral
2021-04-01 12:04:00.000,1033.0,1034.95,1019.1,1024.0,1084820.0,Lupin Ltd. stock price up 0.63 per cent as Sensex climbs,"As of 31-Dec-2020, promoters held 46.59 per cent stake in the company, while FIIs held 18.97 per cent and domestic institutional investors had 13.21 per cent.",positive,neutral,-0.8712487899322363,neutral,0.1947419668938656,neutral
2021-04-01 13:31:21.000,1033.0,1034.95,1019.1,1024.0,1084820.0,Lupin Ltd in demand,"Lupin Ltd is quoting at Rs 1032.15, up 1.15% on the day as on 12:49 IST on the NSE. The stock is up 57.38% in last one year as compared to a 82.28% gain in NIFTY and a 67.63% gain in the Nifty Pharma index.",positive,positive,-0.8712487899322363,neutral,0.1947419668938656,neutral
2021-04-01 18:25:00.000,1033.0,1034.95,1019.1,1024.0,1084820.0,"Nifty Pharma index extends gaining spree; Sun Pharma, Lupin, DR Reddys led the pack","Nifty Pharma gained over 0.65% touching a high of 12,374.40 during intraday trade on Thursday.",positive,positive,-0.8712487899322363,neutral,0.1947419668938656,neutral
2021-04-05 01:45:00.000,1027.0,1031.4,1007.25,1029.0,753630.0,"Nifty Pharma index trades lower amid fragile markets; Alkem Lab, DR Reddys, Biocon drag","Sun Pharma, Lupin and Divis Lab also traded in the red. Auro Pharma was the lone gainer at Rs883.10 per piece, up 0.20%.",negative,positive,0.1947419668938656,neutral,1.3359242166626184,positive
2021-04-05 09:50:02.000,1027.0,1031.4,1007.25,1029.0,753630.0,"How Sun Pharma To Lupin Fared In U.S. In January-March, And What Analysts Expect",Analyst take on key pharma stocks after January-March sales show mixed results.,neutral,negative,0.1947419668938656,neutral,1.3359242166626184,positive
2021-04-05 11:07:00.000,1027.0,1031.4,1007.25,1029.0,753630.0,Lupin Ltd. shares drop 1.43% as Sensex falls,"A total of 45,271 shares changed hands on the counter till 11:07AM (IST)",negative,neutral,0.1947419668938656,neutral,1.3359242166626184,positive
2021-04-05 12:36:53.000,1029.25,1047.15,1029.25,1043.0,1687143.0,"Bharti Airtel, SBI And Lupin Among 15 Stocks That Axis Securities Is Betting On This Month","With an expectation of improved earnings for the broader market, the brokerage firm believes small and midcap companies could outperform largecaps in FY22",neutral,positive,1.3359242166626184,positive,-1.0526315789473684,negative
2021-04-06 10:57:00.000,1029.25,1047.15,1029.25,1043.0,1687143.0,Lupin Ltd. stock price up 0.86 per cent as Sensex climbs,"As of 31-Dec-2020, promoters held 46.59 per cent stake in the company, while FIIs held 18.97 per cent and domestic institutional investors had 13.21 per cent.",positive,neutral,1.3359242166626184,positive,-1.0526315789473684,negative
2021-04-06 13:04:10.000,1045.0,1051.05,1032.0,1034.0,1888338.0,Lupin Ltd gains for fifth session,"Lupin Ltd is quoting at Rs 1036.75, up 0.76% on the day as on 12:49 IST on the NSE. The stock is up 48.1% in last one year as compared to a 66.74% spurt in NIFTY and a 53.33% spurt in the Nifty Pharma.",positive,positive,-1.0526315789473684,negative,1.4310578224714712,positive
2021-04-07 14:09:00.000,1034.2,1056.95,1034.0,1049.0,1216464.0,Lupin shares up 0.08% as Nifty gains,"A total of 101,396 shares changed hands on the counter till time (IST).",positive,neutral,1.4310578224714712,positive,2.9551954242135365,positive
2021-04-08 06:45:00.000,1034.2,1056.95,1034.0,1049.0,1216464.0,"Nifty Pharma maintains gaining spree; Cadila, Lupin led the pack",Divis Lab also gained over 1% to lift performance. Torrent Pharma slipped 1% to drag.,positive,positive,1.4310578224714712,positive,2.9551954242135365,positive
2021-04-08 12:51:00.000,1049.0,1087.0,1045.75,1080.0,3348721.0,Lupin share price up 1.72 per cent,"A total of 180,956 shares changed hands on the counter till 12:51PM (IST).",positive,neutral,2.9551954242135365,positive,-2.782931354359926,negative
2021-04-12 10:01:48.000,1078.0,1099.95,1036.0,1048.0,3868281.0,"Lupin, Bharti Airtel & IGL Can Give Up To 9% Return Each In Near Term: Gaurav Ratnaparkhi Of Sharekhan","Traders and investors need to have exposure in the metal stocks but they should wait for a fresh setup to make an entry, says Ratnaparkhi.",neutral,neutral,-2.782931354359926,negative,-0.7714285714285628,neutral
2021-04-12 10:05:00.000,1078.0,1099.95,1036.0,1048.0,3868281.0,Lupin rises 0.6% as Sensex slides,"The stock traded at a P/E multiple of 43.09, while the price-to-book value ratio stood at 2.13.",positive,neutral,-2.782931354359926,negative,-0.7714285714285628,neutral
2021-04-12 20:40:13.000,1050.0,1058.7,1022.1,1041.9,1526541.0,LUPIN Q4 PAT Seen Up 3.5% YoY To Rs. 317.2 Cr: Sharekhan,"Net Sales are expected to increase by 3.5 percent Y-o-Y (down 0.9 percent Q-o-Q) to Rs. 3,979 crore, according to Sharekhan.",neutral,positive,-0.7714285714285628,neutral,2.91105121293801,positive
2021-04-13 13:53:00.000,1050.0,1058.7,1022.1,1041.9,1526541.0,Lupin shares drop 0.09% as Sensex rises,"A total of 91,533 shares changed hands on the counter till 01:53PM (IST)",negative,neutral,-0.7714285714285628,neutral,2.91105121293801,positive
2021-04-13 16:54:00.000,1050.0,1058.7,1022.1,1041.9,1526541.0,"Nifty Pharma shed 1% amid rising COVID cases; Heavyweights Cadila, Dr Reddys, Lupin drag","Cadila Healthcare was the biggest laggard at Rs482.55 per piece lower by 3.43%, while Dr Reddy’s was 3.14% down dragged the sector most",negative,negative,-0.7714285714285628,neutral,2.91105121293801,positive
2021-04-16 17:42:00.000,1054.0,1069.15,1043.5,1052.7,1743060.0,"Nifty Pharma trade higher; Auro Pharma, Cadila gain momentum",Cipla also advanced 0.83% while DR Reddys was up 0.73%. Biocon gained 0.59% while Lupin and Sun Pharma traded higher 0.38% and 0.32% respectively.,positive,positive,-0.1233396584440184,neutral,2.583732057416268,positive
2021-04-19 08:41:46.000,1045.0,1072.75,1028.7,1072.0,2238820.0,Experts give ‘buy’ tag to this pharma stock of Rakesh Jhunjhunwala portfolio,"Rakesh Jhunjhunwala Portfolio Shares: The ‘Warren Buffett’ of India’ holds 7,245,605 Lupin shares which is around 1.6 per cent of the net Lupin stocks available in the market for public holdings",positive,neutral,2.583732057416268,positive,1.3801115241635604,positive
2021-04-19 10:21:00.000,1045.0,1072.75,1028.7,1072.0,2238820.0,Lupin shares drop 0.65% as Sensex falls,The stock quoted a 52-week high of Rs 1121.85 and a 52-week low of Rs 792.8.,negative,negative,2.583732057416268,positive,1.3801115241635604,positive
2021-04-21 10:09:00.000,1100.0,1106.9,1057.0,1059.0,5113304.0,Many companies in talks to hold vaccination camps for employees,"Companies such as RPG Group, Lupin, and Dalmia Bharat Group said they have been conducting vaccination camps at their factory premises over the last week.",neutral,neutral,-3.727272727272727,negative,2.304015296367104,positive
2021-04-22 07:18:31.000,1100.0,1106.9,1057.0,1059.0,5113304.0,"Hot Stocks | Info Edge, Glenmark Pharma, Lupin Can Give Up To 18% Return In Short Term","Call writers were seen adding hefty open interest at 14,500, 14,600 and 14,700 strikes which should act as a major hurdle for Nifty and will cap any sharp upside.",neutral,positive,-3.727272727272727,negative,2.304015296367104,positive
2021-04-22 08:47:00.000,1100.0,1106.9,1057.0,1059.0,5113304.0,Lupin incorporates wholly owned subsidiary Lupin Oncology in the USA,LOI will be engaged in the development/co-development and commercialization of multiple oncology Products globally.,neutral,neutral,-3.727272727272727,negative,2.304015296367104,positive
2021-04-22 08:49:00.000,1100.0,1106.9,1057.0,1059.0,5113304.0,"Stocks to watch: Nestle India, Hero Moto, ICICI Securities, Cyient, Lupin","Cyient, Tata Elxsi and 10 other companies will release their quarterly earnings on April 22",neutral,neutral,-3.727272727272727,negative,2.304015296367104,positive
2021-04-22 11:25:00.000,1100.0,1106.9,1057.0,1059.0,5113304.0,Lupin stock price down 0.83 per cent as Sensex slides,"As of 31-Mar-2021, promoters held 46.58 per cent stake in the company, while FIIs held 17.87 per cent and domestic institutional investors had 13.05 per cent.",negative,neutral,-3.727272727272727,negative,2.304015296367104,positive
2021-04-22 12:57:00.000,1046.0,1083.6,1036.6,1070.1,4643577.0,Lupin incorporates subsidiary in US,"The drug major has incorporated a wholly-owned subsidiary in the USA under the name, Lupin Oncology Inc. (LOI).",neutral,neutral,2.304015296367104,positive,-0.7395692822922039,neutral
2021-04-23 12:08:35.000,1046.0,1083.6,1036.6,1070.1,4643577.0,"Heartburn Drug Approval For Rival Negative For Lupin, Says Jefferies",Novitium has received FDA approval for Famotidine oral suspension generic.,neutral,positive,2.304015296367104,positive,-0.7395692822922039,neutral
2021-04-23 17:00:00.000,1046.0,1083.6,1036.6,1070.1,4643577.0,"Nifty Pharma underperforms amid Covid concerns; Heavyweights Lupin, Dr Reddy’s Lab, Cadila drag","Lupin was the top underperformer of the index tumbling by 1.5% at Rs1,044.80 per piece.",negative,negative,2.304015296367104,positive,-0.7395692822922039,neutral
2021-04-25 10:59:00.000,1074.95,1080.9,1056.65,1067.0,2019998.0,"Lupin, Sun Pharma, Jubilant Cadista recall drugs in US market","According to the USFDA, the company is recalling the affected lot for being “Superpotent”. The affected lot has been manufactured at Lupin’s Mandideep plant in Madhya Pradesh and distributed in the US by Baltimore-based Lupin Pharmaceuticals Inc, the report stated.",neutral,negative,-0.7395692822922039,neutral,-0.173220973782763,neutral
2021-04-25 13:31:35.000,1074.95,1080.9,1056.65,1067.0,2019998.0,"Madhya Pradesh connect: Lupin, Sun Pharma, Jubilant Cadista recall drugs in US market","The affected lot has been manufactured at Lupin’s Mandideep plant in Madhya Pradesh and distributed in the US by Baltimore-based Lupin Pharmaceuticals Inc, the report stated.",neutral,neutral,-0.7395692822922039,neutral,-0.173220973782763,neutral
2021-04-27 10:07:00.000,1068.0,1072.95,1051.1,1066.15,1347629.0,Go for Lupin and Sun Pharma with a long-term view: Nooresh Merani,We would be looking out for Lupin in pharma and Tata Power in energy for next week,neutral,neutral,-0.173220973782763,neutral,-1.4953271028037385,negative
2021-04-27 12:20:00.000,1070.0,1074.55,1051.1,1054.0,1481530.0,Lupin stock price up 0.33 per cent as Sensex climbs,"As of 31-Mar-2021, promoters held 46.58 per cent stake in the company, while FIIs held 17.87 per cent and domestic institutional investors had 13.05 per cent.",positive,neutral,-1.4953271028037385,negative,-0.6132075471698114,neutral
2021-04-29 12:21:00.000,1045.0,1082.9,1045.0,1068.2,1819391.0,Lupin shares gain 0.83% as Sensex rises,"A total of 34,168 shares changed hands on the counter till 12:21PM (IST)",positive,neutral,2.220095693779909,positive,0.5149812734082396,neutral
2021-04-30 11:49:00.000,1045.0,1082.9,1045.0,1068.2,1819391.0,Shares of Lupin rise as Nifty drops,"On the technical charts, the 200-day moving average of the stock stood at Rs 988.49.",neutral,neutral,2.220095693779909,positive,0.5149812734082396,neutral
2021-04-30 16:55:00.000,1045.0,1082.9,1045.0,1068.2,1819391.0,"Nifty Pharma shines despite weak markets; Divi’s Labs top bull; Heavyweights Dr Reddy’s, Cadila, Lupin lift the index","Divi’s Laboratories outperforms on the index surging by 1.33% at Rs3,963.00 per piece.",positive,positive,2.220095693779909,positive,0.5149812734082396,neutral
2021-04-30 17:39:41.000,1045.0,1082.9,1045.0,1068.2,1819391.0,"After Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma, now Ipca Laboratories invests Rs 25 crore in ABCD Technologies","Mumbai-based pharmaceuticals company Ipca Laboratories will complete the purchase of 4.03 per cent stake by April 30, 2021 in ABCD Technologies LLP (which will be renamed as IndoHealth Services LLP), stated the pharma company in its filing. The pharma company will be investing Rs 25 crore in ABCD…",neutral,neutral,2.220095693779909,positive,0.5149812734082396,neutral
2021-05-04 13:27:00.000,1078.1,1209.0,1068.95,1203.0,26458485.0,Lupin shares fall 1.0% as Nifty drops,"A total of 21,426 shares changed hands on the counter till time (IST).",negative,neutral,11.58519617846212,positive,-1.3885445078105778,negative
2021-05-05 08:53:00.000,1078.1,1209.0,1068.95,1203.0,26458485.0,Markets close higher; Pharma stocks outperformed,"Pharma stocks were among the top outperformers as the major heavyweight stocks like Lupin, Aurobindo & Sunpharma closed with a strong gains.",positive,positive,11.58519617846212,positive,-1.3885445078105778,negative
2021-05-05 09:21:58.000,1078.1,1209.0,1068.95,1203.0,26458485.0,Rakesh Jhunjhunwala Portfolio: Experts give ‘buy’ tag to this pharma stock,"Lupin shares have made a breakout around a month ago but after that it has been trading sideways, say experts",positive,neutral,11.58519617846212,positive,-1.3885445078105778,negative
2021-05-05 10:00:00.000,1078.1,1209.0,1068.95,1203.0,26458485.0,Lupin shares rise 2.93% as Nifty gains,The stock quoted a 52-week high price of Rs 1121.85 and a 52-week low of Rs 808.5.,positive,negative,11.58519617846212,positive,-1.3885445078105778,negative
2021-05-05 11:11:00.000,1078.1,1209.0,1068.95,1203.0,26458485.0,"Lupin soars 8%, hits over three-year high on heavy volumes","The stock surpassed its previous high of Rs 1,121.85 touched on September 2020 and was trading at the highest level since July 2017",positive,positive,11.58519617846212,positive,-1.3885445078105778,negative
2021-05-05 11:34:54.000,1078.1,1209.0,1068.95,1203.0,26458485.0,Healthcare stocks rise as RBI eases lending,"BSE Healthcare index surged nearly 2%.Among gainers, Lupin advanced 6%, Wockhardt 6%, Sun Pharmaceuticals 4%, Alkem Lab 4%, Metropolis Healthcare 3%, Glenmark Pharma 1.6%, Dr Reddy’s Lab 1.5%, and Indraprastha Medical 1.5%",positive,positive,11.58519617846212,positive,-1.3885445078105778,negative
2021-05-05 12:04:58.000,1209.9,1219.2,1170.5,1193.1,9041545.0,Agro Tech Foods Ltd leads gainers in ‘A’ group,"Great Eastern Shipping Company Ltd, Parag Milk Foods Ltd, Hikal Ltd and Lupin Ltd are among the other gainers in the BSE’s ‘A’ group today, 05 May 2021.",positive,neutral,-1.3885445078105778,negative,0.1757469244288148,neutral
2021-05-05 16:54:00.000,1209.9,1219.2,1170.5,1193.1,9041545.0,"Nifty Pharma climbs 3% after RBI announces on-tap liquidity of Rs50,000cr; Lupin, Alkem Labs, Sun Pharma in sharp rally",Lupin was the top bull skyrocketing by 8% followed by Alkem Laboratories surging by nearly 4%.,positive,neutral,-1.3885445078105778,negative,0.1757469244288148,neutral
2021-05-06 06:30:00.000,1209.9,1219.2,1170.5,1193.1,9041545.0,"Nifty Pharma pares early gains as bears hover, index plunges near 1%; Lupin, Cadila, Torrent Pharma drag","The index has touched an intraday high and low of 13,960.80 and 13,661.40 respectively.",neutral,negative,-1.3885445078105778,negative,0.1757469244288148,neutral
2021-05-07 10:05:00.000,1194.9,1241.0,1190.0,1197.0,6624809.0,Lupin shares gain 2.67% as Sensex rises,"A total of 71,592 shares changed hands on the counter till 10:05AM (IST)",positive,neutral,0.1757469244288148,neutral,-0.5695687550854354,neutral
2021-05-09 10:22:00.000,1229.0,1241.55,1205.5,1222.0,4864851.0,"Q4 earnings, vaccination among key factors that may guide market this week","Among Nifty stocks, Asian Paints, Lupin, UPL, Vedanta, Cipla, Dr Reddy’s Laboratories, and Larsen & Toubro will announce numbers this week.",neutral,neutral,-0.5695687550854354,neutral,-1.6312812525616929,negative
2021-05-09 17:51:00.000,1229.0,1241.55,1205.5,1222.0,4864851.0,Ahead of Market: 12 things that will decide stock action on Monday,"BSE, Happiest Minds, KSB, Lupin, Marico, UTI AMC, Wipro, NALCO, Hindustan Copper and NMDC witnessed strong buying interest from market participants as they scaled their fresh 52-week highs on Friday, signalling bullish sentiment.",neutral,positive,-0.5695687550854354,neutral,-1.6312812525616929,negative
2021-05-10 09:09:15.000,1229.0,1241.55,1205.5,1222.0,4864851.0,"COVID-19 Treatment: Eli Lilly Partners With Cipla, Lupin, Sun Pharma To Manufacture, Distribute Baricitinib In India",Eli Lilly said it iwa also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses.,neutral,positive,-0.5695687550854354,neutral,-1.6312812525616929,negative
2021-05-10 10:06:00.000,1229.0,1241.55,1205.5,1222.0,4864851.0,"Cipla, Lupin, Sun Pharma to make, sell low-cost versions of Lilly’s COVID-19 drug",Lilly said the company is also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses. These voluntary licensing agreements will ensure high quality manufacturing and accessibility of Baricitinib,neutral,positive,-0.5695687550854354,neutral,-1.6312812525616929,negative
2021-05-10 10:21:00.000,1229.0,1241.55,1205.5,1222.0,4864851.0,Lupin shares gain 2.55% as Sensex rises,"A total of 89,828 shares changed hands on the counter till 10:21AM (IST)",positive,neutral,-0.5695687550854354,neutral,-1.6312812525616929,negative
2021-05-10 10:36:00.000,1229.0,1241.55,1205.5,1222.0,4864851.0,Lupin enters into a license agreement with Eli Lilly for manufacturing Baricitinib in India to treat Covid,"Lilly has received permission from Central Drugs Standard Control Organization (CDSCO), Ministry of Health, for restricted emergency use of Baricitinib.",positive,neutral,-0.5695687550854354,neutral,-1.6312812525616929,negative
2021-05-10 12:14:00.000,1219.9,1246.8,1193.0,1200.0,3808418.0,Irish drug regulator clears Lupin Pune unit after virtual inspection,Lupins Pune facility is known for its R&D and manufacturing work related to biosimilars.,neutral,neutral,-1.6312812525616929,negative,-0.1608977268039148,neutral
2021-05-10 13:09:00.000,1219.9,1246.8,1193.0,1200.0,3808418.0,Lupin enters into licensing agreement with Eli Lilly,For manufacture and sale of Baricitinib in India,positive,neutral,-1.6312812525616929,negative,-0.1608977268039148,neutral
2021-05-10 14:16:27.000,1219.9,1246.8,1193.0,1200.0,3808418.0,"Lilly signs agreements with Cipla, Lupin and Sun Pharma for Baricitinib",US pharma also in discussions with other Indian manufacturers to grant additional licences,positive,positive,-1.6312812525616929,negative,-0.1608977268039148,neutral
2021-05-10 16:14:02.000,1219.9,1246.8,1193.0,1200.0,3808418.0,Lilly issues voluntary licences to firms to speed up availability of baricitinib,"The royalty-free, non-exclusive voluntary licences have been issued to Cipla, Lupin and Sun Pharmaceutical Industries Ltd",neutral,neutral,-1.6312812525616929,negative,-0.1608977268039148,neutral
2021-05-11 00:53:00.000,1219.9,1246.8,1193.0,1200.0,3808418.0,"Eli Lilly signs licensing pact with Cipla, Sun, Lupin for Covid-19 drug","Olumiant, or Baricitinib, is an oral drug developed by US biopharmaceutical major, Incyte Corporation, and licensed to Eli Lilly",positive,neutral,-1.6312812525616929,negative,-0.1608977268039148,neutral
2021-05-11 07:00:32.000,1219.9,1246.8,1193.0,1200.0,3808418.0,"Cipla, Lupin, Sun Pharma sign deals to make Lilly’s Covid drug","These voluntary licensing pacts will ensure high-quality manufacturing and accessibility of baricitinib during the pandemic, improving the local treatment options available to those battling by the deadly infection, the company said in a statement.",positive,positive,-1.6312812525616929,negative,-0.1608977268039148,neutral
2021-05-11 07:34:00.000,1219.9,1246.8,1193.0,1200.0,3808418.0,"Nifty Pharma pares early gains, index dips nearly 1%; Aurobindo, Divis Lab, Lupin drag","The index pulled back from its record high gains of 14,282.90 witnessed in the early deals.",neutral,positive,-1.6312812525616929,negative,-0.1608977268039148,neutral
2021-05-11 07:47:00.000,1219.9,1246.8,1193.0,1200.0,3808418.0,"Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in India","As the threat of compulsory licence (CL) looms over big pharma in India, companies are rushing in to sign voluntary licensing agreements that might potentially help them stave off demands for compulsory licence from activists, and questions from courts.",positive,neutral,-1.6312812525616929,negative,-0.1608977268039148,neutral
2021-05-11 10:30:15.000,1219.9,1246.8,1193.0,1200.0,3808418.0,This Rakesh Jhunjhunwala portfolio stock delivers near 17.5% return in a week,Rakesh Jhunjhunwala maintained his 1.6 per cent stake in Lupin in March 2021 quarter,positive,neutral,-1.6312812525616929,negative,-0.1608977268039148,neutral
2021-05-11 10:57:00.000,1219.9,1246.8,1193.0,1200.0,3808418.0,Lupin share price down 0.07 per cent,"A total of 124,487 shares changed hands on the counter till 10:57AM (IST).",negative,neutral,-1.6312812525616929,negative,-0.1608977268039148,neutral
2021-05-11 12:47:00.000,1211.95,1226.6,1193.4,1210.0,3602276.0,Sun Pharma share hits new 52-week high after firm wins licence to make Covid-19 drug,"The three Indian drugmakers - Cipla Ltd, Lupin Ltd, and Sun Pharma will collaborate with Lilly to manufacture and distribute Baricitinib in India. The drug is approved by the Central Drugs Standard Control Organization (CDSCO) for restricted emergency use in India",positive,positive,-0.1608977268039148,neutral,-2.772727272727269,negative
2021-05-12 07:56:00.000,1211.95,1226.6,1193.4,1210.0,3602276.0,"Market Ahead Podcast, May 12: Top factors that could guide markets today","A total of 36 companies are slated to post their March quarter numbers today, including Asian Paints, UPL, Pidilite Industries, Lupin, Tata Power and Voltas",neutral,neutral,-0.1608977268039148,neutral,-2.772727272727269,negative
2021-05-12 08:09:33.000,1211.95,1226.6,1193.4,1210.0,3602276.0,"Stocks to Watch: M&M, Dr Reddy’s, Godrej Consumer, Infosys, Asian Paints, UPL","UPL and Asian Paints are the Nifty companies that will declare their March quarter earnings on Wednesday. Other companies which will report earnings include Pidilite Industries, Apollo Tyres, Tata Power, Jindal Steel & Power, Birla Corporation, Happiest Minds Technologies, and Lupin",neutral,neutral,-0.1608977268039148,neutral,-2.772727272727269,negative
2021-05-12 08:36:25.000,1211.95,1226.6,1193.4,1210.0,3602276.0,"RIL, Bharti Airtel, Vodafone Idea, Yes Bank, Asian Paints, Lupin, Infosys, Dr Reddy’s stocks in focus","Nifty futures were trading 46.55 points or 0.31 per cent down at 14,828 on Singaporean Exchange, suggesting a negative opening for BSE Sensex and Nifty 50",neutral,negative,-0.1608977268039148,neutral,-2.772727272727269,negative
2021-05-12 09:17:00.000,1211.95,1226.6,1193.4,1210.0,3602276.0,"Stocks in the news: Asian Paints, Dr Reddy’s Labs, GCPL, Lupin and UPL","Happiest Minds, Apollo Tyres, Birla Corp, Prince Pipes and Fittings, Sonata Softwares, Orient Electric, Borosil Renewables and Saregama India are among companies that will announce their March quarter results today.",neutral,neutral,-0.1608977268039148,neutral,-2.772727272727269,negative
2021-05-12 13:00:00.000,1211.95,1226.6,1193.4,1210.0,3602276.0,"Top stocks in focus: Dr. Reddy’s, TCS, Infosys, Kalpataru Power, Asian Paints, Lupin",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.1608977268039148,neutral,-2.772727272727269,negative
2021-05-12 16:55:00.000,1211.95,1226.6,1193.4,1210.0,3602276.0,"Nifty Pharma holds steady amid fragile markets; Cadila, Torrent Pharma, Lupin lift the performance",Cadila Healthcare was the top bull surging by 3.5% at Rs651.80 per piece.,positive,positive,-0.1608977268039148,neutral,-2.772727272727269,negative
2021-05-13 08:15:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,Lupin consolidated net profit rises 18.15% in the March 2021 quarter,Sales decline 0.84% to Rs 3759.27 crore,positive,negative,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-13 09:25:21.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"Eli Lilly Gives Out Licences For COVID-19 Drug Baricitinib To Dr Reddy’s, Torrent Pharma And MSN Labs","Lilly has so far given six licenses for Baricitinib in India. On May 10, the American pharma company signed agreements with Cipla, Lupin and Sun Pharmaceutical Industries.",neutral,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-13 10:30:53.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"Lupin Q4 Net Profit Grows 18.2% Led By Cost Optimisation, India Sales Growth","The company reported a net profit of Rs 460.4 crore in the quarter-ended March 31, but the revenue dropped by 1.6 percent YoY to Rs 3,783 crore",neutral,negative,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-13 11:58:07.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"SBI, Lupin, Bharti Airtel, ACC Among Axis Securities’ Top Picks For 14-34% Upside","Overall, the market can correct but it will be an opportunity to accumulate quality stocks for long-term returns, Axis Securities has said.",neutral,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-13 12:56:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr","Drug maker Lupin on Thursday reported an 18 per cent increase in its consolidated net profit at Rs 460 crore for the fourth quarter, driven by robust sales across domestic and international markets",positive,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-13 13:02:44.000,1210.0,1233.8,1166.0,1176.45,5382016.0,Lupin Q4 net rises 18% at ₹460 cr,"FY21 net profit at ₹1,216 crore, compared to a net loss of ₹269 crore in the previous year",positive,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-13 13:05:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"Lupin back in the black in FY20, reports Rs 1,216-crore profit","On a quarterly basis, net profit rose 18.15% in last quarter to Rs 460 crore against Rs 389 crore in the corresponding period of previous fiscal",neutral,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-13 13:14:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,Lupin willing to take partners to bring mRNA Covid-19 vaccines to India,Executive says company is looking for tie-ups to bring in drugs like Remdesivir,neutral,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-13 13:40:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"Lupin Q4 results: Net profit increases by 18% at Rs 460 crore; FY21 profit at Rs 1,216 crore","The company’s total income from operations however declined to Rs 3,783 crore during the fourth quarter, as compared to Rs 3,846 crore in the corresponding period of FY20, Lupin Ltd said in a statement.",positive,negative,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-13 14:08:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,Lupin Q4 PAT grows 19% to Rs 464 cr,"The drug major’s consolidated net profit jumped 18.7% to Rs 464.37 crore on 0.8% fall in net sales to Rs 3,759.27 crore in Q4 March 2021 over Q4 March 2020.",positive,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-13 14:47:45.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"Lupin Aims To Bring COVID-19 Drugs, Jabs; Approaches Gilead For Remdesivir","Lupin aims to be actively involved in prevention and treatment of COVID-19, changing its strategy of being relatively less active during the first wave of the pandemic last year.",neutral,neutral,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-13 17:11:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"COVID: Lupin looks to tie-up with global companies, ramp up production","There are new products from Merck and Pfizer for COVID-19 management and it would be Lupin’s intention to be in the first wave of all these products as they hit the market, Lupin said.",positive,neutral,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 01:10:43.000,1210.0,1233.8,1166.0,1176.45,5382016.0,Margin improvement offsets weak sales for Lupin in March quarter,Lupin has seen sharp gains of more than 13% in May and is trading at about 31 times FY22 earnings estimates,positive,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 08:17:06.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"L&T, Cipla, Lupin, Dr Reddy’s, Vedanta, GAIL, Tata Power, Reliance Infrastructure stocks in focus","Nifty futures were trading 191.50 points or 1.32 per cent higher at 14,699 on Singaporean Exchange, indicating a strong opening for BSE Sensex and Nifty 50",neutral,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 09:11:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"Stocks in news: Apollo Tyres, Lupin, Asian Paints, Vedanta and more","Stocks to watch today: Apollo Tyres, Lupin, Asian Paints,Vedanta, Shriram City Union Finance, Tata Power, Infosys, Lupin, Polycab India and more",neutral,neutral,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 09:32:47.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"What Should Investors Do With Lupin Post Q2 Result: Buy, Sell Or Hold?","The drugmaker reported an 18.2 percent year-on-year growth in net profit (profit after tax) at Rs 460.4 crore in the quarter ended March 31, 2021.",neutral,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 11:03:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"Neutral on Lupin, target price Rs 1320: Motilal Oswal","Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 54321.39 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 11:16:19.000,1210.0,1233.8,1166.0,1176.45,5382016.0,Lupin: Focus On Inhalation And Bio-similars To Aid Margins In Medium Term,"In the medium term, the focus is likely to be on the inhalation and biosimilar categories for Lupin, with scale-up in both US and European markets",neutral,neutral,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 11:37:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,Lupin shares slide 4% amid profit booking post March quarter results,"During the past six trading days, Lupin outperformed the market and surged 15 per cent as compared to a per cent rise in the S&P BSE Sensex till Wednesday",negative,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 11:37:29.000,1210.0,1233.8,1166.0,1176.45,5382016.0,Keen to bring in mRNA products: Lupin MD,"There are about half a dozen mRNA vaccines that are in a meaningful stage of development, says Nilesh Gupta",neutral,neutral,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 12:33:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,"Lupin share falls 3% post Q4 earnings, here’s what brokerages say","Share of Lupin fell up to 3.7% to Rs 1165.95 against previous close of Rs 1,210 on BSE",neutral,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 12:58:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,Share price of Lupin falls as Nifty weakens,"A total of 205,773 shares changed hands on the counter till 12:58PM (IST).",neutral,neutral,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 16:30:00.000,1210.0,1233.8,1166.0,1176.45,5382016.0,Lupin records 18% yoy growth in Q4 PAT to Rs460cr,"For the financial year FY21, the company’s profit was at Rs1,216.5cr compared to a loss of Rs269.4cr of FY20.",positive,positive,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-14 16:50:18.000,1210.0,1233.8,1166.0,1176.45,5382016.0,Lupin Q4 Review - Medium Term Triggers Adequately Priced: Motilal Oswal,Lupin Q4 Review - Medium Term Triggers Adequately Priced: Motilal Oswal,neutral,neutral,-2.772727272727269,negative,-0.4983249581239569,neutral
2021-05-16 00:21:19.000,1194.0,1194.0,1170.0,1188.05,2604211.0,Why short strangle may be the ideal strategy for Lupin this week,"As wild swings can result in heavy losses, conservative traders can stay away",neutral,negative,-0.4983249581239569,neutral,-0.7525083612040134,neutral
2021-05-16 23:01:12.000,1194.0,1194.0,1170.0,1188.05,2604211.0,"Lupin eyes deals with foreign players for covid drugs, jabs","Lupin Ltd is working on acquiring licences and partnerships for various covid-19 drugs and vaccines, chief executive officer Vinita Gupta said, after the drug maker missed out on launching drugs in the first wave of the coronavirus pandemic",neutral,positive,-0.4983249581239569,neutral,-0.7525083612040134,neutral
2021-05-17 02:51:06.000,1194.0,1194.0,1170.0,1188.05,2604211.0,Lupin eyes deals with foreign players,"The company is also exploring partnerships with Pfizer and Moderna for their covid-19 vaccines, Gupta said, though it is not close to any agreements in this respect yet.",neutral,neutral,-0.4983249581239569,neutral,-0.7525083612040134,neutral
2021-05-17 12:33:00.000,1196.0,1201.0,1182.05,1187.0,1886185.0,"Eli Lilly buckles under pressure, offers voluntary licence to Natco Pharma","Lily has issued voluntary licenses for Barcitinib to six Indian drug makers besides Natco, these include- Sun Pharma, Cipla, Dr Reddy’s, Lupin, Torrent Pharma and MSN Labs. Barcitinib, in combination with Remdesivir, received emergency approval last year from the USFDA for treatment of hospitalized …",positive,positive,-0.7525083612040134,neutral,1.466509790738702,positive
2021-05-17 15:22:12.000,1196.0,1201.0,1182.05,1187.0,1886185.0,Eli Lilly in pact with Natco Pharma for Baricitinib drug used to treat Covid 19,"It also has licence agreements with Cipla, Lupin, Sun Pharma, Dr. Reddy’s, MSN Laboratories and Torrent Pharma for the drug",positive,positive,-0.7525083612040134,neutral,1.466509790738702,positive
2021-05-18 11:29:00.000,1196.0,1201.0,1182.05,1187.0,1886185.0,"Add Lupin, target price Rs 1275: Centrum Broking","Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 54035.57 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.7525083612040134,neutral,1.466509790738702,positive
2021-05-18 13:47:00.000,1189.9,1219.35,1185.5,1207.35,2942002.0,Lupin shares down 0.04% as Nifty gains,"A total of 45,385 shares changed hands on the counter till 01:47PM (IST).",negative,neutral,1.466509790738702,positive,-0.7144616900714499,neutral
2021-05-19 18:25:00.000,1217.7,1220.0,1197.45,1209.0,1834084.0,Nifty Pharma stocks outperform; Torrent Pharma leads gain on earnings,"Lupin, Cadila, Cipla and Sun Pharma also gained around 1.5% to lift the performance of the sector.",positive,positive,-0.7144616900714499,neutral,0.3634561374525104,neutral
2021-05-20 10:31:00.000,1217.7,1220.0,1197.45,1209.0,1834084.0,Share price of Lupin jumps as Sensex gains 22.51 points,"A total of 40,786 shares changed hands on the counter till 10:31AM (IST)",positive,neutral,-0.7144616900714499,neutral,0.3634561374525104,neutral
2021-05-21 12:20:00.000,1210.6,1217.9,1205.5,1215.0,1246450.0,Lupin shares gain 0.29% as Sensex rises,"A total of 48,484 shares changed hands on the counter till 12:19PM (IST)",positive,neutral,0.3634561374525104,neutral,-0.9509303474394826,negative
2021-05-21 17:00:00.000,1210.6,1217.9,1205.5,1215.0,1246450.0,"Nifty Pharma witness modest gains; Divi’s Labs top bull; Sun Pharma, Lupin lift sentiments","Divis Labs performed as top bull surging by 1.35% at Rs4,095.20 per piece.",positive,positive,0.3634561374525104,neutral,-0.9509303474394826,negative
2021-05-24 10:41:00.000,1214.6,1237.6,1195.6,1203.05,3050780.0,Lupin share price down 0.05 per cent,"A total of 85,886 shares changed hands on the counter till 10:41AM (IST).",negative,neutral,-0.9509303474394826,negative,0.0247995370753041,neutral
2021-05-25 16:43:00.000,1218.6,1219.35,1193.3,1195.95,1184129.0,"Lupin allots 42,494 equity shares under ESOP","In view of the above, the issued and paid-up capital of the Company has been increased to Rs 90,75,41,808 consisting 45,37,70,904 equity shares of Rs 2/- each.",neutral,neutral,-1.8586903003446469,negative,-0.1079823905640154,neutral
2021-05-26 07:45:00.000,1218.6,1219.35,1193.3,1195.95,1184129.0,Nifty Pharma gains momentum in trade; Sun Pharma and Cipla lead gains,"Lupin, Torrent Pharma, and DR Reddy’s were under pressure.",positive,neutral,-1.8586903003446469,negative,-0.1079823905640154,neutral
2021-05-26 12:04:00.000,1203.9,1206.95,1188.0,1202.6,2724801.0,Share price of Lupin falls as Nifty strengthens,"A total of 27,980 shares changed hands on the counter till 12:04PM (IST).",positive,neutral,-0.1079823905640154,neutral,0.2617692275730329,neutral
2021-05-27 11:32:00.000,1203.9,1206.95,1188.0,1202.6,2724801.0,Lupin receives USD 50 mn for key milestone in development of oncology compound,"As part of the agreement, Lupin has received payment of USD 50 million from Boehringer Ingelheim for achievement of key milestones.",positive,positive,-0.1079823905640154,neutral,0.2617692275730329,neutral
2021-05-27 11:48:26.000,1203.9,1206.95,1188.0,1202.6,2724801.0,Lupin Gets $50 Million From Boehringer Ingelheim As ‘milestone Payment’ For Anti-cancer Drug,"Lupin and Boehringer Ingelheim inked a licensing, development and commercialisation agreement in 2019 for the Indain company’s novel oncology compound for difficult-to-treat cancers.",neutral,positive,-0.1079823905640154,neutral,0.2617692275730329,neutral
2021-05-27 11:50:00.000,1203.9,1206.95,1188.0,1202.6,2724801.0,Lupin receives $50 million from Boehringer Ingelheim for achievement of key milestones,In a regulatory filing Lupin announced “the achievement of key milestones for Lupin’s MEK inhibitor compound (LNP3794) that is planned for development by Boehringer Ingelheim in combination as potential targeted therapy for patients with difficult-to-treat cancers.”,neutral,positive,-0.1079823905640154,neutral,0.2617692275730329,neutral
2021-05-27 12:51:00.000,1203.35,1211.7,1190.55,1206.5,1126335.0,Lupin shares up 0.45% as Nifty gains,"A total of 41,453 shares changed hands on the counter till 12:51PM (IST).",positive,neutral,0.2617692275730329,neutral,0.8609271523178884,neutral
2021-05-27 16:03:00.000,1203.35,1211.7,1190.55,1206.5,1126335.0,"Lupin board grants 42,494 equity shares under ESOP","Lupin board grants 42,494 equity shares under ESOP.",neutral,neutral,0.2617692275730329,neutral,0.8609271523178884,neutral
2021-05-27 16:36:00.000,1203.35,1211.7,1190.55,1206.5,1126335.0,Lupin announces achievement of key milestones for its Clinical Stage MEK Inhibitor Compound,"As part of the agreement, Lupin has received payment of USD 50 million from Boehringer Ingelheim for the achievement of key milestones.",positive,positive,0.2617692275730329,neutral,0.8609271523178884,neutral
2021-05-28 13:33:00.000,1203.35,1211.7,1190.55,1206.5,1126335.0,Lupin shares gain 0.05% as Sensex rises,"A total of 35,198 shares changed hands on the counter till 01:33PM (IST)",positive,neutral,0.2617692275730329,neutral,0.8609271523178884,neutral
2021-06-01 13:42:00.000,1211.8,1267.65,1211.0,1241.3,7157358.0,Lupin share price down 0.89 per cent,"A total of 42,581 shares changed hands on the counter till 01:42PM (IST).",negative,neutral,2.434395114705397,positive,-1.7810893732318531,negative
2021-06-02 10:00:00.000,1211.8,1267.65,1211.0,1241.3,7157358.0,Lupin shares up 2.58% as Nifty drops,"A total of 73,205 shares changed hands on the counter till 10:00AM (IST).",positive,neutral,2.434395114705397,positive,-1.7810893732318531,negative
2021-06-02 10:44:00.000,1211.8,1267.65,1211.0,1241.3,7157358.0,Lupin ends 3% higher on receiving USFDA nod for Pegfilgrastim Biosimilar application,Pegfilgrastim has estimated annual sales of USD 3.66 billion in the U.S. (IQVIA MAT December 2020).,positive,neutral,2.434395114705397,positive,-1.7810893732318531,negative
2021-06-02 11:32:00.000,1211.8,1267.65,1211.0,1241.3,7157358.0,This Rakesh Jhunjhunwala-owned pharma stock hits over 4-year high,"Lupin rose 4 per cent to Rs 1,258.70 on the BSE in intra-day trade on Wednesday, a level that was last seen in May 2017",positive,positive,2.434395114705397,positive,-1.7810893732318531,negative
2021-06-02 14:17:03.000,1254.85,1254.85,1226.5,1232.5,1717235.0,Rakesh Jhunjhunwala-owned drug stock hits new 52-week high; charts show it may rally up to 20% more,"Rakesh Jhunjhunwala-owned Lupin share price surged as high as 4.7 per cent to Rs 1,266.35 apiece in intraday deals on BSE, in an otherwise weak market.",positive,positive,-1.7810893732318531,negative,-0.9408926417370362,negative
2021-06-02 14:41:00.000,1254.85,1254.85,1226.5,1232.5,1717235.0,Lupin jumps after USFDA accepts pegfilgrastim biosimilar application,"Lupin gained 3.66% to Rs 1,252.90 after the US drug regulator accepted the company’s Biologics License Application (BLA) for its proposed biosimilar to Neulasta (pegfilgrastim) through a filing using the 351(k) pathway.",neutral,positive,-1.7810893732318531,negative,-0.9408926417370362,negative
2021-06-02 16:45:00.000,1254.85,1254.85,1226.5,1232.5,1717235.0,"Nifty Pharma witness modest gains; Lupin emerges top bull; Cadila, Divi’s Lab lift sentiments","Lupin performed as top bull surging by 2.38% at Rs1,238 per piece.",positive,positive,-1.7810893732318531,negative,-0.9408926417370362,negative
2021-06-02 17:49:00.000,1254.85,1254.85,1226.5,1232.5,1717235.0,Lupin announces USFDA acceptance for a biosimilar application,"The pegfilgrastim filing is the company’s first biosimilar filing in the US and is a milestone in the drug maker’s research and innovation journey, Lupin MD Nilesh Gupta noted.",positive,positive,-1.7810893732318531,negative,-0.9408926417370362,negative
2021-06-02 18:03:00.000,1254.85,1254.85,1226.5,1232.5,1717235.0,Rakesh Jhunjhunwala’s pharma bet hits new 52-week high; Should you buy?,"According to the shareholding pattern for March 2021, Rakesh Jhunjhunwala held 1.6 per cent stake or 72,45,605 Lupin shares at the end of Q4",positive,neutral,-1.7810893732318531,negative,-0.9408926417370362,negative
2021-06-03 08:22:01.000,1254.85,1254.85,1226.5,1232.5,1717235.0,Indian equities likely to outperform global peers,"RIL, Sun Pharma, Lupin, Tata Power, Rossari to remain in focus",positive,neutral,-1.7810893732318531,negative,-0.9408926417370362,negative
2021-06-03 10:31:06.000,1254.85,1254.85,1226.5,1232.5,1717235.0,Rakesh Jhunjhunwala portfolio company enters into digital healthcare business,"The company recently incorporated a new entity in the name of Lupin Digital Health Limited, as a wholly owned subsidiary, which will undertake this.",neutral,neutral,-1.7810893732318531,negative,-0.9408926417370362,negative
2021-06-03 10:55:00.000,1254.85,1254.85,1226.5,1232.5,1717235.0,Lupin incorporates Lupin Digital Health for foray into digital healthcare,"The Company recently incorporated a new entity in the name of Lupin Digital Health, as a wholly owned subsidiary, which will undertake this.",neutral,neutral,-1.7810893732318531,negative,-0.9408926417370362,negative
2021-06-03 11:36:00.000,1254.85,1254.85,1226.5,1232.5,1717235.0,Lupin to enter digital healthcare space; to provide platform for doctors,Lupin said it will enter the digital healthcare space in India with a focus to provide a digital therapeutics platform for doctors and patients.,neutral,neutral,-1.7810893732318531,negative,-0.9408926417370362,negative
2021-06-03 12:06:10.000,1243.5,1244.0,1223.0,1231.8,1495872.0,Lupin to enter digital healthcare space in India,Drug major Lupin on Thursday said it will enter the digital healthcare space in India with a focus to provide a digital therapeutics platform for doctors and patients. In a regulatory filing the compa,neutral,positive,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-03 13:18:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,Lupin to enter digital healthcare space,The board of the drug major has approved foraying into the digital healthcare space with a focus to provide a digital therapeutics platform for doctors and patients in India.,neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-03 16:28:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,Lupin announces entry into digital healthcare space; Stock trades flat,The entry will provide a digital therapeutics platform for doctors and patients in India.,neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-03 16:46:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,"Nifty Pharma shines amid positive markets; Heavyweights Alkem Labs, Torrent Pharma drive sectoral gains; Lupin drags",Zydus Cadila receives tentative approval from USFDA to market Osimertinib Tablets used to treat lung cancer.,positive,positive,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 07:28:20.000,1243.5,1244.0,1223.0,1231.8,1495872.0,"Stocks To Watch: Bharat Forge, Lupin, MOIL, M&M, NIIT, Nilkamal, Quess Corp",Here are the stocks to watch in trade today...,neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 08:27:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,"Stocks to watch: M&M, PNB, Bharat Forge, Lupin, rate sensitive stocks",ABB Power Products on Thursday said it has resumed operations at its manufacturing facility in Bengaluru from May 28,neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 08:27:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,"Stocks in focus: Bharat Forge, Gujarat state Petronet, M&M, Lupin, HFCL, Britannia, Tata Motors and more",Here are the top stocks that are likely to be in focus in today’s trading.,neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 08:27:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,"Stocks in focus: Bharat Forge, Gujarat state Petronet, M&M, Lupin, HFCL, Britannia, Tata Motors and more",Here are the top stocks that are likely to be in focus in today’s trading.,neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 08:30:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,Lupin launches authorized generic version of Brovana in the US,"Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL, is indicated for the long-term, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients.",neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 08:31:09.000,1243.5,1244.0,1223.0,1231.8,1495872.0,"Stocks to Watch: IDBI Bank, Lupin, Tata motors, SBI, Snowman Logistics","Punjab National Bank, Bharat Forge, Bank of India, NIIT and Jammu Kashmir Bank key companies which will announce their March quarter results today",neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 08:39:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,"Bharti Airtel, M&M, Lupin in focus","Bharti Airtel informed that ICRA has reaffirmed [ICRA]AA- (Stable) issuer rating of the company. However, since the company, presently has no instrument rated under this rating, ICRA has withdrawn this rating at company’s request.",neutral,positive,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 08:44:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,Lupin launches authorized generic version of Brovana in US,"Lupin announced the launch of the authorized generic version of Brovana (arformoterol tartrate) Inhalation Solution 15 mcgꝉ/2 mL, unit-dose vials, of Sunovion Pharmaceuticals Inc.",neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 08:48:08.000,1243.5,1244.0,1223.0,1231.8,1495872.0,Market may open flat ahead of RBI policy announcements,"Stocks to watch out for today: Standard Industries, Lupin, KP Energy, Confidence Petroleum, and Cadila Healthcare",neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 09:55:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,"Neutral on Lupin, target price Rs 1320: Motilal Oswal","Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 55707.38 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 12:21:46.000,1243.5,1244.0,1223.0,1231.8,1495872.0,Lupin launches generic inhalation product in US market,The drug is to be used by nebulisation only,positive,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 12:28:53.000,1243.5,1244.0,1223.0,1231.8,1495872.0,Lupin Launches Generic Inhalation Product In US Market,"Arformoterol Tartrate inhalation solution is indicated for the long-term treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.",neutral,positive,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 12:55:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,"Top stocks in focus: Bharti Airtel, Lupin, M&M, DCB Bank, Cupid",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-04 16:45:00.000,1243.5,1244.0,1223.0,1231.8,1495872.0,"Nifty Pharma holds steady post RBI policy; Cadila, Torrent Pharma, Lupin add to gains","In last 24 hours, India recorded 1.30 lakh fresh covid cases and 2,713 deaths.",positive,negative,-0.9408926417370362,negative,0.2394577702017164,neutral
2021-06-07 10:15:00.000,1231.95,1237.7,1223.15,1234.9,1036910.0,Lupin receives USFDA approval to market generic HIV drug,"The product will be manufactured at Lupin’s facility in Nagpur, India.",positive,neutral,0.2394577702017164,neutral,0.2510324722649533,neutral
2021-06-07 11:00:00.000,1231.95,1237.7,1223.15,1234.9,1036910.0,Lupin launches Digital Asthma Educator platform,"According to estimates, India has nearly 35 million people living with asthma, including children. While there is no cure for Asthma, it is manageable with proper treatment, vigilance, drug adherence and regular medical checks, thus enabling",neutral,neutral,0.2394577702017164,neutral,0.2510324722649533,neutral
2021-06-07 11:35:00.000,1231.95,1237.7,1223.15,1234.9,1036910.0,Lupin launches Digital Asthma Educator platform under its 'Joint Airways Initiative',The platform guides asthma patients on the correct technique of using inhalers.,neutral,neutral,0.2394577702017164,neutral,0.2510324722649533,neutral
2021-06-07 11:53:34.000,1231.95,1237.7,1223.15,1234.9,1036910.0,Lupin launches digital asthma educator platform,Drug major Lupin on Monday announced the launch of its digital asthma educator platform to guide patients on the correct technique of using inhalers. The new platform is the latest initiative under Lu,neutral,neutral,0.2394577702017164,neutral,0.2510324722649533,neutral
2021-06-07 11:59:36.000,1231.95,1237.7,1223.15,1234.9,1036910.0,Lupin Launches Digital Asthma Educator Platform,"The new platform is the latest initiative under Lupin″s long running umbrella programme, Joint Airways Initiative (JAI), for patients suffering from respiratory ailments.",neutral,neutral,0.2394577702017164,neutral,0.2510324722649533,neutral
2021-06-07 14:28:00.000,1234.9,1242.7,1218.4,1238.0,1032367.0,Lupin receives USFDA final approval for Emtricitabine and Tenofovir Disoproxil,"Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg, are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. It is also used for for pre-exposure prophylaxis (PrEP) to reduce the risk",positive,positive,0.2510324722649533,neutral,-1.317704122877927,negative
2021-06-07 15:54:00.000,1234.9,1242.7,1218.4,1238.0,1032367.0,Lupin gets USFDA nod to market generic HIV drug,"The company has received approval from the United States Food and Drug Administration (USFDA) to market its Emtricitabine and Tenofovir Disoproxil Fumarate tablets, 200 mg/300 mg, Lupin said in a regulatory filing.",neutral,positive,0.2510324722649533,neutral,-1.317704122877927,negative
2021-06-07 16:51:00.000,1234.9,1242.7,1218.4,1238.0,1032367.0,Drug firm Lupin gets US FDA approval to market generic HIV drug,The product will be manufactured at the company’s facility in Nagpur,positive,neutral,0.2510324722649533,neutral,-1.317704122877927,negative
2021-06-08 08:11:46.000,1234.9,1242.7,1218.4,1238.0,1032367.0,"Stocks to Watch: Central Bank of India, DHFL, ICICI Pru Life, L&T, Lupin","InterGlobe Aviation Ltd eyes a ₹4,500 crore fundraise by securing credit lines from lenders and entering into sale and leaseback (SLB) arrangement for new aircrafts",neutral,neutral,0.2510324722649533,neutral,-1.317704122877927,negative
2021-06-08 12:36:00.000,1237.0,1258.8,1214.3,1220.7,2214142.0,Lupin shares drop 0.41% as Sensex falls,"A total of 38,550 shares changed hands on the counter till 12:36PM (IST)",negative,neutral,-1.317704122877927,negative,0.3644553644553682,neutral
2021-06-08 16:50:00.000,1237.0,1258.8,1214.3,1220.7,2214142.0,"Nifty Pharma under pressure post vaccination drive announcements; Lupin, Dr Reddy’s top bears",Biocon and Torrent Pharma were only gainers to support the index.,neutral,neutral,-1.317704122877927,negative,0.3644553644553682,neutral
2021-06-10 10:14:00.000,1221.0,1243.0,1221.0,1225.45,1047188.0,"Tata Motors, Escorts and Lupin among 7 fundamental stock picks that are likely to beat the Street - Money making ideas","As the number of Covid cases come down and the economy starts reopening, economists have started talking about a U-shaped recovery from August. Of course, the market being forward looking, traders had started betting on the unlock theme while still being in the throes of Covid upsurge. Sectors under…",positive,neutral,0.3644553644553682,neutral,-0.0934959349593569,neutral
2021-06-10 11:08:00.000,1221.0,1243.0,1221.0,1225.45,1047188.0,Lupin shares rise 0.85% as Sensex climbs,"A total of 15,802 shares changed hands on the counter till 11:07AM (IST)",positive,neutral,0.3644553644553682,neutral,-0.0934959349593569,neutral
2021-06-10 17:54:00.000,1230.0,1239.9,1225.0,1228.85,1158622.0,"Nifty Pharma at fresh record highs with all stocks in green; Divis Lab, Cipla hit new 52-week high; Dr Reddy’s, Lupin, Cadila add to gains","India has reported 94,052 Daily New Cases in the last 24 hours. The country has recorded less than 1 lakh Daily New Cases for 3 continuous days now.",positive,neutral,-0.0934959349593569,neutral,0.4117647058823606,neutral
2021-06-11 13:14:00.000,1230.0,1239.9,1225.0,1228.85,1158622.0,Lupin shares rise 0.77 per cent in Friday’s trading session,The Relative Strength Index of the stock stood at 62.3 on Friday.,positive,neutral,-0.0934959349593569,neutral,0.4117647058823606,neutral
2021-06-13 14:32:02.000,1190.0,1205.5,1173.1,1194.9,2886886.0,Lupin Receives U.S. FDA Warning Letter for Somerset Facility,The Indian drugmaker said it received a warning letter from the U.S. FDA for the company’s Somerset facility in New Jersey.,neutral,negative,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-13 16:00:34.000,1190.0,1205.5,1173.1,1194.9,2886886.0,Lupin Gets USFDA’s Warning Letter For Its Somerset Facility In US,Lupin said in a statement to stock exchanges that it believed the letter won’t have any impact on supplies or existing revenues.,neutral,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-13 16:40:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,Lupin gets warning letter from USFDA for Somerset facility,"The United States Food and Drug Administration (USFDA) had inspected the company’s Somerset, New Jersey, facility from September 10, 2020, to November 5, 2020, Lupin said in a regulatory filing.",negative,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-13 16:58:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,Lupin gets warning letter from US health regulator for Somerset facility,"The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility, it said",negative,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-13 17:10:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,Lupin gets warning letter from US health regulator for its Somerset facility,"The United States Food and Drug Administration (USFDA) had inspected the company’s Somerset, New Jersey, facility from September 10, 2020, to November 5, 2020, Lupin said in a regulatory filing",negative,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 07:40:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,"Stocks in the news: Lupin, Ruchi Soya, Adani Total Gas, Coal India, Reliance Power and Sun TV",Leading exchanges BSE and NSE will suspend trading in the shares of Dewan Housing Finance Corporation Ltd (DHFL) with effect from Monday.,neutral,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 07:46:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,Lupin to address concerns raised by USFDA in warning letter for New Jersey facility,"The USFDA had inspected the Lupin Somerset site from September 10, 2020, to November 5, 2020.",neutral,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 08:13:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,"Nifty Pharma reverses bearish trend, holds steady; Torrent Pharma, Alkem, Divis Lab led the pack; Lupin tumbles",India continues to report a sustained slide in the daily new COVID cases.,positive,negative,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 08:22:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,"Stocks in focus: BHEL, DLF, JK Cement, Lupin, Religare Ent, Adani Total Gas, Coal India, Reliance Power and more","Nifty futures on Singapore Exchange traded 55 points, or 0.35 per cent lower at 15,768.00 signaling that Dalal Street was headed for a negative start on Monday. Here are a dozen stocks that may buzz the most in today’s trade:",neutral,negative,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 08:37:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,"Lupin donates oxygen plants to Maharashtra, MP, Gujarat",The respective State governments will oversee the distribution of the oxygen produced at these plants to Government hospitals and COVID care centres.,neutral,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 08:41:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,USFDA issues warning letter for Lupin’s Somerset facility,"Lupin said that the company has received a warning letter from the U.S. FDA for the company’s Somerset, New Jersey facility.",neutral,negative,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 09:06:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,"Stocks to watch: Adani group stocks, Reliance Power, Lupin, BHEL, DLF","Reliance Power Limited has announced it will raise Rs 1,325 crore by issuing preferential shares and warrants to its parent, Reliance Infrastructure",neutral,positive,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 10:15:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,"Neutral on Lupin, target price Rs 1320: Motilal Oswal","Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 54257.88 Crore) operating in Pharmaceuticals sector.",neutral,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 10:21:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit,Lupin said the company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility,neutral,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 10:42:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,Lupin-led UK subsidiary gets approval to launch Luforbec for asthma treatment,Luforbec 100/6 µg pMDI is indicated for regular treatment of asthma.,positive,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 11:15:00.000,1190.0,1205.5,1173.1,1194.9,2886886.0,Lupin receives USFDA warning letter for its Somerset site,The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility.,positive,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 11:18:39.000,1190.0,1205.5,1173.1,1194.9,2886886.0,Lupin gets warning letter from USFDA for Somerset facility; shares dip over 3%,"The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility, Lupin said.",negative,neutral,0.4117647058823606,neutral,-0.5156584077474607,neutral
2021-06-14 12:43:14.000,1192.65,1199.85,1183.1,1186.5,1217694.0,Lupin shares drop nearly 3% on USFDA warning letter for Somerset facility,"The regulator had inspected the Lupin Somerset site from September 10, 2020 to November 5, 2020",negative,neutral,-0.5156584077474607,neutral,-1.3361344537815203,negative
2021-06-14 13:00:00.000,1192.65,1199.85,1183.1,1186.5,1217694.0,"Top stocks in focus: Lupin, DLF, BHEL, Sun TV, Adani Enterprises, Coal India",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.5156584077474607,neutral,-1.3361344537815203,negative
2021-06-14 14:19:00.000,1192.65,1199.85,1183.1,1186.5,1217694.0,"Netflix launches online store to sell merchandise around Lupin, The Witcher, Stranger Things and other shows",Netflix has launched its e-commerce store in the US that will roll out to users in other countries soon.,neutral,neutral,-0.5156584077474607,neutral,-1.3361344537815203,negative
2021-06-14 14:57:38.000,1192.65,1199.85,1183.1,1186.5,1217694.0,USFDA warning letter to Lupin’s US facility,Lupin now has 5 sites under warning letters from the USFDA,negative,neutral,-0.5156584077474607,neutral,-1.3361344537815203,negative
2021-06-14 16:22:02.000,1192.65,1199.85,1183.1,1186.5,1217694.0,Lupin Gets UK Nod To Launch Generic Asthma Inhaler Drug Fostair,Respiratory diseases affect one in five people. It is the third biggest cause of death in the UK and is a clinical priority for the NHS.,neutral,neutral,-0.5156584077474607,neutral,-1.3361344537815203,negative
2021-06-15 13:37:00.000,1190.0,1193.2,1173.3,1174.1,936570.0,Lupin shares fall 0.21 per cent in Tuesday’s trading session,The Relative Strength Index of the stock stood at 48.67 on Tuesday.,negative,neutral,-1.3361344537815203,negative,-0.5977796754910333,neutral
2021-06-16 07:28:47.000,1190.0,1193.2,1173.3,1174.1,936570.0,"Buzzing Stocks: LIC Housing Finance, Lupin, Wipro And Other Stocks In News Today",Stocks In News: Check out the companies making the biggest headlines before the opening bell.,neutral,neutral,-1.3361344537815203,negative,-0.5977796754910333,neutral
2021-06-16 08:56:00.000,1190.0,1193.2,1173.3,1174.1,936570.0,"Stocks to watch: ICICI Bank, Dish TV, Adani Ports, Jubilant Pharmova, Lupin",Dr Reddy’s Laboratories (DRL) on Tuesday said it has been asked to pay $46.25 million to Australia-based Hatchtech Pty Ltd as part of an asset purchase agreement between the two parties in 2015,neutral,neutral,-1.3361344537815203,negative,-0.5977796754910333,neutral
2021-06-16 09:23:52.000,1190.0,1193.2,1173.3,1174.1,936570.0,"LIC Housing Finance, Wipro, Lupin: Top Stocks For Investors on June 16",Indian stock markets may open lower on Wednesday amid mixed global cues and investors await the interest rates decision to be announced by the US Federal Reserve.,neutral,negative,-1.3361344537815203,negative,-0.5977796754910333,neutral
2021-06-16 10:05:00.000,1190.0,1193.2,1173.3,1174.1,936570.0,LIC hikes stake in Lupin,Life Insurance Corporation of India (LIC) added 2.019% stake in Lupin via open market purchase between 16 March 2021 to 14 June 2021.,neutral,positive,-1.3361344537815203,negative,-0.5977796754910333,neutral
2021-06-16 11:23:00.000,1190.0,1193.2,1173.3,1174.1,936570.0,Share price of Lupin falls as Nifty weakens,"A total of 75,405 shares changed hands on the counter till 11:23AM (IST).",neutral,neutral,-1.3361344537815203,negative,-0.5977796754910333,neutral
2021-06-16 12:36:00.000,1171.0,1181.55,1153.0,1164.0,1284972.0,"Top stocks in focus: KEC International, Infosys, RITES, Lupin, Welspun Enterprises",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.5977796754910333,neutral,-0.6180257510729653,neutral
2021-06-17 10:40:00.000,1171.0,1181.55,1153.0,1164.0,1284972.0,Lupin receives USFDA nod to market Sevelamer Hydrochloride Tablets,"The product will be manufactured at Lupin’s facility in Nagpur, India.",neutral,neutral,-0.5977796754910333,neutral,-0.6180257510729653,neutral
2021-06-17 11:10:14.000,1171.0,1181.55,1153.0,1164.0,1284972.0,Lupin - U.S.FDA Warning Letter For Somerset Facility Will Not Disrupt Supplies Or Revenues: Centrum Broking,Lupin - U.S.FDA Warning Letter For Somerset Facility Will Not Disrupt Its Supplies Or Impact Revenues: Centrum,neutral,neutral,-0.5977796754910333,neutral,-0.6180257510729653,neutral
2021-06-17 11:28:00.000,1171.0,1181.55,1153.0,1164.0,1284972.0,Lupin shares gain 0.07% as Sensex falls,"On the technical charts, the RSI of the stock stood at 45.38.",positive,neutral,-0.5977796754910333,neutral,-0.6180257510729653,neutral
2021-06-17 14:28:00.000,1165.0,1172.9,1141.1,1157.8,1377823.0,Lupin gets USFDA approval for sevelamer hydrochloride tablets,The drug major on Thursday announced that it has received US drug regulator’s approval to market sevelamer hydrochloride tablets.,positive,positive,-0.6180257510729653,neutral,0.6652173913043558,neutral
2021-06-17 15:53:53.000,1165.0,1172.9,1141.1,1157.8,1377823.0,Lupin gets USFDA nod for Sevelamer tablets used for treatment of kidney disease,Sevelamer Hydrochloride Tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis,neutral,neutral,-0.6180257510729653,neutral,0.6652173913043558,neutral
2021-06-17 19:41:00.000,1165.0,1172.9,1141.1,1157.8,1377823.0,Lupin receives USFDA approval for Sevelamer Hydrochloride Tablets,Sevelamer Hydrochloride Tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.,positive,neutral,-0.6180257510729653,neutral,0.6652173913043558,neutral
2021-06-18 11:12:00.000,1165.0,1172.9,1141.1,1157.8,1377823.0,Shares of Lupin fall as Nifty drops,"On the technical charts, the 200-day moving average of the stock stood at Rs 1035.17.",neutral,neutral,-0.6180257510729653,neutral,0.6652173913043558,neutral
2021-06-18 16:45:00.000,1165.0,1172.9,1141.1,1157.8,1377823.0,"Nifty Pharma under selling pressure; Alkem, Torrent Pharma, Lupin weigh down","Heavyweight Divis Lab was the top gainer by 0.23% at Rs4,312.20.",neutral,positive,-0.6180257510729653,neutral,0.6652173913043558,neutral
2021-06-21 12:29:00.000,1162.1,1165.9,1152.85,1157.0,887974.0,Lupin shares down 0.09% as Nifty drops,"A total of 30,063 shares changed hands on the counter till 12:29PM (IST).",negative,neutral,-0.4388606832458402,neutral,-0.6890611541774333,neutral
2021-06-22 13:52:00.000,1161.0,1173.8,1151.5,1153.0,1243249.0,Lupin shares up 0.09% as Nifty gains,"A total of 58,904 shares changed hands on the counter till 01:52PM (IST).",positive,neutral,-0.6890611541774333,neutral,-1.2300229546537351,negative
2021-06-22 15:09:00.000,1161.0,1173.8,1151.5,1153.0,1243249.0,Lupin allots 1.31 lakh equity shares under ESOP,"n view of the above, the issued and paid-up capital of the Company has been increased to Rs 90,78,05,596 consisting 45,39,02,798 equity shares of Rs 2/- each.",neutral,neutral,-0.6890611541774333,neutral,-1.2300229546537351,negative
2021-06-23 08:19:00.000,1161.0,1173.8,1151.5,1153.0,1243249.0,"Trading calls by Ajit Mishra of Religare Broking: Buy Britannia, Lupin","Britannia has been trading in a broader consolidation range of Rs 3,350-3,840 for the last one year and is currently hovering in the middle",neutral,neutral,-0.6890611541774333,neutral,-1.2300229546537351,negative
2021-06-23 16:55:00.000,1154.45,1158.6,1131.35,1140.25,1156185.0,"Nifty Pharma holds steady; Heavyweights Sun Pharma, Dr Reddys, Lupin drive sectoral gains; Biocon underperforms",Sun Pharma settles patent litigation Celgene over cancer drug.,positive,neutral,-1.2300229546537351,negative,0.1349703935910792,neutral
2021-06-23 17:37:00.000,1154.45,1158.6,1131.35,1140.25,1156185.0,Lupin board grants allotment of over 1.31 lakh equity shares under ESOP,"The issued and paid-up capital of the Company has been increased to Rs90,78,05,596 consisting 45,39,02,798 equity shares of Rs2/- each.",neutral,positive,-1.2300229546537351,negative,0.1349703935910792,neutral
2021-06-24 07:30:00.000,1154.45,1158.6,1131.35,1140.25,1156185.0,"Nifty Pharma index under pressure: Lupin, Cipla top losers","Auro Pharma and Cadila were also under pressure 0.8% and 0.7% respectively. Dr. Reddy, Alkem Lab, and Torrent Pharma were also trading lower.",neutral,negative,-1.2300229546537351,negative,0.1349703935910792,neutral
2021-06-24 13:51:00.000,1148.4,1160.65,1134.0,1149.95,851965.0,Lupin share price down 1.25 per cent,"A total of 27,148 shares changed hands on the counter till 01:51PM (IST).",negative,neutral,0.1349703935910792,neutral,0.5094551420430093,neutral
2021-06-25 06:30:00.000,1148.4,1160.65,1134.0,1149.95,851965.0,"Nifty Pharma stocks rally nearly 1%; Sun Pharma, Alkem Lab led the charge",Auro Pharma and Cadila also gained over 1% while DR Reddy and Lupin also made significant gains.,positive,positive,0.1349703935910792,neutral,0.5094551420430093,neutral
2021-06-25 11:38:00.000,1148.4,1160.65,1134.0,1149.95,851965.0,Lupin shares up 1.41% as Nifty gains,The stock quoted a 52-week high price of Rs 1267.5 and low of Rs 828.65.,positive,negative,0.1349703935910792,neutral,0.5094551420430093,neutral
2021-06-25 20:05:00.000,1148.4,1160.65,1134.0,1149.95,851965.0,Lupin launches Emtricitabine and Tenofovir Disoproxil Fumarate Tablets,"Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg, are the generic equivalent of Truvada Tablets 200 mg/300 mg, of Gilead Sciences, Inc., and indicated in combination with other antiretroviral agents for the treatment of HIV-1",neutral,neutral,0.1349703935910792,neutral,0.5094551420430093,neutral
2021-06-25 22:26:00.000,1148.4,1160.65,1134.0,1149.95,851965.0,Lupin launches generic HIV-1 drug in US,"The drug maker’s product is the generic version of Gilead Sciences, Inc’s Truvada tablets and indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.",positive,neutral,0.1349703935910792,neutral,0.5094551420430093,neutral
2021-06-28 08:04:07.000,1158.1,1169.35,1155.15,1164.0,1298602.0,"Stocks To Watch: Thyrocare Technologies, Barbeque Nation, Lupin, JSW Energy, Finolex Industries",Here are the stocks to watch in trade today...,neutral,neutral,0.5094551420430093,neutral,0.9471908654470002,positive
2021-06-28 08:22:00.000,1158.1,1169.35,1155.15,1164.0,1298602.0,"Stocks in the news: KIMS, Dodla, NTPC, Lupin, Affle and Indigo","National Aluminium, Graphite India, NLC India, IFCI, Triveni Turbine, Welspun Corp, Kiri Industries, Tamilnadu Petroproducts will announce their March quarter results today.",neutral,neutral,0.5094551420430093,neutral,0.9471908654470002,positive
2021-06-28 08:41:00.000,1158.1,1169.35,1155.15,1164.0,1298602.0,"Lupin launches Emtricitabine, Tenofovir Disoproxil Fumarate tablets in US","Lupin announced the launch of Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg, having received an approval from the United States Food and Drug Administration (FDA).",neutral,positive,0.5094551420430093,neutral,0.9471908654470002,positive
2021-06-28 08:45:00.000,1158.1,1169.35,1155.15,1164.0,1298602.0,Markets closed lower; Pharma stocks outperformed,"The Nifty Pharma index was among the top outperformers closing ~1.3% higher with stocks like Dr Reddys, Cipla, Biocon & Lupin adding fresh long positions.",negative,positive,0.5094551420430093,neutral,0.9471908654470002,positive
2021-06-28 08:57:00.000,1158.1,1169.35,1155.15,1164.0,1298602.0,"Stocks to watch: Dodla Dairy, KIMS, Barbeque Nation, Thyrocare, SBI, Lupin",Realty firm Ashiana Housing on Saturday reported a consolidated net loss of Rs 5.2 crore for the quarter ending March. Its net loss stood at Rs 8.63 crore in the year-ago period,neutral,negative,0.5094551420430093,neutral,0.9471908654470002,positive
2021-06-28 09:31:00.000,1158.1,1169.35,1155.15,1164.0,1298602.0,Lupin launches Emtricitabine and Tenofovir Disoproxil Fumarate Tablets in the US,"It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection, Lupin said.",neutral,neutral,0.5094551420430093,neutral,0.9471908654470002,positive
2021-06-28 11:27:00.000,1158.1,1169.35,1155.15,1164.0,1298602.0,Lupin shares gain 0.76% as Sensex falls,"On the technical charts, the RSI of the stock stood at 44.68.",positive,neutral,0.5094551420430093,neutral,0.9471908654470002,positive
2021-06-28 13:00:00.000,1156.05,1174.25,1155.35,1167.0,827845.0,"Top stocks in focus: Lupin, Tech Mahindra, Thyrocare Technologies, Brigade Enterprises, Zuari Agro Chemicals",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.9471908654470002,positive,-1.0776791102681265,negative
2021-06-28 19:07:02.000,1156.05,1174.25,1155.35,1167.0,827845.0,"Stocks to Watch Today: NTPC, Finolex Industries and Lupin","Indian stock markets are likely to open flat on Monday, June 28, amid mixed trends from Asian peers.",neutral,positive,0.9471908654470002,positive,-1.0776791102681265,negative
2021-06-30 08:30:00.000,1159.9,1165.0,1145.6,1147.4,1011700.0,Nifty Pharma trades marginally lower; Divis Lab lead gainer while Lupin drags,"Dr Reddy, Sun Pharma, Torrent Pharma, and Cipla were under pressure after joining hands-on Wednesday for the clinical trial of the investigational oral anti-viral drug Molnupiravir",positive,neutral,-1.0776791102681265,negative,-0.2003484320557451,neutral
2021-06-30 10:14:46.000,1159.9,1165.0,1145.6,1147.4,1011700.0,USFDA Warning Letter On Lupin’s Somerset Facility Cites Repeated GMP Violations At Lupin’s Manufacturing Network,"“Repeated violations at multiple sites demonstrate that your company’s corporate oversight and control over the manufacture of drugs is inadequate,” USFDA said in its warning letter addressed to Vinita Gupta, CEO of Lupin.",neutral,negative,-1.0776791102681265,negative,-0.2003484320557451,neutral
2021-06-30 11:51:00.000,1159.9,1165.0,1145.6,1147.4,1011700.0,"Lupin receives USFDA nod for Dolutegravir, Lamivudine and TLD tablets","The drug major bagged tentative approval from the USFDA under the US President’s Emergency Plan for AIDS Relief for its New Drug Application for Dolutegravir, Lamivudine & Tenofovir Disoproxil Fumarate tablets and antiretroviral Fixed Dose",neutral,positive,-1.0776791102681265,negative,-0.2003484320557451,neutral
2021-06-30 12:43:00.000,1148.0,1153.95,1139.5,1145.7,819528.0,Lupin gets USFDA nod for HIV drug under PEPFAR,Lupin got a green signal from the US health regulator to sell HIV drug in the American market. The product that has received a nod under US President’s Emergency Plan for AIDS Relief (PEPFAR).,neutral,neutral,-0.2003484320557451,neutral,0.7856243760579846,neutral
2021-06-30 17:40:00.000,1148.0,1153.95,1139.5,1145.7,819528.0,Lupin’s new drug application gets USFDA tentative nod under US President’s Emergency Plan for AIDS Relief,This product would be manufactured at Lupin’s Nagpur facility in India.,positive,neutral,-0.2003484320557451,neutral,0.7856243760579846,neutral
2021-07-01 07:10:00.000,1148.0,1153.95,1139.5,1145.7,819528.0,"Nifty Pharma picks up pace, trades higher; Sun Pharma, Dr Reddys shine",Cadila emerges top laggard while Lupin also remains under pressure.,positive,positive,-0.2003484320557451,neutral,0.7856243760579846,neutral
2021-07-01 08:30:13.000,1148.0,1153.95,1139.5,1145.7,819528.0,"Sensex, Nifty to see flat opening amidst mixed global cues","Stocks to watch out for today: Ramco Cements, Sakthi Sugars, Embassy Office Parks REIT, Lupin, Triveni Engineering, and Macrotech Developers.",positive,neutral,-0.2003484320557451,neutral,0.7856243760579846,neutral
2021-07-02 07:20:20.000,1151.95,1167.0,1149.05,1161.0,1221832.0,"Stocks To Watch: Gail, NCC, Eicher Motors, Hero MotoCorp, Lupin, NMDC, Coal India, Aurobindo Pharma",Here are the stocks to watch in trade today...,neutral,neutral,0.7856243760579846,neutral,-0.9407620602259588,negative
2021-07-02 08:15:00.000,1151.95,1167.0,1149.05,1161.0,1221832.0,"Nifty Pharma near fresh record level; Divis, Dr Reddy’s, Torrent Pharma hit new 52-week high; Lupin, Aurobindo add to gains","The index has touched a new record high of 14,575.30.",positive,positive,0.7856243760579846,neutral,-0.9407620602259588,negative
2021-07-02 08:17:47.000,1151.95,1167.0,1149.05,1161.0,1221832.0,"Markets likely to remain range-bound; banks, telecom stocks, Lupin in focus",RBI said that banks should brace themselves for another wave of stress as bad loans may touch 9.8% of their loan book by the end of the fiscal year from 7.5% in FY21,neutral,negative,0.7856243760579846,neutral,-0.9407620602259588,negative
2021-07-02 08:52:00.000,1151.95,1167.0,1149.05,1161.0,1221832.0,Lupin gets US FDA nod for SOLOSEC to treat trichomoniasis,"Lupin said that its U.S. based wholly-owned subsidiary Lupin Pharmaceuticals, Inc., has received supplemental new drug application approval from US regulator for Solosec.",neutral,positive,0.7856243760579846,neutral,-0.9407620602259588,negative
2021-07-02 17:11:00.000,1151.95,1167.0,1149.05,1161.0,1221832.0,Lupin’s US-based subsidiary bags USFDA nod on supplemental New Drug Application for SOLOSEC,"The approval is based, in part, on trial results that demonstrated a clinically and statistically significant cure rate of 92.2% for patients with trichomoniasis treated with SOLOSEC.",neutral,neutral,0.7856243760579846,neutral,-0.9407620602259588,negative
2021-07-12 19:56:46.000,1156.0,1170.0,1150.9,1162.7,1268538.0,Lupin Q1 PAT Seen Up 474% YoY To Rs 613.6 Cr: ICICI Direct,"Net Sales are expected to increase by 20.6 percent Y-o-Y (up 12.5 percent Q-o-Q) to Rs 4,256 crore, according to ICICI Direct.",neutral,positive,0.5795847750865091,neutral,0.4282655246252677,neutral
2021-07-13 09:45:00.000,1156.0,1170.0,1150.9,1162.7,1268538.0,Lupin ends 1% higher after launching Tavaborole Topical Solution in US market,"The product will be manufactured at Lupin’s facility in Pithampur, India.",positive,neutral,0.5795847750865091,neutral,0.4282655246252677,neutral
2021-07-13 11:37:57.000,1156.0,1170.0,1150.9,1162.7,1268538.0,Lupin Q1 PAT Seen Up 258.7% YoY To Rs 389.9 Cr: KRChoksey,"Net Sales are expected to increase by 17 percent Y-o-Y (up 9.1 percent Q-o-Q) to Rs 4,127.6 crore, according to KRChoksey.",neutral,positive,0.5795847750865091,neutral,0.4282655246252677,neutral
2021-07-13 14:04:34.000,1167.5,1174.9,1158.2,1172.5,720723.0,Lupin Ltd stays supported,"Lupin Ltd is quoting at Rs 1165.35, up 1.27% on the day as on 12:54 IST on the NSE. The stock is up 33.49% in last one year as compared to a 48.86% spurt in NIFTY and a 42.61% spurt in the Nifty Pharma index.",neutral,positive,0.4282655246252677,neutral,-0.8928571428571428,neutral
2021-07-13 14:29:00.000,1167.5,1174.9,1158.2,1172.5,720723.0,Lupin launches Tavaborole Topical Solution in US market,"Tavaborole Topical Solution, 5%, is generic equivalent of Kerydin Topical Solution, 5%, of Anacor Pharmaceuticals, Inc. and is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum",positive,neutral,0.4282655246252677,neutral,-0.8928571428571428,neutral
2021-07-13 15:07:00.000,1167.5,1174.9,1158.2,1172.5,720723.0,Lupin rises after launching tavaborole topical solution in US,"Lupin rose 1.11% to Rs 1,164.95 after the drug major announced the US launch of tavaborole topical solution after receiving an approval from the US drug regulator.",neutral,positive,0.4282655246252677,neutral,-0.8928571428571428,neutral
2021-07-13 16:42:01.000,1167.5,1174.9,1158.2,1172.5,720723.0,Lupin Launches Generic Antifungal Product In US Market,"The product will be manufactured at the company’s Pithampur-based facility, the drug maker said in a statement.",neutral,neutral,0.4282655246252677,neutral,-0.8928571428571428,neutral
2021-07-13 17:38:00.000,1167.5,1174.9,1158.2,1172.5,720723.0,Lupin launches generic antifungal Tavaborole Topical Solution in US market,Drug maker Lupin on Tuesday said it has launched antifungal product Tavaborole Topical Solution in the US market.,positive,positive,0.4282655246252677,neutral,-0.8928571428571428,neutral
2021-07-14 07:52:50.000,1167.5,1174.9,1158.2,1172.5,720723.0,Rakesh Jhunjhunwala portfolio: Big Bull leaves stake unchanged in these 2 stocks,Rakesh Jhunjhunwala holdings in Lupin and TARC have been left unchanged by the Big Bull of Indian market,neutral,neutral,0.4282655246252677,neutral,-0.8928571428571428,neutral
2021-07-14 08:53:32.000,1167.5,1174.9,1158.2,1172.5,720723.0,"Buy HDFC, Axis Bank, Lupin, M&M stocks to pocket gains; Nifty support at 15,700-15,750",On Wednesday 15900/15930 (53000/53100) would be major hurdles and support would be at 15730/52500 and 15700/52400 levels.,positive,neutral,0.4282655246252677,neutral,-0.8928571428571428,neutral
2021-07-15 07:18:55.000,1176.0,1177.9,1159.6,1165.5,850701.0,"Hot Stocks | Can Bet On Lupin, Tata Steel And IndusInd Bank For Short Term","If Nifty breaks the upper band of the pattern which is placed near 15,920, then it may witness a major breakout which will help them cross the 16,100 level.",neutral,positive,-0.8928571428571428,neutral,1.3943880185918442,positive
2021-07-20 19:16:00.000,1191.0,1191.55,1166.5,1170.9,938000.0,"Lupin allots 60,596 equity shares under ESOP","In view of the above, the issued and paid-up capital of the Company has been increased to ₹ 90,79,26,788 consisting 45,39,63,394 equity shares of ₹ 2/- each.",neutral,neutral,-1.6876574307304708,negative,0.3398470688190314,neutral
2021-07-23 13:29:21.000,1179.45,1186.0,1176.05,1181.9,827417.0,Lupin Annual Report Analysis - Year Of Many Firsts: Dolat Capital,Lupin Annual Report Analysis - Year Of Many Firsts: Dolat Capital,neutral,neutral,0.2077239391241719,neutral,-0.6112054329371854,neutral
2021-07-27 15:04:16.000,1111.6,1117.95,1088.4,1104.0,1352977.0,Alembic Pharmaceuticals Ltd leads losers in ‘A’ group,"Dr Reddys Laboratories Ltd, Sun Pharma Advanced Research Company Ltd, Lupin Ltd and Glenmark Pharmaceuticals Ltd are among the other losers in the BSE’s ‘A’ group today, 27 July 2021.",negative,negative,-0.6836991723641517,neutral,-1.7671046669687356,negative
2021-07-27 18:21:00.000,1111.6,1117.95,1088.4,1104.0,1352977.0,"Nifty Pharma in a steep nosedive, index dips 430 pts as Dr Reddy’s slump 8% after Q1; Aurobindo, Cipla, Lupin drag too","Nifty Pharma index has slipped to at least nearly 435 points with an intraday low of 14,246.15.",negative,negative,-0.6836991723641517,neutral,-1.7671046669687356,negative
2021-07-29 07:35:00.000,1103.5,1110.0,1077.55,1084.0,1393594.0,Nifty Pharma recovers early losses; Sun Pharma surges 2% to boost the Index,Alkem Lab and Torrent Pharma dragged the most. Lupin also struggled while DR Reddy’s also remained under pressure post Q1 earnings.,positive,negative,-1.7671046669687356,negative,1.834862385321101,positive
2021-07-30 06:55:00.000,1090.0,1127.6,1080.9,1110.0,1454239.0,Lupin acquires Southern Cross Pharma in Australia; Stock rises 1.5%,This will significantly increase Lupin’s value proposition and market share in the Australian market.,positive,positive,1.834862385321101,positive,1.0046645138141412,positive
2021-07-30 12:00:00.000,1090.0,1127.6,1080.9,1110.0,1454239.0,Lupin to acquire Australia-based Southern Cross Pharma,"Generic Health, the Australia based wholly-owned subsidiary of Lupin, has entered into a definitive agreement under which Lupin will acquire 100 per cent of the shares of Southern Cross Pharma Pty Ltd (SCP), Lupin said in a regulatory filing.",neutral,positive,1.834862385321101,positive,1.0046645138141412,positive
2021-07-30 12:19:09.000,1090.0,1127.6,1080.9,1110.0,1454239.0,Lupin Acquires Melbourne-based Drug Maker SCP To Bolster Australia Generics Business,"As a part of the transaction, Lupin will gain access to over 60 registered products having sales of over AUD 30 million",neutral,positive,1.834862385321101,positive,1.0046645138141412,positive
2021-07-30 13:04:00.000,1090.0,1127.6,1080.9,1110.0,1454239.0,Lupin acquires Australia’s Southern Cross Pharma,"As a part of the transaction, Lupin’s Australia subsidiary Generic Health will gain access to over 60 registered products having sales of over $22 million.",neutral,neutral,1.834862385321101,positive,1.0046645138141412,positive
2021-07-30 16:02:00.000,1090.0,1127.6,1080.9,1110.0,1454239.0,Lupin Acquires Southern Cross Pharma In Australia,Lupin will acquire 100% shares of Southern Cross Pharma.,neutral,neutral,1.834862385321101,positive,1.0046645138141412,positive
2021-07-30 21:19:02.000,1090.0,1127.6,1080.9,1110.0,1454239.0,Lupin arm to acquire Australian pharma firm,"Generic Health, the Australia-based wholly owned subsidiary of Lupin Ltd., said it has entered into a definitive agreement to acquire 100% shares of Southern Cross Pharma Pty. Ltd. (SCP) for an unspec",neutral,positive,1.834862385321101,positive,1.0046645138141412,positive
2021-08-03 07:40:00.000,1132.0,1149.5,1126.15,1142.0,1526693.0,Nifty Pharma gains 1% amid bullish markets; Sun Pharma emerges top gainer,"Lupin and Divis Lab also outperformed. Biocon was the lone stock in the red, trading 0.12% lower.",positive,positive,0.88339222614841,neutral,-0.1688384778561882,neutral
2021-08-05 15:04:27.000,1147.05,1155.6,1142.55,1152.0,416378.0,"Stocks to buy in August 2021: Bharti Airtel, ICICI Bank HCL Tech, SBI, Lupin, others may rally up to 26%","Benchmark indices BSE Sensex and Nifty 50 hit a fresh record high on Thursday, 5 August 2021. The Nifty 50 index surged past the crucial 16,300, while the 30-share Sensex crossed 54,700 levels.",positive,positive,0.4315417810906277,neutral,-1.944648967040586,negative
2021-08-09 08:59:42.000,1154.45,1156.4,1118.0,1132.0,1072424.0,"Nifty to rally if it holds above 16,350, Bank Nifty may head to 36,800; TCS, Lupin stocks in focus","For the week, we expect Nifty to trade in the range of 16500-16000 with a positive bias.",positive,positive,-1.944648967040586,negative,-2.190614162166912,negative
2021-08-10 07:38:39.000,1138.95,1151.5,1110.05,1114.0,1481468.0,"Stocks To Watch: Coal India, Shree Cement, Power Grid, JSPL, Lupin, Zomato",Here are the stocks to watch in trade today...,neutral,neutral,-2.190614162166912,negative,-2.680679661095425,negative
2021-08-10 08:16:05.000,1138.95,1151.5,1110.05,1114.0,1481468.0,"Markets likely to be under pressure; Zomato, PowerGrid, Future in focus","Among key companies Power Grid Corporation, Zomato, Coal India, Siemens, Motherson Sumi Systems, Lupin, Jindal Steel & Power, Max Financial Services, Trent, Max Healthcare Institute, Whirlpool of India, Manappuram Finance and Computer Age Management Services will announce June quarter earnings today",neutral,neutral,-2.190614162166912,negative,-2.680679661095425,negative
2021-08-10 08:18:00.000,1138.95,1151.5,1110.05,1114.0,1481468.0,"Market Ahead Podcast, August 10: Top factors that could guide markets today","Zomato, Coal India, Lupin, Power Grid Corporation of India, Ashoka Buildcon, Deepak Fertilisers, and Whirlpool of India are among over 200 companies slated to post their quarterly earnings today.",neutral,neutral,-2.190614162166912,negative,-2.680679661095425,negative
2021-08-10 08:25:49.000,1138.95,1151.5,1110.05,1114.0,1481468.0,"Stocks to Watch: Aviation stocks, PNB Housing, Future Retail, Tata group","Ashoka Buildcon , Century Plyboards India, Chalet Hotels, Coal India, Cochin Shipyard Ltd, Deepak Fertilisers & Petrochemicals, IRB Infrastructure Developers, Jindal Steel & Power, Lupin, Manappuram Finance, Power Grid Corp., Zomato, among other companies will post their Q1 results today",neutral,neutral,-2.190614162166912,negative,-2.680679661095425,negative
2021-08-10 16:04:00.000,1079.95,1091.0,1035.4,1051.0,6301575.0,"Important results today: Coal India, Lupin, Jindal Steel, Zomato among others","Deepak Fertilisers & Petrochemicals, Godrej Agrovet Ltd, Infibeam Avenues Ltd, IRB Infrastructure Developers among other companies will post their Q1 results today.",neutral,neutral,-2.680679661095425,negative,-5.0,negative
2021-08-11 07:20:00.000,1079.95,1091.0,1035.4,1051.0,6301575.0,"Nifty Healthcare sheds over 125 points; Lupin, Sanofi, Torrent Pharma among major losers",Alkem Lab and Natco Pharma gained over 2%. Fortis was also trading 1% higher.,neutral,positive,-2.680679661095425,negative,-5.0,negative
2021-08-11 07:49:00.000,1079.95,1091.0,1035.4,1051.0,6301575.0,Lupin consolidated net profit rises 407.45% in the June 2021 quarter,Sales rise 22.16% to Rs 4237.39 crore,positive,positive,-2.680679661095425,negative,-5.0,negative
2021-08-11 08:03:00.000,1079.95,1091.0,1035.4,1051.0,6301575.0,"Lupin Q1 profit jumps 5-fold to Rs542cr, India formulation sales rise over 27% yoy","Lupin’s India formulation sales for Q1 FY2022 were INR 16,362 mn, up 27.2% as compared to INR 12,866 mn in Q4 FY2021 and up 27.3% as compared to INR 12,854 mn in Q1 FY2021; accounting for 42% of Lupin’s global sales.",positive,positive,-2.680679661095425,negative,-5.0,negative
2021-08-11 08:21:00.000,1079.95,1091.0,1035.4,1051.0,6301575.0,"Nifty Pharma sheds 300 pts amid major earnings; Alkem hits new high, all other stocks in red; Lupin nosedives 6%, Cadila dips 2% post Q1","The index has touched an intraday high and low of 14,480.75 and 14,145.45 respectively.",neutral,negative,-2.680679661095425,negative,-5.0,negative
2021-08-11 08:35:00.000,1079.95,1091.0,1035.4,1051.0,6301575.0,"Power Grid, Lupin, Godrej Agrovet, Zomato in focus",Power Grid Corporation of India reported 192.82% rise in consolidated net profit to Rs 5998.28 crore in Q1FY22 over Q1FY21. Total income rose 35.87% to Rs 13938.37 crore.,neutral,positive,-2.680679661095425,negative,-5.0,negative
2021-08-11 09:11:01.000,1079.95,1091.0,1035.4,1051.0,6301575.0,"Lupin Consolidated June 2021 Net Sales At Rs 4,270.19 Crore, Up 21.04% Y-o-Y",,neutral,neutral,-2.680679661095425,negative,-5.0,negative
2021-08-11 09:11:25.000,1079.95,1091.0,1035.4,1051.0,6301575.0,"Lupin Standalone June 2021 Net Sales At Rs 3,314.12 Crore, Up 22.97% Y-o-Y",,neutral,neutral,-2.680679661095425,negative,-5.0,negative
2021-08-11 10:25:00.000,1079.95,1091.0,1035.4,1051.0,6301575.0,Lupin Q1 PAT soars 404% to Rs 548 cr,"On a consolidated basis, the drug major’s net profit soared 404.30% to Rs 548.16 crore on 22.2% jump in net sales to Rs 4,237.39 crore in Q1 June 2021 (Q1 FY22) over Q1 June 2020 (Q1 FY21).",neutral,positive,-2.680679661095425,negative,-5.0,negative
2021-08-11 11:21:40.000,1079.95,1091.0,1035.4,1051.0,6301575.0,"Stocks to Watch Today: Lupin, Godrej Agrovet, Power Grid Corporation",The Indian bourses are likely to open with a flat-to-positive bias on Wednesday following gaining trends in global peers.,neutral,positive,-2.680679661095425,negative,-5.0,negative
2021-08-11 11:29:00.000,1079.95,1091.0,1035.4,1051.0,6301575.0,Lupin Q1 results: Net profit jumps 5-fold to Rs 542 crore,The significant jump in June quarter net profit was on account of robust sales and income received from biopharmaceutical firm Boehringer Ingelheim for achieving key milestones for its novel MEK inhibitor compound collaboration.,positive,positive,-2.680679661095425,negative,-5.0,negative
2021-08-11 11:31:29.000,1079.95,1091.0,1035.4,1051.0,6301575.0,Lupin net profit jumps 5-fold to Rs 542 cr in Q1; shares decline,,positive,neutral,-2.680679661095425,negative,-5.0,negative
2021-08-11 12:54:17.000,1030.0,1033.0,973.1,978.5,9742644.0,Rakesh Jhunjhunwala-owned pharma stock falls 7% post Q1 results,"Lupin Q1 consolidated net profit significantly jumped to ₹542 crore for the quarter ended June 30, 2021",negative,positive,-5.0,negative,-1.3157894736842104,negative
2021-08-11 14:11:00.000,1030.0,1033.0,973.1,978.5,9742644.0,"Lupin falls 7% post Q1 results, hits over three month low",The pharmaceutical company reported a disappointing April-June quarter (Q1FY22) performance on the margins front,negative,negative,-5.0,negative,-1.3157894736842104,negative
2021-08-11 15:50:11.000,1030.0,1033.0,973.1,978.5,9742644.0,Sequent Scientific Ltd leads losers in ‘A’ group,"Manappuram Finance Ltd, Huhtamaki India Ltd, Jai Corp Ltd and Lupin Ltd are among the other losers in the BSE’s ‘A’ group today, 11 August 2021.",negative,negative,-5.0,negative,-1.3157894736842104,negative
2021-08-11 17:30:00.000,1030.0,1033.0,973.1,978.5,9742644.0,This stock held by Rakesh Jhunjhunwala falls 7% post Q1 earnings,"Lupin stock touched an intraday low of Rs 1,035.65, falling 7.46% against previous close of Rs 1,119 on BSE",neutral,negative,-5.0,negative,-1.3157894736842104,negative
2021-08-11 23:28:23.000,1030.0,1033.0,973.1,978.5,9742644.0,Lupin’s Q1 disappoints Street as sales hit a bump in the US,The miss in US sales during the quarter is largely attributed to pricing pressure in key famotidine generics,negative,negative,-5.0,negative,-1.3157894736842104,negative
2021-08-12 08:13:00.000,1030.0,1033.0,973.1,978.5,9742644.0,Nifty Pharma nosedives 150 pts as Lupin and Cadila drag after Q1 results; Torrent Pharma only gainer,"A broad-based selloff was recorded in Nifty Pharma. Except for Torrent Pharma, all other stocks were in the red.",neutral,positive,-5.0,negative,-1.3157894736842104,negative
2021-08-12 09:00:56.000,1030.0,1033.0,973.1,978.5,9742644.0,"Lupin Q1 Review - Ex-Milestone Income, Disappointing Quarter, U.S. To Kick From FY23/24E: Dolat Capital","Lupin Q1 Review - Ex-Milestone Income, Disappointing Quarter, U.S. To Kick From FY23/24E: Dolat Capital",neutral,neutral,-5.0,negative,-1.3157894736842104,negative
2021-08-12 11:01:39.000,1030.0,1033.0,973.1,978.5,9742644.0,Jhunjhunwala portfolio stock Lupin falls 12% in two days. What brokerages say,"Lupin share price was down more than 5% to ₹990 per share on the BSE in Thursday’s early deals, falling for second straight day",neutral,negative,-5.0,negative,-1.3157894736842104,negative
2021-08-12 11:28:00.000,1030.0,1033.0,973.1,978.5,9742644.0,"Results Review for PGCIL, Lupin, Max Financial, Trent, Computer Age Management","Results Review for PGCIL, Lupin, Max Financial, Trent, Computer Age Management",neutral,neutral,-5.0,negative,-1.3157894736842104,negative
2021-08-12 11:50:05.000,1030.0,1033.0,973.1,978.5,9742644.0,Volumes jump at Lupin Ltd counter,"Lupin Ltd witnessed volume of 13.78 lakh shares by 10:50 IST on BSE, a 15.11 times surge over two-week average daily volume of 91208 shares",neutral,positive,-5.0,negative,-1.3157894736842104,negative
2021-08-12 14:00:26.000,988.0,989.95,953.8,975.0,5347085.0,"Lupin Shares Crack 6% Amid High Selling Pressure Post Q1 Numbers, Brokerages Remain Mixed","In 2021, the stock has gained 7 percent against a 14 percent rise in the benchmark Sensex",neutral,positive,-1.3157894736842104,negative,-1.013461636894096,negative
2021-08-12 14:09:10.000,988.0,989.95,953.8,975.0,5347085.0,"Lupin’s Q1 Earnings Weighed Down By U.S. Business, Analysts Cautious",Here’s what brokerage had to say after Lupin’s Q1 earnings.,neutral,neutral,-1.3157894736842104,negative,-1.013461636894096,negative
2021-08-12 15:31:18.000,988.0,989.95,953.8,975.0,5347085.0,GIC Housing Finance Ltd leads losers in ‘A’ group,"Lupin Ltd, GE Power India Ltd, Aurobindo Pharma Ltd and Cadila Healthcare Ltd are among the other losers in the BSE’s ‘A’ group today, 12 August 2021.",positive,negative,-1.3157894736842104,negative,-1.013461636894096,negative
2021-08-12 22:28:33.000,988.0,989.95,953.8,975.0,5347085.0,"Lupin Q1 Review - FY22 Begins On Weak Note, Led By Competitive Pressures In U.S.: Motilal Oswal","Lupin Q1 Review - FY22 Begins On Weak Note, Led By Competitive Pressures In U.S.: Motilal Oswal",neutral,neutral,-1.3157894736842104,negative,-1.013461636894096,negative
2021-08-13 00:50:10.000,988.0,989.95,953.8,975.0,5347085.0,Lupin Ltd ADR 2022 Q1 - Results - Earnings Call Presentation (OTCMKTS:LUPNY),The following slide deck was published by Lupin Ltd ADR in conjunction with their 2022 Q1 earnings call.,neutral,neutral,-1.3157894736842104,negative,-1.013461636894096,negative
2021-08-13 10:33:05.000,988.0,989.95,953.8,975.0,5347085.0,Lupin: Margin Guidance Downgrade Keeps Us Cautious,"The management of Lupin is confident of scaling back $200 million quarterly revenue run rate for US market by Q3, but at the same time, alluded to overall EBITDA margin guidance of 16-17 per cent in FY22",neutral,positive,-1.3157894736842104,negative,-1.013461636894096,negative
2021-08-13 14:04:05.000,988.0,989.95,953.8,975.0,5347085.0,Lupin Ltd eases for fifth straight session,"Lupin Ltd is quoting at Rs 969.55, down 0.66% on the day as on 13:24 IST on the NSE. The stock tumbled 4.78% in last one year as compared to a 47.56% rally in NIFTY and a 20.79% spurt in the Nifty Pharma index.",positive,negative,-1.3157894736842104,negative,-1.013461636894096,negative
2021-08-16 13:43:07.000,975.0,984.3,969.7,974.9,3123282.0,"Rakesh Jhunjhunwala’s favorite stock Lupin tanks 17% in 7 days; should you buy, sell or hold?","Lupin share price fell nearly 2 per cent to Rs 958.70 apiece in intraday deals, following the April-June quarter earnings last week.",positive,negative,-0.0102564102564125,neutral,-0.9238936246235472,negative
2021-08-16 18:47:00.000,975.0,984.3,969.7,974.9,3123282.0,Lupin receives USFDA tentative approval for Brivaracetam Tablets,This product will be manufactured at Lupin’s Nagpur facility in India. Brivaracetam Tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older.,positive,neutral,-0.0102564102564125,neutral,-0.9238936246235472,negative
2021-08-16 19:55:00.000,975.0,984.3,969.7,974.9,3123282.0,Lupin gets tentative nod from USFDA to market partial-onset seizures drug,Drug firm Lupin on Monday said it has received tentative nod from the US health regulator to market its generic Brivaracetam tablets used for the treatment of partial-onset seizures,neutral,positive,-0.0102564102564125,neutral,-0.9238936246235472,negative
2021-08-17 00:30:00.000,975.0,984.3,969.7,974.9,3123282.0,"Lupin bets big on inhalation segment, plans to enter Chinese market",Lupin’s portfolio and pipeline addresses 70 per cent of the entire market,positive,neutral,-0.0102564102564125,neutral,-0.9238936246235472,negative
2021-08-17 07:06:00.000,975.0,984.3,969.7,974.9,3123282.0,Lupin bags tentative approval from USFDA for Brivaracetam Tablets; Stock gains,This product will be manufactured at Lupin’s Nagpur facility in India.,positive,neutral,-0.0102564102564125,neutral,-0.9238936246235472,negative
2021-08-17 07:40:48.000,975.0,984.3,969.7,974.9,3123282.0,"Buzzing Stocks: Exxaro Tiles, Windlas Biotech, Lupin And Other Stocks In News Today",Stocks In the News: Check out the companies making the biggest headlines before the opening bell.,neutral,neutral,-0.0102564102564125,neutral,-0.9238936246235472,negative
2021-08-17 08:22:57.000,975.0,984.3,969.7,974.9,3123282.0,"Stocks to Watch: Adani, Lupin, NTPC, RailTel, Ruchi Soya, RIL","NTPC has started the groundwork to hold initial share sales of its units NTPC Vidyut Vyapar Nigam Ltd (NVVN) and NTPC Renewable Energy Ltd (NTPC REL), with merchant bankers making preliminary presentations, said two people aware of the development",neutral,neutral,-0.0102564102564125,neutral,-0.9238936246235472,negative
2021-08-17 08:40:00.000,975.0,984.3,969.7,974.9,3123282.0,"Infosys, Lupin, Fiem Industries in focus","Infosys has agreed with TidalScale Inc, leading software-defined-server technology startup, to invest an additional sum of US$ 0.45 million (till date, the Company had invested US$ 3.0 million) taking the cumulative investment to US$ 3.45 million",neutral,neutral,-0.0102564102564125,neutral,-0.9238936246235472,negative
2021-08-17 08:45:00.000,975.0,984.3,969.7,974.9,3123282.0,Lupin gets tentative U.S. FDA nod for Brivaracetam tablets,Lupin announced that it has received tentative approval from the USFDA for its Abbreviated New Drug Application (ANDA) Brivaracetam Tablets.,neutral,positive,-0.0102564102564125,neutral,-0.9238936246235472,negative
2021-08-17 13:25:00.000,979.55,980.0,965.0,970.5,1847167.0,"Top stocks in focus: Suven Life Sciences, Lupin, Adani Enterprises, SBI Mutual Fund, Star Paper Mills",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.9238936246235472,negative,-4.1755277763369465,negative
2021-08-17 15:54:22.000,979.55,980.0,965.0,970.5,1847167.0,"Top Stocks for Investors on August 17: Infosys, Lupin, Coal India","The Indian benchmark indices may open on a subdued note on Tuesday, August 17, following mixed global cues.",neutral,positive,-0.9238936246235472,negative,-4.1755277763369465,negative
2021-08-17 17:30:00.000,979.55,980.0,965.0,970.5,1847167.0,"Stocks in news: Adani Enterprises, Ruchi Soya, RIL, Lupin and more","On Monday, Sensex ended 145 points higher at a new peak of 55,582 and Nifty advanced 34 points to a fresh high of 16,563",neutral,positive,-0.9238936246235472,negative,-4.1755277763369465,negative
2021-08-17 18:21:21.000,979.55,980.0,965.0,970.5,1847167.0,Hold Lupin: Target Of Rs 1025: ICICI Direct,"ICICI Direct recommended hold rating on Lupin with a target price of Rs 1025 in its research report dated August 12, 2021.",neutral,positive,-0.9238936246235472,negative,-4.1755277763369465,negative
2021-08-19 14:12:38.000,963.95,967.75,921.0,923.7,3337938.0,Neutral Lupin; Target Of Rs 1040: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 1040 in its research report dated August 11, 2021.",neutral,positive,-4.1755277763369465,negative,-0.7478632478632479,neutral
2021-08-19 15:23:00.000,963.95,967.75,921.0,923.7,3337938.0,"Lupin allots 57,696 equity shares under ESOP","In view of the above, the issued and paid-up capital of the Company has been increased to Rs 90,80,42,180 consisting 45,40,21,090 equity shares of Rs 2 each.",neutral,neutral,-4.1755277763369465,negative,-0.7478632478632479,neutral
2021-08-19 17:03:15.000,963.95,967.75,921.0,923.7,3337938.0,LIC bought shares of these companies in April-June quarter; stocks trade with losses this quarter,"LIC’s largest investments during the previous quarter include Dr Reddy’s Laboratories, Adani Enterprises, Tech Mahindra, Union Bank, Apollo Hospitals, Tata Consumer Products, and Lupin.",neutral,neutral,-4.1755277763369465,negative,-0.7478632478632479,neutral
2021-08-20 09:37:33.000,963.95,967.75,921.0,923.7,3337938.0,Rakesh Jhunjhunwala portfolio stock dips 17% in 1 month. Should you buy?,"Rakesh Jhunjhunwala portfolio: Big Bull is not immune to losses. One of the Rakesh Jhunjhunwala stocks, Lupin share price has crashed to the tune of 17 per cent in the last one month",positive,negative,-4.1755277763369465,negative,-0.7478632478632479,neutral
2021-08-23 13:55:08.000,932.0,943.2,915.75,939.65,3106590.0,Buy Lupin; Target Of Rs 1400: Sharekhan,"Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1400 in its research report dated August 11, 2021.",neutral,positive,0.8208154506437745,neutral,-0.1907183725365495,neutral
2021-08-24 07:42:00.000,932.0,943.2,915.75,939.65,3106590.0,"Nifty Pharma rallies 1.2%; Biocon, Cipla, Sun Pharma, Lupin lead the winning streaks","Cipla, Sun Pharma, Lupin, DR Reddy’s also advanced to lift the spirits after a gloomy morning.",positive,positive,0.8208154506437745,neutral,-0.1907183725365495,neutral
2021-08-24 09:35:00.000,932.0,943.2,915.75,939.65,3106590.0,Lupin-led arm launches Luforbec for asthma and COPD treatment in UK,Lupin is approved to manufacture Luforbec at its sites in Pithampur in India and Coral Springs in the US.,neutral,positive,0.8208154506437745,neutral,-0.1907183725365495,neutral
2021-08-24 16:43:00.000,943.8,946.0,933.2,942.0,1500230.0,Lupin launches generic asthma inhaler drug in UK,"The drug major has launched Luforbec 100/6 μg pMDI, first branded generic alternative to Fostair, for treatment of Asthma & COPD, in the UK.",neutral,positive,-0.1907183725365495,neutral,-0.8203228367292934,neutral
2021-08-29 17:04:00.000,942.0,956.0,942.0,953.5,883289.0,"Lupin, Glenmark shift focus to inhalation and nasal Covid-19 drugs",Lupin working on remdesivir powder inhaler; Glenmark to do trials on Nitric Oxide Nasal Spray,neutral,neutral,1.220806794055202,positive,0.2724224643755263,neutral
2021-08-30 08:05:00.000,942.0,956.0,942.0,953.5,883289.0,"Nifty Pharma picks speed to advance 2%; Divis Lab, Biocon, Sun Pharma lift performance",Dr Reddy’s Laboratories (up 1.73%) and Torrent Pharmaceuticals (up 1.564%) were also bullish. Lupin and Cipla advanced over 1.2%.,positive,positive,1.220806794055202,positive,0.2724224643755263,neutral
2021-09-02 13:16:33.000,972.9,972.9,964.0,969.5,495555.0,"Lupin Ltd soars 0.35%, rises for fifth straight session","Lupin Ltd is quoting at Rs 965.65, up 0.35% on the day as on 12:49 IST on the NSE. The stock is up 0.41% in last one year as compared to a 48.92% spurt in NIFTY and a 25.65% spurt in the Nifty Pharma.",positive,positive,-0.3494706547435479,neutral,0.625641025641028,neutral
2021-09-06 11:04:04.000,975.0,994.8,967.85,981.1,1823654.0,TB Alliance grants Lupin non-exclusive license to manufacture anti-TB drug,Powered by Capital Market - Live News,positive,neutral,0.625641025641028,neutral,0.1115618661257629,neutral
2021-09-06 11:55:00.000,975.0,994.8,967.85,981.1,1823654.0,Lupin rises after partnership for new therapy for highly drug-resistant TB,Lupin added 0.75% to Rs 976.75 after the company secured a non-exclusive license from TB Alliance to manufacture the anti-TB drug pretomanid.,positive,neutral,0.625641025641028,neutral,0.1115618661257629,neutral
2021-09-06 12:47:48.000,986.0,991.5,978.1,987.1,678101.0,TB Alliance ropes in Lupin to bolster global supplies of Pretomanid,Pretomanid is part of a three-drug regimen BPaL that includes bedaquiline and linezolid and is used to treat extensively drug-resistant TB.,positive,neutral,0.1115618661257629,neutral,-1.0050505050505096,negative
2021-09-06 12:53:00.000,986.0,991.5,978.1,987.1,678101.0,"Lupin, TB Alliance join hands for new therapy for drug-resistant tuberculosis",TB Alliance President and CEO Mel Spigelman said that partnering with Lupin -- a well-established manufacturer with experience delivering high-quality TB therapies -- will help further enable widespread access to the novel regimen while promoting a competitive market to drive affordability.,positive,positive,0.1115618661257629,neutral,-1.0050505050505096,negative
2021-09-06 13:33:57.000,986.0,991.5,978.1,987.1,678101.0,"Lupin, TB Alliance Join Hands For New Therapy For Drug-resistant Tuberculosis","The Mumbai-based company said it intends to commercialise the medicine in around 140 countries and territories, including many of the highest TB burden nations around the world.",neutral,positive,0.1115618661257629,neutral,-1.0050505050505096,negative
2021-09-06 17:22:00.000,986.0,991.5,978.1,987.1,678101.0,Lupin join hands with TB Alliance for a new therapy of highly drug-resistant TB; Stock gains 1%,Lupin intends to commercialize antituberculosis (TB) medicine in approximately 140 countries and territories.,positive,positive,0.1115618661257629,neutral,-1.0050505050505096,negative
2021-09-07 11:45:35.000,986.0,991.5,978.1,987.1,678101.0,"Top Stock Picks For September - HDFC Bank, Lupin, UPL And More: KRChoksey","Top Stock Picks For September - HDFC Bank, Lupin, UPL And More: KRChoksey",neutral,neutral,0.1115618661257629,neutral,-1.0050505050505096,negative
2021-09-14 06:30:00.000,984.5,990.1,979.05,981.45,658702.0,"Nifty Pharma stocks steady amid bullish markets; Dr Reddy’s, Auro Pharma outperform",Lupin dragged 0.4% at Rs980.15 per piece while Torrent Pharma was also 0.13% lower.,positive,neutral,-0.3098019299136571,neutral,-0.0354412434813335,neutral
2021-09-15 15:04:00.000,980.0,985.0,957.45,960.0,2931106.0,Lupin launches rheumatoid arthritis treatment drug in US,Lupin on Wednesday announced the launch of rheumatoid arthritis treatment drug in the US market.,positive,positive,-2.0408163265306123,negative,-1.962809917355372,negative
2021-09-15 16:09:00.000,980.0,985.0,957.45,960.0,2931106.0,Lupin launches generic Duexis tablets in US to treat rheumatoid arthritis,Drug firm Lupin on Wednesday said it has launched generic Duexis tablets used to treat the symptoms of rheumatoid arthritis and osteoarthritis in the US market.,positive,positive,-2.0408163265306123,negative,-1.962809917355372,negative
2021-09-15 22:19:00.000,980.0,985.0,957.45,960.0,2931106.0,"Lupin launches Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg","Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg, are indicated for the relief of signs and symptoms of rheumatoid arthritis, osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers, which in the clinical trials was",neutral,positive,-2.0408163265306123,negative,-1.962809917355372,negative
2021-09-16 08:32:56.000,980.0,985.0,957.45,960.0,2931106.0,"Stocks To Watch: Vodafone Idea, Tata Consumer, Lupin, Wipro and More",The Indian markets on Thursday may open in the positive territory-taking positive cues from global markets.,neutral,positive,-2.0408163265306123,negative,-1.962809917355372,negative
2021-09-16 11:37:19.000,980.0,985.0,957.45,960.0,2931106.0,Lupin Settles Diabetes Drug Suit In U.S.,Lupin opted for an out-of-court settlement of litigation against its diabetes drug Glumetza.,neutral,positive,-2.0408163265306123,negative,-1.962809917355372,negative
2021-09-16 14:34:00.000,968.0,968.0,943.85,949.0,2475896.0,Lupin board nods to settle litigations in Glumetza matter,Lupin assured that this settlement will not have a significant impact on the financial position of the Company.,neutral,neutral,-1.962809917355372,negative,1.0857763300760044,positive
2021-09-16 16:22:00.000,968.0,968.0,943.85,949.0,2475896.0,Lupin launches authorized generic version of Duexis in the US,Ibuprofen and Famotidine Tablets (RLD: Duexis) had estimated annual sales of USD 765 million in the U.S. (IQVIA MAT July 2021).,neutral,neutral,-1.962809917355372,negative,1.0857763300760044,positive
2021-09-19 20:53:00.000,921.0,941.9,912.0,931.0,3466848.0,"Lupin’s Goa plant gets 7 observations from USFDA, firm unperturbed","Says confident of resolving matter, does not share nature of observations",neutral,neutral,1.0857763300760044,positive,0.0,neutral
2021-09-20 08:09:14.000,921.0,941.9,912.0,931.0,3466848.0,"Stocks to Watch: IDBI Bank, Eicher Motors, Lupin, Cadila","Escorts, Exide Industries, Indiabulls Housing Finance, IRCTC, NALCO, Punjab National Bank, SAIL, and Sun TV Network are under the F&O ban for 20 September",neutral,neutral,1.0857763300760044,positive,0.0,neutral
2021-09-20 08:54:00.000,921.0,941.9,912.0,931.0,3466848.0,"Stocks to watch: Wipro, Zomato, Welspun India, Lupin, Rail Vikas Nigam",MAS Financial Services has raised Rs 100 crore through private placement of market-linked non-convertible debentures,neutral,positive,1.0857763300760044,positive,0.0,neutral
2021-09-20 09:07:28.000,921.0,941.9,912.0,931.0,3466848.0,Stocks that will see action today,"Buzzing stocks: Nazara, Sterling & Wilson, Lupin, KEC International, Rail Vikas Nigam",neutral,neutral,1.0857763300760044,positive,0.0,neutral
2021-09-20 09:23:00.000,921.0,941.9,912.0,931.0,3466848.0,Lupin slips after USFDA issues seven observations,Drug maker Lupin fell 1.45% to Rs 936.9 after the U.S. Food and Drug Administration (USFDA) issued even observations to company’s Goa facility.,neutral,negative,1.0857763300760044,positive,0.0,neutral
2021-09-20 10:17:00.000,921.0,941.9,912.0,931.0,3466848.0,Lupin slips 4% as Goa plant gets 7 observations from the USFDA,"These observations which has been under regulatory oversight for 4 years, and can impact investor sentiment although revenue will not be impacted in the near term, ICICI Securities note stated",neutral,neutral,1.0857763300760044,positive,0.0,neutral
2021-09-20 12:51:00.000,930.0,936.95,914.3,930.0,1705513.0,"Top stocks in focus: Lupin, Cadila, Zee, IRB Infrastructure, Wipro",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.0,neutral,1.1719169981722373,positive
2021-09-20 16:14:00.000,930.0,936.95,914.3,930.0,1705513.0,Lupin receives seven observations from USFDA after inspection at the Goa facility,"The US health regulator carried the inspection between September 10 to September 18, 2021, and closed with seven observations.",neutral,neutral,0.0,neutral,1.1719169981722373,positive
2021-09-20 17:30:00.000,930.0,936.95,914.3,930.0,1705513.0,"Stocks in news: Wipro, Zomato, Vodafone Idea, Cadila Healthcare, Lupin and more","On September 17, the benchmark indices ended lower after scaling record highs as investors booked profits at higher levels. After moving in a range of 866 points during the day, Sensex closed 125.27 points lower at 59,015 and Nifty slipped 44.35 points to 17,585.",neutral,negative,0.0,neutral,1.1719169981722373,positive
2021-09-20 19:04:00.000,930.0,936.95,914.3,930.0,1705513.0,Lupin’s underperformance may continue on US-driven regulatory challenges,"US sales trajectory, margins key triggers over the next couple of quarters",negative,neutral,0.0,neutral,1.1719169981722373,positive
2021-09-21 06:11:21.000,930.0,936.95,914.3,930.0,1705513.0,Regulatory headwinds to keep Lupin’s earnings under check,"Not surprising, the stock is down 25% from the highs touched in June, including the roughly 2% fall on Monday.",negative,negative,0.0,neutral,1.1719169981722373,positive
2021-09-21 08:30:00.000,930.0,936.95,914.3,930.0,1705513.0,"Nifty Pharma index rallies 1.2%; Biocon, Auro Pharma lead the gains",Torrent Pharma and Lupin were under pressure on the flip side.,positive,neutral,0.0,neutral,1.1719169981722373,positive
2021-09-21 14:32:00.000,930.1,944.0,929.7,941.0,1575561.0,Lupin allots 9389 equity shares under ESOP,"In view of the above, the issued and paid-up capital of the Company has been increased tot 90,80,60,958 consisting 45,40,30,479 equity shares of Rs 2/- each.",neutral,neutral,1.1719169981722373,positive,-1.023206751054857,negative
2021-09-23 13:11:09.000,943.0,947.0,922.8,926.35,1083743.0,"Lupin’s Goa Plant: USFDA Finds Certain Investigation, Material Testing Deficiencies",Lupin said the company is confident of addressing the observations satisfactorily,neutral,positive,-1.7656415694591705,negative,0.6845254136797309,neutral
2021-09-27 06:35:00.000,927.65,940.8,915.05,934.0,1694688.0,Nifty Pharma stocks trade lower; Divis Lab sinks over 3%,Cadila Healthcare was also under extreme pressure. Lupin and Alkem Lab were only Pharma companies to trade in the green.,negative,neutral,0.6845254136797309,neutral,1.340425531914896,positive
2021-09-27 15:22:45.000,940.0,953.65,928.0,952.6,2234745.0,"88academics India Raises $3 Million Funding From Aarin Capital Partners, Others","The pre-series A round also saw participation from Piyush Gupta (DBS Group CEO), Vinod Gupta (VG Learning Destination MD), P S Jayakumar (ex-MD and CEO of Bank of Baroda), Ramesh Swaminathan (Lupin Group CFO), Ajay Abrol (ex-Head Proprietary Trading of Nomura Singapore), Prem Rajani (Rajani Associat…",neutral,positive,1.340425531914896,positive,-0.9371727748691148,negative
2021-09-27 17:11:42.000,940.0,953.65,928.0,952.6,2234745.0,U.S. FDA Flags Quality Lapses At Lupin’s Goa Facility,The U.S. FDA has flagged concerns over manufacturing and testing standards at Lupin’s Goa facility.,neutral,negative,1.340425531914896,positive,-0.9371727748691148,negative
2021-09-28 06:04:00.000,940.0,953.65,928.0,952.6,2234745.0,Lupin forays into diagnostics business; launch expected next month,"Also, Lupin is looking for franchise partners with an investment of Rs 2-5 lakh without any security deposit",neutral,neutral,1.340425531914896,positive,-0.9371727748691148,negative
2021-09-28 07:31:00.000,940.0,953.65,928.0,952.6,2234745.0,Top headlines: Govt moves on bank privatisation; Lupin to enter diagnostics,"Govt will be borrowing Rs 5.03 trillion from the market in the second half, unchanged from what it had planned, but including the GST compensation paid to states. More in top headlines of the day",neutral,neutral,1.340425531914896,positive,-0.9371727748691148,negative
2021-09-28 08:31:00.000,940.0,953.65,928.0,952.6,2234745.0,"Nifty Pharma declines for second straight day; Divis Lab, Cadila continue to tumble",Lupin continued to outperform for the second consecutive day.,negative,positive,1.340425531914896,positive,-0.9371727748691148,negative
2021-09-28 18:38:00.000,955.0,964.05,945.0,946.05,3375771.0,Lupin launches Droxidopa Capsules in US market,"The product is manufactured at Lupin’s facility in Nagpur, India. Droxidopa Capsules, 100 mg, 200 mg, and 300 mg is a generic equivalent of Northera Capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck NA, indicated for the treatment of orthostatic",neutral,neutral,-0.9371727748691148,negative,-0.2103270585760858,neutral
2021-09-29 07:29:08.000,955.0,964.05,945.0,946.05,3375771.0,"Stocks To Watch: HDFC AMC, Lupin, M&M, Bharti Airtel, Future Group",Here are the stocks to watch in trade today...,neutral,neutral,-0.9371727748691148,negative,-0.2103270585760858,neutral
2021-09-29 07:44:31.000,955.0,964.05,945.0,946.05,3375771.0,"Stocks To Watch: Infosys, HCL, Bharti Airtel, HDFC AMC, Lupin, KSE, Atul Auto and More","Indian markets on Wednesday tracking negative global cues may open flat, However PMI Manufacturing, Infrastructure output data that are scheduled to be released this week will decide the course of the market.",neutral,neutral,-0.9371727748691148,negative,-0.2103270585760858,neutral
2021-09-29 08:32:00.000,955.0,964.05,945.0,946.05,3375771.0,"HCL Tech, Bharti Airtel, HDFC AMC, Lupin in focus",HCL Technologies has joined the AWS Service Delivery Program and become an AWS Contact Center Intelligence Partner.,neutral,neutral,-0.9371727748691148,negative,-0.2103270585760858,neutral
2021-09-29 08:50:00.000,955.0,964.05,945.0,946.05,3375771.0,"Stocks to watch: HDFC AMC, Airtel, Atul Auto, Lupin, Future Group stocks",NCLT allowed Kishore Biyani-led Future Group firms to hold meetings of its shareholders and creditors to seek approval for the sale of assets to Reliance Retail,neutral,neutral,-0.9371727748691148,negative,-0.2103270585760858,neutral
2021-09-29 10:32:00.000,955.0,964.05,945.0,946.05,3375771.0,Lupin launches Droxidopa capsules in the United States,"Lupin said that the company has launched Droxidopa capsules in the United States, having received an approval from the United States Food and Drug Administration (US FDA).",neutral,positive,-0.9371727748691148,negative,-0.2103270585760858,neutral
2021-09-29 13:00:00.000,950.9,960.9,946.2,948.9,1393056.0,"Top stocks in focus: HDFC AMC, Atul Auto, Lupin, Compucom Software, Bharti Airtel",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.2103270585760858,neutral,2.2145877378435563,positive
2021-09-29 16:14:00.000,950.9,960.9,946.2,948.9,1393056.0,Lupin launches Droxidopa Capsules in the US after the FDA approval,Lupi stated that Droxidopa Capsules had estimated annual sales of $294M in the U.S.,neutral,neutral,-0.2103270585760858,neutral,2.2145877378435563,positive
2021-09-29 16:15:00.000,950.9,960.9,946.2,948.9,1393056.0,"Nifty Pharma witness modest gains; Lupin top bull; Divi’s Lab, Cadila worst hit",Nifty Pharma trades bullish with 7 scrips were in advancing note.,positive,positive,-0.2103270585760858,neutral,2.2145877378435563,positive
2021-09-30 06:30:00.000,950.9,960.9,946.2,948.9,1393056.0,"Nifty Pharma stocks continue winning streak; Abbott India, IPCA Lab stocks outperform",Sun Pharma and Cadila also advanced to push the sectorial gains while Biocon and Lupin were also in the fast lane.,positive,positive,-0.2103270585760858,neutral,2.2145877378435563,positive
2021-10-01 08:18:00.000,946.0,968.0,943.0,966.95,1264243.0,"Stock picks by Osho Krishan of Anand Rathi: Buy Lupin, Gujarat Gas",LUPIN has corrected over 25 per cent from its 52 weeks high and is currently placed near its historical demand zone of 900 odd levels,neutral,neutral,2.2145877378435563,positive,-0.8351376430559875,neutral
2021-10-06 18:00:49.000,960.0,961.95,951.0,954.15,689123.0,Lupin Q2 PAT Seen Up 33.1% YoY To Rs 280.9 Cr: Prabhudas Lilladher,"Net Sales are expected to increase by 0.6 percent Y-o-Y (down 1.6 percent Q-o-Q) to Rs 3,802.8 crore, according to Prabhudas Lilladher.",neutral,positive,-0.6093750000000023,neutral,-1.3541666666666667,negative
2021-10-06 19:07:00.000,960.0,961.95,951.0,954.15,689123.0,Lupin gets tentative nod from USFDA to market generic Brexpiprazole tablets,"The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Brexpiprazole tablets in the strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, Lupin said in a regulatory filing.",neutral,positive,-0.6093750000000023,neutral,-1.3541666666666667,negative
2021-10-07 08:03:03.000,960.0,961.95,951.0,954.15,689123.0,"Stocks To Watch: Titan, Zee Entertainment, Nazara Tech, Lupin, Sobha, Ambuja Cements",Here are the stocks to watch in trade today...,neutral,neutral,-0.6093750000000023,neutral,-1.3541666666666667,negative
2021-10-07 08:43:25.000,960.0,961.95,951.0,954.15,689123.0,Stocks that will see action on October 7,"Buzzing stocks: Banks, Infy, TCS, Ultratech, RIL, Oil majors, GAIL India, Trigent Tech, NIIT, Nazara, RVNL, Balaji Amines, CAMS, Lupin, Coal India",neutral,neutral,-0.6093750000000023,neutral,-1.3541666666666667,negative
2021-10-07 08:45:00.000,960.0,961.95,951.0,954.15,689123.0,"Titan Company, Lupin, PNB Housing Finance in focus","Titan Company witnessed strong recovery in demand after the second wave across its consumer businesses with sales moving swiftly above or close to pre-pandemic levels in most of the divisions. Apart from its thrust on digital and omni channels, the",neutral,positive,-0.6093750000000023,neutral,-1.3541666666666667,negative
2021-10-07 08:51:00.000,960.0,961.95,951.0,954.15,689123.0,"Stocks to watch: RIL, ZEEL, Sobha, Lupin, Nazar Tech, Titan, Inox Wind",Tata group firm Titan on Wednesday said it has witnessed a strong recovery in demand in the July-September quarter,neutral,positive,-0.6093750000000023,neutral,-1.3541666666666667,negative
2021-10-07 10:55:00.000,960.0,961.95,951.0,954.15,689123.0,Lupin gains after receiving tentative nod for brexpiprazole tablets,Lupin rose 0.83% to Rs 955.50 after the drug company received tentative approval from the United States Food and Drug Administration (USFDA) for brexpiprazole tablets.,positive,positive,-0.6093750000000023,neutral,-1.3541666666666667,negative
2021-10-07 14:48:00.000,960.0,965.75,945.55,947.0,901542.0,Lupin receives tentative approval from USFDA for Brexpiprazole tablets; Stock rises 1%,This product will be manufactured at Lupin’s Pithampur facility in India.,positive,neutral,-1.3541666666666667,negative,0.9453781512605042,positive
2021-10-14 12:29:17.000,963.3,968.15,945.0,945.95,934371.0,"Rakesh Jhunjhunwala cuts stake in Lupin; stock remains under pressure, loses over 4% so far this year",Rakesh Jhunjhunwala has trimmed stake in pharma major Lupin to below one per cent.,negative,negative,-1.8011003840963262,negative,-0.0532481363152289,neutral
2021-10-14 19:14:00.000,963.3,968.15,945.0,945.95,934371.0,Lupin recalls 2 hypertension drugs in US due to potential impurity,Drug firm Lupin on Thursday said its US-based arm is voluntarily recalling all batches of two hypertension drugs due to potential presence of a substance that could cause cancer.,negative,negative,-1.8011003840963262,negative,-0.0532481363152289,neutral
2021-10-14 20:32:22.000,963.3,968.15,945.0,945.95,934371.0,Lupin recalls all batches lrbesartan Tablets & lrbesartan and Hydrochlorothiazide Tablets in the US,Powered by Capital Market - Live News,neutral,neutral,-1.8011003840963262,negative,-0.0532481363152289,neutral
2021-10-14 23:22:54.000,963.3,968.15,945.0,945.95,934371.0,Drug Impurity Woes Worsen as Lupin Recalls Some Pills in U.S.,Drug Impurity Woes Worsen as Lupin Recalls Some Pills in U.S.,neutral,neutral,-1.8011003840963262,negative,-0.0532481363152289,neutral
2021-10-18 14:26:00.000,941.8,945.5,933.3,935.8,1699486.0,Lupin declines after issuing voluntarily recall of hypertension treatment tablets,Lupin slipped 0.54% to Rs 941 after the company said its US based subsidiary is voluntarily recalling the batches of Irbesartan tablets and Irbesartan and Hydrochlorothiazide tablets to the consumer level.,negative,negative,-0.6370779358674878,neutral,-0.8418584825234418,neutral
2021-10-18 15:28:47.000,941.8,945.5,933.3,935.8,1699486.0,"Rakesh Jhunjhunwala exits MCX, cuts stakes in 2 more firms after Lupin, Fortis Healthcare","Rakesh Jhunjhunwala has exited MCX, after trimming his stakes in at least four firms -- Lupin, Fortis Healthcare, The Mandhana Retail Ventures, and TARC",negative,neutral,-0.6370779358674878,neutral,-0.8418584825234418,neutral
2021-10-21 06:35:00.000,937.9,937.9,908.05,924.0,1333601.0,"Nifty Pharma joins bear markets; Index sheds 1%; Strides, Granules soar while Gland Pharma, Laurus Labs emerge laggards","Dr Reddy’s also shed 2.65% while Glenmark and Lupin also were around 1.8% on the downside. IPCA Labs, Pfizer, and Cadila were also under heavy pressure.",neutral,neutral,-1.4820343320183365,negative,-0.5734069025208217,neutral
2021-10-22 11:37:00.000,924.3,939.85,914.0,919.0,1489338.0,Lupin ropes in Hrithik Roshan as brand ambassador for ayurvedic health supplement - Be One,"Be One is a scientifically tested supplement with the goodness of eight Ayurvedic ingredients like Ashwagandha, Pippali and Shatavari in a single vegetarian capsule. Being energetic Is the new currency in today’s day and age where individuals",neutral,neutral,-0.5734069025208217,neutral,1.3524523382760356,positive
2021-10-22 13:36:30.000,924.3,939.85,914.0,919.0,1489338.0,Lupin Ropes In Hrithik Roshan For Ayurvedic Energy Supplement Brand,The Mumbai-based company has brought in the actor as brand ambassador for LupinLife’s Be One brand.,neutral,positive,-0.5734069025208217,neutral,1.3524523382760356,positive
2021-10-27 08:11:47.000,934.7,945.35,930.6,934.9,832958.0,"Stocks to Watch: Adani Ports, Maruti, ITC, Bajaj Auto, PNB, Titan","Adani Ports And Sez, Larsen & Toubro, Maruti Suzuki, Bajaj Auto, Titan Company, ITC, IndusInd Bank, Adani Enterprises, SBI Life Insurance Company, Indian Overseas Bank, Punjab National Bank, Lupin, among others, are scheduled to announce their September quarter earnings today",neutral,neutral,0.0213972397560641,neutral,-2.609273724447394,negative
2021-10-27 08:20:32.000,934.7,945.35,930.6,934.9,832958.0,"Indian stock markets may be under pressure; Zee, ITC, Maruti, L&T in focus","Among key companies, ITC, Maruti, L&T, Bajaj Auto, Adani Enterprises, Adani Ports, SBI Life Insurance, Punjab National Bank, Lupin, Titan and Indian Overseas Bank will declare their September quarter results today",negative,neutral,0.0213972397560641,neutral,-2.609273724447394,negative
2021-10-27 08:44:00.000,934.7,945.35,930.6,934.9,832958.0,"Axis Bank, Bajaj Finance, Cipla to react to September quarterly results","Larsen & Toubro, ITC, IndusInd Bank, Bajaj Auto, Titan Company, Lupin, Maruti Suzuki India, SBI Life Insurance Company, Zee Entertainment Enterprises, Adani Enterprises, Adani Ports and Special Economic Zone, United Spirits among others will",positive,neutral,0.0213972397560641,neutral,-2.609273724447394,negative
2021-10-27 13:31:36.000,902.55,929.95,878.0,879.0,3479961.0,Lupin Ltd up for third straight session,"Lupin Ltd is quoting at Rs 941.5, up 1.26% on the day as on 12:54 IST on the NSE. The stock is down 0.04% in last one year as compared to a 56.03% jump in NIFTY and a 25.04% jump in the Nifty Pharma index.",positive,positive,-2.609273724447394,negative,3.459821428571429,positive
2021-10-27 17:57:00.000,902.55,929.95,878.0,879.0,3479961.0,"Nifty Pharma tops 200 pts on broad-based buying; Lupin, Cipla in focus; Divis Lab, Sun Pharma top bulls","Nifty Pharma index has gained to more than 14,200-level on broad-based buying as major companies have lined up to announce their Q2 financial performance.",neutral,positive,-2.609273724447394,negative,3.459821428571429,positive
2021-10-28 09:08:00.000,902.55,929.95,878.0,879.0,3479961.0,Lupin reports consolidated net loss of Rs 2098.04 crore in the September 2021 quarter,Sales rise 5.86% to Rs 4003.42 crore,negative,positive,-2.609273724447394,negative,3.459821428571429,positive
2021-10-28 09:34:00.000,902.55,929.95,878.0,879.0,3479961.0,Lupin reports Q2 loss at Rs 2098 cr,The drug maker reported a consolidated net loss of Rs 2098.04 crore in Q2 September 2021 as against net profit of Rs 211.02 crore in Q2 September 2020.,negative,negative,-2.609273724447394,negative,3.459821428571429,positive
2021-10-28 11:36:13.000,902.55,929.95,878.0,879.0,3479961.0,"Lupin Reports Consolidated Net Loss Of Rs 2,098 Crore In Q2",The company had posted a net profit of Rs 211 crore in the July-September period of previous fiscal.,neutral,neutral,-2.609273724447394,negative,3.459821428571429,positive
2021-10-28 13:06:34.000,896.0,955.0,881.25,927.0,7109960.0,"Buzzing Stocks: PNB Shares Tumble Nearly 10 Per Cent, Lupin Plunges falls Over 2 Per Cent","The state-owned bank reported a 78 per cent rise in net profit to Rs 1,105 crore for the second quarter ended on September 30 despite a fall in income.",neutral,positive,3.459821428571429,positive,2.154427645788342,positive
2021-10-28 13:07:00.000,896.0,955.0,881.25,927.0,7109960.0,"Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2",Drug maker Lupin on Thursday reported a consolidated net loss,negative,negative,3.459821428571429,positive,2.154427645788342,positive
2021-10-28 14:33:45.000,896.0,955.0,881.25,927.0,7109960.0,"Lupin Standalone September 2021 Net Sales At Rs 2,870.17 Crore, Down 5.67% Y-o-Y",,neutral,neutral,3.459821428571429,positive,2.154427645788342,positive
2021-10-28 14:44:47.000,896.0,955.0,881.25,927.0,7109960.0,"Lupin Consolidated September 2021 Net Sales At Rs 4,091.33 Crore, Up 6.68% Y-o-Y",,neutral,neutral,3.459821428571429,positive,2.154427645788342,positive
2021-10-28 15:21:47.000,896.0,955.0,881.25,927.0,7109960.0,Q2 Results: Lupin’s Loss An One-Off Event?,Q2 Results: Lupin’s Loss An One-Off Event?,neutral,neutral,3.459821428571429,positive,2.154427645788342,positive
2021-10-28 17:01:00.000,896.0,955.0,881.25,927.0,7109960.0,"Lupin logs a Q2 consolidated net loss of Rs2,094.9cr, remains focused on ramping-up revenues in US market","In the quarter, sales stood at Rs4,003.4cr increasing by 5.9% yoy but lower by 5.5% qoq.",positive,positive,3.459821428571429,positive,2.154427645788342,positive
2021-10-28 18:51:00.000,896.0,955.0,881.25,927.0,7109960.0,"Lupin says trying to find marketing partner, or open to possible sale of specialty drug Solosec","Indian drug makers like Lupin, Dr Reddy’s, Sun Pharma, among others have placed bets on specialty drugs that are protected by patents as strategy to mitigate the rapid price erosion and commoditization of plain vanilla generic drugs in the US.",neutral,positive,3.459821428571429,positive,2.154427645788342,positive
2021-10-29 00:53:57.000,896.0,955.0,881.25,927.0,7109960.0,Settling regulatory hurdles in the US will be crucial for Lupin,"Lupin, however, needs to resolve the long-standing issues with the US drug regulator pertaining to its multiple manufacturing facilities",neutral,neutral,3.459821428571429,positive,2.154427645788342,positive
2021-10-29 08:45:00.000,896.0,955.0,881.25,927.0,7109960.0,"Stocks to Watch: IRCTC, Airtel, SBI Cards, DLF, Tata Power, Lupin, Escorts","IRCTC and Bharti Airtel could be in focus owing to negative news flow, apart from the stocks that are likely to react to corporate earnings",neutral,negative,3.459821428571429,positive,2.154427645788342,positive
2021-10-29 09:35:57.000,896.0,955.0,881.25,927.0,7109960.0,"Lupin Q2 Review - Operationally Disappointing, Reset Mode On, U.S. To Kick From FY23/24E: Dolat Capital","Lupin Q2 Review - Operationally Disappointing, Reset Mode On, U.S. To Kick From FY23/24E: Dolat Capital",neutral,neutral,3.459821428571429,positive,2.154427645788342,positive
2021-10-29 10:11:21.000,896.0,955.0,881.25,927.0,7109960.0,Lupin: Competitive Pressure Remains In The US Market,"Lupin guided for 16 percent EBITDA margin in H1 of FY22. While sequentially it indicates normalisation, given the elevated pricing pressure in the US market, execution will be closely monitored",neutral,positive,3.459821428571429,positive,2.154427645788342,positive
2021-10-29 11:12:57.000,896.0,955.0,881.25,927.0,7109960.0,"Buy Lupin; Target Of Rs 1,210: Sharekhan","Sharekhan is bullish on Lupin has recommended buy rating on the stock with a revised PT of 1,210 in its research report dated October 28, 2021.",neutral,positive,3.459821428571429,positive,2.154427645788342,positive
2021-10-29 12:39:36.000,896.0,955.0,881.25,927.0,7109960.0,Lupin Q2 Results Review: Shares Jump Most In Six Months As Analysts See U.S. Sales Recovery,Here’s what brokerages have to say about Lupin’s Q2 FY22 results:,neutral,neutral,3.459821428571429,positive,2.154427645788342,positive
2021-10-29 12:44:55.000,896.0,955.0,881.25,927.0,7109960.0,"Lupin Standalone September 2021 Net Sales At Rs 2,870.17 Crore, Down 5.67% Y-o-Y",,neutral,neutral,3.459821428571429,positive,2.154427645788342,positive
2021-10-29 12:58:00.000,896.0,955.0,881.25,927.0,7109960.0,"Results Review For Bajaj Auto, Marico, United Spirits, Gujarat Gas, Lupin, Dalmia","Results Review For Bajaj Auto, Marico, United Spirits, Gujarat Gas, Lupin, Dalmia",neutral,neutral,3.459821428571429,positive,2.154427645788342,positive
2021-10-29 14:22:36.000,896.0,955.0,881.25,927.0,7109960.0,"Lupin Consolidated September 2021 Net Sales At Rs 4,091.33 Crore, Up 6.68% Y-o-Y",,neutral,neutral,3.459821428571429,positive,2.154427645788342,positive
2021-11-01 06:35:00.000,926.0,947.85,920.6,945.95,1013984.0,"Nifty Pharma gains 1% amid bullish markets; Dr Reddy’s, Lupin and Alkem Lab in the fast lane","Glenmark, Sun Pharma, and Divis Lab gained over 1%. Laurus Labs dragged over 4.5%.",positive,positive,2.154427645788342,positive,-1.762253996728743,negative
2021-11-03 19:34:00.000,940.0,941.0,932.0,934.0,62764.0,Drug firm Lupin launches generic Fenofibrate capsules in United States,Lupin on Wednesday said it has launched the capsules,positive,neutral,-0.6382978723404255,neutral,-0.53475935828877,neutral
2021-11-04 11:53:00.000,940.0,941.0,932.0,934.0,62764.0,Lupin’s Namuscla is recommended by NICE for treatment of symptomatic myotonia in adults,Namuscla is licensed in the European Union and the UK for the symptomatic treatment of myotonia inadults with NDM.,neutral,positive,-0.6382978723404255,neutral,-0.53475935828877,neutral
2021-11-04 14:51:42.000,940.0,941.0,932.0,934.0,62764.0,"Stocks To Watch: Eicher Motors, HCL Tech, Pfizer, Gujarat State Petronet, PNB, Lupin",Here are the stocks to watch in trade today...,neutral,neutral,-0.6382978723404255,neutral,-0.53475935828877,neutral
2021-11-04 17:40:00.000,940.0,941.0,932.0,934.0,62764.0,"HCL Tech, Eicher Motors, Pfizer, Lupin in focus",HCL Technologies has launched its Amazon Web Services (AWS) Business Unit (AWS BU) to help enterprises worldwide accelerate their cloud transformation journey.,neutral,positive,-0.6382978723404255,neutral,-0.53475935828877,neutral
2021-11-04 18:30:00.000,940.0,941.0,932.0,934.0,62764.0,Lupin receives NICE recommendation for Namuscla for treatment of myotonia in adults with NDM,Namuscla is licensed in the European Union and the UK for the symptomatic treatment of myotonia in adults with NDM.,positive,positive,-0.6382978723404255,neutral,-0.53475935828877,neutral
2021-11-07 10:42:43.000,935.0,935.95,912.0,930.0,600192.0,"Sun Pharma, Lupin Recall Products In US Market","As per the latest enforcement report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling 22,752 blister packs of Loratadine-D extended-release tablets, used for the treatment of allergic rhinitis and the common cold, in the US market.",neutral,negative,-0.53475935828877,neutral,0.5682427361423774,neutral
2021-11-07 11:00:00.000,935.0,935.95,912.0,930.0,600192.0,"Sun Pharma, Lupin recall products in US market","According to USFDA, the Mumbai-based drug maker is recalling the affected lot due to “failed moisture limits.”",negative,negative,-0.53475935828877,neutral,0.5682427361423774,neutral
2021-11-07 12:25:00.000,935.0,935.95,912.0,930.0,600192.0,"Leading drug makers Sun Pharma, Lupin recall products in US market","According to USFDA, the Mumbai-based drug maker is recalling the affected lot due to “failed moisture limits.”",negative,negative,-0.53475935828877,neutral,0.5682427361423774,neutral
2021-11-07 17:30:00.000,935.0,935.95,912.0,930.0,600192.0,"Sun Pharma, Lupin recall products in US market, says USFDA","As per the latest enforcement report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling 22,752 blister packs of Loratadine-D extended-release tablets, used for the treatment of allergic rhinitis and the common cold, in the US market.",negative,negative,-0.53475935828877,neutral,0.5682427361423774,neutral
2021-11-08 08:42:00.000,935.0,935.95,912.0,930.0,600192.0,"Grasim Industries, Sun Pharma, PVR, Lupin in focus","Grasim Industries said it commissioned Chloromethane (CMS) project at Vilayat Unit in Gujarat on 4 November 2021. Grasim Industries said the project has a capacity of 150 ton per day (TPD) / 50,000 ton per annum (TPA). It will cater to both",neutral,positive,-0.53475935828877,neutral,0.5682427361423774,neutral
2021-11-08 08:54:00.000,935.0,935.95,912.0,930.0,600192.0,Lupin’s Namuscla (mexiletine) recommended by NICE for treatment of symptomatic myotonia,Namuscla is licensed in the European Union and the UK for the symptomatic treatment of myotonia in adults with NDM.,neutral,positive,-0.53475935828877,neutral,0.5682427361423774,neutral
2021-11-09 08:24:00.000,932.7,942.55,926.5,938.0,672627.0,"Lupin, Sun Pharma confirms voluntary recall of products in US market; Stocks trade mixed",Both the companies have clarified stock exchanges over news reports claiming the same.,negative,neutral,0.5682427361423774,neutral,0.5490990510715404,neutral
2021-11-09 15:11:00.000,937.9,949.6,934.95,943.05,863419.0,Lupin receives credit ratings for bank facilities,From ICRA,neutral,neutral,0.5490990510715404,neutral,-0.7483679210232954,neutral
2021-11-09 18:26:00.000,937.9,949.6,934.95,943.05,863419.0,"Lupin’s consumer healthcare biz wins the best packaging design, graphics and brand value add award",This award is an initiative by Informa Markets in India to honour the best branding initiatives from the pharma packaging space.,positive,positive,0.5490990510715404,neutral,-0.7483679210232954,neutral
2021-11-10 09:31:07.000,937.9,949.6,934.95,943.05,863419.0,Lupin raises awareness about mental health,Powered by Capital Market - Live News,neutral,neutral,0.5490990510715404,neutral,-0.7483679210232954,neutral
2021-11-10 18:04:00.000,942.05,943.9,927.0,935.0,435740.0,Lupin assigns credit rating on enhanced bank facilities,A1+ is the highest rating by ICRA for short-term bank facilities.,neutral,neutral,-0.7483679210232954,neutral,0.8501594048884166,neutral
2021-11-17 16:42:00.000,907.0,907.0,891.0,898.0,1050982.0,Nifty Pharma under pressure; Healthcare stocks surge over 1%; Apollo Hospitals hits new high,"Metropolis Healthcare, Torrent Pharma, and Biocon were also in the fast lane. IPCA Labs, Lupin, Glenmark, Star, Auro Pharma, and Divis Lab were under pressure.",positive,neutral,-0.9922822491730982,negative,-3.4073909911906477,negative
2021-11-18 13:25:00.000,907.0,907.0,891.0,898.0,1050982.0,Lupin share price down 0.87 per cent,"A total of 47,511 shares changed hands on the counter till 01:25PM (IST).",negative,neutral,-0.9922822491730982,negative,-3.4073909911906477,negative
2021-11-22 09:43:00.000,902.45,902.45,868.45,871.7,1151799.0,"Sell Lupin, target price Rs 850: Chandan Taparia","Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Other Operating Revenue and Other Services for the year ending 31-Mar-2021.",neutral,neutral,-3.4073909911906477,negative,2.186421173762946,positive
2021-11-22 13:36:00.000,869.0,888.6,863.15,888.0,803680.0,Lupin shares drop 2.71% as Sensex falls,"A total of 53,139 shares changed hands on the counter till 01:36PM (IST)",negative,neutral,2.186421173762946,positive,0.4720161834120078,neutral
2021-11-22 15:11:00.000,869.0,888.6,863.15,888.0,803680.0,"Hero MotoCorp, Lupin, Colgate, Aurobindo, Amara Raja hit 52-week lows","In past four trading days, the S&P BSE Sensex has tanked 4 per cent or 2,412 points on concerns about European Covid-19 curbs and on risk of the US Federal Reserve speeding up stimulus withdrawal.",neutral,positive,2.186421173762946,positive,0.4720161834120078,neutral
2021-11-24 11:32:00.000,889.8,901.0,885.25,894.0,839493.0,Lupin shares gain 1.73% as Sensex rises,The stock quoted a 52-week high of Rs 1267.5 and a 52-week low of Rs 863.55.,positive,negative,0.4720161834120078,neutral,0.3568242640499605,neutral
2021-11-25 12:08:00.000,894.0,931.0,891.65,916.0,2234218.0,Lupin shares gain 0.51% as Sensex rises,"A total of 29,428 shares changed hands on the counter till 12:08PM (IST)",positive,neutral,2.460850111856823,positive,-4.311364369422645,negative
2021-11-30 11:31:34.000,893.9,898.75,877.15,883.0,1884521.0,Lupin launches Sciflix for post-graduate medical students,Powered by Capital Market - Live News,neutral,neutral,-1.2193757691016869,negative,-1.7867176087200782,negative
2021-11-30 11:54:21.000,893.9,898.75,877.15,883.0,1884521.0,Lupin announces launch of educational mobile website Sciflix,It will assist future pulmonologists in staying abreast of the latest medical advances relevant to their speciality,neutral,neutral,-1.2193757691016869,negative,-1.7867176087200782,negative
2021-11-30 12:13:00.000,889.9,895.0,864.05,874.0,1071231.0,Lupin launches educational website Sciflix for medical students,"Sciflix is a comprehensive learning platform in pulmonology where all scientific needs of postgraduate students will be addressed by a multisource library under one roof, the company said in a regulatory filing.",neutral,neutral,-1.7867176087200782,negative,-0.3416856492027335,neutral
2021-11-30 12:17:37.000,889.9,895.0,864.05,874.0,1071231.0,Lupin Launches Educational Website Sciflix For Medical Students,"Sciflix is a comprehensive learning platform in pulmonology where all scientific needs of postgraduate students will be addressed by a multisource library under one roof, the company said in a regulatory filing.",neutral,neutral,-1.7867176087200782,negative,-0.3416856492027335,neutral
2021-11-30 12:21:35.000,889.9,895.0,864.05,874.0,1071231.0,Lupin launches mobile compatible educational website for medical students,"Sciflix is a comprehensive learning platform in pulmonology where all scientific needs of postgraduate students will be addressed by a multisource library under one roof, the company said in a regulatory filing.",neutral,neutral,-1.7867176087200782,negative,-0.3416856492027335,neutral
2021-11-30 13:26:47.000,889.9,895.0,864.05,874.0,1071231.0,"Lupin launches Sciflix, a mobile-friendly learning platform, for postgraduate students","Lupin launches Sciflix, a mobile-friendly learning platform, for postgraduate students",neutral,neutral,-1.7867176087200782,negative,-0.3416856492027335,neutral
2021-11-30 14:10:00.000,889.9,895.0,864.05,874.0,1071231.0,Lupin shares up 0.34% as Nifty gains,"A total of 60,935 shares changed hands on the counter till time (IST).",positive,neutral,-1.7867176087200782,negative,-0.3416856492027335,neutral
2021-11-30 17:12:00.000,889.9,895.0,864.05,874.0,1071231.0,Lupin launches Sciflix a mobile friendly learning platform for post graduate students specializing in pulmonology,The platform will help students pursuing pulmonology access the latest research and medical innovations at the touch of their fingertips.,neutral,neutral,-1.7867176087200782,negative,-0.3416856492027335,neutral
2021-12-01 13:04:00.000,878.0,883.6,867.7,875.0,1014734.0,Shares of Lupin fall as Nifty gains,"On the technical charts, the 200-day moving average of the stock stood at Rs 1049.91.",positive,neutral,-0.3416856492027335,neutral,-0.3645477329687778,neutral
2021-12-02 06:52:00.000,878.0,883.6,867.7,875.0,1014734.0,Lupin’s subsidiary partners with TTP for Soft-mist Inhalation Technology Platform,Lupin expects to provide healthcare professionals with alternative solutions for delivering affordable Inhaled medicines to patients across the globe.,neutral,positive,-0.3416856492027335,neutral,-0.3645477329687778,neutral
2021-12-02 10:52:00.000,878.0,883.6,867.7,875.0,1014734.0,Lupin partners with TTP plc UK for Soft-mist Inhalation Technology Platform,"By leveraging this technology, Lupin expects to provide healthcare professionals with alternative solutions for delivering affordable Inhaled medicines to patients across the globe.",neutral,positive,-0.3416856492027335,neutral,-0.3645477329687778,neutral
2021-12-02 11:05:00.000,878.0,883.6,867.7,875.0,1014734.0,"Lupin subsidary, TTP PLC sign deal to develop soft-mist inhalation technology platform","The wholly-owned subsidiary of Lupin, Lupin Inc., entered into an agreement with UK-based TTP PLC to buy exclusive worldwide rights to develop, manufacture & commercialize Inhalation products using TTP’s soft-mist inhalation technology platform.",positive,positive,-0.3416856492027335,neutral,-0.3645477329687778,neutral
2021-12-02 11:59:00.000,878.0,883.6,867.7,875.0,1014734.0,"Lupin acquires exclusive rights to develop, manufacture TTP inhalation products","By leveraging this technology, Lupin expects to provide healthcare professionals with alternative solutions for delivering affordable inhaled medicines to patients across the globe",positive,positive,-0.3416856492027335,neutral,-0.3645477329687778,neutral
2021-12-03 12:28:00.000,877.8,884.0,871.05,874.6,835398.0,Lupin shares gain 0.19% as Sensex falls,"A total of 27,107 shares changed hands on the counter till 12:28PM (IST)",positive,neutral,-0.3645477329687778,neutral,-2.267174271265417,negative
2021-12-03 16:24:08.000,877.8,884.0,871.05,874.6,835398.0,Upskilling start-up Vani.Coach eyeing $2mn fund raise,"The B2B firm started operation about six-months back and counts companies such as L&T, Lupin, CEAT, Cipla, Reckitt Benckiser and Kotak Mahindra Bank as its clients.",positive,neutral,-0.3645477329687778,neutral,-2.267174271265417,negative
2021-12-03 20:26:00.000,877.8,884.0,871.05,874.6,835398.0,"Drug maker Lupin inks pact to distribute, market Pegfilgrastim in Brazil",The company has entered into an exclusive distribution and marketing agreement with Biomm SA in Brazil,neutral,positive,-0.3645477329687778,neutral,-2.267174271265417,negative
2021-12-06 07:48:44.000,879.95,882.85,856.05,860.0,785710.0,"Stocks To Watch: Tech Mahindra, Eris Lifesciences, Lupin, Carborundum Universal",Here are the stocks to watch in trade today...,neutral,neutral,-2.267174271265417,negative,0.3704561241028068,neutral
2021-12-06 08:26:00.000,879.95,882.85,856.05,860.0,785710.0,"Stocks in the news: Tata Motors, Tech Mahindra, SBI, Lupin and IB Housing","With input costs continuing to rise, automaker like Tata Motors are looking to increase vehicle prices from January next year to offset the impact.",neutral,positive,-2.267174271265417,negative,0.3704561241028068,neutral
2021-12-06 08:35:00.000,879.95,882.85,856.05,860.0,785710.0,"Tech Mahindra, Godrej Properties, Lupin in spotlight","Tech Mahindra announced that it has acquired a 100% stake in US-based Activus Connect, a leading provider of work at home customer experience management solutions. For the financial year ended 31 December 2020, it recorded revenue of $17 million.",neutral,positive,-2.267174271265417,negative,0.3704561241028068,neutral
2021-12-06 09:35:04.000,879.95,882.85,856.05,860.0,785710.0,Stocks that will see action today,"Buzzing stocks: Tech Mahindra, Jet Airways, SBI, RSWM, PTC India Financial, Anjani Portland, Lupin, CUMI, Narayana Hrudayalaya, Steelcast",neutral,neutral,-2.267174271265417,negative,0.3704561241028068,neutral
2021-12-06 13:00:00.000,863.8,875.9,853.5,867.0,815892.0,"Top stocks in focus: Nykaa, PTC India Financial Services, Tech Mahindra, Lupin, GAIL",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.3704561241028068,neutral,2.2768983711860544,positive
2021-12-06 15:20:00.000,863.8,875.9,853.5,867.0,815892.0,Lupin and Biomm enter into a Distribution and Marketing Agreement for Pegfilgrastim in Brazil,Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy.,neutral,neutral,0.3704561241028068,neutral,2.2768983711860544,positive
2021-12-06 17:30:00.000,863.8,875.9,853.5,867.0,815892.0,"Stocks in news: Tata Motors, MRPL, Tech Mahindra, Lupin and more","Stocks in news: Tata Motors, MRPL, Tech Mahindra, Lupin, Indiabulls Housing Finance and more",neutral,neutral,0.3704561241028068,neutral,2.2768983711860544,positive
2021-12-07 12:27:00.000,871.8,891.85,869.45,891.65,1786132.0,Lupin share price up 0.91 per cent,"A total of 17,785 shares changed hands on the counter till 12:27PM (IST).",positive,neutral,2.2768983711860544,positive,-0.9415566326814914,negative
2021-12-10 08:05:00.000,885.0,894.45,880.6,883.4,655196.0,Lupin launches Diagnostics Business in India,"As part of its strategy to provide integrated healthcare in India, Lupin Diagnostics, a wholly owned subsidiary of Lupin has formally commenced operations.",neutral,neutral,-0.1807909604519799,neutral,-1.5242881072026775,negative
2021-12-10 13:31:06.000,885.0,894.45,880.6,883.4,655196.0,Lupin forays into diagnostics segment,The company launches Lupin Diagnostics in India,neutral,neutral,-0.1807909604519799,neutral,-1.5242881072026775,negative
2021-12-10 13:42:00.000,885.0,894.45,880.6,883.4,655196.0,Lupin announces launch of its diagnostics business,"Commenting on the development, Lupin Managing Director Nilesh Gupta said, “combining decades of experience and knowledge in the field of therapeutics, we aim to provide our doctors, patients and consumers with the same experience offering quality diagnostic services that are built on trust.”",neutral,positive,-0.1807909604519799,neutral,-1.5242881072026775,negative
2021-12-10 13:48:00.000,885.0,894.45,880.6,883.4,655196.0,Pharma major Lupin announces launch of its diagnostics business,Homegrown pharma major Lupin Ltd on Friday announced the launch of its diagnostics arm as part of its strategy to provide integrated healthcare in India.,neutral,positive,-0.1807909604519799,neutral,-1.5242881072026775,negative
2021-12-10 15:41:00.000,885.0,894.45,880.6,883.4,655196.0,"Communication fitness firm vani.coach to skill corp execs, eyes $15 mn ARR","Pune-based firm counts Lupin, L&T, Asian Paints, Reckitt and Cipla among clients; has raised a pre-seed round of $150,000, and is now in talks with some venture capitalists for a seed round",neutral,positive,-0.1807909604519799,neutral,-1.5242881072026775,negative
2021-12-10 16:11:48.000,885.0,894.45,880.6,883.4,655196.0,"Lupin Launches Diagnostic Labs, To Expand Pan-India",Lupin forayed into diagnostics as part of the drugmaker’s strategy to provide integrated healthcare in India.,neutral,positive,-0.1807909604519799,neutral,-1.5242881072026775,negative
2021-12-10 16:23:21.000,885.0,894.45,880.6,883.4,655196.0,Pharma firm Lupin forays into diagnostics business,Pharma firm Lupin forays into diagnostics business,neutral,neutral,-0.1807909604519799,neutral,-1.5242881072026775,negative
2021-12-10 17:30:00.000,885.0,894.45,880.6,883.4,655196.0,Lupin announces launch of diagnostics business in India,"Lupin also stated that it has established a 45,000 sq ft National Reference Laboratory in Navi Mumbai.",neutral,neutral,-0.1807909604519799,neutral,-1.5242881072026775,negative
2021-12-10 18:20:00.000,885.0,894.45,880.6,883.4,655196.0,"Lupin to set up 100 diagnostic labs and 1,000 collection centres in 5 yrs",Announced foray into fragmented diagnostic business where organised chains have less than 20% share of overall business,neutral,neutral,-0.1807909604519799,neutral,-1.5242881072026775,negative
2021-12-10 20:01:00.000,885.0,894.45,880.6,883.4,655196.0,"Lupin forays into diagnostics, to open 100 labs pan India in next 3 years","The company launched operations with 11 labs including a 45,000 square feet national reference lab in Navi Mumbai and 200 collection centres in West and East India. The drug maker said it plans to open over 100 labs across and 1000 collection centres across India in the next three years. About 90% o…",positive,neutral,-0.1807909604519799,neutral,-1.5242881072026775,negative
2021-12-12 12:38:00.000,895.5,896.35,877.7,881.85,1370564.0,"Lupin recalls 4,113 cartons of oral contraceptive medicine in US market","The company is recalling the lot due to it being “Subpotent Drug”, the US health regulator noted in the report.",neutral,negative,-1.5242881072026775,negative,6.802145074795371,positive
2021-12-13 06:10:00.000,895.5,896.35,877.7,881.85,1370564.0,Lupin’s foray into diagnostics appears a calculated risk,"The under-performing pharma company’s foray into a competitive services business like diagnostics may seem counter-intuitive, as Lupin has been facing many challenges in its US business, including pricing pressure, increased competitive intensity, compliance and drug settlement costs.",neutral,negative,-1.5242881072026775,negative,6.802145074795371,positive
2021-12-13 07:32:00.000,895.5,896.35,877.7,881.85,1370564.0,"Stocks to Watch: RIL, Lupin, SBI, Maruti, PowerGrid, Minda, BoM, Vedanta",Maruti Suzuki India (MSI) is currently analysing customer feedback to ascertain if the Jimny brand can be introduced in India,neutral,neutral,-1.5242881072026775,negative,6.802145074795371,positive
2021-12-13 07:59:27.000,895.5,896.35,877.7,881.85,1370564.0,"Stocks to Watch: RIL, ONGC, Vedanta, Lupin","Tega Industries will make its debut on stock exchanges today. The IPO was subscribed 219 times by the end of the bidding, making it one of the most successful issues of this year. The initial share sale was of up to 1,36,69,478 equity shares and had a price range of ₹443-453 a share",neutral,neutral,-1.5242881072026775,negative,6.802145074795371,positive
2021-12-13 08:16:00.000,895.5,896.35,877.7,881.85,1370564.0,"Stocks in the news: Tega Industries, ONGC, Vedanta, Lupin, Tata Motors",Tega Industries will make a its Dalal Street debut on Monday. The Rs 619.23 crore issue was open for subscription between December 1-3 in the price range of Rs 443-453 per share.,neutral,neutral,-1.5242881072026775,negative,6.802145074795371,positive
2021-12-13 11:06:00.000,895.5,896.35,877.7,881.85,1370564.0,Lupin shares up 0.89% as Nifty gains,"A total of 8,061 shares changed hands on the counter till time (IST).",positive,neutral,-1.5242881072026775,negative,6.802145074795371,positive
2021-12-13 17:30:00.000,885.75,972.4,882.6,946.0,10433447.0,"Stocks in news: Tega Industries, Tata Motors, Vedanta, Reliance Industries and more","Stocks in news: Lupin, Bank of Maharashtra, IIFL Securities, Sterlite Technologies, Reliance Industries, Tega Industries, Tata Motors, Vedanta and more",neutral,neutral,6.802145074795371,positive,-2.841871295512268,negative
2021-12-14 06:57:00.000,885.75,972.4,882.6,946.0,10433447.0,Lupin stock zooms over 5% after its Goa manufacturing plant gets EIR from USFDA,FDA changes inspection classification of facility to Voluntary Action Indicated.,neutral,neutral,6.802145074795371,positive,-2.841871295512268,negative
2021-12-14 10:00:00.000,885.75,972.4,882.6,946.0,10433447.0,Lupin shares gain 6.23% as Sensex falls,"A total of 82,371 shares changed hands on the counter till 10:00AM (IST)",positive,neutral,6.802145074795371,positive,-2.841871295512268,negative
2021-12-14 10:09:00.000,885.75,972.4,882.6,946.0,10433447.0,Lupin in demand after manufacturing facility gets EIR USFDA,Lupin jumped 6.78% to Rs 944 after the drug maker received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its Goa manufacturing facility.,positive,positive,6.802145074795371,positive,-2.841871295512268,negative
2021-12-14 10:38:00.000,885.75,972.4,882.6,946.0,10433447.0,Lupin surges 10% on good volumes after getting EIR from USFDA for Goa plant,"Despite of today’s gain, the stock has underperformed the market by falling 18 per cent in past six months, as compared to 10.5 per cent rally in the S&P BSE Sensex",positive,positive,6.802145074795371,positive,-2.841871295512268,negative
2021-12-14 11:06:00.000,885.75,972.4,882.6,946.0,10433447.0,Lupin shares jump 10% in a sudden move; here’s why,"The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI), the Mumbai-headquartered company said in a regulatory exchange filing.",positive,neutral,6.802145074795371,positive,-2.841871295512268,negative
2021-12-14 11:28:34.000,885.75,972.4,882.6,946.0,10433447.0,Lupin Share Price Jumps 10% As Goa Plant Receives EIR From USFDA,Analysts had said USFDA scrutiny on Lupin’s Goa plant and Pithampur (unit-II) were key overhangs on the stock,neutral,negative,6.802145074795371,positive,-2.841871295512268,negative
2021-12-14 12:04:16.000,944.8,944.8,915.55,917.95,1623629.0,Patel Engineering Ltd leads gainers in ‘A’ group,"T.V. Today Network Ltd, Lupin Ltd, TV18 Broadcast Ltd and Bombay Burmah Trading Corporation Ltd are among the other gainers in the BSE’s ‘A’ group today, 14 December 2021.",positive,neutral,-2.841871295512268,negative,-2.1374458874458875,negative
2021-12-14 12:37:00.000,944.8,944.8,915.55,917.95,1623629.0,"Lupin receives EIR from USFDA for its Goa manufacturing site, shares gain","Lupin said USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI), which means USFDA will not recommend regulatory or enforcement action because the objectionable conditions do not meet the threshold for action.",positive,neutral,-2.841871295512268,negative,-2.1374458874458875,negative
2021-12-14 13:12:04.000,944.8,944.8,915.55,917.95,1623629.0,Lupin shares jump over 7 per cent,USFDA’s inspection report a shot in the arm for the company,positive,neutral,-2.841871295512268,negative,-2.1374458874458875,negative
2021-12-14 13:50:08.000,944.8,944.8,915.55,917.95,1623629.0,Lupin receives EIR for its Goa manufacturing facility,Powered by Capital Market - Live News,neutral,neutral,-2.841871295512268,negative,-2.1374458874458875,negative
2021-12-14 16:44:00.000,944.8,944.8,915.55,917.95,1623629.0,Lupin receives inspection report from USFDA for Goa manufacturing facility,Homegrown pharma major Lupin Ltd on Tuesday said it has received the Establishment Inspection Report (EIR) from USFDA for its Goa manufacturing facility after an inspection in Sept 2021,neutral,positive,-2.841871295512268,negative,-2.1374458874458875,negative
2021-12-14 17:39:59.000,944.8,944.8,915.55,917.95,1623629.0,Lupin Shares Jump As U.S. FDA Paves Way For Fresh Approvals From Goa,The U.S. FDA has determined that the inspection classification of the facility is voluntary action indicated.,neutral,neutral,-2.841871295512268,negative,-2.1374458874458875,negative
2021-12-14 17:40:00.000,944.8,944.8,915.55,917.95,1623629.0,"Nifty Pharma shrugs off weak markets, index soars nearly 1%; Lupin surges 6%; Aurobindo, Gland, Torrent Pharma add to gains","Auro Pharma, Gland Pharma, and Torrent Pharma also outperformed. Strides Pharma and Abbot India were under pressure.",positive,positive,-2.841871295512268,negative,-2.1374458874458875,negative
2021-12-14 18:18:04.000,944.8,944.8,915.55,917.95,1623629.0,Lupin - Inspection Report For Goa Facility From U.S. FDA Provides Significant Respite: ICICI Direct,Lupin - Inspection Report For Goa Facility From U.S. FDA Provides Significant Respite: ICICI Direct,neutral,neutral,-2.841871295512268,negative,-2.1374458874458875,negative
2021-12-14 19:13:00.000,944.8,944.8,915.55,917.95,1623629.0,"US FDA clears Lupin’s Goa plant, paves way for new product approvals","Goa plant has an annual capacity of 6 billion units of tablets, capsules or oral suspension drugs. It accounts for 18-20% of firm’s US revenue",positive,neutral,-2.841871295512268,negative,-2.1374458874458875,negative
2021-12-15 08:19:00.000,944.8,944.8,915.55,917.95,1623629.0,"Stocks to Watch: ITC, Lupin, ABFRL, Glenmark, NBFCs, Tata group stocks",The RBI on Tuesday introduced a prompt corrective action (PCA) framework for large non-banking financial companies (NBFCs),neutral,neutral,-2.841871295512268,negative,-2.1374458874458875,negative
2021-12-15 10:09:29.000,944.8,944.8,915.55,917.95,1623629.0,Lupin - U.S. FDA Regulatory Hurdle Crossed At Goa: Motilal Oswal,Lupin - U.S. FDA Regulatory Hurdle Crossed At Goa: Motilal Oswal,neutral,neutral,-2.841871295512268,negative,-2.1374458874458875,negative
2021-12-15 12:06:00.000,924.0,924.9,897.5,904.25,801939.0,"Hold Lupin, target price Rs 1015: ICICI Direct","Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 42043.22 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-2.1374458874458875,negative,-3.482587064676617,negative
2021-12-15 16:10:00.000,924.0,924.9,897.5,904.25,801939.0,"Nifty Pharma joins bear markets, index sheds 1%; Pfizer, Divis Lab, Lupin, Dr Reddy’s weigh down","Pfizer was the top bear on the index nosediving around 3% at Rs5,039 per piece.",neutral,neutral,-2.1374458874458875,negative,-3.482587064676617,negative
2021-12-16 12:35:00.000,904.5,907.2,870.25,873.0,1278291.0,Lupin declines 2.26% as Sensex climbs,"The stock traded at a P/E multiple of -62.26, while the price-to-book value ratio stood at 3.36.",negative,neutral,-3.482587064676617,negative,0.2580275229357798,neutral
2021-12-16 17:13:00.000,904.5,907.2,870.25,873.0,1278291.0,"US business rebound key to further upsides in Lupin, VAI may offer relief",Clearance for Goa unit is positive; near-term triggers are new launches and market share gains,positive,positive,-3.482587064676617,negative,0.2580275229357798,neutral
2021-12-17 00:10:09.000,904.5,907.2,870.25,873.0,1278291.0,US FDA hands a chill pill to Lupin,"Faster approval of products are crucial for Lupin, which has been under pressure in its US business",neutral,positive,-3.482587064676617,negative,0.2580275229357798,neutral
2021-12-17 10:10:00.000,904.5,907.2,870.25,873.0,1278291.0,"Buy Lupin, target price Rs 1150: Emkay Global","Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 40422.33 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-3.482587064676617,negative,0.2580275229357798,neutral
2021-12-17 15:23:40.000,904.5,907.2,870.25,873.0,1278291.0,Neutral Lupin; Target Of Rs 990: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 990 in its research report dated December 14, 2021.",neutral,neutral,-3.482587064676617,negative,0.2580275229357798,neutral
2021-12-17 17:25:00.000,904.5,907.2,870.25,873.0,1278291.0,"Lupin allots 53,374 equity shares under ESOP","In view of the above, the issued and paid-up capital of the Company has been increased to Rs 90,83,93,732 consisting 45,41,96,866 equity shares of 2/- each.",neutral,neutral,-3.482587064676617,negative,0.2580275229357798,neutral
2021-12-20 15:08:23.000,880.0,885.5,873.05,875.0,689428.0,Hold Lupin; Target Of Rs 1015: ICICI Direct,"ICICI Direct recommended hold rating on Lupin with a target price of Rs 1015 in its research report dated December 14, 2021.",neutral,positive,-0.5681818181818182,neutral,3.0786773090079818,positive
2021-12-21 15:17:56.000,877.0,908.2,875.55,904.0,1274923.0,Buy Lupin: Target Of Rs 1210: Sharekhan,"Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1210 in its research report dated December 20, 2021.",neutral,positive,3.0786773090079818,positive,0.3909691629955897,neutral
2021-12-22 13:31:21.000,908.0,914.1,898.75,911.55,1037000.0,Lupin Ltd soars 1.86%,"Lupin Ltd is quoting at Rs 892, up 1.86% on the day as on 12:54 IST on the NSE. The stock is down 7.41% in last one year as compared to a 24.2% jump in NIFTY and a 5.4% jump in the Nifty Pharma index.",positive,positive,0.3909691629955897,neutral,-1.8545872312489795,negative
2021-12-24 10:13:00.000,913.95,925.7,895.6,897.0,1352430.0,Lupin receives USFDA approval for Azilsartan Medoxomil Tablets,Azilsartan Medoxomil Tablets (RLD: Edarbi Tablets) had estimated annual sales of USD 103.4 million in the U.S. (IQVIA MAT September 2021).,positive,neutral,-1.8545872312489795,negative,1.5545474662536034,positive
2021-12-24 10:17:00.000,913.95,925.7,895.6,897.0,1352430.0,Lupin receives USFDA nod on Azilsartan Medoxomil tablets,"Global pharma major Lupin intimated that it has secured a tentative approval from the US-based drug regulator, United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Azilsartan Medoxomil tablets.",neutral,positive,-1.8545872312489795,negative,1.5545474662536034,positive
2021-12-24 12:00:56.000,913.95,925.7,895.6,897.0,1352430.0,Lupin Receives Tentative USFDA Nod For Generic Azilsartan Medoxomil Tablets,"The tentative approval by the US Food and Drug Administration (USFDA) for the abbreviated new drug application (ANDA) Azilsartan Medoxomil tablets is for strengths of 40 mg and 80 mg, Lupin said in a regulatory filing.",neutral,positive,-1.8545872312489795,negative,1.5545474662536034,positive
2021-12-24 14:20:00.000,913.95,925.7,895.6,897.0,1352430.0,Lupin receives tentative USFDA nod for generic Azilsartan Medoxomil tablets,The tentative approval by the US Food and Drug Administration (USFDA) for the abbreviated new drug application (ANDA) Azilsartan Medoxomil tablets is for strengths of 40 mg and 80 mg,neutral,positive,-1.8545872312489795,negative,1.5545474662536034,positive
2021-12-24 15:23:00.000,913.95,925.7,895.6,897.0,1352430.0,Lupin gets tentative approval from USFDA for Azilsartan Medoxomil Tablets,This product will be manufactured at Lupin’s Nagpur facility in India.,positive,neutral,-1.8545872312489795,negative,1.5545474662536034,positive
2021-12-27 05:30:00.000,903.8,918.0,900.0,917.85,1572870.0,Lupin Climbs Over 2% on Monday; Shares Rise 7.3% in 6 Sessions: Details,Lupin Climbs Over 2% on Monday; Shares Rise 7.3% in 6 Sessions: Details,neutral,neutral,1.5545474662536034,positive,-0.2233115468409536,neutral
2021-12-27 07:45:00.000,903.8,918.0,900.0,917.85,1572870.0,"Stocks in the news: HP Adhesives, RIL, Aster DM, Lupin, IDBI Bank and RBL Bank","HP Adhesives, the adhesive and sealant company will be listed today as the company raised Rs 125.96 crore via its IPO between December 15-17 as the company sold its share in the range of Rs 262-274 apiece.",neutral,positive,1.5545474662536034,positive,-0.2233115468409536,neutral
2021-12-27 08:13:00.000,903.8,918.0,900.0,917.85,1572870.0,"Stocks to Watch: HP Adhesives, RBL Bank, Adani Trans, HUL, Lupin, CBI","HP Adhesives is likely to debut with a 20-25 per cent listing gain, as per indications from the GMP",neutral,positive,1.5545474662536034,positive,-0.2233115468409536,neutral
2021-12-27 09:12:17.000,903.8,918.0,900.0,917.85,1572870.0,Stocks that will see action today,"Buzzing stocks: RBL Bank, Paytm, Lupin, Adani Transmission, Ashoka Buildcon, Suzlon, IL&FS Transportation, Prestige L&T, Prestige Estates Projects, GMR",neutral,neutral,1.5545474662536034,positive,-0.2233115468409536,neutral
2021-12-27 09:20:00.000,903.8,918.0,900.0,917.85,1572870.0,Lupin gains on US FDA nod for Renvela generic,Lupin rose 1.55% to Rs 911.10 after the company said that it has received approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) Sevelamer Carbonate for oral suspension.,positive,positive,1.5545474662536034,positive,-0.2233115468409536,neutral
2021-12-27 09:20:00.000,903.8,918.0,900.0,917.85,1572870.0,Lupin gains on US FDA nod for Sevelamer Carbonate generic,Lupin rose 1.55% to Rs 911.10 after the company said that it has received approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) Sevelamer Carbonate for oral suspension.,positive,positive,1.5545474662536034,positive,-0.2233115468409536,neutral
2021-12-27 09:50:31.000,903.8,918.0,900.0,917.85,1572870.0,Lupin Rises 2% On USFDA Nod For Sevelamer Carbonate Used In Treatment Of Chronic Kidney Disease,"The stock touched a 52-week high of Rs 1,267.50 and a 52-week low of Rs 854 on June 2, 2021 and December 20, 2021, respectively.",neutral,negative,1.5545474662536034,positive,-0.2233115468409536,neutral
2021-12-27 10:15:00.000,903.8,918.0,900.0,917.85,1572870.0,Lupin shares rise 1.36% as Sensex slides,"A total of 35,981 shares changed hands on the counter till 10:15AM (IST)",positive,neutral,1.5545474662536034,positive,-0.2233115468409536,neutral
2021-12-27 10:31:00.000,903.8,918.0,900.0,917.85,1572870.0,Lupin gains on USFDA nod to market Sevelamer Carbonate,"According to data for September 2021 released by IQVIA MAT September, Sevelamer Carbonate for oral suspension had estimated annual sales of $51.7 million in the US, news agency PTI reported.",positive,neutral,1.5545474662536034,positive,-0.2233115468409536,neutral
2021-12-27 15:15:00.000,918.0,924.0,913.75,915.95,593731.0,Lupin receives approval from USFDA for Sevelamer Carbonate for Oral Suspension; Stock up 1.5%,This product will be manufactured at Lupin’s Goa facility in India.,positive,neutral,-0.2233115468409536,neutral,1.0893246187363834,positive
2021-12-27 17:30:00.000,918.0,924.0,913.75,915.95,593731.0,"Stocks in news: RIL, Emami Realty, HP Adhesives, RBL Bank and more","Stocks in news: HP Adhesives, RIL, RBL Bank, Lupin, Canara Bank, Adani Transmission, IRCON International, IDBI Bank, Aditya Birla Money, Visagar Polytex, Emami Realty and more",neutral,neutral,-0.2233115468409536,neutral,1.0893246187363834,positive
2021-12-27 17:42:00.000,918.0,924.0,913.75,915.95,593731.0,"Nifty Pharma leads market revival; Index surges over 1%; Lupin, Cipla among top gainers","Laurus Labs, Torrent Pharma, Natco Pharma, and Glenmark Pharma outperformed. Pfizer was under pressure.",positive,positive,-0.2233115468409536,neutral,1.0893246187363834,positive
2021-12-28 13:39:00.000,918.0,934.9,918.0,928.0,1204983.0,Lupin stock price up 0.25 per cent as Sensex climbs,"As of 30-Sep-2021, promoters held 46.54 per cent stake in the company, while FIIs held 15.66 per cent and domestic institutional investors had 13.33 per cent.",positive,neutral,1.0893246187363834,positive,1.6378378378378355,positive
2021-12-29 10:40:00.000,918.0,934.9,918.0,928.0,1204983.0,Lupin share price up 1.23 per cent,"A total of 22,719 shares changed hands on the counter till 10:40AM (IST).",positive,neutral,1.0893246187363834,positive,1.6378378378378355,positive
2021-12-29 13:31:34.000,925.0,941.25,925.0,940.15,1052548.0,Lupin Ltd sees good buying,"Lupin Ltd is quoting at Rs 929.35, up 1.39% on the day as on 12:54 IST on the NSE. The stock is down 4.94% in last one year as compared to a 23.22% jump in NIFTY and a 9.34% jump in the Nifty Pharma index.",positive,positive,1.6378378378378355,positive,0.9564293304994688,positive
2021-12-30 10:15:00.000,925.0,941.25,925.0,940.15,1052548.0,Lupin rises 0.47% as Sensex climbs,"The stock traded at a P/E multiple of -64.34, while the price-to-book value ratio stood at 3.36.",positive,neutral,1.6378378378378355,positive,0.9564293304994688,positive
2021-12-31 13:04:16.000,941.0,956.8,936.1,950.0,1432366.0,Lupin Ltd up for fifth session,"Lupin Ltd is quoting at Rs 952.95, up 1.61% on the day as on 12:49 IST on the NSE. The stock is down 4.79% in last one year as compared to a 24.07% spurt in NIFTY and a 9.42% spurt in the Nifty Pharma.",neutral,positive,0.9564293304994688,positive,-0.7150368033648743,neutral
2022-01-03 13:34:00.000,945.3,951.15,930.0,931.0,379799.0,Lupin share price down 0.67 per cent,"A total of 33,731 shares changed hands on the counter till 01:34PM (IST).",negative,neutral,-1.5127472759970333,negative,-0.1766595289079204,neutral
2022-01-04 13:24:00.000,934.0,939.6,924.0,932.35,452709.0,Lupin shares drop 1.09% as Sensex rises,"A total of 17,234 shares changed hands on the counter till 01:24PM (IST)",negative,neutral,-0.1766595289079204,neutral,-0.949570815450646,negative
2022-01-05 07:11:00.000,934.0,939.6,924.0,932.35,452709.0,Companies to prioritise booster shots for staff’s family,"Several large companies including Tata Steel, Vedanta, Lupin, ITC, Panasonic and Mindtree are working on plans to organise vaccination drives through collaboration with hospitals and other healthcare centres.",neutral,neutral,-0.1766595289079204,neutral,-0.949570815450646,negative
2022-01-05 12:53:00.000,932.0,941.05,921.25,923.15,635793.0,Lupin declines 0.21% as Sensex climbs,"The stock traded at a P/E multiple of -64.27, while the price-to-book value ratio stood at 3.36.",neutral,neutral,-0.949570815450646,negative,-1.5053763440860215,negative
2022-01-06 10:35:00.000,932.0,941.05,921.25,923.15,635793.0,Lupin shares gain 0.43% as Sensex falls,"On the technical charts, the RSI of the stock stood at 57.0.",positive,neutral,-0.949570815450646,negative,-1.5053763440860215,negative
2022-01-07 09:28:00.000,930.0,931.15,914.0,916.0,665153.0,Lupin launches Molnupiravir in India,Used for treatment of Covid-19 in high -risk adult patients,neutral,neutral,-1.5053763440860215,negative,2.399127589967285,positive
2022-01-07 09:32:00.000,930.0,931.15,914.0,916.0,665153.0,Lupin launches Molnupiravir for the COVID-19 treatment in India,Lupin has announced the launch of Molnupiravir in India under the brand name Molnulup.,positive,neutral,-1.5053763440860215,negative,2.399127589967285,positive
2022-01-07 09:56:20.000,930.0,931.15,914.0,916.0,665153.0,Lupin launches Molnupiravir for the treatment of COVID-19 in adults in India,"This drug has been given emergency use authorization by the Drug Controller General of India (DCGI) for treatment of adult patients with Covid-19, with SpO2 > 93%, and the ones who have a high risk of progression of the disease including hospitalization.",neutral,positive,-1.5053763440860215,negative,2.399127589967285,positive
2022-01-07 12:31:00.000,930.0,931.15,914.0,916.0,665153.0,Lupin launches Molnulup for COVID-19 treatment,"Molnupiravir has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult COVID-19 patients who have a high risk of progression of the disease, including hospitalisation.",neutral,neutral,-1.5053763440860215,negative,2.399127589967285,positive
2022-01-07 12:43:09.000,930.0,931.15,914.0,916.0,665153.0,Lupin Launches Molnulup For COVID-19 Treatment,"Molnupiravir has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult COVID-19 patients who have a high risk of progression of the disease, including hospitalisation.",neutral,neutral,-1.5053763440860215,negative,2.399127589967285,positive
2022-01-07 13:21:46.000,930.0,931.15,914.0,916.0,665153.0,Lupin Launches Covid-19 Drug Molnulup In India,It has been given emergency use authorisation by the (DCGI) for the treatment of adult Covid-19 patients who have a high risk of progression of the disease.,neutral,neutral,-1.5053763440860215,negative,2.399127589967285,positive
2022-01-07 13:44:00.000,930.0,931.15,914.0,916.0,665153.0,Lupin launches Molnulup for treatment of Covid-19,Molnulup is Lupin’s brand name for antiviral medication Molnupiravir,neutral,neutral,-1.5053763440860215,negative,2.399127589967285,positive
2022-01-07 13:51:01.000,930.0,931.15,914.0,916.0,665153.0,Lupin Ltd stays slippery,"Lupin Ltd is quoting at Rs 917.4, down 0.62% on the day as on 13:24 IST on the NSE. The stock tumbled 11.69% in last one year as compared to a 23.88% rally in NIFTY and a 4.74% spurt in the Nifty Pharma index.",negative,negative,-1.5053763440860215,negative,2.399127589967285,positive
2022-01-07 17:30:00.000,930.0,931.15,914.0,916.0,665153.0,Lupin launches COVID-19 drug Molnupiravir in India,The drug has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult patients with COVID-19 and the ones who have a high risk of progression of the disease including hospitalisation.,neutral,neutral,-1.5053763440860215,negative,2.399127589967285,positive
2022-01-07 17:58:00.000,930.0,931.15,914.0,916.0,665153.0,Lupin launches covid-19 drug Molnupiravir under brand ‘Molnulup’ in India,Clinical data suggests that it is effective on patients with co-morbidities.,neutral,neutral,-1.5053763440860215,negative,2.399127589967285,positive
2022-01-07 20:13:00.000,930.0,931.15,914.0,916.0,665153.0,"India Inc steps up surveillance, testing amid surging cases","Companies such as Lupin, Crompton Greaves Consumer Electricals, Panasonic, CEAT, JLL India, Licious, Pfizer, Fortis, Axis Bank, are among those following such measures stringently.",neutral,neutral,-1.5053763440860215,negative,2.399127589967285,positive
2022-01-10 11:06:00.000,917.0,941.75,916.05,939.0,981499.0,Lupin rises 1.11% as Sensex climbs,"The stock traded at a P/E multiple of -64.05, while the price-to-book value ratio stood at 3.36.",positive,neutral,2.399127589967285,positive,0.3238135683193617,neutral
2022-01-12 11:33:00.000,948.35,954.45,937.1,953.4,900870.0,"Buy Lupin, target price Rs 1150: Emkay Global","Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 42717.22 Crore) operating in Pharmaceuticals sector.",neutral,neutral,0.5325038224284235,neutral,0.3459119496855298,neutral
2022-01-13 16:10:00.000,958.95,962.85,948.55,950.05,533882.0,"Nifty Pharma advances 120 pts amid volatility; Sun Pharma emerges top bull; Cipla, Gland Pharma, Lupin add to winnings",Sun Pharma performed as top gainer surging by 3% after hitting 52-week high Rs861.50 per piece.,positive,positive,-0.92809844100319,negative,-1.019121664215164,negative
2022-01-14 10:53:00.000,958.95,962.85,948.55,950.05,533882.0,Lupin is a contrarian bet for this year: Sandip Sabharwal,"“Don’t see any big upsides coming into Reliance, at least this year.”",neutral,positive,-0.92809844100319,negative,-1.019121664215164,negative
2022-01-16 16:52:55.000,951.8,953.7,935.25,942.1,708932.0,"Sun Pharma, Lupin recall products in US market","Sun Pharma, Lupin recall products in US market",negative,negative,-1.019121664215164,negative,0.2229299363057349,neutral
2022-01-17 10:26:00.000,951.8,953.7,935.25,942.1,708932.0,Lupin skids as failed USFDA specifications lead to recalls of 2 drugs,The companys scrip fell to a low of Rs 937.15 as against Rs 951.80 at previous close on the National Stock Exchange.,negative,negative,-1.019121664215164,negative,0.2229299363057349,neutral
2022-01-17 13:55:00.000,942.0,962.0,937.0,944.1,1619687.0,Lupin declines 1.4% as Sensex climbs,"The stock traded at a P/E multiple of -65.68, while the price-to-book value ratio stood at 3.36.",negative,neutral,0.2229299363057349,neutral,1.5608465608465607,positive
2022-01-18 11:37:00.000,942.0,962.0,937.0,944.1,1619687.0,Lupin stock price up 0.84 per cent as Sensex slides,"As of 31-Dec-2021, promoters held 46.53 per cent stake in the company, while FIIs held 15.28 per cent and domestic institutional investors had 13.26 per cent.",positive,neutral,0.2229299363057349,neutral,1.5608465608465607,positive
2022-01-18 15:48:00.000,945.0,969.35,933.1,959.75,1270028.0,Board of Lupin approves acquisition of a portfolio of brands of Anglo-French Drugs & Industries,At meeting held on 17 January 2022,neutral,neutral,1.5608465608465607,positive,-2.0650813516896074,negative
2022-01-19 11:40:39.000,945.0,969.35,933.1,959.75,1270028.0,Lupin - A Potentially Accretive Acquisition Over The Medium-Term: Motilal Oswal,Lupin - A Potentially Accretive Acquisition Over The Medium-Term: Motilal Oswal,neutral,neutral,1.5608465608465607,positive,-2.0650813516896074,negative
2022-01-19 12:03:59.000,958.8,959.8,934.05,939.0,964641.0,Lupin’s acquisition of branded portfolio to boost domestic sales,"Sales growth in the US is a key monitorable, though. Lupin has been facing pricing pressure in its base business in the US, having reported low single-digit sales growth during Q2",positive,negative,-2.0650813516896074,negative,-3.141500880046941,negative
2022-01-19 12:08:00.000,958.8,959.8,934.05,939.0,964641.0,Lupin Inks Pact With Shenzhen Foncoo To Introduce Products In China,"This is the company’s first partnership arrangement in China and reinforces drug maker’s commitment to bringing high-quality generic and complex generic medicines to patients around the world, Lupin said in a statement.",neutral,positive,-2.0650813516896074,negative,-3.141500880046941,negative
2022-01-19 12:10:00.000,958.8,959.8,934.05,939.0,964641.0,Lupin inks pact with Shenzhen Foncoo to introduce products in China,"The company would continue to explore additional partnership opportunities in China to leverage its global portfolio including complex generics and specialty medicines, Lupin President – Growth Markets, Fabrice Egros, said.",positive,positive,-2.0650813516896074,negative,-3.141500880046941,negative
2022-01-19 12:35:38.000,958.8,959.8,934.05,939.0,964641.0,Lupin ties up with China’s Fancoo Pharma,“Lupin is committed to serving the healthcare needs of the Chinese population by providing high quality products”,neutral,neutral,-2.0650813516896074,negative,-3.141500880046941,negative
2022-01-19 12:35:38.000,958.8,959.8,934.05,939.0,964641.0,Lupin ties up with China’s Fancoo Pharma,“Lupin is committed to serving the healthcare needs of the Chinese population by providing high quality products”,neutral,neutral,-2.0650813516896074,negative,-3.141500880046941,negative
2022-01-19 15:01:42.000,958.8,959.8,934.05,939.0,964641.0,Lupin signs first partnership agreement with Foncoo for China,Lupin signs first partnership agreement with Foncoo for China,positive,positive,-2.0650813516896074,negative,-3.141500880046941,negative
2022-01-19 17:30:00.000,958.8,959.8,934.05,939.0,964641.0,Stocks that will see action today (January 19),"Buzzing stocks: Bajaj Auto, Ceat, ICICI Lombard, JSW Energy, Tata Communications, Tata Investments, Sterlite Tech, L&T Infotech, Nelco, Lupin, RITES, Shalimar Paints, Wardwizard, Orient Green Power",neutral,neutral,-2.0650813516896074,negative,-3.141500880046941,negative
2022-01-21 16:10:00.000,937.45,937.95,897.6,908.0,1197622.0,"Nifty Pharma joins bear markets, index sheds near 1%; Dr Reddy’s, Lupin, Glenmark, Gland Pharma weigh down","In last 24 hours, India recorded 3.47 lakh new Covid cases, 9% more than yesterday.",neutral,positive,-3.141500880046941,negative,2.2815804117974405,positive
2022-01-24 10:10:00.000,898.5,933.5,898.5,919.0,2302907.0,Shares of Lupin rise as Nifty drops,"On the technical charts, the 200-day moving average of the stock stood at Rs 1027.38.",neutral,neutral,2.2815804117974405,positive,0.4497833360759171,neutral
2022-01-24 12:04:21.000,911.55,930.6,908.0,915.65,1479902.0,Sharda Cropchem Ltd leads gainers in ‘A’ group,"India Tourism Development Corporation Ltd, Astec Lifesciences Ltd, CSB Bank Ltd and Lupin Ltd are among the other gainers in the BSE’s ‘A’ group today, 24 January 2022.",positive,neutral,0.4497833360759171,neutral,-2.960976410705485,negative
2022-01-25 07:41:26.000,911.55,930.6,908.0,915.65,1479902.0,"Trade Spotlight | What Should You Do With Sharda Cropchem, Bandhan Bank, Lupin, Cipla, Global Education?","Here’s what Malay Thakkar of GEPL Capital, suggests investors possessing these stocks when the market resumes trading today",neutral,neutral,0.4497833360759171,neutral,-2.960976410705485,negative
2022-01-25 15:07:00.000,911.55,930.6,908.0,915.65,1479902.0,Lupin shares drop 0.99% as Sensex rises,"A total of 65,676 shares changed hands on the counter till 03:07PM (IST)",negative,neutral,0.4497833360759171,neutral,-2.960976410705485,negative
2022-01-27 21:38:00.000,893.4,922.0,889.2,900.5,1122485.0,Lupin partners with Exeltis for marketing its specialty drug Solosec in US,ET reported in October about Lupin trying to find a marketing partner or even be open to the idea of possible sale of its key specialty drug Solosec in the US.,neutral,neutral,0.7947168121781983,neutral,1.0219383504582111,positive
2022-01-28 07:42:00.000,893.4,922.0,889.2,900.5,1122485.0,"Stocks in the news: Lupin, BHEL, Canara Bank, RBL Bank, L&T and PNB","Kotak Mahindra Bank, L&T, Vedanta, Britannia, Dr Reddy’s Labs, Marico, Info Edge, Bharat Electronics, Au SFB and Oberoi Realty are among the companies that will announce their December quarter results today.",neutral,neutral,0.7947168121781983,neutral,1.0219383504582111,positive
2022-01-28 17:30:00.000,893.4,922.0,889.2,900.5,1122485.0,"Stocks that will see action on January 28, 2022","Buzzing stocks: TVS Motor, L&T, Dr Reddy’s, Lupin, Kotak Bank, Vedanta, BEL, Central Bank, UTI Asset, Blue Dart, Britannia, Karnataka Bank, Happiest Minds, Suzlon, Chemplast Sanmar",neutral,neutral,0.7947168121781983,neutral,1.0219383504582111,positive
2022-02-01 11:39:00.000,922.0,923.3,900.55,903.6,1218395.0,"Lupin enters into license, supply and technology sharing agreement with Axantia",For Pegfilgrastim in the Middle East and North Africa,positive,neutral,-1.9956616052060716,negative,0.0820838349567691,neutral
2022-02-01 11:57:00.000,922.0,923.3,900.55,903.6,1218395.0,Lupin shares up 1.01% as Nifty gains,"A total of 26,739 shares changed hands on the counter till time (IST).",positive,neutral,-1.9956616052060716,negative,0.0820838349567691,neutral
2022-02-01 13:42:56.000,913.7,918.75,904.5,914.45,1010285.0,Lupin Inks Licensing Pact With Axantia For Pegfilgrastim,"The Mumbai-based drug firm has entered into a license, supply and technology sharing agreement with Axantia Holding, a leading pharmaceutical company in the Middle East region, Lupin said in a statement.",neutral,positive,0.0820838349567691,neutral,-1.043046357615899,negative
2022-02-01 13:43:00.000,913.7,918.75,904.5,914.45,1010285.0,Drug maker Lupin inks licensing pact with Axantia for Pegfilgrastim,Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy. Lupin had earlier received the USFDA acceptance for review of the Biologics License Application (BLA) for its proposed biosimilar to Neulasta (pegfilgrastim).…,positive,positive,0.0820838349567691,neutral,-1.043046357615899,negative
2022-02-01 17:14:00.000,913.7,918.75,904.5,914.45,1010285.0,"Lupin, Axantia enter into a license, supply and technology sharing agreement","Lupin intimated that they have entered into a license, supply and technology sharing agreement with Axantia Holding (Axantia), operating through its pharmaceutical subsidiaries - Pharma International Company and Med City Pharmaceutical Industries.",positive,positive,0.0820838349567691,neutral,-1.043046357615899,negative
2022-02-02 11:31:00.000,913.7,918.75,904.5,914.45,1010285.0,Lupin shares gain 0.6% as Sensex rises,"A total of 15,474 shares changed hands on the counter till 11:31AM (IST)",positive,neutral,0.0820838349567691,neutral,-1.043046357615899,negative
2022-02-03 08:05:18.000,906.0,913.15,896.0,896.55,1414529.0,"Stocks to Watch: ITC, Titan Company, Adani Power, Welspun India","Shares of firms like ITC, Lupin, Adani Power, Adani Transmission, Titan Company, Godrej Properties, Welspun India, GAIL (India), Kirloskar Industries, Kalyan Jewellers, Torrent Power will be in focus as they will announce their Q3 results today",neutral,neutral,-1.043046357615899,negative,-1.335963923337094,negative
2022-02-03 08:21:00.000,906.0,913.15,896.0,896.55,1414529.0,"Stocks to Watch: HDFC, Jubilant Food, IOB, ZEEL, Timken, Oil & Gas, Tyre","Adani Power, Barbeque Nation, Cadila, GAIL, Godrej Properties, HCC, ITC, JK Tyre, Kalyan Jewellers, Lupin, Mahindra Holidays, TBZ and Titan are some of the major companies to announce results today",neutral,neutral,-1.043046357615899,negative,-1.335963923337094,negative
2022-02-03 08:43:00.000,906.0,913.15,896.0,896.55,1414529.0,Stocks that will see action today (Feb 3),"Buzzing stocks: GAIL, ITC, Titan, Adani Power, Adani Transmission, Bharat Dynamics, Barbeque, Godrej Properties, Lupin, Kalyani Jewellers, tyre stocks, Hercules Hoists, Cupid",neutral,neutral,-1.043046357615899,negative,-1.335963923337094,negative
2022-02-03 12:53:00.000,887.0,899.95,859.4,875.15,7578305.0,Lupin shares fall 1.46% as Nifty drops,"A total of 24,224 shares changed hands on the counter till time (IST).",negative,neutral,-1.335963923337094,negative,-6.431897555296858,negative
2022-02-04 08:20:00.000,887.0,899.95,859.4,875.15,7578305.0,"Stocks to Watch: RIL, ITC, TCS, Titan, Cadila, Emami, Lupin, EIH, Tyre","BoI, Devyani Intl, Eveready, FSL, Mahindra Life, Paytm, REC, Siemens, Sintex, SPARC, Tata Steel, Thermax and Vijaya Diagnostics are some of the prominent companies to announce results today.",neutral,neutral,-1.335963923337094,negative,-6.431897555296858,negative
2022-02-04 08:55:14.000,887.0,899.95,859.4,875.15,7578305.0,"Lupin Q3 Results: Profit Rises On Tax Reversal, Margin Contracts","The drugmaker reported a net profit of Rs 545.5 crore in the October-December period, up 24% year-on-year.",neutral,positive,-1.335963923337094,negative,-6.431897555296858,negative
2022-02-04 09:50:00.000,887.0,899.95,859.4,875.15,7578305.0,Lupin Q3 PAT spurts 24% YoY to Rs 546 cr,Lupin’s consolidated net profit jumped 24.47% to Rs 545.52 crore on a 3.57% rise in total revenue from operations to Rs 4160.93 crore in Q3 FY22 over Q3 FY21.,neutral,positive,-1.335963923337094,negative,-6.431897555296858,negative
2022-02-04 13:17:55.000,887.0,899.95,859.4,875.15,7578305.0,Lupin Q3 net profit up 24 per cent at Rs 545 crore,"The company’s sales increased to Rs 4,087.5 crore in the third quarter, against Rs 3,917.3 crore in the same period of 2020-21, Lupin said in a statement.",positive,positive,-1.335963923337094,negative,-6.431897555296858,negative
2022-02-04 13:23:44.000,887.0,899.95,859.4,875.15,7578305.0,Lupin Q3 net profit up 24 per cent at ₹546 cr,,positive,neutral,-1.335963923337094,negative,-6.431897555296858,negative
2022-02-04 13:25:00.000,887.0,899.95,859.4,875.15,7578305.0,"Lupin slips 5%, nears 52-week low post December quarter results",The company reported lower-than-expected margins and net profit in December quarter due to one-time expenses related to residual metformin returns and provision for aged stock returns of Oseltamivir.,negative,negative,-1.335963923337094,negative,-6.431897555296858,negative
2022-02-04 14:11:52.000,887.0,899.95,859.4,875.15,7578305.0,"Lupin Consolidated December 2021 Net Sales At Rs 4,160.93 Crore, Up 3.57% Y-o-Y",,neutral,neutral,-1.335963923337094,negative,-6.431897555296858,negative
2022-02-04 20:46:31.000,887.0,899.95,859.4,875.15,7578305.0,Lupin Ltd ADR 2022 Q3 - Results - Earnings Call Presentation (OTCMKTS:LUPNY),The following slide deck was published by Lupin Ltd ADR in conjunction with their 2022 Q3 earnings call.,neutral,neutral,-1.335963923337094,negative,-6.431897555296858,negative
2022-02-04 22:59:12.000,887.0,899.95,859.4,875.15,7578305.0,Lupin Ltd ADR (LUPNY) CEO Vinita Gupta On Q3 2022 Results - Earnings Call Transcript,"Lupin Ltd ADR (OTC:LUPNY) Q3 2022 Earnings Conference Call February 4, 2022, 08:00 AM ET",neutral,neutral,-1.335963923337094,negative,-6.431897555296858,negative
2022-02-04 23:53:00.000,887.0,899.95,859.4,875.15,7578305.0,Lupin consolidated net profit up 24% at Rs 545 crore in Dec quarter,Drugmaker Lupin reported a 24.45 per cent rise in its consolidated net profit at Rs 545.5 crore for the third quarter ended December 31,positive,positive,-1.335963923337094,negative,-6.431897555296858,negative
2022-02-07 06:11:00.000,859.0,862.9,801.55,803.75,5292172.0,We are working on developing a China pipeline: Lupin CEO Vinita Gupta,Lupin’s CEO Vinita Gupta tells Sohini Das about the company’s global plans,neutral,neutral,-6.431897555296858,negative,-2.2118670394532405,negative
2022-02-07 08:09:00.000,859.0,862.9,801.55,803.75,5292172.0,"Stocks to Watch: Tata Steel, Paytm, Go Fashion, BoB, Lupin, IndiGo, PSBs","Castrol, Indian Bank, Nalco, PolicyBazaar, Tarsons Products, Tube Investments of India, TVS Motor and Union Bank of India are some of the prominent companies to announce result today.",neutral,neutral,-6.431897555296858,negative,-2.2118670394532405,negative
2022-02-07 10:15:00.000,859.0,862.9,801.55,803.75,5292172.0,"Results Review For Shree Cement, Siemens, Alkem Labs, Godrej Properties, Lupin","Results Review For Shree Cement, Siemens, Alkem Labs, Godrej Properties, Lupin",neutral,neutral,-6.431897555296858,negative,-2.2118670394532405,negative
2022-02-07 10:22:13.000,859.0,862.9,801.55,803.75,5292172.0,Lupin Q3 Results Review: Shares Fall As Brokerages See Cost Pressure To Linger,Lupin Q3 Review: Lower Margins Lead To Mixed Reactions Among Brokerages,neutral,neutral,-6.431897555296858,negative,-2.2118670394532405,negative
2022-02-07 10:24:52.000,859.0,862.9,801.55,803.75,5292172.0,"Lupin Q3 Review - Niche Launches, Cost Optimisation Key To A Turnaround: Motilal Oswal","Lupin Q3 Review - Niche Launches, Cost Optimisation Key To A Turnaround: Motilal Oswal",neutral,neutral,-6.431897555296858,negative,-2.2118670394532405,negative
2022-02-07 11:08:00.000,859.0,862.9,801.55,803.75,5292172.0,"Lupin slips 9% in two days, hits 52-week low on disappointing Q3 results","In the past six months, the stock has shed nearly 30 per cent, as compared to a 7 per cent rise in the S&P BSE Sensex.",negative,negative,-6.431897555296858,negative,-2.2118670394532405,negative
2022-02-07 12:22:46.000,804.75,810.85,784.45,786.95,3617241.0,"Lupin stock at 52-week low on margin pressure, earnings downgrade","Amid disappointment on the margin front and cut in forward earnings estimates, the recovery for Lupin’s performance hinges on the large product launches in the US.",negative,negative,-2.2118670394532405,negative,1.055276381909545,positive
2022-02-07 15:16:04.000,804.75,810.85,784.45,786.95,3617241.0,Ujjivan Financial Services Ltd leads losers in ‘A’ group,"Torrent Power Ltd, Lupin Ltd, Jubilant Pharmova Ltd and Time Technoplast Ltd are among the other losers in the BSE’s ‘A’ group today, 07 February 2022.",negative,negative,-2.2118670394532405,negative,1.055276381909545,positive
2022-02-07 16:10:28.000,804.75,810.85,784.45,786.95,3617241.0,"Sensex crashes 1,023 pts, Nifty settles near 17,200; Lupin drops 7 per cent",The key benchmark indices started on a mixed note on Monday amid weak global cues as US bond yields surged,neutral,negative,-2.2118670394532405,negative,1.055276381909545,positive
2022-02-09 08:00:00.000,796.0,804.9,786.15,804.4,2370445.0,"TMS Ep104: Brands & politics, Vinita Gupta, markets, Central Vista",Why brands should stay away from politics? What are Lupin CEO’s plans for growth in US & China? Can investors benefit from Brent crude rally? What is the Central Vista project? Find all answers here,neutral,positive,1.055276381909545,positive,-0.2164636031912919,neutral
2022-02-09 08:30:00.000,796.0,804.9,786.15,804.4,2370445.0,What are Lupin CEO Vinita Gupta’s plans for growth in US & China?,"In conversation with Business Standard’s Sohini Das, Lupin CEO Vinita Gupta shared her company’s growth plans in the US and in China. Let us listen in to the interview",neutral,neutral,1.055276381909545,positive,-0.2164636031912919,neutral
2022-02-09 09:21:49.000,796.0,804.9,786.15,804.4,2370445.0,Stocks that will see action today (Feb 9),"Buzzing stocks: Vedanta, Tata Power, Wipro, Tata Communications, ICICI Bank, Nykaa, BSE, Airtel, Thermax, Lupin, ACC, Aurobindo Pharma, PowerGrid, Bosch, GMR Infra, Paras Defence, SAIL, Sundaram-Clayton",neutral,neutral,1.055276381909545,positive,-0.2164636031912919,neutral
2022-02-09 17:30:00.000,808.45,812.0,800.0,806.7,1577139.0,"Stocks in news: ICICI Bank, Bharti Airtel, IRCTC, Lupin and more","Stocks in news: ICICI Bank, Lupin, Vedanta, Bata India, ACC, Berger Paints India, Bharti Airtel, IRCTC and more",neutral,neutral,-0.2164636031912919,neutral,-1.2912036749643168,negative
2022-02-09 19:32:00.000,808.45,812.0,800.0,806.7,1577139.0,Lupin enters pact with Medis to distribute orphan drug in Europe,"NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction. NaMuscla reduces myotonia symptoms in people with NDM, resulting in a significant improvement in quality of life and other functional and cli…",positive,neutral,-0.2164636031912919,neutral,-1.2912036749643168,negative
2022-02-10 09:02:44.000,808.45,812.0,800.0,806.7,1577139.0,Stocks that will see action today (February 10),"Buzzing stocks: Zomato, M&M, ABB, Amara Raja, BEML, CAMS, Hero MotoCorp, Hindalco, GVK Power, M&M, MRF, IRB Infra, Tata Steel Long, Lupin, Dr Reddy’s Lab, RPower",neutral,neutral,-0.2164636031912919,neutral,-1.2912036749643168,negative
2022-02-15 14:23:55.000,775.45,782.2,766.6,777.3,1198098.0,Accumulate Lupin; target of Rs 950: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Lupin with a target price of Rs 950 in its research report February 07, 2022.",neutral,positive,0.2385711522341748,neutral,-1.7700241945753186,negative
2022-02-16 11:29:00.000,775.45,782.2,766.6,777.3,1198098.0,Share price of Lupin jumps as Sensex drops 175.34 points,"A total of 13,606 shares changed hands on the counter till 11:29AM (IST)",positive,neutral,0.2385711522341748,neutral,-1.7700241945753186,negative
2022-02-17 20:12:00.000,773.85,778.8,764.8,765.05,1427818.0,Lupin gets USFDA nod for using specialty drug Solosec on adolescents,The supplemental adolescent approval enhances Solosec’s strong position as the first and only single-dose oral prescription antimicrobial agent approved for the treatment of both trichomoniasis and BV.,neutral,positive,-1.1371712864250263,negative,-0.0721974271462266,neutral
2022-02-17 20:49:00.000,773.85,778.8,764.8,765.05,1427818.0,Lupin receives USFDA approval for antibiotic Solosec,Lupin Ltd on Thursday said it has received approval from the US health regulator for its supplemental New Drug Application (sNDA) for usage of its antibiotic Solosec.,positive,positive,-1.1371712864250263,negative,-0.0721974271462266,neutral
2022-02-18 06:48:36.000,773.85,778.8,764.8,765.05,1427818.0,"Buzzing Stocks | Wipro, Ambuja Cements, Lupin and others in news today",Stocks In the News: Check out the companies making headlines before the opening bell.,neutral,neutral,-1.1371712864250263,negative,-0.0721974271462266,neutral
2022-02-18 07:42:39.000,773.85,778.8,764.8,765.05,1427818.0,Lupin receives USFDA approval for antibiotic Solosec,"The US Food and Drug Administration (USFDA) has approved the company’s sNDA to expand the use of Solosec in the treatment of bacterial vaginosis (BV) for female patients 12 years of age and older and in the treatment of trichomoniasis for all patients 12 years of age and above, Lupin Ltd said in a r…",positive,positive,-1.1371712864250263,negative,-0.0721974271462266,neutral
2022-02-18 08:07:44.000,773.85,778.8,764.8,765.05,1427818.0,"Stocks to Watch Today: Wipro, Lupin, HDFC, Ambuja Cements, and Others","Stocks to watch: Shares of firms like Wipro, Lupin, HDFC, Ambuja Cements will be in focus in Friday’s trade Today’s biggest stock Gainers Market News at news18.com",neutral,neutral,-1.1371712864250263,negative,-0.0721974271462266,neutral
2022-02-18 17:30:00.000,773.85,778.8,764.8,765.05,1427818.0,Stocks that will see action today: Feb 18,"Buzzing stocks: Ambuja Cements, Wipro, Confidence Petroleum, Hinduja Global Solutions, Lupin, Wanbury, Hindustan Adhesives",neutral,neutral,-1.1371712864250263,negative,-0.0721974271462266,neutral
2022-02-18 17:30:00.000,773.85,778.8,764.8,765.05,1427818.0,"Stocks in news: Wipro, Lupin, Torrent Power, Ambuja Cements and more","The Indian equity market is likely to open on a flat note today as SGX Nifty fell 17 points to 17,250. Sensex and Nifty closed lower in volatile trade for the second session on Thursday amid a selloff led by banking shares.",neutral,negative,-1.1371712864250263,negative,-0.0721974271462266,neutral
2022-02-23 08:35:00.000,754.7,763.0,753.35,755.5,994645.0,Fabrice Egros to assume Corporate Development responsibilities at Lupin; stock trades flat,"For the past six years, Dr. Egros has played an integral role in Lupin, leading businesses across both Growth and Developed markets.",neutral,neutral,0.1060023850536576,neutral,-3.662162162162165,negative
2022-02-23 16:04:09.000,740.0,742.0,711.0,712.9,1974495.0,Lupin announces change in leadership for corporate development,Powered by Capital Market - Live News,neutral,neutral,-3.662162162162165,negative,3.894921190893164,positive
2022-02-28 17:30:00.000,737.0,748.65,728.9,743.5,1243897.0,"Russia-Ukraine war: Cadila, Lupin, Glenmark Pharma shares among top losers",Shares of Indian pharma firms have emerged as major losers amid the ongoing Russia-Ukraine war. Indian pharma companies have significant exposure mainly to Russia and also Ukraine and their stocks have turned red till date since the war between the two neighbours started.,negative,negative,0.8819538670284939,neutral,-1.6734143049932493,negative
2022-03-01 17:06:00.000,741.0,749.35,723.0,728.6,1183490.0,Lupin launches generic medication in US market,"Lupin has launched Sevelamer Hydrochloride tablets (800 mg), used to treat hyperphosphatemia in patients with chronic kidney disease, in the US market. The company has launched the product after having received approval from the US Food and Drug Administration (USFDA).",positive,positive,-1.6734143049932493,negative,-2.63816546032605,negative
2022-03-01 17:39:00.000,741.0,749.35,723.0,728.6,1183490.0,"Lupin launches generic medication, to be manufactured in Nagpur, in US","Drug maker Lupin on Tuesday said it has launched Sevelamer Hydrochloride tablets (800 mg), used to treat hyperphosphatemia in patients with chronic kidney disease, in the US market",neutral,positive,-1.6734143049932493,negative,-2.63816546032605,negative
2022-03-02 09:23:41.000,741.0,749.35,723.0,728.6,1183490.0,Stocks that will see action on March 2,"Buzzing stocks: Reliance Ind, automobile cos, L&T Finance Holdings, Vipul Organics, Prestige Estates, Bharat Forge, Syngene International, Lupin, Lemon Tree, Route Mobile, Quint Digital, Infibeam Avenues, IIFL Asset",neutral,neutral,-1.6734143049932493,negative,-2.63816546032605,negative
2022-03-03 09:35:00.000,739.15,739.15,717.05,719.65,863375.0,Lupin receives USFDA approval for Efinaconazole Topical Solution,"The product will be manufactured at Lupin’s facility in Pithampur, India.",positive,neutral,-2.63816546032605,negative,-1.4755244755244692,negative
2022-03-03 16:10:00.000,715.0,719.0,702.8,704.45,1470313.0,Lupin gets FDA nod to market Efinaconazole topical solution in US,"Drug major Lupin on Thursday said it has received approval from the US health regulator to market Efinaconazole topical solution, used to treat fungal toenail infections, in the American market",neutral,positive,-1.4755244755244692,negative,0.5236728837876581,neutral
2022-03-03 16:16:19.000,715.0,719.0,702.8,704.45,1470313.0,Lupin gets USFDA nod to market generic product,"The company has received approval from the United States Food and Drug Administration (FDA) to market the generic version of Bausch Health Americas’ Jublia topical solution, the Mumbai-based drug maker said in a regulatory filing.",neutral,positive,-1.4755244755244692,negative,0.5236728837876581,neutral
2022-03-07 21:44:00.000,700.8,711.5,692.5,707.15,1447983.0,Lupin signs Mary Kom as brand ambassador for its Shakti campaign,Homegrown pharma major Lupin Ltd on Monday said it has signed six-time world boxing champion and Olympics bronze medallist Mary Kom as brand ambassador for its Shakti campaign,neutral,positive,0.9061073059360764,positive,2.740297677006544,positive
2022-03-07 22:09:00.000,700.8,711.5,692.5,707.15,1447983.0,Lupin signs boxing champion Mary Kom as brand ambassador for Shakti campaign,"“With Mary Kom anchoring the campaign, we hope to drive the much-needed awareness on the issue and encourage women to sign up for early screening checks and take corrective measures to avoid future risk of heart diseases,” Lupin Ltd, President, India Regional Formulations, Rajeev Sibal said.",positive,positive,0.9061073059360764,positive,2.740297677006544,positive
2022-03-10 17:30:00.000,738.0,754.5,737.55,746.0,1371247.0,Lupin diagnostics opens its first reference laboratory in Kolkata,The company had forayed into the diagnostics segment in December last year as part of its strategy to provide integrated healthcare in India.,neutral,neutral,1.084010840108401,positive,-1.3245033112582782,negative
2022-03-10 18:07:00.000,738.0,754.5,737.55,746.0,1371247.0,Lupin opens main reference lab in Kolkata for expansion in east India,"The company offers a comprehensive range of diagnostics services to doctors, patients and consumers. Some of its key consumer-centric features are GPS-enabled temperature–controlled sample movement, smart reports, NABL accreditation of each laboratory, trend report analysis, and live home collection…",neutral,neutral,1.084010840108401,positive,-1.3245033112582782,negative
2022-03-11 07:45:00.000,738.0,754.5,737.55,746.0,1371247.0,"Stocks to Watch: Lupin, Jindal Steel, Wipro, Future Group, Tata Steel Long",Lupin may be in focus as it has launched its first Reference Laboratory in East India in Kolkata.,neutral,neutral,1.084010840108401,positive,-1.3245033112582782,negative
2022-03-11 08:52:00.000,738.0,754.5,737.55,746.0,1371247.0,Lupin launches its first reference laboratory in East India,Lupin said that Lupin Diagnostics has launched its first reference laboratory in East India in Kolkata.,neutral,neutral,1.084010840108401,positive,-1.3245033112582782,negative
2022-03-11 08:54:31.000,738.0,754.5,737.55,746.0,1371247.0,Stocks that will see action today (March 11),"Buzzing stocks: HDFC, BGR Energy, L&T Finance Holdings, Lupin, Sampre Nutritions, Ashoka Buildcon, Ikab Securities",neutral,neutral,1.084010840108401,positive,-1.3245033112582782,negative
2022-03-11 08:55:30.000,738.0,754.5,737.55,746.0,1371247.0,Lupin diagnostics opens reference laboratory in Kolkata,The company had forayed into the diagnostics segment in December last year as part of its strategy to provide integrated healthcare in India.,neutral,neutral,1.084010840108401,positive,-1.3245033112582782,negative
2022-03-11 09:13:32.000,738.0,754.5,737.55,746.0,1371247.0,Lupin Diagnostics launches its first reference laboratory in east India in Kolkata,"About 70 per cent of treatment decisions are now based on diagnostics tests, says Ravindra Kumar, V-P and Head, Lupin Diagnostics",neutral,neutral,1.084010840108401,positive,-1.3245033112582782,negative
2022-03-11 17:30:00.000,738.0,754.5,737.55,746.0,1371247.0,"Stocks in news: Tata Power, Coforge, Lupin, Shipping Corp and more","Stocks in news: UCO Bank, BLS International,Coforge, Lupin, Bayer CropScience, Tata Power, Britannia Industries, Shipping Corp and more",neutral,neutral,1.084010840108401,positive,-1.3245033112582782,negative
2022-03-11 19:27:00.000,738.0,754.5,737.55,746.0,1371247.0,Lupin gets USFDA approval to market anti-epilepsy drug in US market,Drug firm Lupin on Friday said it has received approval from the US health regulator to market its anti-epilepsy drug Vigabatrin for Oral Solution in the American market.,positive,positive,1.084010840108401,positive,-1.3245033112582782,negative
2022-03-11 20:02:00.000,738.0,754.5,737.55,746.0,1371247.0,Lupin gets USFDA nod to market generic drug,"The company has received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Vigabatrin for Oral Solution USP (500 mg), Lupin said in a statement.",neutral,positive,1.084010840108401,positive,-1.3245033112582782,negative
2022-03-14 08:09:41.000,755.0,761.9,737.0,745.0,1307057.0,"Stocks to Watch: Paytm, Gail, Maruti, Hindalco, SAIL, Lupin, Welspun India",Paytm is likely to be in focus after RBI’s ban on fresh onboarding of customers to its arm Paytm Payments Bank with immediate effect over the weekend.,neutral,neutral,-1.3245033112582782,negative,-1.4189143966267197,negative
2022-03-14 09:18:00.000,755.0,761.9,737.0,745.0,1307057.0,Lupin gets US FDA nod for epilepsy drug,Lupin said that it has received approval from the United States Food and Drug Administration (FDA) for Vigabatrin for oral solution USP.,neutral,positive,-1.3245033112582782,negative,-1.4189143966267197,negative
2022-03-14 17:30:00.000,747.05,757.9,733.2,736.45,1167330.0,"Stocks in news: Tech Mahindra, ICICI Bank, Lupin, Ruchi Soya and more","Stocks in news: One97 Communications, Sobha, DB Realty, Jubilant FoodWorks, CESC, Lupin, Ruchi Soya, Tech Mahindra, ICICI Bank and more",neutral,neutral,-1.4189143966267197,negative,0.8742434431741762,neutral
2022-03-21 05:48:00.000,766.85,776.95,752.7,755.1,1071335.0,Beaten-down blue chips could be first to rebound,"Stocks such as HDFC Life, Lupin, Dalmia Bharat, Godrej Industries, ICICI Securities, Tata Communications, Godrej Consumer, Gujarat Gas and Jubilant Foodworks, among others, are still down over 20% so far this year. Dr. Reddy’s, Ambuja Cement, Info Edge, Havells, Tech Mahindra, Wipro, Godrej Properti…",neutral,negative,-1.5322422898872008,negative,-0.6595000989250149,neutral
2022-03-23 17:30:00.000,745.0,777.75,742.2,772.2,2158626.0,"Nifty Pharma stocks continue to rally; Dr. Reddy’s, Strides Pharma emerge top gainers","Alkem Lab, Pfizer, and Divis Lab were also among the top gainers. Cipla, Granules India, and Lupin were trading in the red.",positive,positive,3.651006711409402,positive,-2.7866957750096373,negative
2022-03-24 09:15:00.000,745.0,777.75,742.2,772.2,2158626.0,Lupin receives USFDA approval for Sildenafil for Oral Suspension; Stock ends 3.5% higher,"The product will be manufactured at Lupin’s facility in Goa, India.",positive,neutral,3.651006711409402,positive,-2.7866957750096373,negative
2022-03-24 14:14:31.000,778.7,779.05,748.65,757.0,1023986.0,Lupin gets USFDA nod for generic product,"The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Sildenafil for Oral Suspension, 10 mg/mL, Lupin said in a statement.",neutral,positive,-2.7866957750096373,negative,-0.1326259946949602,neutral
2022-03-31 20:31:00.000,744.95,766.9,735.8,763.45,1092957.0,Lupin’s New Jersey facility gets 13 US FDA observations,"The observations do not, however, imply any restriction on supplies",neutral,neutral,2.4833881468554937,positive,2.7308192457737324,positive
2022-04-01 05:30:00.000,744.95,766.9,735.8,763.45,1092957.0,"Stocks Under Focus on Apr 1: Lupin, Vedanta, Ruchi Soya & More","Stocks Under Focus on Apr 1: Lupin, Vedanta, Ruchi Soya & More",neutral,neutral,2.4833881468554937,positive,2.7308192457737324,positive
2022-04-01 07:44:00.000,744.95,766.9,735.8,763.45,1092957.0,"Stocks to Watch: Hero Moto, Vedanta, Lupin, Future Retail, ONGC, Tech M","The SGX Nifty futures were quoting at 17,431 levels at 7:30 am, hinting at a gap-down start of 100 points on the Nifty50.",neutral,positive,2.4833881468554937,positive,2.7308192457737324,positive
2022-04-01 08:55:59.000,744.95,766.9,735.8,763.45,1092957.0,Stocks that will see action on April 1,"Buzzing stocks: Automobile stocks, Lupin, Vedanta, NCC, Hindustan Oil, Omax Autos, Raymond, Nuvoco Vistas, Sterlite Tech, HG Infra",neutral,neutral,2.4833881468554937,positive,2.7308192457737324,positive
2022-04-01 10:41:00.000,744.95,766.9,735.8,763.45,1092957.0,Lupin gets 13 observations from USFDA for its New Jersey plant,"“US FDA inspection of the Company’s Somerset, New Jersey (US) facility. The USFDA has concluded an inspection at the Company’s wholly owned subsidiary Novel Laboratories, Inc., based in Somerset, NJ. The inspection commenced on March 7, 2022 and concluded on March 30, 2022.The inspection closed with…",neutral,neutral,2.4833881468554937,positive,2.7308192457737324,positive
2022-04-01 10:58:00.000,744.95,766.9,735.8,763.45,1092957.0,Lupin New Jersey subsidiary gets thirteen observations,"The pharma major after market hours on Thursday announced that its wholly owned subsidiary Novel Laboratories based in Somerset, New Jersey (USA) received thirteen observations from USFDA.",neutral,neutral,2.4833881468554937,positive,2.7308192457737324,positive
2022-04-01 17:30:00.000,744.95,766.9,735.8,763.45,1092957.0,"Stocks in news: Vedanta, GAIL, Lupin, Future Retail and more","Stocks in news: Vedanta, Hero MotoCorp, Axis Bank, Vodafone Idea, GAIL, Ruchi Soya, Future Retail and more",neutral,neutral,2.4833881468554937,positive,2.7308192457737324,positive
2022-04-04 07:55:12.000,769.0,792.15,762.25,790.0,3216190.0,"Stocks to Watch Today: Wipro, HDFC Bank, Lupin, DMart and Others","Stocks to watch today: Shares of firms like Wipro, HDFC Bank, Lupin, DMart, and others will be in focus in Monday’s trade",neutral,neutral,2.7308192457737324,positive,-2.586532410320951,negative
2022-04-04 08:36:00.000,769.0,792.15,762.25,790.0,3216190.0,"Wipro, Maruti Suzuki, Lupin, Bharat Dynamics in spotlight","Wipro: Wipro announced a three-year collaboration with the University of South Carolina and the Indian Institute of Technology, Patna (IIT, Patna) under a co-innovation model for AI research.",neutral,positive,2.7308192457737324,positive,-2.586532410320951,negative
2022-04-04 09:08:50.000,769.0,792.15,762.25,790.0,3216190.0,Stocks that will see action on April 4,"Buzzing stocks: Avenue Supermarts, Wipro, TVS Motor, IEX, ONGC, GOCL Corp, GHCL, Jubilant Pharmova, Lupin, Vascon Engineers, Dr Reddy’s Lab",neutral,neutral,2.7308192457737324,positive,-2.586532410320951,negative
2022-04-05 14:14:00.000,774.45,786.0,771.0,772.1,916957.0,Lupin gets four observations on USFDA inspection at Tarapur facility,"The US-based drug regulatory body, United States Food & Drug Administration (USFDA) concluded an inspection at Lupin’s Tarapur manufacturing facility in Maharashtra.",neutral,positive,-0.3034411517851407,neutral,1.3225806451612905,positive
2022-04-05 17:30:00.000,774.45,786.0,771.0,772.1,916957.0,Lupin inks licensing pact with Alvion to market drugs in Southeast Asia,Lupin said that it is committed to providing new affordable treatment options to healthcare providers and patients.,positive,positive,-0.3034411517851407,neutral,1.3225806451612905,positive
2022-04-06 08:27:00.000,774.45,786.0,771.0,772.1,916957.0,Lupin gets four USFDA inspection for its Tarapur manufacturing facility,"The inspection was carried out between March 22, 2022 and April 4, 2022.",neutral,neutral,-0.3034411517851407,neutral,1.3225806451612905,positive
2022-04-06 10:25:00.000,774.45,786.0,771.0,772.1,916957.0,Lupin inks pact with Alvion to market cardiometabolic drugs in Southeast Asia,Lupin will play a significant role in improving the quality of healthcare and access to medicines.,positive,positive,-0.3034411517851407,neutral,1.3225806451612905,positive
2022-04-06 17:30:00.000,775.0,787.0,768.0,785.25,1298414.0,"Stocks in news: Bandhan Bank, Marico, Tata Steel, Ruchi Soya and more","Stocks in news: Bandhan Bank, SBI Cards, Marico,Lupin, Tata Steel, Tata Power Company, Tata Consultancy Services, Ruchi Soya Industries, Adani Enterprises and more",neutral,neutral,1.3225806451612905,positive,-1.1240212174791586,negative
2022-04-07 08:22:00.000,775.0,787.0,768.0,785.25,1298414.0,Lupin completes acquisition of brands from Anglo-French; Stock gains 1%,"Shailesh Gadre, Founder of GCV Life was the exclusive advisor for the transaction",positive,positive,1.3225806451612905,positive,-1.1240212174791586,negative
2022-04-07 14:03:00.000,791.8,791.8,778.25,782.9,788241.0,Lupin completes acquisition of portfolio of brands from Anglo-French Drugs & Industries,"“India is critical in shaping Lupin’s growth story going forward. This acquisition strengthens our position in the Indian market, where we have already established ourselves as a leading provider of quality pharmaceuticals and a trusted partner,” Lupin Managing Director Nilesh Gupta noted.",neutral,positive,-1.1240212174791586,negative,0.2551020408163265,neutral
2022-04-07 16:54:00.000,791.8,791.8,778.25,782.9,788241.0,Lupin launches generic contraceptive drug in US,"Drug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market. The Mumbai-based drug maker has launched the product in the US market under exclusive license, marketing and distribution agreement with Slayback Pharma LLC, Lupin Ltd said in…",neutral,positive,-1.1240212174791586,negative,0.2551020408163265,neutral
2022-04-07 17:15:00.000,791.8,791.8,778.25,782.9,788241.0,Lupin launches generic contraceptive drug Merzee capsules in US,Slayback had earlier launched this product in the US in February 2021,neutral,neutral,-1.1240212174791586,negative,0.2551020408163265,neutral
2022-04-08 09:24:50.000,791.8,791.8,778.25,782.9,788241.0,Stocks that will see action on April 8,"Buzzing stocks: Lupin, Infosys, Sobha, Sonata Software, Cholamandalam Investment, Ashapuri Gold Ornaments, Hester Biosciences, Paras Defence, Yash Pakka",neutral,neutral,-1.1240212174791586,negative,0.2551020408163265,neutral
2022-04-12 20:57:00.000,777.0,779.65,766.0,774.3,970129.0,"Lupin looks to hire talent in digital health, diagnostics, data science","“The pharma industry is very bullish on growth right now. We are focusing on ramping up for new-age roles like product development specialists, product design professionals, biotech experts, commercial product pricing skills, legal know-how in pharma,” Mahadik told ET.",positive,positive,-0.3474903474903533,neutral,-0.5097103038905794,neutral
2022-04-18 13:41:00.000,775.0,783.3,761.0,766.25,1626418.0,Lupin receives USFDA tentative approval for Tenofovir Alafenamide Tablets,Tenofovir Alafenamide Tablets (RLD: Vemlidy Tablets) had estimated annual sales of USD484.2 million in the U.S. (IQVIA MAT December 2021).,positive,neutral,-1.129032258064516,negative,0.9415584415584416,positive
2022-04-18 14:02:00.000,775.0,783.3,761.0,766.25,1626418.0,Lupin receives tentative approval for Hepatitis B virus drug,"Lupin on Monday announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), tenofovir alafenamide tablets.",positive,positive,-1.129032258064516,negative,0.9415584415584416,positive
2022-04-18 15:52:00.000,775.0,783.3,761.0,766.25,1626418.0,Lupin | USFDA :Lupin gets USFDA nod to market drug used to treat chronic hepatitis B,"The company has received tentative approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application for Tenofovir Alafenamide tablets (25 mg), Lupin said in a statement.",neutral,positive,-1.129032258064516,negative,0.9415584415584416,positive
2022-04-18 16:30:59.000,775.0,783.3,761.0,766.25,1626418.0,Lupin Gets 4 Observations For Tarapur Manufacturing Plant From USFDA; Know Why,"Drug maker Lupin’s Tarapur active pharmaceutical ingredient (API) plant has got four observations from the US Food and Drug Administration (USFDA). The company has been issued Form 483 for the facility, which was inspected between March 22 and April 4",neutral,neutral,-1.129032258064516,negative,0.9415584415584416,positive
2022-04-18 17:30:00.000,775.0,783.3,761.0,766.25,1626418.0,Lupin gets tentative US FDA nod for pill used to treat hepatitis B,"Tenofovir alafenamide tablets had estimated annual sales of $484.2 million in the US, Lupin stated.",positive,neutral,-1.129032258064516,negative,0.9415584415584416,positive
2022-04-18 19:50:10.000,775.0,783.3,761.0,766.25,1626418.0,Lupin gets USFDA nod to market generic drug,New Delhi,neutral,neutral,-1.129032258064516,negative,0.9415584415584416,positive
2022-04-19 13:56:00.000,770.0,797.5,770.0,777.25,1613106.0,Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets,This product will be manufactured at Lupin’s Nagpur facility in India.,positive,neutral,0.9415584415584416,positive,-0.2544529262086514,neutral
2022-04-27 11:41:00.000,755.9,756.5,740.5,744.0,554793.0,"Lupin, Yabao announce strategic partnership in China for pediatric formulations",Lupin on Wednesday announced that it entered into a strategic partnership with Yabao Pharmaceutical Co. Inc to meet demand for quality drugs with pediatric formulations in the Chinese markets.,positive,positive,-1.574282312475192,negative,-0.3473149879775611,neutral
2022-04-27 17:30:00.000,748.6,754.5,739.05,746.0,755238.0,Lupin inks pact with Yabao to market paediatric formulations in China,"The latest Chinese paediatric pharmaceutical market report indicates that the market for paediatric drugs in China is expected to reach 210 billion CNY (33 billion USD) in 2021, growing at a rate of 9.23%.",positive,positive,-0.3473149879775611,neutral,-0.4,neutral
2022-04-29 15:16:00.000,750.0,767.85,742.45,747.0,919447.0,Lupin Diagnostics opens reference laboratory in Guwahati,"The Reference Laboratory in Guwahati has capabilities to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytogenetics, flow cytometry, histopathology, cytology, microbiology, serology, hematology,",neutral,neutral,-0.4,neutral,0.2229729729729699,neutral
2022-04-29 17:30:00.000,750.0,767.85,742.45,747.0,919447.0,Lupin Diagnostics launches regional reference laboratory in Guwahati,"The expansion is in line with Lupin Diagnostics’ strategy to expand its presence across India and increase access to quality testing, the company said in a statement.",neutral,positive,-0.4,neutral,0.2229729729729699,neutral
2022-05-06 14:16:52.000,720.5,729.0,712.1,724.85,697600.0,Lupin Ltd slips for fifth straight session,"Lupin Ltd is quoting at Rs 715.9, down 1.44% on the day as on 13:19 IST on the NSE. The stock tumbled 40.17% in last one year as compared to a 10.4% rally in NIFTY and a 7.29% fall in the Nifty Pharma index.",positive,negative,0.6037473976405305,neutral,1.2088139807971263,positive
2022-05-06 17:01:09.000,720.5,729.0,712.1,724.85,697600.0,Lupin receives USFDA approval to market generic Pregabalin capsules,"The approval granted by the US Food and Drug Administration (FDA) for the abbreviated new drug application (ANDA) is for Pregabalin capsules of strengths 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg, the company said in a regulatory filing.",positive,neutral,0.6037473976405305,neutral,1.2088139807971263,positive
2022-05-06 18:12:00.000,720.5,729.0,712.1,724.85,697600.0,Lupin receives USFDA approval for Pregabalin Capsules,Pregabalin Capsules (RLD Lyrica) had estimated annual sales of USD 263 million in the U.S. (IQVIA MAT March 2022).,positive,neutral,0.6037473976405305,neutral,1.2088139807971263,positive
2022-05-09 18:01:00.000,732.85,743.45,711.8,714.95,755400.0,Lupin receives USFDA approval for Iloperidone Tablets; Stock rises,"The product will be manufactured at Lupin’s facility in Goa, India.",positive,neutral,-2.4425189329330665,negative,-0.159944367176631,neutral
2022-05-11 03:00:00.000,719.0,724.65,701.05,717.85,1815117.0,Cloud computing: Cloud regimen speeds up Lupin’s digital journey | The Financial Express,"The pharmaceutical major has deployed the HPE GreenLake edge-to-cloud platform to accelerate digitisation, transform critical business processes and improve performance",neutral,positive,-0.159944367176631,neutral,-2.661064425770308,negative
2022-05-15 15:52:45.000,698.0,700.35,672.5,687.3,1173948.0,"Lupin, Glenmark, Dr. Reddy’s Recall Drugs In U.S. Market",The Indian drug majors are recalling different products in the United States due to deviation from standard manufacturing norms.,neutral,negative,-1.5329512893982873,negative,-0.217391304347826,neutral
2022-05-16 09:38:27.000,698.0,700.35,672.5,687.3,1173948.0,Stocks that will see action today,"Buzzing stocks: ACC, Ambuja Cements, Vodafone Idea, KIMS, Maruti Suzuki, Neogen Chem, RailTel, Lupin, Dr Reddy’s, Glenmark, Triveni Engineering, HDFC Bank, Dodla Dairy, Bharat Forge, Glaxo Pharma, Fino Payments Bank, MCX",neutral,neutral,-1.5329512893982873,negative,-0.217391304347826,neutral
2022-05-18 08:58:54.000,691.0,702.65,680.7,681.5,1429172.0,Stocks that will see action today (May 18),"Buzzing stocks: ITC, Lupin, Motilal Oswal, TVS Motor, LIC Housing, GIC HF, Route Mobile, IOB, Zydus Life, Ashoka Buildcon, Ramco Industries, Manappuram Fin, Interglobe Aviation",neutral,neutral,-1.374819102749638,negative,0.1180637544273907,neutral
2022-05-18 21:51:36.000,635.25,654.75,620.0,636.0,7720507.0,"Lupin Q4 Results: Posts Surprise Loss On Higher Input Costs, U.S. Price Erosion","Lupin reported a surprise loss in the fourth quarter on higher input and freight costs, and impairment.",neutral,negative,0.1180637544273907,neutral,0.2515723270440287,neutral
2022-05-18 22:39:00.000,635.25,654.75,620.0,636.0,7720507.0,"Lupin logs net loss of Rs 512 cr in Q4 on rising costs, impairment expense","Quarter was challenging due to ‘headwinds in the US on account of price erosion’, says company.",negative,negative,0.1180637544273907,neutral,0.2515723270440287,neutral
2022-05-19 08:09:00.000,635.25,654.75,620.0,636.0,7720507.0,"Stocks to Watch: ITC, Lupin, Ruchi Soya, Manappuram Finance, JSW, Biocon","Stocks to Watch today: Ashok Leyland, Bosch, Chambal Fertilisers & Chemicals, Container Corp, Dr Reddy’s will be in focus ahead of their Q4 results today.",neutral,neutral,0.1180637544273907,neutral,0.2515723270440287,neutral
2022-05-19 09:40:00.000,635.25,654.75,620.0,636.0,7720507.0,"Lupin slips 9%, hits 2-year low on disappointing March quarter results",Lupin’s performance was skewed on revenues front amid US and India posting lower than expected sales while RoW and South Africa saw better than anticipated traction this quarter.,negative,negative,0.1180637544273907,neutral,0.2515723270440287,neutral
2022-05-19 14:42:43.000,636.0,646.0,626.0,637.6,2623510.0,Lupin’s weak margins in Q4 take a toll on the stock,"Lupin’s consolidated Ebitda in Q4 declined a whopping 68% year-on-year to ₹227.6 crore. This at a time when revenues have risen 2.6% to ₹3,883 crore",negative,negative,0.2515723270440287,neutral,-3.7394827048924895,negative
2022-05-19 15:04:36.000,636.0,646.0,626.0,637.6,2623510.0,Manappuram Finance Ltd leads losers in ‘A’ group,"Tamil Nadu Newsprint & Papers Ltd, Route Mobile Ltd, Sudarshan Chemical Industries Ltd and Lupin Ltd are among the other losers in the BSE’s ‘A’ group today, 19 May 2022.",positive,negative,0.2515723270440287,neutral,-3.7394827048924895,negative
2022-05-20 08:49:05.000,636.0,646.0,626.0,637.6,2623510.0,Lupin AT ADR’s (LUPNY) CEO Vinita Gupta on Q4 2022 Results - Earnings Call Transcript,"Lupin AT ADR (OTC:LUPNY) Q4 2022 Earnings Conference Call May 19, 2022 6:00 AM ET Company Participants Vinita Gupta – Chief Executive Officer Ramesh Swaminathan – Chief Financial Officer...",neutral,neutral,0.2515723270440287,neutral,-3.7394827048924895,negative
2022-05-20 08:49:47.000,636.0,646.0,626.0,637.6,2623510.0,"Lupin Q4 Review - Growth Contingent On Niche Launches, Cost Optimisation: Motilal Oswal","Lupin Q4 Review - Growth Contingent On Niche Launches, Cost Optimisation: Motilal Oswal",neutral,neutral,0.2515723270440287,neutral,-3.7394827048924895,negative
2022-05-20 11:20:00.000,636.0,646.0,626.0,637.6,2623510.0,"What CLSA says on Lupin; Morgan Stanley on DRL, Godrej Consumer","In the case of DRL, Morgan Stanley said that the drug maker continued to deliver granular growth and that the growth trend should continue in FY23.",neutral,positive,0.2515723270440287,neutral,-3.7394827048924895,negative
2022-05-20 12:19:42.000,636.0,646.0,626.0,637.6,2623510.0,Lupin Q4 Review - Worst-Ever Margins: ICICI Securities,Lupin Q4 Review - Worst-Ever Margins: ICICI Securities,neutral,neutral,0.2515723270440287,neutral,-3.7394827048924895,negative
2022-05-20 12:21:36.000,636.0,646.0,626.0,637.6,2623510.0,Lupin Q4 Review - Sharp Operating Miss; Recovery Remains Elusive: Prabhudas Lilladher,Lupin Q4 Review - Sharp Operating Miss; Recovery Remains Elusive: Prabhudas Lilladher,neutral,neutral,0.2515723270440287,neutral,-3.7394827048924895,negative
2022-05-20 12:22:30.000,636.0,646.0,626.0,637.6,2623510.0,Lupin: Pricing erosion intensifies in US,"Near-term growth visibility is low due to a lack of major product launches, aggravating pricing erosion and input cost pressure for Lupin",positive,negative,0.2515723270440287,neutral,-3.7394827048924895,negative
2022-05-20 13:15:45.000,636.0,646.0,626.0,637.6,2623510.0,Lupin Q4 Review - Downbeat Margins; Triggers For U.S. Awaited: ICICI Direct,Lupin Q4 Review - Downbeat Margins; Triggers For U.S. Awaited: ICICI Direct,neutral,neutral,0.2515723270440287,neutral,-3.7394827048924895,negative
2022-05-20 15:09:27.000,636.0,646.0,626.0,637.6,2623510.0,"After Surprise Loss, Lupin Expects Much-Better Earnings In Second Half Of FY23","While Q4 is always a weaker quarter for India, the U.S. market was plagued with recalls and price erosion, says CFO Swaminathan.",neutral,negative,0.2515723270440287,neutral,-3.7394827048924895,negative
2022-05-24 17:50:00.000,602.5,609.2,583.0,591.0,1312929.0,"Lupin, Divis Labs Fall To 52-week Low; How Have They Fared Against Nifty Pharma?","Lupin, Divis Labs Fall To 52-week Low; How Have They Fared Against Nifty Pharma?",neutral,neutral,-1.9087136929460584,negative,1.488497970230033,positive
2022-05-25 07:30:00.000,602.5,609.2,583.0,591.0,1312929.0,"Lupin to resize portfolio, slash costs in US biz turnaround","In an interview to ET, CEO Vinita Gupta said the company had already exited a few products filed from its Somerset facility in New Jersey and has identified 15-20 more products to exit. “We need to look at whether we can sell through the inventory, we need to make sure that we don’t really have the …",neutral,neutral,-1.9087136929460584,negative,1.488497970230033,positive
2022-06-01 12:39:00.000,606.05,614.5,602.0,612.4,892851.0,"Titan, Lupin, Indian Hotels: How to trade Rakesh Jhunjhunwala-owned stocks","Titan and Lupin seem poised for solid gains among Rakesh Jhunjhunwala’s portfolio, while shares of Lupin, Star Health and Jubilant Pharmova can be avoided for now.",neutral,positive,1.047768335945883,positive,0.1060964661715461,neutral
2022-06-03 14:30:00.000,612.65,621.9,606.2,613.3,1493620.0,Indian pharma firms hiring former USFDA officers to tide over compliance issues,Lupin has hired a former USFDA officer to tide over compliance issues and it is not the only company to do so. The street believes this will help the company but past such hirings have not always been successful.,neutral,neutral,0.1060964661715461,neutral,-0.7608606725026552,neutral
2022-06-06 11:21:00.000,611.15,613.4,599.0,606.5,1547478.0,Lupin share price down 1.47 per cent,"A total of 22,284 shares changed hands on the counter till 11:21AM (IST).",negative,neutral,-0.7608606725026552,neutral,1.0251322751322829,positive
2022-06-07 17:30:00.000,606.15,614.9,603.0,612.5,903605.0,Taking Stock | Market snaps six-day losing streak on yet another volatile day,"Voltas, HDFC Bank, REC, Lupin, Dixon Technologies and Indus Towers were among the stocks that touched their 52-week low on the BSE",negative,negative,1.047595479666753,positive,0.7018116533376781,neutral
2022-06-08 06:30:00.000,606.15,614.9,603.0,612.5,903605.0,Lupin bags Tentative Approval from USFDA for Ivacaftor Tablets,"The approval received is to market a generic equivalent of Kalydeco Tablets, 150 mg of Vertex Pharmaceuticals Incorporated.",neutral,neutral,1.047595479666753,positive,0.7018116533376781,neutral
2022-06-08 14:30:23.000,612.7,627.95,609.0,617.0,953972.0,Lupin gets USFDA nod for generic drug,"The company has received tentative approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Ivacaftor tablets, 150 mg strength, Lupin said in a statement.",neutral,positive,0.7018116533376781,neutral,0.2118298843082865,neutral
2022-06-08 17:30:00.000,612.7,627.95,609.0,617.0,953972.0,Lupin bags tentative approval from US FDA for Ivacaftor Tablets,"As per the company, the product will be manufactured at Lupin’s Nagpur facility in India",positive,neutral,0.7018116533376781,neutral,0.2118298843082865,neutral
2022-06-09 00:42:19.000,612.7,627.95,609.0,617.0,953972.0,Lupin receives tentative approval from USFDA to market Ivacaftor tablets,"The product is the generic equivalent of Vertex Pharmaceuticals’ Kalydeco tablets, Lupin said in a statement",positive,neutral,0.7018116533376781,neutral,0.2118298843082865,neutral
2022-06-09 08:19:17.000,612.7,627.95,609.0,617.0,953972.0,"Stocks to Watch: Banks, Lupin, YES Bank, CG Electricals, Ujjivan SFB, Sugar","Stocks to Watch Today: Sugar industry has requested the government that the additional 1 MT export order be given the mills, and not trader or exporters.",neutral,neutral,0.7018116533376781,neutral,0.2118298843082865,neutral
2022-06-15 09:20:00.000,614.35,616.5,608.0,613.85,522973.0,Lupin Diagnostics launches its first Regional Reference Laboratory in Patna,"By establishing a presence in Patna, the company now looks forward to making a deeper foray into Bihar.",neutral,positive,-0.0813868316106454,neutral,-1.9577579203899196,negative
2022-06-15 16:16:06.000,615.5,618.3,600.25,603.45,1302738.0,Lupin launches first reference laboratory in Patna,"The drug major on Wednesday announced that Lupin Diagnostics has launched its first regional reference laboratory in Patna, Bihar.",neutral,neutral,-1.9577579203899196,negative,-0.125,neutral
2022-06-16 09:00:29.000,615.5,618.3,600.25,603.45,1302738.0,Stocks that will see action today (June 16),"Buzzing stocks: TCS, NBCC, Lupin, UPL, Astron Paper, Binny, Tata Power, ASI Industries",neutral,neutral,-1.9577579203899196,negative,-0.125,neutral
2022-07-01 07:49:12.000,613.1,630.55,608.7,627.3,904120.0,"Stocks to watch: Maruti Suzuki, Airtel, Hind Copper, IHCL, SAIL, UPL, Lupin",Stocks to watch today: Maruti Suzuki launched refurbished version of popular compact SUV - Brezza; Future Enterprises defaulted on payment of interest of Rs 6.1 crore for NCDs.,neutral,neutral,2.316098515739672,positive,0.5423512521933287,neutral
2022-07-01 08:30:16.000,613.1,630.55,608.7,627.3,904120.0,"Stocks to Watch Today: Airtel, UPL, Auto Stock, Lupin, HUL, and Others","Stocks to watch today: Shares of firms like Airtel, UPL, Auto Stock, Lupin, HUL, and others will be in focus in Friday’s trade",neutral,neutral,2.316098515739672,positive,0.5423512521933287,neutral
2022-07-01 08:44:45.000,613.1,630.55,608.7,627.3,904120.0,Stocks that will see action today (July 1),"Buzzing stocks: Auto stocks, Reliance Industries, UPL, Lupin, Phoenix Mills and Globus Spirits",neutral,neutral,2.316098515739672,positive,0.5423512521933287,neutral
2022-07-01 17:30:00.000,613.1,630.55,608.7,627.3,904120.0,"Stocks in news: Reliance Industries, Indian Oil, HUL, Bharti Airtel and more","Stocks in news: Reliance Industries, Indian Oil, HUL, Lupin, Bharti Airtel, Indiabulls Housing Finance and more",neutral,neutral,2.316098515739672,positive,0.5423512521933287,neutral
2022-07-07 12:12:20.000,640.0,641.25,630.05,633.7,678106.0,Lupin’s Somerset manufacturing plant receives EIR from US FDA,The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated,neutral,neutral,-0.9843749999999928,negative,1.8049398353388184,positive
2022-07-07 16:32:00.000,640.0,641.25,630.05,633.7,678106.0,Lupin’s Somerset Manufacturing Plant secures EIR from USFDA; stock rises,The USFDA has determined that the facility’s inspection classification is Voluntary Action Indicated (VAI).,positive,neutral,-0.9843749999999928,negative,1.8049398353388184,positive
2022-07-19 15:05:01.000,647.0,661.85,643.7,657.8,658818.0,Lupin Diagnostics launches its first reference lab in Ranchi,"In order to serve East India comprehensively, Lupin Diagnostics has already established processing laboratories in Assam, West Bengal, and Bihar. Currently, Lupin Diagnostics has over 100 LupiMitra (Lupin’s franchise collection centers) already",neutral,neutral,1.669242658423486,positive,-1.3636363636363635,negative
2022-07-25 01:37:00.000,643.35,643.35,626.0,631.0,814348.0,"FMCG spices it up, pharma takes a shot at diagnostics","Ahmedabad-based drug major Torrent Pharma is reportedly set to foray into the diagnostics business, although a formal announcement is awaited. Last year, its Mumbai-based peer Lupin made an organic foray into the ₹70,000-crore sector. Mankind Pharma and Reliance Life Sciences are other large players…",neutral,neutral,-1.919639387580636,negative,-1.4472235331131107,negative
2022-07-25 19:18:00.000,635.7,636.0,625.0,626.5,692727.0,Lupin gets USFDA approval for generic blood pressure lowering drug,Drug firm Lupin on Monday said it has received an approval from the US Health regulator to market generic medication to treat high blood pressure.,positive,positive,-1.4472235331131107,negative,2.56,positive
2022-07-26 07:53:00.000,635.7,636.0,625.0,626.5,692727.0,"Stocks to watch: Asian Paints, Bajaj Auto, Tata Steel, Axis Bank, Lupin","Stocks to watch today: Asian Paints, Bajaj Auto will report their June quarter results (Q1FY23) on Tuesday, July 26; Lupin received approval from USFDA to market medication for high blood pressure.",neutral,neutral,-1.4472235331131107,negative,2.56,positive
2022-07-26 09:04:58.000,635.7,636.0,625.0,626.5,692727.0,Lupin gets USFDA nod for generic hypertension drug,The drug major on Monday (25 July 2022) announced that it received approval from the US drug regulator for Azilsartan Medoxomil tablets.,neutral,positive,-1.4472235331131107,negative,2.56,positive
2022-07-26 14:45:00.000,625.0,641.75,623.1,641.0,584286.0,Lupin bags USFDA approval for Azilsartan Medoxomil Tablets; stock rises,"In the United States, Azilsartan Medoxomil Tablets (RLD Edarbi®) had an estimated annual sale of USD 101 million as per IQVIA MAT March 2022.",positive,neutral,2.56,positive,-0.3798449612403171,neutral
2022-08-03 07:49:33.000,639.0,644.0,624.65,628.0,1183594.0,"Stocks to Watch Today: Voltas, Lupin, InterGlobe Aviation, Vodafone Idea, and Others","Stocks to watch today: Shares of firms like Voltas, Lupin, InterGlobe Aviation, Vodafone Idea, and others will be in focus in Wednesday’s trade",neutral,neutral,-1.7214397496087637,negative,7.84313725490196,positive
2022-08-04 00:11:28.000,612.0,664.25,603.0,660.0,13119105.0,"Lupin Q1 Results: Net Loss On Weak Show In Major Markets, Higher Operating Expenses","Despite muted numbers in this quarter, the company expects a strong bounce-back from Q2 onwards, Gupta said.",neutral,positive,7.84313725490196,positive,1.578388222795565,positive
2022-08-04 09:04:51.000,612.0,664.25,603.0,660.0,13119105.0,Lupin reports consolidated net loss of Rs 89.08 crore in the June 2022 quarter,Sales decline 14.95% to Rs 3603.96 crore,negative,negative,7.84313725490196,positive,1.578388222795565,positive
2022-08-04 15:00:00.000,658.9,670.0,653.95,669.3,2974368.0,Lupin reports a net loss of Rs86.80 crore in Q1FY23; stock slips ~1%,"Nilesh Gupta, Managing Director, Lupin Limited, commented on the results, saying,",negative,neutral,1.578388222795565,positive,-0.4253731343283616,neutral
2022-08-04 17:07:59.000,658.9,670.0,653.95,669.3,2974368.0,Lupin Gains Most In Eight Months Despite Q1 Miss In A Volatile Session,"Shares of Lupin Ltd. opened lower before surging to end with 5% gains in a volatile session, despite Q1 miss.",neutral,negative,1.578388222795565,positive,-0.4253731343283616,neutral
2022-08-04 17:30:00.000,658.9,670.0,653.95,669.3,2974368.0,Pharma major Lupin’s sales in India and US decline in Q1,"The company, however, expects a strong bounce back in the next quarter. “Our numbers are muted this quarter, but we expect a strong bounce back Q2 onwards,” Lupin said.",negative,positive,1.578388222795565,positive,-0.4253731343283616,neutral
2022-08-04 21:30:08.000,658.9,670.0,653.95,669.3,2974368.0,Lupin reports Q1 net loss at Rs 89 cr on lower US sales; revenue falls 12%,"‘Our numbers are muted this quarter, but we expect a strong bounce back from Q2 onwards,’ says Lupin MD",negative,positive,1.578388222795565,positive,-0.4253731343283616,neutral
2022-08-04 23:31:23.000,658.9,670.0,653.95,669.3,2974368.0,"Sun, Cipla’s US show tops Dr Reddy’s, Lupin in Q1",Pricing pressure continues to remain a key headwind for the growth of pharma companies in the US market,positive,negative,1.578388222795565,positive,-0.4253731343283616,neutral
2022-08-05 08:27:15.000,658.9,670.0,653.95,669.3,2974368.0,Lupin Q1 Review - Disappointing Quarter: Dolat Capital,Lupin Q1 Review - Disappointing Quarter: Dolat Capital,neutral,neutral,1.578388222795565,positive,-0.4253731343283616,neutral
2022-08-05 10:00:00.000,658.9,670.0,653.95,669.3,2974368.0,Can pharma sustain the rally? Chakri Lokapriya answers,"“There is a move towards more complex generics which are higher margin and are subject to less price erosion in the US and also in the advanced markets. The US has traditionally been stronger pricing wise versus Europe. Against this whole backdrop, Lupin and Cipla because of the move towards comple…",positive,neutral,1.578388222795565,positive,-0.4253731343283616,neutral
2022-08-05 12:24:07.000,658.9,670.0,653.95,669.3,2974368.0,"Lupin Q1 Review - Outlook Hinges On Niche Approvals, Cost Minimisation: Motilal Oswal","Lupin Q1 Review - Outlook Hinges On Niche Approvals, Cost Minimisation: Motilal Oswal",neutral,neutral,1.578388222795565,positive,-0.4253731343283616,neutral
2022-08-05 12:24:24.000,658.9,670.0,653.95,669.3,2974368.0,Lupin Q1 Review - Worst Of Margin Woes May Have Passed: Yes Securities,Lupin Q1 Review - Worst Of Margin Woes May Have Passed: Yes Securities,neutral,neutral,1.578388222795565,positive,-0.4253731343283616,neutral
2022-08-12 08:27:41.000,693.45,694.0,681.0,682.8,748473.0,F&O Strategy: Nandish Shah recommends a Bull Spread on Lupin,The technical analyst from HDFC Securities recommends buying Lupin 700 Call and simultaneously selling 720 Call for the August series.,neutral,positive,-1.535799264546844,negative,-0.7776727959880838,neutral
2022-08-12 16:04:05.000,693.45,694.0,681.0,682.8,748473.0,Lupin receives USFDA approval for Meclizine Hydrochloride Tablets,Meclizine Hydrochloride Tablets (RLD Antivert) had estimated annual sales of USD 29 million in the U.S. (IQVIA MAT June 2022).,positive,neutral,-1.535799264546844,negative,-0.7776727959880838,neutral
2022-08-15 01:34:23.000,687.95,689.9,675.0,682.6,842874.0,Lupin revising product portfolio in US to overcome price erosion impact,Lupin’s transitioning of the portfolio from the simple generic oral solids to complex generics had started with short-acting bronchodilator albuterol,positive,neutral,-0.7776727959880838,neutral,0.583941605839416,neutral
2022-08-18 08:01:00.000,687.95,692.0,678.35,689.0,888311.0,Lupin gets USFDA approval for Rufinamide Tablets USP,"The product will be manufactured at Lupin’s facility located in Goa, India.",positive,neutral,0.1526273711752241,neutral,0.437956204379562,neutral
2022-08-18 14:31:37.000,685.0,696.45,685.0,688.0,1077017.0,Lupin gets USFDA nod for seizure treatment drug,"The pharma major on Thursday announced that it has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Rufinamide tablets USP.",neutral,positive,0.437956204379562,neutral,0.3289473684210526,neutral
2022-08-18 15:41:38.000,685.0,696.45,685.0,688.0,1077017.0,Lupin receives USFDA nod for rufinamide tablets to treat seizures,"Pharmaceuticals firm Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic rufinamide tablets to treat seizures, manufacturing to begin in Goa.",neutral,positive,0.437956204379562,neutral,0.3289473684210526,neutral
2022-08-24 16:05:00.000,681.0,681.0,661.95,663.75,2366993.0,Lupin receives USFDA approval for Formoterol Fumarate Inhalation Solution,Formoterol Fumarate Inhalation Solution (RLD Perforomist) had estimated annual sales of USD 282 million in the U.S. (IQVIA MAT June 2022).,positive,neutral,-2.5330396475770924,negative,-3.035714285714282,negative
2022-08-24 17:30:00.000,681.0,681.0,661.95,663.75,2366993.0,Lupin gets USFDA nod for generic medication,"As per IQVIA MAT June 2022 data, the medication had annual sales of around USD 282 million in the US market.",neutral,neutral,-2.5330396475770924,negative,-3.035714285714282,negative
2022-08-24 21:34:40.000,681.0,681.0,661.95,663.75,2366993.0,Lupin gets USFDA approval for Formoterol Fumarate Inhalation Solution,"The company has received approval from the USFA for the product which is a generic version of Mylan Specialty’s Perforomist Inhalation Solution, the Mumbai-based drug maker said in a statement",positive,positive,-2.5330396475770924,negative,-3.035714285714282,negative
2022-08-24 22:41:00.000,681.0,681.0,661.95,663.75,2366993.0,Lupin Gets U.S. FDA Nod For Formoterol Fumarate Inhalation Solution,Lupin’s new offering can be used in treating symptoms of chronic obstructive pulmonary disease.,neutral,neutral,-2.5330396475770924,negative,-3.035714285714282,negative
2022-08-25 07:21:00.000,681.0,681.0,661.95,663.75,2366993.0,"Stocks in the news: Wipro, Tata Power, Lupin, Adani Green and TVS Motor","The IT major Wipro announced the appointment of Wagner Jesus as country head and managing director for operations in Brazil. Wagner joined Wipro three years ago, taking the lead of the non-financial business cluster.",neutral,neutral,-2.5330396475770924,negative,-3.035714285714282,negative
2022-08-25 08:18:39.000,681.0,681.0,661.95,663.75,2366993.0,"Stocks To Watch Today: Bharti Airtel, NHPC, Lupin, PB Fintech, PSP Projects",Stocks to watch before going into trade today.,neutral,neutral,-2.5330396475770924,negative,-3.035714285714282,negative
2022-08-25 08:45:00.000,681.0,681.0,661.95,663.75,2366993.0,Lupin and I’rom inks agreement for Denosumab biosimilar for Japan,Denosumab is indicated for the treatment of postmenopausal women with osteoporosis.,positive,neutral,-2.5330396475770924,negative,-3.035714285714282,negative
2022-08-25 09:06:34.000,681.0,681.0,661.95,663.75,2366993.0,"Stocks to Watch Today: Wipro, Lupin, Tata Power, TVS Motor, and Others","Stocks to watch today: Shares of firms like Wipro, Lupin, Tata Power, TVS Motor, and others will be in focus in Thursday’s trade",neutral,neutral,-2.5330396475770924,negative,-3.035714285714282,negative
2022-08-25 09:16:20.000,681.0,681.0,661.95,663.75,2366993.0,Stocks that will see action today (August 25),"Buzzing stocks: Bharti Airtel, Wipro, Adani Enterprises, TVS Motor, Lupin, Amara Raja Batteries, PSP Projects",neutral,neutral,-2.5330396475770924,negative,-3.035714285714282,negative
2022-08-25 11:17:29.000,681.0,681.0,661.95,663.75,2366993.0,Lupin signs deed for acquisition of two brands in Germany,"Lupin announced that the company has entered into deed of assignment with Boehringer Ingelheim International GmbH for the acquisition of brands Ondero and Ondero Met, including trademark rights associated with the brands.",neutral,positive,-2.5330396475770924,negative,-3.035714285714282,negative
2022-08-25 12:42:00.000,672.0,672.0,650.85,651.6,1648704.0,Lupin inks licensing pact with Japan-based I’rom Group,"Denosumab is indicated for the treatment of postmenopausal women with osteoporosis at high risk of fracture and prevention of skeletal-related events in patients with bone metastases from solid tumours, among other indications. Following the completion of the clinical trial and receipt of marketing …",positive,neutral,-3.035714285714282,negative,3.562499999999993,positive
2022-08-25 13:04:07.000,672.0,672.0,650.85,651.6,1648704.0,Lupin enters into exclusive licensing agreement with I’rom,For distribution and marketing of biosimilar Denosumab in Japan,positive,neutral,-3.035714285714282,negative,3.562499999999993,positive
2022-08-25 13:16:26.000,672.0,672.0,650.85,651.6,1648704.0,Lupin pharmaceutical inks licensing pact with Japan-based I’rom Group,"Drug maker Lupin said it has inked a licensing pact with Japan-based I’rom Group Co for a product used in the treatment of postmenopausal women with osteoporosis, among others",positive,positive,-3.035714285714282,negative,3.562499999999993,positive
2022-08-25 13:55:18.000,672.0,672.0,650.85,651.6,1648704.0,Lupin Inks Licensing Pact With Japan-Based I’rom Group,Drug maker Lupin on Thursday said it has inked a licensing pact with Japan-based I’rom Group Co.,neutral,positive,-3.035714285714282,negative,3.562499999999993,positive
2022-08-25 17:30:00.000,672.0,672.0,650.85,651.6,1648704.0,Lupin signs agreement with I’rom for clinical trials and marketing of post-menopause drug in Japan,Denosumab is indicated for the treatment of postmenopausal women with osteoporosis at high risk of fracture and prevention of skeletal-related events in patients with bone metastases from solid tumors among other indications.,positive,neutral,-3.035714285714282,negative,3.562499999999993,positive
2022-08-25 17:30:00.000,672.0,672.0,650.85,651.6,1648704.0,"Stocks in news: Tata Power, TVS Motor, Lupin, RBL Bank and more","Stocks in news: Tata Power, Barbeque-Nation Hospitality, TVS Motor, Lupin, NHPC, RBL Bank and more",neutral,neutral,-3.035714285714282,negative,3.562499999999993,positive
2022-08-26 06:33:00.000,672.0,672.0,650.85,651.6,1648704.0,Lupin gets UK MHRA Approval of ‘Lutio’ for Treatment of COPD; stock slips ~1.5%,"When made available to UK patients, Lutio has the potential to provide considerable cost reductions.",neutral,positive,-3.035714285714282,negative,3.562499999999993,positive
2022-08-26 13:16:06.000,672.0,672.0,650.85,651.6,1648704.0,Lupin UK subsidiary gets MHRA nod for COPD treatment drug,"The pharma major on Friday announced that its UK subsidiary, Lupin Healthcare has received approval from Medicines and Healthcare products Regulatory Agency (MHRA) for Lutio (Tiotropium bromide inhalation powder).",neutral,positive,-3.035714285714282,negative,3.562499999999993,positive
2022-08-26 14:35:07.000,672.0,672.0,650.85,651.6,1648704.0,"Lupin gets UK MHRA nod for generic drug to manage COPD, asthma","Lupin Healthcare (UK) has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) to market a generic version of Spiriva, the Mumbai-based drug firm said in a statement.",neutral,positive,-3.035714285714282,negative,3.562499999999993,positive
2022-08-26 15:28:00.000,672.0,672.0,650.85,651.6,1648704.0,Lupin’s arm gets UK regulator nod for COPD treatment,"Global pharma major Lupin Limited on Friday announced that its UK subsidiary, Lupin Healthcare (UK) Limited, has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market a generic version of Spiriva, stated a press release.",neutral,positive,-3.035714285714282,negative,3.562499999999993,positive
2022-08-26 16:31:07.000,672.0,672.0,650.85,651.6,1648704.0,Lupin launches Desvenlafaxine ER Tablets in United States,"Desvenlafaxine Extended-Release Tablets, 25 mg is a generic equivalent of Pristiq Extended-Release Tablets, 25 mg of PF PRISM C.V.",neutral,neutral,-3.035714285714282,negative,3.562499999999993,positive
2022-08-29 08:52:00.000,640.0,664.4,634.65,662.8,1428729.0,Lupin bags USFDA tentative approval for Dasatinib Tablets; stock jumps ~2%,"Dasatinib Tablets (RLD Sprycel) has expected annual sales in the United States of USD 1,569 million, as per the IQVIA MAT June 2022.",positive,neutral,3.562499999999993,positive,0.4662355241389717,neutral
2022-08-29 17:09:00.000,664.9,671.95,661.7,668.0,1278909.0,Lupin gets USFDA nod for generic cancer treatment drug,"Lupin in partnership with Pharmascience Inc. has received approval from the US Food and Drug Administration (FDA) for Dasatinib tablets in strengths of 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, it said in a statement.",neutral,positive,0.4662355241389717,neutral,-0.7732732732732698,neutral
2022-08-29 17:15:11.000,664.9,671.95,661.7,668.0,1278909.0,Lupin gets USFDA approval to market generic cancer treatment drug,"Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America",positive,positive,0.4662355241389717,neutral,-0.7732732732732698,neutral
2022-08-30 07:52:13.000,664.9,671.95,661.7,668.0,1278909.0,"Stocks to Watch Today: Vodafone Idea, Lupin, L&T Tech, and Others","Stocks to watch today: Shares of firms like Vodafone Idea, Lupin, L&T Tech, and others will be in focus in Tuesday’s trade",neutral,neutral,0.4662355241389717,neutral,-0.7732732732732698,neutral
2022-08-30 08:13:17.000,664.9,671.95,661.7,668.0,1278909.0,"Stocks to watch: RIL, L&T Tech, ICICI Bank, Axis Bank, Lupin, Ashok Leyland","Stocks to watch today: ICICI Bank, Axis Bank, and IDFC First Bank have increased interest rates on deposits worth Rs 2 crore & above; BPCL plans to scale up renewable energy portfolio to 10 GW by 2040",neutral,positive,0.4662355241389717,neutral,-0.7732732732732698,neutral
2022-08-30 17:30:00.000,664.9,671.95,661.7,668.0,1278909.0,"Stocks in news: Reliance Industries, Quick Heal, Axis Bank, Lupin and more","Stocks in news: Reliance Industries, Quick Heal, Axis Bank, Lupin, ICRA, Thyrocare Technologies and more",neutral,neutral,0.4662355241389717,neutral,-0.7732732732732698,neutral
2022-09-02 17:30:00.000,661.65,665.3,652.05,653.75,530528.0,"Zydus Lifesciences, Lupin recall products in US market","According to the USFDA, the company’s US-based unit is recalling the affected lot due to “Failed Impurities/Degradation Specifications”.",negative,negative,-1.193984735131864,negative,0.0458926112895754,neutral
2022-09-02 18:28:00.000,661.65,665.3,652.05,653.75,530528.0,"Zydus Lifesciences, Lupin recall products in US market owing to manufacturing issues","Zydus initiated the Class II voluntary recall on July 15 this year. Similarly, Baltimore-based Lupin Pharmaceuticals, Inc, is recalling 7,872 bottles of Rifampin Capsules, a medication used to treat infections caused by bacteria.",negative,negative,-1.193984735131864,negative,0.0458926112895754,neutral
2022-09-07 14:34:33.000,673.0,673.0,664.05,665.95,473226.0,"Lupin inks licensing, supply pact with DKSH to commercialise Alvotech’s five biosimilars in Philippines",DKSH is a leading partner for healthcare companies seeking to grow their business in Asia and beyond.,positive,positive,-1.0475482912332772,negative,-0.4484304932735426,neutral
2022-09-07 16:44:00.000,673.0,673.0,664.05,665.95,473226.0,"Lupin, DKSH enter pact to commercials Alvotech biosimilars in Philippines","The biosimilars planned under this agreement include biosimilar Prolia (denosumab 60mg/ml) and Xgeva (denosumab 70 mg/ml) for treating osteoporosis, Simponi (golimumab) for treating rheumatoid arthritis, and Eylea (aflibercept) against wet-age macular degeneration as well as two undisclosed proposed…",neutral,neutral,-1.0475482912332772,negative,-0.4484304932735426,neutral
2022-09-09 08:45:00.000,669.0,673.7,666.0,666.0,584443.0,Lupin launches Generic Suprep Bowel Prep Kit in US,"Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution (RLD Suprep Bowel Prep Kit) had estimated annual sales of USD 202 million in the U.S.",neutral,neutral,-0.4484304932735426,neutral,0.5010844364669842,neutral
2022-09-09 11:39:04.000,669.0,673.7,666.0,666.0,584443.0,Lupin receives US FDA approval for generic Suprep Bowel Prep Kit,"The approval by the US Food and Drug Administration (USFDA) is for sodium sulfate, potassium sulfate and magnesium sulfate oral solution of strength 17.5 g/3.13 g/1.6 g per 6 ounces, Lupin Ltd said in a regulatory filing.",positive,neutral,-0.4484304932735426,neutral,0.5010844364669842,neutral
2022-09-09 12:00:00.000,669.0,673.7,666.0,666.0,584443.0,Lupin gets US FDA approval for generic used to cleanse colon,"US FDA’s approval is for sodium sulfate, potassium sulfate and magnesium sulfate oral solution of strength 17.5 g/3.13 g/1.6 g per 6 ounces, Lupin said in a stock exchange filing. Sodium sulfate, potassium sulfate and magnesium sulfate oral solution had estimated annual sales of USD 202 million in t…",positive,neutral,-0.4484304932735426,neutral,0.5010844364669842,neutral
2022-09-09 12:55:11.000,669.0,673.7,666.0,666.0,584443.0,Lupin receives US FDA approval for kit used in colonoscopy preparation,"The approval by the US Food and Drug Administration (USFDA) is for sodium sulfate, potassium sulfate and magnesium sulfate oral solution of strength 17.5 g/3.13 g/1.6 g per 6 ounces",positive,neutral,-0.4484304932735426,neutral,0.5010844364669842,neutral
2022-09-13 08:38:00.000,674.0,675.05,668.5,673.85,528001.0,Health Canada grants approval for Lupin’s Rymti biosimilar etanercept,"Lupin is dedicated to increasing patient access to high-quality, life-improving biosimilars.",positive,positive,-0.0222551928783349,neutral,0.1726726726726692,neutral
2022-09-13 16:36:15.000,666.0,671.5,663.6,667.15,415835.0,Lupin gets nod for arthritis drug ‘Rymti’ from Canadian health authority,"It underscores the scientific success of the company’s biosimilar programmes and commitment to advancing healthcare through innovation, he added",neutral,positive,0.1726726726726692,neutral,-1.1571481896229938,negative
2022-09-14 08:05:10.000,666.0,671.5,663.6,667.15,415835.0,"Stocks to Watch Today: Infosys, Bharat Forge, PVR, Lupin, JSW Steel, and Others","Stocks to watch today: Shares of firms like Infosys, Bharat Forge, PVR, Lupin, JSW Steel, and others will be in focus in Wednesday’s trade",neutral,neutral,0.1726726726726692,neutral,-1.1571481896229938,negative
2022-09-19 22:02:26.000,644.5,673.95,642.25,670.0,1892929.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, there were 57 stocks including India Cements, Nifty Financial, Astral, Lupin, and Bajaj Auto in which a short-covering was seen",neutral,neutral,3.95655546935609,positive,-1.4328358208955256,negative
2022-09-23 08:03:12.000,666.3,668.0,647.0,647.0,531674.0,"Stocks to Watch: M&M Financials, Fortis, Airtel, Hero MotoCorp, Lupin","Ambuja Cements, Delta Corp, RBL Bank, Can Fin Homes, and Punjab National Bank will be under the F&O ban list for Thursday. These stocks will be under the ban for the F&O segment as they have crossed 95% of the market-wide position limit (MWPL), as per the NSE.",neutral,neutral,-2.8965931262194142,negative,1.4763014763014763,positive
2022-09-23 17:30:00.000,666.3,668.0,647.0,647.0,531674.0,"Stocks in news: Tata Steel, Reliance Industries, M&M, Bharti Airtel and more","Shares to watch out for today: Tata Steel, Reliance Industries, M&M, Bharti Airtel, Cipla, Lupin, Century Textiles and more",neutral,neutral,-2.8965931262194142,negative,1.4763014763014763,positive
2022-09-29 10:39:00.000,673.6,674.1,644.8,655.05,4372713.0,US FDA issues warning letter to Lupin’s Tarapur unit,"The United States Food and Drug Administration (US FDA) has issued a warning letter to Lupin’s Tarapur, Maharashtra facility, the company said in a stock exchange filing on Thursday. Lupin in a statement said it does not believe that the warning letter will have an impact or disruption of supplies o…",negative,negative,-2.7538598574821957,negative,2.8257575757575726,positive
2022-09-29 10:59:00.000,673.6,674.1,644.8,655.05,4372713.0,Lupin dips 3% as US FDA issues warning letter for Tarapur facility,Lupin said it does not believe the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility,neutral,neutral,-2.7538598574821957,negative,2.8257575757575726,positive
2022-09-29 11:17:33.000,673.6,674.1,644.8,655.05,4372713.0,"US watchdog sniffs Lupin’s Tarapur facility, growls",The company said it will address the concerns raised by the watchdog and the news will not impact its revenue.,neutral,neutral,-2.7538598574821957,negative,2.8257575757575726,positive
2022-09-29 15:50:43.000,660.0,682.8,660.0,678.65,4001234.0,Lupin launches generic version of Revatio in US market,The drug major announced the launch of Sildenafil for oral suspension in the US market with an approval from the US Food and Drug Administration (USFDA).,positive,positive,2.8257575757575726,positive,6.185567010309279,positive
2022-09-29 18:07:00.000,660.0,682.8,660.0,678.65,4001234.0,Lupin’s Tarapur unit receives warning from USFDA; stock dips ~1.5%,The company believes that the warning letter will have no effect on supply disruptions.,negative,neutral,2.8257575757575726,positive,6.185567010309279,positive
2022-09-29 18:31:00.000,660.0,682.8,660.0,678.65,4001234.0,Lupin gets warning letter from USFDA for Tarapur API plant,"Drug firm Lupin on Thursday said it has received a warning letter from the US health regulator for its Tarapur-based manufacturing facility in Maharashtra. The US Food and Drug Administration (USFDA) inspected the site from March 22, 2022 to April 4, 2022.",negative,negative,2.8257575757575726,positive,6.185567010309279,positive
2022-09-29 19:26:19.000,660.0,682.8,660.0,678.65,4001234.0,Lupin gets warning letter from USFDA for Tarapur API plant in Maharashtra,Drug firm Lupin on Thursday said it has received a warning letter from the US health regulator for its Tarapur-based manufacturing facility in Maharashtra,negative,negative,2.8257575757575726,positive,6.185567010309279,positive
2022-09-29 20:16:41.000,660.0,682.8,660.0,678.65,4001234.0,Lupin receives USFDA approval for Mirabegron Extended-Release Tablets,"Mirabegron Extended-Release Tablets, 25 mg and 50 mg, (RLD Myrbetriq) had estimated annual sales of USD 2403 million in the U.S. (IQVIA MAT June 2022).",positive,neutral,2.8257575757575726,positive,6.185567010309279,positive
2022-09-29 21:00:46.000,660.0,682.8,660.0,678.65,4001234.0,Lupin gets warning letter for Tarapur API plant,"Manufacturing will not be affected, says drugmaker",negative,neutral,2.8257575757575726,positive,6.185567010309279,positive
2022-09-30 05:00:00.000,660.0,682.8,660.0,678.65,4001234.0,"Stocks To Watch: Adani Power, Hero MotoCorp, Adani Green, Lupin, PNB, Bajaj Electricals, Deepak Nitrite",Stocks to watch before going into trade today.,neutral,neutral,2.8257575757575726,positive,6.185567010309279,positive
2022-09-30 07:37:05.000,660.0,682.8,660.0,678.65,4001234.0,"Stocks to Watch Today: Lupin, PNB, Rail Vikas Nigam, Hero MotoCorp, and Others","Stocks to watch today: Shares of firms like Lupin, PNB, Rail Vikas Nigam, Hero MotoCorp, and others will be in focus in Friday’s trade",neutral,neutral,2.8257575757575726,positive,6.185567010309279,positive
2022-09-30 08:28:01.000,660.0,682.8,660.0,678.65,4001234.0,Stocks that will see action today (September 30),"Buzzing stocks: Index entrants, Adani Ports, Hero MotoCorp, Deepak Nitrite, Adani Power, Coforge, Lupin, Goa Carbon, Lumax",neutral,neutral,2.8257575757575726,positive,6.185567010309279,positive
2022-09-30 09:04:08.000,660.0,682.8,660.0,678.65,4001234.0,"Hero MotoCorp, Tata Communications, Lupin, PNB in focus","Hero MotoCorp: Hero MotoCorp is finalizing a collaboration agreement with Zero Motorcycles, the California (USA)-based manufacturer of premium electric motorcycles and powertrains. The collaboration will focus on codeveloping Electric motorcycles.",neutral,positive,2.8257575757575726,positive,6.185567010309279,positive
2022-09-30 10:04:12.000,660.0,682.8,660.0,678.65,4001234.0,Lupin gains on USFDA nod on Mirabegron tablets,Lupin advanced 3.59% to Rs 677.45 after the drug maker said that it has received ANDA approval for its Mirabegron extended-release tablet from the US Food and Drug Administration (USFDA).,positive,positive,2.8257575757575726,positive,6.185567010309279,positive
2022-10-03 09:21:12.000,679.0,726.7,678.95,721.0,6616192.0,"Stocks that will see action on October 3, 2022","Buzzing stocks: Suzlon, Automobile cos, Lupin, CreditGrameen, Coal India, Kaveri Seed, Bata India, Prestige Estates, Century Plywood, Narayana Hrudayalaya, Newgen, STL, HFCL, Tejas Networks, Shalby, Sampre Nutritions, Panorama Studios",neutral,neutral,6.185567010309279,positive,2.200000000000006,positive
2022-10-03 12:50:09.000,725.0,750.55,712.15,740.95,4211487.0,Lupin spurts as Gujarat facility gets EIR from USFDA,"Lupin gained 5.14% to Rs 714.55 after the pharma major announced that it has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its Ankleshwar manufacturing facility, located in Gujarat,",neutral,positive,2.200000000000006,positive,-3.1948452916303194,negative
2022-10-03 12:51:18.000,725.0,750.55,712.15,740.95,4211487.0,"Nifty Pharma outshines benchmarks, up 2%; Cipla, Sun Pharma hit 52-wk highs","Shares of Glenmark Pharma, Granules India, Divi’s Laboratories, Torrent Pharma, Lupin and Aurobindo Pharma, surged in the range of 2 per cent to 6 per cent in Monday’s intra-day trade",positive,positive,2.200000000000006,positive,-3.1948452916303194,negative
2022-10-04 08:40:00.000,725.0,750.55,712.15,740.95,4211487.0,Lupin bags USFDA approval for Darunavir Tablets; Stock soars near 3%,"The product will be manufactured at Lupin’s facility in Nagpur, India.",positive,neutral,2.200000000000006,positive,-3.1948452916303194,negative
2022-10-04 13:31:17.000,725.0,750.55,712.15,740.95,4211487.0,Lupin Ltd up for third straight session,"Lupin Ltd is quoting at Rs 732.45, up 1.43% on the day as on 12:49 IST on the NSE. The stock is down 24% in last one year as compared to a 3.19% slide in NIFTY and a 10.4% slide in the Nifty Metal index.",positive,positive,2.200000000000006,positive,-3.1948452916303194,negative
2022-10-04 13:31:25.000,725.0,750.55,712.15,740.95,4211487.0,Lupin gains on bagging US FDA nod for HIV treatment drug,"Shares of the global pharma major Lupin advanced 1.67% to Rs 734.65 after the company announced that it has received approval from the United States Food and Drug Administration (US FDA) for its ANDA for Darunavir Tablets, 600 mg and 800 mg.",positive,positive,2.200000000000006,positive,-3.1948452916303194,negative
2022-10-04 14:31:00.000,725.0,750.55,712.15,740.95,4211487.0,Lupin gets USFDA nod for generic HIV drug,"Drug firm Lupin on Tuesday said it has received an approval from the US health regulator to market Darunavir Tablets, used to treat Human Immunodeficiency Virus (HIV) infection, in the American market.",neutral,positive,2.200000000000006,positive,-3.1948452916303194,negative
2022-10-04 14:50:06.000,725.0,750.55,712.15,740.95,4211487.0,Lupin receives USFDA approval for Darunavir Tablets,Lupin is the exclusive first filer for 800 mg tablets and is eligible for 180-day exclusivity.,positive,positive,2.200000000000006,positive,-3.1948452916303194,negative
2022-10-04 15:46:49.000,725.0,750.55,712.15,740.95,4211487.0,Lupin gets USFDA nod to market generic HIV drug Darunavir tablets,"Drug firm Lupin on Tuesday said it has received an approval from the US health regulator to market Darunavir Tablets, used to treat Human Immunodeficiency Virus (HIV) infection, in the American market",neutral,positive,2.200000000000006,positive,-3.1948452916303194,negative
2022-10-06 09:27:39.000,744.95,744.95,720.9,721.15,2051714.0,"Stocks that will see action on October 6, 2022","Buzzing stocks: Reliance, Tata Steel, JSW Energy, Jubilant FoodWorks, Apollo Hospitals, Lemon Tree, Lupin, Ratnamani Metal, Gagan Gases, Aditya Birla Capital, IndusInd Bank, Atul Auto, NPR Finance, Trimurthi",neutral,neutral,-3.1948452916303194,negative,0.5086044729324848,neutral
2022-10-07 05:00:00.000,717.65,727.9,713.3,721.3,1517912.0,"Stocks To Watch: Dabur, Titan, Nykaa, RIL, Lupin, Yes Bank, Biocon, Quess Corp",Stocks to watch before going into trade today.,neutral,neutral,0.5086044729324848,neutral,-1.4202172096909,negative
2022-10-07 08:35:00.000,717.65,727.9,713.3,721.3,1517912.0,Lupin ties with global agencies to increase patient access to tuberculosis prevention treatment,Makes Rifapentine based treatment available at an affordable price to support TB prevention in low-and middle-income countries.,positive,positive,0.5086044729324848,neutral,-1.4202172096909,negative
2022-10-07 12:50:14.000,717.65,727.9,713.3,721.3,1517912.0,Lupin partners with global agencies to increase patient access to tuberculosis prevention treatment,"The pharmaceutical company on Friday announced that it has reached an agreement with Unitaid, The Aurum Institute, the Clinton Health Access Initiative (CHAI), and other global procurement agencies to support tuberculosis prevention treatment.",positive,positive,0.5086044729324848,neutral,-1.4202172096909,negative
2022-10-07 15:03:07.000,717.65,727.9,713.3,721.3,1517912.0,Lupin ties up with global agencies to support tuberculosis treatment,"Drug firm Lupin has tied up with Unitaid, The Aurum Institute, the Clinton Health Access Initiative, and other global procurement agencies to support tuberculosis prevention treatment initiative",neutral,positive,0.5086044729324848,neutral,-1.4202172096909,negative
2022-10-07 21:34:30.000,717.65,727.9,713.3,721.3,1517912.0,Lupin partners with global agencies to expand access to TB drugs,The company is introducing a combination of Rifapentine + Isoniazid and Rifapentine at an affordable price,positive,positive,0.5086044729324848,neutral,-1.4202172096909,negative
2022-10-10 08:26:39.000,718.2,718.7,703.5,708.0,861907.0,"Stocks to Watch Today: TCS, Lupin, HDFC, IDBI Bank, Power Grid, and Others","Stocks to watch today: Shares of firms like CS, Lupin, HDFC, IDBI Bank, Power Grid, and others will be in focus in Monday’s trade",neutral,neutral,-1.4202172096909,negative,-3.947740112994357,negative
2022-10-11 13:50:00.000,684.4,685.35,673.3,679.2,694880.0,Lupin stock price down 1.92 per cent as Sensex slides,"As of 30-Jun-2022, promoters held 46.82 per cent stake in the company, while FIIs held 14.27 per cent and domestic institutional investors had 15.86 per cent.",negative,neutral,-0.7597895967270503,neutral,1.391137936110709,positive
2022-10-11 22:48:26.000,684.4,685.35,673.3,679.2,694880.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, there were 80 stocks including India Cements, Abbott India, Indiabulls Housing Finance, Lupin and TCS, in which a long unwinding was seen",neutral,neutral,-0.7597895967270503,neutral,1.391137936110709,positive
2022-10-20 07:00:00.000,672.0,691.4,671.3,677.65,1578452.0,Lupin launches Paliperidone extended-release tablets in the United States,"In the United States, paliperidone extended-release tablets (RLD Invega) had expected annual sales of USD 112 million (IQVIA MAT August 2022).",neutral,neutral,0.8407738095238062,neutral,-0.5878030859662012,neutral
2022-10-20 08:50:05.000,672.0,691.4,671.3,677.65,1578452.0,Lupin to acquire two inhalation brands from Sunovion,The drug maker expects the transaction to be accretive to earnings in the first year.,neutral,positive,0.8407738095238062,neutral,-0.5878030859662012,neutral
2022-10-20 09:32:25.000,672.0,691.4,671.3,677.65,1578452.0,Lupin goes up as company reveals pact to acquire two inhalation brands from Sunovion,The global pharmaceutical major will acquire all rights to Brovana (arformoterol tartrate) Inhalation Solution and Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol for $75 million.,neutral,positive,0.8407738095238062,neutral,-0.5878030859662012,neutral
2022-10-20 10:38:00.000,672.0,691.4,671.3,677.65,1578452.0,Lupin inks pact to acquire two inhalation brands from Sunovion for USD 75 mn,"The acquisition of these two brands will expand the company’s inhalation product portfolio in the US and strengthen its presence in the respiratory therapy area while continuing to provide patients access to these important medicines, Lupin said in a statement. Brovana is indicated for long-term mai…",positive,positive,0.8407738095238062,neutral,-0.5878030859662012,neutral
2022-10-20 14:43:46.000,680.5,688.35,675.0,676.5,434669.0,Lupin acquires rights to two inhalation brands from Sunovion Pharmaceuticals Inc,The addition of the two acquired brands enhances Lupin’s position in the respiratory segment,neutral,positive,-0.5878030859662012,neutral,0.1466275659824047,neutral
2022-10-20 14:52:50.000,680.5,688.35,675.0,676.5,434669.0,Lupin Inks Pact To Acquire Two Inhalation Brands From Sunovion For $75 Million,The Mumbai-based firm expects the transaction to be accretive to earnings in the first year.,neutral,positive,-0.5878030859662012,neutral,0.1466275659824047,neutral
2022-10-20 17:29:07.000,680.5,688.35,675.0,676.5,434669.0,Lupin inks pact to acquire two inhalation brands from Sunovion for $75 mn,The Mumbai-based firm expects the transaction to be accretive to earnings in the first year,neutral,positive,-0.5878030859662012,neutral,0.1466275659824047,neutral
2022-10-27 14:31:58.000,706.85,706.85,693.05,695.6,603272.0,"U.S. FDA Flags Quality, Procedural Lapses At Lupin’s Pune Facility",The Form 483 letter will not have any impact on the existing revenues from the operations of the facility.,neutral,neutral,-1.5915682252245875,negative,0.4532374100719392,neutral
2022-10-30 06:41:00.000,695.0,705.55,688.3,698.15,683848.0,BCCI’s pay parity shot may power companies to up their game,"Companies like PepsiCo, Lupin and Axis Bank are among companies that have pay equity as the mainstay of their employee agenda and vouch for it being a diversity and inclusion enabler for them. Any move to enable equal pay is a powerful force multiplier, say gender experts and HR heads.",neutral,neutral,0.4532374100719392,neutral,1.007142857142851,positive
2022-10-30 19:13:36.000,695.0,705.55,688.3,698.15,683848.0,U.S. FDA Issues Form-483 With 5 Observations To Lupin’s Unit-2 Injectable Manufacturing Facility At Nagpur,"The inspection was a pre-approval Inspection of the injectable facility, Lupin said.",neutral,neutral,0.4532374100719392,neutral,1.007142857142851,positive
2022-10-31 08:50:06.000,695.0,705.55,688.3,698.15,683848.0,Lupin’s Nagpur Unit-2 facility gets USFDA observations,The US Food and Drug Administration (USFDA) inspected the drug maker’s Nagpur Unit-2 injectable manufacturing facility from 17th to 29th October 2022.,neutral,neutral,0.4532374100719392,neutral,1.007142857142851,positive
2022-10-31 09:03:12.000,695.0,705.55,688.3,698.15,683848.0,Stocks that will see action today (Oct 31),"Buzzing stocks: Tata Steel, L&T, Bharti Airtel, Maruti Suzuki, Equitas Bank, Fino Payments, Motherson Sumi, Reliance Ind, HFCL, Lupin, Sugar stocks, Engineers India, VST Tillers, Aether Ind, Zydus, Kopran, Jubilant Pharmova",neutral,neutral,0.4532374100719392,neutral,1.007142857142851,positive
2022-10-31 09:50:21.000,695.0,705.55,688.3,698.15,683848.0,Lupin’s Nagpur unit undergoes USFDA inspection,Receives five observations under Form 483,neutral,neutral,0.4532374100719392,neutral,1.007142857142851,positive
2022-10-31 14:53:00.000,700.0,714.8,700.0,707.05,790520.0,USFDA issues 5 observations in Form 483 to Lupin’s Nagpur Unit-2,The injection facility was subjected to a Pre-Approval Inspection.,neutral,neutral,1.007142857142851,positive,-0.4721634954193126,neutral
2022-11-02 20:38:41.000,704.85,714.0,701.3,712.85,501613.0,USFDA issues warning letter to Lupin for Maharashtra-based API plant,FDA then checks to ensure that the company’s corrections are adequate,neutral,neutral,1.134993260977513,positive,-0.9453781512605042,negative
2022-11-03 08:11:18.000,704.85,714.0,701.3,712.85,501613.0,"Stocks to Watch Today: HDFC, Wipro, Mahindra Finance, JK Paper, Lupin, and Others","Stocks to watch today: Shares of firms like HDFC, Wipro, Mahindra Finance, JK Paper, Lupin, and others will be in focus in Thursday’s trade",neutral,neutral,1.134993260977513,positive,-0.9453781512605042,negative
2022-11-03 09:22:25.000,704.85,714.0,701.3,712.85,501613.0,"Stocks that will see action on November 03, 2022","Stocks to watch: HDFC, Hero MotoCorp, Adani group stocks, Bank of India, Indian Bank, JK Cement, Wipro, L&T Tech, Lupin, CL Educate, Shri Keshav Cements, Reliance Capital, Amara Raja, Vodafone Idea",neutral,neutral,1.134993260977513,positive,-0.9453781512605042,negative
2022-11-04 06:56:00.000,714.0,716.3,702.5,707.25,789985.0,Lupin receives USFDA tentative approval for Drospirenone Tablets,Drospirenone Tablets (RLD Slynd) had estimated annual sales of USD 141 million in the U.S.,positive,neutral,-0.9453781512605042,negative,-0.3511235955056179,neutral
2022-11-04 08:22:15.000,714.0,716.3,702.5,707.25,789985.0,"Stocks to Watch Today: Vodafone Idea, Hero MotoCorp, Adani Enterprises, and Others","Stocks to watch today: Shares of firms like HDFC, Wipro, Mahindra Finance, JK Paper, Lupin, and others will be in focus in Thursday’s trade",neutral,neutral,-0.9453781512605042,negative,-0.3511235955056179,neutral
2022-11-04 13:47:00.000,714.0,716.3,702.5,707.25,789985.0,Lupin gets USFDA nod for generic oral contraceptive pill,"Lupin has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Drospirenone Tablets in 4 mg strength, the Mumbai-based drug maker said in a statement.",neutral,positive,-0.9453781512605042,negative,-0.3511235955056179,neutral
2022-11-04 13:56:16.000,714.0,716.3,702.5,707.25,789985.0,Lupin gets US drug regulator’s nod for generic oral contraceptive pill,"The company has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Drospirenone Tablets in 4 mg strength",neutral,positive,-0.9453781512605042,negative,-0.3511235955056179,neutral
2022-11-07 16:10:23.000,712.0,723.95,706.55,709.5,1087639.0,U.S. FDA Flags Procedural Lapses At Lupin’s Nagpur Facility,The company said it will address the observation at the earliest and gain approval for injectable manufacturing for the U.S.,neutral,neutral,-0.3511235955056179,neutral,-2.524544179523142,negative
2022-11-08 17:40:24.000,713.0,715.4,688.05,695.0,1395541.0,Drug firm Lupin gets USFDA nod to market generic antibiotic medicine in US,Drug firm Lupin on Tuesday said it has received approval from the US health regulator to market Doxycycline Capsules used to treat bacterial infections in the American market,neutral,positive,-2.524544179523142,negative,0.6274400446179587,neutral
2022-11-09 05:00:00.000,713.0,715.4,688.05,695.0,1395541.0,"Tata Motors, Lupin, Pidilite, Star Health, Quess Corp Q2 Results Today — Earning Estimates","Earnings estimates for Tata Motors, Lupin, Pidilite, Star Health, Quess Corp and others.",neutral,neutral,-2.524544179523142,negative,0.6274400446179587,neutral
2022-11-09 05:30:00.000,713.0,715.4,688.05,695.0,1395541.0,"Street Awaits Q2 Results of Tata Motors, Lupin, NALCO, Star Health & More Today","Street Awaits Q2 Results of Tata Motors, Lupin, NALCO, Star Health & More Today",neutral,neutral,-2.524544179523142,negative,0.6274400446179587,neutral
2022-11-09 08:01:58.000,713.0,715.4,688.05,695.0,1395541.0,"Stocks to Watch Today: Tata Motors, Lupin, PB Fintech, Bharat Electronics, and Others","Stocks to watch today: Shares of firms like Tata Motors, Lupin, PB Fintech, Bharat Electronics, and others will be in focus in Wednesday’s trade",neutral,neutral,-2.524544179523142,negative,0.6274400446179587,neutral
2022-11-09 08:50:05.000,713.0,715.4,688.05,695.0,1395541.0,Lupin gets tentative USFDA approval for Doxycycline capsules,The drug firm said it has received approval from the US health regulator to market Doxycycline Capsules used to treat bacterial infections in the American market.,positive,positive,-2.524544179523142,negative,0.6274400446179587,neutral
2022-11-09 21:21:31.000,717.2,754.0,707.6,721.7,11671172.0,Lupin Q2 Results: Net Profit In Line With Estimates,"Lupin reported a net profit of Rs 130 crore in the second quarter compared with a net loss of Rs 2,098 crore a year earlier.",neutral,positive,0.6274400446179587,neutral,2.9448275862069,positive
2022-11-09 21:41:23.000,717.2,754.0,707.6,721.7,11671172.0,Lupin posts Q2 net profit of ₹134 crore,"Focused on sustaining this positive momentum, says Nilesh Gupta, MD",neutral,positive,0.6274400446179587,neutral,2.9448275862069,positive
2022-11-09 22:22:43.000,717.2,754.0,707.6,721.7,11671172.0,"Lupin posts net profit of Rs 130 cr in Q2, revenue rises to Rs 4,145 cr","The Mumbai-based company had reported a net loss of Rs 2,098 crore in the July-September period of the previous fiscal",positive,negative,0.6274400446179587,neutral,2.9448275862069,positive
2022-11-10 05:00:00.000,717.2,754.0,707.6,721.7,11671172.0,"Stocks To Watch: Tata Motors, Lupin, Axis Bank, Adani Ports, Quess Corp, HUL, Divi’s Labs",Stocks to watch before going into trade today.,neutral,neutral,0.6274400446179587,neutral,2.9448275862069,positive
2022-11-10 08:55:21.000,717.2,754.0,707.6,721.7,11671172.0,Lupin share price gains 8% after reporting Rs 129.7-crore profit in Q2,"Revenue of the company was up 1.3% at Rs 4,145.5 crore versus Rs 4,091.3 crore, YoY.",positive,positive,0.6274400446179587,neutral,2.9448275862069,positive
2022-11-10 09:32:29.000,717.2,754.0,707.6,721.7,11671172.0,Lupin soars after turnaround performance in Q2; India sales up 2.6% YoY,"Lupin jumped 7.67% to Rs 747.30 after the company reported a consolidated net profit of Rs 129.7 crore in Q2 FY23 as against a net loss of Rs 2,098 crore recorded in Q2 FY22.",positive,positive,0.6274400446179587,neutral,2.9448275862069,positive
2022-11-10 12:59:43.000,725.0,749.0,725.0,746.35,3262837.0,Q2 Review: Lupin Jumps From Red To Black In Q2; Is It Sustainable?,"Q2 Review: Lupin Jumps From Red To Black In Q2; Is It Sustainable? #Q2WithBQ | Lupin jumps from red to black in Q2, with margins meeting street estimates.Global CFO Ramesh Swaminathan talks about projections for FY23.",neutral,positive,2.9448275862069,positive,1.268357810413885,positive
2022-11-10 17:09:30.000,725.0,749.0,725.0,746.35,3262837.0,Lifting the lid off the questions of India’s largest food quiz,"Lupin Aptivate’s School Foodie Quiz 2022 whips up a full course meal with over 10,000 entries from more than 300 cities",neutral,neutral,2.9448275862069,positive,1.268357810413885,positive
2022-11-10 17:30:00.000,725.0,749.0,725.0,746.35,3262837.0,Lupin shares seen rising up to 20% post Q2 earnings; here’s why,Lupin share price today: Lupin stock gained 8.62 per cent to Rs 753.90 against the previous close of Rs 694.05 on BSE,positive,positive,2.9448275862069,positive,1.268357810413885,positive
2022-11-11 06:06:00.000,725.0,749.0,725.0,746.35,3262837.0,Lupin surges 4% on positive brokerage commentary post Q2,"Macquarie maintained its ‘outperform’ rating on the stock with a 12-month target price of ₹790 per share as profitability missed estimates due to cost pressures after revenue came in line with expectations, it said.",positive,negative,2.9448275862069,positive,1.268357810413885,positive
2022-11-11 08:38:56.000,725.0,749.0,725.0,746.35,3262837.0,Lupin Q2 Results Review - Strong Recovery In North America Business; Beat On Margins: Systematix,"North America business reported sales of $159 mn, due to a low base in Q1, contribution from new launches and market share gains.",neutral,positive,2.9448275862069,positive,1.268357810413885,positive
2022-11-13 18:22:11.000,749.0,760.8,737.4,758.5,1638774.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, there were 83 stocks in which short-covering was seen, including Mphasis, Indraprastha Gas, Tata Motors, Cummins India, and Lupin.",neutral,neutral,1.268357810413885,positive,-0.7227332457293035,neutral
2022-11-14 13:31:20.000,761.0,763.4,748.3,755.5,740965.0,Lupin Ltd up for third straight session,"Lupin Ltd is quoting at Rs 756.5, up 1.27% on the day as on 12:49 IST on the NSE. The stock is down 19.93% in last one year as compared to a 1.2% jump in NIFTY and a 7.2% jump in the Nifty Metal index.",positive,positive,-0.7227332457293035,neutral,-1.5415282392026608,negative
2022-11-15 08:19:13.000,761.0,763.4,748.3,755.5,740965.0,Mehul Kothari expects Ashok Leyland to break its all-time high; Check why,"According to the technical analyst from Anand Rathi, Ashok Leyland can potentially break its all-time high at Rs 169.45, while he is also bullish on Lupin.",neutral,positive,-0.7227332457293035,neutral,-1.5415282392026608,negative
2022-11-15 14:22:02.000,752.5,756.85,732.25,740.9,1831117.0,Hold Lupin; target of Rs 650: Prabhudas Lilladher,"Prabhudas Lilladher recommended hold rating on Lupin with a target price of Rs 650 in its research report dated November 11, 2022.",neutral,positive,-1.5415282392026608,negative,-0.6756756756756757,neutral
2022-11-16 13:11:00.000,740.0,746.7,730.1,735.0,646233.0,Is this time to be a contra buyer in Lupin? This is what Hemang Jani has to say,"“There is a tactical pullback in global denominated fintech and consumer tech business. Maybe a 10-15-20% move can be expected in some of the names but core allocation will have to be with largecaps, particularly sectors that have delivered well this year and where there is a growth visibility. That…",neutral,neutral,-0.6756756756756757,neutral,-2.1872028257030327,negative
2022-11-16 15:49:19.000,740.0,746.7,730.1,735.0,646233.0,Neutral Lupin; target of Rs 680: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 680 in its research report dated November 10, 2022.",neutral,positive,-0.6756756756756757,neutral,-2.1872028257030327,negative
2022-11-20 19:43:45.000,721.0,724.6,713.0,720.95,704850.0,Buy Lupin; target of Rs 855: Sharekhan,"Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 855 in its research report dated November 14, 2022.",neutral,positive,-0.0069348127600491,neutral,-0.6211180124223602,neutral
2022-11-22 05:00:00.000,724.5,726.85,714.0,720.0,1106504.0,"Stocks To Watch: Reliance Industries, Lupin, Punjab National Bank, Kirloskar Electric Company",Stocks to watch before going into trade.,neutral,neutral,-0.6211180124223602,neutral,-0.9641873278236914,negative
2022-11-22 05:30:00.000,724.5,726.85,714.0,720.0,1106504.0,Lupin signs MoU with Rajasthan government; Check the details and latest target,Lupin signs MoU with Rajasthan government; Check the details and latest target,neutral,neutral,-0.6211180124223602,neutral,-0.9641873278236914,negative
2022-11-22 06:45:00.000,724.5,726.85,714.0,720.0,1106504.0,Lupin grants over 1.77 lakh stock options under ESOP; Stock under pressure,The vesting schedule of stock options will be 25%:25%:25%:25% over four years upon completion of one year.,neutral,neutral,-0.6211180124223602,neutral,-0.9641873278236914,negative
2022-11-22 08:13:12.000,724.5,726.85,714.0,720.0,1106504.0,"Stocks that will see action on November 22, 2022","NDTV, Nykaa, Lupin, JK Paper, Kirloskar Electric, PFC, Dhunseri Tea, Warren Tea, Lambodhara Textiles, Loyal Equipments, MIC Electronics",neutral,neutral,-0.6211180124223602,neutral,-0.9641873278236914,negative
2022-11-22 17:30:00.000,726.0,729.35,717.3,719.0,1205898.0,"Stocks in news: Lupin, Delhivery, Nykaa, Kaynes Tech and more","Stocks to watch out for today: Kaynes Technologies, Lupin, MIC Electronics, Force Motors, Archean Chemical, JK Paper, Blue Star, Sensex, Nifty, Power Finance Corporation, BHEL, stocks in news, Jubilant Foodworks, Delhivery, Nykaa, and more",neutral,neutral,-0.9641873278236914,negative,-0.3054707025826222,neutral
2022-11-23 14:46:33.000,720.2,723.4,711.4,718.0,639782.0,Reduce Lupin; target of Rs 680: ICICI Direct,"ICICI Direct recommended reduce rating on Lupin with a target price of Rs 680 in its research report dated November 11, 2022.",neutral,negative,-0.3054707025826222,neutral,-0.1668752607426012,neutral
2022-11-24 17:09:00.000,719.1,722.65,708.05,717.9,844789.0,"USFDA issues Form-483 with 8 observations to Lupin’s drug, API production facilities in Mandideep plant","The USFDA had inspected the Mandideep Unit-1 facility in Madhya Pradesh from November 14, 2022, to November 23, 2022, the Mumbai-based drug maker said in a regulatory filing. “The inspection of the facility closed with issuance of a Form-483 with eight observations each for the drug product facility…",neutral,neutral,-0.1668752607426012,neutral,1.9798541160125045,positive
2022-11-25 05:00:00.000,719.1,722.65,708.05,717.9,844789.0,"Stocks To Watch: Indian Oil, PNB, Bharti Airtel, SBI, Biocon, Lupin",Stocks to watch before going into trade today.,neutral,neutral,-0.1668752607426012,neutral,1.9798541160125045,positive
2022-11-25 07:59:47.000,719.1,722.65,708.05,717.9,844789.0,"Stocks to Watch: PNB, Tube Investments, Indian Oil, Laurus Labs, SBI, Lupin",Stocks to Watch: Punjab National Bank (PNB) on Thursday said it received the government’s approval to divest its entire stake (15.22 per cent) in UTI Asset Management Company,neutral,neutral,-0.1668752607426012,neutral,1.9798541160125045,positive
2022-11-25 08:40:02.000,719.1,722.65,708.05,717.9,844789.0,"Stocks to Watch Today: Lupin, Biocon, PNB, SBI, HDFC Bank, and Others","Stocks to watch today: Shares of firms like Lupin, Biocon, PNB, SBI, HDFC Bank, and others will be in focus in Friday’s trade, Stock Market Latest News Update at news18.com",neutral,neutral,-0.1668752607426012,neutral,1.9798541160125045,positive
2022-11-25 17:30:00.000,719.1,722.65,708.05,717.9,844789.0,"Stocks in news: Lupin, Biocon, Policybazaar, Cummins India and more","Stocks to watch out for today: Lupin, Biocon, Veranda Learning Solutions, Fino Payments Bank, PB Fintech, Hariom Pipe Industries, Cummins India, Tube Investments, PNB and more",neutral,neutral,-0.1668752607426012,neutral,1.9798541160125045,positive
2022-11-28 18:49:50.000,744.0,759.35,740.0,750.8,3691519.0,Buy Lupin; target of Rs 855: Sharekhan,"Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 855 in its research report dated November 14, 2022.",neutral,positive,0.91397849462365,positive,2.0203362796570654,positive
2022-11-28 19:49:00.000,744.0,759.35,740.0,750.8,3691519.0,Lupin’s Brazil subsidiary acquires 9 brands from Bausch Health,"As part of the transaction, MedQuímica will acquire rights to nine products including Limbitrol, Melleril and Dalmadorm for Central Nervous System related conditions, Bacrocin, Glyquin, Solaquin, Oxipelle™ and Efurix as topical oncological treatments, and Cuprimine for the treatment of Wilsons disea…",neutral,neutral,0.91397849462365,positive,2.0203362796570654,positive
2022-11-29 08:27:24.000,744.0,759.35,740.0,750.8,3691519.0,"Stocks to Watch: HCL Tech, Lupin, Fusion Micro Fin, Five-Star, NBCC, PNB",Stocks to Watch Today: Newly listed Fusion Micro Finance and Five-Star Business are likely to be in focus on the back of strong Q2 performance reported by the companies.,neutral,neutral,0.91397849462365,positive,2.0203362796570654,positive
2022-11-29 08:52:41.000,744.0,759.35,740.0,750.8,3691519.0,"Stocks that will see action on November 29, 2022","Stocks to watch: NBCC, Tata Communications, Filatex Fashions, Piramal Enterprises, Lupin, Shri Dinesh Mills and Ganesh Benzoplast",neutral,neutral,0.91397849462365,positive,2.0203362796570654,positive
2022-11-29 17:30:00.000,752.35,769.0,747.5,767.55,1960294.0,"Stocks in news: TCS, HCL Tech, Lupin, Can Fin Homes and more","Stocks to watch out for today: TCS, HCL Technology, Lupin, Ami Organics, Can Fin Homes and more",neutral,neutral,2.0203362796570654,positive,0.2540551104162654,neutral
2022-11-30 13:04:17.000,767.55,773.85,762.2,769.5,792542.0,"Lupin Ltd spurts 0.81%, rises for fifth straight session","Lupin Ltd is quoting at Rs 757.5, up 0.81% on the day as on 12:44 IST on the NSE. The stock is down 13.07% in last one year as compared to a 8.66% spurt in NIFTY and a 2.58% spurt in the Nifty Metal.",positive,positive,0.2540551104162654,neutral,0.2922267679719462,neutral
2022-12-04 10:21:03.000,778.0,778.0,761.35,768.9,733565.0,"After the anti-diabetic market, India’s cardiac market in for a shake-up","Sun Pharma has the largest share in the Indian cardiac market, followed by Torrent Pharma, Lupin and USV",neutral,neutral,-1.1696658097686403,negative,0.3594771241830065,neutral
2022-12-05 13:50:24.000,765.0,769.6,762.0,767.75,369654.0,Lupin launches Rufinamide Tablets,Rufinamide Tablets (RLD Banzel) had estimated annual sales of USD 138 million in the U.S. (IQVIA MAT October 2022).,neutral,neutral,0.3594771241830065,neutral,0.130039011703511,neutral
2022-12-05 16:05:34.000,765.0,769.6,762.0,767.75,369654.0,Lupin gets USFDA nod for generic medication,"As per IQVIA data, Rufinamide tablets had estimated annual sales of USD 138 million in the US.",neutral,neutral,0.3594771241830065,neutral,0.130039011703511,neutral
2022-12-05 18:24:50.000,765.0,769.6,762.0,767.75,369654.0,Lupin Gets U.S. FDA Nod For Generic Medication,"Drug firm Lupin said it has launched Rufinamide Tablets, an anticonvulsant medication, in the American market.",neutral,positive,0.3594771241830065,neutral,0.130039011703511,neutral
2022-12-08 22:25:00.000,755.0,760.8,746.6,751.0,525646.0,Lupin appoints Spiro Gavaris as president of US generics biz,"Spiro, who had most recently served as president of Specialty Generics business at Mallinckrodt Pharmaceuticals and the president of US Injectables at Hikma, will be responsible for the overall strategy, implementation and growth of Lupin’s US generics business, the company said in a regulatory fili…",neutral,neutral,-0.5298013245033113,neutral,0.4748528624933058,neutral
2022-12-09 06:29:46.000,755.0,760.8,746.6,751.0,525646.0,"Buzzing Stocks: HUL, Adani Enterprises, Lupin, Jyoti, and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,-0.5298013245033113,neutral,0.4748528624933058,neutral
2022-12-09 08:45:12.000,755.0,760.8,746.6,751.0,525646.0,"Stocks that will see action on December 9, 2022","Buzzing stocks: Hindustan Unilever, Ashok Leyland, Paytm, Sun Pharma, Triveni Engineering, Lupin, Ahluwalia Contracts, IndusInd Bank, Kalpataru Power, Jyoti",neutral,neutral,-0.5298013245033113,neutral,0.4748528624933058,neutral
2022-12-09 13:45:00.000,755.0,760.8,746.6,751.0,525646.0,Lupin launches generic joint pain drug in US market,"The company’s product -- Diclofenac Sodium Topical Solution 2 per cent -- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement. As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 mi…",positive,neutral,-0.5298013245033113,neutral,0.4748528624933058,neutral
2022-12-09 17:30:00.000,755.0,760.8,746.6,751.0,525646.0,"Stocks in news: Paytm, HUL, Adani Enterprises, Lupin and more","Stocks to watch out for today: Hindustan Unilever, Adani Enterprises, Lupin, RateGain Travel, Sun Pharmaceutical, InterGlobe Aviation, Paytm, Kalyan Jewellers and more",neutral,neutral,-0.5298013245033113,neutral,0.4748528624933058,neutral
2022-12-09 22:31:25.000,755.0,760.8,746.6,751.0,525646.0,Lupin to enter cardio-vascular therapeutics space in 10 cities by Feb,"Move will mark firm’s digital healthcare foray 18 months after announcement; firm also plans to enter mental and respiratory illness segments, cover 28-30 cities by CY 2023-end",neutral,neutral,-0.5298013245033113,neutral,0.4748528624933058,neutral
2022-12-12 07:41:35.000,747.6,756.9,745.85,751.15,593370.0,"Stocks to watch: Glenmark Pharma, NTPC, V-Guard Inds, Lupin, YES Bank, NDTV","Stocks to watch today: Jaiprakash Associates has called a board meeting on Monday, December 12, to mull over sale of their Nilgrie cement unit in Madhya Pradesh",neutral,neutral,0.4748528624933058,neutral,-1.596026490066219,negative
2022-12-12 08:27:06.000,747.6,756.9,745.85,751.15,593370.0,"Stocks to Watch Today: Uniparts, Glenmark Pharma, NTPC, Lupin, YES Bank, and Others","Stocks to watch today: Shares of firms like Uniparts, Glenmark Pharma, NTPC, Lupin, YES Bank, and others will be in focus in Monday’s trade, Stock Market Latest News Update at news18.com",neutral,neutral,0.4748528624933058,neutral,-1.596026490066219,negative
2022-12-21 05:30:00.000,727.5,757.8,722.1,750.95,1646291.0,"Lupin Zooms Over 4% in Weak Market, USFDA Approves ANDA For Briviact Tablets","Lupin Zooms Over 4% in Weak Market, USFDA Approves ANDA For Briviact Tablets",neutral,neutral,3.223367697594508,positive,1.9867549668874172,positive
2022-12-21 13:16:27.000,755.0,771.0,748.85,770.0,2192481.0,Lupin gains on USFDA nod for Brivaracetam tablets,Lupin rallied 3.50% to Rs 750.55 after the drug maker said that it has received an approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Brivaracetam tablets.,positive,positive,1.9867549668874172,positive,-0.974025974025974,negative
2022-12-21 15:50:13.000,755.0,771.0,748.85,770.0,2192481.0,Lupin Diagnostics opens its Regional Reference Laboratory in Indore,"Lupin announced today the launch of its Regional Reference Laboratory in Indore, Madhya Pradesh, as part of its expansion in Central India. Lupin Diagnostics currently operates 325+ LupiMitra (Lupin’s franchise collection centers) and 23",neutral,positive,1.9867549668874172,positive,-0.974025974025974,negative
2022-12-22 08:53:53.000,755.0,771.0,748.85,770.0,2192481.0,"Stocks to Watch Today: Sula Vineyards, Reliance, Paytm, Lupin, Zee, and Others","Stocks to watch today: Shares of firms like Sula Vineyards, Reliance, Paytm, Lupin, Zee, Dabur, and others will be in focus in Thursday’s trade, Stock Market Latest News Update at news18.com",neutral,neutral,1.9867549668874172,positive,-0.974025974025974,negative
2022-12-22 19:34:36.000,770.0,788.9,752.05,762.5,4158382.0,Lupin Arm Recalls Blood Pressure Tablets In U.S. Market,Lupin said its U.S.-based arm is recalling four lots of Quinapril tablets used to treat high blood pressure due to the presence of a nitrosamine impurity.,neutral,negative,-0.974025974025974,negative,-2.182630990730381,negative
2022-12-22 20:42:42.000,770.0,788.9,752.05,762.5,4158382.0,Lupin recalls hypertension drug Quinapril tablets in U.S.,"An angiotensin-converting enzyme inhibitor, Quinapril tablet USP is indicated for the treatment of hypertension",neutral,neutral,-0.974025974025974,negative,-2.182630990730381,negative
2022-12-23 00:21:38.000,770.0,788.9,752.05,762.5,4158382.0,Lupin Pharma’s US-based arm recalls blood pressure tablets in US market,Pharmaceuticals firm Lupin Ltd on Thursday said its US-based arm is recalling four lots of Quinapril tablets used to treat high blood pressure due to the presence of a nitrosamine impurity.,neutral,negative,-0.974025974025974,negative,-2.182630990730381,negative
2022-12-23 01:13:35.000,770.0,788.9,752.05,762.5,4158382.0,Lupin set to gain market share in US flu season; shares up 6% in 2 sessions,The stock has underperformed peers and the benchmark over the past year,positive,negative,-0.974025974025974,negative,-2.182630990730381,negative
2022-12-23 05:00:00.000,770.0,788.9,752.05,762.5,4158382.0,"Stocks To Watch: Reliance Industries, Biocon, IDFC First Bank, Lupin, Yes Bank, NTPC, Granules India",Stocks to watch before going into trade today.,neutral,neutral,-0.974025974025974,negative,-2.182630990730381,negative
2022-12-23 07:08:27.000,770.0,788.9,752.05,762.5,4158382.0,"Hot Stocks | Why you should bet on Lupin and TVS Motor, and sell Indian Hotels for short term",Lupin has been overall moving in a rising channel and recently taken support near to Rs 720 zone which is also its 50 DEMA. It formed a bullish candle along with a decisive hold Rs 760 zone.,neutral,positive,-0.974025974025974,negative,-2.182630990730381,negative
2022-12-23 07:36:41.000,770.0,788.9,752.05,762.5,4158382.0,"Stocks to Watch: Aban Holdings, Landmark Cars, RIL, Lupin, Gail, JK Cement",Stocks to Watch Aban Holdings and Landmak Cars will be debuting on the stock exchanges on Friday. Both these stocks are likely to witness a tepid start to trade.,neutral,neutral,-0.974025974025974,negative,-2.182630990730381,negative
2022-12-23 08:28:55.000,770.0,788.9,752.05,762.5,4158382.0,"Stocks that will see action on December 23, 2022","Reliance, JK Cement, RVNL, IRCTC, RailTel, IFCI, YES Bank, 3i Infotech, Indian Hotels, Kansai Nerolac, Zydus Lifesciences, NTPC, Lupin, Bank of Maharashtra, Schneider Electric,",neutral,neutral,-0.974025974025974,negative,-2.182630990730381,negative
2022-12-23 10:04:12.000,770.0,788.9,752.05,762.5,4158382.0,Lupin recalls 4 lots of Quinapril tablets,Lupin announced that it has voluntarily recalled four lots of Quinapril tablets due to the presence of a nitrosamine impurity observed in recent testing above the acceptable daily intake (ADI) level.,neutral,negative,-0.974025974025974,negative,-2.182630990730381,negative
2022-12-23 17:30:00.000,770.0,788.9,752.05,762.5,4158382.0,"Stocks in the news: YES Bank, IRCTC, India Cements, Droneacharya Aerial, Landmark Cars & Lupin","YES Bank has transferred invoked shares of seven companies, including Dish TV, Asian Hotels (North) and Avantha Realty, to JC Flowers Asset Reconstruction, which has been assigned to recover debt worth over Rs 48,000 crore of the private sector lender",neutral,neutral,-0.974025974025974,negative,-2.182630990730381,negative
2023-01-04 07:30:37.000,737.95,741.8,730.0,733.0,704144.0,"India-Australia FTA: Cipla, Lupin, Sun And Other Top Drugmakers to Go Down Under in Bid to Push Up Exports","Starting on February 6, the business delegation is scheduled to meet government officials, drug procurement agencies, the pharmacy guild and the local regulatory agency of Australia",neutral,neutral,-0.6707771529236459,neutral,0.8972267536704761,neutral
2023-01-05 14:42:00.000,742.1,746.95,733.8,737.55,608338.0,Sun Pharma Stocks | Cipla Stocks: Nithya Balasubramanian on 2 pharma names to bet on besides Sun & Cipla,"“Coming to the complex generics opportunity, Cipla and Lupin are most exposed. We like Cipla more than Lupin because at least in the near term, there are multiple assets waiting to play out. For Cipla this year, we are hoping to see generic Advair, generic Abraxane which is most likely in the price …",neutral,neutral,-0.6131249157795537,neutral,1.0784578053383662,positive
2023-01-05 18:05:05.000,742.1,746.95,733.8,737.55,608338.0,Lupin launches fixed-dose triple drug combination to manage asthma,"Pharmaceuticals firm Lupin Ltd on Thursday said it has launched a fixed-dose triple drug combination of Indacaterol, Glycopyrronium and Mometasone for managing asthma.",neutral,positive,-0.6131249157795537,neutral,1.0784578053383662,positive
2023-01-06 17:50:10.000,742.1,746.95,733.8,737.55,608338.0,Lupin receives USFDA approval for Fesoterodine Fumarate ER Tablets,"The product will be manufactured at Lupin’s facility in Goa, India.",positive,neutral,-0.6131249157795537,neutral,1.0784578053383662,positive
2023-01-06 18:58:00.000,742.1,746.95,733.8,737.55,608338.0,Lupin gets USFDA nod for generic medication,"The company has received approval from the US Food and Drug Administration to market Fesoterodine Fumarate extended-release tablets in strengths of 4 mg and 8 mg, the Mumbai-based drug maker said in a regulatory filing",neutral,positive,-0.6131249157795537,neutral,1.0784578053383662,positive
2023-01-09 08:52:44.000,741.8,757.3,741.0,749.8,1246147.0,"Stocks to Watch Today: TCS, Paytm, IDBI Bank, Lupin, Dr Lal PathLabs, and Others","Stocks to watch: Shares of firms like TCS, Paytm, IDBI Bank, Lupin, Dr Lal PathLabs, and others will be in focus in Monday’s trade.",neutral,neutral,1.0784578053383662,positive,0.8035062089116082,neutral
2023-01-09 09:04:09.000,741.8,757.3,741.0,749.8,1246147.0,Lupin gets USFDA approval for generic antispasmodic drug,"The global pharma major announced that it received approval from the US drug regulator for its Abbreviated New Drug Application (ANDA), Fesoterodine Fumarate extended-release tablets, 4 mg and 8 mg.",positive,positive,1.0784578053383662,positive,0.8035062089116082,neutral
2023-01-09 11:47:06.000,741.8,757.3,741.0,749.8,1246147.0,Lupin trades higher on USFDA nod for generic bladder drug,Lupin Pharmaceutical got the United States’ drug regulator’s nod to market fesoterodine fumarate extended-release tablets,positive,neutral,1.0784578053383662,positive,0.8035062089116082,neutral
2023-01-09 17:30:00.000,752.95,764.6,750.0,759.0,1421287.0,"Stocks in the news: TCS, Tata Steel, Titan, Paytm, Lupin, IDBI Bank and more","India’s largest software exporter Tata Consultancy Services will announce its results for the quarter ended on December 31, 2022",neutral,neutral,0.8035062089116082,neutral,-0.8432147562582315,neutral
2023-01-10 09:16:20.000,752.95,764.6,750.0,759.0,1421287.0,"TCS, Tata Motors, KFin Technologies, Lupin in focus","TCS: The IT major’s consolidated net profit rose 3.98% to Rs 10846 crore on 5.28% increase in net sales to Rs 58,229 crore in Q3 December 2022 (Q3 FY23) over Q2 September 2022 (Q2 FY23). On a year-on-year (YoY) basis, the IT major’s net profit rose",neutral,positive,0.8035062089116082,neutral,-0.8432147562582315,neutral
2023-01-10 10:51:00.000,752.95,764.6,750.0,759.0,1421287.0,Lupin rises on MSCBC nod to market NaMuscla in Spain,Lupin rose 1.40% to Rs 759.70 after the company said that the Spanish Ministry of Health (MSCBC) has approved the reimbursement of its NaMuscla for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders.,neutral,positive,0.8035062089116082,neutral,-0.8432147562582315,neutral
2023-01-10 17:52:39.000,759.0,759.0,747.2,752.6,908681.0,Lupin rises on USFDA nod for strokes prevention drug,"Lupin advanced 1.33% to Rs 759.15 after the pharma major announced that it has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Prasugrel tablets.",neutral,positive,-0.8432147562582315,neutral,0.338420703384201,neutral
2023-01-10 18:21:31.000,759.0,759.0,747.2,752.6,908681.0,Lupin gets US FDA nod for generic medicine to treat heart ailments,Pharmaceuticals firm Lupin Ltd on Tuesday said it has received approval from the US health regulator for its generic version of Prasugrel tablets.,neutral,positive,-0.8432147562582315,neutral,0.338420703384201,neutral
2023-01-16 10:04:12.000,751.8,760.0,747.15,755.6,442600.0,Lupin’s Somerset facility gets two USFDA observations,"The US Food and Drug Administration (USFDA) inspected the drug maker’s Somerset, New Jersey, U.S.A. manufacturing facility from 2 January to 13 January 2023.",neutral,neutral,0.5054535780792856,neutral,-0.4689873835788451,neutral
2023-01-16 13:53:22.000,756.95,758.7,749.0,753.4,463284.0,Lupin gets USFDA nod for generic drugs to treat HIV infection,"The tentative approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Dolutegravir and Rilpivirine tablets of strength 50 mg/25 mg, Lupin said in a regulatory filing.",neutral,neutral,-0.4689873835788451,neutral,1.3361555761344124,positive
2023-01-16 14:45:10.000,756.95,758.7,749.0,753.4,463284.0,Lupin Gets U.S. FDA Nod For Generic Drugs To Treat HIV Infection,"The Dolutegravir and Rilpivirine tablets, 50 mg/25 mg had estimated annual sales of $666 million in the U.S.",neutral,neutral,-0.4689873835788451,neutral,1.3361555761344124,positive
2023-01-17 00:14:18.000,756.95,758.7,749.0,753.4,463284.0,Lupin gets USFDA tentative nod for generic drugs to treat HIV infection,Pharmaceutical firm Lupin on Monday said it has received tentative approval from the US health regulator to market its generic version of Dolutegravir and Rilpivirine tablets used in treatment of HIV infection.,neutral,positive,-0.4689873835788451,neutral,1.3361555761344124,positive
2023-01-18 15:50:04.000,767.25,767.25,758.5,759.5,281470.0,Lupin gains on launching combination drug for heart failure patients,"Lupin rose 1.85% to Rs 767 after the drug maker announced that it has launched a combination drug Sacubitril and Valsartan for heart failure patients, under two brand names, Valentas and Arnipin in India.",positive,positive,-1.0101010101010102,negative,-0.5595050026329647,neutral
2023-01-18 19:14:47.000,767.25,767.25,758.5,759.5,281470.0,Lupin launches combination drug for patients with heart failure conditions,"The company said it has introduced Sacubitril and Valsartan under two brand names, Valentas and Arnipin, in strengths of 200 mg, 100 mg, and 50 mg, in India",positive,neutral,-1.0101010101010102,negative,-0.5595050026329647,neutral
2023-01-24 20:35:16.000,754.0,754.0,740.0,746.9,676057.0,"Lupin Digital launches Lyfe, a 24x7 monitoring ecosystem for heart patients","Cardiac attack : Company aims to onboard one million patients the platform, which aims to help them improve heart health through doctor-connected online and offline modules",neutral,neutral,-0.9416445623342204,negative,-0.6711409395973155,neutral
2023-01-29 09:11:00.000,737.7,749.8,730.55,735.1,630777.0,"What to buy as Sensex dives below 59,500? Dilip Bhat answers","“Pharma is certainly one of the spaces that one should look at because that is one of the space which has not done anything at all. They have only gone down. I think one should definitely look into some of the frontline pharma stocks like Sun Pharma, Lupin, Cipla. I will also be a little more comfor…",neutral,neutral,-0.3524467940897414,neutral,-0.0812512695510898,neutral
2023-01-31 13:03:00.000,740.0,750.5,728.15,733.2,354833.0,"Lupin gets tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tablets","The tentative approval by the United States Food and Drug Administration (USFDA) has been granted under the President’s emergency plan for AIDS relief (PEPFAR), Lupin said in a regulatory filing.",neutral,positive,-0.9189189189189128,negative,0.9387755102040783,positive
2023-02-01 17:30:00.000,735.0,743.9,730.5,741.9,517376.0,"Stocks in news: Adani Enterprises, Reliance Industries, Jindal Steel, Lupin and more","Stocks to watch out for today: Adani Enterprises, Sun Pharma, Indian Oil, UPL, Lupin, Reliance Industries, Max Financial , Jindal Steel and more",neutral,neutral,0.9387755102040783,positive,-0.5187980056596176,neutral
2023-02-02 18:59:49.000,742.1,747.3,733.05,738.25,383206.0,Business initiative that has a heart: Lupin eyes Lyfe beyond the pill,Its digital health initiative for cardiac patients is part of its strategy to diversify into healthcare services,neutral,neutral,-0.5187980056596176,neutral,1.008187292780287,positive
2023-02-09 05:00:00.000,767.55,785.75,766.55,771.15,1330384.0,"LIC, Hindustan Petroleum, Hindalco, MRF, HAL, Lupin, IRCTC Q3 Results Today — Earnings Estimates","LIC, Hindustan Petroleum, MRF, Hindalco, Lupin, Zomato, and Pfizer will announce their quarterly results today.",neutral,neutral,0.4690248192300205,neutral,-1.1155913978494565,negative
2023-02-09 08:47:38.000,767.55,785.75,766.55,771.15,1330384.0,"Stocks that will see action on February 9, 2023","LIC, Hindalco, HPCL, Zomato, HAL, IRCTC, Adani Total Gas, Aurobindo Pharma, Bajaj Consumer Care, Bombay Dyeing, GIC, Jet Airways, MRF, Page Industries, Suzlon, Voltas, Adani Total Gas, Syngenta, TCS, Techno Electric, Symphony, Uno Minda, IVP, IOB, KIMS, Lupin",neutral,neutral,0.4690248192300205,neutral,-1.1155913978494565,negative
2023-02-09 11:22:49.000,767.55,785.75,766.55,771.15,1330384.0,Lupin receives approval from USFDA for Glycopyrrolate Injection USP,"Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S.FDA) for its abbreviated new drug application for Glycopyrrolate Injection USP, via an exchange filing.",positive,positive,0.4690248192300205,neutral,-1.1155913978494565,negative
2023-02-09 12:04:54.000,744.0,750.0,726.05,735.7,3047036.0,Lupin gets USFDA nod for Glycopyrrolate Injection USP,"The drug major has received US Food and Drug Administration (USFDA) approval for its abbreviated new drug application (ANDA) for Glycopyrrolate Injection, USP.",neutral,positive,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-09 14:20:59.000,744.0,750.0,726.05,735.7,3047036.0,Lupin bags USFDA nod to market generic product in US market,"The company has received approval from the US Food and Drug Administration (USFDA) for Glycopyrrolate Injection, a generic equivalent of Hikma Pharmaceuticals’ Robinul Injection, the Mumbai-based drug maker said in a statement.",neutral,positive,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-09 14:47:03.000,744.0,750.0,726.05,735.7,3047036.0,Lupin bags gets approval from USFDA to market generic product in America,"Drug maker Lupin on Thursday said it has received approval from the US health regulator to market a generic medication, used before a surgery to decrease the volume of secretions from mouth, lungs and stomach, in the American market.",positive,positive,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-09 15:07:30.000,744.0,750.0,726.05,735.7,3047036.0,Lupin shares trade flat ahead of Q3 result; here’s what to expect,The EBIDTA margin is likely to improve sequentially on the back of a marginal recovery in US sales and sustained cost-cutting measures,neutral,positive,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-09 23:19:17.000,744.0,750.0,726.05,735.7,3047036.0,"Lupin Q3 Results: Profit Drops 72%, Revenue Rises","Lupin’s Q3 decline in year-on-year net profit was on a high base, which included the impact of a deferred tax reversal.",neutral,negative,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-10 05:00:00.000,744.0,750.0,726.05,735.7,3047036.0,"Stocks To Watch: Adani Total Gas, Zomato, LIC, Pfizer, Mahindra & Mahindra, Lupin",Stocks to watch before going into trade today.,neutral,neutral,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-10 06:39:07.000,744.0,750.0,726.05,735.7,3047036.0,"Lupin Q3 profit plunges 72% to Rs 153 crore due to high base, revenue grows 4%","Lupin filed 7 ANDAs (abbreviated new drug applications) during the quarter, received 2 ANDA approvals from the US FDA, and launched 4 products in the US. The company now has 166 generic products in the US.",negative,positive,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-10 09:12:14.000,744.0,750.0,726.05,735.7,3047036.0,Lupin consolidated net profit declines 71.87% in the December 2022 quarter,Sales rise 3.84% to Rs 4244.56 crore,negative,positive,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-10 10:28:54.000,744.0,750.0,726.05,735.7,3047036.0,Decline in Q3 net profit drags Lupin; stock slumps 6%,The drugmaker’s bottomline for the Oct-Dec period fell 72 percent on year primarily due to a high base in the corresponding quarter last year.,negative,negative,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-10 11:00:32.000,744.0,750.0,726.05,735.7,3047036.0,"Lupin Consolidated December 2022 Net Sales at Rs 4,322.22 crore, up 3.88% Y-o-Y",,positive,neutral,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-10 11:50:53.000,744.0,750.0,726.05,735.7,3047036.0,Drug marker Lupin reports 72% decline in Q3 net profit to Rs 153 cr,"Drug maker Lupin has reported 72 per cent decline in consolidated net profit at Rs 153 crore for the third quarter ended December 31, 2022.",negative,negative,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-10 13:12:02.000,744.0,750.0,726.05,735.7,3047036.0,Lupin Q3 consolidated profit down 72 per cent,"The company posted a consolidated revenue of ₹4,322 crore, up 3.8 per cent from ₹4,087 crore, registered in Q3 FY22",negative,positive,-1.1155913978494565,negative,-6.201388888888886,negative
2023-02-13 10:10:26.000,720.0,720.0,671.65,675.35,4976325.0,Lupin Q3 Earnings Review: Shares Drop As Brokerages Express Concerns Around Growth And Margin,:Lupin shares fell for the second consecutive day as analysts express concerns on growth prospects and margins,neutral,negative,-6.201388888888886,negative,-2.2566371681415864,negative
2023-02-13 12:01:19.000,678.0,678.3,657.1,662.7,1914680.0,Lupin: Why avoid despite improving US business,The improvement in both top line and margins are expected to be gradual,positive,positive,-2.2566371681415864,negative,1.0710514406396172,positive
2023-02-13 12:30:01.000,678.0,678.3,657.1,662.7,1914680.0,Brokerages downgrade Lupin post weak Q3; see up to 17% downside,Lupin shares fell 7.5 per cent to Rs 681 apiece on the BSE in the intra-day trade,negative,negative,-2.2566371681415864,negative,1.0710514406396172,positive
2023-02-13 22:42:50.000,678.0,678.3,657.1,662.7,1914680.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the OI percentage, 81 stocks, including City Union Bank, Coforge, Lupin, BHEL, and Info Edge India, saw a short build-up",neutral,positive,-2.2566371681415864,negative,1.0710514406396172,positive
2023-02-14 06:22:00.000,678.0,678.3,657.1,662.7,1914680.0,"Analysts bearish on ‘expensive’ Lupin after Q3 disappoints, stock falls 9%","Of the 44 analysts, 18 of them have a ‘sell’ rating while 15 remain neutral. On aggregate, analysts slashed consensus price targets by 4.35% to ₹708.29, showed a Bloomberg poll of analysts.",negative,negative,-2.2566371681415864,negative,1.0710514406396172,positive
2023-02-14 20:03:55.000,662.9,670.55,656.85,670.0,819871.0,"Lupin forays into neuro-rehab services, plans for more centres",Lupin’s Atharv Ability Centre is possibly the only one of its kind in the country with a range of rehabilitation programs,neutral,neutral,1.0710514406396172,positive,1.589433624356405,positive
2023-02-16 12:31:12.000,680.0,687.45,668.05,669.05,820384.0,"Lupin allots 65,284 equity shares under ESOP","In view of the above, the issued and paid-up capital of the Company has been increased to Rs 90,98,81,566 consisting of 45,49,40,783 eql!ity shares of Rs 2 each.",neutral,neutral,-1.6102941176470658,negative,-0.7758877946881595,neutral
2023-02-16 22:43:48.000,680.0,687.45,668.05,669.05,820384.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest percentage, as many as 55 stocks were on the short-covering list. These included City Union Bank, Lupin, MCX India, Torrent Power, and Bajaj Finserv.",neutral,neutral,-1.6102941176470658,negative,-0.7758877946881595,neutral
2023-02-17 10:00:31.000,680.0,687.45,668.05,669.05,820384.0,Lupin’s Nagpur injectables facility gets establishment inspection report,"The USFDA report was issued after the inspection during October 17-29, 2022",neutral,neutral,-1.6102941176470658,negative,-0.7758877946881595,neutral
2023-02-17 10:31:47.000,680.0,687.45,668.05,669.05,820384.0,Lupin receives Establishment Inspection Report for its new injectable unit in Nagpur,Powered by Capital Market - Live News,neutral,neutral,-1.6102941176470658,negative,-0.7758877946881595,neutral
2023-02-17 11:04:14.000,680.0,687.45,668.05,669.05,820384.0,Lupin gets EIR from USFDA for Nagpur facility,"Lupin announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its new injectable facility located in Nagpur, India.",neutral,positive,-1.6102941176470658,negative,-0.7758877946881595,neutral
2023-02-17 16:56:00.000,680.0,687.45,668.05,669.05,820384.0,Lupin receives USFDA’s establishment inspection report for its Nagpur facility,"The establishment inspection report (EIR) was issued after the last inspection of the facility conducted from October 17-29, 2022, the company said in a regulatory filing. The injectable facility at Nagpur is designed to the highest quality standards and adheres to international regulations with adv…",neutral,neutral,-1.6102941176470658,negative,-0.7758877946881595,neutral
2023-02-17 19:22:15.000,680.0,687.45,668.05,669.05,820384.0,Lupin gets a breather on Nagpur facility,"USFDA gave an EIR after inspecting the facility from October 17 to October 29, 2022",neutral,neutral,-1.6102941176470658,negative,-0.7758877946881595,neutral
2023-02-21 13:39:08.000,670.9,676.7,660.65,662.2,683689.0,Lupin launches Lurasidone Hydrochloride Tablets in the United States,"Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg (RLD Latuda) had estimated annual sales of USD 4.2 billion in the U.S.",neutral,neutral,-1.2967655388284294,negative,-0.9820826148886824,negative
2023-02-21 14:50:15.000,670.9,676.7,660.65,662.2,683689.0,Lupin launches schizophrenia drug in US,Lupin announced that it has launched Lurasidone Hydrochloride tablets to market in the United States.,positive,positive,-1.2967655388284294,negative,-0.9820826148886824,negative
2023-02-21 14:51:30.000,670.9,676.7,660.65,662.2,683689.0,Lupin Pharma launches Lurasidone Hydrochloride Tablets in US,The generic equivalent of Latuda tablets has been launched in the US markets,neutral,neutral,-1.2967655388284294,negative,-0.9820826148886824,negative
2023-02-22 08:03:00.000,670.9,676.7,660.65,662.2,683689.0,Lupin launches generic medication in US market,"Drug firm Lupin on Tuesday said it has launched a generic anti-psychotic medication in the US market. The company’s product, in strengths of 20 mg, 40 mg, 60 mg, 80 mg and 120 mg, is the generic equivalent of Sunovion Pharmaceuticals Inc’s Latuda tablets.",positive,neutral,-1.2967655388284294,negative,-0.9820826148886824,negative
2023-02-22 08:51:30.000,670.9,676.7,660.65,662.2,683689.0,"Stocks that will see action on February 22, 2023","Paytm, SBI, Reliance Industries, Sapphire Foods, HCL Technologies, BEL, Lupin, LIC Housing Finance, Toyam Sports, MPS",neutral,neutral,-1.2967655388284294,negative,-0.9820826148886824,negative
2023-03-01 16:04:10.000,661.4,666.55,657.0,659.95,408375.0,Lupin launches its new Regional Reference Laboratory in Hyderabad,Powered by Capital Market - Live News,neutral,neutral,-0.2192319322648823,neutral,-0.0829500037704478,neutral
2023-03-02 09:05:55.000,661.4,666.55,657.0,659.95,408375.0,"Stocks to watch: HDFC Bank, NMDC, PVR, Lupin, Sunteck Realty, Tata Motors","Stocks to watch today: From HDFC to PVR, here are top stocks to watch in Thursday’s trading session",neutral,neutral,-0.2192319322648823,neutral,-0.0829500037704478,neutral
2023-03-02 12:48:53.000,663.05,666.9,659.0,662.5,289409.0,Sun Pharma reports ‘information security incident’,"Sun Pharma ‘security incident’ similar to 2020 breaches at Dr Reddy’s, Lupin",neutral,neutral,-0.0829500037704478,neutral,-0.3684487555455365,neutral
2023-03-03 12:20:15.000,663.05,666.9,659.0,662.5,289409.0,"Lupin Limited announced allotment of 15,638 equity shares","Lupin Limited announced that the Allotment Committee of Directors at its meeting held today, i.e., on March 3, 2023, allotted 15,638 fully paid-up equity shares of Rs 21 each, via an exchange filing. These shares have been allotted upon the exercise of options granted to the employees under the sto…",neutral,neutral,-0.0829500037704478,neutral,-0.3684487555455365,neutral
2023-03-03 14:31:38.000,663.05,666.9,659.0,662.5,289409.0,"Lupin allots 15,638 equity shares under ESOP","In view of the above, the issued and paid-up capital of the Company has been increased to Rs 90,99, 12,842 consisting of 45,49,56,421 equity shares of Rs 2 each.",neutral,neutral,-0.0829500037704478,neutral,-0.3684487555455365,neutral
2023-03-03 21:09:07.000,663.05,666.9,659.0,662.5,289409.0,"Health Monitoring, Risk Scores, WhatsApp Alerts: How This Company Hopes to Predict a Heart Attack","Lupin India has roped in more than 300 cardiologists since January with an aim to capture over 4,500 by the end of this year, across the top 30 cities of India... It also wants to create ‘Heart Health’, which can predict the possibility of having a heart attack",neutral,neutral,-0.0829500037704478,neutral,-0.3684487555455365,neutral
2023-03-06 16:48:00.000,664.95,669.5,661.2,662.5,329397.0,Sun Pharma reports “information security incident”; isolates impacted IT assets,"“The company is investigating the matter and appropriate containment and remediation actions are being taken in a controlled manner to address the incident,” the drug maker said. In 2020, drug makers Dr Reddy’s Laboratories and Lupin had also reported cyber security breaches.",neutral,neutral,-0.3684487555455365,neutral,0.3695324283559646,neutral
2023-03-09 15:53:32.000,655.0,658.8,649.35,656.8,443257.0,Reduce Lupin; target of Rs 660: Sharekhan,"Sharekhan recommended reduce rating on Lupin with a target price of Rs 660 in its research report dated February 10, 2023.",neutral,negative,0.2748091603053366,neutral,-1.08333333333333,negative
2023-03-10 20:40:00.000,655.0,658.8,649.35,656.8,443257.0,Lupin’s Vizag unit gets no observations from USFDA,"“We are pleased with the successful completion of the inspection at our Vizag facility. This accomplishment is a testament to our commitment to upholding global quality standards across all our manufacturing sites, and to provide quality affordable healthcare for all,” said Nilesh Gupta, managing di…",neutral,positive,0.2748091603053366,neutral,-1.08333333333333,negative
2023-03-10 20:52:08.000,655.0,658.8,649.35,656.8,443257.0,US FDA completes inspection of Vizag Facility with no observations: Lupin,The inspection was conducted from March 6 to March 10,neutral,neutral,0.2748091603053366,neutral,-1.08333333333333,negative
2023-03-13 05:00:00.000,660.0,664.95,651.15,652.85,468799.0,"Stocks To Watch: Hindustan Aeronautics, ICICI Bank, Ujjivan Financial Services, IndusInd Bank, Lupin",Stocks to watch before going into trade today.,neutral,neutral,-1.08333333333333,negative,-0.0304321363359777,neutral
2023-03-13 08:52:03.000,660.0,664.95,651.15,652.85,468799.0,"Stocks that will see action on March 13, 2023","Tech Mahindra, Nazara Tech, Infosys, Hindustan Zinc, ambuja Cements, Finolex Ind, Godrej Properties, Tata Power, Elgi Equipments, Sona Comstar, M&M, Mahindra CIE, Spananda Sphoorty,VA Tech Wabag, Zydus Lifesciences, JSW Steel, Sula Vineyards, Lloyds Metals, Lupin",neutral,neutral,-1.08333333333333,negative,-0.0304321363359777,neutral
2023-03-13 09:04:52.000,660.0,664.95,651.15,652.85,468799.0,"M&M, IndusInd Bank, Lupin, Nazara Technologies in focus","Mahindra & Mahindra (M&M): M&M on Friday announced that the company’s total production of automobiles advanced 14.04% to 56,997 units in February 2023 as compared with 49,979 units sold in February 2022. The auto major’s total sales rose 9.51% to",neutral,positive,-1.08333333333333,negative,-0.0304321363359777,neutral
2023-03-13 10:51:00.000,660.0,664.95,651.15,652.85,468799.0,Lupin shares up 0.18% as Sensex rises,"A total of 8,075 shares changed hands on the counter till 10:51AM (IST)",positive,neutral,-1.08333333333333,negative,-0.0304321363359777,neutral
2023-03-13 20:12:13.000,657.2,668.9,652.2,657.0,965293.0,US regulatory inspection at bioresearch facility completed with no observations: Lupin,Lupin’s bioresearch centre conducts a range of bio-equivalence and biosimilar studies,neutral,neutral,-0.0304321363359777,neutral,0.1291400790033286,neutral
2023-03-14 07:57:46.000,657.2,668.9,652.2,657.0,965293.0,"Stocks to Watch: LIC, Dr Reddy’s, NALCO, Lupin, GAIL, Varun Beverages, and Others","Stocks to watch: Shares of firms like LIC, Dr Reddy’s, NALCO, Lupin, GAIL, Varun Beverages, and others will be in focus on Tuesday’s trade.",neutral,neutral,-0.0304321363359777,neutral,0.1291400790033286,neutral
2023-03-14 07:58:54.000,657.2,668.9,652.2,657.0,965293.0,"Stocks to watch: Lupin, GAIL, PNB Housing, Shriram Finance, Axita Cotton","Stocks to Watch Today: From Lupin to Gail (India), here are stocks to watch out in Tuesday’s trading session",neutral,neutral,-0.0304321363359777,neutral,0.1291400790033286,neutral
2023-03-14 08:47:06.000,657.2,668.9,652.2,657.0,965293.0,"Stocks that will see action on March 14, 2023","Sona Comstar, Tube Investments, Data Patterns, Nalco, GAIL, Dhanlaxmi Fabrics, Varun Beverages, Lupin, Tata Chemicals, Surya Roshni, BL Kaashyap, Taylormade Renewables",neutral,neutral,-0.0304321363359777,neutral,0.1291400790033286,neutral
2023-03-14 09:52:58.000,657.2,668.9,652.2,657.0,965293.0,Lupin share price gains on ‘no observation’ certificate from USFDA inspection,"Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.",positive,neutral,-0.0304321363359777,neutral,0.1291400790033286,neutral
2023-03-14 17:30:00.000,658.2,666.45,655.0,659.05,678861.0,"Stocks in news: Tata Chemicals, Sona BLW Precision, Lupin, GAIL, Apollo Pipes and more","Stocks to watch out for today: Tata Chemicals, Mahindra CIE Automotive, Sona BLW Precision Forgings, Lupin, GAIL, Apollo Pipes and more",neutral,neutral,0.1291400790033286,neutral,1.1125406796336976,positive
2023-03-16 17:30:00.000,668.0,669.0,654.3,655.9,697796.0,"Adani Ports, Tata Steel, Lupin: How should you trade these stocks amid volatility","After witnessing a sharp correction, Adani Ports has given a strong pullback. The scrip is consolidating in the Rs 660-640 zone and is maintaining its support of Rs 620.",neutral,positive,-1.8113772455089852,negative,-1.366516527979242,negative
2023-03-21 09:29:06.000,655.0,655.45,646.1,650.0,298939.0,Lupin shares gain after partner receives USFDA approval to 2 drugs,"The share touched a 52-week high of Rs 798.90 and a 52-week low of Rs 583.05 on 05 April, 2022 and 25 May, 2022, respectively.",positive,negative,-0.7633587786259541,neutral,1.7608612072279963,positive
2023-03-21 10:26:50.000,655.0,655.45,646.1,650.0,298939.0,"Stocks that will see action on March 21, 2023","Buzzing stocks: Uno India, NTPC, IOC, CEAT, Sterling & Wilson, Lupin, Windsor, Shipping Corporation",neutral,neutral,-0.7633587786259541,neutral,1.7608612072279963,positive
2023-03-21 11:16:19.000,655.0,655.45,646.1,650.0,298939.0,Lupin’s partner receives USFDA approval for 2 drugs,"The drug major on Monday announced that its alliance partner, Caplin Steriles received final approval from the United States Food and Drug Administration (USFDA) to market Rocuronium Bromide Injection and Thiamine Hydrochloride Injection USP.",positive,positive,-0.7633587786259541,neutral,1.7608612072279963,positive
2023-03-21 17:46:45.000,650.25,662.0,649.0,661.7,278309.0,"Lupin gets approval for generic medicine for schizophrenia, depression",Pharmaceuticals firm Lupin Ltd on Tuesday said it has received approval from the US health regulator for its generic Brexpiprazole tablets used to treat the symptoms of schizophrenia and depression.,positive,positive,1.7608612072279963,positive,-1.749072461573418,negative
2023-03-22 08:59:57.000,650.25,662.0,649.0,661.7,278309.0,"Stocks that will see action on March 22, 2023","Buzzing stocks: Hindustan Zinc, Tata Power, Indian Oil Corporation, Lyka Labs, Lupin, J Kumar Infraprojects, Pidilite Industries, HG Infra, BL Kashyap, Compucom Software, Sharda Motor",neutral,neutral,1.7608612072279963,positive,-1.749072461573418,negative
2023-03-23 18:31:26.000,651.0,654.85,638.35,639.25,720182.0,Lupin receives USFDA tentative approval for Obeticholic Acid Tablets,Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of USD 255 million in the U.S. (IQVIA MAT December 2022).,positive,neutral,-1.8049155145929336,negative,2.4145962732919184,positive
2023-03-24 08:49:49.000,651.0,654.85,638.35,639.25,720182.0,India rejects Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug,"Johnson & Johnson’s primary patents on Bedaquiline expire in July, paving the way for generic drug manufacturers such as Lupin and Macleods to produce Bedaquiline",positive,positive,-1.8049155145929336,negative,2.4145962732919184,positive
2023-03-24 09:04:37.000,651.0,654.85,638.35,639.25,720182.0,"Tata Steel, Bharat Electronics, Lupin, RVNL in focus","Tata Steel: Tata Steel has acquired the balance 1.35 crore equity shares of Rs 10 each, at a premium of Rs 2.81 per share, of Tata Steel Advanced Materials (TSAML), an indirect wholly owned subsidiary of the company, from Tata Steel Downstream",neutral,positive,-1.8049155145929336,negative,2.4145962732919184,positive
2023-03-24 09:07:41.000,651.0,654.85,638.35,639.25,720182.0,"Stocks that will see action on March 24, 2023","Buzzing stocks of Canara Bank, SBI, IDFC First Bank, IDFC, Tata Steel, RVNL, Lupin, Bajaj Hindusthan, BHEL, DIC India, Ganesh Housing, Vascon Engineers, Esab India, WS Industries, and RPP Infra",neutral,neutral,-1.8049155145929336,negative,2.4145962732919184,positive
2023-03-24 09:31:16.000,651.0,654.85,638.35,639.25,720182.0,Lupin gets tentative USFDA nod for liver disease drug,"The drug maker on Thursday announced that it has received tentative approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Obeticholic Acid Tablets.",neutral,positive,-1.8049155145929336,negative,2.4145962732919184,positive
2023-03-24 09:49:18.000,651.0,654.85,638.35,639.25,720182.0,"Lupin gets tentative USFDA approval for obeticholic acid tablets, shares gain","Lupin’s share touched a 52-week high of Rs 798.90 on April 5, 2022 and a 52-week low of Rs 583.05 on May 25, 2022.",positive,negative,-1.8049155145929336,negative,2.4145962732919184,positive
2023-03-26 10:58:44.000,644.0,673.75,641.75,659.55,3963764.0,UK MHRA completes inspection at Lupin’s Pithampur facilities,"The inspection was conducted from March 20 to March 24, 2023.",neutral,neutral,2.4145962732919184,positive,-2.4021755552198187,negative
2023-03-26 13:11:29.000,644.0,673.75,641.75,659.55,3963764.0,USFDA completes inspections of Lupin’s operations,The inspection closed with no observations.,neutral,neutral,2.4145962732919184,positive,-2.4021755552198187,negative
2023-03-27 08:34:06.000,644.0,673.75,641.75,659.55,3963764.0,"Stocks to Watch: Lupin, Tata Steel, Nykaa, Adani Stocks, Paytm, Sun Pharma, and Others","Stocks to watch: Shares of firms like Lupin, Tata Steel, Nykaa, Adani Stocks, Paytm, Sun Pharma, and others will be in focus on Monday’s trade.",neutral,neutral,2.4145962732919184,positive,-2.4021755552198187,negative
2023-03-27 09:13:31.000,644.0,673.75,641.75,659.55,3963764.0,"Stocks that will see action on March 27, 2023","Buzzing stocks: Reliance Industries, Sun Pharma, Tube Investments, SecureKloud, CG Consumer, Gandhimathi Appliances, Grasim Industries, Zydus Lifesciences, Lupin, Morepen Lab, M&M, IOB, Kajaria Ceramics, Veranda Learning, WS Industries, Suraj Industries, Bharat Electronics, Khadim India",neutral,neutral,2.4145962732919184,positive,-2.4021755552198187,negative
2023-03-27 10:27:09.000,644.0,673.75,641.75,659.55,3963764.0,Lupin shares gain on tentative USFDA approval for Valbenazine capsules,"Lupin also announced that USFDA has completed a post-marketing adverse drug experience (PADE) inspection of the company’s operations, which closed with no observations.",positive,neutral,2.4145962732919184,positive,-2.4021755552198187,negative
2023-03-27 16:24:00.000,661.9,661.9,640.95,646.0,993979.0,Lupin gets tentative USFDA approval to market generic valbenazine capsules,"These are the generic equivalent of Ingrezza capsules, 40 mg, 60 mg, and 80 mg, of Neurocrine Biosciences, Inc, it added. Valbenazine capsules had estimated annual sales of USD 1,235 million in the US, the company said, citing IQVIA MAT December 2022 data.",positive,neutral,-2.4021755552198187,negative,1.334574798261953,positive
2023-03-27 17:30:00.000,661.9,661.9,640.95,646.0,993979.0,"Stocks in news: Tata Steel, Bharti Airtel, Axis Bank, Paytm and more","Stocks to watch out for today: Kajaria Ceramics, Lupin, Tata Steel, Bharti Airtel, Axis Bank, Paytm and more",neutral,neutral,-2.4021755552198187,negative,1.334574798261953,positive
2023-03-30 16:49:50.000,644.65,650.95,628.0,648.0,1980755.0,USFDA issues Form-483 with 10 observations to Lupin’s Pithampur plant,Drug firm Lupin on Thursday said the US health regulator has issued a Form-483 with ten observations after inspecting its Pithampur Unit-2 manufacturing facility.,neutral,neutral,0.5196618320018651,neutral,0.0539166602480201,neutral
2023-03-30 21:16:16.000,644.65,650.95,628.0,648.0,1980755.0,U.S. FDA issues Form 483 with 10 observations to Lupin facility,"The U.S. FDA had inspected facility, in Madhya Pradesh, from March 21-29",neutral,neutral,0.5196618320018651,neutral,0.0539166602480201,neutral
2023-03-31 10:15:03.000,644.65,650.95,628.0,648.0,1980755.0,Lupin shares slip as US FDA issues ten observations for Pithampur unit,Lupin’s Pithampur plant also holds significance for the company as it plans to manufacture the generic of Spiriva at the facility. Spiriva is a prescription drug that is used long term to improve breathing in people with certain respiratory conditions.,negative,neutral,0.5196618320018651,neutral,0.0539166602480201,neutral
2023-03-31 14:14:00.000,644.65,650.95,628.0,648.0,1980755.0,Lupin shares down 0.87% as Nifty gains,"A total of 86,498 shares changed hands on the counter till 02:14PM (IST).",negative,neutral,0.5196618320018651,neutral,0.0539166602480201,neutral
2023-03-31 17:30:00.000,644.65,650.95,628.0,648.0,1980755.0,"Tata Power, Reliance Industries, Lupin, Wipro and other stocks to watch out for today","Stocks to watch out for today: GR Infraprojects, Kalyan Jewellers, Tata Power, Reliance Industries, Lupin, Quess Corp, Wipro, BEL and more",neutral,neutral,0.5196618320018651,neutral,0.0539166602480201,neutral
2023-03-31 17:30:00.000,644.65,650.95,628.0,648.0,1980755.0,Lupin shares fall 4% after USFDA issues Form 483 for Pithampur plant,"Lupin shares plunged 3.18% to Rs 106.50 against the previous close of Rs 110 on BSE. Market cap of the firm fell to Rs 10,970 crore",negative,negative,0.5196618320018651,neutral,0.0539166602480201,neutral
2023-04-02 23:08:57.000,649.15,654.5,644.0,649.5,807245.0,"We can raise money in our new venture firms in future, says Lupin MD","In a digital health venture, I would love to go into areas where we have equity with doctors. Respiratory is one area where I am very interested in, says Nilesh Gupta, MD, Lupin",positive,neutral,0.0539166602480201,neutral,1.4442651916724247,positive
2023-04-10 11:58:00.000,664.0,667.0,661.0,663.2,352301.0,Lupin shares fall 0.29 per cent in Monday’s trading session,The Relative Strength Index of the stock stood at 49.98 on Monday.,negative,neutral,-0.1204819277108365,neutral,-0.6542829209596184,neutral
2023-04-12 12:29:56.000,672.25,678.4,667.0,671.8,807812.0,"Improved sentiment, hopes of better sales fuel gains in pharma stocks; Divi’s Lab spurts 8%","Multiple counters in the pharmaceutical space, including Divi’s Laboratories, Cipla, Sun Pharmaceuticals, Lupin, and Natco Pharma also witnessed large deals on April 12.",positive,positive,-0.0669393826701443,neutral,-1.7164179104477613,negative
2023-04-12 19:22:00.000,672.25,678.4,667.0,671.8,807812.0,"Lupin opens regional lab in Bengaluru, plans expansion in Karnataka","The company is focused on providing fast turnaround time along with affordability to its customers, Lupin Diagnostics CEO Ravindra Kumar told ET. “Bengaluru is a tech-savvy place, we see it as a market where there are a lot of national and regional players. Karnataka though has low penetration of di…",positive,neutral,-0.0669393826701443,neutral,-1.7164179104477613,negative
2023-04-12 20:36:45.000,672.25,678.4,667.0,671.8,807812.0,Lupin to add 17 regional reference labs more in FY24,"According to Lupin, the total diagnostic market in India is ₹90,000 crore, annually growing almost 15-16 per cent CAGR y-o-y with only 16 per cent being managed by organised players.",neutral,positive,-0.0669393826701443,neutral,-1.7164179104477613,negative
2023-04-12 21:11:55.000,672.25,678.4,667.0,671.8,807812.0,Lupin Diagnostics launches regional reference laboratory in Bengaluru,"After establishing a presence in Hyderabad, this launch expands footprint in South India",neutral,positive,-0.0669393826701443,neutral,-1.7164179104477613,negative
2023-05-05 20:55:00.000,707.0,713.25,702.4,702.8,266772.0,Lupin to acquire French firm Medisol for around Rs 160 cr,"Pharmaceuticals firm Lupin Ltd on Friday said it will fully acquire French pharmaceutical company Medisol for 18 million euros (over Rs 160 crore). The company has entered into a definitive agreement to acquire the entire share capital of Medisol, subject to approval from the French Ministry of Econ…",neutral,positive,-0.5940594059406005,neutral,3.6777707051418074,positive
2023-05-05 22:39:54.000,707.0,713.25,702.4,702.8,266772.0,Lupin to acquire French pharma firm Medisol,Acquisition part of Lupin’s strategy to expand presence in the EU and accelerate injectables franchise in France,neutral,positive,-0.5940594059406005,neutral,3.6777707051418074,positive
2023-05-05 23:15:24.000,707.0,713.25,702.4,702.8,266772.0,Lupin to acquire French pharma company Medisol for around Rs 160 crore,"The company has entered into a definitive agreement to acquire the entire share capital of Medisol, subject to approval from the French Ministry of Economy and Finance",neutral,positive,-0.5940594059406005,neutral,3.6777707051418074,positive
2023-05-07 17:30:00.000,706.95,736.85,704.1,732.95,1479717.0,"Sensex, Nifty this week: From IIP data to US inflation to Q4 earnings, factors that may drive Dalal Street","Coal India, Canara Bank, Pidilite Industries, UPL, Apollo Tyres, Lupin, Raymond, Larsen & Toubro, Asian Paints, and Eicher Motors are among the major companies that will announce their March quarter numbers in the upcoming week.",neutral,neutral,3.6777707051418074,positive,1.5006821282401093,positive
2023-05-08 06:50:18.000,706.95,736.85,704.1,732.95,1479717.0,"Stocks To Watch: Adani Power, Britannia Industries, Paytm, Marico, Canara Bank, Manappuram Finance, Lupin, UPL",Stocks to watch before going into market today.,neutral,neutral,3.6777707051418074,positive,1.5006821282401093,positive
2023-05-08 08:11:17.000,706.95,736.85,704.1,732.95,1479717.0,"Stocks to watch: Coal India, Adani Transmission, Adani Total Gas, Paytm, Britannia, Lupin, Ajanta Pharma, Marico | The Financial Express","UPL, Canara Bank, Indian Bank, Aarti Industries, Apollo Pipes, Birlasoft, CG Power and Industrial Solutions, Craftsman Automation, Exide Industries, Happiest Minds Technologies and others will be in focus ahead of quarterly earnings on May 8.",neutral,neutral,3.6777707051418074,positive,1.5006821282401093,positive
2023-05-08 08:50:00.000,706.95,736.85,704.1,732.95,1479717.0,Will Hero MotoCorp and Lupin turn out to be good bets for Rajat Sharma?,"Sana Securities’ Rajat Sharma, prefers smaller banks like IDFC First Bank, while larger banks don’t seem attractive to him. Sharma is negative on the banking space where dispersals and offtake of loans are slowing down due to rising interest rates. He has both Federal Bank and IDFC First Bank in his…",positive,neutral,3.6777707051418074,positive,1.5006821282401093,positive
2023-05-08 09:07:48.000,706.95,736.85,704.1,732.95,1479717.0,"Stocks that will see action on May 8, 2023","Buzzing stocks: Indian Bank, Canara Bank, Manappuram Finance, TCNS, ABFRL, Aarti Industries, ITC, ADF Foods, PNC Infratech, Amara Raja Batteries, Thermax, SJVN, Bharat Forge, DCB Bank, Lupin, Mahanagar Gas, CUMI, Exide Industries, Happiest Minds, UPL, Pidilite Industries",neutral,neutral,3.6777707051418074,positive,1.5006821282401093,positive
2023-05-09 05:00:00.000,733.0,752.0,726.0,744.0,1894782.0,"Stocks To Watch: Pidilite, Kalpataru Power, Mahanagar Gas, Lupin, Apollo Tyres, Greenply Industries",Stocks to watch before going into market today.,neutral,neutral,1.5006821282401093,positive,-0.1133333333333363,neutral
2023-05-09 07:44:26.000,733.0,752.0,726.0,744.0,1894782.0,"Buzzing Stocks: Lupin, Raymond, Mahanagar Gas, Mankind Pharma stocks and others in focus",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,1.5006821282401093,positive,-0.1133333333333363,neutral
2023-05-09 09:28:52.000,733.0,752.0,726.0,744.0,1894782.0,"Stocks to Watch: Aarti Industries, Lupin, Pidilite, Mankind, Nazara Tech, and Others","Stocks to watch: Shares of firms like Aarti Industries, Lupin, Pidilite, Mankind Pharma, Nazara Tech, and others will be in focus on Tuesday’s trade.",neutral,neutral,1.5006821282401093,positive,-0.1133333333333363,neutral
2023-05-09 09:54:32.000,733.0,752.0,726.0,744.0,1894782.0,"Stocks to watch today — May 9, 2023","Buzzing stocks: R Systems, Apollo Tyres, Castrol, Lupin, Reliance Infra, Elantas Beck, Godrej Agro, Ganesh Housing, Nazara, Latent View, NLC, Krsnaa Diagnostics, Emami, RHI Magnesita, PNB, Kansai Nerolac, Greenply, Raymond, SRF, Shipping Corporation",neutral,neutral,1.5006821282401093,positive,-0.1133333333333363,neutral
2023-05-09 10:01:00.000,733.0,752.0,726.0,744.0,1894782.0,"Q4 results today: What to expect from Lupin, Apollo Tyres and Westlife Foodworld","Lupin, Apollo Tyres, Westlife, Raymond and Nazara are set to release their Q4 results on Tuesday. Lupin is expected to report a profit of Rs 233 crore, down from the last quarter but considerably better than the loss of Rs 518 crore reported last year. Apollo Tyres is expected to see its profit more…",neutral,negative,1.5006821282401093,positive,-0.1133333333333363,neutral
2023-05-09 17:30:00.000,750.0,770.8,734.3,749.15,4787749.0,"Raymond, Apollo Tyres, Lupin, Nazara, Jaiprakash Power Ventures to share Q4 results today","Lupin, Phillip Capital said, may report a profit of Rs 155 crore against a loss of Rs 6 crore last year. It sees revenue for Lupin to rise 8 per cent YoY to Rs 4,187 crore against Rs 3,883 crore YoY.",neutral,positive,-0.1133333333333363,neutral,1.8854097268487648,positive
2023-05-09 23:29:43.000,750.0,770.8,734.3,749.15,4787749.0,"Lupin reports 12% rise in Q4 sales riding on API, US and India biz",The revenue growth came from a strong API business performance along with US and domestic market sales growth,positive,positive,-0.1133333333333363,neutral,1.8854097268487648,positive
2023-05-10 05:00:00.000,750.0,770.8,734.3,749.15,4787749.0,"Stocks To Watch: L&T, Dr Reddy’s, Bosch, Apollo Tyres, Lupin, Nazara Tech, Eveready, Godrej Consumer",Stocks to watch before going into market today.,neutral,neutral,-0.1133333333333363,neutral,1.8854097268487648,positive
2023-05-10 07:50:40.000,750.0,770.8,734.3,749.15,4787749.0,"Stocks To Watch: Raymond, Lupin, Mankind Pharma, Birla Corporation, Nazara Technologies | The Financial Express","Mankind Pharma, Raymond, Lupin, Birla Corporation and Nazara Technologies stocks are in focus today.",neutral,neutral,-0.1133333333333363,neutral,1.8854097268487648,positive
2023-05-10 08:30:32.000,750.0,770.8,734.3,749.15,4787749.0,"Lupin’s Q4 net profit at Rs 236 crore, sales rise 12.1% YoY",An improved product mix also helped Lupin expand its EBIDTA margin for the quarter by 690 basis points on year.,positive,positive,-0.1133333333333363,neutral,1.8854097268487648,positive
2023-05-10 09:53:09.000,750.0,770.8,734.3,749.15,4787749.0,"Lupin Standalone March 2023 Net Sales at Rs 2,836.27 crore, down 0.67% Y-o-Y",,negative,neutral,-0.1133333333333363,neutral,1.8854097268487648,positive
2023-05-10 09:53:12.000,750.0,770.8,734.3,749.15,4787749.0,"Lupin Consolidated March 2023 Net Sales at Rs 4,430.08 crore, up 14.09% Y-o-Y",,positive,neutral,-0.1133333333333363,neutral,1.8854097268487648,positive
2023-05-10 11:26:57.000,750.0,770.8,734.3,749.15,4787749.0,"Lupin reports Q4FY23 profit at Rs 235.9 crore, revenue up 14% at Rs 4,430 crore; 200% dividend announced | The Financial Express","Lupin posted revenue from operations at Rs 4,430.08 crore, up 14.1 per cent from Rs 3,883.03 crore in the fourth quarter of FY22.",positive,positive,-0.1133333333333363,neutral,1.8854097268487648,positive
2023-05-10 12:44:56.000,750.5,767.8,742.45,764.65,1234170.0,Lupin records ₹236 crore net profit in Q4 FY23,"Lupin’s consolidated revenues for the financial year 2023 stood at ₹16,641 crore compared to ₹16,405 crore in FY22, with a net profit of ₹430 crore in FY23 compared to a loss of ₹1,528 crore in FY22.",positive,positive,1.8854097268487648,positive,1.8618421052631549,positive
2023-05-10 17:30:00.000,750.5,767.8,742.45,764.65,1234170.0,"Lupin, Dr Reddy’s Labs, Gujarat Gas: What should be your trading strategy for these stocks?",Lupin witnessed a breakout of a rounding bottom formation with strong volumes on the daily chart. Rounding bottoms are found at the end of extended downward trends.,neutral,neutral,1.8854097268487648,positive,1.8618421052631549,positive
2023-05-10 22:58:48.000,750.5,767.8,742.45,764.65,1234170.0,Trade setup for Thursday: Top 15 things to know before the opening bell,"Based on the OI percentage, 61 stocks were on the short-covering list. These included Oracle Financial, Lupin, Pidilite Industries, Samvardhana Motherson International and Voltas.",neutral,neutral,1.8854097268487648,positive,1.8618421052631549,positive
2023-05-11 17:30:00.000,760.0,776.05,757.05,774.15,1451767.0,"Godrej Consumer, L&T, Dr Reddy’s, Raymond among stocks to watch out for today","Stocks to watch out for today: Godrej Consumer, L&T, Cera Sanitaryware, Dr Reddy’s, Gujarat Gas, Lupin, Raymond, Escorts Kubota and more",neutral,neutral,1.8618421052631549,positive,0.555732992654107,neutral
2023-05-11 19:21:22.000,760.0,776.05,757.05,774.15,1451767.0,Broker’s Call: Lupin (Buy),Broker’s Call: Lupin (Buy),neutral,neutral,1.8618421052631549,positive,0.555732992654107,neutral
2023-05-12 16:12:57.000,760.0,776.05,757.05,774.15,1451767.0,Buy Lupin target of Rs 920: YES Securities,"YES Securities is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 920 in its research report dated May 11, 2023.",neutral,positive,1.8618421052631549,positive,0.555732992654107,neutral
2023-05-14 07:48:14.000,782.75,800.0,771.9,787.1,1893578.0,Lupin Ltd (LUPNY) Q4 2023 Earnings Call Transcript,"Lupin Ltd (OTC:LUPNY) Q4 2023 Earnings Conference Call May 10, 2023 6:30 AM ETCompany ParticipantsVinita Gupta - CEO & Executive DirectorRamesh Swaminathan - Global CFO, Head Corporate...",neutral,neutral,0.555732992654107,neutral,0.0126742712294071,neutral
2023-05-15 09:56:00.000,782.75,800.0,771.9,787.1,1893578.0,"Hot Stocks: Brokerages on HPCL, Manappuram Finance, Dr Lal Pathlabs and Lupin",Jefferies maintained an underperform rating on Hindustan Petroleum Corporation Limited (HPCL) citing weak marketing and transitory refining weakness. CLSA retained a buy rating on Manappuram Finance as yields fell but growth became visible. Credit Suisse upheld an underperform rating on Dr Lal Pathl…,neutral,positive,0.555732992654107,neutral,0.0126742712294071,neutral
2023-05-15 11:23:06.000,782.75,800.0,771.9,787.1,1893578.0,"Lupin extends gain, hits 52-wk high post Q4 results; surges 20% in 1 month",Analysts believe the stock is factoring margin recovery and certain niche launches in the US.,positive,positive,0.555732992654107,neutral,0.0126742712294071,neutral
2023-05-16 01:35:00.000,789.0,796.75,779.25,789.1,1229478.0,Market awaits Lupin’s new product launch | The Financial Express,Company anticipates Ebitda margin boost from gSpiriva in August.,positive,positive,0.0126742712294071,neutral,-0.7931472081218274,neutral
2023-05-25 18:06:32.000,778.85,783.6,773.2,780.55,368807.0,Lupin Diagnostics opens satellite lab in Vijayawada,The expansion move is part of the Lupin Diagnostics’ aim at enhancing access to high-quality testing services and increasing the diagnostics network across the country.,neutral,positive,0.2182705270591169,neutral,2.2272986864648714,positive
2023-05-29 09:02:27.000,787.95,811.7,780.0,805.5,1893649.0,"Stocks to watch on May 29, 2023","Buzzing stocks: RITES, PFC, IRCTC, RVNL, Aurobindo Pharma, Sun Pharma, Reliance Industries, Lupin, Alfa Transformers",neutral,neutral,2.2272986864648714,positive,-0.8641975308641975,neutral
2023-05-29 13:53:27.000,810.0,813.75,798.1,803.0,1330739.0,"Lupin Digital Health to expand digital heartcare platform, Lyfe","Lupin Digital Health plans to expand its digital therapeutics platform to 33 cities in the next three to four months. LDH has already reached out to cardiologists in 21 cities and plans to cover 80% of them by September. The subscription-based program costs between ₹6,000 to ₹25,000 per year, depen…",positive,positive,-0.8641975308641975,neutral,-0.0186069590026641,neutral
2023-05-29 14:39:14.000,810.0,813.75,798.1,803.0,1330739.0,"Lupin arm secures Health Canada nod for Spiriva generic version, shares rise 3.12%",Lupin’s Canadian arm has received approval from Health Canada to market a generic version of Spiriva (tiotropium bromide inhalation powder) in the country.,positive,positive,-0.8641975308641975,neutral,-0.0186069590026641,neutral
2023-05-29 23:11:42.000,810.0,813.75,798.1,803.0,1330739.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the OI percentage, 87 stocks, including Astral, Lupin, Indiabulls Housing Finance, Titan Company and National Aluminimum Company, saw long build-ups.",neutral,neutral,-0.8641975308641975,neutral,-0.0186069590026641,neutral
2023-05-30 20:36:00.000,806.15,813.0,801.25,806.0,1120424.0,Lupin launches biosimilar cetuximab in pact with Enzene,Cetuximab has received approval from the Drug Controller General of India (DCGI) for its effectiveness in treating head and neck cancer,neutral,positive,-0.0186069590026641,neutral,0.9305210918114144,positive
2023-05-31 00:07:00.000,806.15,813.0,801.25,806.0,1120424.0,Lupin Partners Enzene to roll out biosimilar Cetuximab here,"In July 2009, the US Food and Drug Administration (USFDA) approved Eli Lilly and Merck’s cetuximab (Erbitux) for treatment of metastatic colorectal cancer and head and neck cancer. Head and neck cancer presents a significant public health challenge in India, with a staggering annual incidence of ove…",neutral,positive,-0.0186069590026641,neutral,0.9305210918114144,positive
2023-05-31 05:00:00.000,806.15,813.0,801.25,806.0,1120424.0,"Stocks To Watch: Adani Ports, Welspun Corp, Patanjali Foods, Coal India, Axis Bank, HDFC AMC, Lupin",Stocks to watch before going into trade today.,neutral,neutral,-0.0186069590026641,neutral,0.9305210918114144,positive
2023-05-31 07:32:52.000,806.15,813.0,801.25,806.0,1120424.0,"Buzzing Stocks: Lupin, HDFC Life, Mazagon Dock, Adani Ports, Ador Welding, others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,-0.0186069590026641,neutral,0.9305210918114144,positive
2023-05-31 08:50:26.000,806.15,813.0,801.25,806.0,1120424.0,"Stocks to watch on May 31, 2023","Buzzing stocks: Coal India, Sona BLW, HDFC Life Insurance, Lupin, HDFC Asset Management, Aurobindo Pharma, Axis Bank, Sun Pharma, Kalpataru Power",neutral,neutral,-0.0186069590026641,neutral,0.9305210918114144,positive
2023-05-31 18:59:30.000,806.0,817.35,805.0,813.5,902055.0,Two Indian drugmakers to sell first biosimilar version of Cetuximab,"Two Indian drug companies, Alkem and Lupin, will now market the first biosimilar version of Cetuximab, indicated for head and neck cancer, for under ₹10,000 a via",neutral,positive,0.9305210918114144,positive,0.5337423312883463,neutral
2023-06-01 10:05:38.000,806.0,817.35,805.0,813.5,902055.0,"Stocks to Watch: Adani Group, TCS, Coal India, Lupin, SAIL, Patanjali Foods and Others","Stocks to watch: Shares of firms like Adani Group, TCS, Coal India, Lupin, SAIL, Patanjali Foods, and others will be in focus on Thursday’s trade.",neutral,neutral,0.9305210918114144,positive,0.5337423312883463,neutral
2023-06-01 15:36:45.000,815.0,820.5,806.1,819.35,584694.0,Pharma major Lupin receives approval from US FDA for diazepam rectal gel,Diazepam Rectal Gel had estimated annual sales of $34 million in the US,positive,neutral,0.5337423312883463,neutral,-0.775757575757573,neutral
2023-06-05 08:47:55.000,825.0,831.35,818.0,818.6,1469960.0,"Stocks to Watch: Tata Motors, Oil Stocks, NTPC, Wipro, Lupin, Tech M, and Others","Stocks to watch: Shares of firms like Tata Motors, Oil Stocks, NTPC, Wipro, Lupin, Tech M, and others will be in focus on Monday’s trade.",neutral,neutral,-0.775757575757573,neutral,-0.0303822081788904,neutral
2023-06-05 09:36:57.000,825.0,831.35,818.0,818.6,1469960.0,Lupin shares hit 52-week high after launch of Darunavir tablets,,positive,neutral,-0.775757575757573,neutral,-0.0303822081788904,neutral
2023-06-05 09:40:39.000,825.0,831.35,818.0,818.6,1469960.0,"Stocks to watch today — June 5, 2023","Railway stocks, NTPC, IOC, Tech Mahindra, Induce Remedies, Vedanta, Lemon Tree Hotels, Lupin, Bajaj Finserv, IPCA Lab, Wonderla Holidays and Indo Rama Synthetics",neutral,neutral,-0.775757575757573,neutral,-0.0303822081788904,neutral
2023-06-05 22:53:13.000,822.85,824.45,814.35,822.6,426389.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the OI percentage, 53 stocks including Oracle Financial, India Cements, Indiabulls Housing Finance, Lupin and Deepak Nitrite saw long buildups.",neutral,neutral,-0.0303822081788904,neutral,-0.5403764420157918,neutral
2023-06-19 12:54:28.000,830.0,831.2,821.6,829.9,419660.0,Lupin launches injection to cure thiamine deficiency in US,The launch follows alliance partner Caplin Steriles receiving an approval for its ANDA (Abbreviated New Drug Application) from the US Food and Drug Administration (USFDA).,neutral,positive,-0.012048192771087,neutral,5.168269230769231,positive
2023-06-19 13:15:00.000,830.0,831.2,821.6,829.9,419660.0,Pharma major Lupin launches injection to cure thiamine deficiency in US,Pharmaceutical company Lupin on Monday announced that it has launched its generic Thiamine Hydrochloride injection 200 mg/2 mL (100 mg/mL) multiple-dose vials used for treatment of thiamine deficiency in the US. The launch follows alliance partner Caplin Steriles receiving an approval for its ANDA …,neutral,positive,-0.012048192771087,neutral,5.168269230769231,positive
2023-06-19 15:42:54.000,830.0,831.2,821.6,829.9,419660.0,Lupin Vizag: Pharma major Lupin gets establishment inspection report from USFDA,"Lupin Limited received an inspection classification of “No Action Indicated” (NAI) after the inspection, which was conducted between March 6 to March 10",neutral,neutral,-0.012048192771087,neutral,5.168269230769231,positive
2023-06-20 09:12:13.000,830.0,831.2,821.6,829.9,419660.0,"Stocks to watch today — June 20, 2023","HDFC Asset Management, Indigo, HDFC, IIFL Securities, ITC, 3i Infotech, ITI, Royal Orchid, Lupin, Zydus LifeSciences, Easymytrip, Olectra Greenwich, Arihant Superstructures, Isgec Heavy, Bharat Agri, PVP Ventures, HPCL, Som Distilleries, Timken India, Aether Industries",neutral,neutral,-0.012048192771087,neutral,5.168269230769231,positive
2023-06-20 16:33:16.000,832.0,885.3,829.05,875.0,5767243.0,Lupin signs MoU with Maharashtra govt to combat rising prevalence of CVD,"Collaboration to enhance healthcare services, ensure timely diagnosis, and improve accessibility of healthcare services",positive,positive,5.168269230769231,positive,-2.2958743310892507,negative
2023-06-21 08:40:02.000,832.0,885.3,829.05,875.0,5767243.0,"Stocks to Watch: Coal India, Lupin, HDFC Life, RVNL, BEL, Pidilite, and Others - News18","Stocks to watch: Shares of firms like Coal India, Lupin, HDFC Life, RVNL, BEL, Pidilite, and others will be in focus on Wednesday’s trade.",neutral,neutral,5.168269230769231,positive,-2.2958743310892507,negative
2023-06-21 09:08:35.000,832.0,885.3,829.05,875.0,5767243.0,"Stocks to watch today — June 21, 2023","BEL, Piramal Enterprises, Shriram Finance, HDFC, RVNL, Aptech, Airtel, NBCC (India), Lupin, QGO Finance, Dynacons, Madhav Infra, Pidilite, Tamilnadu Petroproducts, Vivanta Ind",neutral,neutral,5.168269230769231,positive,-2.2958743310892507,negative
2023-06-21 14:17:51.000,868.95,868.95,835.0,849.0,3852727.0,Lupin hits 52-wk high; rallies 7% on US FDA nod for key respiratory drug,"Lupin has received US FDA nod for Tiotropium Bromide Inhalation Powder in the strength of 18 mcg per capsule. The drug is a generic equivalent of Spiriva HandiHaler, used for pulmonary patients",positive,neutral,-2.2958743310892507,negative,0.6518292324857542,neutral
2023-06-21 14:25:47.000,868.95,868.95,835.0,849.0,3852727.0,Lupin Shares Hit 52-Week High On Much-Awaited Drug Nod By U.S. FDA,"The drug will be manufactured at Lupin’s Pithampur facility in India, it said in an exchange filing.",neutral,neutral,-2.2958743310892507,negative,0.6518292324857542,neutral
2023-06-21 17:30:00.000,868.95,868.95,835.0,849.0,3852727.0,Lupin gets US FDA approval for key respiratory drug Spiriva generic; stock jumps over 5%,This product will be manufactured at Lupin’s Pithampur facility in India,positive,neutral,-2.2958743310892507,negative,0.6518292324857542,neutral
2023-06-21 20:36:26.000,868.95,868.95,835.0,849.0,3852727.0,"Lupin’s gSpiriva approval: Good addition, but factored into valuations","Lupin on Wednesday announced US FDA approval for gSpiriva Handihaler, a respiratory product with innovator sales of $1.2 billion in the US last year. For FY24, Lupin should be able to generate $70-100 million (₹500-800 crore) from the product, assuming 50-per cent price erosion and gradual increase …",neutral,positive,-2.2958743310892507,negative,0.6518292324857542,neutral
2023-06-22 10:49:52.000,868.95,868.95,835.0,849.0,3852727.0,Lupin - gSpiriva Approval An Overall Turnaround In The Business: Axis Securities,This is the first generic version of Spiriva that provides edge for Lupin to garner higher market share.,neutral,positive,-2.2958743310892507,negative,0.6518292324857542,neutral
2023-06-22 11:08:26.000,868.95,868.95,835.0,849.0,3852727.0,Sell Lupin; target of Rs 740: ICICI Securities,"ICICI Securities is bearish on Lupin has recommended sell rating on the stock with a target price of Rs 740 in its research report dated June 22, 2023.",neutral,negative,-2.2958743310892507,negative,0.6518292324857542,neutral
2023-06-22 11:32:41.000,868.95,868.95,835.0,849.0,3852727.0,"Stocks In Focus: Glenmark, Lupin, NTPC, HDFC Life, Metal Stocks And More","Stocks In Focus: Glenmark, Lupin, NTPC, HDFC Life, Metal Stocks And More",neutral,neutral,-2.2958743310892507,negative,0.6518292324857542,neutral
2023-06-22 16:04:23.000,851.45,865.8,846.3,857.0,2170158.0,"Lupin Remains Optimistic About Generic Version Of Spiriva, Even As Shares Decline",The company has guidance for $140 million in revenue from the generic version of Spiriva by FY24.,neutral,neutral,0.6518292324857542,neutral,1.6607423809801296,positive
2023-06-26 11:01:59.000,858.05,875.0,852.35,872.3,970859.0,Reduce Lupin; target of Rs 779: Sharekhan,"Sharekhan recommended reduce rating on Lupin with a target price of Rs 779 in its research report dated June 23, 2023.",neutral,negative,1.6607423809801296,positive,-0.1137656427758816,neutral
2023-06-27 08:09:03.000,879.0,889.9,875.0,878.0,1413145.0,"Stocks to Watch: Lupin, Vi, Tech M, Bharti Airtel, Aditya Birla Capital","Stocks to Watch on June 27, 2023: Lupin: As per reports, Lupin is considering a restructuring move to unlock value by demerging its API (active pharmaceutical ingredients) business",neutral,positive,-0.1137656427758816,neutral,1.8383826814042803,positive
2023-06-27 08:15:42.000,879.0,889.9,875.0,878.0,1413145.0,"Stocks to Watch: TCS, Zee Ent, Airtel, Lupin, Sapphire Foods, SBI Life, and Others - News18","Stocks to watch: Shares of firms like TCS, Zee Ent, Airtel, Lupin, Sapphire Foods, SBI Life, and others will be in focus on Tuesday’s trade.",neutral,neutral,-0.1137656427758816,neutral,1.8383826814042803,positive
2023-06-27 09:50:13.000,879.0,889.9,875.0,878.0,1413145.0,Lupin hits 52-week high on buzz of API business demerger,"Lupin’s rival Glenmark Pharma had undergone a similar restructuring when it hived off its API business into a new company, Glenmark Life Sciences.",neutral,neutral,-0.1137656427758816,neutral,1.8383826814042803,positive
2023-06-27 17:30:00.000,873.05,894.0,873.05,889.1,1437414.0,"Lupin undergoing significant tech adoption, upgrade, says pharma major’s top exec","In an interview with BT, Sreeji Gopinathan, Chief Information Officer of Lupin, says cloud technology has provided the firm flexibility in terms of storage of applications like test instances, proof-of-concepts (POCs), and pilots",positive,positive,1.8383826814042803,positive,0.8865447200089751,neutral
2023-06-27 21:06:37.000,873.05,894.0,873.05,889.1,1437414.0,Lupin likely to demerge its active pharmaceutical ingredients business,As such the API business contributes around 7 percent to Lupin’s overall turnover,neutral,neutral,1.8383826814042803,positive,0.8865447200089751,neutral
2023-06-28 12:26:00.000,873.05,894.0,873.05,889.1,1437414.0,Have we missed the bulk of the comeback rally in pharma stocks? Nithya Balasubramanian answers,"“Sun, Cipla, Lupin being market leaders, should be able to do well. Most of these companies have actually added on the Street last year. While all those costs are in the P&L, we are expecting that this year, we will see their productivity improve.”",negative,positive,1.8383826814042803,positive,0.8865447200089751,neutral
2023-06-28 17:36:00.000,873.05,894.0,873.05,889.1,1437414.0,"Vedanta, ACC among 7 stocks with rising delivery percentage and strong volumes","Investors are optimistic about the stock market as several stocks show increased delivery percentages and strong trading volumes. NHPC, Union Bank of India, Vedanta, Lupin, Devyani International, Indian Bank, and ACC have all experienced rising delivery percentages compared to the previous day and m…",positive,positive,1.8383826814042803,positive,0.8865447200089751,neutral
2023-06-29 17:30:00.000,891.1,908.4,890.0,899.0,1147941.0,Lupin receives $25 million from AbbVie to initiate Phase 1 clinical trial for blood cancer treatment,Lupin’s Novel Drug Discovery and Development (NDDD) team is focused on building a pipeline of highly differentiated and innovative new chemical entities in the field of oncology,neutral,neutral,0.8865447200089751,neutral,-1.0709133281544754,negative
2023-06-29 17:31:29.000,891.1,908.4,890.0,899.0,1147941.0,Lupin gets $25 mn from AbbVie for meeting key product development milestone,Drug firm Lupin on Thursday said it has received USD 25 million (around Rs 205 crore) from AbbVie Inc for meeting a key development milestone for a product to treat hematological cancers.,neutral,positive,0.8865447200089751,neutral,-1.0709133281544754,negative
2023-06-29 18:34:00.000,891.1,908.4,890.0,899.0,1147941.0,Lupin gets USD 25 million from AbbVie for meeting key product development milestone,"The company has achieved a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program that is partnered with AbbVie Inc towards treatment across a range of hematological cancers, the Mumbai-based drug maker said in a statement.",neutral,positive,0.8865447200089751,neutral,-1.0709133281544754,negative
2023-06-29 21:58:16.000,891.1,908.4,890.0,899.0,1147941.0,Lupin gets $25 million from AbbVie for advancing cancer treatment research,"Lupin receives a $25 million milestone payment from AbbVie for successful Phase 1 clinical trials of its novel oncology product targeting hematological cancers. The licensing agreement grants Lupin commercial rights, while AbbVie has exclusive global development rights for Lupin’s MALT1 inhibitor.",neutral,positive,0.8865447200089751,neutral,-1.0709133281544754,negative
2023-06-30 08:49:38.000,891.1,908.4,890.0,899.0,1147941.0,"Stocks to watch on June 30, 2023","Buzzing stocks of TCS, ICICI Securities, ICICI Bank, JK Tyre, BPCL, MCX, Canara Bank, Tata Communications, Zydus Life, ICRA, Lupin, Bajaj Healthcare, United Nilgiri, P&G, Coromandel International",neutral,neutral,0.8865447200089751,neutral,-1.0709133281544754,negative
2023-07-03 16:52:37.000,899.95,902.9,887.8,892.5,557947.0,Lupin receives US regulator’s approval for Cyanocobalamin nasal spray |,The nasal spray manufactured by Lupin is a generic version of Nascobal nasal spray,positive,neutral,-0.8278237679871153,neutral,-0.300467393723575,neutral
2023-07-03 21:30:17.000,899.95,902.9,887.8,892.5,557947.0,Lupin Gets U.S. FDA Nod For Cyanocobalamin Nasal Spray,Cyanocobalamin nasal spray is used to maintain normal vitamin B12 blood levels in patients with pernicious anaemia.,neutral,neutral,-0.8278237679871153,neutral,-0.300467393723575,neutral
2023-07-04 08:57:00.000,899.95,902.9,887.8,892.5,557947.0,Stocks that will see action today (July 4),"Stocks to watch on July 4 include Reliance Industries, Tube Investments, IDFC First Bank, IDFC, Biocon, Anupam Rasayan, Lupin, IndusInd Bank, Eris Lifesciences, Genus Power, SRG Housing, Waaree Renewables",neutral,neutral,-0.8278237679871153,neutral,-0.300467393723575,neutral
2023-07-04 10:07:07.000,899.95,902.9,887.8,892.5,557947.0,Lupin share price gains on USFDA approval for nasal spray,Lupin has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application for Cyanocobalamin Nasal Spray.,positive,positive,-0.8278237679871153,neutral,-0.300467393723575,neutral
2023-07-05 06:41:35.000,898.6,902.5,892.35,895.9,711344.0,"Buzzing Stocks: SBI, BHEL, LTIMindtree, Aurobindo Pharma, Lupin, others in focus",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,-0.300467393723575,neutral,0.5222512361797801,neutral
2023-07-05 08:03:08.000,898.6,902.5,892.35,895.9,711344.0,"Stocks to Watch today, July 5: LTIMindtree, Bandhan Bk, Lupin, Adani Power","Stocks to Watch on Wednesday, July 5: LTIMindtree will replace HDFC in the benchmark Nifty50 index, while LIC Housing Finance will likely replace it in the Nifty Financial Services index",neutral,neutral,-0.300467393723575,neutral,0.5222512361797801,neutral
2023-07-05 08:44:52.000,898.6,902.5,892.35,895.9,711344.0,"Stocks to Watch: LTIMindtree, SBI, RBL Bank, Bandhan Bank, Lupin, AU SFB, and Others - News18","Stocks to watch: Shares of firms like LTIMindtree, SBI, RBL Bank, Bandhan Bank, Lupin, AU SFBs, and others will be in focus on Wednesday’s trade.",neutral,neutral,-0.300467393723575,neutral,0.5222512361797801,neutral
2023-07-05 10:29:14.000,898.6,902.5,892.35,895.9,711344.0,Lupin shares trade higher after US FDA approval to sell HIV drug,"Lupin Limited’s total revenue increased 1 percent year-on-year to Rs 16,715 crore in FY23. The drug maker made a profit of Rs 430 crore in FY23 as compared to a loss of Rs 1528 crore in FY22.",positive,positive,-0.300467393723575,neutral,0.5222512361797801,neutral
2023-07-11 20:18:00.000,930.0,942.95,915.05,940.35,2260182.0,"Lupin gets EIR for Pithampur Unit-2, paves way for resolving warning letter","The EIR represents the closure of the inspection, and also paves the way for possible lifting of warning letters on the facility imposed by the US drug regulator. VAI means the facility is generally in compliance, with only minor violations that do not meet the threshold for action. Lupins Indore Un…",positive,neutral,1.1129032258064542,positive,-1.2599681020733675,negative
2023-07-12 05:00:00.000,930.0,942.95,915.05,940.35,2260182.0,"Stocks To Watch: Delta Corp, Adani Enterprises, PVR-Inox, Lupin, Nazara Technologies",Here are the stocks to watch before going into trade today.,neutral,neutral,1.1129032258064542,positive,-1.2599681020733675,negative
2023-07-12 09:11:48.000,930.0,942.95,915.05,940.35,2260182.0,"Stocks In Focus: Adani, Indian Hotels, Lupin, Kalpataru, in news Today","Buzzing stocks: Adani group, Lupin, gaming stocks (Nazara Zensar, Delta), Happiest Minds, Indian Hotels, Hindustan Oil Exploration, Kalpataru, Schaeffler India, Usha Martin, Kinetic Engineering, 3i Infotech, STL, Wanbury",neutral,neutral,1.1129032258064542,positive,-1.2599681020733675,negative
2023-07-12 17:30:00.000,940.5,942.1,921.9,928.65,1063220.0,"Stocks in news: TCS, Nazara Technologies, Delta Corp, PVR Inox and more","Stocks to watch out for today: TCS, Nazara Technologies, Delta Corp, PVR Inox, Lupin and more",neutral,neutral,-1.2599681020733675,negative,-0.1019367991845104,neutral
2023-07-13 05:00:00.000,940.5,942.1,921.9,928.65,1063220.0,"Stocks To Watch: Patanjali, SpiceJet, Titan, Kalyan, JSW Steel, Aurobindo, Hindalco, Brigade, Lupin",Here are the stocks to watch before going into trade today.,neutral,neutral,-1.2599681020733675,negative,-0.1019367991845104,neutral
2023-07-13 08:30:00.000,940.5,942.1,921.9,928.65,1063220.0,USFDA issues Form-483 with two observations for Lupin’s Nagpur plant,Lupin’s Nagpur facility has received two observations from the USFDA through Form-483 due to violations of the Food Drug and Cosmetic (FD&C) Act and related Acts. The company assured that it would resolve the issues raised and is confident of doing so soon. The USFDA conducted an inspection of the f…,neutral,neutral,-1.2599681020733675,negative,-0.1019367991845104,neutral
2023-07-13 09:34:31.000,940.5,942.1,921.9,928.65,1063220.0,Lupin share price falls as USFDA issues 2 observations for Nagpur facility,"The share touched a 52-week high of Rs 943.10 and a 52-week low of Rs 602.80 on 12 July, 2023 and 04 August, 2022, respectively.",negative,negative,-1.2599681020733675,negative,-0.1019367991845104,neutral
2023-07-13 19:55:26.000,931.95,934.9,925.35,931.0,601039.0,U.S. FDA issues observations on Lupin’s oral solid dosage plant in Nagpur,"Pithampur Unit-2 facility inspected from Mar. 21-29, classified as Voluntary Action Indicated",neutral,neutral,-0.1019367991845104,neutral,-0.4322305229455661,neutral
2023-07-17 09:34:52.000,937.0,941.4,931.45,932.95,692654.0,Lupin shares gain on approval from USFDA for chlorpromazine hydrochloride tablets,This product will be manufactured at Lupin’s Somerset facility in the US.,positive,neutral,-0.4322305229455661,neutral,0.0695633561643811,neutral
2023-07-18 22:17:16.000,935.0,941.9,929.25,932.45,333961.0,Three Indian firms line up to make TB drug Bedaquiline as patent expires,"As the primary patent on Tuberculosis drug Bedaquiline expires in India and other countries on Tuesday, at least three Indian companies — Lupin, Natco and Macleods — are poised to bring out their generic versions of the drug",positive,positive,-0.2727272727272678,neutral,1.0737753085100652,positive
2023-07-21 09:28:45.000,944.5,947.45,933.25,933.7,416677.0,U.S. FDA Flags Two Lapses At Lupin’s Oral Solid Dosage Facility In Nagpur,The US FDA had inspected the Nagpur facility from July 3 to July 11.,neutral,neutral,-1.1434621492853312,negative,-0.0106632544252408,neutral
2023-07-21 15:13:00.000,944.5,947.45,933.25,933.7,416677.0,Lupin unit introduces inhaler for asthma patients in Germany,"Drug firm Lupin on Friday said its unit has launched a pressurized metered dose inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD) in Germany. Hormosan Pharma GmbH, a wholly-owned subsidiary of the company in Germany, has introduced Luforbec in the European nation, …",neutral,positive,-1.1434621492853312,negative,-0.0106632544252408,neutral
2023-07-24 09:53:46.000,937.8,944.85,933.8,937.7,420566.0,Lupin share price rises on tentative USFDA approval for HIV drug,The Dolutegravir Lamivudine and Tenofovir Alafenamide tablets will be manufactured at Lupin’s Nagpur facility.,positive,neutral,-0.0106632544252408,neutral,0.0053307745615389,neutral
2023-07-24 12:24:14.000,937.95,944.15,931.5,938.0,254050.0,"Stocks that will see action: July 24, 2024","Deccan Gold Mines Ltd, Brightcom Group, Naukri Internet Services, SoftTech Engineers, Hikal Ltd, SJVN Ltd, Lupin, Power Finance Corp, Aurobindo Pharma, Biocon, Arunachal Pradesh, Aarti Drugs, Trident, GNA Axles, Jaykay Enterprises, Equipp Social Impact Tech & SenecaGlobal form JV, & Results Calendar…",neutral,neutral,0.0053307745615389,neutral,0.1965993623804487,neutral
2023-07-25 10:20:02.000,937.95,944.15,931.5,938.0,254050.0,Lupin collaborates with American College of Cardiology to offer patients and caregivers at-home solutions,"Lupin Digital Health has partnered with the American College of Cardiology (ACC) to introduce at-home cardiovascular care using their digital therapeutics platform, Lyfe, in India. Lyfe employs artificial intelligence and machine learning to offer personalised patient experiences. With India facing …",positive,positive,0.0053307745615389,neutral,0.1965993623804487,neutral
2023-07-26 16:03:03.000,956.0,990.15,941.05,980.6,3298171.0,Lupin Receives Approval from TGA Australia For Tiotropium Dry Powder,The product will be manufactured at Lupin’s Pithampur facility in India.,neutral,neutral,2.573221757322178,positive,-1.010152284263964,negative
2023-07-27 17:58:00.000,985.0,991.0,966.25,975.05,1121554.0,Lupin says USFDA warning on Goa and Pithampur facilities are resolved,"Lupin on Thursday said it has received correspondence from the USFDA that it has now addressed the concerns raised in the Warning Letter for its facilities in Goa and Pithampur Unit-2, Indore. Nilesh Gupta, MD of Lupin, said, “We are pleased to be informed by the USFDA that we have addressed the con…",positive,positive,-1.010152284263964,negative,1.1984980196492043,positive
2023-07-28 09:44:22.000,985.0,991.0,966.25,975.05,1121554.0,Lupin shares hit 52-week high post satisfactory evaluation by USFDA,"On July 14, the company’s subsidiary, Lupin Inc., based in Somerset, New Jersey, received USFDA approval for Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg.",positive,positive,-1.010152284263964,negative,1.1984980196492043,positive
2023-07-28 12:52:34.000,985.0,991.0,966.25,975.05,1121554.0,"Stocks In Focus: M&M, ACC, Cipla, Lupin, DRL and More","Stocks In Focus: M&M, ACC, Cipla, Lupin, DRL and More",neutral,neutral,-1.010152284263964,negative,1.1984980196492043,positive
2023-07-28 17:34:00.000,985.0,991.0,966.25,975.05,1121554.0,"Tata Communications, Godrej Properties, 6 other midcap stocks cross new 52-week high","Eight BSE MidCap stocks achieved new 52-week highs on the latest trading day. Godrej Properties and Oberoi Realty take the lead, accompanied by other prominent companies like Lupin and Tata Communications, reflecting positive market momentum and growth potential.",neutral,positive,-1.010152284263964,negative,1.1984980196492043,positive
2023-08-01 08:40:56.000,984.8,994.9,976.7,987.5,779196.0,"Stocks to Watch: PVR Inox, Maruti, ITC, SBI, Power Grid, Lupin, and Others - News18","Stocks to watch: Shares of firms like PVR Inox, Maruti, ITC, SBI, Power Grid, Lupin, and others will be in focus on Tuesday’s trade.",neutral,neutral,0.2741673436230752,neutral,0.7041183324046447,neutral
2023-08-02 11:32:20.000,987.05,998.7,975.0,994.0,863176.0,"Lupin Q1 Preview: Healthy US sales, favourable base to lift earnings","Easing headwinds which dragged Lupin’s financials in the base quarter, along with healthy sales in the US are likely to lift financials for the drugmaker in Q1.",positive,positive,0.7041183324046447,neutral,3.4307560742491985,positive
2023-08-02 13:43:26.000,993.95,1040.85,988.0,1028.05,3957791.0,Lupin bags USFDA approval for Turqoz tablets,"Lupin Limited granted USFDA approval for Turqoz (norgestrel & ethinyl estradiol tablets USP) 0.3 mg/0.03 mg, allowing them to market a generic version of Wyeth Pharmaceuticals LLC’s Lo/Ovral-28. Estimated annual sales of $34 million in US. Shares fell 0.73% to Rs 981 on BSE.",positive,negative,3.4307560742491985,positive,2.896518375241784,positive
2023-08-02 14:57:00.000,993.95,1040.85,988.0,1028.05,3957791.0,Lupin gets USFDA nod to market generic skin treatment medication,Lupin said its American subsidiary has received an approval from the US health regulator to market a generic product used for treatment of skin issues. New Jersey-based Novel Laboratories Inc has received the approval from the US Food and Drug Administration (USFDA) for Fluocinolone Acetonide Topica…,neutral,positive,3.4307560742491985,positive,2.896518375241784,positive
2023-08-02 22:27:37.000,993.95,1040.85,988.0,1028.05,3957791.0,Lupin’s U.S. arm recalls contraceptive after out of specifications results,Lupin is voluntarily recalling them since significant reduction in the amount of inactive content (ascorbic acid) could potentially impact the effectiveness of the product,neutral,negative,3.4307560742491985,positive,2.896518375241784,positive
2023-08-03 05:00:00.000,993.95,1040.85,988.0,1028.05,3957791.0,"Sun Pharma, Lupin, Bharti Airtel, Dabur India, Zomato Q1 Results Today — Earnings Estimates",Here are the earnings estimates of major companies that are scheduled to announce their Q1 results on Thursday.,neutral,neutral,3.4307560742491985,positive,2.896518375241784,positive
2023-08-03 17:30:00.000,1034.0,1078.45,1011.1,1063.95,4959387.0,"Ashok Leyland, Lupin, Federal Bank among top 4 midcap picks of Axis Securities with up to 21% upside potential",Fitch downgraded the US government’s top credit rating. Fitch’s latest move led to havoc as bears dragged the indices lower.,positive,negative,2.896518375241784,positive,1.349451785212266,positive
2023-08-03 22:13:45.000,1034.0,1078.45,1011.1,1063.95,4959387.0,"Lupin Q1 results: Net profit at Rs 453.33 crore from year-ago loss, tops Street estimates",The Street had pegged Lupin’s net profit at Rs 276.2 crore for the April- June quarter,positive,neutral,2.896518375241784,positive,1.349451785212266,positive
2023-08-04 08:41:46.000,1034.0,1078.45,1011.1,1063.95,4959387.0,"Stocks to Watch: SBI, Zomato, Vedanta, Eicher Motors, Airtel, Paytm, Lupin, and Others - News18","Stocks to watch: Shares of firms like SBI, Zomato, Vedanta, Eicher Motors, Airtel, Paytm, Lupin, and others will be in focus on Friday’s trade.",neutral,neutral,2.896518375241784,positive,1.349451785212266,positive
2023-08-04 11:35:24.000,1034.0,1078.45,1011.1,1063.95,4959387.0,"Stocks In Focus | Zomato, Dabur, Lupin, SBI, Eicher Motors","Stocks In Focus | Zomato, Dabur, Lupin, SBI, Eicher Motors #StocksInFocus | Sharmila Joshi shares insight on #Zomato, #Dabur, #SBI and other stocks to watch as markets recover from lows.",neutral,positive,2.896518375241784,positive,1.349451785212266,positive
2023-08-04 12:44:53.000,1034.0,1078.45,1011.1,1063.95,4959387.0,"Lupin Standalone June 2023 Net Sales at Rs 3,495.64 crore, up 27.93% Y-o-Y",,positive,neutral,2.896518375241784,positive,1.349451785212266,positive
2023-08-04 14:00:00.000,1034.0,1078.45,1011.1,1063.95,4959387.0,What triggered Lupin’s growth spurt & can it be sustained?,"“From Q2 onwards, we expected to get back to double digit growth and are very happy that it is happening in Q1 itself. The growth year on year was 10.2%. In fact, if we take out the Cidmus 50 effect from the base and adjust for price impact, the growth was actually 13.6% – ahead of market growth. An…",neutral,positive,2.896518375241784,positive,1.349451785212266,positive
2023-08-04 18:33:01.000,1034.0,1078.45,1011.1,1063.95,4959387.0,"Lupin Allots 10,769 Stock Options To Employees As ESOPs","The 2,545 stock options are allotted under Lupin Subsidiary Companies Employees Stock Option Plan 2011 and 8,224 stock options under Lupin Subsidiary Companies Employees Stock Option Plan 2014.",neutral,neutral,2.896518375241784,positive,1.349451785212266,positive
2023-08-07 09:30:00.000,1067.1,1094.7,1043.5,1081.5,2593871.0,"Buy Lupin, target price Rs 1120: Motilal Oswal Financial Services","Strong run-up in weekly scale with recent breakoutabove 1,000 zones and sector supporting up move.",neutral,neutral,1.349451785212266,positive,-0.2668016008096132,neutral
2023-08-07 10:51:35.000,1067.1,1094.7,1043.5,1081.5,2593871.0,Lupin Shares Rise After Brokerages Hike Target Price,Jefferies maintains ‘buy’ rating with a revised target price of Rs 810 from Rs 610.,neutral,positive,1.349451785212266,positive,-0.2668016008096132,neutral
2023-08-07 21:25:54.000,1086.95,1094.5,1071.4,1084.05,1132811.0,Hold Lupin; target of Rs 1010: Prabhudas Lilladher,"Prabhudas Lilladher recommended hold rating on Lupin with a target price of Rs 1010 in its research report dated August 06, 2023.",neutral,positive,-0.2668016008096132,neutral,0.4616298733945751,neutral
2023-08-08 11:30:41.000,1086.95,1094.5,1071.4,1084.05,1132811.0,Hold Lupin; target of Rs 1181: Sharekhan,"Sharekhan recommended Hold rating on Lupin with a target price of Rs 1181 in its research report dated August 05, 2023.",neutral,positive,-0.2668016008096132,neutral,0.4616298733945751,neutral
2023-08-08 20:13:00.000,1093.95,1109.0,1086.85,1099.0,1693191.0,Lupin Digital Health launches first-of-its-kind digital heart failure clinic,"The digital clinic provides in-clinic consultation with at-home patient monitoring and care. A team of experts, including paramedics, nurses, cardio-therapists, health coaches and care managers, work together with the treating cardiologist to deliver improved patient health outcomes.",neutral,positive,0.4616298733945751,neutral,-1.5653357531760437,negative
2023-08-09 05:00:00.000,1093.95,1109.0,1086.85,1099.0,1693191.0,"Stocks To Watch: Inox Wind Energy, Lupin, Tata Power, IRCTC, Berger Paints, Coal India, Siemens, Oil India",Here are the stocks to watch before going into trade today.,neutral,neutral,0.4616298733945751,neutral,-1.5653357531760437,negative
2023-08-09 06:56:38.000,1093.95,1109.0,1086.85,1099.0,1693191.0,"Buzzing Stocks: Coal India, Lupin, Zee Learn, Oil India, Prestige Estates, others in news",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,0.4616298733945751,neutral,-1.5653357531760437,negative
2023-08-09 08:25:11.000,1093.95,1109.0,1086.85,1099.0,1693191.0,"Focus on Adani Enterprises, Adani Wilmar, Singer India, CCI, Netlink Solutions, Lupin, Capital India Finance, Power Grid, Aarti Drugs, Zee Learn, Abbott India & More Ahead of Q2 Earnings on August 9",Adani Ent. & Adani Wilmar to remain in focus as former explores selling stake. Singer India suspends BIS Certification Marks License. CCI approves HDFC Credila Financial Services’ acquisition. Netlink Solutions to open subsidiary in USA. Lupin’s US-based subsidiary gets US FDA approval. Capital Indi…,neutral,neutral,0.4616298733945751,neutral,-1.5653357531760437,negative
2023-08-09 10:42:00.000,1093.95,1109.0,1086.85,1099.0,1693191.0,Is the comeback in pharma here to stay? Should you buy expensive capital goods stocks?,"“The next few quarters may certainly be very good for pharma companies. But these are no longer the secular growth stories which we have pursued back in the 2000 or 2010 era, when companies like Sun Pharma, Lupin, Dr. Reddy, Cipla were easily growing at 20% plus,” says Dipan Mehta.",neutral,positive,0.4616298733945751,neutral,-1.5653357531760437,negative
2023-08-09 11:29:23.000,1093.95,1109.0,1086.85,1099.0,1693191.0,Lupin gains after new drug approval from US FDA,The pharma major said that its New Jersey-based subsidiary Novel Laboratories has received approval from the US FDA for its abbreviated new drug application for fluocinolone acetonide oil.,positive,positive,0.4616298733945751,neutral,-1.5653357531760437,negative
2023-08-14 08:19:43.000,1080.0,1105.95,1078.0,1080.25,2335735.0,"Stocks that will see action today: August 14, 2023",.SIS Ltd. extends 100% corporate guarantee to 4 subsidiaries; Lupin’s Unit-2 passes US FDA inspection; Alps Industries appoints Jamil Ahmed Khan as CFO; Prism Global Ventures sells 25.75 lakh shares of Prime Flix; Sobhagya Merchantile to raise Rs 25 cr via right issue; Adani Ports & SEX appoints M S…,neutral,neutral,0.0231481481481481,neutral,2.4496736832429327,positive
2023-08-14 09:58:42.000,1080.0,1105.95,1078.0,1080.25,2335735.0,Lupin share price gains as USFDA concludes inspection without observations,"The company had recorded a consolidated net profit of Rs 453.33 crore for the April-June quarter FY24, as against a consolidated net loss of Rs 86.8 crore reported in the same period a year ago.",positive,positive,0.0231481481481481,neutral,2.4496736832429327,positive
2023-08-16 15:52:00.000,1125.0,1143.95,1087.35,1090.45,3196011.0,Lupin gets USFDA nod for Bromfenac Ophthalmic Solution,Pharma major Lupin on Wednesday said it has received approval from the US health regulator to market its generic Bromfenac Ophthalmic Solution used to treat post-operative inflammation in patients who have undergone cataract surgery. The approval by the US Food and Drug Administration (USFDA) is for…,neutral,positive,-3.071111111111107,negative,-2.899079223265583,negative
2023-08-17 07:46:14.000,1125.0,1143.95,1087.35,1090.45,3196011.0,"Stocks that will see action today: August 17, 2023",Lupin launches generic COPD treatment in US; Criisl upgrades Aditya Vision’s rating; Aurobindo gets USFDA nod for HIV drug; Govt to sell part of IRFC stake; Antfin transfers 10.3% stake in One97 to Sharma; PFC gets first full-time women CMD; Nava Ltd suffers accidental damage; Wockhardt shareholder…,neutral,neutral,-3.071111111111107,negative,-2.899079223265583,negative
2023-08-18 19:08:03.000,1096.9,1096.9,1064.1,1065.1,1342996.0,Lupin acquires two brands of diabetes medicines from Boehringer Ingelheim,Drugmaker Lupin has acquired diabetes medicine brands Ondero and Ondero Met from Boehringer Ingelheim International GmbH for ₹235 crore,neutral,positive,-2.899079223265583,negative,2.1575984990619137,positive
2023-08-18 19:40:04.000,1096.9,1096.9,1064.1,1065.1,1342996.0,"Lupin acquires two brands from Boehringer Ingelheim, boosts diabetes portfolio",Lupin acquires diabetes brands ONDERO and ONDERO MET from Boehringer Ingelheim for €26M. Strengthens commitment to providing superior treatment options for diabetes patients. Consolidates position as market leader in anti-diabetes segment.,positive,positive,-2.899079223265583,negative,2.1575984990619137,positive
2023-08-18 21:46:00.000,1096.9,1096.9,1064.1,1065.1,1342996.0,Lupin acquires two diabetes brands from Boehringer Ingelheim,Lupin has been marketing Ondero and Ondero Met since 2015 in the Indian market as part of a co-marketing agreement with Boehringer Ingelheim and the Indian pharma company acquired the two diabetes brands for Rs 235 crore.,neutral,neutral,-2.899079223265583,negative,2.1575984990619137,positive
2023-08-21 21:24:49.000,1091.35,1094.0,1085.95,1091.35,885525.0,Trade setup for Tuesday: Top 15 things to know before the opening bell,"Based on the OI percentage, 81 stocks were on the short-covering list. These included ITC, Granules India, Ipca Laboratories, Lupin, and Atul. A decrease in OI along with a price increase is an indication of short-covering.",neutral,neutral,0.0,neutral,-0.0915750915750915,neutral
2023-08-23 17:30:00.000,1094.45,1100.0,1085.0,1088.0,436923.0,"Is Pharma back on growth track? Here’s why Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma","Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma with up to 19 per cent upside potential.",neutral,positive,-0.5893371099639129,neutral,-1.4207149404216315,negative
2023-08-25 13:52:20.000,1091.0,1093.05,1072.2,1075.5,638065.0,Lupin gets USFDA nod to market generic drug,"The company has received approval from the US Food and Drug Administration (USFDA) to market Pirfenidone tablets in strengths of 267 mg and 801 mg, the Mumbai-based drug maker said in a statement.",neutral,positive,-1.4207149404216315,negative,2.5926441259681874,positive
2023-08-25 14:20:00.000,1091.0,1093.05,1072.2,1075.5,638065.0,Lupin gets USFDA nod to market generic drug for treatment of lung disease,"Lupin on Friday said it has received approval from US FDA to market a generic product, used in the treatment of a lung disease, in the American market. The company has received approval from the US Food and Drug Administration (USFDA) to market Pirfenidone tablets in strengths of 267 mg and 801 mg, …",neutral,positive,-1.4207149404216315,negative,2.5926441259681874,positive
2023-08-31 08:43:12.000,1103.95,1110.0,1090.5,1092.0,1234736.0,"Stocks to Watch: Zomato, BHEL, ZEE, Sula Vineyards, Lupin, Aeroflex, RVNL, and Others - News18","Stocks to watch: Shares of firms like Zomato, BHEL, ZEE, Sula Vineyards, Lupin, Aeroflex, RVNL, and others will be in focus on Thursday’s trade.",neutral,neutral,-1.082476561438475,negative,-0.0912450385510287,neutral
2023-09-07 05:00:00.000,1144.9,1148.75,1128.15,1137.45,823373.0,"Stocks To Watch: TCS, Jio, RIL, Adani Total Gas, Lupin, REC, Tata Consumer Products, 360 One Wam, Biocon",Here are the stocks to watch before going into trade today.,neutral,neutral,-0.6507118525635466,neutral,-1.1811023622047243,negative
